Aldosterone-specific membrane receptors
membrane receptors and
receptors and rapid
and rapid non-genomic
rapid non-genomic actions
non-genomic actions of
actions of mineralocorticoids
Functional studies in
studies in extrarenal
in extrarenal non-epithelial
extrarenal non-epithelial cells
non-epithelial cells such
cells such as
such as smooth
as smooth muscle
smooth muscle cells
muscle cells and
cells and more
and more recently
more recently circulating
recently circulating human
circulating human lymphocytes
human lymphocytes have
lymphocytes have provided
have provided increasing
provided increasing evidence
increasing evidence that
evidence that aldosterone
that aldosterone produces
aldosterone produces not
produces not only
not only classical
only classical genomic
classical genomic effects
genomic effects but
effects but also
but also rapid
also rapid non-genomic
rapid non-genomic effects
non-genomic effects on
effects on transmembrane
on transmembrane electrolyte
transmembrane electrolyte movements
These involve activation
involve activation of
activation of the
of the sodium/proton
the sodium/proton exchanger
sodium/proton exchanger of
exchanger of the
of the cell
the cell membrane
cell membrane at
membrane at very
at very low
very low physiological
low physiological concentrations
physiological concentrations of
concentrations of aldosterone
of aldosterone with
aldosterone with an
with an acute
an acute onset
acute onset within
onset within 1-2
within 1-2 min
A second messenger
second messenger cascade
messenger cascade involved
cascade involved is
involved is the
is the inositol
the inositol 145-trisphosphate/calcium
inositol 145-trisphosphate/calcium pathway
145-trisphosphate/calcium pathway which
pathway which responds
which responds over
responds over the
over the same
the same rapid
same rapid time
rapid time course
Such changes clearly
changes clearly cannot
clearly cannot be
cannot be explained
be explained by
explained by genomic
by genomic mechanisms
genomic mechanisms which
mechanisms which are
which are responsible
are responsible for
responsible for later
for later effects
later effects than
effects than the
than the membrane
the membrane related
membrane related rapid
related rapid responses
The mechanisms underlying
mechanisms underlying these
underlying these rapid
these rapid effects
rapid effects of
effects of aldosterone
of aldosterone on
aldosterone on electrolytes
on electrolytes have
electrolytes have been
have been extensively
been extensively studied
extensively studied in
studied in human
in human lymphocytes
human lymphocytes which
lymphocytes which thus
which thus may
thus may represent
may represent valuable
represent valuable tools
valuable tools in
tools in the
in the delineation
the delineation of
delineation of the
of the receptor-effector
the receptor-effector mechanisms
receptor-effector mechanisms involved
The unique characteristics
unique characteristics of
characteristics of this
of this new
this new pathway
new pathway for
pathway for steroid
for steroid action
steroid action include
action include its
include its rapid
its rapid time
rapid time course
time course 10000-fold
course 10000-fold selectivity
10000-fold selectivity for
selectivity for aldosterone
for aldosterone over
aldosterone over cortisol
over cortisol and
cortisol and the
and the ineffectiveness
the ineffectiveness of
ineffectiveness of spironolactones
of spironolactones classical
spironolactones classical mineralocorticoid
classical mineralocorticoid antagonists
mineralocorticoid antagonists as
antagonists as antagonists
as antagonists of
antagonists of the
of the response
Human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 Nef
1 Nef protein
Nef protein inhibits
protein inhibits NF-kappa
inhibits NF-kappa B
NF-kappa B induction
B induction in
induction in human
in human T
human T cells
Human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 can
HIV-1 can establish
can establish a
establish a persistent
a persistent and
persistent and latent
and latent infection
latent infection in
infection in CD4+
in CD4+ T
CD4+ T lymphocytes
T lymphocytes WCGreene
lymphocytes WCGreene NEnglJ
WCGreene NEnglJ Med324:308-317
NEnglJ Med324:308-317 1991;
Med324:308-317 1991; SMSchnittman
1991; SMSchnittman MCPsallidopoulos
SMSchnittman MCPsallidopoulos HC
MCPsallidopoulos HC Lane
HC Lane LThompson
Lane LThompson MBaseler
LThompson MBaseler FMassari
MBaseler FMassari CHFox
FMassari CHFox NPSalzman
CHFox NPSalzman and
NPSalzman and ASFauci
and ASFauci Science
ASFauci Science 245:305-308
Science 245:305-308 1989
Production of HIV-1
of HIV-1 from
HIV-1 from latently
from latently infected
latently infected cells
infected cells requires
cells requires host
requires host cell
host cell activation
cell activation by
activation by T-cell
by T-cell mitogens
T-cell mitogens TFolks
mitogens TFolks DMPowell
TFolks DMPowell MMLightfoote
DMPowell MMLightfoote SBenn
MMLightfoote SBenn MA
SBenn MA Martin
MA Martin and
Martin and ASFauci
and ASFauci Science
ASFauci Science 231:600-602
Science 231:600-602 1986;
231:600-602 1986; DZagury
1986; DZagury J
DZagury J Bernard
J Bernard RLeonard
Bernard RLeonard RCheynier
RLeonard RCheynier MFeldman
RCheynier MFeldman PSSarin
MFeldman PSSarin and
PSSarin and RC
and RC Gallo
RC Gallo Science
Gallo Science 231:850-853
Science 231:850-853 1986
This activation is
activation is mediated
is mediated by
mediated by the
by the host
the host transcription
host transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B [GNabel
B [GNabel and
[GNabel and DBaltimore
and DBaltimore Nature
DBaltimore Nature London
Nature London 326:711-717
London 326:711-717 1987]
We report here
report here that
here that the
that the HIV-1-encoded
the HIV-1-encoded Nef
HIV-1-encoded Nef protein
Nef protein inhibits
protein inhibits the
inhibits the induction
the induction of
induction of NF-kappa
of NF-kappa B
NF-kappa B DNA-binding
B DNA-binding activity
DNA-binding activity by
activity by T-
by T- cell
T- cell mitogens
However Nef does
Nef does not
does not affect
not affect the
affect the DNA-binding
the DNA-binding activity
DNA-binding activity of
activity of other
of other transcription
other transcription factors
transcription factors implicated
factors implicated in
implicated in HIV-1
in HIV-1 regulation
HIV-1 regulation including
regulation including SP-1
including SP-1 USF
SP-1 USF URS
USF URS and
URS and NF-AT
Additionally Nef inhibits
Nef inhibits the
inhibits the induction
the induction of
induction of HIV-1-
of HIV-1- and
HIV-1- and interleukin
and interleukin 2-directed
interleukin 2-directed gene
2-directed gene expression
gene expression and
expression and the
and the effect
the effect on
effect on HIV-1
on HIV-1 transcription
HIV-1 transcription depends
transcription depends on
depends on an
on an intact
an intact NF-kappa
intact NF-kappa B-binding
NF-kappa B-binding site
These results indicate
results indicate that
indicate that defective
that defective recruitment
defective recruitment of
recruitment of NF-kappa
of NF-kappa B
NF-kappa B may
B may underlie
may underlie Nef's
underlie Nef's negative
Nef's negative transcriptional
negative transcriptional effects
transcriptional effects on
effects on the
on the HIV-1
the HIV-1 and
HIV-1 and interleukin
and interleukin 2
interleukin 2 promoters
Further evidence suggests
evidence suggests that
suggests that Nef
that Nef inhibits
Nef inhibits NF-kappa
inhibits NF-kappa B
NF-kappa B induction
B induction by
induction by interfering
by interfering with
interfering with a
with a signal
a signal derived
signal derived from
derived from the
from the T-cell
the T-cell receptor
T-cell receptor complex
Expression of c-fos
of c-fos c-jun
c-fos c-jun and
c-jun and jun
and jun B
jun B in
B in peripheral
in peripheral blood
peripheral blood lymphocytes
blood lymphocytes from
lymphocytes from young
from young and
young and elderly
and elderly adults
The expression of
expression of c-fos
of c-fos c-jun
c-fos c-jun and
c-jun and jun
and jun B
jun B proto-oncogenes
B proto-oncogenes was
proto-oncogenes was studied
was studied in
studied in phytohemagglutinin
in phytohemagglutinin PHA
phytohemagglutinin PHA activated
PHA activated peripheral
activated peripheral blood
peripheral blood lymphocytes
blood lymphocytes PBL
lymphocytes PBL from
PBL from young
from young and
young and aged
and aged humans
Specific mRNAs for
mRNAs for c-fos
for c-fos and
c-fos and c-jun
and c-jun were
c-jun were detectable
were detectable within
detectable within 30
within 30 min
30 min after
min after cell
after cell activation
cell activation and
activation and reached
and reached maximal
reached maximal levels
maximal levels within
levels within 2
within 2 h
Both c-fos and
c-fos and jun
and jun B
jun B mRNAs
B mRNAs decreased
mRNAs decreased to
decreased to pre-activation
to pre-activation levels
pre-activation levels within
levels within 6
within 6 h
6 h while
h while c-jun
while c-jun mRNA
c-jun mRNA remained
mRNA remained elevated
In PHA-activated PBL
PHA-activated PBL no
PBL no age-related
no age-related differences
age-related differences were
differences were observed
were observed in
observed in c-fos
in c-fos or
c-fos or jun
or jun B
jun B mRNA
B mRNA expression
However c-jun mRNA
c-jun mRNA levels
mRNA levels decreased
levels decreased significantly
decreased significantly 173
significantly 173 +/-
173 +/- 008
+/- 008 vs
008 vs 116
vs 116 +/-
116 +/- 009
+/- 009 arbitrary
009 arbitrary units
arbitrary units P
units P <
P < 001
< 001 young
001 young vs
young vs old
vs old in
old in PBL
in PBL from
PBL from elderly
from elderly individuals
elderly individuals activated
individuals activated with
activated with PHA
Because previous work
previous work has
work has demonstrated
has demonstrated that
demonstrated that T
that T cells
T cells from
cells from elderly
from elderly individuals
elderly individuals may
individuals may display
may display normal
display normal proliferative
normal proliferative responses
proliferative responses when
responses when activated
when activated via
activated via the
via the anti-CD2
the anti-CD2 pathway
anti-CD2 pathway c-jun
pathway c-jun and
c-jun and jun
and jun B
jun B mRNA
B mRNA expression
mRNA expression was
expression was also
was also studied
also studied in
studied in anti-CD2-activated
in anti-CD2-activated purified
anti-CD2-activated purified T
purified T cells
No age-related differences
age-related differences were
differences were found
were found in
found in the
in the expression
the expression of
expression of either
of either of
either of these
of these two
these two proto-oncogenes
two proto-oncogenes by
proto-oncogenes by anti-CD2
by anti-CD2 activated
anti-CD2 activated T
activated T cells
These results suggest
results suggest that
suggest that the
that the decreased
the decreased IL-2
decreased IL-2 production
IL-2 production and
production and proliferative
and proliferative response
proliferative response displayed
response displayed by
displayed by PHA-activated
by PHA-activated PBL
PHA-activated PBL from
PBL from elderly
from elderly adults
elderly adults may
adults may be
may be related
be related to
related to age-related
to age-related changes
age-related changes in
changes in c-jun
in c-jun mRNA
c-jun mRNA expression
mRNA expression and
expression and in
and in the
in the ratio
the ratio of
ratio of c-fos
of c-fos to
c-fos to c-jun
to c-jun mRNA
Oct2 transactivation from
transactivation from a
from a remote
a remote enhancer
remote enhancer position
enhancer position requires
position requires a
requires a B-cell-restricted
a B-cell-restricted activity
Previous cotransfection experiments
cotransfection experiments had
experiments had demonstrated
had demonstrated that
demonstrated that ectopic
that ectopic expression
ectopic expression of
expression of the
of the lymphocyte-specific
the lymphocyte-specific transcription
lymphocyte-specific transcription factor
transcription factor Oct2
factor Oct2 could
Oct2 could efficiently
could efficiently activate
efficiently activate a
activate a promoter
a promoter containing
promoter containing an
containing an octamer
an octamer motif
Oct2 expression was
expression was unable
was unable to
unable to stimulate
to stimulate a
stimulate a multimerized
a multimerized octamer
multimerized octamer enhancer
octamer enhancer element
enhancer element in
element in HeLa
in HeLa cells
HeLa cells however
We have tested
have tested a
tested a variety
a variety of
variety of Oct2
of Oct2 isoforms
Oct2 isoforms generated
isoforms generated by
generated by alternative
by alternative splicing
alternative splicing for
splicing for the
for the capability
the capability to
capability to activate
to activate an
activate an octamer
an octamer enhancer
octamer enhancer in
enhancer in nonlymphoid
in nonlymphoid cells
nonlymphoid cells and
cells and a
and a B-cell
a B-cell line
Our analyses show
analyses show that
show that several
that several Oct2
several Oct2 isoforms
Oct2 isoforms can
isoforms can stimulate
can stimulate from
stimulate from a
from a remote
a remote position
remote position but
position but that
but that this
that this stimulation
this stimulation is
stimulation is restricted
is restricted to
restricted to B
to B cells
This result indicates
result indicates the
indicates the involvement
the involvement of
involvement of either
of either a
either a B-cell-specific
a B-cell-specific cofactor
B-cell-specific cofactor or
cofactor or a
or a specific
a specific modification
specific modification of
modification of a
of a cofactor
a cofactor or
cofactor or the
or the Oct2
the Oct2 protein
Oct2 protein in
protein in Oct2-mediated
in Oct2-mediated enhancer
Oct2-mediated enhancer activation
Mutational analyses indicate
analyses indicate that
indicate that the
that the carboxy-terminal
the carboxy-terminal domain
carboxy-terminal domain of
domain of Oct2
of Oct2 is
Oct2 is critical
is critical for
critical for enhancer
for enhancer activation
Moreover this domain
this domain conferred
domain conferred enhancing
conferred enhancing activity
enhancing activity when
activity when fused
when fused to
fused to the
to the Oct1
the Oct1 protein
Oct1 protein which
protein which by
which by itself
by itself was
itself was unable
was unable to
unable to stimulate
to stimulate from
stimulate from a
from a remote
a remote position
The glutamine-rich activation
glutamine-rich activation domain
activation domain present
domain present in
present in the
in the amino-terminal
the amino-terminal portion
amino-terminal portion of
portion of Oct2
of Oct2 and
Oct2 and the
and the POU
the POU domain
POU domain contribute
domain contribute only
contribute only marginally
only marginally to
marginally to the
to the transactivation
the transactivation function
transactivation function from
function from a
from a distal
a distal position
The promoter of
promoter of the
of the CD19
the CD19 gene
CD19 gene is
gene is a
is a target
a target for
target for the
for the B-cell-specific
the B-cell-specific transcription
B-cell-specific transcription factor
transcription factor BSAP
The CD19 protein
CD19 protein is
protein is expressed
is expressed on
expressed on the
on the surface
the surface of
surface of all
of all B-lymphoid
all B-lymphoid cells
B-lymphoid cells with
cells with the
with the exception
the exception of
exception of terminally
of terminally differentiated
terminally differentiated plasma
differentiated plasma cells
plasma cells and
cells and has
and has been
has been implicated
been implicated as
implicated as a
as a signal-transducing
a signal-transducing receptor
signal-transducing receptor in
receptor in the
in the control
the control of
control of proliferation
of proliferation and
proliferation and differentiation
Here we demonstrate
we demonstrate complete
demonstrate complete correlation
complete correlation between
correlation between the
between the expression
the expression pattern
expression pattern of
pattern of the
of the CD19
the CD19 gene
CD19 gene and
gene and the
and the B-cell-specific
the B-cell-specific transcription
B-cell-specific transcription factor
transcription factor BSAP
factor BSAP in
BSAP in a
in a large
a large panel
large panel of
panel of B-lymphoid
of B-lymphoid cell
B-lymphoid cell lines
The human CD19
human CD19 gene
CD19 gene has
gene has been
has been cloned
been cloned and
cloned and several
and several BSAP-binding
several BSAP-binding sites
BSAP-binding sites have
sites have been
have been mapped
been mapped by
mapped by in
by in vitro
in vitro protein-DNA
vitro protein-DNA binding
protein-DNA binding studies
In particular a
particular a high-affinity
a high-affinity BSAP-binding
high-affinity BSAP-binding site
BSAP-binding site instead
site instead of
instead of a
of a TATA
a TATA sequence
TATA sequence is
sequence is located
is located in
located in the
in the -30
the -30 promoter
-30 promoter region
promoter region upstream
region upstream of
upstream of a
of a cluster
a cluster of
cluster of heterogeneous
of heterogeneous transcription
heterogeneous transcription start
transcription start sites
Moreover this site
this site is
site is occupied
is occupied by
occupied by BSAP
by BSAP in
BSAP in vivo
in vivo in
vivo in a
in a CD19-expressing
a CD19-expressing B-cell
CD19-expressing B-cell line
B-cell line but
line but not
but not in
not in plasma
in plasma or
plasma or HeLa
or HeLa cells
This high-affinity site
high-affinity site has
site has been
has been conserved
been conserved in
conserved in the
in the promoters
the promoters of
promoters of both
of both human
both human and
human and mouse
and mouse CD19
mouse CD19 genes
CD19 genes and
genes and was
and was furthermore
was furthermore shown
furthermore shown to
shown to confer
to confer B-cell
confer B-cell specificity
B-cell specificity to
specificity to a
to a beta-globin
a beta-globin reporter
beta-globin reporter gene
reporter gene in
gene in transient
in transient transfection
transient transfection experiments
In addition BSAP
addition BSAP was
BSAP was found
was found to
found to be
to be the
be the only
the only abundant
only abundant DNA-binding
abundant DNA-binding activity
DNA-binding activity of
activity of B-cell
of B-cell nuclear
B-cell nuclear extracts
nuclear extracts that
extracts that interacts
that interacts with
interacts with the
with the CD19
the CD19 promoter
Together this evidence
this evidence strongly
evidence strongly implicates
strongly implicates BSAP
implicates BSAP in
BSAP in the
in the regulation
the regulation of
regulation of the
of the CD19
the CD19 gene
Eicosanoids in breast
in breast cancer
breast cancer patients
cancer patients before
patients before and
before and after
and after mastectomy
In 19 patients
19 patients with
patients with a
with a malignant
a malignant breast
malignant breast tumor
breast tumor tumor
tumor tumor tissue
tumor tissue and
tissue and blood
and blood were
blood were taken
were taken to
taken to determine
to determine the
determine the eicosanoid
the eicosanoid profile
eicosanoid profile and
profile and platelet
and platelet aggregation
Values were compared
were compared with
compared with those
with those of
those of patients
of patients with
patients with benign
with benign tumors
benign tumors n
tumors n =
n = 4
= 4 or
4 or undergoing
or undergoing a
undergoing a mammary
a mammary reduction
mammary reduction n
reduction n =
n = 7
Postoperatively blood was
blood was taken
was taken as
taken as well
as well in
well in order
in order to
order to compare
to compare pre-
compare pre- and
pre- and postoperative
and postoperative values
Eicosanoids were measured
were measured in
measured in peripheral
in peripheral blood
peripheral blood monocytes
blood monocytes and
monocytes and mammary
and mammary tissue
mammary tissue by
tissue by means
by means of
means of HPLC;
of HPLC; furthermore
HPLC; furthermore TXA2
furthermore TXA2 6-keto-PGF1
TXA2 6-keto-PGF1 alpha
6-keto-PGF1 alpha and
alpha and PGE2
and PGE2 were
PGE2 were determined
were determined by
determined by RIA
Differences in pre-
in pre- and
pre- and postoperative
and postoperative values
postoperative values of
values of cancer
of cancer patients
cancer patients were
patients were seen
were seen in
seen in plasma
in plasma RIA
plasma RIA values:
RIA values: PGE2
values: PGE2 and
PGE2 and 6-k-PGF1
and 6-k-PGF1 alpha
6-k-PGF1 alpha were
alpha were significantly
were significantly higher
significantly higher preoperatively
higher preoperatively when
preoperatively when compared
when compared with
compared with postoperatively
with postoperatively however
postoperatively however such
however such differences
such differences were
differences were seen
were seen in
seen in the
in the control
the control groups
control groups as
groups as well
Compared to benign
to benign tumor
benign tumor or
tumor or mammary
or mammary reduction
mammary reduction test
reduction test material
test material the
material the eicosanoid
the eicosanoid profile
eicosanoid profile of
profile of tissue
of tissue obtained
tissue obtained from
obtained from malignant
from malignant mammary
malignant mammary tumors
mammary tumors showed
tumors showed important
showed important differences
Except for PGF2
for PGF2 alpha
PGF2 alpha HHT
alpha HHT and
HHT and 15-HETE
and 15-HETE no
15-HETE no detectable
no detectable quantities
detectable quantities of
quantities of eicosanoids
of eicosanoids were
eicosanoids were found
were found in
found in the
in the non-tumor
the non-tumor material
non-tumor material whereas
material whereas in
whereas in the
in the malignant
the malignant tumor
malignant tumor material
tumor material substantial
material substantial quantities
substantial quantities of
quantities of a
of a number
a number of
number of eicosanoid
of eicosanoid metabolites
eicosanoid metabolites were
metabolites were present
Statistically significant correlations
significant correlations could
correlations could be
could be established
be established between
established between patient/histopathology
between patient/histopathology data
patient/histopathology data and
data and the
and the results
the results of
results of the
of the platelet
the platelet aggregation
platelet aggregation assays
aggregation assays eg
assays eg between
eg between menopausal
between menopausal status
menopausal status and
status and ADP
and ADP aggregation;
ADP aggregation; oestrogen
aggregation; oestrogen receptor
oestrogen receptor +/-
receptor +/- and
+/- and collagen
and collagen and
collagen and arachidonic
and arachidonic acid
arachidonic acid aggregation
acid aggregation inflammatory
aggregation inflammatory cell
inflammatory cell infiltration
cell infiltration score
infiltration score and
score and arachidonic
and arachidonic acid
arachidonic acid aggregation
acid aggregation and
aggregation and fibrosis
and fibrosis score
fibrosis score and
score and ADP
and ADP aggregation
The results show
results show that
show that eicosanoid
that eicosanoid synthesis
eicosanoid synthesis in
synthesis in material
in material from
material from mammary
from mammary cancer
mammary cancer patients
cancer patients is
patients is different
is different from
different from that
from that in
that in benign
in benign mammary
benign mammary tissue
The implications in
implications in particular
in particular in
particular in relation
in relation to
relation to future
to future prognosis
future prognosis of
prognosis of the
of the patient
the patient remain
patient remain obscure
Mineralocorticoids and mineralocorticoid
and mineralocorticoid receptors
mineralocorticoid receptors in
receptors in mononuclear
in mononuclear leukocytes
mononuclear leukocytes in
leukocytes in patients
in patients with
patients with pregnancy-induced
with pregnancy-induced hypertension
To examine the
examine the role
the role of
role of mineralocorticoids
of mineralocorticoids in
mineralocorticoids in the
in the pathophysiology
the pathophysiology of
pathophysiology of pregnancy-induced
of pregnancy-induced hypertension
pregnancy-induced hypertension PIH
hypertension PIH we
PIH we studied
we studied plasma
studied plasma aldosterone
plasma aldosterone and
aldosterone and 18-hydroxycorticosterone
and 18-hydroxycorticosterone levels
18-hydroxycorticosterone levels in
levels in 25
in 25 women
25 women with
women with PIH
with PIH and
PIH and 25
and 25 normal
25 normal pregnant
normal pregnant women
pregnant women as
women as controls
Furthermore we evaluated
we evaluated the
evaluated the mineralocorticoid
the mineralocorticoid receptor
mineralocorticoid receptor MR
receptor MR status
MR status in
status in mononuclear
in mononuclear leukocytes
mononuclear leukocytes in
leukocytes in the
in the 2
the 2 groups
MR count was
count was significantly
was significantly P
significantly P less
P less than
less than 00005
than 00005 decreased
00005 decreased in
decreased in the
in the PIH
the PIH group
PIH group 148
group 148 +/-
148 +/- 9
+/- 9 binding
9 binding sites/cell
binding sites/cell compared
sites/cell compared with
compared with the
with the control
the control group
control group 300
group 300 +/-
300 +/- 17
+/- 17 binding
17 binding sites/cell;
binding sites/cell; mean
sites/cell; mean +/-
mean +/- SEM
Plasma aldosterone in
aldosterone in women
in women with
women with PIH
with PIH was
PIH was 281
was 281 +/-
281 +/- 61
+/- 61 pmol/L;
61 pmol/L; in
pmol/L; in normal
in normal pregnant
normal pregnant women
pregnant women it
women it was
it was 697
was 697 +/-
697 +/- 172
+/- 172 pmol/L
172 pmol/L P
pmol/L P less
P less than
less than 0025
Plasma 18-hydroxycorticosterone was
18-hydroxycorticosterone was also
was also significantly
also significantly P
significantly P less
P less than
less than 0025
than 0025 lower
0025 lower PIH
lower PIH 1071
PIH 1071 +/-
1071 +/- 149
+/- 149 pmol/L;
149 pmol/L; controls
pmol/L; controls 1907
controls 1907 +/-
1907 +/- 318
+/- 318 pmol/L
These values were
values were determined
were determined at
determined at the
at the onset
the onset of
onset of clinical
of clinical symptoms
clinical symptoms of
symptoms of PIH
These results cannot
results cannot be
cannot be explained
be explained by
explained by receptor
by receptor down-regulation
receptor down-regulation due
down-regulation due to
due to higher
to higher levels
higher levels of
levels of mineralocorticoids
of mineralocorticoids in
mineralocorticoids in PIH;
in PIH; a
PIH; a hitherto
a hitherto unknown
hitherto unknown mineralocorticoid
unknown mineralocorticoid may
mineralocorticoid may thus
may thus be
thus be responsible
be responsible for
responsible for the
for the hypertension
the hypertension and
hypertension and altered
and altered MR
altered MR status
Structure function analysis
function analysis of
analysis of vitamin
of vitamin D
vitamin D analogs
D analogs with
analogs with C-ring
with C-ring modifications
Analogs of 1
of 1 alpha25-dihydroxyvitamin
1 alpha25-dihydroxyvitamin D3
alpha25-dihydroxyvitamin D3 1
D3 1 alpha25-OH2D3
1 alpha25-OH2D3 with
alpha25-OH2D3 with substitutions
with substitutions on
substitutions on C-11
on C-11 were
C-11 were synthesized
Small apolar substitutions
apolar substitutions 11
substitutions 11 alpha-methyl
11 alpha-methyl 11
alpha-methyl 11 alpha-fluoromethyl
11 alpha-fluoromethyl did
alpha-fluoromethyl did not
did not markedly
not markedly decrease
markedly decrease the
decrease the affinity
the affinity for
affinity for the
for the vitamin
the vitamin D
vitamin D receptor
D receptor but
receptor but larger
but larger 11
larger 11 alpha-chloromethyl
11 alpha-chloromethyl or
alpha-chloromethyl or 11
or 11 alpha-
11 alpha- or
alpha- or 11
or 11 beta-phenyl
11 beta-phenyl or
beta-phenyl or more
or more polar
more polar substitutions
polar substitutions 11
substitutions 11 alpha-hydroxymethyl
11 alpha-hydroxymethyl 11
alpha-hydroxymethyl 11 alpha-2-hydroxyethyl]
11 alpha-2-hydroxyethyl] decreased
alpha-2-hydroxyethyl] decreased the
decreased the affinity
the affinity to
affinity to less
to less than
less than 5%
than 5% of
5% of that
of that of
that of 1
of 1 alpha25-OH2D3
Their affinity for
affinity for the
for the vitamin
the vitamin D-binding
vitamin D-binding protein
D-binding protein however
protein however increased
however increased up
increased up to
up to 4-fold
The biological activity
biological activity of
activity of 11
of 11 alpha-methyl-1
11 alpha-methyl-1 alpha25-OH2D3
alpha-methyl-1 alpha25-OH2D3 closely
alpha25-OH2D3 closely resembled
closely resembled that
resembled that of
that of the
of the natural
the natural hormone
natural hormone on
hormone on normal
on normal and
normal and leukemic
and leukemic cell
leukemic cell proliferation
cell proliferation and
proliferation and bone
and bone resorption
bone resorption whereas
resorption whereas its
whereas its in
its in vivo
in vivo effect
vivo effect on
effect on calcium
on calcium metabolism
calcium metabolism of
metabolism of the
of the rachitic
the rachitic chick
rachitic chick was
chick was about
was about 50%
about 50% of
50% of that
of that of
that of 1
of 1 alpha25-OH2D3
The 11 beta-methyl
11 beta-methyl analog
beta-methyl analog had
analog had a
had a greater
a greater than
greater than 10-fold
than 10-fold lower
10-fold lower activity
The differentiating effects
differentiating effects of
effects of the
of the other
the other C-11
other C-11 analogs
C-11 analogs on
analogs on human
on human promyeloid
human promyeloid leukemia
promyeloid leukemia cells
leukemia cells HL-60
cells HL-60 agreed
HL-60 agreed well
agreed well with
well with their
with their bone-resorbing
their bone-resorbing activity
bone-resorbing activity and
activity and receptor
and receptor affinity
receptor affinity but
affinity but they
but they demonstrated
they demonstrated lower
demonstrated lower calcemic
lower calcemic effects
calcemic effects in
effects in vivo
Large or polar
or polar substitutions
polar substitutions on
substitutions on C-11
on C-11 of
C-11 of 1
of 1 alpha25-OH2D3
1 alpha25-OH2D3 thus
alpha25-OH2D3 thus impair
thus impair the
impair the binding
the binding of
binding of the
of the vitamin
the vitamin D
vitamin D receptor
D receptor but
receptor but increase
but increase the
increase the affinity
the affinity to
affinity to vitamin
to vitamin D-binding
vitamin D-binding protein
The effects of
effects of many
of many C-11-substituted
many C-11-substituted 1
C-11-substituted 1 alpha25-OH2D3
1 alpha25-OH2D3 analogs
alpha25-OH2D3 analogs on
analogs on HL-60
on HL-60 cell
HL-60 cell differentiation
cell differentiation exceeded
differentiation exceeded their
exceeded their activity
their activity on
activity on calcium
on calcium metabolism
Glucocorticoid receptor binding
receptor binding in
binding in three
in three different
three different cell
different cell types
cell types in
types in major
in major depressive
major depressive disorder:
depressive disorder: lack
disorder: lack of
lack of evidence
of evidence of
evidence of receptor
of receptor binding
receptor binding defect
In order to
order to further
to further understand
further understand the
understand the apparent
the apparent glucocorticoid
apparent glucocorticoid resistance
glucocorticoid resistance in
resistance in major
in major depressive
major depressive disorder
depressive disorder circadian
disorder circadian variation
circadian variation in
variation in cortisol
in cortisol concentration
cortisol concentration dexamethasone
concentration dexamethasone suppression
dexamethasone suppression and
suppression and glucocorticoid
and glucocorticoid receptor
glucocorticoid receptor binding
receptor binding in
binding in mononuclear
in mononuclear leukocytes
mononuclear leukocytes polymorphonuclear
leukocytes polymorphonuclear leukocytes
polymorphonuclear leukocytes and
leukocytes and cultured
and cultured skin
cultured skin fibroblasts
skin fibroblasts were
fibroblasts were measured
were measured in
measured in rigidly
in rigidly defined
rigidly defined major
defined major depressive
major depressive disorder
depressive disorder patients
disorder patients and
patients and non-depressed
and non-depressed psychiatric
non-depressed psychiatric controls
Mononuclear leukocytes binding
leukocytes binding to
binding to glucocorticoid
to glucocorticoid correlated
glucocorticoid correlated significantly
correlated significantly with
significantly with polymorphonuclear
with polymorphonuclear leukocytes
polymorphonuclear leukocytes binding
leukocytes binding to
binding to glucocorticoid
to glucocorticoid but
glucocorticoid but both
but both determinations
both determinations failed
determinations failed to
failed to differentiate
to differentiate major
differentiate major depressive
major depressive disorder
depressive disorder and
disorder and control
and control subjects
Initial and post-dexamethasone
and post-dexamethasone in
post-dexamethasone in vitro
in vitro fibroblast
vitro fibroblast binding
fibroblast binding to
binding to glucocorticoid
to glucocorticoid was
glucocorticoid was not
was not different
not different between
different between major
between major depressive
major depressive disorder
depressive disorder and
disorder and non-depressed
and non-depressed control
non-depressed control subjects
The phenomenon of
phenomenon of glucocorticoid
of glucocorticoid resistance
glucocorticoid resistance in
resistance in major
in major depressive
major depressive disorder
depressive disorder remains
disorder remains unexplained
High affinity aldosterone
affinity aldosterone binding
aldosterone binding to
binding to plasma
to plasma membrane
plasma membrane rich
membrane rich fractions
rich fractions from
fractions from mononuclear
from mononuclear leukocytes:
mononuclear leukocytes: is
leukocytes: is there
is there a
there a membrane
a membrane receptor
membrane receptor for
receptor for mineralocorticoids?
In vitro effects
vitro effects of
effects of aldosterone
of aldosterone on
aldosterone on the
on the intracellular
the intracellular concentrations
intracellular concentrations of
concentrations of sodium
of sodium potassium
sodium potassium and
potassium and calcium
and calcium cell
calcium cell volume
cell volume and
volume and the
and the sodium-proton-antiport
the sodium-proton-antiport have
sodium-proton-antiport have been
have been described
been described in
described in intact
in intact human
intact human mononuclear
human mononuclear leukocytes
mononuclear leukocytes HML
In the present
the present paper
present paper the
paper the binding
the binding of
binding of a
of a [125I]-labeled
a [125I]-labeled aldosterone
[125I]-labeled aldosterone derivative
aldosterone derivative to
derivative to plasma
to plasma membrane
plasma membrane rich
membrane rich fractions
rich fractions of
fractions of HML
of HML was
HML was studied
High affinity binding
affinity binding of
binding of the
of the radioligand
the radioligand with
radioligand with an
with an apparent
an apparent Kd
apparent Kd of
Kd of approximately
of approximately 01
approximately 01 nM
01 nM was
nM was found
Aldosterone displaced the
displaced the tracer
the tracer at
tracer at a
at a similar
a similar Kd
Both canrenone and
canrenone and cortisol
and cortisol were
cortisol were inactive
were inactive as
inactive as ligands
as ligands up
ligands up to
up to concentrations
to concentrations of
concentrations of 01
of 01 microM
The findings are
findings are the
are the first
the first to
first to demonstrate
to demonstrate membrane
demonstrate membrane binding
membrane binding sites
binding sites with
sites with a
with a high
a high affinity
high affinity for
affinity for aldosterone
for aldosterone but
aldosterone but not
but not for
not for cortisol
These data are
data are perfectly
are perfectly compatible
perfectly compatible with
compatible with major
with major properties
major properties of
properties of steroidal
of steroidal effects
steroidal effects on
effects on the
on the sodium-proton-antiport
the sodium-proton-antiport in
sodium-proton-antiport in HML
in HML and
HML and thus
and thus very
thus very likely
very likely represent
likely represent membrane
represent membrane receptors
membrane receptors for
receptors for aldosterone
Natural variants of
variants of the
of the HIV-1
the HIV-1 long
HIV-1 long terminal
long terminal repeat:
terminal repeat: analysis
repeat: analysis of
analysis of promoters
of promoters with
promoters with duplicated
with duplicated DNA
duplicated DNA regulatory
DNA regulatory motifs
Sequence variation in
variation in the
in the long
the long terminal
long terminal repeat
terminal repeat LTR
repeat LTR region
LTR region of
region of HIV-1
of HIV-1 was
HIV-1 was analyzed
was analyzed in
analyzed in viral
in viral isolates
viral isolates of
isolates of 17
of 17 infected
17 infected individuals
Two classes of
classes of LTR
of LTR size
LTR size variants
size variants were
variants were found
One HIV-1 variant
HIV-1 variant was
variant was detected
was detected containing
detected containing an
containing an additional
an additional binding
additional binding site
binding site for
site for the
for the transcription
the transcription factor
transcription factor Sp1
Another LTR size
LTR size variation
size variation was
variation was observed
was observed in
observed in four
in four patients
four patients in
patients in a
in a region
a region just
region just upstream
just upstream of
upstream of the
of the NF-kappa
the NF-kappa B
NF-kappa B enhancer
This variation was
variation was the
was the result
the result of
result of a
of a duplication
a duplication of
duplication of a
of a short
a short DNA
short DNA sequence
DNA sequence CTG-motif
Cell culture experiments
culture experiments demonstrated
experiments demonstrated that
demonstrated that the
that the natural
the natural variant
natural variant with
variant with four
with four Sp1
four Sp1 sites
Sp1 sites had
sites had a
had a slightly
a slightly higher
slightly higher promoter
higher promoter activity
promoter activity and
activity and viral
and viral replication
viral replication rate
replication rate than
rate than the
than the isogenic
the isogenic control
isogenic control LTR
control LTR with
LTR with three
with three Sp1
three Sp1 sites
No positive effect
positive effect of
effect of the
of the duplicated
the duplicated CTG-motif
duplicated CTG-motif could
CTG-motif could be
could be detected
In order to
order to measure
to measure small
measure small differences
small differences in
differences in virus
in virus production
virus production more
production more accurately
more accurately equal
accurately equal amounts
equal amounts of
amounts of a
of a size
a size variant
size variant and
variant and the
and the wild-type
the wild-type plasmid
wild-type plasmid were
plasmid were cotransfected
were cotransfected into
cotransfected into T-cells
The virus with
virus with four
with four Sp1
four Sp1 sites
Sp1 sites did
sites did outgrow
did outgrow the
outgrow the three
the three Sp1
three Sp1 virus
Sp1 virus in
virus in 35
in 35 days
35 days of
days of culture
of culture and
culture and CTG-monomer
and CTG-monomer virus
CTG-monomer virus outcompeted
virus outcompeted the
outcompeted the CTG-dimer
the CTG-dimer virus
CTG-dimer virus in
virus in 42
in 42 days
Based on these
on these results
these results we
results we estimate
we estimate a
estimate a 5-10%
a 5-10% difference
5-10% difference in
difference in virus
in virus production
virus production of
production of the
of the LTR
the LTR variants
LTR variants when
variants when compared
when compared to
compared to that
to that of
that of wild-type
A novel B
novel B cell-derived
B cell-derived coactivator
cell-derived coactivator potentiates
coactivator potentiates the
potentiates the activation
the activation of
activation of immunoglobulin
of immunoglobulin promoters
immunoglobulin promoters by
promoters by octamer-binding
by octamer-binding transcription
octamer-binding transcription factors
A novel B
novel B cell-restricted
B cell-restricted activity
cell-restricted activity required
activity required for
required for high
for high levels
high levels of
levels of octamer/Oct-dependent
of octamer/Oct-dependent transcription
octamer/Oct-dependent transcription from
transcription from an
from an immunoglobulin
an immunoglobulin heavy
immunoglobulin heavy chain
heavy chain IgH
chain IgH promoter
IgH promoter was
promoter was detected
was detected in
detected in an
in an in
an in vitro
in vitro system
vitro system consisting
system consisting of
consisting of HeLa
of HeLa cell-derived
HeLa cell-derived extracts
cell-derived extracts complemented
extracts complemented with
complemented with fractionated
with fractionated B
fractionated B cell
B cell nuclear
cell nuclear proteins
The factor responsible
factor responsible for
responsible for this
for this activity
this activity was
activity was designated
was designated Oct
designated Oct coactivator
Oct coactivator from
coactivator from B
from B cells
B cells OCA-B
OCA-B stimulates the
stimulates the transcription
the transcription from
transcription from an
from an IgH
an IgH promoter
IgH promoter in
promoter in conjunction
in conjunction with
conjunction with either
with either Oct-1
either Oct-1 or
Oct-1 or Oct-2
or Oct-2 but
Oct-2 but shows
but shows no
shows no significant
no significant effect
significant effect on
effect on the
on the octamer/Oct-dependent
the octamer/Oct-dependent transcription
octamer/Oct-dependent transcription of
transcription of the
of the ubiquitously
the ubiquitously expressed
ubiquitously expressed histone
expressed histone H2B
histone H2B promoter
H2B promoter and
promoter and the
and the transcription
the transcription of
transcription of USF-
of USF- and
USF- and Sp1-regulated
and Sp1-regulated promoters
Taken together our
together our results
our results suggest
results suggest that
suggest that OCA-B
that OCA-B is
OCA-B is a
is a tissue-
a tissue- promoter-
tissue- promoter- and
promoter- and factor-specific
and factor-specific coactivator
factor-specific coactivator and
coactivator and that
and that OCA-B
that OCA-B may
OCA-B may be
may be a
be a major
a major determinant
major determinant for
determinant for B
for B cell-specific
B cell-specific activation
cell-specific activation of
activation of immunoglobulin
of immunoglobulin promoters
In light of
light of the
of the evidence
the evidence showing
evidence showing physical
showing physical and
physical and functional
and functional interactions
functional interactions between
interactions between Oct
between Oct factors
Oct factors and
factors and OCA-B
and OCA-B we
OCA-B we propose
we propose a
propose a mechanism
a mechanism of
mechanism of action
of action for
action for OCA-B
for OCA-B and
OCA-B and discuss
and discuss the
discuss the implications
the implications of
implications of OCA-B
of OCA-B for
OCA-B for the
for the transcriptional
the transcriptional regulation
transcriptional regulation of
regulation of other
of other tissue-specific
other tissue-specific promoters
SCL and related
and related hemopoietic
related hemopoietic helix-loop-helix
hemopoietic helix-loop-helix transcription
helix-loop-helix transcription factors
The helix-loop-helix HLH
helix-loop-helix HLH proteins
HLH proteins are
proteins are a
are a family
a family of
family of transcription
of transcription factors
transcription factors that
factors that include
that include proteins
include proteins critical
proteins critical to
critical to differentiation
to differentiation and
differentiation and development
and development in
development in species
in species ranging
species ranging from
ranging from plants
from plants to
plants to mammals
Five members of
members of this
of this family
this family MYC
family MYC SCL
MYC SCL TAL-2
SCL TAL-2 LYL-1
TAL-2 LYL-1 and
LYL-1 and E2A
and E2A are
E2A are implicated
are implicated in
implicated in oncogenic
in oncogenic events
oncogenic events in
events in human
in human lymphoid
human lymphoid tumors
lymphoid tumors because
tumors because of
because of their
of their consistent
their consistent involvement
consistent involvement in
involvement in chromosomal
in chromosomal translocations
Although activated in
activated in T
in T cell
T cell leukemias
cell leukemias expression
leukemias expression of
expression of SCL
of SCL and
SCL and LYL-1
and LYL-1 is
LYL-1 is low
is low or
low or undetectable
or undetectable in
undetectable in normal
in normal T
normal T cell
T cell populations
SCL is expressed
is expressed in
expressed in erythroid
in erythroid megakaryocyte
erythroid megakaryocyte and
megakaryocyte and mast
and mast cell
mast cell populations
cell populations the
populations the same
the same cell
same cell lineages
cell lineages as
lineages as GATA-1
as GATA-1 a
GATA-1 a zinc-finger
a zinc-finger transcription
zinc-finger transcription factor
In addition both
addition both SCL
both SCL and
SCL and GATA-1
and GATA-1 undergo
GATA-1 undergo coordinate
undergo coordinate modulation
coordinate modulation during
modulation during chemically
during chemically induced
chemically induced erythroid
induced erythroid differentiation
erythroid differentiation of
differentiation of mouse
of mouse erythroleukemia
mouse erythroleukemia cells
erythroleukemia cells and
cells and are
and are down-modulated
are down-modulated during
down-modulated during myeloid
during myeloid differentiation
myeloid differentiation of
differentiation of human
of human K562
human K562 cells
K562 cells thus
cells thus implying
thus implying a
implying a role
a role for
role for SCL
for SCL in
SCL in erythroid
in erythroid differentiation
erythroid differentiation events
However in contrast
in contrast to
contrast to GATA-1
to GATA-1 SCL
GATA-1 SCL is
SCL is expressed
is expressed in
expressed in the
in the developing
the developing brain
Studies of the
of the function
the function of
function of SCL
of SCL suggest
SCL suggest it
suggest it is
it is also
is also important
also important in
important in proliferation
in proliferation and
proliferation and self-renewal
and self-renewal events
self-renewal events in
events in erythroid
in erythroid cells
Induction of the
of the POU
the POU domain
POU domain transcription
domain transcription factor
transcription factor Oct-2
factor Oct-2 during
Oct-2 during T-cell
during T-cell activation
T-cell activation by
activation by cognate
by cognate antigen
Oct-2 is a
is a transcription
a transcription factor
transcription factor that
factor that binds
that binds specifically
binds specifically to
specifically to octamer
to octamer DNA
octamer DNA motifs
DNA motifs in
motifs in the
in the promoters
the promoters of
promoters of immunoglobulin
of immunoglobulin and
immunoglobulin and interleukin-2
and interleukin-2 genes
All tumor cell
tumor cell lines
cell lines from
lines from the
from the B-cell
the B-cell lineage
B-cell lineage and
lineage and a
and a few
a few from
few from the
from the T-cell
the T-cell lineage
T-cell lineage express
lineage express Oct-2
To address the
address the role
the role of
role of Oct-2
of Oct-2 in
Oct-2 in the
in the T-cell
the T-cell lineage
T-cell lineage we
lineage we studied
we studied the
studied the expression
the expression of
expression of Oct-2
of Oct-2 mRNA
Oct-2 mRNA and
mRNA and protein
and protein in
protein in nontransformed
in nontransformed human
nontransformed human and
human and mouse
and mouse T
mouse T cells
Oct-2 was found
was found in
found in CD4+
in CD4+ and
CD4+ and CD8+
and CD8+ T
CD8+ T cells
T cells prepared
cells prepared from
prepared from human
from human peripheral
human peripheral blood
peripheral blood and
blood and in
and in mouse
in mouse lymph
mouse lymph node
lymph node T
node T cells
In a T-cell
a T-cell clone
T-cell clone specific
clone specific for
specific for pigeon
for pigeon cytochrome
pigeon cytochrome c
cytochrome c in
c in the
in the context
the context of
context of I-Ek
of I-Ek Oct-2
I-Ek Oct-2 was
Oct-2 was induced
was induced by
induced by antigen
by antigen stimulation
antigen stimulation with
stimulation with the
with the increase
the increase in
increase in Oct-2
in Oct-2 protein
Oct-2 protein seen
protein seen first
seen first at
first at 3
at 3 h
3 h after
h after activation
after activation and
activation and continuing
and continuing for
continuing for at
for at least
at least 24
least 24 h
Oct-2 mRNA induction
mRNA induction during
induction during antigen-driven
during antigen-driven T-cell
antigen-driven T-cell activation
T-cell activation was
activation was blocked
was blocked by
blocked by cyclosporin
by cyclosporin A
cyclosporin A as
A as well
as well as
well as by
as by protein
by protein synthesis
protein synthesis inhibitors
These results suggest
results suggest that
suggest that Oct-2
that Oct-2 participates
Oct-2 participates in
participates in transcriptional
in transcriptional regulation
transcriptional regulation during
regulation during T-cell
during T-cell activation
T-cell activation The
activation The relatively
The relatively delayed
relatively delayed kinetics
delayed kinetics of
kinetics of Oct-2
of Oct-2 induction
Oct-2 induction suggests
induction suggests that
suggests that Oct-2
that Oct-2 mediates
Oct-2 mediates the
mediates the changes
the changes in
changes in gene
in gene expression
gene expression which
expression which occur
which occur many
occur many hours
many hours or
hours or days
or days following
days following antigen
following antigen stimulation
antigen stimulation of
stimulation of T
of T lymphocytes
Glucocorticoid receptor in
receptor in patients
in patients with
patients with lupus
with lupus nephritis:
lupus nephritis: relationship
nephritis: relationship between
relationship between receptor
between receptor levels
receptor levels in
levels in mononuclear
in mononuclear leukocytes
mononuclear leukocytes and
leukocytes and effect
and effect of
effect of glucocorticoid
of glucocorticoid therapy
We investigated the
investigated the clinical
the clinical significance
clinical significance of
significance of glucocorticoid
of glucocorticoid receptor
glucocorticoid receptor determination
receptor determination in
determination in 20
in 20 patients
20 patients with
patients with systemic
with systemic lupus
systemic lupus erythematosus
lupus erythematosus SLE
erythematosus SLE who
SLE who afterwards
who afterwards developed
afterwards developed nephrotic
developed nephrotic syndrome
Glucocorticoid receptor concentrations
receptor concentrations in
concentrations in mononuclear
in mononuclear leukocytes
mononuclear leukocytes MNL
leukocytes MNL in
MNL in these
in these patients
these patients were
patients were comparable
were comparable with
comparable with those
with those in
those in both
in both other
both other patients
other patients with
patients with SLE
with SLE and
SLE and healthy
and healthy persons
Improvement in urinary
in urinary protein
urinary protein excretion
protein excretion and
excretion and in
and in disease
in disease activity
disease activity which
activity which was
which was scored
was scored according
scored according to
according to the
to the SLE
the SLE Disease
SLE Disease Activity
Disease Activity Index
Activity Index system
Index system of
system of the
of the University
the University of
University of Toronto
of Toronto closely
Toronto closely related
closely related to
related to the
to the glucocorticoid
the glucocorticoid receptor
glucocorticoid receptor concentrations
receptor concentrations in
concentrations in MNL
in MNL isolated
MNL isolated from
isolated from the
from the corresponding
the corresponding patients
In summary glucocorticoid
summary glucocorticoid receptor
glucocorticoid receptor determination
receptor determination in
determination in patients
in patients with
patients with lupus
with lupus nephritis
lupus nephritis may
nephritis may be
may be a
be a predictive
a predictive clue
predictive clue for
clue for assessing
for assessing responsiveness
assessing responsiveness to
responsiveness to glucocorticoid
to glucocorticoid therapy
[Changes in plasma
in plasma interleukin-1
plasma interleukin-1 and
interleukin-1 and their
and their possible
their possible relationship
possible relationship with
relationship with the
with the changes
the changes in
changes in glucocorticoid
in glucocorticoid receptor
glucocorticoid receptor in
receptor in aged
in aged long-distance
aged long-distance runner]
For the study
the study of
study of the
of the changes
the changes in
changes in plasma
in plasma interleukin-1
plasma interleukin-1 IL-1
interleukin-1 IL-1 and
IL-1 and their
and their possible
their possible relationship
possible relationship with
relationship with the
with the changes
the changes in
changes in glucocorticoid
in glucocorticoid receptor
glucocorticoid receptor GR
receptor GR plasma
GR plasma IL-1
plasma IL-1 and
IL-1 and GR
and GR in
GR in peripheral
in peripheral blood
peripheral blood leukocytes
blood leukocytes in
leukocytes in aged
in aged long-distance
aged long-distance runner
long-distance runner were
runner were measured
were measured simultaneously
The activity of
activity of IL-1
of IL-1 was
IL-1 was expressed
was expressed as
expressed as its
as its ability
its ability to
ability to stimulate
to stimulate 3H-TdR
stimulate 3H-TdR incorporation
3H-TdR incorporation in
incorporation in the
in the thymocytes
the thymocytes of
thymocytes of C57
of C57 mice
GR was determined
was determined by
determined by whole
by whole cell
whole cell assay
cell assay with
assay with 3H-Dex
The results showed
results showed that
showed that the
that the activity
the activity of
activity of plasma
of plasma IL-1
plasma IL-1 in
IL-1 in aged
in aged long-distance
aged long-distance runner
long-distance runner was
runner was 209%
was 209% 223%
209% 223% and
223% and 145%
and 145% of
145% of the
of the control
the control at
control at 147-187
at 147-187 38-70
147-187 38-70 and
38-70 and 15-26
and 15-26 KD
15-26 KD fractions
The GR in
GR in peripheral
in peripheral blood
peripheral blood leukocytes
blood leukocytes in
leukocytes in aged
in aged runner
aged runner was
runner was 65%
was 65% of
65% of the
of the control
Possible relationship between
relationship between the
between the changes
the changes in
changes in IL-1
in IL-1 and
IL-1 and GR
and GR in
GR in aged
in aged long-distance
aged long-distance runner
long-distance runner and
runner and its
and its physiological
its physiological significance
physiological significance are
significance are discussed
Mineralocorticoid effector mechanism
effector mechanism in
mechanism in preeclampsia
Mineralocorticoid effector mechanisms
effector mechanisms were
mechanisms were evaluated
were evaluated in
evaluated in 29
in 29 patients
29 patients with
patients with preeclampsia
with preeclampsia and
preeclampsia and in
and in 25
in 25 uncomplicated
25 uncomplicated pregnancies
uncomplicated pregnancies by
pregnancies by measurement
by measurement of
measurement of plasma
of plasma aldosterone
plasma aldosterone levels
aldosterone levels of
levels of mineralocorticoid
of mineralocorticoid receptor
mineralocorticoid receptor MR
receptor MR in
MR in mononuclear
in mononuclear leucocytes
mononuclear leucocytes and
leucocytes and subtraction
and subtraction potential
subtraction potential difference
potential difference SPD;
difference SPD; rectal
SPD; rectal minus
rectal minus oral
minus oral values
Mean values for
values for plasma
for plasma aldosterone
plasma aldosterone were
aldosterone were not
were not different
not different between
different between the
between the two
the two groups
two groups but
groups but significant
but significant differences
significant differences were
differences were observed
were observed for
observed for MR
for MR preeclampsia
MR preeclampsia 81
preeclampsia 81 +/-
81 +/- 44
+/- 44 receptors/cell;
44 receptors/cell; controls
receptors/cell; controls 306
controls 306 +/-
306 +/- 168
+/- 168 and
168 and SPD
and SPD preeclampsia
SPD preeclampsia 65
preeclampsia 65 +/-
65 +/- 7
+/- 7 mV;
7 mV; controls
mV; controls 12
controls 12 +/-
12 +/- 5
+/- 5 mV
In six cases
six cases we
cases we determined
we determined MR
determined MR plasma
MR plasma aldosterone
plasma aldosterone and
aldosterone and SPD
and SPD in
SPD in patients
in patients with
patients with preeclampsia
with preeclampsia before
preeclampsia before and
before and 3
and 3 months
3 months after
months after delivery
MR were reduced
were reduced before
reduced before delivery
before delivery 96
delivery 96 +/-
96 +/- 27
+/- 27 receptors/cell
27 receptors/cell and
receptors/cell and SPD
and SPD increased
SPD increased 64
increased 64 +/-
64 +/- 8
+/- 8 mV
8 mV with
mV with both
with both parameters
both parameters normalizing
parameters normalizing after
normalizing after delivery
after delivery MR
delivery MR 242
MR 242 +/-
242 +/- 79;
+/- 79; SPD
79; SPD 140
SPD 140 +/-
140 +/- 4
+/- 4 mV
Aldosterone levels returned
levels returned to
returned to normal
to normal nonpregnant
normal nonpregnant values
nonpregnant values after
values after delivery
These data suggest
data suggest an
suggest an important
an important role
important role for
role for abnormalities
for abnormalities in
abnormalities in mineralocorticoid
in mineralocorticoid effector
mineralocorticoid effector mechanisms
effector mechanisms in
mechanisms in the
in the etiology
the etiology of
etiology of preeclampsia
of preeclampsia and
preeclampsia and could
and could be
could be an
be an useful
an useful marker
useful marker for
marker for diagnosis
Kinetics of nuclear
of nuclear translocation
nuclear translocation and
translocation and turnover
and turnover of
turnover of the
of the vitamin
the vitamin D
vitamin D receptor
D receptor in
receptor in human
in human HL60
human HL60 leukemia
HL60 leukemia cells
leukemia cells and
cells and peripheral
and peripheral blood
peripheral blood lymphocytes--coincident
blood lymphocytes--coincident rise
lymphocytes--coincident rise of
rise of DNA-relaxing
of DNA-relaxing activity
DNA-relaxing activity in
activity in nuclear
in nuclear extracts
High affinity receptors
affinity receptors VDR
receptors VDR for
VDR for 125-dihydroxycholecalciferol
for 125-dihydroxycholecalciferol calcitriol
125-dihydroxycholecalciferol calcitriol are
calcitriol are expressed
are expressed in
expressed in HL60
in HL60 human
HL60 human leukemia
human leukemia cells
leukemia cells and
cells and in
and in low
in low numbers
low numbers in
numbers in peripheral
in peripheral blood
peripheral blood lymphocytes
blood lymphocytes PBL
HL60 cells expressing
cells expressing some
expressing some characteristics
some characteristics of
characteristics of promyelocytes
of promyelocytes can
promyelocytes can be
can be induced
be induced to
induced to monocytoid
to monocytoid differentiation
monocytoid differentiation by
differentiation by calcitriol
Specific nuclear translocation
nuclear translocation of
translocation of [3H]calcitriol/VDR
of [3H]calcitriol/VDR was
[3H]calcitriol/VDR was examined
was examined after
examined after exposure
after exposure of
exposure of whole
of whole cells
whole cells to
cells to 10-9
to 10-9 M/l
10-9 M/l calcitriol
M/l calcitriol in
calcitriol in the
in the presence
the presence and
presence and absence
and absence of
absence of a
of a 500-fold
a 500-fold excess
500-fold excess of
excess of unlabeled
of unlabeled ligand
unlabeled ligand and
ligand and subsequent
and subsequent isolation
subsequent isolation of
isolation of nuclei
Specific nuclear translocation
nuclear translocation of
translocation of [3H]calcitriol/VDR
of [3H]calcitriol/VDR was
[3H]calcitriol/VDR was found
was found to
found to be
to be time
be time dependent
time dependent reaching
dependent reaching a
reaching a maximum
a maximum of
maximum of approximately
of approximately 2100
approximately 2100 binding
2100 binding sites/nucleus
binding sites/nucleus after
sites/nucleus after 3
after 3 h
3 h of
h of incubation
of incubation in
incubation in HL60
in HL60 cells
HL60 cells whereas
cells whereas a
whereas a maximum
a maximum of
maximum of approximately
of approximately 310
approximately 310 binding
310 binding sites/nucleus
binding sites/nucleus was
sites/nucleus was found
was found after
found after 3
after 3 h
3 h in
h in PBL
Pulse exposure of
exposure of HL60
of HL60 to
HL60 to radiolabeled
to radiolabeled hormone
radiolabeled hormone for
hormone for 3
for 3 h
3 h followed
h followed by
followed by culture
by culture in
culture in medium
in medium without
medium without serum
without serum and
serum and calcitriol
and calcitriol lead
calcitriol lead to
lead to nuclear
to nuclear retention
nuclear retention of
retention of approximately
of approximately 1600
approximately 1600 radiolabeled
1600 radiolabeled VDR
radiolabeled VDR by
VDR by 8
by 8 h
8 h and
h and approximately
and approximately 1000
approximately 1000 VDR
1000 VDR by
VDR by 24
by 24 h
Radiolabeled VDR disappeared
VDR disappeared from
disappeared from the
from the nuclear
the nuclear compartment
nuclear compartment with
compartment with a
with a halflife
a halflife of
halflife of approximately
of approximately 30
approximately 30 min
30 min if
min if cells
if cells were
cells were cultured
were cultured with
cultured with identical
with identical concentrations
identical concentrations of
concentrations of unlabeled
of unlabeled hormone
unlabeled hormone after
hormone after the
after the pulse
the pulse pulse/chase-experiments
No difference of
difference of VDR
of VDR retention
VDR retention in
retention in pulse
in pulse and
pulse and pulse/chase-experiments
and pulse/chase-experiments was
pulse/chase-experiments was seen
was seen in
seen in PBL
in PBL where
PBL where VDR
where VDR halflife
VDR halflife was
halflife was approximately
was approximately 30
approximately 30 min
No specific translocation
specific translocation into
translocation into the
into the nuclear
the nuclear compartment
nuclear compartment was
compartment was seen
was seen when
seen when isolated
when isolated nuclei
isolated nuclei were
nuclei were incubated
were incubated in
incubated in [3H]calcitriol
Radiolabeled hormone/receptor complexes
hormone/receptor complexes of
complexes of nuclei
of nuclei isolated
nuclei isolated from
isolated from cells
from cells exposed
cells exposed for
exposed for 3
for 3 h
3 h to
h to radiolabeled
to radiolabeled hormone--in
radiolabeled hormone--in contrast
hormone--in contrast to
contrast to identical
to identical experiments
identical experiments with
experiments with intact
with intact cells--did
intact cells--did not
cells--did not disappear
not disappear from
disappear from the
from the nuclear
the nuclear compartment
nuclear compartment upon
compartment upon incubation
upon incubation of
incubation of nuclei
of nuclei with
nuclei with identical
with identical concentrations
identical concentrations of
concentrations of the
of the unlabeled
the unlabeled compound
The activity of
activity of DNA
of DNA relaxing
DNA relaxing enzymes
relaxing enzymes eg
enzymes eg topoisomerases
eg topoisomerases I
topoisomerases I and
I and II
and II in
II in nuclear
in nuclear extracts
nuclear extracts was
extracts was measured
was measured using
measured using a
using a PBR
a PBR 322-relaxation-assay
Enhanced overall enzyme
overall enzyme activity
enzyme activity was
activity was found
was found in
found in nuclear
in nuclear extracts
nuclear extracts by
extracts by 1
by 1 h
1 h after
h after incubation
after incubation with
incubation with calcitriol
with calcitriol final
calcitriol final ethanol
final ethanol concentration
ethanol concentration 00001%
concentration 00001% v/v
00001% v/v in
v/v in HL60
in HL60 and
HL60 and PBL
The enhanced activity
enhanced activity disappeared
activity disappeared after
disappeared after 2
after 2 h
2 h in
h in PBL
in PBL whereas
PBL whereas it
whereas it was
it was still
was still enhanced
still enhanced by
enhanced by 4
by 4 h
4 h in
h in HL60
No effect was
effect was seen
was seen in
seen in ethanol
in ethanol treated
ethanol treated controls
We conclude that
conclude that a
that a specific
a specific nuclear
specific nuclear translocation
nuclear translocation mechanism
translocation mechanism exists
mechanism exists for
exists for calcitriol
for calcitriol in
calcitriol in both
in both cell
both cell types
cell types examined
types examined most
examined most likely
most likely due
likely due to
due to translocation
to translocation of
translocation of receptor
of receptor proteins
receptor proteins after
proteins after hormone
after hormone binding
Translocated hormone/receptor complexes
hormone/receptor complexes compete
complexes compete for
compete for a
for a limited
a limited number
limited number of
number of specific
of specific nuclear
specific nuclear binding
nuclear binding sites
Enhanced activity of
activity of topoisomerases
of topoisomerases in
topoisomerases in nuclear
in nuclear extracts
nuclear extracts upon
extracts upon translocation
upon translocation of
translocation of VDR
of VDR might
VDR might reflect
might reflect interaction
reflect interaction of
interaction of both
of both within
both within the
within the nuclear
the nuclear compartment
nuclear compartment thus
compartment thus initiating
thus initiating DNA-unwinding
initiating DNA-unwinding a
DNA-unwinding a prerequisite
a prerequisite of
prerequisite of transcription
of transcription initiation
Influence of estradiol
of estradiol and
estradiol and tamoxifen
and tamoxifen on
tamoxifen on susceptibility
on susceptibility of
susceptibility of human
of human breast
human breast cancer
breast cancer cell
cancer cell lines
cell lines to
lines to lysis
to lysis by
lysis by lymphokine-activated
by lymphokine-activated killer
lymphokine-activated killer cells
The design of
design of combination
of combination hormonal
combination hormonal and
hormonal and immunotherapeutic
and immunotherapeutic protocols
immunotherapeutic protocols for
protocols for breast
for breast cancer
breast cancer patients
cancer patients may
patients may be
may be facilitated
be facilitated by
facilitated by analysis
by analysis of
analysis of preclinical
of preclinical in
preclinical in vitro
in vitro model
vitro model systems
Estrogen receptor positive
receptor positive ER+:
positive ER+: MCF-7
ER+: MCF-7 and
MCF-7 and negative
and negative ER-:
negative ER-: MDA-MB-231
ER-: MDA-MB-231 human
MDA-MB-231 human breast
human breast cancer
breast cancer cell
cancer cell lines
cell lines were
lines were utilized
were utilized to
utilized to evaluate
to evaluate the
evaluate the effects
the effects of
effects of tamoxifen
of tamoxifen TAM
tamoxifen TAM and
TAM and estradiol
and estradiol E2
estradiol E2 on
E2 on modulation
on modulation of
modulation of breast
of breast cancer
breast cancer target
cancer target susceptibility
target susceptibility to
susceptibility to lysis
to lysis by
lysis by lymphokine-activated
by lymphokine-activated killer
lymphokine-activated killer LAK
killer LAK cells
E2-stimulated ER+ cells
ER+ cells were
cells were more
were more susceptible
more susceptible to
susceptible to lysis
to lysis by
lysis by LAK
by LAK cells
LAK cells than
cells than corresponding
than corresponding TAM-treated
corresponding TAM-treated or
TAM-treated or control
or control cells
control cells while
cells while treatment
while treatment of
treatment of ER-
of ER- cells
ER- cells with
cells with either
with either E2
either E2 or
E2 or TAM
or TAM alone
TAM alone did
alone did not
did not alter
not alter from
alter from control
from control their
control their susceptibility
their susceptibility to
susceptibility to this
to this immune-mediated
this immune-mediated lysis
All ER+ and
ER+ and ER-
and ER- cells
ER- cells tested
cells tested remained
tested remained sensitive
remained sensitive after
sensitive after treatment
after treatment with
treatment with TAM
with TAM to
TAM to lysis
to lysis by
lysis by LAK
by LAK cells
In addition an
addition an adenocarcinoma
an adenocarcinoma reactive
adenocarcinoma reactive human-mouse
reactive human-mouse chimeric
human-mouse chimeric monoclonal
chimeric monoclonal antibody
monoclonal antibody ING-1
antibody ING-1 was
ING-1 was able
was able to
able to significantly
to significantly boost
significantly boost in
boost in vivo
in vivo generated
vivo generated LAK
generated LAK cell-mediated
LAK cell-mediated lysis
cell-mediated lysis of
lysis of control
of control E2-treated
control E2-treated and
E2-treated and TAM-treated
and TAM-treated ER+
TAM-treated ER+ and
ER+ and ER-
and ER- cells
These in vitro
in vitro results
vitro results provide
results provide a
provide a preclinical
a preclinical rationale
preclinical rationale for
rationale for in
for in vivo
in vivo testing
vivo testing of
testing of TAM
of TAM interleukin-2
TAM interleukin-2 IL-2
interleukin-2 IL-2 and
IL-2 and breast
and breast cancer
breast cancer reactive
cancer reactive antibody-dependent
reactive antibody-dependent cellular
antibody-dependent cellular cytotoxicity
cellular cytotoxicity facilitating
cytotoxicity facilitating antibody
facilitating antibody in
antibody in patients
in patients with
patients with refractory
with refractory or
refractory or high
or high risk
high risk breast
risk breast cancer
The cellular oncogene
cellular oncogene c-myb
oncogene c-myb can
c-myb can interact
can interact synergistically
interact synergistically with
synergistically with the
with the Epstein-Barr
the Epstein-Barr virus
Epstein-Barr virus BZLF1
virus BZLF1 transactivator
BZLF1 transactivator in
transactivator in lymphoid
in lymphoid cells
Regulation of replicative
of replicative functions
replicative functions in
functions in the
in the Epstein-Barr
the Epstein-Barr virus
Epstein-Barr virus EBV
virus EBV genome
EBV genome is
genome is mediated
is mediated through
mediated through activation
through activation of
activation of a
of a virally
a virally encoded
virally encoded transcription
encoded transcription factor
transcription factor Z
factor Z BZLF1
We have shown
have shown that
shown that the
that the Z
the Z gene
Z gene product
gene product which
product which binds
which binds to
binds to AP-1
to AP-1 sites
AP-1 sites as
sites as a
as a homodimer
a homodimer and
homodimer and has
and has sequence
has sequence similarity
sequence similarity to
similarity to c-Fos
to c-Fos can
c-Fos can efficiently
can efficiently activate
efficiently activate the
activate the EBV
the EBV early
EBV early promoter
early promoter BMRF1
promoter BMRF1 in
BMRF1 in certain
in certain cell
certain cell types
cell types ie
types ie HeLa
ie HeLa cells
HeLa cells but
cells but not
but not others
not others ie
others ie Jurkat
ie Jurkat cells
Here we demonstrate
we demonstrate that
demonstrate that the
that the c-myb
the c-myb proto-oncogene
c-myb proto-oncogene product
proto-oncogene product which
product which is
which is itself
is itself a
itself a DNA-binding
a DNA-binding protein
DNA-binding protein and
protein and transcriptional
and transcriptional transactivator
transcriptional transactivator can
transactivator can interact
can interact synergistically
interact synergistically with
synergistically with Z
with Z in
Z in activating
in activating the
activating the BMRF1
the BMRF1 promoter
BMRF1 promoter in
promoter in Jurkat
in Jurkat cells
Jurkat cells a
cells a T-cell
a T-cell line
T-cell line or
line or Raji
or Raji cells
Raji cells an
cells an EBV-positive
an EBV-positive B-cell
EBV-positive B-cell whereas
B-cell whereas the
whereas the c-myb
the c-myb gene
c-myb gene product
gene product by
product by itself
by itself has
itself has little
has little effect
The simian virus
simian virus 40
virus 40 early
40 early promoter
early promoter is
promoter is also
is also synergistically
also synergistically activated
synergistically activated by
activated by the
by the Z/c-myb
the Z/c-myb combination
Synergistic transactivation of
transactivation of the
of the BMRF1
the BMRF1 promoter
BMRF1 promoter by
promoter by the
by the Z/c-myb
the Z/c-myb combination
Z/c-myb combination appears
combination appears to
appears to involve
to involve direct
involve direct binding
direct binding by
binding by the
by the Z
the Z protein
Z protein but
protein but not
but not the
not the c-myb
the c-myb protein
A 30-bp sequence
30-bp sequence in
sequence in the
in the BMRF1
the BMRF1 promoter
BMRF1 promoter which
promoter which contains
which contains a
contains a Z
a Z binding
Z binding site
binding site a
site a consensus
a consensus AP-1
consensus AP-1 site
AP-1 site is
site is sufficient
is sufficient to
sufficient to transfer
to transfer high-level
transfer high-level lymphoid-specific
high-level lymphoid-specific responsiveness
lymphoid-specific responsiveness to
responsiveness to the
to the Z/c-myb
the Z/c-myb combination
Z/c-myb combination to
combination to a
to a heterologous
a heterologous promoter
That the c-myb
the c-myb oncogene
c-myb oncogene product
oncogene product can
product can interact
can interact synergistically
interact synergistically with
synergistically with an
with an EBV-encoded
an EBV-encoded member
EBV-encoded member of
member of the
of the leucine
the leucine zipper
leucine zipper protein
zipper protein family
protein family suggests
family suggests c-myb
suggests c-myb is
c-myb is likely
is likely to
likely to engage
to engage in
engage in similar
in similar interactions
similar interactions with
interactions with cellularly
with cellularly encoded
cellularly encoded transcription
encoded transcription factors
Alpha-lipoic acid is
acid is a
is a potent
a potent inhibitor
potent inhibitor of
inhibitor of NF-kappa
of NF-kappa B
NF-kappa B activation
B activation in
activation in human
in human T
human T cells
Acquired immunodeficiency syndrome
immunodeficiency syndrome AIDS
syndrome AIDS results
AIDS results from
results from infection
from infection with
infection with a
with a human
a human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
The long terminal
long terminal repeat
terminal repeat LTR
repeat LTR region
LTR region of
region of HIV
of HIV proviral
HIV proviral DNA
proviral DNA contains
DNA contains binding
contains binding sites
binding sites for
sites for nuclear
for nuclear factor
nuclear factor kappa
factor kappa B
kappa B NF-kappa
B NF-kappa B
NF-kappa B and
B and this
and this transcriptional
this transcriptional activator
transcriptional activator appears
activator appears to
appears to regulate
to regulate HIV
regulate HIV activation
Recent findings suggest
findings suggest an
suggest an involvement
an involvement of
involvement of reactive
of reactive oxygen
reactive oxygen species
oxygen species ROS
species ROS in
ROS in signal
in signal transduction
signal transduction pathways
transduction pathways leading
pathways leading to
leading to NF-kappa
to NF-kappa B
NF-kappa B activation
The present study
present study was
study was based
was based on
based on reports
on reports that
reports that antioxidants
that antioxidants which
antioxidants which eliminate
which eliminate ROS
eliminate ROS should
ROS should block
should block the
block the activation
the activation of
activation of NF-kappa
of NF-kappa B
NF-kappa B and
B and subsequently
and subsequently HIV
subsequently HIV transcription
HIV transcription and
transcription and thus
and thus antioxidants
thus antioxidants can
antioxidants can be
can be used
be used as
used as therapeutic
as therapeutic agents
therapeutic agents for
agents for AIDS
Incubation of Jurkat
of Jurkat T
Jurkat T cells
T cells 1
cells 1 x
1 x 106
x 106 cells/ml
106 cells/ml with
cells/ml with a
with a natural
a natural thiol
natural thiol antioxidant
thiol antioxidant alpha-lipoic
antioxidant alpha-lipoic acid
alpha-lipoic acid prior
acid prior to
prior to the
to the stimulation
the stimulation of
stimulation of cells
of cells was
cells was found
was found to
found to inhibit
to inhibit NF-kappa
inhibit NF-kappa B
NF-kappa B activation
B activation induced
activation induced by
induced by tumor
by tumor necrosis
tumor necrosis factor-alpha
necrosis factor-alpha 25
factor-alpha 25 ng/ml
25 ng/ml or
ng/ml or by
or by phorbol
by phorbol 12-myristate
phorbol 12-myristate 13-acetate
12-myristate 13-acetate 50
13-acetate 50 ng/ml
The inhibitory action
inhibitory action of
action of alpha-lipoic
of alpha-lipoic acid
alpha-lipoic acid was
acid was found
was found to
found to be
to be very
be very potent
very potent as
potent as only
as only 4
only 4 mM
4 mM was
mM was needed
was needed for
needed for a
for a complete
a complete inhibition
complete inhibition whereas
inhibition whereas 20
whereas 20 mM
20 mM was
mM was required
was required for
required for N-acetylcysteine
These results indicate
results indicate that
indicate that alpha-lipoic
that alpha-lipoic acid
alpha-lipoic acid may
acid may be
may be effective
be effective in
effective in AIDS
in AIDS therapeutics
Reticuloendotheliosis virus long
virus long terminal
long terminal repeat
terminal repeat elements
repeat elements are
elements are efficient
are efficient promoters
efficient promoters in
promoters in cells
in cells of
cells of various
of various species
various species and
species and tissue
and tissue origin
tissue origin including
origin including human
including human lymphoid
human lymphoid cells
Promiscuous transcriptional activity
transcriptional activity of
activity of the
of the reticuloendotheliosis
the reticuloendotheliosis virus
reticuloendotheliosis virus REV
virus REV long
REV long terminal
long terminal repeat
terminal repeat LTR
repeat LTR was
LTR was detected
was detected in
detected in transient
in transient expression
transient expression assays
expression assays using
assays using LTR-chloramphenicol
using LTR-chloramphenicol acetyltransferase-encoding
LTR-chloramphenicol acetyltransferase-encoding gene
acetyltransferase-encoding gene chimeras
gene chimeras and
chimeras and cells
and cells of
cells of diverse
of diverse species
diverse species and
species and tissue
and tissue type;
tissue type; levels
type; levels of
levels of expression
of expression from
expression from two
from two different
two different REV
different REV LTRs
REV LTRs correlate
LTRs correlate with
correlate with reports
with reports of
reports of pathogenicity
of pathogenicity of
pathogenicity of the
of the respective
the respective viruses
respective viruses in
viruses in vivo
REVs do not
do not encode
not encode a
encode a transactivator
a transactivator targeted
transactivator targeted to
targeted to the
to the viral
the viral LTR
viral LTR and
LTR and cells
and cells infected
cells infected with
infected with Marek's
with Marek's disease
Marek's disease virus
disease virus a
virus a herpesvirus
a herpesvirus with
herpesvirus with an
with an overlapping
an overlapping host
overlapping host range
host range do
range do not
do not express
not express factors
express factors that
factors that preferentially
that preferentially enhance
preferentially enhance expression
enhance expression from
expression from REV
from REV or
REV or avian
or avian sarcoma/leukemia
avian sarcoma/leukemia virus
sarcoma/leukemia virus LTRs
REV LTRs work
LTRs work efficiently
work efficiently in
efficiently in human
in human lymphoid
human lymphoid cells
lymphoid cells and
cells and are
and are viable
are viable alternatives
viable alternatives to
alternatives to promoters
to promoters commonly
promoters commonly used
commonly used for
used for expression
for expression of
expression of cloned
of cloned genes
They may also
may also prove
also prove useful
prove useful in
useful in the
in the identification
the identification of
identification of new
of new ubiquitous
new ubiquitous cellular
ubiquitous cellular transcription
cellular transcription factors
A novel Ets-related
novel Ets-related transcription
Ets-related transcription factor
transcription factor Elf-1
factor Elf-1 binds
Elf-1 binds to
binds to human
to human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 2
type 2 regulatory
2 regulatory elements
regulatory elements that
elements that are
that are required
are required for
required for inducible
for inducible trans
inducible trans activation
trans activation in
activation in T
in T cells
Human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 and
HIV-1 and HIV-2
and HIV-2 are
HIV-2 are structurally
are structurally related
structurally related retroviruses
related retroviruses which
retroviruses which both
which both cause
both cause AIDS
cause AIDS in
AIDS in humans
Although both viruses
both viruses establish
viruses establish latency
establish latency in
latency in quiescent
in quiescent human-peripheral-blood
quiescent human-peripheral-blood T
human-peripheral-blood T cells
T cells the
cells the asymptomatic
the asymptomatic phase
asymptomatic phase of
phase of HIV-2
of HIV-2 infection
HIV-2 infection may
infection may be
may be more
be more prolonged
more prolonged than
prolonged than that
than that of
that of HIV-1
The latent phases
latent phases of
phases of both
of both HIV-1
both HIV-1 and
HIV-1 and HIV-2
and HIV-2 infection
HIV-2 infection have
infection have been
have been shown
been shown to
shown to be
to be disrupted
be disrupted by
disrupted by T-cell
by T-cell activation
T-cell activation a
activation a process
a process that
process that requires
that requires host
requires host cell
host cell transcription
cell transcription factors
In the case
the case of
case of HIV-1
of HIV-1 the
HIV-1 the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B is
B is sufficient
is sufficient for
sufficient for inducible
for inducible transcriptional
inducible transcriptional activation
In contrast factors
contrast factors in
factors in addition
in addition to
addition to NF-kappa
to NF-kappa B
NF-kappa B are
B are required
are required to
required to activate
to activate HIV-2
activate HIV-2 transcription
HIV-2 transcription in
transcription in infected
in infected T
infected T cells
In this report
this report we
report we demonstrate
we demonstrate that
demonstrate that a
that a novel
a novel Ets-related
novel Ets-related transcription
Ets-related transcription factor
transcription factor Elf-1
factor Elf-1 binds
Elf-1 binds specifically
binds specifically to
specifically to two
to two purine-rich
two purine-rich motifs
purine-rich motifs in
motifs in the
in the HIV-2
the HIV-2 enhancer
Mutagenesis experiments demonstrated
experiments demonstrated that
demonstrated that these
that these Elf-1
these Elf-1 binding
Elf-1 binding sites
binding sites are
sites are required
are required for
required for induction
for induction of
induction of HIV-2
of HIV-2 transcription
HIV-2 transcription following
transcription following T-cell-receptor-mediated
following T-cell-receptor-mediated T-cell
T-cell-receptor-mediated T-cell activation
Moreover Elf-1 is
Elf-1 is the
is the only
the only factor
only factor present
factor present in
present in activated
in activated T-cell
activated T-cell nuclear
T-cell nuclear extracts
nuclear extracts that
extracts that binds
that binds to
binds to these
to these sites
these sites in
sites in electrophoretic
in electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
Thus Elf-1 is
Elf-1 is a
is a novel
a novel transcription
novel transcription factor
transcription factor that
factor that appears
that appears to
appears to be
to be required
be required for
required for the
for the T-cell-receptor-mediated
the T-cell-receptor-mediated trans
T-cell-receptor-mediated trans activation
trans activation of
activation of HIV-2
of HIV-2 gene
HIV-2 gene expression
These results may
results may explain
may explain differences
explain differences in
differences in the
in the clinical
the clinical spectra
clinical spectra of
spectra of diseases
of diseases caused
diseases caused by
caused by HIV-1
by HIV-1 and
HIV-1 and HIV-2
and HIV-2 and
HIV-2 and may
and may also
may also have
also have implications
have implications for
implications for the
for the design
the design of
design of therapeutic
of therapeutic approaches
therapeutic approaches to
approaches to HIV-2
to HIV-2 infection
Okadaic acid is
acid is a
is a potent
a potent inducer
potent inducer of
inducer of AP-1
of AP-1 NF-kappa
AP-1 NF-kappa B
NF-kappa B and
B and tumor
and tumor necrosis
tumor necrosis factor-alpha
necrosis factor-alpha in
factor-alpha in human
in human B
human B lymphocytes
Treatment of human
of human B
human B lymphocytes
B lymphocytes with
lymphocytes with an
with an optimal
an optimal concentration
optimal concentration of
concentration of okadaic
of okadaic acid
okadaic acid an
acid an inhibitor
an inhibitor of
inhibitor of phosphatases
of phosphatases 1
phosphatases 1 and
1 and 2A
and 2A resulted
2A resulted in
resulted in the
in the induction
the induction of
induction of the
of the transcription
the transcription factor
transcription factor AP-1
factor AP-1 and
AP-1 and a
and a marked
a marked increase
marked increase in
increase in NF-kappa
in NF-kappa B
NF-kappa B levels
In contrast no
contrast no effect
no effect on
effect on the
on the levels
the levels of
levels of the
of the octamer
the octamer binding
octamer binding proteins
binding proteins Oct-1
proteins Oct-1 or
Oct-1 or Oct-2
or Oct-2 were
Oct-2 were found
Since both AP-1
both AP-1 and
AP-1 and NF-kappa
and NF-kappa B
NF-kappa B have
B have been
have been reported
been reported to
reported to be
to be important
be important in
important in the
in the induction
the induction of
induction of the
of the tumor
the tumor necrosis
tumor necrosis factor-alpha
necrosis factor-alpha TNF-alpha
factor-alpha TNF-alpha gene
TNF-alpha gene we
gene we examined
we examined the
examined the effects
the effects of
effects of okadaic
of okadaic acid
okadaic acid on
acid on TNF-alpha
on TNF-alpha mRNA
TNF-alpha mRNA levels
Treatment with okadaic
with okadaic acid
okadaic acid resulted
acid resulted in
resulted in a
in a striking
a striking increase
striking increase in
increase in TNF-alpha
in TNF-alpha mRNA
TNF-alpha mRNA transcripts
mRNA transcripts within
transcripts within 1
within 1 h
1 h of
h of stimulation
of stimulation and
stimulation and large
and large amounts
large amounts of
amounts of TNF-alpha
of TNF-alpha were
TNF-alpha were released
were released into
released into the
into the culture
the culture media
Although okadaic acid
okadaic acid provides
acid provides a
provides a potent
a potent inductive
potent inductive signal
inductive signal for
signal for AP-1
for AP-1 and
AP-1 and NF-kappa
and NF-kappa B
NF-kappa B it
B it did
it did not
did not induce
not induce either
induce either B
either B cell
B cell proliferation
cell proliferation or
proliferation or immunoglobulin
or immunoglobulin secretion
Heterodimerization and transcriptional
and transcriptional activation
transcriptional activation in
activation in vitro
in vitro by
vitro by NF-kappa
by NF-kappa B
NF-kappa B proteins
The NF-kappa B
NF-kappa B family
B family of
family of transcription
of transcription proteins
transcription proteins represents
proteins represents multiple
represents multiple DNA
multiple DNA binding
DNA binding rel
binding rel related
rel related polypeptides
related polypeptides that
polypeptides that contribute
that contribute to
contribute to regulation
to regulation of
regulation of genes
of genes involved
genes involved in
involved in immune
in immune responsiveness
immune responsiveness and
responsiveness and inflammation
and inflammation as
inflammation as well
as well as
well as activation
as activation of
activation of the
of the HIV
the HIV long
HIV long terminal
long terminal repeat
In this study
this study multiple
study multiple NF-kappa
multiple NF-kappa B
NF-kappa B related
B related polypeptides
related polypeptides ranging
polypeptides ranging from
ranging from 85
from 85 to
85 to 45
to 45 kDa
45 kDa were
kDa were examined
were examined for
examined for their
for their capacity
their capacity to
capacity to interact
to interact with
interact with the
with the PRDII
the PRDII regulatory
PRDII regulatory element
regulatory element of
element of interferon
of interferon beta
interferon beta and
beta and were
and were shown
were shown to
shown to possess
to possess distinct
possess distinct intrinsic
distinct intrinsic DNA
intrinsic DNA binding
DNA binding affinities
binding affinities for
affinities for this
for this NF-kappa
this NF-kappa B
NF-kappa B site
B site and
site and form
and form multiple
form multiple DNA
multiple DNA binding
DNA binding homo-
binding homo- and
homo- and heterodimer
and heterodimer complexes
heterodimer complexes in
complexes in co-renaturation
in co-renaturation experiments
Furthermore using DNA
using DNA templates
DNA templates containing
templates containing two
containing two copies
two copies of
copies of the
of the PRDII
the PRDII domain
PRDII domain linked
domain linked to
linked to the
to the rabbit
the rabbit beta
rabbit beta globin
beta globin gene
globin gene the
gene the purified
the purified polypeptides
purified polypeptides specifically
polypeptides specifically stimulated
specifically stimulated NF-kappa
stimulated NF-kappa B
NF-kappa B dependent
B dependent transcription
dependent transcription in
transcription in an
in an in
an in vitro
in vitro reconstitution
vitro reconstitution assay
reconstitution assay as
assay as heterodimers
as heterodimers but
heterodimers but not
but not as
not as p50
as p50 homodimers
These experiments emphasize
experiments emphasize the
emphasize the role
the role of
role of NF-kappa
of NF-kappa B
NF-kappa B dimerization
B dimerization as
dimerization as a
as a distinct
a distinct level
distinct level of
level of transcriptional
of transcriptional control
transcriptional control that
control that may
that may permit
may permit functional
permit functional diversification
functional diversification of
diversification of a
of a limited
a limited number
limited number of
number of regulatory
of regulatory proteins
c-myc mRNA expression
mRNA expression in
expression in minor
in minor salivary
minor salivary glands
salivary glands of
glands of patients
of patients with
patients with Sjogren's
with Sjogren's syndrome
c-myc protooncogene is
protooncogene is implicated
is implicated in
implicated in the
in the pathogenesis
the pathogenesis of
pathogenesis of B
of B cell
B cell lymphoid
cell lymphoid malignancies
lymphoid malignancies and
malignancies and high
and high levels
high levels of
levels of c-myc
of c-myc mRNA
c-myc mRNA expression
mRNA expression are
expression are observed
are observed in
observed in activated
in activated blood
activated blood mononuclear
blood mononuclear cells
Sjogren's syndrome SS
syndrome SS is
SS is characterized
is characterized by
characterized by lymphocytic
by lymphocytic infiltrates
lymphocytic infiltrates of
infiltrates of exocrine
of exocrine glands
exocrine glands remarkable
glands remarkable B
remarkable B cell
B cell hyperreactivity
cell hyperreactivity and
hyperreactivity and a
and a strong
a strong predisposition
strong predisposition to
predisposition to B
to B cell
B cell neoplasia
In this study
this study c-myc
study c-myc protooncogene
c-myc protooncogene mRNA
protooncogene mRNA expression
mRNA expression in
expression in 29
in 29 labial
29 labial minor
labial minor salivary
minor salivary gland
salivary gland biopsies
gland biopsies from
biopsies from patients
from patients with
patients with primary
with primary SS
primary SS and
SS and 15
and 15 controls
15 controls was
controls was examined
was examined using
examined using in
using in situ
in situ hybridization
situ hybridization histochemistry
Two 40mer oligonucleotides
40mer oligonucleotides from
oligonucleotides from the
from the 1st
the 1st and
1st and the
and the 2nd
the 2nd exon
2nd exon of
exon of the
of the c-myc
the c-myc gene
c-myc gene labeled
gene labeled with
labeled with 35S
with 35S were
35S were used
were used as
used as probes
To detect the
detect the origin
the origin of
origin of the
of the cell
the cell hybridized
cell hybridized with
hybridized with a
with a c-myc
a c-myc probe
c-myc probe a
probe a combined
a combined immunochemistry
combined immunochemistry in
immunochemistry in situ
in situ hybridization
situ hybridization histochemistry
hybridization histochemistry technique
histochemistry technique was
technique was used
High c-myc mRNA
c-myc mRNA expression
mRNA expression was
expression was detected
was detected on
detected on acinar
on acinar epithelial
acinar epithelial cells
c-myc did not
did not correlate
not correlate with
correlate with c-fos
with c-fos and
c-fos and c-jun
and c-jun protein
c-jun protein expression
Stronger c-myc mRNA
c-myc mRNA expression
mRNA expression was
expression was detected
was detected in
detected in labial
in labial salivary
labial salivary glands
salivary glands of
glands of patients
of patients with
patients with longer
with longer disease
longer disease duration
disease duration p
duration p less
p less than
less than or
than or equal
or equal to
equal to 0002
to 0002 and
0002 and more
and more intense
more intense T
intense T lymphocyte
T lymphocyte infiltrates
lymphocyte infiltrates p
infiltrates p less
p less than
less than 005
than 005 although
005 although these
although these patients
these patients revealed
patients revealed no
revealed no hypergammaglobulinemia
No correlation was
correlation was observed
was observed between
observed between c-myc
between c-myc mRNA
c-myc mRNA and
mRNA and B
and B lymphocyte
B lymphocyte monoclonicity
lymphocyte monoclonicity or
monoclonicity or lymphoma
In conclusion strong
conclusion strong c-myc
strong c-myc mRNA
c-myc mRNA expression
mRNA expression was
expression was observed
was observed on
observed on epithelial
on epithelial cells
epithelial cells of
cells of labial
of labial salivary
labial salivary glands
salivary glands from
glands from patients
from patients with
patients with primary
with primary SS
Our findings may
findings may indicate
may indicate the
indicate the presence
the presence of
presence of a
of a reactivated
a reactivated virus
reactivated virus hosted
virus hosted in
hosted in these
in these cells
Corticosteroid receptors and
receptors and lymphocyte
and lymphocyte subsets
lymphocyte subsets in
subsets in mononuclear
in mononuclear leukocytes
mononuclear leukocytes in
leukocytes in aging
Plasma cortisol and
cortisol and aldosterone
and aldosterone levels
aldosterone levels and
levels and number
and number of
number of related
of related receptors
related receptors in
receptors in mononuclear
in mononuclear leukocytes
mononuclear leukocytes were
leukocytes were measured
were measured in
measured in 49
in 49 healthy
49 healthy aged
healthy aged subjects
aged subjects 62-97
subjects 62-97 yr
62-97 yr and
yr and in
and in 21
in 21 adult
21 adult controls
adult controls 21-50
controls 21-50 yr
In all subjects
all subjects in
subjects in addition
in addition lymphocyte
addition lymphocyte subsets
lymphocyte subsets were
subsets were determined
were determined as
determined as an
as an index
an index of
index of corticosteroid
of corticosteroid action
The mean number
mean number of
number of type
of type I
type I and
I and type
and type II
type II receptors
II receptors was
receptors was significantly
was significantly lower
significantly lower in
lower in aged
in aged subjects
aged subjects than
subjects than in
than in controls
in controls respectively
controls respectively 198
respectively 198 +/-
198 +/- 96
+/- 96 and
96 and 272
and 272 +/-
272 +/- 97
+/- 97 receptors/cell
97 receptors/cell for
receptors/cell for type
for type I
type I and
I and 1794
and 1794 +/-
1794 +/- 803
+/- 803 and
803 and 3339
and 3339 +/-
3339 +/- 918
+/- 918 for
918 for type
for type II
type II receptors
Plasma aldosterone and
aldosterone and cortisol
and cortisol and
cortisol and lymphocyte
and lymphocyte subsets
lymphocyte subsets were
subsets were not
were not different
not different in
different in the
in the two
the two groups
All of the
of the parameters
the parameters were
parameters were also
were also tested
also tested for
tested for correlation
for correlation and
correlation and a
and a significant
a significant inverse
significant inverse correlation
inverse correlation was
correlation was found
was found between
found between age
between age and
age and type
and type I
type I and
I and type
and type II
type II receptors
II receptors when
receptors when all
when all subjects
all subjects were
subjects were plotted
were plotted and
plotted and between
and between aged
between aged and
aged and CD4
and CD4 and
CD4 and age
and age and
age and CD4/CD8
and CD4/CD8 in
CD4/CD8 in the
in the aged
the aged group
These data show
data show that
show that aged
that aged subjects
aged subjects have
subjects have reductions
have reductions of
reductions of corticosteroid
of corticosteroid receptors
corticosteroid receptors that
receptors that are
that are not
are not associated
not associated with
associated with increase
with increase of
increase of related
of related steroids
related steroids and
steroids and that
and that this
that this situation
this situation probably
situation probably represents
probably represents a
represents a concomitant
a concomitant of
concomitant of the
of the normal
the normal aging
normal aging process
T cell-specific negative
cell-specific negative regulation
negative regulation of
regulation of transcription
of transcription of
transcription of the
of the human
the human cytokine
human cytokine IL-4
IL-4 secreted by
secreted by activated
by activated T
activated T cells
T cells is
cells is a
is a pleiotropic
a pleiotropic cytokine
pleiotropic cytokine affecting
cytokine affecting growth
affecting growth and
growth and differentiation
and differentiation of
differentiation of diverse
of diverse cell
diverse cell types
cell types such
types such as
such as T
as T cells
T cells B
cells B cells
B cells and
cells and mast
and mast cells
We investigated the
investigated the upstream
the upstream regulatory
upstream regulatory elements
regulatory elements of
elements of the
of the human
the human IL-4
human IL-4 promoter
A novel T
novel T cell-specific
T cell-specific negative
cell-specific negative regulatory
negative regulatory element
regulatory element NRE
element NRE composed
NRE composed of
composed of two
of two protein-binding
two protein-binding sites
protein-binding sites were
sites were mapped
were mapped in
mapped in the
in the 5'
the 5' flanking
5' flanking region
flanking region of
region of the
of the IL-4
the IL-4 gene:
IL-4 gene: -311CTCCCTTCT-303
gene: -311CTCCCTTCT-303 NRE-I
-311CTCCCTTCT-303 NRE-I and
NRE-I and -288CTTTTTGCTT-TGC-300
and -288CTTTTTGCTT-TGC-300 NRE-II
A T cell-specific
T cell-specific protein
cell-specific protein Neg-1
protein Neg-1 and
Neg-1 and a
and a ubiquitous
a ubiquitous protein
ubiquitous protein Neg-2
protein Neg-2 binding
Neg-2 binding to
binding to NRE-I
to NRE-I and
NRE-I and NRE-II
and NRE-II respectively
NRE-II respectively were
respectively were identified
Furthermore a positive
a positive regulatory
positive regulatory element
regulatory element was
element was found
was found 45
found 45 bp
45 bp downstream
bp downstream of
downstream of the
of the NRE
The enhancer activity
enhancer activity of
activity of the
of the PRE
the PRE was
PRE was completely
was completely suppressed
completely suppressed when
suppressed when the
when the NRE
the NRE was
NRE was present
These data suggest
data suggest that
suggest that IL-4
that IL-4 promoter
IL-4 promoter activity
promoter activity is
activity is normally
is normally down-regulated
normally down-regulated by
down-regulated by an
by an NRE
an NRE via
NRE via repression
via repression of
repression of the
of the enhancer
the enhancer positive
enhancer positive regulatory
positive regulatory element
These data may
data may have
may have implications
have implications for
implications for the
for the stringent
the stringent control
stringent control of
control of IL-4
of IL-4 expression
IL-4 expression in
expression in T
in T cells
Interleukin 6-induced differentiation
6-induced differentiation of
differentiation of a
of a human
a human B
human B cell
B cell line
cell line into
line into IgM-secreting
into IgM-secreting plasma
IgM-secreting plasma cells
plasma cells is
cells is mediated
is mediated by
mediated by c-fos
The role of
role of the
of the protooncogene
the protooncogene c-fos
protooncogene c-fos in
c-fos in interleukin
in interleukin IL
interleukin IL 6-induced
IL 6-induced B
6-induced B cell
B cell differentiation
cell differentiation was
differentiation was assessed
Treatment of SKW
of SKW 64
SKW 64 cells
64 cells with
cells with IL
with IL 6
IL 6 induced
6 induced a
induced a transient
a transient and
transient and early
and early stimulation
early stimulation of
stimulation of c-fos
of c-fos sense
c-fos sense mRNA
sense mRNA expression
The effect appeared
effect appeared within
appeared within 30
within 30 min
30 min and
min and returned
and returned to
returned to basal
to basal levels
basal levels after
levels after 2
after 2 h
The addition of
addition of antisense
of antisense oligonucleotides
antisense oligonucleotides to
oligonucleotides to c-fos
to c-fos significantly
c-fos significantly inhibited
significantly inhibited IL
inhibited IL 6-induced
IL 6-induced IgM
6-induced IgM production
IgM production by
production by SKW
by SKW 64
SKW 64 cells
64 cells p
cells p less
p less than
less than 0001
than 0001 whereas
0001 whereas control
whereas control oligonucleotides
control oligonucleotides had
oligonucleotides had no
had no inhibitory
no inhibitory effect
These results indicate
results indicate that
indicate that activation
that activation of
activation of c-fos
of c-fos is
c-fos is involved
is involved in
involved in IL
in IL 6-induced
IL 6-induced differentiation
6-induced differentiation of
differentiation of SKW
of SKW 64
SKW 64 cells
64 cells into
cells into IgM-secreting
into IgM-secreting cells
Transcriptional regulation during
regulation during T-cell
during T-cell development:
T-cell development: the
development: the alpha
the alpha TCR
alpha TCR gene
TCR gene as
gene as a
as a molecular
a molecular model
The regulation of
regulation of gene
of gene expression
gene expression during
expression during lymphocyte
during lymphocyte differentiation
lymphocyte differentiation is
differentiation is a
is a complex
a complex process
complex process involving
process involving interactions
involving interactions between
interactions between multiple
between multiple positive
multiple positive and
positive and negative
and negative transcriptional
negative transcriptional regulatory
transcriptional regulatory elements
In this article
this article transcriptional
article transcriptional regulation
transcriptional regulation of
regulation of the
of the archetypal
the archetypal T-cell-specific
archetypal T-cell-specific gene
T-cell-specific gene alpha
gene alpha TCR
alpha TCR is
TCR is discussed
Major recent developments
recent developments including
developments including the
including the identification
the identification of
identification of novel
of novel families
novel families of
families of transcription
of transcription factors
transcription factors that
factors that regulate
that regulate multiple
regulate multiple T-cell
multiple T-cell genes
T-cell genes during
genes during thymocyte
during thymocyte ontogeny
thymocyte ontogeny and
ontogeny and T-cell
and T-cell activation
T-cell activation are
activation are described
Photoaffinity labeling of
labeling of plasma
of plasma membrane
plasma membrane receptors
membrane receptors for
receptors for aldosterone
for aldosterone from
aldosterone from human
from human mononuclear
human mononuclear leukocytes
Non-genomic effects of
effects of aldosterone
of aldosterone on
aldosterone on the
on the sodium-proton-antiport
the sodium-proton-antiport have
sodium-proton-antiport have been
have been shown
been shown in
shown in human
in human mononuclear
human mononuclear leukocytes
mononuclear leukocytes which
leukocytes which could
which could be
could be related
be related to
related to a
to a new
a new aldosterone
new aldosterone membrane
aldosterone membrane receptor
In the present
the present paper
present paper plasma
paper plasma membranes
plasma membranes from
membranes from human
from human mononuclear
human mononuclear leukocytes
mononuclear leukocytes were
leukocytes were covalently
were covalently photolabeled
covalently photolabeled with
photolabeled with a
with a [125I]-aldosterone
a [125I]-aldosterone derivative
Sodium dodecyl sulfate-polyacrylamide
dodecyl sulfate-polyacrylamide gel
sulfate-polyacrylamide gel electrophoresis
gel electrophoresis showed
electrophoresis showed significant
showed significant aldosterone
significant aldosterone binding
aldosterone binding at
binding at a
at a molecular
a molecular weight
molecular weight of
weight of approximately
of approximately 50000
approximately 50000 Dalton
50000 Dalton which
Dalton which was
which was absent
was absent with
absent with 1
with 1 microM
1 microM cold
microM cold aldosterone
cold aldosterone but
aldosterone but not
but not cortisol
not cortisol in
cortisol in the
in the binding
the binding media
The presence of
presence of the
of the sulfhydryl
the sulfhydryl agent
sulfhydryl agent dithiothreitol
agent dithiothreitol did
dithiothreitol did not
did not affect
not affect results
affect results suggesting
results suggesting the
suggesting the absence
the absence of
absence of disulfide
of disulfide bridges
disulfide bridges in
bridges in the
in the steroid
the steroid binding
steroid binding domain
binding domain of
domain of the
of the receptor
These data are
data are the
are the first
the first to
first to define
to define the
define the molecular
the molecular weight
molecular weight of
weight of the
of the membrane
the membrane receptor
membrane receptor for
receptor for aldosterone
Redox status of
status of cells
of cells influences
cells influences constitutive
influences constitutive or
constitutive or induced
or induced NF-kappa
induced NF-kappa B
NF-kappa B translocation
B translocation and
translocation and HIV
and HIV long
HIV long terminal
long terminal repeat
terminal repeat activity
repeat activity in
activity in human
in human T
human T and
T and monocytic
and monocytic cell
monocytic cell lines
We have tested
have tested the
tested the hypothesis
the hypothesis that
hypothesis that cellular
that cellular activation
cellular activation events
activation events occurring
events occurring in
occurring in T
in T lymphocytes
T lymphocytes and
lymphocytes and monocytes
and monocytes and
monocytes and mediated
and mediated through
mediated through translocation
through translocation of
translocation of the
of the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B are
B are dependent
are dependent upon
dependent upon the
upon the constitutive
the constitutive redox
constitutive redox status
redox status of
status of these
of these cells
We used phenolic
used phenolic lipid-soluble
phenolic lipid-soluble chain-breaking
lipid-soluble chain-breaking antioxidants
chain-breaking antioxidants butylated
antioxidants butylated hydroxyanisole
butylated hydroxyanisole BHA
hydroxyanisole BHA nordihydroquairetic
BHA nordihydroquairetic acid
nordihydroquairetic acid or
acid or alpha-tocopherol
or alpha-tocopherol vitamin
alpha-tocopherol vitamin E
vitamin E to
E to show
to show that
show that peroxyl
that peroxyl radical
peroxyl radical scavenging
radical scavenging in
scavenging in unstimulated
in unstimulated and
unstimulated and PMA-
and PMA- or
PMA- or TNF-stimulated
or TNF-stimulated cells
TNF-stimulated cells blocks
cells blocks the
blocks the functions
the functions depending
functions depending on
depending on NF-kappa
on NF-kappa B
NF-kappa B activation
BHA was found
was found to
found to suppress
to suppress not
suppress not only
not only PMA-
only PMA- or
PMA- or TNF-induced
or TNF-induced but
TNF-induced but also
but also constitutive
also constitutive HIV-enhancer
constitutive HIV-enhancer activity
HIV-enhancer activity concomitant
activity concomitant to
concomitant to an
to an inhibition
an inhibition of
inhibition of NF-kappa
of NF-kappa B
NF-kappa B binding
B binding activity
binding activity in
activity in both
in both lymphoblastoid
both lymphoblastoid T
lymphoblastoid T JJhan
T JJhan and
JJhan and monocytic
and monocytic U937
monocytic U937 cell
U937 cell lines
This was also
was also true
also true for
true for KBF
for KBF p50
KBF p50 homodimer
p50 homodimer binding
homodimer binding activity
binding activity in
activity in U937
in U937 cells
Secretion of TNF
of TNF the
TNF the product
the product of
product of another
of another NF-kappa
another NF-kappa B-dependent
NF-kappa B-dependent gene
B-dependent gene was
gene was abolished
was abolished by
abolished by BHA
by BHA in
BHA in PMA-stimulated
in PMA-stimulated U937
PMA-stimulated U937 cells
The anti-oxidative effect
anti-oxidative effect of
effect of BHA
of BHA was
BHA was accompanied
was accompanied by
accompanied by an
by an increase
an increase in
increase in thiol
in thiol but
thiol but not
but not glutathione
not glutathione content
glutathione content in
content in stimulated
in stimulated and
stimulated and unstimulated
and unstimulated T
unstimulated T cell
T cell whereas
cell whereas TNF
whereas TNF stimulation
TNF stimulation itself
stimulation itself barely
itself barely modified
barely modified the
modified the cellular
the cellular thiol
cellular thiol level
Oxidative stress obtained
stress obtained by
obtained by the
by the addition
the addition of
addition of H2O2
of H2O2 to
H2O2 to the
to the culture
the culture medium
culture medium of
medium of JJhan
of JJhan or
JJhan or U937
or U937 cells
U937 cells could
cells could not
could not by
not by itself
by itself induce
itself induce NF-kappa
induce NF-kappa B
NF-kappa B activation
These observations suggest
observations suggest that
suggest that TNF
that TNF and
TNF and PMA
and PMA do
PMA do not
do not lead
not lead to
lead to NF-kappa
to NF-kappa B
NF-kappa B activation
B activation through
activation through induction
through induction of
induction of changes
of changes in
changes in the
in the cell
the cell redox
cell redox status
Rather TNF and
TNF and PMA
and PMA can
PMA can exert
can exert their
exert their effect
their effect only
effect only if
only if cells
if cells are
cells are in
are in an
in an appropriate
an appropriate redox
appropriate redox status
redox status because
status because prior
because prior modification
prior modification toward
modification toward reduction
toward reduction with
reduction with BHA
with BHA treatment
BHA treatment prevents
treatment prevents this
prevents this activation
It appears that
appears that a
that a basal
a basal redox
basal redox equilibrium
redox equilibrium tending
equilibrium tending toward
tending toward oxidation
toward oxidation is
oxidation is a
is a prerequisite
a prerequisite for
prerequisite for full
for full activation
full activation of
activation of transduction
of transduction pathways
transduction pathways regulating
pathways regulating the
regulating the activity
the activity of
activity of NF-kappa
of NF-kappa B-dependent
NF-kappa B-dependent genes
Selection of optimal
of optimal kappa
optimal kappa B/Rel
kappa B/Rel DNA-binding
B/Rel DNA-binding motifs:
DNA-binding motifs: interaction
motifs: interaction of
interaction of both
of both subunits
both subunits of
subunits of NF-kappa
of NF-kappa B
NF-kappa B with
B with DNA
with DNA is
DNA is required
is required for
required for transcriptional
for transcriptional activation
Analysis of the
of the p50
the p50 and
p50 and p65
and p65 subunits
p65 subunits of
subunits of the
of the NF-kappa
the NF-kappa B
NF-kappa B transcription
B transcription factor
transcription factor complex
factor complex has
complex has revealed
has revealed that
revealed that both
that both proteins
both proteins can
proteins can interact
can interact with
interact with related
with related DNA
related DNA sequences
DNA sequences through
sequences through either
through either homo-
either homo- or
homo- or heterodimer
or heterodimer formation
In addition the
addition the product
the product of
product of the
of the proto-oncogene
the proto-oncogene c-rel
proto-oncogene c-rel can
c-rel can bind
can bind to
bind to similar
to similar DNA
similar DNA motifs
DNA motifs by
motifs by itself
by itself or
itself or as
or as a
as a heterodimer
a heterodimer with
heterodimer with p50
with p50 or
p50 or p65
However these studies
these studies have
studies have used
have used a
used a limited
a limited number
limited number of
number of known
of known kappa
known kappa B
kappa B DNA
B DNA motifs
DNA motifs and
motifs and the
and the question
the question of
question of the
of the optimal
the optimal DNA
optimal DNA sequences
DNA sequences preferred
sequences preferred by
preferred by each
by each homodimer
each homodimer has
homodimer has not
has not been
not been addressed
Using purified recombinant
purified recombinant p50
recombinant p50 p65
p50 p65 and
p65 and c-Rel
and c-Rel proteins
c-Rel proteins optimal
proteins optimal DNA-binding
optimal DNA-binding motifs
DNA-binding motifs were
motifs were selected
were selected from
selected from a
from a pool
a pool of
pool of random
of random oligonucleotides
Alignment of the
of the selected
the selected sequences
selected sequences allowed
sequences allowed us
allowed us to
us to predict
to predict a
predict a consensus
a consensus sequence
consensus sequence for
sequence for binding
for binding of
binding of the
of the individual
the individual homodimeric
individual homodimeric Rel-related
homodimeric Rel-related proteins
Rel-related proteins and
proteins and DNA-protein
and DNA-protein binding
DNA-protein binding analysis
binding analysis of
analysis of the
of the selected
the selected DNA
selected DNA sequences
DNA sequences revealed
sequences revealed sequence
revealed sequence specificity
sequence specificity of
specificity of the
of the proteins
Contrary to previous
to previous assumptions
previous assumptions we
assumptions we observed
we observed that
observed that p65
that p65 homodimers
p65 homodimers can
homodimers can interact
can interact with
interact with a
with a subset
a subset of
subset of DNA
of DNA sequences
DNA sequences not
sequences not recognized
not recognized by
recognized by p50
by p50 homodimers
Differential binding affinities
binding affinities were
affinities were also
were also obtained
also obtained with
obtained with p50-
with p50- and
p50- and c-Rel-selected
and c-Rel-selected sequences
Using either a
either a p50-
a p50- or
p50- or p65-
or p65- selected
p65- selected kappa
selected kappa B
kappa B motif
B motif which
motif which displayed
which displayed differential
displayed differential binding
differential binding with
binding with respect
with respect to
respect to the
to the other
the other protein
other protein little
protein little to
little to no
to no binding
no binding was
binding was observed
was observed with
observed with the
with the heterodimeric
the heterodimeric NF-kappa
heterodimeric NF-kappa B
NF-kappa B complex
Similarly in transfection
in transfection experiments
transfection experiments in
experiments in which
in which the
which the selective
the selective kappa
selective kappa B
kappa B binding
B binding sites
binding sites were
sites were used
were used to
used to drive
to drive the
drive the expression
the expression of
expression of a
of a chloramphenicol
a chloramphenicol acetyltransferase
chloramphenicol acetyltransferase reporter
acetyltransferase reporter construct
reporter construct the
construct the p65
the p65 -and
p65 -and p50-selected
-and p50-selected motifs
p50-selected motifs were
motifs were activated
were activated only
activated only in
only in the
in the presence
the presence of
presence of p65
of p65 and
p65 and p50/65
and p50/65 a
p50/65 a chimeric
a chimeric protein
chimeric protein with
protein with the
with the p50
the p50 DNA
p50 DNA binding
DNA binding domain
binding domain and
domain and p65
and p65 activation
p65 activation domain
activation domain expression
domain expression vectors
expression vectors respectively
vectors respectively and
respectively and neither
and neither demonstrated
neither demonstrated a
demonstrated a significant
a significant response
significant response to
response to stimuli
to stimuli that
stimuli that induce
that induce NF-kappa
induce NF-kappa B
NF-kappa B activity
These findings demonstrate
findings demonstrate that
demonstrate that interaction
that interaction of
interaction of both
of both subunits
both subunits of
subunits of the
of the heterodimeric
the heterodimeric NF-kappa
heterodimeric NF-kappa B
NF-kappa B complex
B complex with
complex with DNA
with DNA is
DNA is required
is required for
required for DNA
for DNA binding
DNA binding and
binding and transcriptional
and transcriptional activation
transcriptional activation and
activation and suggest
and suggest that
suggest that transcriptional
that transcriptional activation
transcriptional activation mediated
activation mediated by
mediated by the
by the individual
the individual rel-related
individual rel-related proteins
rel-related proteins will
proteins will differ
will differ dramatically
differ dramatically depending
dramatically depending on
depending on the
on the specific
the specific kappa
specific kappa B
kappa B motifs
B motifs present
NF-kappa B-dependent induction
B-dependent induction of
induction of the
of the NF-kappa
the NF-kappa B
NF-kappa B p50
B p50 subunit
p50 subunit gene
subunit gene promoter
gene promoter underlies
promoter underlies self-perpetuation
underlies self-perpetuation of
self-perpetuation of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus transcription
virus transcription in
transcription in monocytic
in monocytic cells
The molecular mechanisms
molecular mechanisms underlying
mechanisms underlying the
underlying the sustained
the sustained nuclear
sustained nuclear translocation
nuclear translocation of
translocation of NF-kappa
of NF-kappa B
NF-kappa B observed
B observed in
observed in U937
in U937 monocytic
U937 monocytic cells
monocytic cells chronically
cells chronically infected
chronically infected with
infected with human
with human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV were
HIV were studied
The activity of
activity of the
of the promoter
the promoter regulating
promoter regulating the
regulating the synthesis
the synthesis of
synthesis of the
of the p105
the p105 precursor
p105 precursor of
precursor of the
of the NF-kappa
the NF-kappa B
NF-kappa B p50
B p50 subunit
p50 subunit was
subunit was enhanced
was enhanced in
enhanced in these
in these cells
Deletions in this
in this promoter
this promoter indicated
promoter indicated that
indicated that this
that this upregulation
this upregulation was
upregulation was mediated
was mediated through
mediated through the
through the NF-kappa
the NF-kappa B-
NF-kappa B- but
B- but not
but not the
not the AP-1-binding
the AP-1-binding motif
AP-1-binding motif by
motif by bona
by bona fide
bona fide p50/p65
fide p50/p65 heterodimers
Analysis of cytosolic
of cytosolic extracts
cytosolic extracts indicated
extracts indicated that
indicated that NF-kappa
that NF-kappa B
NF-kappa B levels
B levels were
levels were increased
were increased in
increased in HIV-infected
in HIV-infected cells
In contrast to
contrast to the
to the transient
the transient NF-kappa
transient NF-kappa B
NF-kappa B activation
B activation induced
activation induced by
induced by phorbol
by phorbol ester
phorbol ester the
ester the permanent
the permanent NF-kappa
permanent NF-kappa B
NF-kappa B translocation
B translocation induced
translocation induced by
induced by HIV
by HIV infection
HIV infection was
infection was not
was not dependent
not dependent on
dependent on PKC
on PKC isoenzymes
PKC isoenzymes alpha
isoenzymes alpha and
alpha and beta
and beta as
beta as shown
as shown by
shown by the
by the use
the use of
use of a
of a specific
a specific inhibitor
specific inhibitor GF
inhibitor GF 109203X
These observations indicate
observations indicate that
indicate that during
that during chronic
during chronic HIV
chronic HIV infection
HIV infection of
infection of U937
of U937 cells
U937 cells continuous
cells continuous NF-kappa
continuous NF-kappa B
NF-kappa B p50/p65
B p50/p65 translocation
p50/p65 translocation results
translocation results in
results in p105
in p105 promoter
p105 promoter upregulation
promoter upregulation with
upregulation with subsequent
with subsequent cytosolic
subsequent cytosolic NF-kappa
cytosolic NF-kappa B
NF-kappa B accumulation
B accumulation ready
accumulation ready for
ready for further
for further translocation
This HIV-mediated mechanism
HIV-mediated mechanism results
mechanism results in
results in a
in a self-perpetuating
a self-perpetuating loop
self-perpetuating loop of
loop of NF-kappa
of NF-kappa B
NF-kappa B production
Activation of NF-kappa
of NF-kappa B
NF-kappa B by
B by interleukin
by interleukin 2
interleukin 2 in
2 in human
in human blood
human blood monocytes
We report here
report here that
here that interleukin
that interleukin 2
interleukin 2 IL-2
2 IL-2 acts
IL-2 acts on
acts on human
on human blood
human blood monocytes
blood monocytes by
monocytes by enhancing
by enhancing binding
enhancing binding activity
binding activity of
activity of the
of the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B to
B to its
to its consensus
its consensus sequence
consensus sequence in
sequence in the
in the 5'
the 5' regulatory
5' regulatory enhancer
regulatory enhancer region
enhancer region of
region of the
of the IL-2
the IL-2 receptor
IL-2 receptor alpha
receptor alpha chain
alpha chain p55
Similarly IL-2 activates
IL-2 activates NF-kappa
activates NF-kappa B
NF-kappa B in
B in the
in the human
the human monocytic
human monocytic cell
monocytic cell line
cell line U
line U 937
U 937 but
937 but not
but not in
not in resting
in resting human
resting human T-cells
This effect is
effect is detectable
is detectable within
detectable within 15
within 15 min
15 min and
min and peaks
and peaks 1
peaks 1 h
1 h after
h after exposure
after exposure to
exposure to IL-2
Enhanced NF-kappa B
NF-kappa B binding
B binding activity
binding activity is
activity is followed
is followed by
followed by functional
by functional activation
functional activation in
activation in that
in that inducibility
that inducibility of
inducibility of the
of the IL-2
the IL-2 receptor
IL-2 receptor alpha
receptor alpha chain
alpha chain is
chain is mediated
is mediated by
mediated by enhanced
by enhanced NF-kappa
enhanced NF-kappa B
NF-kappa B binding
B binding and
binding and that
and that a
that a heterologous
a heterologous promoter
heterologous promoter containing
promoter containing the
containing the NF-kappa
the NF-kappa B
NF-kappa B consensus
B consensus sequence
consensus sequence -291
sequence -291 to
-291 to -245
to -245 of
-245 of the
of the IL-2
the IL-2 receptor
IL-2 receptor alpha
receptor alpha chain
alpha chain gene
chain gene is
gene is activated
In addition IL-2
addition IL-2 is
IL-2 is capable
is capable of
capable of increasing
of increasing transcript
increasing transcript levels
transcript levels of
levels of the
of the p50
the p50 gene
p50 gene coding
gene coding for
coding for the
for the p50
the p50 subunit
p50 subunit of
subunit of the
of the NF-kappa
the NF-kappa B
NF-kappa B transcription
B transcription factor
transcription factor whereas
factor whereas mRNA
whereas mRNA levels
mRNA levels of
levels of the
of the p65
the p65 NF-kappa
p65 NF-kappa B
NF-kappa B gene
B gene remained
gene remained unchanged
Studies on the
on the biological
the biological activity
biological activity of
activity of triiodothyronine
of triiodothyronine sulfate
Hepatic microsomes and
microsomes and isolated
and isolated hepatocytes
isolated hepatocytes in
hepatocytes in short
in short term
short term culture
term culture desulfate
culture desulfate T3
desulfate T3 sulfate
T3 sulfate T3SO4
We therefore wished
therefore wished to
wished to determine
to determine whether
determine whether T3SO4
whether T3SO4 could
T3SO4 could mimic
could mimic the
mimic the action
the action of
action of thyroid
of thyroid hormone
thyroid hormone in
hormone in vitro
T3SO4 had no
had no thyromimetic
no thyromimetic effect
thyromimetic effect on
effect on the
on the activity
the activity of
activity of Ca2+-ATPase
of Ca2+-ATPase in
Ca2+-ATPase in human
in human erythrocyte
human erythrocyte membranes
erythrocyte membranes at
membranes at doses
at doses up
doses up to
up to 10000
to 10000 times
10000 times the
times the maximally
the maximally effective
maximally effective dose
effective dose of
dose of T3
of T3 10-10
T3 10-10 mol/L
In GH4C1 pituitary
GH4C1 pituitary cells
pituitary cells T3SO4
cells T3SO4 failed
T3SO4 failed to
failed to displace
to displace [125I]T3
displace [125I]T3 from
[125I]T3 from nuclear
from nuclear receptors
nuclear receptors in
receptors in intact
in intact cells
intact cells or
cells or soluble
or soluble preparations
Thus T3SO4 was
T3SO4 was not
was not directly
not directly thyromimetic
directly thyromimetic in
thyromimetic in either
in either an
either an isolated
an isolated human
isolated human membrane
human membrane system
membrane system or
system or a
or a pituitary
a pituitary cell
pituitary cell system
cell system in
system in which
in which nuclear
which nuclear receptor
nuclear receptor occupancy
receptor occupancy correlates
occupancy correlates with
correlates with GH
with GH synthesis
Thyroid hormones inhibit
hormones inhibit [3H]glycosaminoglycan
inhibit [3H]glycosaminoglycan synthesis
[3H]glycosaminoglycan synthesis by
synthesis by cultured
by cultured human
cultured human dermal
human dermal fibroblasts
dermal fibroblasts and
fibroblasts and T3SO4
and T3SO4 displayed
T3SO4 displayed about
displayed about 05%
about 05% the
05% the activity
the activity of
activity of T3
of T3 at
T3 at 72
at 72 h
Human fibroblasts contained
fibroblasts contained roughly
contained roughly the
roughly the same
the same level
same level of
level of microsomal
of microsomal p-nitrophenyl
microsomal p-nitrophenyl sulfatase
p-nitrophenyl sulfatase activity
sulfatase activity as
activity as that
as that previously
that previously observed
previously observed in
observed in hepatic
in hepatic microsomes
Propylthiouracil 50 mumol/L
50 mumol/L did
mumol/L did not
did not affect
not affect the
affect the action
the action of
action of T3SO4
of T3SO4 suggesting
T3SO4 suggesting that
suggesting that deiodination
that deiodination was
deiodination was not
was not important
not important for
important for this
for this activity
this activity of
activity of T3SO4
Thus it appears
it appears T3SO4
appears T3SO4 has
T3SO4 has no
has no intrinsic
no intrinsic biological
intrinsic biological activity
biological activity but
activity but under
but under certain
under certain circumstances
certain circumstances may
circumstances may be
may be reactivated
be reactivated by
reactivated by desulfation
Human T cell
T cell activation
cell activation through
activation through the
through the activation-inducer
the activation-inducer molecule/CD69
activation-inducer molecule/CD69 enhances
molecule/CD69 enhances the
enhances the activity
the activity of
activity of transcription
of transcription factor
transcription factor AP-1
The induction of
induction of the
of the AP-1
the AP-1 transcription
AP-1 transcription factor
transcription factor has
factor has been
has been ascribed
been ascribed to
ascribed to the
to the early
the early events
early events leading
events leading to
leading to T
to T cell
T cell differentiation
cell differentiation and
differentiation and activation
We have studied
have studied the
studied the regulation
the regulation of
regulation of AP-1
of AP-1 activity
AP-1 activity in
activity in human
in human peripheral
human peripheral blood
peripheral blood T
blood T lymphocytes
T lymphocytes stimulated
lymphocytes stimulated through
stimulated through the
through the activation
the activation inducer
activation inducer molecule
inducer molecule AIM/CD69
molecule AIM/CD69 activation
AIM/CD69 activation pathway
Phorbol esters are
esters are required
are required to
required to induce
to induce AIM/CD69
induce AIM/CD69 cell-surface
AIM/CD69 cell-surface expression
cell-surface expression as
expression as well
as well as
well as for
as for triggering
for triggering the
triggering the proliferation
the proliferation of
proliferation of T
of T cells
T cells in
cells in conjunction
in conjunction with
conjunction with anti-AIM
with anti-AIM mAb
Mobility shift assays
shift assays showed
assays showed that
showed that addition
that addition of
addition of anti-AIM
of anti-AIM mAb
anti-AIM mAb to
mAb to PMA-treated
to PMA-treated T
PMA-treated T lymphocytes
T lymphocytes markedly
lymphocytes markedly enhanced
markedly enhanced the
enhanced the binding
the binding activity
binding activity of
activity of AP-1
of AP-1 to
AP-1 to its
to its cognate
its cognate sequence
cognate sequence the
sequence the phorbol
the phorbol ester
phorbol ester response
ester response element
In contrast anti-AIM
contrast anti-AIM mAb
anti-AIM mAb did
mAb did not
did not induce
not induce any
induce any change
any change in
change in the
in the binding
the binding activity
binding activity of
activity of NF-kappa
of NF-kappa B
NF-kappa B a
B a transcription
a transcription factor
transcription factor whose
factor whose activity
whose activity is
activity is also
is also regulated
also regulated by
regulated by protein
by protein kinase
protein kinase C
The increase in
increase in AP-1-binding
in AP-1-binding activity
AP-1-binding activity was
activity was accompanied
was accompanied by
accompanied by the
by the marked
the marked stimulation
marked stimulation of
stimulation of the
of the transcription
the transcription of
transcription of c-fos
of c-fos but
c-fos but not
but not that
not that of
that of c-jun
Blockade of the
of the DNA-binding
the DNA-binding complexes
DNA-binding complexes with
complexes with an
with an anti-Fos
an anti-Fos mAb
anti-Fos mAb demonstrated
mAb demonstrated a
demonstrated a direct
a direct participation
direct participation of
participation of c-Fos
of c-Fos in
c-Fos in the
in the AP-1
the AP-1 complexes
AP-1 complexes induced
complexes induced by
induced by anti-AIM
by anti-AIM mAb
Most of the
of the AP-1
the AP-1 activity
AP-1 activity could
activity could be
could be eliminated
be eliminated when
eliminated when the
when the anti-AIM
the anti-AIM mAb
anti-AIM mAb was
mAb was added
was added to
added to the
to the culture
the culture medium
culture medium in
medium in the
in the presence
the presence of
presence of cycloheximide
of cycloheximide suggesting
cycloheximide suggesting that
suggesting that de
that de novo
de novo protein
novo protein synthesis
protein synthesis is
synthesis is crucial
is crucial for
crucial for the
for the induction
the induction of
induction of AP-1-binding
of AP-1-binding activity
These data provide
data provide the
provide the evidence
the evidence that
evidence that activation
that activation of
activation of human
of human peripheral
human peripheral blood
peripheral blood T
blood T cells
T cells through
cells through the
through the AIM
the AIM activation
AIM activation pathway
activation pathway regulate
pathway regulate the
regulate the activity
the activity of
activity of AP-1
Therefore this pathway
this pathway appears
pathway appears as
appears as a
as a crucial
a crucial step
crucial step in
step in the
in the initiation
the initiation of
initiation of early
of early T
early T cell
T cell activation
cell activation events
Gangliosides suppress tumor
suppress tumor necrosis
tumor necrosis factor
necrosis factor production
factor production in
production in human
in human monocytes
Both normal and
normal and malignant
and malignant cells
malignant cells contain
cells contain gangliosides
contain gangliosides as
gangliosides as important
as important cell
important cell membrane
cell membrane constituents
membrane constituents that
constituents that after
that after being
after being shed
being shed may
shed may influence
may influence cells
influence cells of
cells of the
of the immune
the immune system
We have studied
have studied the
studied the impact
the impact of
impact of gangliosides
of gangliosides on
gangliosides on the
on the expression
the expression of
expression of TNF
of TNF in
TNF in blood
in blood monocytes
blood monocytes and
monocytes and in
and in the
in the monocytic
the monocytic cell
monocytic cell line
cell line Mono
line Mono Mac
Mono Mac 6
Although under standard
under standard culture
standard culture conditions
culture conditions bovine
conditions bovine brain
bovine brain gangliosides
brain gangliosides 100
gangliosides 100 micrograms/ml
100 micrograms/ml suppressed
micrograms/ml suppressed LPS-stimulated
suppressed LPS-stimulated TNF
LPS-stimulated TNF production
TNF production 5-fold
production 5-fold in
5-fold in PBMC
in PBMC and
PBMC and 10-fold
and 10-fold in
10-fold in Mono
in Mono Mac
Mono Mac 6
Mac 6 cells
6 cells suppression
cells suppression was
suppression was more
was more efficient
more efficient under
efficient under serum-free
under serum-free conditions
Looking at highly
at highly purified
highly purified gangliosides
purified gangliosides GD3
gangliosides GD3 GD1a
GD3 GD1a GM3
GD1a GM3 GM2
GM3 GM2 and
GM2 and GM1
and GM1 were
GM1 were all
were all effective
all effective in
effective in reducing
in reducing TNF
reducing TNF production
TNF production in
production in PBMC
in PBMC and
PBMC and in
and in Mono
in Mono Mac
Mono Mac 6
Mac 6 by
6 by factor
by factor 10
factor 10 to
10 to 50
The suppressive activity
suppressive activity was
activity was lost
was lost in
lost in molecules
in molecules lacking
molecules lacking the
lacking the sugar
the sugar moiety
sugar moiety or
moiety or the
or the lipid
the lipid moiety
Gangliosides appear to
appear to act
to act at
act at an
at an early
an early step
early step of
step of activation
of activation in
activation in that
in that TNF
that TNF transcripts
TNF transcripts were
transcripts were reduced
were reduced and
reduced and the
and the mobilization
the mobilization of
mobilization of the
of the nuclear
the nuclear factor
nuclear factor kappa
factor kappa B
kappa B was
B was blocked
Furthermore in time
in time kinetics
time kinetics gangliosides
kinetics gangliosides were
gangliosides were effective
were effective for
effective for up
for up to
up to 30
to 30 min
30 min after
min after addition
after addition of
addition of LPS
of LPS but
LPS but not
but not thereafter
However the expression
the expression of
expression of the
of the CD14
the CD14 Ag
CD14 Ag a
Ag a receptor
a receptor molecule
receptor molecule for
molecule for LPS-LPS
for LPS-LPS binding
LPS-LPS binding protein
binding protein complexes
protein complexes was
complexes was unaffected
was unaffected by
unaffected by gangliosides
Finally when using
when using Staphylococcus
using Staphylococcus aureus
Staphylococcus aureus or
aureus or platelet
or platelet activating
platelet activating factor
activating factor as
factor as a
as a stimulus
a stimulus gangliosides
stimulus gangliosides were
gangliosides were able
were able to
able to suppress
to suppress TNF
suppress TNF production
TNF production in
production in Mono
in Mono Mac
Mono Mac 6
Mac 6 cells
6 cells by
cells by factor
by factor 5
factor 5 to
5 to 10
to 10 as
10 as well
On the other
the other hand
other hand phorbol
hand phorbol ester-induced
phorbol ester-induced production
ester-induced production of
production of O2-
of O2- was
O2- was similar
was similar in
similar in cells
in cells treated
cells treated with
treated with and
with and without
and without gangliosides
Taken together our
together our data
our data demonstrate
data demonstrate that
demonstrate that TNF
that TNF gene
TNF gene expression
gene expression in
expression in monocytes
in monocytes induced
monocytes induced by
induced by different
by different types
different types of
types of stimuli
of stimuli can
stimuli can be
can be blocked
be blocked by
blocked by gangliosides
by gangliosides at
gangliosides at an
at an early
an early step
early step of
step of signal
of signal transduction
A novel mitogen-inducible
novel mitogen-inducible gene
mitogen-inducible gene product
gene product related
product related to
related to p50/p105-NF-kappa
to p50/p105-NF-kappa B
p50/p105-NF-kappa B participates
B participates in
participates in transactivation
in transactivation through
transactivation through a
through a kappa
a kappa B
kappa B site
A Rel-related mitogen-inducible
Rel-related mitogen-inducible kappa
mitogen-inducible kappa B-binding
kappa B-binding protein
B-binding protein has
protein has been
has been cloned
been cloned as
cloned as an
as an immediate-early
an immediate-early activation
immediate-early activation gene
activation gene of
gene of human
of human peripheral
human peripheral blood
peripheral blood T
blood T cells
The cDNA has
cDNA has an
has an open
an open reading
open reading frame
reading frame of
frame of 900
of 900 amino
900 amino acids
amino acids capable
acids capable of
capable of encoding
of encoding a
encoding a 97-kDa
a 97-kDa protein
This protein is
protein is most
is most similar
most similar to
similar to the
to the 105-kDa
the 105-kDa precursor
105-kDa precursor polypeptide
precursor polypeptide of
polypeptide of p50-NF-kappa
of p50-NF-kappa B
Like the 105-kDa
the 105-kDa precursor
105-kDa precursor it
precursor it contains
it contains an
contains an amino-terminal
an amino-terminal Rel-related
amino-terminal Rel-related domain
Rel-related domain of
domain of about
of about 300
about 300 amino
300 amino acids
amino acids and
acids and a
and a carboxy-terminal
a carboxy-terminal domain
carboxy-terminal domain containing
domain containing six
containing six full
six full cell
full cell cycle
cell cycle or
cycle or ankyrin
or ankyrin repeats
In vitro-translated proteins
vitro-translated proteins truncated
proteins truncated downstream
truncated downstream of
downstream of the
of the Rel
the Rel domain
Rel domain and
domain and excluding
and excluding the
excluding the repeats
the repeats bind
repeats bind kappa
bind kappa B
kappa B sites
We refer to
refer to the
to the kappa
the kappa B-binding
kappa B-binding truncated
B-binding truncated protein
truncated protein as
protein as p50B
as p50B by
p50B by analogy
by analogy with
analogy with p50-NF-kappa
with p50-NF-kappa B
p50-NF-kappa B and
B and to
and to the
to the full-length
the full-length protein
full-length protein as
protein as p97
p50B is able
is able to
able to form
to form heteromeric
form heteromeric kappa
heteromeric kappa B-binding
kappa B-binding complexes
B-binding complexes with
complexes with RelB
with RelB as
RelB as well
as well as
well as with
as with p65
with p65 and
p65 and p50
and p50 the
p50 the two
the two subunits
two subunits of
subunits of NF-kappa
of NF-kappa B
Transient-transfection experiments in
experiments in embryonal
in embryonal carcinoma
embryonal carcinoma cells
carcinoma cells demonstrate
cells demonstrate a
demonstrate a functional
a functional cooperation
functional cooperation between
cooperation between p50B
between p50B and
p50B and RelB
and RelB or
RelB or p65
or p65 in
p65 in transactivation
in transactivation of
transactivation of a
of a reporter
a reporter plasmid
reporter plasmid dependent
plasmid dependent on
dependent on a
on a kappa
a kappa B
kappa B site
The data imply
data imply the
imply the existence
the existence of
existence of a
of a complex
a complex family
complex family of
family of NF-kappa
of NF-kappa B-like
NF-kappa B-like transcription
B-like transcription factors
Surrogate thyroglobulin receptors
thyroglobulin receptors and
receptors and T
and T cell
T cell proliferation
cell proliferation in
proliferation in Hashimoto's
in Hashimoto's thyroiditis
Immunoglobulin molecules on
molecules on the
on the surface
the surface of
surface of a
of a B
a B lymphocyte
B lymphocyte are
lymphocyte are the
are the endogenous
the endogenous "receptors"
endogenous "receptors" to
"receptors" to which
to which specific
which specific antigens
specific antigens bind
Studies in mice
in mice have
mice have shown
have shown that
shown that a
that a monoclonal
a monoclonal antibody
monoclonal antibody conjugated
antibody conjugated with
conjugated with palmitate
with palmitate to
palmitate to provide
to provide a
provide a lipid
a lipid tail
lipid tail can
tail can be
can be inserted
be inserted into
inserted into the
into the cell
the cell membrane
cell membrane to
membrane to provide
to provide a
provide a "surrogate"
a "surrogate" antigen
"surrogate" antigen receptor
We have investigated
have investigated whether
investigated whether a
whether a palmitate
a palmitate conjugate
palmitate conjugate of
conjugate of a
of a human
a human monoclonal
human monoclonal antibody
monoclonal antibody specific
antibody specific for
specific for thyroglobulin
for thyroglobulin TG
thyroglobulin TG could
TG could function
could function as
function as a
as a surrogate
a surrogate TG
surrogate TG receptor
TG receptor on
receptor on blood
on blood mononuclear
blood mononuclear cells
mononuclear cells separated
cells separated into
separated into fractions
into fractions enriched
fractions enriched for
enriched for T
for T cells
T cells or
cells or depleted
or depleted of
depleted of T
of T cells
T cells non-T
cells non-T cells
Using flow cytometry
flow cytometry we
cytometry we detected
we detected surrogate
detected surrogate TG
surrogate TG receptors
TG receptors on
receptors on non-T
on non-T but
non-T but not
but not on
not on T
on T cells
T cells from
cells from 11
from 11 of
11 of 11
of 11 individuals
11 individuals studied
individuals studied 5
studied 5 Hashimoto
5 Hashimoto patients
Hashimoto patients and
patients and 6
and 6 control
6 control donors
In contrast endogenous
contrast endogenous TG
endogenous TG receptors
TG receptors could
receptors could only
could only be
only be detected
be detected on
detected on non-T
on non-T cells
non-T cells from
cells from 1
from 1 of
1 of 3
of 3 Hashimoto
3 Hashimoto patients
Hashimoto patients and
patients and from
and from 0
from 0 of
0 of 4
of 4 control
4 control donors
Because of the
of the efficient
the efficient binding
efficient binding of
binding of TG
of TG by
TG by surrogate
by surrogate receptors
surrogate receptors on
receptors on non-T
on non-T cells
non-T cells we
cells we assessed
we assessed the
assessed the ability
the ability of
ability of such
of such cells
such cells to
cells to present
to present TG
present TG to
TG to T
to T cells
Proliferation in response
in response to
response to TG
to TG was
TG was observed
was observed in
observed in T
in T cells
T cells from
cells from only
from only 1
only 1 of
1 of 5
of 5 Hashimoto
5 Hashimoto patients
This low frequency
low frequency of
frequency of response
of response was
response was no
was no different
no different from
different from that
from that previously
that previously detected
previously detected using
detected using cultures
using cultures of
cultures of T
of T cells
T cells and
cells and autologous
and autologous dendritic
autologous dendritic cells
Therefore the successful
the successful generation
successful generation of
generation of surrogate
of surrogate receptors
surrogate receptors on
receptors on non-T
on non-T cells
non-T cells is
cells is not
is not associated
not associated with
associated with more
with more efficient
more efficient TG
efficient TG presentation
TG presentation of
presentation of T
of T cells
Furthermore the significance
the significance of
significance of the
of the present
the present study
present study is
study is that
is that the
that the T
the T cells
T cells not
cells not the
not the antigen-presenting
the antigen-presenting cells
antigen-presenting cells are
cells are likely
are likely to
likely to be
to be the
be the limiting
the limiting element
limiting element in
element in the
in the T
the T cell
T cell proliferative
cell proliferative response
proliferative response to
response to TG
to TG and
TG and other
and other thyroid
other thyroid autoantigens
Targeted degradation of
degradation of c-Fos
of c-Fos but
c-Fos but not
but not v-Fos
not v-Fos by
v-Fos by a
by a phosphorylation-dependent
a phosphorylation-dependent signal
phosphorylation-dependent signal on
signal on c-Jun
The proto-oncogene products
proto-oncogene products c-Fos
products c-Fos and
c-Fos and c-Jun
and c-Jun heterodimerize
c-Jun heterodimerize through
heterodimerize through their
through their leucine
their leucine zippers
leucine zippers to
zippers to form
to form the
form the AP-1
the AP-1 transcription
AP-1 transcription factor
The transcriptional activity
transcriptional activity of
activity of the
of the heterodimer
the heterodimer is
heterodimer is regulated
is regulated by
regulated by signal-dependent
by signal-dependent phosphorylation
signal-dependent phosphorylation and
phosphorylation and dephosphorylation
and dephosphorylation events
The stability of
stability of c-Fos
of c-Fos was
c-Fos was found
was found to
found to also
to also be
also be controlled
be controlled by
controlled by intracellular
by intracellular signal
intracellular signal transduction
In transient expression
transient expression and
expression and in
and in vitro
in vitro degradation
vitro degradation experiments
degradation experiments the
experiments the stability
the stability of
stability of c-Fos
of c-Fos was
c-Fos was decreased
was decreased when
decreased when the
when the protein
the protein was
protein was dimerized
was dimerized with
dimerized with phosphorylated
with phosphorylated c-Jun
c-Jun protein isolated
protein isolated from
isolated from phorbol
from phorbol ester-induced
phorbol ester-induced cells
ester-induced cells did
cells did not
did not target
not target c-Fos
target c-Fos for
c-Fos for degradation
for degradation which
degradation which suggests
which suggests that
suggests that c-Fos
that c-Fos is
c-Fos is transiently
is transiently stabilized
transiently stabilized after
stabilized after stimulation
after stimulation of
stimulation of cell
of cell growth
v-Fos protein the
protein the retroviral
the retroviral counterpart
retroviral counterpart of
counterpart of c-Fos
of c-Fos was
c-Fos was not
was not susceptible
not susceptible to
susceptible to degradation
to degradation targeted
degradation targeted by
targeted by c-Jun
The regulation of
regulation of the
of the human
the human tumor
human tumor necrosis
tumor necrosis factor
necrosis factor alpha
factor alpha promoter
alpha promoter region
promoter region in
region in macrophage
in macrophage T
macrophage T cell
T cell and
cell and B
and B cell
B cell lines
The 1311-base pair
1311-base pair human
pair human tumor
human tumor necrosis
tumor necrosis factor
necrosis factor TNF
factor TNF alpha
TNF alpha promoter
alpha promoter region
promoter region was
region was fused
was fused to
fused to the
to the luciferase
the luciferase Luc
luciferase Luc reporter
Luc reporter gene
reporter gene and
gene and studied
and studied in
studied in a
in a transient
a transient transfection
transient transfection system
transfection system in
system in three
in three TNF
three TNF producing
TNF producing cell
producing cell lines
cell lines the
lines the U937
the U937 macrophage
U937 macrophage cell
macrophage cell line
cell line the
line the MLA
the MLA 144
MLA 144 T
144 T cell
T cell line
cell line and
line and the
and the 729-6
the 729-6 B
729-6 B cell
B cell line
This full length
full length promoter
length promoter construct
promoter construct can
construct can be
can be induced
be induced by
induced by phorbol
by phorbol 13-myristate
phorbol 13-myristate acetate
13-myristate acetate PMA
acetate PMA in
PMA in each
in each of
each of these
of these cell
these cell types
Analysis of a
of a series
a series of
series of 5'-truncations
of 5'-truncations showed
5'-truncations showed several
showed several peaks
several peaks of
peaks of basal
of basal and
basal and PMA
and PMA induced
PMA induced activity
induced activity suggesting
activity suggesting the
suggesting the presence
the presence of
presence of several
of several positive
several positive and
positive and negative
and negative regulatory
negative regulatory elements
A PMA responsive
PMA responsive element
responsive element was
element was localized
was localized to
localized to a
to a region
a region between
region between -95
between -95 and
-95 and -36
and -36 bp
-36 bp relative
bp relative to
relative to the
to the transcription
the transcription start
transcription start site
Within this region
this region single
region single AP-2-
single AP-2- and
AP-2- and AP-1-
and AP-1- like
AP-1- like consensus
like consensus sequences
consensus sequences were
sequences were noted
These AP-2 and
AP-2 and AP-1
and AP-1 sites
AP-1 sites were
sites were each
were each modified
each modified with
modified with a
with a double
a double point
double point mutation
A modest 20-50%
modest 20-50% reduction
20-50% reduction in
reduction in TNF
in TNF promoter
TNF promoter activity
promoter activity was
activity was observed
was observed with
observed with the
with the AP-2
the AP-2 site
AP-2 site mutation
However mutation of
mutation of the
of the AP-1
the AP-1 site
AP-1 site markedly
site markedly diminished
markedly diminished both
diminished both the
both the basal
the basal and
basal and PMA-activated
and PMA-activated promoter
PMA-activated promoter activity
Also co-transfections of
co-transfections of the
of the wild-type
the wild-type promoter
wild-type promoter construct
promoter construct with
construct with an
with an AP-1/c-jun
an AP-1/c-jun expression
AP-1/c-jun expression vector
expression vector resulted
vector resulted in
resulted in augmented
in augmented basal
augmented basal and
basal and PMA-induced
and PMA-induced promoter
PMA-induced promoter activity
Stable expression of
expression of transdominant
of transdominant Rev
transdominant Rev protein
Rev protein in
protein in human
in human T
human T cells
T cells inhibits
cells inhibits human
inhibits human immunodeficiency
human immunodeficiency virus
immunodeficiency virus replication
The human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV Rev
HIV Rev protein
Rev protein is
protein is essential
is essential for
essential for viral
for viral structural
viral structural protein
structural protein expression
protein expression Gag
expression Gag Pol
Gag Pol and
Pol and Env
and Env and
Env and hence
and hence for
hence for viral
for viral replication
In transient transfection
transient transfection assays
transfection assays mutant
assays mutant forms
mutant forms of
forms of Rev
of Rev have
Rev have been
have been identified
been identified that
identified that inhibit
that inhibit wild-type
inhibit wild-type Rev
wild-type Rev activity
Rev activity and
activity and therefore
and therefore suppress
therefore suppress viral
suppress viral replication
To determine whether
determine whether such
whether such transdominant
such transdominant Rev
transdominant Rev proteins
Rev proteins could
proteins could provide
could provide long-term
provide long-term protection
long-term protection against
protection against HIV
against HIV infection
HIV infection without
infection without affecting
without affecting T
affecting T cell
T cell function
cell function T
function T leukemia
T leukemia cell
leukemia cell lines
cell lines were
lines were stably
were stably transduced
stably transduced with
transduced with a
with a retroviral
a retroviral vector
retroviral vector encoding
vector encoding a
encoding a transdominant
a transdominant mutant
transdominant mutant of
mutant of the
of the Rev
the Rev protein
Rev protein M10
While all the
all the M10-expressing
the M10-expressing cell
M10-expressing cell lines
cell lines remained
lines remained infectable
remained infectable by
infectable by HIV-1
by HIV-1 these
HIV-1 these same
these same cells
same cells failed
cells failed to
failed to support
to support a
support a productive
a productive replication
productive replication cycle
replication cycle when
cycle when infected
when infected with
infected with a
with a cloned
a cloned isolate
cloned isolate of
isolate of HIV-1
In addition two
addition two out
two out of
out of three
of three M10-expressing
three M10-expressing CEM
M10-expressing CEM clones
CEM clones were
clones were also
were also resistant
also resistant to
resistant to highly
to highly productive
highly productive infection
productive infection by
infection by a
by a heterogeneous
a heterogeneous HIV-1
heterogeneous HIV-1 pool
Expression of M10
of M10 did
M10 did not
did not affect
not affect induction
affect induction of
induction of HIV
of HIV transcription
HIV transcription mediated
transcription mediated by
mediated by the
by the kappa
the kappa B
kappa B regulatory
B regulatory element
regulatory element or
element or Tat
Importantly constitutive expression
constitutive expression of
expression of Rev
of Rev M10
Rev M10 did
M10 did not
did not alter
not alter the
alter the secretion
the secretion of
secretion of interleukin
of interleukin 2
interleukin 2 in
2 in response
in response to
response to mitogen
to mitogen stimulation
mitogen stimulation of
stimulation of EL-4
of EL-4 and
EL-4 and Jurkat
and Jurkat cells
The inhibition of
inhibition of HIV
of HIV infection
HIV infection in
infection in cells
in cells stably
cells stably expressing
stably expressing a
expressing a transdominant
a transdominant Rev
transdominant Rev protein
Rev protein in
protein in the
in the absence
the absence of
absence of any
of any deleterious
any deleterious effect
deleterious effect on
effect on T
on T cell
T cell function
cell function suggests
function suggests that
suggests that such
that such a
such a strategy
a strategy could
strategy could provide
could provide a
provide a therapeutic
a therapeutic effect
therapeutic effect in
effect in the
in the T
the T lymphocytes
T lymphocytes of
lymphocytes of acquired
of acquired immunodeficiency
acquired immunodeficiency syndrome
immunodeficiency syndrome patients
Simple derivation of
derivation of TFIID-dependent
of TFIID-dependent RNA
TFIID-dependent RNA polymerase
RNA polymerase II
polymerase II transcription
II transcription systems
transcription systems from
systems from Schizosaccharomyces
from Schizosaccharomyces pombe
Schizosaccharomyces pombe and
pombe and other
and other organisms
other organisms and
organisms and factors
and factors required
factors required for
required for transcriptional
for transcriptional activation
Resolution of whole
of whole cell
whole cell extract
cell extract through
extract through two
through two chromatographic
two chromatographic steps
chromatographic steps yields
steps yields a
yields a single
a single protein
single protein fraction
protein fraction requiring
fraction requiring only
requiring only the
only the addition
the addition of
addition of TFIID
of TFIID for
TFIID for the
for the initiation
the initiation of
initiation of transcription
of transcription at
transcription at RNA
at RNA polymerase
RNA polymerase II
polymerase II promoters
This approach allows
approach allows the
allows the convenient
the convenient generation
convenient generation of
generation of RNA
of RNA polymerase
RNA polymerase II
polymerase II transcription
II transcription systems
transcription systems from
systems from Saccharomyces
from Saccharomyces cerevisiae
Saccharomyces cerevisiae human
cerevisiae human lymphocytes
human lymphocytes and
lymphocytes and Schizosaccharomyces
and Schizosaccharomyces pombe
TFIIDs from all
from all three
all three organisms
three organisms are
organisms are interchangeable
are interchangeable among
interchangeable among all
among all three
all three systems
The S cerevisiae
S cerevisiae and
cerevisiae and Sch
and Sch pombe
Sch pombe systems
pombe systems support
systems support effects
support effects of
effects of acidic
of acidic activator
acidic activator proteins
activator proteins provided
proteins provided a
provided a further
a further protein
further protein fraction
protein fraction from
fraction from S
from S cerevisiae
S cerevisiae is
cerevisiae is supplied
This further fraction
further fraction is
fraction is distinct
is distinct from
distinct from the
from the mediator
the mediator of
mediator of transcriptional
of transcriptional activation
transcriptional activation described
activation described previously
described previously and
previously and represents
and represents a
represents a second
a second component
second component in
component in addition
in addition to
addition to general
to general initiation
general initiation factors
initiation factors that
factors that may
that may facilitate
may facilitate a
facilitate a response
a response to
response to acidic
to acidic activators
Regulation of c-jun
of c-jun expression
c-jun expression during
expression during induction
during induction of
induction of monocytic
of monocytic differentiation
monocytic differentiation by
differentiation by okadaic
by okadaic acid
The present work
present work has
work has examined
has examined the
examined the effects
the effects of
effects of okadaic
of okadaic acid
okadaic acid an
acid an inhibitor
an inhibitor of
inhibitor of type
of type 1
type 1 and
1 and 2A
and 2A protein
2A protein phosphatases
protein phosphatases on
phosphatases on the
on the regulation
the regulation of
regulation of c-jun
of c-jun expression
c-jun expression during
expression during monocytic
during monocytic differentiation
monocytic differentiation of
differentiation of U-937
of U-937 leukemia
U-937 leukemia cells
The results demonstrate
results demonstrate that
demonstrate that okadaic
that okadaic acid
okadaic acid treatment
acid treatment is
treatment is associated
is associated with
associated with induction
with induction of
induction of a
of a differentiated
a differentiated monocyte
differentiated monocyte phenotype
monocyte phenotype characterized
phenotype characterized by:
characterized by: a
by: a growth
a growth arrest;
growth arrest; b
arrest; b increases
b increases in
increases in Mac-1
in Mac-1 cell
Mac-1 cell surface
cell surface antigen
surface antigen expression;
antigen expression; c
expression; c down-regulation
c down-regulation of
down-regulation of c-myc
of c-myc transcripts;
c-myc transcripts; and
transcripts; and d
and d induction
d induction of
induction of tumor
of tumor necrosis
tumor necrosis factor
necrosis factor gene
factor gene expression
This induction of
induction of monocytic
of monocytic differentiation
monocytic differentiation was
differentiation was associated
was associated with
associated with transient
with transient increases
transient increases in
increases in c-jun
in c-jun mRNA
c-jun mRNA levels
mRNA levels which
levels which were
which were maximal
were maximal at
maximal at 6
at 6 h
Similar effects were
effects were obtained
were obtained for
obtained for the
for the c-fos
the c-fos gene
Run-on analysis demonstrated
analysis demonstrated detectable
demonstrated detectable levels
detectable levels of
levels of c-jun
of c-jun transcription
c-jun transcription in
transcription in U-937
in U-937 cells
U-937 cells and
cells and that
and that this
that this rate
this rate is
rate is increased
is increased approximately
increased approximately 40-fold
approximately 40-fold following
40-fold following okadaic
following okadaic acid
okadaic acid exposure
c-jun mRNA levels
mRNA levels were
levels were superinduced
were superinduced in
superinduced in cells
in cells treated
cells treated with
treated with both
with both okadaic
both okadaic acid
okadaic acid and
acid and cycloheximide
and cycloheximide whereas
cycloheximide whereas inhibition
whereas inhibition of
inhibition of protein
of protein synthesis
protein synthesis had
synthesis had little
had little if
little if any
if any effect
any effect on
effect on okadaic
on okadaic acid-induced
okadaic acid-induced c-jun
acid-induced c-jun transcription
The half-life of
half-life of c-jun
of c-jun mRNA
c-jun mRNA was
mRNA was similar
was similar 45-50
similar 45-50 min
45-50 min in
min in both
in both untreated
both untreated and
untreated and okadaic
and okadaic acid-induced
okadaic acid-induced cells
In contrast treatment
contrast treatment with
treatment with both
with both okadaic
both okadaic acid
okadaic acid and
acid and cycloheximide
and cycloheximide was
cycloheximide was associated
was associated with
associated with stabilization
with stabilization t
stabilization t 1/2
t 1/2 =
1/2 = 90
= 90 min
90 min of
min of c-jun
of c-jun transcripts
Taken together these
together these findings
these findings indicate
findings indicate that
indicate that the
that the induction
the induction of
induction of c-jun
of c-jun transcription
c-jun transcription by
transcription by okadaic
by okadaic acid
okadaic acid is
acid is controlled
is controlled primarily
controlled primarily by
primarily by a
by a transcriptional
a transcriptional mechanism
Since previous studies
previous studies have
studies have demonstrated
have demonstrated that
demonstrated that the
that the c-jun
the c-jun gene
c-jun gene is
gene is autoinduced
is autoinduced by
autoinduced by Jun/AP-1
by Jun/AP-1 we
Jun/AP-1 we also
we also studied
also studied transcription
studied transcription of
transcription of c-jun
of c-jun promoter
c-jun promoter positions
promoter positions -132/+170-reporter
positions -132/+170-reporter gene
-132/+170-reporter gene constructs
gene constructs with
constructs with and
with and without
and without a
without a mutated
a mutated AP-1
mutated AP-1 element
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Mitogen stimulation of
stimulation of T-cells
of T-cells increases
T-cells increases c-Fos
increases c-Fos and
c-Fos and c-Jun
and c-Jun protein
c-Jun protein levels
protein levels AP-1
levels AP-1 binding
AP-1 binding and
binding and AP-1
and AP-1 transcriptional
AP-1 transcriptional activity
We have analysed
have analysed the
analysed the effect
the effect of
effect of mitogenic
of mitogenic lectins
mitogenic lectins on
lectins on c-Fos
on c-Fos and
c-Fos and c-Jun
and c-Jun protein
c-Jun protein levels
protein levels as
levels as well
as well as
well as on
as on activator
on activator protein-1
activator protein-1 AP-1
protein-1 AP-1 binding
AP-1 binding and
binding and enhancer
and enhancer activity
enhancer activity in
activity in Jurkat
in Jurkat T-cells
Both c-Fos and
c-Fos and c-Jun
and c-Jun protein
c-Jun protein levels
protein levels were
levels were increased
were increased after
increased after Con
after Con A
Con A and
A and PHA
and PHA stimulation
Since T-cell stimulation
T-cell stimulation increases
stimulation increases both
increases both intracellular
both intracellular Ca2+
intracellular Ca2+ and
Ca2+ and cAMP
and cAMP levels
cAMP levels and
levels and activates
and activates protein
activates protein kinase
protein kinase C
kinase C PKC
C PKC the
PKC the possible
the possible involvement
possible involvement of
involvement of these
of these intracellular
these intracellular messengers
intracellular messengers in
messengers in c-Fos
in c-Fos and
c-Fos and c-Jun
and c-Jun induction
c-Jun induction was
induction was tested
PMA which directly
which directly activates
directly activates PKC
activates PKC mimicked
PKC mimicked the
mimicked the effect
the effect of
effect of the
of the lectins
the lectins on
lectins on c-Fos
on c-Fos and
c-Fos and c-Jun
and c-Jun but
c-Jun but elevation
but elevation of
elevation of either
of either intracellular
either intracellular Ca2+
intracellular Ca2+ or
Ca2+ or cAMP
or cAMP levels
cAMP levels had
levels had little
had little or
little or no
or no effect
The mitogen-induced increase
mitogen-induced increase of
increase of c-Fos
of c-Fos and
c-Fos and c-Jun
and c-Jun immunoreactivity
c-Jun immunoreactivity was
immunoreactivity was inhibited
was inhibited by
inhibited by H-7
by H-7 a
H-7 a kinase
a kinase inhibitor
kinase inhibitor with
inhibitor with relatively
with relatively high
relatively high specificity
high specificity for
specificity for PKC
for PKC and
PKC and less
and less efficiently
less efficiently by
efficiently by H-8
by H-8 a
H-8 a structurally
a structurally related
structurally related kinase
related kinase inhibitor
kinase inhibitor less
inhibitor less active
less active on
active on PKC
on PKC but
PKC but more
but more active
more active on
active on cyclic
on cyclic nucleotide-dependent
cyclic nucleotide-dependent kinases
Con A stimulation
A stimulation was
stimulation was found
was found to
found to increase
to increase both
increase both binding
both binding of
binding of AP-1
of AP-1 to
AP-1 to the
to the AP-1
the AP-1 consensus
AP-1 consensus sequence
consensus sequence TRE
sequence TRE and
TRE and AP-1
and AP-1 enhancer
AP-1 enhancer activity
enhancer activity in
activity in Jurkat
in Jurkat cells
PMA was also
was also found
also found to
found to increase
to increase the
increase the AP-1
the AP-1 enhancer
AP-1 enhancer activity
enhancer activity whereas
activity whereas elevation
whereas elevation of
elevation of Ca2+
of Ca2+ or
Ca2+ or cAMP
or cAMP had
cAMP had only
had only minor
only minor effects
We conclude that
conclude that stimulation
that stimulation with
stimulation with mitogenic
with mitogenic lectins
mitogenic lectins is
lectins is sufficient
is sufficient to
sufficient to increase
to increase both
increase both c-Fos
both c-Fos and
c-Fos and c-Jun
and c-Jun protein
c-Jun protein levels
protein levels AP-1
levels AP-1 binding
AP-1 binding and
binding and AP-1
and AP-1 enhancer
AP-1 enhancer activity
enhancer activity in
activity in Jurkat
in Jurkat cells
Jurkat cells and
cells and that
and that they
that they act
they act via
act via mechanisms
via mechanisms that
mechanisms that could
that could involve
could involve the
involve the activation
the activation of
activation of PKC
An 11-base-pair DNA
11-base-pair DNA sequence
DNA sequence motif
sequence motif apparently
motif apparently unique
apparently unique to
unique to the
to the human
the human interleukin
human interleukin 4
interleukin 4 gene
4 gene confers
gene confers responsiveness
confers responsiveness to
responsiveness to T-cell
to T-cell activation
T-cell activation signals
We have identified
have identified a
identified a DNA
a DNA segment
DNA segment that
segment that confers
that confers responsiveness
confers responsiveness to
responsiveness to antigen
to antigen stimulation
antigen stimulation signals
stimulation signals on
signals on the
on the human
the human interleukin
human interleukin IL
interleukin IL 4
IL 4 gene
4 gene in
gene in Jurkat
in Jurkat cells
The human IL-4
human IL-4 gene
IL-4 gene of
gene of 10
of 10 kilobases
10 kilobases is
kilobases is composed
is composed of
composed of four
of four exons
four exons and
exons and three
and three introns
A cis-acting element
cis-acting element P
element P sequence
P sequence resides
sequence resides in
resides in the
in the 5'
the 5' upstream
5' upstream region;
upstream region; no
region; no additional
no additional DNA
additional DNA segments
DNA segments with
segments with enhancer
with enhancer activity
enhancer activity were
activity were identified
were identified in
identified in the
in the human
the human IL-4
human IL-4 gene
For further mapping
further mapping purposes
mapping purposes a
purposes a fusion
a fusion promoter
fusion promoter was
promoter was constructed
was constructed with
constructed with the
with the granulocyte/macrophage
the granulocyte/macrophage colony-stimulating
granulocyte/macrophage colony-stimulating factor
colony-stimulating factor basic
factor basic promoter
basic promoter containing
promoter containing 60
containing 60 base
60 base pairs
base pairs of
pairs of sequence
of sequence upstream
sequence upstream from
upstream from the
from the cap
the cap site
cap site of
site of the
of the mouse
the mouse granulocyte/macrophage
mouse granulocyte/macrophage colony-stimulating
granulocyte/macrophage colony-stimulating factor
colony-stimulating factor gene
factor gene and
gene and various
and various lengths
various lengths of
lengths of the
of the 5'
the 5' upstream
5' upstream sequence
upstream sequence of
sequence of the
of the IL-4
the IL-4 gene
The P sequence
P sequence was
sequence was located
was located between
located between positions
between positions -79
positions -79 and
-79 and -69
and -69 relative
-69 relative to
relative to the
to the transcription
the transcription start
transcription start site
start site of
site of the
of the human
the human IL-4
human IL-4 gene
IL-4 gene and
gene and this
and this location
this location was
location was confirmed
was confirmed by
confirmed by base-substitution
by base-substitution mutations
The plasmids carrying
plasmids carrying multiple
carrying multiple copies
multiple copies of
copies of the
of the P
the P sequence
P sequence showed
sequence showed higher
showed higher responsiveness
higher responsiveness to
responsiveness to the
to the stimulation
The binding proteins
binding proteins that
proteins that recognize
that recognize the
recognize the P
the P sequence
P sequence of
sequence of the
of the IL-4
the IL-4 gene
IL-4 gene were
gene were identified
were identified by
identified by DNA-mobility-shift
by DNA-mobility-shift assays
The binding of
binding of NFP
of NFP a
NFP a DNA
a DNA binding
DNA binding protein
binding protein that
protein that specifically
that specifically recognizes
specifically recognizes the
recognizes the P
the P sequence
P sequence to
sequence to the
to the P
the P sequence
P sequence was
sequence was abolished
was abolished when
abolished when oligonucleotides
when oligonucleotides carrying
oligonucleotides carrying base
carrying base substitutions
base substitutions were
substitutions were used
were used indicating
used indicating that
indicating that the
that the NFP
the NFP interaction
NFP interaction is
interaction is sequence-specific
is sequence-specific and
sequence-specific and that
and that binding
that binding specificity
binding specificity of
specificity of the
of the protein
the protein paralleled
protein paralleled the
paralleled the sequence
the sequence requirements
sequence requirements for
requirements for IL-4
for IL-4 expression
IL-4 expression in
expression in vivo
The P sequence
P sequence does
sequence does not
does not share
not share homology
share homology with
homology with the
with the 5'
the 5' upstream
5' upstream sequence
upstream sequence of
sequence of the
of the IL-2
the IL-2 gene
IL-2 gene even
gene even though
even though surrounding
though surrounding sequences
surrounding sequences of
sequences of the
of the IL-4
the IL-4 gene
IL-4 gene share
gene share high
share high homology
high homology with
homology with the
with the IL-2
the IL-2 gene
We conclude that
conclude that a
that a different
a different set
different set of
set of proteins
of proteins recognize
proteins recognize IL-2
recognize IL-2 and
IL-2 and IL-4
and IL-4 genes
Leukotriene B4 stimulates
B4 stimulates c-fos
stimulates c-fos and
c-fos and c-jun
and c-jun gene
c-jun gene transcription
gene transcription and
transcription and AP-1
and AP-1 binding
AP-1 binding activity
binding activity in
activity in human
in human monocytes
We have examined
have examined the
examined the effect
the effect of
effect of leukotriene
of leukotriene B4
leukotriene B4 LTB4
B4 LTB4 a
LTB4 a potent
a potent lipid
potent lipid proinflammatory
lipid proinflammatory mediator
proinflammatory mediator on
mediator on the
on the expression
the expression of
expression of the
of the proto-oncogenes
the proto-oncogenes c-jun
proto-oncogenes c-jun and
c-jun and c-fos
In addition we
addition we looked
we looked at
looked at the
at the modulation
the modulation of
modulation of nuclear
of nuclear factors
nuclear factors binding
factors binding specifically
binding specifically to
specifically to the
to the AP-1
the AP-1 element
AP-1 element after
element after LTB4
after LTB4 stimulation
LTB4 increased the
increased the expression
the expression of
expression of the
of the c-fos
the c-fos gene
c-fos gene in
gene in a
in a time-
a time- and
time- and concentration-dependent
and concentration-dependent manner
The c-jun mRNA
c-jun mRNA which
mRNA which is
which is constitutively
is constitutively expressed
constitutively expressed in
expressed in human
in human peripheral-blood
human peripheral-blood monocytes
peripheral-blood monocytes at
monocytes at relatively
at relatively high
relatively high levels
high levels was
levels was also
was also slightly
also slightly augmented
slightly augmented by
augmented by LTB4
by LTB4 although
LTB4 although to
although to a
to a much
a much lower
much lower extent
lower extent than
extent than c-fos
The kinetics of
kinetics of expression
of expression of
expression of the
of the two
the two genes
two genes were
genes were also
were also slightly
also slightly different
slightly different with
different with c-fos
with c-fos mRNA
c-fos mRNA reaching
mRNA reaching a
reaching a peak
a peak at
peak at 15
at 15 min
15 min after
min after stimulation
after stimulation and
stimulation and c-jun
and c-jun at
c-jun at 30
at 30 min
Both messages rapidly
messages rapidly declined
rapidly declined thereafter
Stability of the
of the c-fos
the c-fos and
c-fos and c-jun
and c-jun mRNA
c-jun mRNA was
mRNA was not
was not affected
not affected by
affected by LTB4
by LTB4 as
LTB4 as assessed
as assessed after
assessed after actinomycin
after actinomycin D
actinomycin D treatment
Nuclear transcription studies
transcription studies in
studies in vitro
in vitro showed
vitro showed that
showed that LTB4
that LTB4 increased
LTB4 increased the
increased the transcription
the transcription of
transcription of the
of the c-fos
the c-fos gene
c-fos gene 7-fold
gene 7-fold and
7-fold and the
and the c-jun
the c-jun gene
c-jun gene 14-fold
Resting monocytes contained
monocytes contained nuclear
contained nuclear factors
nuclear factors binding
factors binding to
binding to the
to the AP-1
the AP-1 element
AP-1 element but
element but stimulation
but stimulation of
stimulation of monocytes
of monocytes with
monocytes with LTB4
with LTB4 induced
LTB4 induced greater
induced greater AP-1-binding
greater AP-1-binding activity
AP-1-binding activity of
activity of nuclear
of nuclear proteins
These results indicate
results indicate that
indicate that LTB4
that LTB4 may
LTB4 may regulate
may regulate the
regulate the production
the production of
production of different
of different cytokines
different cytokines by
cytokines by modulating
by modulating the
modulating the yield
the yield and/or
yield and/or the
and/or the function
the function of
function of transcription
of transcription factors
transcription factors such
factors such as
such as AP-1-binding
as AP-1-binding proto-oncogene
AP-1-binding proto-oncogene products
Modulation of normal
of normal erythroid
normal erythroid differentiation
erythroid differentiation by
differentiation by the
by the endogenous
the endogenous thyroid
endogenous thyroid hormone
thyroid hormone and
hormone and retinoic
and retinoic acid
retinoic acid receptors:
acid receptors: a
receptors: a possible
a possible target
possible target for
target for v-erbA
for v-erbA oncogene
v-erbA oncogene action
The v-erbA oncogene
v-erbA oncogene a
oncogene a mutated
a mutated version
mutated version of
version of the
of the thyroid
the thyroid hormone
thyroid hormone receptor
hormone receptor alpha
receptor alpha c-erbA/TR-alpha
alpha c-erbA/TR-alpha inhibits
c-erbA/TR-alpha inhibits erythroid
inhibits erythroid differentiation
erythroid differentiation and
differentiation and constitutively
and constitutively represses
constitutively represses transcription
represses transcription of
transcription of certain
of certain erythrocyte
certain erythrocyte genes
erythrocyte genes suggesting
genes suggesting a
suggesting a normal
a normal function
normal function of
function of the
of the proto-oncogene
the proto-oncogene c-erbA
proto-oncogene c-erbA in
c-erbA in erythropoiesis
Here we demonstrate
we demonstrate that
demonstrate that the
that the endogenous
the endogenous thyroid
endogenous thyroid hormone
thyroid hormone receptor
hormone receptor alpha
receptor alpha c-erbA/TR-alpha
alpha c-erbA/TR-alpha and
c-erbA/TR-alpha and the
and the closely
the closely related
closely related retinoic
related retinoic acid
retinoic acid receptor
acid receptor alpha
receptor alpha RAR-alpha
alpha RAR-alpha play
RAR-alpha play a
play a role
a role in
role in the
in the regulation
the regulation of
regulation of normal
of normal erythroid
normal erythroid differentiation
Retinoic acid RA
acid RA distinctly
RA distinctly modulated
distinctly modulated the
modulated the erythroid
the erythroid differentiation
erythroid differentiation program
differentiation program of
program of normal
of normal erythroid
normal erythroid progenitors
erythroid progenitors and
progenitors and erythroblasts
and erythroblasts reversibly
erythroblasts reversibly transformed
reversibly transformed by
transformed by a
by a conditional
a conditional tyrosine
conditional tyrosine kinase
tyrosine kinase oncogene
When added pulsewise
added pulsewise to
pulsewise to immature
to immature cells
immature cells differentiation
cells differentiation was
differentiation was accelerated
was accelerated while
accelerated while more
while more mature
more mature cells
mature cells underwent
cells underwent premature
underwent premature cell
premature cell death
Thyroid hormone T3
hormone T3 alone
T3 alone caused
alone caused similar
caused similar but
similar but weaker
but weaker effects
Interestingly T3 strongly
T3 strongly enhanced
strongly enhanced the
enhanced the action
the action of
action of RA
of RA suggesting
RA suggesting cooperative
suggesting cooperative action
cooperative action of
action of the
of the two
the two receptors
two receptors in
receptors in modulating
in modulating erythroid
modulating erythroid differentiation
Expression of the
of the human
the human RAR-alpha
human RAR-alpha in
RAR-alpha in receptor-negative
in receptor-negative erythroblasts
receptor-negative erythroblasts conferred
erythroblasts conferred RA-induced
conferred RA-induced regulation
RA-induced regulation of
regulation of differentiation
of differentiation to
differentiation to the
to the otherwise
the otherwise unresponsive
otherwise unresponsive cells
unresponsive cells thus
cells thus showing
thus showing that
showing that the
that the RAR-alpha
the RAR-alpha is
RAR-alpha is essential
is essential for
essential for the
for the RA
the RA effect
Likewise enhanced expression
enhanced expression of
expression of exogenous
of exogenous c-erbA/TR-alpha
exogenous c-erbA/TR-alpha in
c-erbA/TR-alpha in erythroblasts
in erythroblasts rendered
erythroblasts rendered them
rendered them susceptible
them susceptible to
susceptible to modulation
to modulation of
modulation of differentiation
of differentiation by
differentiation by T3
by T3 suggesting
T3 suggesting a
suggesting a similar
a similar function
similar function of
function of both
of both receptors
Activation of lymphokine
of lymphokine genes
lymphokine genes in
genes in T
in T cells:
T cells: role
cells: role of
role of cis-acting
of cis-acting DNA
cis-acting DNA elements
DNA elements that
elements that respond
that respond to
respond to T
to T cell
T cell activation
cell activation signals
Activation of T
of T cells
T cells is
cells is initiated
is initiated by
initiated by the
by the recognition
the recognition of
recognition of antigen
of antigen on
antigen on antigen
on antigen presenting
antigen presenting cells
presenting cells to
cells to exert
to exert the
exert the effector
the effector functions
effector functions in
functions in immune
in immune and
immune and inflammatory
and inflammatory responses
Two types of
types of helper
of helper T
helper T cell
T cell Th
cell Th clones
Th clones Th1
clones Th1 and
Th1 and Th2
and Th2 are
Th2 are defined
are defined on
defined on the
on the basis
the basis of
basis of different
of different patterns
different patterns of
patterns of cytokine
of cytokine lymphokine
cytokine lymphokine secretion
They determine the
determine the outcome
the outcome of
outcome of an
of an antigenic
an antigenic response
antigenic response toward
response toward humoral
toward humoral or
humoral or cell-mediated
or cell-mediated immunity
Although lymphokine genes
lymphokine genes are
genes are coordinately
are coordinately regulated
coordinately regulated upon
regulated upon antigen
upon antigen stimulation
antigen stimulation they
stimulation they are
they are regulated
are regulated by
regulated by the
by the mechanisms
the mechanisms common
mechanisms common to
common to all
to all as
all as well
as well as
well as those
as those which
those which are
which are unique
are unique to
unique to each
to each gene
For most lymphokine
most lymphokine genes
lymphokine genes a
genes a combination
a combination of
combination of phorbol
of phorbol esters
phorbol esters phorbol
esters phorbol 12-myristate
phorbol 12-myristate 13
12-myristate 13 acetate
13 acetate PMA
acetate PMA and
PMA and calcium
and calcium ionophores
calcium ionophores A23187
ionophores A23187 is
A23187 is required
is required for
required for their
for their maximal
their maximal induction
Yet phorbol ester
phorbol ester alone
ester alone or
alone or calcium
or calcium ionophore
calcium ionophore alone
ionophore alone produce
alone produce several
produce several lymphokines
The production of
production of the
of the granulocyte-macrophage
the granulocyte-macrophage colony
granulocyte-macrophage colony stimulating
colony stimulating factor
stimulating factor GM-CSF
factor GM-CSF is
GM-CSF is completely
is completely dependent
completely dependent on
dependent on the
on the two
the two signals
We have previously
have previously found
previously found a
found a cis-acting
a cis-acting region
cis-acting region spanning
region spanning the
spanning the GM-CSF
the GM-CSF promoter
GM-CSF promoter region
promoter region positions
region positions -95
positions -95 to
-95 to +27
to +27 that
+27 that confers
that confers inducibility
confers inducibility to
inducibility to reporter
to reporter genes
reporter genes in
genes in transient
in transient transfection
transient transfection assays
Further analysis identified
analysis identified three
identified three elements
three elements required
elements required for
required for efficient
for efficient induction
efficient induction referred
induction referred to
referred to as
to as GM2
as GM2 GC-box
GM2 GC-box and
GC-box and conserved
and conserved lymphokine
conserved lymphokine element
lymphokine element CLE0
GM2 defines a
defines a binding
a binding site
binding site for
site for proteins
for proteins whose
proteins whose binding
whose binding is
binding is inducible
is inducible by
inducible by PMA
One protein NF-GM2
protein NF-GM2 is
NF-GM2 is similar
is similar to
similar to the
to the transcription
the transcription factor
transcription factor NF-kB
GC-box is a
is a binding
a binding site
binding site for
site for constitutively
for constitutively bound
constitutively bound proteins
CLEO defines a
defines a binding
a binding site
binding site for
site for proteins
for proteins whose
proteins whose optimum
whose optimum binding
optimum binding is
binding is stimulated
is stimulated by
stimulated by PMA
by PMA and
PMA and A23187
Viral trans-activators such
trans-activators such as
such as Tax
as Tax human
Tax human T
human T cell
T cell leukemia
cell leukemia virus-1
leukemia virus-1 HTLV-1
virus-1 HTLV-1 and
HTLV-1 and E2
and E2 bovine
E2 bovine papilloma
bovine papilloma virus
papilloma virus BPV
virus BPV proteins
BPV proteins are
proteins are other
are other agents
other agents which
agents which activate
which activate lymphokine
activate lymphokine gene
lymphokine gene expression
gene expression by
expression by bypassing
by bypassing T
bypassing T cell
T cell receptor
cell receptor TCR
receptor TCR mediated
TCR mediated signaling
The trans-activation domain
trans-activation domain of
domain of E2
of E2 and
E2 and Tax
and Tax is
Tax is interchangeable
is interchangeable although
interchangeable although they
although they have
they have no
have no obvious
no obvious sequence
obvious sequence homology
sequence homology between
homology between them
The viral trans-activators
viral trans-activators appear
trans-activators appear to
appear to target
to target specific
target specific DNA
specific DNA binding
DNA binding protein
binding protein such
protein such as
such as NF-kB
as NF-kB and
NF-kB and Sp1
and Sp1 to
Sp1 to cis-acting
to cis-acting DNA
cis-acting DNA site
DNA site and
site and promote
and promote lymphokine
promote lymphokine gene
lymphokine gene expression
gene expression without
expression without TCR-mediated
without TCR-mediated stimulation
Mutations in the
in the Pit-1
the Pit-1 gene
Pit-1 gene in
gene in children
in children with
children with combined
with combined pituitary
combined pituitary hormone
pituitary hormone deficiency
Pit-1 is a
is a pituitary-specific
a pituitary-specific transcription
pituitary-specific transcription factor
transcription factor that
factor that binds
that binds to
binds to and
to and transactivates
and transactivates promoters
transactivates promoters of
promoters of growth
of growth hormone
growth hormone and
hormone and prolactin
and prolactin genes
In three unrelated
three unrelated Japanese
unrelated Japanese children
Japanese children with
children with combined
with combined pituitary
combined pituitary hormone
pituitary hormone deficiency
hormone deficiency we
deficiency we identified
we identified three
identified three point
three point mutations
point mutations in
mutations in the
in the Pit-1
the Pit-1 gene
Pit-1 gene Pro24Leu
gene Pro24Leu Arg143Gln
Pro24Leu Arg143Gln and
Arg143Gln and Arg271Trp
and Arg271Trp located
Arg271Trp located on
located on the
on the major
the major transactivation
major transactivation region
transactivation region POU-specific
region POU-specific domain
POU-specific domain and
domain and POU-homeodomain
and POU-homeodomain respectively
Activation of protein
of protein kinase
protein kinase C
kinase C and
C and elevation
and elevation of
elevation of cAMP
of cAMP interact
cAMP interact synergistically
interact synergistically to
synergistically to raise
to raise c-Fos
raise c-Fos and
c-Fos and AP-1
and AP-1 activity
AP-1 activity in
activity in Jurkat
in Jurkat cells
We have earlier
have earlier found
earlier found that
found that in
that in Jurkat
in Jurkat cells
Jurkat cells activation
cells activation of
activation of protein
of protein kinase
protein kinase C
kinase C PKC
C PKC enhances
PKC enhances the
enhances the cyclic
the cyclic adenosine
cyclic adenosine monophosphate
adenosine monophosphate cAMP
monophosphate cAMP accumulation
cAMP accumulation induced
accumulation induced by
induced by adenosine
by adenosine receptor
adenosine receptor stimulation
receptor stimulation or
stimulation or activation
or activation of
activation of Gs
Here we have
we have therefore
have therefore examined
therefore examined the
examined the effect
the effect of
effect of the
of the phorbol
the phorbol ester
phorbol ester PMA
ester PMA phorbol
PMA phorbol 12-myristate
phorbol 12-myristate 13-acetate
12-myristate 13-acetate which
13-acetate which stimulates
which stimulates PKC
stimulates PKC and
PKC and a
and a combination
a combination of
combination of the
of the adenosine
the adenosine receptor
adenosine receptor agonist
receptor agonist NECA
agonist NECA 5'-N-ethyl-carboxamido
NECA 5'-N-ethyl-carboxamido adenosine
5'-N-ethyl-carboxamido adenosine and
adenosine and forskolin
and forskolin to
forskolin to raise
to raise cAMP
raise cAMP on
cAMP on the
on the levels
the levels of
levels of c-Fos
of c-Fos and
c-Fos and Jun
and Jun and
Jun and on
and on the
on the binding
the binding and
binding and transcriptional
and transcriptional activity
transcriptional activity of
activity of the
of the transcription
the transcription factor
transcription factor activator
factor activator protein-1
activator protein-1 AP-1
PMA treatment caused
treatment caused a
caused a concentration-
a concentration- and
concentration- and time-dependent
and time-dependent increase
time-dependent increase in
increase in both
in both c-Fos
both c-Fos and
c-Fos and Jun
and Jun immunoreactivity
Jun immunoreactivity in
immunoreactivity in contrast
in contrast to
contrast to cAMP
to cAMP elevation
cAMP elevation that
elevation that had
that had only
had only a
only a slight
a slight effect
Both PMA and
PMA and the
and the combination
the combination of
combination of NECA
of NECA and
NECA and forskolin
and forskolin acted
forskolin acted together
acted together either
together either to
either to increase
to increase c-Fos
increase c-Fos or
c-Fos or decrease
or decrease Jun
decrease Jun protein
Jun protein levels
protein levels as
levels as well
as well as
well as increasing
as increasing AP-1
increasing AP-1 binding
AP-1 binding as
binding as judged
as judged by
judged by gel-shift
by gel-shift assay
gel-shift assay and
assay and AP-1
and AP-1 transcriptional
AP-1 transcriptional activity
Furthermore there was
there was a
was a clear-cut
a clear-cut synergy
clear-cut synergy between
synergy between the
between the PKC
the PKC stimulator
PKC stimulator and
stimulator and the
and the cAMP
the cAMP elevating
cAMP elevating agents
The results demonstrate
results demonstrate that
demonstrate that the
that the simultaneous
the simultaneous activation
simultaneous activation of
activation of PKC
of PKC and
PKC and elevation
and elevation of
elevation of cAMP
of cAMP leads
cAMP leads to
leads to an
to an enhanced
an enhanced AP-1
enhanced AP-1 transcriptional
AP-1 transcriptional activity
transcriptional activity in
activity in a
in a T-leukemia
a T-leukemia cell
T-leukemia cell line
cell line suggesting
line suggesting that
suggesting that the
that the previously
the previously observed
previously observed interaction
observed interaction between
interaction between the
between the parallel
the parallel signal
parallel signal transduction
signal transduction pathways
transduction pathways may
pathways may have
may have functional
have functional consequences
functional consequences at
consequences at the
at the level
the level of
level of gene
of gene transcription
Inhibition of anti-CD3
of anti-CD3 monoclonal
anti-CD3 monoclonal antibody-induced
monoclonal antibody-induced T-cell
antibody-induced T-cell proliferation
T-cell proliferation by
proliferation by dexamethasone
by dexamethasone isoproterenol
dexamethasone isoproterenol or
isoproterenol or prostaglandin
or prostaglandin E2
prostaglandin E2 either
E2 either alone
either alone or
alone or in
or in combination
The purpose of
purpose of these
of these studies
these studies was
studies was to
was to investigate
to investigate the
investigate the modulation
the modulation of
modulation of the
of the proliferation
the proliferation of
proliferation of human
of human T
human T cells
T cells obtained
cells obtained from
obtained from peripheral
from peripheral blood
peripheral blood by
blood by dexamethasone
by dexamethasone DEX
dexamethasone DEX isoproterenol
DEX isoproterenol ISO
isoproterenol ISO and
ISO and prostaglandin
and prostaglandin E2
prostaglandin E2 PGE2
The former two
former two substances
two substances interact
substances interact with
interact with T
with T cells
T cells via
cells via the
via the glucocorticoid
the glucocorticoid and
glucocorticoid and beta-adrenergic
and beta-adrenergic receptors
beta-adrenergic receptors respectively
When occupied by
occupied by their
by their natural
their natural ligands
natural ligands glucocorticosteroids
ligands glucocorticosteroids and
glucocorticosteroids and catecholamines
and catecholamines these
catecholamines these receptors
these receptors have
receptors have a
have a role
a role in
role in modulating
in modulating T-cell
modulating T-cell function
T-cell function during
function during stress
During the inflammatory
the inflammatory response
inflammatory response increased
response increased levels
increased levels of
levels of PGE2
of PGE2 bind
PGE2 bind to
bind to their
to their receptors
their receptors on
receptors on T
on T cells
T cells and
cells and thus
and thus alter
thus alter responsiveness
Proliferation of T
of T cells
T cells was
cells was induced
was induced by
induced by immobilized
by immobilized anti-CD3
immobilized anti-CD3 monoclonal
anti-CD3 monoclonal antibody
monoclonal antibody mAb
antibody mAb in
mAb in the
in the presence
the presence or
presence or absence
or absence of
absence of an
of an additional
an additional costimulatory
additional costimulatory signal
costimulatory signal delivered
signal delivered by
delivered by anti-CD28
by anti-CD28 mAb
Various physiologic concentrations
physiologic concentrations of
concentrations of DEX
of DEX ISO
DEX ISO or
ISO or PGE2
or PGE2 were
PGE2 were added
were added at
added at the
at the time
the time of
time of initiation
of initiation of
initiation of the
of the cultures
the cultures and
cultures and subsequent
and subsequent proliferation
subsequent proliferation of
proliferation of the
of the unstimulated
the unstimulated T
unstimulated T cells
T cells was
cells was determined
The results demonstrate
results demonstrate that
demonstrate that physiologic
that physiologic concentrations
physiologic concentrations of
concentrations of all
of all three
all three of
three of these
of these agents
these agents inhibit
agents inhibit the
inhibit the anti-CD3
the anti-CD3 mAb-induced
anti-CD3 mAb-induced proliferation
mAb-induced proliferation of
proliferation of T
of T cells
Although DEX and
DEX and PGE2
and PGE2 were
PGE2 were equipotent
were equipotent in
equipotent in suppressing
in suppressing T-cell
suppressing T-cell proliferation
T-cell proliferation ISO
proliferation ISO was
ISO was much
was much less
much less effective
Because concomitant elevations
concomitant elevations in
elevations in the
in the peripheral
the peripheral levels
peripheral levels of
levels of these
of these substances
these substances may
substances may occur
may occur experiments
occur experiments were
experiments were performed
were performed to
performed to determine
to determine the
determine the T-cell
the T-cell inhibitory
T-cell inhibitory effects
inhibitory effects of
effects of DEX
of DEX together
DEX together with
together with either
with either PGE2
either PGE2 or
PGE2 or ISO
Synergistic suppression of
suppression of T-cell
of T-cell proliferation
T-cell proliferation was
proliferation was observed
was observed when
observed when various
when various concentrations
various concentrations of
concentrations of DEX
of DEX and
DEX and PGE2
and PGE2 but
PGE2 but not
but not DEX
not DEX and
DEX and ISO
and ISO were
ISO were added
were added to
added to cultures
This synergistic suppression
synergistic suppression could
suppression could not
could not be
not be explained
be explained by
explained by an
by an increase
an increase in
increase in cAMP
in cAMP accumulation
cAMP accumulation in
accumulation in T
in T cells
T cells stimulated
cells stimulated with
stimulated with DEX
with DEX and
DEX and PGE2
Finally the addition
the addition of
addition of anti-CD28
of anti-CD28 mAb
anti-CD28 mAb to
mAb to anti-CD3
to anti-CD3 mAb-stimulated
anti-CD3 mAb-stimulated T
mAb-stimulated T cells
T cells overcame
cells overcame much
overcame much of
much of the
of the suppression
the suppression of
suppression of proliferation
of proliferation induced
proliferation induced by
induced by PGE2
by PGE2 or
PGE2 or ISO
or ISO but
ISO but less
but less so
less so than
so than that
than that induced
that induced by
induced by DEX
In vivo footprint
vivo footprint analysis
footprint analysis of
analysis of the
of the HLA-DRA
the HLA-DRA gene
HLA-DRA gene promoter:
gene promoter: cell-specific
promoter: cell-specific interaction
cell-specific interaction at
interaction at the
at the octamer
the octamer site
octamer site and
site and up-regulation
and up-regulation of
up-regulation of X
of X box
X box binding
box binding by
binding by interferon
by interferon gamma
Analysis of the
of the major
the major histocompatibility
major histocompatibility complex
histocompatibility complex class
complex class II
class II gene
II gene promoter
gene promoter DRA
promoter DRA has
DRA has previously
has previously identified
previously identified at
identified at least
at least five
least five cis-acting
five cis-acting regions
cis-acting regions required
regions required for
required for maximal
for maximal expression
We have examined
have examined the
examined the DRA
the DRA promoter
DRA promoter for
promoter for protein-DNA
for protein-DNA interactions
protein-DNA interactions in
interactions in the
in the intact
the intact cell
intact cell which
cell which may
which may mediate
may mediate transcriptional
mediate transcriptional activation
Using in vivo
in vivo genomic
vivo genomic footprinting
genomic footprinting we
footprinting we identified
we identified interactions
identified interactions in
interactions in B-cell
in B-cell lines
B-cell lines at
lines at the
at the octamer
the octamer site
octamer site and
site and the
and the Y
the Y X1
Y X1 and
X1 and X2
and X2 boxes
Class II antigen
II antigen expressing
antigen expressing T-cell
expressing T-cell lines
T-cell lines maintained
lines maintained contacts
maintained contacts identical
contacts identical to
identical to B-cell
to B-cell lines
B-cell lines while
lines while class
while class II-negative
class II-negative T-cell
II-negative T-cell lines
T-cell lines exhibited
lines exhibited no
exhibited no interactions
In lymphoid cell
lymphoid cell lines
cell lines the
lines the octamer
the octamer site
octamer site is
site is occupied
is occupied and
occupied and required
and required for
required for maximal
for maximal expression
This is most
is most likely
most likely due
likely due to
due to the
to the presence
the presence of
presence of the
of the lymphoid-specific
the lymphoid-specific OTF-2
lymphoid-specific OTF-2 factor
In contrast the
contrast the class
the class II-positive
class II-positive nonlymphoid
II-positive nonlymphoid glioblastoma
nonlymphoid glioblastoma cell
glioblastoma cell line
cell line does
line does not
does not exhibit
not exhibit interactions
exhibit interactions at
interactions at the
at the octamer
the octamer site
octamer site despite
site despite the
despite the presence
the presence of
presence of the
of the ubiquitous
the ubiquitous OTF-1
ubiquitous OTF-1 factor
OTF-1 factor and
factor and an
and an open
an open binding
open binding site
Thus the DRA
the DRA promoter
DRA promoter discriminates
promoter discriminates against
discriminates against OTF-1
against OTF-1 activation
OTF-1 activation at
activation at the
at the level
the level of
level of DNA
of DNA binding
DNA binding in
binding in the
in the glioblastoma
the glioblastoma line
Interferon gamma induces
gamma induces class
induces class II
class II expression
II expression in
expression in this
in this glioblastoma
this glioblastoma cell
glioblastoma cell line
cell line and
line and in
and in parallel
in parallel up-regulates
parallel up-regulates X1
up-regulates X1 and
X1 and X2
and X2 box
X2 box protein-DNA
box protein-DNA interactions
protein-DNA interactions while
interactions while all
while all other
all other interactions
other interactions remain
interactions remain unchanged
These results suggest
results suggest that
suggest that interferon
that interferon gamma
interferon gamma functions
gamma functions on
functions on a
on a poised
a poised promoter
poised promoter by
promoter by altering
by altering weak
altering weak nonproductive
weak nonproductive interactions
nonproductive interactions at
interactions at the
at the X
the X boxes
X boxes to
boxes to strong
to strong interactions
These findings provide
findings provide direct
provide direct in
direct in vivo
in vivo evidence
vivo evidence to
evidence to strongly
to strongly suggest
strongly suggest that
suggest that the
that the modulation
the modulation of
modulation of X1
of X1 and
X1 and X2
and X2 interactions
X2 interactions is
interactions is an
is an important
an important constituent
important constituent of
constituent of the
of the interferon
the interferon gamma
interferon gamma induction
gamma induction pathway
Estrogen binding sites
binding sites in
sites in peripheral
in peripheral blood
peripheral blood monocytes
blood monocytes and
monocytes and effects
and effects of
effects of danazol
of danazol on
danazol on their
on their sites
their sites in
sites in vitro
This study was
study was designed
was designed to
designed to investigate
to investigate the
investigate the presence
the presence of
presence of estrogen
of estrogen type
estrogen type I
type I high
I high affinity
high affinity low
affinity low capacity
low capacity and
capacity and type
and type II
type II low
II low affinity
low affinity high
affinity high capacity
high capacity binding
capacity binding sites
binding sites in
sites in human
in human peripheral
human peripheral blood
peripheral blood monocytes
blood monocytes and
monocytes and the
and the effects
the effects of
effects of danazol
of danazol on
danazol on these
on these sites
These two types
two types of
types of estrogen
of estrogen binding
estrogen binding sites
binding sites existed
sites existed in
existed in human
in human peripheral
human peripheral blood
peripheral blood monocytes
Danazol bound to
bound to these
to these sites
these sites in
sites in high
in high concentration
high concentration 10-6
concentration 10-6 M
10-6 M clinical
M clinical serum
clinical serum concentration
serum concentration during
concentration during danazol
during danazol therapy
danazol therapy and
therapy and decreased
and decreased the
decreased the number
the number of
number of both
of both sites
It is suggested
is suggested that
suggested that danazol
that danazol has
danazol has an
has an anti-estrogenic
an anti-estrogenic action
anti-estrogenic action to
action to the
to the monocytes
the monocytes through
monocytes through the
through the competition
the competition and
competition and suppression
and suppression of
suppression of estrogen
of estrogen binding
estrogen binding sites
binding sites as
sites as seen
as seen in
seen in the
in the estrogen
the estrogen target
estrogen target organ
A microtitre assay
microtitre assay system
assay system for
system for glucocorticoid
for glucocorticoid receptors:
glucocorticoid receptors: decreased
receptors: decreased receptor
decreased receptor concentration
receptor concentration in
concentration in myocardial
in myocardial infarction
A major difficulty
major difficulty in
difficulty in determination
in determination of
determination of glucocorticoid
of glucocorticoid receptor
glucocorticoid receptor sites
receptor sites is
sites is the
is the very
the very complicated
very complicated assay
complicated assay procedure
Therefore we describe
we describe a
describe a microtitre
a microtitre assay
microtitre assay system
assay system for
system for glucocorticoid
for glucocorticoid receptors
glucocorticoid receptors which
receptors which is
which is a
is a whole-cell
a whole-cell competitive
whole-cell competitive binding
competitive binding radioassay
binding radioassay using
radioassay using [3H]-dexamethasone
using [3H]-dexamethasone as
[3H]-dexamethasone as radioligand
This modification of
modification of a
of a previously
a previously described
previously described protocol
described protocol simplifies
protocol simplifies and
simplifies and reduces
and reduces laboratory
reduces laboratory work
laboratory work and
work and allows
and allows assay
allows assay reproducibility
assay reproducibility to
reproducibility to be
to be controlled
be controlled more
controlled more reliably
Thus enabled to
enabled to perform
to perform the
perform the test
the test on
test on multiple
on multiple blood
multiple blood samples
blood samples in
samples in parallel
in parallel we
parallel we investigated
we investigated cardiac
investigated cardiac infarction
cardiac infarction patients
infarction patients over
patients over a
over a 12-day
a 12-day period
12-day period to
period to test
to test if
test if glucocorticoid
if glucocorticoid receptor
glucocorticoid receptor binding
receptor binding is
binding is altered
is altered in
altered in this
in this 'stressful'
this 'stressful' disease
On the first
the first day
first day of
day of the
of the disease
the disease glucocorticoid
disease glucocorticoid receptor
glucocorticoid receptor capacity
receptor capacity was
capacity was significantly
was significantly decreased
significantly decreased without
decreased without alteration
without alteration of
alteration of the
of the receptor-ligand
the receptor-ligand affinity
receptor-ligand affinity whereas
affinity whereas on
whereas on days
on days 4
days 4 and
4 and 12
and 12 the
12 the number
the number of
number of receptor
of receptor sites
receptor sites was
sites was normal
was normal again
This result fits
result fits well
fits well into
well into the
into the general
the general observation
general observation of
observation of stress-induced
of stress-induced down-regulation
stress-induced down-regulation of
down-regulation of immune
of immune responses
SRC-related proto-oncogenes and
proto-oncogenes and transcription
and transcription factors
transcription factors in
factors in primary
in primary human
primary human T
human T cells:
T cells: modulation
cells: modulation by
modulation by cyclosporin
by cyclosporin A
cyclosporin A and
A and FK506
Activation of T
of T lymphocytes
T lymphocytes induces
lymphocytes induces transcription
induces transcription of
transcription of genes
of genes encoding
genes encoding for
encoding for lymphokines
Interleukin-2 IL-2 gene
IL-2 gene expression
gene expression is
expression is controlled
is controlled transcriptionally
controlled transcriptionally by
transcriptionally by the
by the cooperative
the cooperative activity
cooperative activity of
activity of specific
of specific trans-activating
specific trans-activating factors
trans-activating factors that
factors that bind
that bind to
bind to the
to the IL-2
the IL-2 enhancer
Cyclosporin A CsA
A CsA and
CsA and FK506
and FK506 inhibit
FK506 inhibit the
inhibit the production
the production of
production of IL-2
of IL-2 in
IL-2 in T
in T lymphocytes
T lymphocytes at
lymphocytes at the
at the level
the level of
level of gene
of gene transcription
A member of
member of the
of the src
the src gene
src gene family
gene family the
family the lymphocyte-specific
the lymphocyte-specific protein
lymphocyte-specific protein tyrosine
protein tyrosine kinase
tyrosine kinase p56lck
kinase p56lck has
p56lck has been
has been implicated
been implicated in
implicated in IL-2
in IL-2 production
CsA was found
was found not
found not to
not to inhibit
to inhibit lck
inhibit lck gene
lck gene expression
gene expression nor
expression nor the
nor the activity
the activity of
activity of the
of the lck
the lck gene
lck gene product
However CsA and
CsA and FK506
and FK506 inhibit
FK506 inhibit the
inhibit the appearance
the appearance of
appearance of DNA
of DNA binding
DNA binding activity
binding activity of
activity of factors
of factors that
factors that bind
that bind to
bind to the
to the NF-AT
the NF-AT and
NF-AT and AP-1
and AP-1 sites
AP-1 sites in
sites in the
in the IL-2
the IL-2 enhancer
Since the induction
the induction of
induction of NF-AT
of NF-AT and
NF-AT and AP-1
and AP-1 is
AP-1 is induced
is induced by
induced by the
by the same
the same stimuli
same stimuli that
stimuli that stimulate
that stimulate IL-2
stimulate IL-2 production
IL-2 production these
production these results
these results indicate
results indicate that
indicate that the
that the immunosuppressant
the immunosuppressant action
immunosuppressant action of
action of CsA
of CsA and
CsA and FK506
and FK506 is
FK506 is exerted
is exerted at
exerted at the
at the level
the level of
level of these
of these trans-activating
these trans-activating factors
The AP-1 site
AP-1 site at
site at -150
at -150 bp
-150 bp but
bp but not
but not the
not the NF-kappa
the NF-kappa B
NF-kappa B site
B site is
site is likely
is likely to
likely to represent
to represent the
represent the major
the major target
major target of
target of protein
of protein kinase
protein kinase C
kinase C in
C in the
in the interleukin
the interleukin 2
interleukin 2 promoter
Stimulation of T
of T cells
T cells with
cells with antigen
with antigen results
antigen results in
results in activation
in activation of
activation of several
of several kinases
several kinases including
kinases including protein
including protein kinase
protein kinase C
kinase C PKC
C PKC that
PKC that may
that may mediate
may mediate the
mediate the later
the later induction
later induction of
induction of activation-related
of activation-related genes
We have examined
have examined the
examined the potential
the potential role
potential role of
role of PKC
of PKC in
PKC in induction
in induction of
induction of the
of the interleukin
the interleukin 2
interleukin 2 IL-2
2 IL-2 gene
IL-2 gene in
gene in T
in T cells
T cells stimulated
cells stimulated through
stimulated through the
through the T
the T cell
T cell receptor/CD3
cell receptor/CD3 complex
We have previously
have previously shown
previously shown that
shown that prolonged
that prolonged treatment
prolonged treatment of
treatment of the
of the untransformed
the untransformed T
untransformed T cell
T cell clone
cell clone Ar-5
clone Ar-5 with
Ar-5 with phorbol
with phorbol esters
phorbol esters results
esters results in
results in downmodulation
in downmodulation of
downmodulation of the
of the alpha
the alpha and
alpha and beta
and beta isozymes
beta isozymes of
isozymes of PKC
of PKC and
PKC and abrogates
and abrogates induction
abrogates induction of
induction of IL-2
of IL-2 mRNA
IL-2 mRNA and
mRNA and protein
Here we show
we show that
show that phorbol
that phorbol ester
phorbol ester treatment
ester treatment also
treatment also abolishes
also abolishes induction
abolishes induction of
induction of chloramphenicol
of chloramphenicol acetyltransferase
chloramphenicol acetyltransferase activity
acetyltransferase activity in
activity in Ar-5
in Ar-5 cells
Ar-5 cells transfected
cells transfected with
transfected with a
with a plasmid
a plasmid containing
plasmid containing the
containing the IL-2
the IL-2 promoter
IL-2 promoter linked
promoter linked to
linked to this
to this reporter
this reporter gene
The IL-2 promoter
IL-2 promoter contains
promoter contains binding
contains binding sites
binding sites for
sites for nuclear
for nuclear factors
nuclear factors including
factors including NFAT-1
including NFAT-1 Oct
NFAT-1 Oct NF-kappa
Oct NF-kappa B
NF-kappa B and
B and AP-1
and AP-1 which
AP-1 which are
which are all
are all potentially
all potentially sensitive
potentially sensitive to
sensitive to activation
to activation of
activation of PKC
We show that
show that induction
that induction of
induction of a
of a trimer
a trimer of
trimer of the
of the NFAT
the NFAT and
NFAT and Oct
and Oct sites
Oct sites is
sites is not
is not sensitive
not sensitive to
sensitive to phorbol
to phorbol ester
phorbol ester treatment
ester treatment and
treatment and that
and that mutations
that mutations in
mutations in the
in the NF-kappa
the NF-kappa B
NF-kappa B site
B site have
site have no
have no effect
no effect on
effect on inducibility
on inducibility of
inducibility of the
of the IL-2
the IL-2 promoter
In contrast mutations
contrast mutations in
mutations in the
in the AP-1
the AP-1 site
AP-1 site located
site located at
located at -150
at -150 bp
-150 bp almost
bp almost completely
almost completely abrogate
completely abrogate induction
abrogate induction of
induction of the
of the IL-2
the IL-2 promoter
IL-2 promoter and
promoter and appearance
and appearance of
appearance of an
of an inducible
an inducible nuclear
inducible nuclear factor
nuclear factor binding
factor binding to
binding to this
to this site
this site is
site is sensitive
is sensitive to
sensitive to PKC
to PKC depletion
Moreover cotransfections with
cotransfections with c-fos
with c-fos and
c-fos and c-jun
and c-jun expression
c-jun expression plasmids
expression plasmids markedly
plasmids markedly enhance
markedly enhance induction
enhance induction of
induction of the
of the IL-2
the IL-2 promoter
IL-2 promoter in
promoter in minimally
in minimally stimulated
minimally stimulated T
stimulated T cells
Our results indicate
results indicate that
indicate that the
that the AP-1
the AP-1 site
AP-1 site at
site at -150
at -150 bp
-150 bp represents
bp represents a
represents a major
a major if
major if not
if not the
not the only
the only site
only site of
site of PKC
of PKC responsiveness
PKC responsiveness in
responsiveness in the
in the IL-2
the IL-2 promoter
[Effect of antihypertensive
of antihypertensive therapy
antihypertensive therapy with
therapy with captopril
with captopril on
captopril on gluco-
on gluco- and
gluco- and mineralocorticoid
and mineralocorticoid receptors
mineralocorticoid receptors of
receptors of peripheral
of peripheral blood
peripheral blood lymphocytes
blood lymphocytes in
lymphocytes in hypertensive
in hypertensive patients
hypertensive patients of
patients of various
of various age]
Binding of 3H-dexamethasone
of 3H-dexamethasone and
3H-dexamethasone and 3H-aldosterone
and 3H-aldosterone by
3H-aldosterone by peripheral
by peripheral lymphocyte
peripheral lymphocyte receptors
lymphocyte receptors was
receptors was investigated
was investigated in
investigated in healthy
in healthy persons
healthy persons and
persons and hypertensive
and hypertensive patients
hypertensive patients before
patients before and
before and after
and after 2-week
after 2-week captopril
2-week captopril treatment
The number of
number of glucocorticoid
of glucocorticoid and
glucocorticoid and mineralocorticoid
and mineralocorticoid binding
mineralocorticoid binding sites
binding sites was
sites was increased
was increased in
increased in hypertensives
in hypertensives vs
hypertensives vs normotensives
The treatment with
treatment with the
with the ACE
the ACE inhibitor
ACE inhibitor captopril
inhibitor captopril led
captopril led to
led to activation
to activation of
activation of hormone-receptor
of hormone-receptor interactions
There was a
was a more
a more marked
more marked rise
marked rise of
rise of the
of the number
the number of
number of receptors
of receptors in
receptors in middle-aged
in middle-aged 44-55
middle-aged 44-55 years
44-55 years hypertensives
years hypertensives vs
hypertensives vs elderly
vs elderly 61-80
elderly 61-80 years
61-80 years subjects
years subjects after
subjects after captopril
after captopril treatment
The use of
use of interferon-gamma-treated
of interferon-gamma-treated U937
interferon-gamma-treated U937 cells
U937 cells in
cells in chemiluminescence
in chemiluminescence assays
chemiluminescence assays to
assays to detect
to detect red
detect red cell
red cell platelet
cell platelet and
platelet and granulocyte
and granulocyte antibodies
granulocyte antibodies of
antibodies of potential
of potential clinical
potential clinical significance
The chemiluminescent CL
chemiluminescent CL response
CL response of
response of interferon-gamma-treated
of interferon-gamma-treated U937
interferon-gamma-treated U937 IFN-U937
U937 IFN-U937 cells
IFN-U937 cells to
cells to sensitized
to sensitized target
sensitized target cells
target cells has
cells has been
has been used
been used to
used to detect
to detect red
detect red cell
red cell platelet
cell platelet and
platelet and granulocyte
and granulocyte antibodies
A clone of
clone of U937
of U937 cells
U937 cells was
cells was selected
was selected which
selected which expressed
which expressed Fc
expressed Fc receptor
Fc receptor I
receptor I Fc
I Fc gamma
Fc gamma RI
gamma RI and
RI and which
and which after
which after incubation
after incubation with
incubation with IFN-gamma
with IFN-gamma for
IFN-gamma for 72
for 72 h
72 h was
h was capable
was capable of
capable of generating
of generating high
generating high levels
high levels of
levels of lucigenin-enhanced
of lucigenin-enhanced CL
The CL responses
CL responses of
responses of IFN-U937
of IFN-U937 cells
IFN-U937 cells and
cells and peripheral
and peripheral blood
peripheral blood human
blood human monocytes
human monocytes to
monocytes to sensitized
to sensitized red
sensitized red cells
red cells platelets
cells platelets or
platelets or granulocytes
or granulocytes were
granulocytes were then
were then compared
Assays using monocytes
using monocytes or
monocytes or IFN-U937
or IFN-U937 cells
IFN-U937 cells were
cells were of
were of comparable
of comparable sensitivity
comparable sensitivity for
sensitivity for detection
for detection of
detection of antibodies
of antibodies against
antibodies against all
against all three
all three types
three types of
types of target
of target cell
In addition the
addition the use
the use of
use of IFN-U937
of IFN-U937 cells
IFN-U937 cells reduced
cells reduced interassay
reduced interassay variation
interassay variation and
variation and simplified
and simplified assay
simplified assay performance
The potential clinical
potential clinical usefulness
clinical usefulness of
usefulness of these
of these CL
these CL assays
CL assays was
assays was suggested
was suggested by
suggested by the
by the ability
the ability of
ability of both
of both monocytes
both monocytes and
monocytes and IFN-U937
and IFN-U937 cells
IFN-U937 cells to
cells to respond
to respond to
respond to red
to red cells
red cells platelets
cells platelets or
platelets or granulocytes
or granulocytes sensitized
granulocytes sensitized with
sensitized with sera
with sera from
sera from pregnant
from pregnant women
pregnant women whose
women whose babies
whose babies had
babies had either
had either haemolytic
either haemolytic disease
haemolytic disease of
disease of the
of the newborn
the newborn HDN
newborn HDN alloimmune
HDN alloimmune thrombocytopenia
alloimmune thrombocytopenia or
thrombocytopenia or alloimmune
or alloimmune neutropenia
alloimmune neutropenia respectively
In addition monocytes
addition monocytes and
monocytes and IFN-U937
and IFN-U937 cells
IFN-U937 cells both
cells both responded
both responded to
responded to red
to red cells
red cells sensitized
cells sensitized with
sensitized with antibodies
with antibodies against
antibodies against a
against a variety
a variety of
variety of specificities
of specificities of
specificities of assumed
of assumed although
assumed although not
although not documented
not documented clinical
documented clinical significance
clinical significance for
significance for blood
for blood transfusion
blood transfusion recipients
In contrast monocytes
contrast monocytes and
monocytes and IFN-U937
and IFN-U937 cells
IFN-U937 cells responded
cells responded only
responded only weakly
only weakly to
weakly to red
to red cells
red cells sensitized
cells sensitized with
sensitized with either
with either anti-D
either anti-D in
anti-D in sera
in sera from
sera from mothers
from mothers of
mothers of babies
of babies unaffected
babies unaffected by
unaffected by HDN
by HDN or
HDN or with
or with antisera
with antisera containing
antisera containing high
containing high titre
high titre antibodies
titre antibodies with
antibodies with specificities
with specificities not
specificities not normally
not normally associated
normally associated with
associated with significantly
with significantly reduced
significantly reduced red
reduced red cell
red cell survival
Ablation of transplanted
of transplanted HTLV-I
transplanted HTLV-I Tax-transformed
HTLV-I Tax-transformed tumors
Tax-transformed tumors in
tumors in mice
in mice by
mice by antisense
by antisense inhibition
antisense inhibition of
inhibition of NF-kappa
of NF-kappa B
NF-kappa B [published
B [published erratum
[published erratum appears
erratum appears in
appears in Science
in Science 1993
Science 1993 Mar
1993 Mar 12;2595101:1523]
Mice transgenic for
transgenic for the
for the human
the human T
human T cell
T cell leukemia
cell leukemia virus
leukemia virus HTLV-I
virus HTLV-I Tax
HTLV-I Tax gene
Tax gene develop
gene develop fibroblastic
develop fibroblastic tumors
fibroblastic tumors that
tumors that express
that express NF-kappa
express NF-kappa B-inducible
NF-kappa B-inducible early
B-inducible early genes
In vitro inhibition
vitro inhibition of
inhibition of NF-kappa
of NF-kappa B
NF-kappa B expression
B expression by
expression by antisense
by antisense oligodeoxynucleotides
antisense oligodeoxynucleotides ODNs
oligodeoxynucleotides ODNs inhibited
ODNs inhibited growth
inhibited growth of
growth of these
of these culture-adapted
these culture-adapted Tax-transformed
culture-adapted Tax-transformed fibroblasts
Tax-transformed fibroblasts as
fibroblasts as well
as well as
well as an
as an HTLV-I-transformed
an HTLV-I-transformed human
HTLV-I-transformed human lymphocyte
human lymphocyte line
In contrast antisense
contrast antisense inhibition
antisense inhibition of
inhibition of Tax
of Tax itself
Tax itself had
itself had no
had no apparent
no apparent effect
apparent effect on
effect on cell
on cell growth
Mice treated with
treated with antisense
with antisense to
antisense to NF-kappa
to NF-kappa B
NF-kappa B ODNs
B ODNs showed
ODNs showed rapid
showed rapid regression
rapid regression of
regression of transplanted
of transplanted fibrosarcomas
This suggests that
suggests that NF-kappa
that NF-kappa B
NF-kappa B expression
B expression may
expression may be
may be necessary
be necessary for
necessary for the
for the maintenance
the maintenance of
maintenance of the
of the malignant
the malignant phenotype
malignant phenotype and
phenotype and provides
and provides a
provides a therapeutic
a therapeutic approach
therapeutic approach for
approach for HTLV-I-associated
for HTLV-I-associated disease
Membrane receptors for
receptors for aldosterone:
for aldosterone: a
aldosterone: a novel
a novel pathway
novel pathway for
pathway for mineralocorticoid
for mineralocorticoid action
Rapid nongenomic in
nongenomic in vitro
in vitro effects
vitro effects of
effects of aldosterone
of aldosterone on
aldosterone on intracellular
on intracellular electrolytes
intracellular electrolytes cell
electrolytes cell volume
cell volume and
volume and Na+-H+
and Na+-H+ antiport
Na+-H+ antiport have
antiport have been
have been found
been found in
found in human
in human mononuclear
human mononuclear leukocytes
mononuclear leukocytes HML
Binding of 125I-labeled
of 125I-labeled aldosterone
125I-labeled aldosterone to
aldosterone to plasma
to plasma membranes
plasma membranes of
membranes of HML
of HML shares
HML shares important
shares important features
important features with
features with these
with these functional
these functional data
This includes a
includes a very
a very low
very low apparent
low apparent dissociation
apparent dissociation constant
dissociation constant Kd
constant Kd of
Kd of 01
of 01 nM
01 nM for
nM for both
for both aldosterone
both aldosterone and
aldosterone and the
and the effect
the effect on
effect on the
on the Na+-H+-antiport
the Na+-H+-antiport a
Na+-H+-antiport a high
a high turnover
high turnover rate
turnover rate and
rate and the
and the almost
the almost exclusive
almost exclusive binding
exclusive binding selectivity
binding selectivity for
selectivity for aldosterone
Dexamethasone RU 26988
RU 26988 corticosterone
26988 corticosterone ouabain
corticosterone ouabain amiloride
ouabain amiloride and
amiloride and 18-hydroxyprogesterone
and 18-hydroxyprogesterone were
18-hydroxyprogesterone were inactive
were inactive as
inactive as ligands
Deoxycorticosterone acetate had
acetate had an
had an intermediate
an intermediate activity
intermediate activity with
activity with an
with an apparent
an apparent Kd
apparent Kd of
Kd of 100
of 100 nM
These findings are
findings are the
are the first
the first to
first to demonstrate
to demonstrate membrane
demonstrate membrane binding
membrane binding of
binding of aldosterone
of aldosterone being
aldosterone being compatible
being compatible with
compatible with major
with major aspects
major aspects of
aspects of its
of its nongenomic
its nongenomic effects
Leukotriene B4 transcriptionally
B4 transcriptionally activates
transcriptionally activates interleukin-6
activates interleukin-6 expression
interleukin-6 expression involving
expression involving NK-chi
involving NK-chi B
NK-chi B and
B and NF-IL6
Leukotriene B4 LTB4
B4 LTB4 is
LTB4 is a
is a notable
a notable participant
notable participant in
participant in inflammation
in inflammation and
inflammation and chemotaxis
It is however
is however still
however still unclear
still unclear whether
unclear whether LTB4
whether LTB4 acts
LTB4 acts in
acts in this
in this regard
this regard directly
regard directly or
directly or indirectly
or indirectly by
indirectly by stimulating
by stimulating the
stimulating the release
the release of
release of chemotactic
of chemotactic and
chemotactic and inflammatory
and inflammatory cytokines
Here we report
we report that
report that LTB4
that LTB4 induces
LTB4 induces synthesis
induces synthesis of
synthesis of interleukin
of interleukin IL-6
interleukin IL-6 by
IL-6 by human
by human blood
human blood monocytes
blood monocytes through
monocytes through transcriptional
through transcriptional activation
transcriptional activation of
activation of the
of the IL-6
the IL-6 gene
We furthermore demonstrate
furthermore demonstrate that
demonstrate that this
that this process
this process involves
process involves activation
involves activation of
activation of the
of the transcription
the transcription factor
transcription factor NF-chi
factor NF-chi B
NF-chi B and
B and to
and to a
to a lesser
a lesser extent
lesser extent of
extent of NF-IL6
of NF-IL6 while
NF-IL6 while the
while the activity
the activity of
activity of the
of the transcription
the transcription factor
transcription factor AP-1
factor AP-1 shown
AP-1 shown to
shown to otherwise
to otherwise confer
otherwise confer IL-6
confer IL-6 inducibility
IL-6 inducibility appeared
inducibility appeared to
appeared to be
to be unaffected
be unaffected by
unaffected by LTB4
Involvement of NF-chi
of NF-chi B
NF-chi B and
B and NF-IL6
and NF-IL6 in
NF-IL6 in induction
in induction of
induction of IL-6
of IL-6 transcription
IL-6 transcription by
transcription by monocytes
by monocytes was
monocytes was demonstrated
was demonstrated using
demonstrated using deleted
using deleted forms
deleted forms of
forms of the
of the IL-6
the IL-6 promoter
Activation of the
of the IL-6
the IL-6 promoter
IL-6 promoter by
promoter by LTB4
by LTB4 was
LTB4 was not
was not only
not only associated
only associated with
associated with accumulation
with accumulation of
accumulation of the
of the respective
the respective transcripts
respective transcripts but
transcripts but resulted
but resulted in
resulted in synthesis
in synthesis of
synthesis of functional
of functional IL-6
functional IL-6 protein
IL-6 protein as
protein as well
In addition LTB4
addition LTB4 mediated
LTB4 mediated transactivation
mediated transactivation of
transactivation of a
of a heterologous
a heterologous promoter
heterologous promoter construct
promoter construct containing
construct containing the
containing the NF-chi
the NF-chi B
NF-chi B or
B or the
or the NF-IL6
the NF-IL6 enhancer
NF-IL6 enhancer but
enhancer but not
but not the
not the AP-1
the AP-1 enhancer
The signaling events
signaling events mediating
events mediating this
mediating this effect
this effect appeared
effect appeared to
appeared to involve
to involve the
involve the release
the release of
release of H2O2
of H2O2 since
H2O2 since LTB4
since LTB4 failed
LTB4 failed to
failed to induce
to induce NF-chi
induce NF-chi B
NF-chi B or
B or NF-IL6
or NF-IL6 in
NF-IL6 in the
in the presence
the presence of
presence of the
of the scavenger
the scavenger of
scavenger of H2O2
of H2O2 N-acetyl-L-cysteine
Bcl-2: a repressor
a repressor of
repressor of lymphocyte
of lymphocyte death
The genes and
genes and mechanisms
and mechanisms that
mechanisms that control
that control programmed
control programmed cell
programmed cell death
cell death are
death are currently
are currently the
currently the subject
the subject of
subject of intense
of intense study
The bcl-2 gene
bcl-2 gene a
gene a repressor
a repressor of
repressor of lymphocyte
of lymphocyte death
lymphocyte death is
death is perhaps
is perhaps the
perhaps the best
the best understood
best understood of
understood of the
of the programmed
the programmed cell
programmed cell death
cell death associated
death associated genes
Here Stanley Korsmeyer
Stanley Korsmeyer provides
Korsmeyer provides a
provides a brief
a brief overview
brief overview of
overview of bcl-2
of bcl-2 concentrating
bcl-2 concentrating on
concentrating on its
on its roles
its roles in
roles in B-
in B- and
B- and T-cell
and T-cell development
T-cell development and
development and in
and in oncogenesis
Cytoplasmic domain heterogeneity
domain heterogeneity and
heterogeneity and functions
and functions of
functions of IgG
of IgG Fc
IgG Fc receptors
Fc receptors in
receptors in B
in B lymphocytes
B lymphocytes and
lymphocytes and macrophages
and macrophages express
macrophages express closely
express closely related
closely related immunoglobulin
related immunoglobulin G
immunoglobulin G IgG
G IgG Fc
IgG Fc receptors
Fc receptors Fc
receptors Fc gamma
Fc gamma RII
gamma RII that
RII that differ
that differ only
differ only in
only in the
in the structures
the structures of
structures of their
of their cytoplasmic
their cytoplasmic domains
Because of cell
of cell type-specific
cell type-specific alternative
type-specific alternative messenger
alternative messenger RNA
messenger RNA splicing
RNA splicing B-cell
splicing B-cell Fc
B-cell Fc gamma
Fc gamma RII
gamma RII contains
RII contains an
contains an insertion
an insertion of
insertion of 47
of 47 amino
47 amino acids
amino acids that
acids that participates
that participates in
participates in determining
in determining receptor
determining receptor function
receptor function in
function in these
in these cells
Transfection of an
of an Fc
an Fc gamma
Fc gamma RII-negative
gamma RII-negative B-cell
RII-negative B-cell line
B-cell line with
line with complementary
with complementary DNA's
complementary DNA's encoding
DNA's encoding the
encoding the two
the two splice
two splice products
splice products and
products and various
and various receptor
various receptor mutants
receptor mutants indicated
mutants indicated that
indicated that the
that the insertion
the insertion was
insertion was responsible
was responsible for
responsible for preventing
for preventing both
preventing both Fc
both Fc gamma
Fc gamma RII-mediated
gamma RII-mediated endocytosis
RII-mediated endocytosis and
endocytosis and Fc
and Fc gamma
Fc gamma RII-mediated
gamma RII-mediated antigen
RII-mediated antigen presentation
The insertion was
insertion was not
was not required
not required for
required for Fc
for Fc gamma
Fc gamma RII
gamma RII to
RII to modulate
to modulate surface
modulate surface immunoglobulin-triggered
surface immunoglobulin-triggered B-cell
immunoglobulin-triggered B-cell activation
Instead regulation of
regulation of activation
of activation involved
activation involved a
involved a region
a region of
region of the
of the cytoplasmic
the cytoplasmic domain
cytoplasmic domain common
domain common to
common to both
to both the
both the lymphocyte
the lymphocyte and
lymphocyte and macrophage
and macrophage receptor
macrophage receptor isoforms
In contrast the
contrast the insertion
the insertion did
insertion did contribute
did contribute to
contribute to the
to the formation
the formation of
formation of caps
of caps in
caps in response
in response to
response to receptor
to receptor cross-linking
receptor cross-linking consistent
cross-linking consistent with
consistent with suggestions
with suggestions that
suggestions that the
that the lymphocyte
the lymphocyte but
lymphocyte but not
but not macrophage
not macrophage form
macrophage form of
form of the
of the receptor
the receptor can
receptor can associate
can associate with
associate with the
with the detergent-insoluble
the detergent-insoluble cytoskeleton
[Age-related changes in
changes in glucocorticoid
in glucocorticoid and
glucocorticoid and mineralocorticoid
and mineralocorticoid receptors
mineralocorticoid receptors in
receptors in lymphocytes
in lymphocytes of
lymphocytes of healthy
of healthy persons
healthy persons and
persons and patients
and patients with
patients with hypertension]
It has been
has been found
been found that
found that the
that the number
the number of
number of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in lymphocytes
in lymphocytes of
lymphocytes of the
of the peripheral
the peripheral blood
peripheral blood of
blood of healthy
of healthy elderly
healthy elderly subjects
elderly subjects increases
subjects increases while
increases while the
while the number
the number of
number of mineralocorticoid
of mineralocorticoid receptors
mineralocorticoid receptors decreases
The mechanisms of
mechanisms of hormone-receptor
of hormone-receptor interactions
hormone-receptor interactions in
interactions in hypertension
in hypertension are
hypertension are activated:
are activated: the
activated: the number
the number of
number of glucocorticoid
of glucocorticoid and
glucocorticoid and mineralocorticoid
and mineralocorticoid binding
mineralocorticoid binding sites
binding sites grows
sites grows in
grows in hypertensive
in hypertensive patients
Still a more
a more essential
more essential rise
essential rise in
rise in the
in the number
the number of
number of receptors
of receptors is
receptors is observed
is observed in
observed in mid-age
in mid-age hypertensive
mid-age hypertensive patients
hypertensive patients than
patients than in
than in elderly
in elderly ones
The mechanism of
mechanism of action
of action of
action of cyclosporin
of cyclosporin A
cyclosporin A and
A and FK506
CsA and FK506
and FK506 are
FK506 are powerful
are powerful suppressors
powerful suppressors of
suppressors of the
of the immune
the immune system
immune system most
system most notably
most notably of
notably of T
of T cells
They act at
act at a
at a point
a point in
point in activation
in activation that
activation that lies
that lies between
lies between receptor
between receptor ligation
receptor ligation and
ligation and the
and the transcription
the transcription of
transcription of early
of early genes
Here Stuart Schreiber
Stuart Schreiber and
Schreiber and Gerald
and Gerald Crabtree
Gerald Crabtree review
Crabtree review recent
review recent findings
recent findings that
findings that indicate
that indicate CsA
indicate CsA and
CsA and FK506
and FK506 operate
FK506 operate as
operate as prodrugs:
as prodrugs: they
prodrugs: they bind
they bind endogenous
bind endogenous intracellular
endogenous intracellular receptors
intracellular receptors the
receptors the immunophilins
the immunophilins and
immunophilins and the
and the resulting
the resulting complex
resulting complex targets
complex targets the
targets the protein
the protein phosphatase
protein phosphatase calcineurin
phosphatase calcineurin to
calcineurin to exert
to exert the
exert the immunosuppressive
the immunosuppressive effect
Induction of monocytic
of monocytic differentiation
monocytic differentiation and
differentiation and NF-kappa
and NF-kappa B-like
NF-kappa B-like activities
B-like activities by
activities by human
by human immunodeficiency
human immunodeficiency virus
immunodeficiency virus 1
virus 1 infection
1 infection of
infection of myelomonoblastic
of myelomonoblastic cells
The effects of
effects of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus 1
virus 1 HIV-1
1 HIV-1 infection
HIV-1 infection on
infection on cellular
on cellular differentiation
cellular differentiation and
differentiation and NF-kappa
and NF-kappa B
NF-kappa B DNA
B DNA binding
DNA binding activity
binding activity have
activity have been
have been investigated
been investigated in
investigated in a
in a new
a new model
new model of
model of myeloid
of myeloid differentiation
PLB-985 cells represent
cells represent a
represent a bipotential
a bipotential myelomonoblastic
bipotential myelomonoblastic cell
myelomonoblastic cell population
cell population capable
population capable of
capable of either
of either granulocytic
either granulocytic or
granulocytic or monocytic
or monocytic differentiation
monocytic differentiation after
differentiation after induction
after induction with
induction with appropriate
with appropriate inducers
By virtue of
virtue of the
of the presence
the presence of
presence of CD4
of CD4 on
CD4 on the
on the cell
the cell surface
cell surface PLB-985
surface PLB-985 cells
PLB-985 cells were
cells were chronically
were chronically infected
chronically infected with
infected with HIV-1
with HIV-1 strain
HIV-1 strain IIIB
PLB-IIIB cells clearly
cells clearly possessed
clearly possessed a
possessed a more
a more monocytic
more monocytic phenotype
monocytic phenotype than
phenotype than the
than the parental
the parental myeloblasts
parental myeloblasts as
myeloblasts as determined
as determined by
determined by differential
by differential staining
differential staining increased
staining increased expression
increased expression of
expression of the
of the myeloid-specific
the myeloid-specific surface
myeloid-specific surface markers
surface markers and
markers and transcription
and transcription of
transcription of the
of the c-fms
the c-fms proto-oncogene
NF-kappa B binding
B binding activity
binding activity was
activity was inducible
was inducible by
inducible by tumor
by tumor necrosis
tumor necrosis factor
necrosis factor and
factor and phorbol
and phorbol myristate
phorbol myristate acetate
myristate acetate in
acetate in PLB-985
However in PLB-IIIB
in PLB-IIIB cells
PLB-IIIB cells constitutive
cells constitutive expression
constitutive expression of
expression of a
of a novel
a novel NF-kappa
novel NF-kappa B
NF-kappa B complex
B complex was
complex was detected
was detected composed
detected composed of
composed of proteins
of proteins ranging
proteins ranging between
ranging between 70
between 70 and
70 and 110
and 110 kD
These proteins interacted
proteins interacted specifically
interacted specifically with
specifically with the
with the symmetric
the symmetric NF-kappa
symmetric NF-kappa B
NF-kappa B site
B site from
site from the
from the interferon
the interferon beta
interferon beta IFN-beta
beta IFN-beta promoter
Mutations affecting the
affecting the 5'
the 5' guanine
5' guanine residues
guanine residues of
residues of the
of the kappa
the kappa B
kappa B site
B site were
site were unable
were unable to
unable to compete
to compete for
compete for these
for these NF-kappa
these NF-kappa B-related
NF-kappa B-related proteins
Inducibility of endogenous
of endogenous IFN-beta
endogenous IFN-beta and
IFN-beta and IFN-alpha
and IFN-alpha RNA
IFN-alpha RNA was
RNA was also
was also increased
also increased in
increased in PLB-IIIB
in PLB-IIIB cells
These studies indicate
studies indicate that
indicate that HIV-1
that HIV-1 infection
HIV-1 infection of
infection of myelomonoblastic
of myelomonoblastic cells
myelomonoblastic cells may
cells may select
may select for
select for a
for a more
a more mature
more mature monocytic
mature monocytic phenotype
monocytic phenotype and
phenotype and that
and that unique
that unique subunit
unique subunit associations
subunit associations of
associations of NF-kappa
of NF-kappa B
NF-kappa B DNA
B DNA binding
DNA binding proteins
binding proteins may
proteins may contribute
may contribute to
contribute to differential
to differential NF-kappa
differential NF-kappa B-mediated
NF-kappa B-mediated gene
B-mediated gene expression
Cortisol receptor resistance:
receptor resistance: the
resistance: the variability
the variability of
variability of its
of its clinical
its clinical presentation
clinical presentation and
presentation and response
and response to
response to treatment
Primary partial cortisol
partial cortisol receptor
cortisol receptor resistance
receptor resistance was
resistance was previously
was previously reported
previously reported in
reported in a
in a total
a total of
total of 7
of 7 patients
7 patients and
patients and 14
and 14 asymptomatic
14 asymptomatic family
asymptomatic family members
Its occurrence is
occurrence is considered
is considered to
considered to be
to be extremely
be extremely rare
In the present
the present study
present study we
study we report
we report on
report on 6
on 6 patients
6 patients 2
patients 2 males
2 males and
males and 4
and 4 females
4 females with
females with the
with the syndrome
The first male
first male patient
male patient presented
patient presented with
presented with mild
with mild hypertension
Hydrochlorothiazide therapy resulted
therapy resulted in
resulted in life-threatening
in life-threatening hypokalemia
The second male
second male patient
male patient had
patient had slight
had slight hypertension
slight hypertension without
hypertension without hypokalemia
All four female
four female patients
female patients presented
patients presented between
presented between the
between the age
the age of
age of 20-30
of 20-30 yr
20-30 yr with
yr with acne
with acne hirsutism
acne hirsutism and
hirsutism and irregular
and irregular menstruations
Low dose dexamethasone
dose dexamethasone therapy
dexamethasone therapy 1-15
therapy 1-15 mg/day
1-15 mg/day was
mg/day was of
was of clinical
of clinical benefit
clinical benefit in
benefit in these
in these patients
All patients showed
patients showed insufficient
showed insufficient suppression
insufficient suppression of
suppression of serum
of serum cortisol
serum cortisol concentrations
cortisol concentrations in
concentrations in the
in the overnight
the overnight 1-mg
overnight 1-mg dexamethasone
1-mg dexamethasone test
The diurnal rhythm
diurnal rhythm of
rhythm of ACTH
of ACTH and
ACTH and cortisol
and cortisol was
cortisol was intact
was intact albeit
intact albeit at
albeit at an
at an elevated
an elevated level
There was a
was a normal
a normal increase
normal increase in
increase in ACTH
in ACTH cortisol
ACTH cortisol and
cortisol and GH
and GH except
GH except in
except in one
in one obese
one obese patient
obese patient in
patient in response
in response to
response to insulin-induced
to insulin-induced hypoglycemia
insulin-induced hypoglycemia while
hypoglycemia while cortisol
while cortisol production
cortisol production was
production was elevated
was elevated in
elevated in three
in three patients
Circulating adrenal androgen
adrenal androgen levels
androgen levels were
levels were increased
were increased in
increased in all
in all patients
Glucocorticoid receptors were
receptors were investigated
were investigated in
investigated in a
in a whole
a whole cell
whole cell dexamethasone
cell dexamethasone binding
dexamethasone binding assay
binding assay in
assay in mononuclear
in mononuclear leukocytes
In the first
the first male
first male patient
male patient the
patient the number
the number of
number of receptors
of receptors was
receptors was very
was very low
very low while
low while the
while the affinity
the affinity was
affinity was lower
was lower than
lower than that
than that in
that in controls
A lowered affinity
lowered affinity to
affinity to dexamethasone
to dexamethasone was
dexamethasone was found
was found in
found in one
in one female
one female patient
female patient while
patient while a
while a lowered
a lowered number
lowered number of
number of receptors
of receptors was
receptors was found
was found in
found in three
in three patients
In the second
the second male
second male patient
male patient no
patient no abnormalities
no abnormalities were
abnormalities were found
As a bioassay
a bioassay for
bioassay for glucocorticoid
for glucocorticoid action
glucocorticoid action we
action we also
we also measured
also measured dexamethasone
measured dexamethasone suppressibility
dexamethasone suppressibility of
suppressibility of mitogen-stimulated
of mitogen-stimulated incorporation
mitogen-stimulated incorporation of
incorporation of [3H]thymidine
of [3H]thymidine in
[3H]thymidine in mononuclear
in mononuclear leukocytes
In the male
the male patient
male patient with
patient with normal
with normal receptor
normal receptor status
receptor status dexamethasone
status dexamethasone suppressibility
dexamethasone suppressibility of
suppressibility of [3H]thymidine
of [3H]thymidine incorporation
[3H]thymidine incorporation was
incorporation was significantly
was significantly lower
significantly lower than
lower than that
than that in
that in healthy
in healthy controls
healthy controls with
controls with respect
with respect to
respect to both
to both maximal
both maximal suppression
maximal suppression and
suppression and IC50
Partial cortisol receptor
cortisol receptor resistance
receptor resistance might
resistance might be
might be less
be less rare
less rare than
rare than previously
than previously thought
In the six
the six patients
six patients presented
patients presented at
presented at least
at least three
least three different
three different forms
different forms can
forms can be
can be recognized
Therapy with dexamethasone
with dexamethasone was
dexamethasone was successful
was successful in
successful in female
in female patients
female patients with
patients with acne
with acne and
acne and hirsutism
and hirsutism as
hirsutism as the
as the secondary
the secondary increase
secondary increase in
increase in the
in the production
the production of
production of adrenal
of adrenal androgens
adrenal androgens was
androgens was effectively
was effectively controlled
The development of
development of functionally
of functionally responsive
functionally responsive T
responsive T cells
The work reviewed
work reviewed in
reviewed in this
in this article
this article separates
article separates T
separates T cell
T cell development
cell development into
development into four
into four phases
First is an
is an expansion
an expansion phase
expansion phase prior
phase prior to
prior to TCR
to TCR rearrangement
TCR rearrangement which
rearrangement which appears
which appears to
appears to be
to be correlated
be correlated with
correlated with programming
with programming of
programming of at
of at least
at least some
least some response
some response genes
response genes for
genes for inducibility
This phase can
phase can occur
can occur to
occur to some
to some extent
some extent outside
extent outside of
outside of the
of the thymus
However the profound
the profound T
profound T cell
T cell deficit
cell deficit of
deficit of nude
of nude mice
nude mice indicates
mice indicates that
indicates that the
that the thymus
the thymus is
thymus is by
is by far
by far the
far the most
the most potent
most potent site
potent site for
site for inducing
for inducing the
inducing the expansion
the expansion per
expansion per se
per se even
se even if
even if other
if other sites
other sites can
sites can induce
can induce some
induce some response
some response acquisition
Second is a
is a controlled
a controlled phase
controlled phase of
phase of TCR
of TCR gene
TCR gene rearrangement
The details of
details of the
of the regulatory
the regulatory mechanism
regulatory mechanism that
mechanism that selects
that selects particular
selects particular loci
particular loci for
loci for rearrangement
for rearrangement are
rearrangement are still
are still not
still not known
It seems that
seems that the
that the rearrangement
the rearrangement of
rearrangement of the
of the TCR
the TCR gamma
TCR gamma loci
gamma loci in
loci in the
in the gamma
the gamma delta
gamma delta lineage
delta lineage may
lineage may not
may not always
not always take
always take place
take place at
place at a
at a developmental
a developmental stage
developmental stage strictly
stage strictly equivalent
strictly equivalent to
equivalent to the
to the rearrangement
the rearrangement of
rearrangement of TCR
of TCR beta
TCR beta in
beta in the
in the alpha
the alpha beta
alpha beta lineage
beta lineage and
lineage and it
and it is
it is not
is not clear
not clear just
clear just how
just how early
how early the
early the two
the two lineages
two lineages diverge
In the TCR
the TCR alpha
TCR alpha beta
alpha beta lineage
beta lineage however
lineage however the
however the final
the final gene
final gene rearrangement
gene rearrangement events
rearrangement events are
events are accompanied
are accompanied by
accompanied by rapid
by rapid proliferation
rapid proliferation and
proliferation and an
and an interruption
an interruption in
interruption in cellular
in cellular response
cellular response gene
response gene inducibility
The loss of
loss of conventional
of conventional responsiveness
conventional responsiveness is
responsiveness is probably
is probably caused
probably caused by
caused by alterations
by alterations at
alterations at the
at the level
the level of
level of signaling
of signaling and
signaling and may
and may be
may be a
be a manifestation
a manifestation of
manifestation of the
of the physiological
the physiological state
physiological state that
state that is
that is a
is a precondition
a precondition for
precondition for selection
Third is the
is the complex
the complex process
complex process of
process of selection
Whereas peripheral T
peripheral T cells
T cells can
cells can undergo
can undergo forms
undergo forms of
forms of positive
of positive selection
positive selection by
selection by antigen-driven
by antigen-driven clonal
antigen-driven clonal expansion
clonal expansion and
expansion and negative
and negative selection
negative selection by
selection by abortive
by abortive stimulation
abortive stimulation leading
stimulation leading to
leading to anergy
to anergy or
anergy or death
or death neither
death neither is
neither is exactly
is exactly the
exactly the same
the same phenomenon
same phenomenon that
phenomenon that occurs
that occurs in
occurs in the
in the thymic
the thymic cortex
Negative selection in
selection in the
in the cortex
the cortex appears
cortex appears to
appears to be
to be a
be a suicidal
a suicidal inversion
suicidal inversion of
inversion of antigen
of antigen responsiveness:
antigen responsiveness: instead
responsiveness: instead of
instead of turning
of turning on
turning on IL-2
on IL-2 expression
IL-2 expression the
expression the activated
the activated cell
activated cell destroys
cell destroys its
destroys its own
its own chromatin
The genes that
genes that need
that need to
need to be
to be induced
be induced for
induced for this
for this response
this response are
response are not
are not yet
not yet identified
yet identified but
identified but it
but it is
it is unquestionably
is unquestionably a
unquestionably a form
a form of
form of activation
It is interesting
is interesting that
interesting that in
that in humans
in humans and
humans and rats
and rats cortical
rats cortical thymocytes
cortical thymocytes undergoing
thymocytes undergoing negative
undergoing negative selection
negative selection can
selection can still
can still induce
still induce IL-2R
induce IL-2R alpha
IL-2R alpha expression
alpha expression and
expression and even
and even be
even be rescued
be rescued in
rescued in vitro
in vitro if
vitro if exogenous
if exogenous IL-2
exogenous IL-2 is
IL-2 is provided
Perhaps murine thymocytes
murine thymocytes are
thymocytes are denied
are denied this
denied this form
this form of
form of rescue
of rescue because
rescue because they
because they shut
they shut off
shut off IL-2R
off IL-2R beta
IL-2R beta chain
beta chain expression
chain expression at
expression at an
at an earlier
an earlier stage
earlier stage or
stage or because
or because they
because they may
they may be
may be uncommonly
be uncommonly Bcl-2
uncommonly Bcl-2 deficient
Bcl-2 deficient cf
deficient cf Sentman
cf Sentman et
Sentman et al
et al 1991;
al 1991; Strasser
1991; Strasser et
Strasser et al
et al 1991
Even so medullary
so medullary thymocytes
medullary thymocytes remain
thymocytes remain at
remain at least
at least partially
least partially susceptible
partially susceptible to
susceptible to negative
to negative selection
negative selection even
selection even as
even as they
as they continue
they continue to
continue to mature
I kappa B/MAD-3
kappa B/MAD-3 masks
B/MAD-3 masks the
masks the nuclear
the nuclear localization
nuclear localization signal
localization signal of
signal of NF-kappa
of NF-kappa B
NF-kappa B p65
B p65 and
p65 and requires
and requires the
requires the transactivation
the transactivation domain
transactivation domain to
domain to inhibit
to inhibit NF-kappa
inhibit NF-kappa B
NF-kappa B p65
B p65 DNA
p65 DNA binding
The active nuclear
active nuclear form
nuclear form of
form of the
of the NF-kappa
the NF-kappa B
NF-kappa B transcription
B transcription factor
transcription factor complex
factor complex is
complex is composed
is composed of
composed of two
of two DNA
two DNA binding
DNA binding subunits
binding subunits NF-kappa
subunits NF-kappa B
NF-kappa B p65
B p65 and
p65 and NF-kappa
and NF-kappa B
NF-kappa B p50
B p50 both
p50 both of
both of which
of which share
which share extensive
share extensive N-terminal
extensive N-terminal sequence
N-terminal sequence homology
sequence homology with
homology with the
with the v-rel
the v-rel oncogene
v-rel oncogene product
The NF-kappa B
NF-kappa B p65
B p65 subunit
p65 subunit provides
subunit provides the
provides the transactivation
the transactivation activity
transactivation activity in
activity in this
in this complex
this complex and
complex and serves
and serves as
serves as an
as an intracellular
an intracellular receptor
intracellular receptor for
receptor for a
for a cytoplasmic
a cytoplasmic inhibitor
cytoplasmic inhibitor of
inhibitor of NF-kappa
of NF-kappa B
NF-kappa B termed
B termed I
termed I kappa
I kappa B
In contrast NF-kappa
contrast NF-kappa B
NF-kappa B p50
B p50 alone
p50 alone fails
alone fails to
fails to stimulate
to stimulate kappa
stimulate kappa B-directed
kappa B-directed transcription
B-directed transcription and
transcription and based
and based on
based on prior
on prior in
prior in vitro
in vitro studies
vitro studies is
studies is not
is not directly
not directly regulated
directly regulated by
regulated by I
by I kappa
I kappa B
To investigate the
investigate the molecular
the molecular basis
molecular basis for
basis for the
for the critical
the critical regulatory
critical regulatory interaction
regulatory interaction between
interaction between NF-kappa
between NF-kappa B
NF-kappa B and
B and I
and I kappa
I kappa B/MAD-3
kappa B/MAD-3 a
B/MAD-3 a series
a series of
series of human
of human NF-kappa
human NF-kappa B
NF-kappa B p65
B p65 mutants
p65 mutants was
mutants was identified
was identified that
identified that functionally
that functionally segregated
functionally segregated DNA
segregated DNA binding
DNA binding I
binding I kappa
I kappa B-mediated
kappa B-mediated inhibition
B-mediated inhibition and
inhibition and I
and I kappa
I kappa B-induced
kappa B-induced nuclear
B-induced nuclear exclusion
nuclear exclusion of
exclusion of this
of this transcription
this transcription factor
Results from in
from in vivo
in vivo expression
vivo expression studies
expression studies performed
studies performed with
performed with these
with these NF-kappa
these NF-kappa B
NF-kappa B p65
B p65 mutants
p65 mutants revealed
mutants revealed the
revealed the following:
the following: 1
following: 1 I
1 I kappa
I kappa B/MAD-3
kappa B/MAD-3 completely
B/MAD-3 completely inhibits
completely inhibits NF-kappa
inhibits NF-kappa B
NF-kappa B p65-dependent
B p65-dependent transcriptional
p65-dependent transcriptional activation
transcriptional activation mediated
activation mediated through
mediated through the
through the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 kappa
1 kappa B
kappa B enhancer
B enhancer in
enhancer in human
in human T
human T lymphocytes
T lymphocytes 2
lymphocytes 2 the
2 the binding
the binding of
binding of I
of I kappa
I kappa B/MAD-3
kappa B/MAD-3 to
B/MAD-3 to NF-kappa
to NF-kappa B
NF-kappa B p65
B p65 is
p65 is sufficient
is sufficient to
sufficient to retarget
to retarget NF-kappa
retarget NF-kappa B
NF-kappa B p65
B p65 from
p65 from the
from the nucleus
the nucleus to
nucleus to the
to the cytoplasm
the cytoplasm 3
cytoplasm 3 selective
3 selective deletion
selective deletion of
deletion of the
of the functional
the functional nuclear
functional nuclear localization
nuclear localization signal
localization signal present
signal present in
present in the
in the Rel
the Rel homology
Rel homology domain
homology domain of
domain of NF-kappa
of NF-kappa B
NF-kappa B p65
B p65 disrupts
p65 disrupts its
disrupts its ability
its ability to
ability to engage
to engage I
engage I kappa
I kappa B/MAD-3
kappa B/MAD-3 and
B/MAD-3 and 4
and 4 the
4 the unique
the unique C-terminus
unique C-terminus of
C-terminus of NF-kappa
of NF-kappa B
NF-kappa B p65
B p65 attenuates
p65 attenuates its
attenuates its own
its own nuclear
own nuclear localization
nuclear localization and
localization and contains
and contains sequences
contains sequences that
sequences that are
that are required
are required for
required for I
for I kappa
I kappa B-mediated
kappa B-mediated inhibition
B-mediated inhibition of
inhibition of NF-kappa
of NF-kappa B
NF-kappa B p65
B p65 DNA
p65 DNA binding
DNA binding activity
Together these findings
these findings suggest
findings suggest that
suggest that the
that the nuclear
the nuclear localization
nuclear localization signal
localization signal and
signal and transactivation
and transactivation domain
transactivation domain of
domain of NF-kappa
of NF-kappa B
NF-kappa B p65
B p65 constitute
p65 constitute a
constitute a bipartite
a bipartite system
bipartite system that
system that is
that is critically
is critically involved
critically involved in
involved in the
in the inhibitory
the inhibitory function
inhibitory function of
function of I
of I kappa
I kappa B/MAD-3
Unexpectedly our in
our in vivo
in vivo studies
vivo studies also
studies also demonstrate
also demonstrate that
demonstrate that I
that I kappa
I kappa B/MAD-3
kappa B/MAD-3 binds
B/MAD-3 binds directly
binds directly to
directly to NF-kappa
to NF-kappa B
NF-kappa B p50
This interaction is
interaction is functional
is functional as
functional as it
as it leads
it leads to
leads to retargeting
to retargeting of
retargeting of NF-kappa
of NF-kappa B
NF-kappa B p50
B p50 from
p50 from the
from the nucleus
the nucleus to
nucleus to the
to the cytoplasm
However no loss
no loss of
loss of DNA
of DNA binding
DNA binding activity
binding activity is
activity is observed
is observed presumably
observed presumably reflecting
presumably reflecting the
reflecting the unique
the unique C-terminal
unique C-terminal domain
C-terminal domain that
domain that is
that is distinct
is distinct from
distinct from that
from that present
that present in
present in NF-kappa
in NF-kappa B
NF-kappa B p65
Characterization of a
of a new
a new tissue-specific
new tissue-specific transcription
tissue-specific transcription factor
transcription factor binding
factor binding to
binding to the
to the simian
the simian virus
simian virus 40
virus 40 enhancer
40 enhancer TC-II
enhancer TC-II NF-kappa
TC-II NF-kappa B
NF-kappa B element
We have biochemically
have biochemically and
biochemically and functionally
and functionally characterized
functionally characterized a
characterized a new
a new transcription
new transcription factor
transcription factor NP-TCII
factor NP-TCII which
NP-TCII which is
which is present
is present in
present in nuclei
in nuclei from
nuclei from unstimulated
from unstimulated T
unstimulated T and
T and B
and B lymphocytes
B lymphocytes but
lymphocytes but is
but is not
is not found
not found in
found in nonhematopoietic
in nonhematopoietic cells
This factor has
factor has a
has a DNA-binding
a DNA-binding specificity
DNA-binding specificity similar
specificity similar to
similar to that
to that of
that of NF-kappa
of NF-kappa B
NF-kappa B but
B but is
but is unrelated
is unrelated to
unrelated to this
to this or
this or other
or other Rel
other Rel proteins
Rel proteins by
proteins by functional
by functional and
functional and biochemical
and biochemical criteria
It can also
can also be
also be distinguished
be distinguished from
distinguished from other
from other previously
other previously described
previously described lymphocyte-specific
described lymphocyte-specific DNA-binding
lymphocyte-specific DNA-binding proteins
The candidate oncoprotein
candidate oncoprotein Bcl-3
oncoprotein Bcl-3 is
Bcl-3 is an
is an antagonist
an antagonist of
antagonist of p50/NF-kappa
of p50/NF-kappa B-mediated
p50/NF-kappa B-mediated inhibition
The candidate oncogene
candidate oncogene bcl-3
oncogene bcl-3 was
bcl-3 was discovered
was discovered as
discovered as a
as a translocation
a translocation into
translocation into the
into the immunoglobulin
the immunoglobulin alpha-locus
immunoglobulin alpha-locus in
alpha-locus in some
in some cases
some cases of
cases of B-cell
of B-cell chronic
B-cell chronic lymphocytic
chronic lymphocytic leukaemias
The protein Bcl-3
protein Bcl-3 contains
Bcl-3 contains seven
contains seven so-called
seven so-called ankyrin
so-called ankyrin repeats
Similar repeat motifs
repeat motifs are
motifs are found
are found in
found in a
in a number
a number of
number of diverse
of diverse regulatory
diverse regulatory proteins
regulatory proteins but
proteins but the
but the motifs
the motifs of
motifs of Bcl-3
of Bcl-3 are
Bcl-3 are most
are most closely
most closely related
closely related to
related to those
to those found
those found in
found in I
in I kappa
I kappa B
kappa B proteins
B proteins in
proteins in which
in which the
which the ankyrin
the ankyrin repeat
ankyrin repeat domain
repeat domain is
domain is thought
is thought to
thought to be
to be directly
be directly involved
directly involved in
involved in inhibition
in inhibition of
inhibition of NF-kappa
of NF-kappa B
NF-kappa B activity
No biological function
biological function has
function has yet
has yet been
yet been described
been described for
described for Bcl-3
for Bcl-3 but
Bcl-3 but it
but it was
it was noted
was noted recently
noted recently that
recently that Bcl-3
that Bcl-3 interferes
Bcl-3 interferes with
interferes with DNA-binding
with DNA-binding of
DNA-binding of the
of the p50
the p50 subunit
p50 subunit of
subunit of NF-kappa
of NF-kappa B
NF-kappa B in
B in vitro
Here we demonstrate
we demonstrate that
demonstrate that Bcl-3
that Bcl-3 can
Bcl-3 can aid
can aid kappa
aid kappa B
kappa B site-dependent
B site-dependent transcription
site-dependent transcription in
transcription in vivo
in vivo by
vivo by counteracting
by counteracting the
counteracting the inhibitory
the inhibitory effects
inhibitory effects of
effects of p50/NF-kappa
of p50/NF-kappa B
p50/NF-kappa B homodimers
Bcl-3 may therefore
may therefore aid
therefore aid activation
aid activation of
activation of select
of select NF-kappa
select NF-kappa B-regulated
NF-kappa B-regulated genes
B-regulated genes including
genes including those
including those of
those of the
of the human
the human immunodeficiency
human immunodeficiency virus
[Mechanism of action
of action of
action of steroid
of steroid hormones
steroid hormones I
hormones I Estrogens]
The steroid hormone
steroid hormone are
hormone are very
are very versatile
very versatile molecules:
versatile molecules: although
molecules: although they
although they are
they are related
are related among
related among them
among them by
them by their
by their chemical
their chemical structure
chemical structure they
structure they have
they have very
have very diverse
very diverse functions
diverse functions and
functions and including
and including antagonic
Their action mechanism
action mechanism is
mechanism is not
is not completely
not completely cleared
The estrogens participate
estrogens participate in
participate in the
in the regulation
the regulation of
regulation of practically
of practically all
practically all the
all the reproductive
the reproductive and
reproductive and sexual
and sexual events
sexual events of
events of the
of the female
the female although
female although the
although the intracellular
the intracellular actions
intracellular actions by
actions by which
by which they
which they take
they take place
take place are
place are not
are not well
not well known
well known and
known and the
and the proposed
the proposed models
proposed models do
models do not
do not adequately
not adequately satisfy
adequately satisfy the
satisfy the questions
Currently it is
it is accepted
is accepted the
accepted the existence
the existence of
existence of a
of a cytoplasmic
a cytoplasmic and/or
cytoplasmic and/or nuclear
and/or nuclear receptor
nuclear receptor without
receptor without explaining
without explaining satisfactorily
explaining satisfactorily how
satisfactorily how the
how the hormones
the hormones come
hormones come to
come to the
to the nucleus
The endocrine events
endocrine events that
events that are
that are rapidly
are rapidly expressed
rapidly expressed seconds
expressed seconds are
seconds are due
are due to
due to a
to a possible
a possible interaction
possible interaction with
interaction with cellular
with cellular membrane
The purpose of
purpose of this
of this review
this review is
review is to
is to analyze
to analyze and
analyze and concilliate
and concilliate the
concilliate the reported
the reported data
reported data on
data on the
on the mechanism
the mechanism of
mechanism of action
of action of
action of estrogens
Reduced susceptibility to
susceptibility to HIV-1
to HIV-1 infection
HIV-1 infection of
infection of ethyl-methanesulfonate-treated
of ethyl-methanesulfonate-treated CEM
ethyl-methanesulfonate-treated CEM subclones
CEM subclones correlates
subclones correlates with
correlates with a
with a blockade
a blockade in
blockade in their
in their protein
their protein kinase
protein kinase C
kinase C signaling
C signaling pathway
We have described
have described the
described the isolation
the isolation of
isolation of chemically
of chemically induced
chemically induced CEM
induced CEM subclones
CEM subclones that
subclones that express
that express CD4
express CD4 receptors
CD4 receptors and
receptors and bind
and bind soluble
bind soluble gp120
soluble gp120 yet
gp120 yet show
yet show a
show a markedly
a markedly reduced
markedly reduced susceptibility
reduced susceptibility to
susceptibility to infection
to infection with
infection with HIV-1
Two subclones were
subclones were found
were found to
found to have
to have an
have an abnormal
an abnormal response
abnormal response to
response to the
to the protein
the protein kinase
protein kinase C
kinase C PKC
C PKC activator
PKC activator PMA
PMA treatment induced
treatment induced CD3
induced CD3 and
CD3 and CD25
and CD25 IL-2R
CD25 IL-2R receptors
IL-2R receptors on
receptors on the
on the parental
the parental line
parental line and
line and on
and on other
on other ethyl-methanesulfonate-derived
other ethyl-methanesulfonate-derived subclones
ethyl-methanesulfonate-derived subclones but
subclones but not
but not on
not on these
on these two
these two mutants
Direct assays of
assays of PKC
of PKC activity
PKC activity were
activity were conducted
Total cellular PKC
cellular PKC enzymatic
PKC enzymatic activity
enzymatic activity was
activity was found
was found to
found to be
to be normal
be normal in
normal in these
in these subclones
PMA-induced CD4 down-modulation
CD4 down-modulation occurred
down-modulation occurred normally
In addition activation
addition activation of
activation of c-raf
of c-raf kinase
c-raf kinase was
kinase was normal
Since HIV-1 long
HIV-1 long terminal
long terminal repeat
terminal repeat contains
repeat contains two
contains two functional
two functional nuclear
functional nuclear factor
nuclear factor kB
factor kB NF-kB
kB NF-kB regulatory
NF-kB regulatory elements
regulatory elements we
elements we studied
we studied the
studied the ability
the ability of
ability of PMA
of PMA to
PMA to induce
to induce NF-kB
induce NF-kB binding
NF-kB binding activity
binding activity by
activity by different
by different assays
Chloramphenicol acetyl transferase
acetyl transferase CAT
transferase CAT assays
CAT assays using
assays using the
using the HIV-1
the HIV-1 -139long
HIV-1 -139long terminal
-139long terminal repeat-CAT
terminal repeat-CAT construct
repeat-CAT construct showed
construct showed no
showed no PMA
no PMA induction
PMA induction of
induction of CAT
of CAT activity
CAT activity in
activity in these
in these subclones
these subclones unlike
subclones unlike the
unlike the parental
the parental line
parental line and
line and other
and other subclones
Okadaic acid an
acid an inhibitor
an inhibitor of
inhibitor of phosphatases
of phosphatases 1
phosphatases 1 and
1 and 2A
and 2A did
2A did not
did not overcome
not overcome the
overcome the defect
the defect in
defect in these
in these subclones
Gel retardation assays
retardation assays using
assays using a
using a 32P-probe
a 32P-probe containing
32P-probe containing the
containing the HIV-1
the HIV-1 NF-kB
HIV-1 NF-kB probe
NF-kB probe and
probe and nuclear
and nuclear extracts
nuclear extracts from
extracts from PMA-treated
from PMA-treated cells
PMA-treated cells showed
cells showed significantly
showed significantly reduced
significantly reduced induction
reduced induction of
induction of nuclear
of nuclear NF-kB
nuclear NF-kB binding
NF-kB binding proteins
binding proteins in
proteins in these
in these two
these two subclones
two subclones compared
subclones compared with
compared with wild
with wild type
wild type CEM
type CEM and
CEM and a
and a control
a control subclone
Deoxycholate treatment of
treatment of cytoplasmic
of cytoplasmic extracts
cytoplasmic extracts from
extracts from these
from these subclones
these subclones released
subclones released much
released much reduced
much reduced NF-kB
reduced NF-kB binding
NF-kB binding proteins
binding proteins from
proteins from their
from their cytoplasmic
their cytoplasmic pools
Thus reduced levels
reduced levels of
levels of PKC-induced
of PKC-induced nuclear
PKC-induced nuclear NF-kB
nuclear NF-kB activity
NF-kB activity in
activity in two
in two T
two T cell
T cell subclones
cell subclones did
subclones did not
did not affect
not affect their
affect their normal
their normal cell
normal cell growth
cell growth but
growth but correlated
but correlated with
correlated with a
with a pronounced
a pronounced reduction
pronounced reduction in
reduction in their
in their susceptibility
their susceptibility to
susceptibility to HIV-1
to HIV-1 infection
Nuclear factor of
factor of activated
of activated T
activated T cells
T cells contains
cells contains Fos
contains Fos and
Fos and Jun
The nuclear factor
nuclear factor NF-AT
factor NF-AT ref
NF-AT ref 1
ref 1 is
1 is induced
is induced in
induced in T
in T cells
T cells stimulated
cells stimulated through
stimulated through the
through the T-cell
the T-cell receptor/CD3
T-cell receptor/CD3 complex
receptor/CD3 complex and
complex and is
and is required
is required for
required for interleukin-2
for interleukin-2 IL-2
interleukin-2 IL-2 gene
IL-2 gene induction
Although NF-AT has
NF-AT has not
has not been
not been cloned
been cloned or
cloned or purified
or purified there
purified there is
there is evidence
is evidence that
evidence that it
that it is
it is a
is a major
a major target
major target for
target for immunosuppression
for immunosuppression by
immunosuppression by cyclosporin
by cyclosporin A
cyclosporin A CsA
A CsA and
CsA and FK506
and FK506 refs
FK506 refs 2-7
NF-AT induction may
induction may require
may require two
require two activation-dependent
two activation-dependent events:
activation-dependent events: the
events: the CsA-sensitive
the CsA-sensitive translocation
CsA-sensitive translocation of
translocation of a
of a pre-existing
a pre-existing component
pre-existing component and
component and the
and the CsA-resistant
the CsA-resistant synthesis
CsA-resistant synthesis of
synthesis of a
of a nuclear
a nuclear component
Here we report
we report that
report that the
that the newly
the newly synthesized
newly synthesized nuclear
synthesized nuclear component
nuclear component of
component of NF-AT
of NF-AT is
NF-AT is the
is the transcription
the transcription factor
transcription factor AP-1
We show that
show that the
that the inducible
the inducible nuclear
inducible nuclear form
nuclear form of
form of NF-AT
of NF-AT contains
NF-AT contains Fos
contains Fos and
Fos and Jun
and Jun proteins
Furthermore we identify
we identify a
identify a pre-existing
a pre-existing NF-AT-binding
pre-existing NF-AT-binding factor
NF-AT-binding factor that
factor that is
that is present
is present in
present in hypotonic
in hypotonic extracts
hypotonic extracts of
extracts of unstimulated
of unstimulated T
unstimulated T cells
On the basis
the basis of
basis of binding
of binding reconstitution
binding reconstitution and
reconstitution and cotransfection
and cotransfection experiments
cotransfection experiments we
experiments we propose
we propose that
propose that activation
that activation of
activation of NF-AT
of NF-AT occurs
NF-AT occurs in
occurs in at
in at least
at least two
least two stages:
two stages: a
stages: a CsA-sensitive
a CsA-sensitive stage
CsA-sensitive stage involving
stage involving modification
involving modification and/or
modification and/or translocation
and/or translocation of
translocation of the
of the pre-existing
the pre-existing NF-AT
pre-existing NF-AT complex
NF-AT complex and
complex and a
and a CsA-insensitive
a CsA-insensitive stage
CsA-insensitive stage involving
stage involving the
involving the addition
the addition of
addition of newly
of newly synthesized
newly synthesized Fos
synthesized Fos or
Fos or Fos/Jun
or Fos/Jun proteins
Fos/Jun proteins to
proteins to the
to the pre-existing
the pre-existing complex
A lymphoid cell-specific
lymphoid cell-specific nuclear
cell-specific nuclear factor
nuclear factor containing
factor containing c-Rel-like
containing c-Rel-like proteins
c-Rel-like proteins preferentially
proteins preferentially interacts
preferentially interacts with
interacts with interleukin-6
with interleukin-6 kappa
interleukin-6 kappa B-related
kappa B-related motifs
B-related motifs whose
motifs whose activities
whose activities are
activities are repressed
are repressed in
repressed in lymphoid
in lymphoid cells
The proto-oncoprotein c-Rel
proto-oncoprotein c-Rel is
c-Rel is a
is a member
a member of
member of the
of the nuclear
the nuclear factor
nuclear factor kappa
factor kappa B
kappa B transcription
B transcription factor
transcription factor family
factor family which
family which includes
which includes the
includes the p50
the p50 and
p50 and p65
and p65 subunits
p65 subunits of
subunits of nuclear
of nuclear factor
nuclear factor kappa
factor kappa B
We show here
show here that
here that c-Rel
that c-Rel binds
c-Rel binds to
binds to kappa
to kappa B
kappa B sites
B sites as
sites as homodimers
as homodimers as
homodimers as well
as well as
well as heterodimers
as heterodimers with
heterodimers with p50
These homodimers and
homodimers and heterodimers
and heterodimers show
heterodimers show distinct
show distinct DNA-binding
distinct DNA-binding specificities
DNA-binding specificities and
specificities and affinities
and affinities for
affinities for various
for various kappa
various kappa B
kappa B motifs
In particular the
particular the c-Rel
the c-Rel homodimer
c-Rel homodimer has
homodimer has a
has a high
a high affinity
high affinity for
affinity for interleukin-6
for interleukin-6 IL-6
interleukin-6 IL-6 and
IL-6 and beta
and beta interferon
beta interferon kappa
interferon kappa B
kappa B sites
In spite of
spite of its
of its association
its association with
association with p50
with p50 in
p50 in vitro
in vitro however
vitro however we
however we found
we found a
found a lymphoid
a lymphoid cell-specific
lymphoid cell-specific nuclear
cell-specific nuclear factor
nuclear factor in
factor in vivo
in vivo that
vivo that contains
that contains c-Rel
contains c-Rel but
c-Rel but not
but not p50
not p50 epitopes;
p50 epitopes; this
epitopes; this factor
this factor termed
factor termed IL-6
termed IL-6 kappa
IL-6 kappa B
kappa B binding
B binding factor
binding factor II
factor II appears
II appears to
appears to contain
to contain the
contain the c-Rel
the c-Rel homodimer
c-Rel homodimer and
homodimer and preferentially
and preferentially recognizes
preferentially recognizes several
recognizes several IL-6
several IL-6 kappa
IL-6 kappa B-related
kappa B-related kappa
B-related kappa B
kappa B motifs
Although it has
it has been
has been previously
been previously shown
previously shown that
shown that the
that the IL-6
the IL-6 kappa
IL-6 kappa B
kappa B motif
B motif functions
motif functions as
functions as a
as a potent
a potent IL-1/tumor
potent IL-1/tumor necrosis
IL-1/tumor necrosis factor-responsive
necrosis factor-responsive element
factor-responsive element in
element in nonlymphoid
in nonlymphoid cells
nonlymphoid cells its
cells its activity
its activity was
activity was found
was found to
found to be
to be repressed
be repressed in
repressed in lymphoid
in lymphoid cells
lymphoid cells such
cells such as
such as a
as a Jurkat
a Jurkat T-cell
Jurkat T-cell line
We also present
also present evidence
present evidence that
evidence that IL-6
that IL-6 kappa
IL-6 kappa B
kappa B binding
B binding factor
binding factor II
factor II functions
II functions as
functions as a
as a repressor
a repressor specific
repressor specific for
specific for IL-6
for IL-6 kappa
IL-6 kappa B-related
kappa B-related kappa
B-related kappa B
kappa B motifs
B motifs in
motifs in lymphoid
in lymphoid cells
Cortisol resistance in
resistance in acquired
in acquired immunodeficiency
acquired immunodeficiency syndrome
This study concerns
study concerns 9
concerns 9 iv
9 iv drug
iv drug abusers
drug abusers with
abusers with acquired
with acquired immunodeficiency
acquired immunodeficiency syndrome
immunodeficiency syndrome AIDS
syndrome AIDS who
AIDS who developed
who developed hypercortisolism
developed hypercortisolism without
hypercortisolism without the
without the clinical
the clinical signs
clinical signs or
signs or metabolic
or metabolic consequences
metabolic consequences of
consequences of hypercortisolism
All patients were
patients were characterized
were characterized by
characterized by an
by an Addisonian
an Addisonian picture
Addisonian picture weakness
picture weakness weight
weakness weight loss
weight loss hypotension
loss hypotension hyponatremia
hypotension hyponatremia and
hyponatremia and intense
and intense mucocutaneous
intense mucocutaneous melanosis
An acquired form
acquired form of
form of peripheral
of peripheral resistance
peripheral resistance to
resistance to glucocorticoids
to glucocorticoids was
glucocorticoids was suspected
We therefore examined
therefore examined glucocorticoid
examined glucocorticoid receptor
glucocorticoid receptor characteristics
receptor characteristics on
characteristics on mononuclear
on mononuclear leukocytes
mononuclear leukocytes by
leukocytes by measuring
by measuring [3H]dexamethasone
measuring [3H]dexamethasone binding
[3H]dexamethasone binding and
binding and the
and the effect
the effect of
effect of dexamethasone
of dexamethasone on
dexamethasone on [3H]thymidine
on [3H]thymidine incorporation
[3H]thymidine incorporation which
incorporation which is
which is one
is one of
one of the
of the effects
the effects of
effects of glucocorticoid
of glucocorticoid receptor
glucocorticoid receptor activation
Glucocorticoid receptor density
receptor density was
density was increased
was increased in
increased in AIDS
in AIDS patients
AIDS patients with
patients with an
with an Addisonian
an Addisonian picture
Addisonian picture group
picture group 1;
group 1; 162
1; 162 +/-
162 +/- 94
+/- 94 fmol/million
94 fmol/million cells
fmol/million cells compared
cells compared to
compared to values
to values in
values in 12
in 12 AIDS
12 AIDS patients
AIDS patients without
patients without an
without an Addisonian
an Addisonian picture
Addisonian picture group
picture group 2;
group 2; 605
2; 605 +/-
605 +/- 26
+/- 26 fmol/million
26 fmol/million cells;
fmol/million cells; P
cells; P less
P less than
less than 001
than 001 and
001 and sex-
and sex- and
sex- and age-matched
and age-matched controls
age-matched controls 315
controls 315 +/-
315 +/- 23
+/- 23 fmol/million
23 fmol/million cells;
fmol/million cells; P
cells; P less
P less than
less than 001
The affinity of
affinity of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors Kd
receptors Kd was
Kd was strikingly
was strikingly decreased
strikingly decreased 936
decreased 936 +/-
936 +/- 344
+/- 344 nM
344 nM in
nM in group
in group 1;
group 1; 32
1; 32 +/-
32 +/- 15
+/- 15 nM
15 nM in
nM in group
in group 2;
group 2; 20
2; 20 +/-
20 +/- 08
+/- 08 nM
08 nM in
nM in controls;
in controls; P
controls; P less
P less than
less than 001
[3H]Thymidine incorporation was
incorporation was decreased
was decreased dose-dependently
decreased dose-dependently by
dose-dependently by dexamethasone
by dexamethasone in
dexamethasone in controls
in controls and
controls and patients;
and patients; the
patients; the effect
the effect was
effect was significantly
was significantly blunted
significantly blunted P
blunted P less
P less than
less than 005
than 005 in
005 in group
in group 1
group 1 patients
1 patients which
patients which suggests
which suggests that
suggests that activation
that activation of
activation of glucocorticoid
of glucocorticoid receptor
glucocorticoid receptor is
receptor is impaired
is impaired as
impaired as a
as a result
a result of
result of the
of the glucocorticoid
the glucocorticoid receptor
glucocorticoid receptor abnormality
In conclusion AIDS
conclusion AIDS patients
AIDS patients with
patients with hypercortisolism
with hypercortisolism and
hypercortisolism and clinical
and clinical features
clinical features of
features of peripheral
of peripheral resistance
peripheral resistance to
resistance to glucocorticoids
to glucocorticoids are
glucocorticoids are characterized
are characterized by
characterized by abnormal
by abnormal glucocorticoid
abnormal glucocorticoid receptors
glucocorticoid receptors on
receptors on lymphocytes
Resistance to glucocorticoids
to glucocorticoids implies
glucocorticoids implies a
implies a complex
a complex change
complex change in
change in immune-endocrine
in immune-endocrine function
immune-endocrine function which
function which may
which may be
may be important
be important in
important in the
in the course
the course of
course of immunodeficiency
of immunodeficiency syndrome
A novel primer
novel primer extension
primer extension method
extension method to
method to detect
to detect the
detect the number
the number of
number of CAG
of CAG repeats
CAG repeats in
repeats in the
in the androgen
the androgen receptor
androgen receptor gene
receptor gene in
gene in families
in families with
families with X-linked
with X-linked spinal
X-linked spinal and
spinal and bulbar
and bulbar muscular
bulbar muscular atrophy
X-linked spinal and
spinal and bulbar
and bulbar muscular
bulbar muscular atrophy
muscular atrophy SBMA
atrophy SBMA an
SBMA an adult-onset
an adult-onset form
adult-onset form of
form of motor
of motor neuron
motor neuron disease
neuron disease was
disease was recently
was recently reported
recently reported to
reported to be
to be caused
be caused by
caused by amplification
by amplification of
amplification of the
of the CAG
the CAG repeats
CAG repeats in
repeats in the
in the androgen
the androgen receptor
androgen receptor gene
We report here
report here a
here a simple
a simple and
simple and rapid
and rapid strategy
rapid strategy to
strategy to detect
to detect the
detect the precise
the precise number
precise number of
number of the
of the CAGs
After the DNA
the DNA fragment
DNA fragment containing
fragment containing the
containing the CAG
the CAG repeats
CAG repeats is
repeats is amplified
is amplified by
amplified by the
by the polymerase
the polymerase chain
polymerase chain reaction
chain reaction a
reaction a primer
a primer extension
primer extension is
extension is carried
is carried out;
carried out; the
out; the extension
the extension of
extension of the
of the end-labelled
the end-labelled reverse
end-labelled reverse primer
reverse primer adjacent
primer adjacent to
adjacent to 3'
to 3' end
3' end of
end of CAG
of CAG repeats
CAG repeats stops
repeats stops at
stops at the
at the first
the first T
first T after
T after CAG
after CAG repeats
CAG repeats with
repeats with the
with the incorporation
the incorporation of
incorporation of dideoxy
of dideoxy ATP
dideoxy ATP in
ATP in the
in the reaction
the reaction mixture
The resultant primer
resultant primer products
primer products are
products are analysed
are analysed by
analysed by denaturing
by denaturing polyacrylamide
denaturing polyacrylamide gel
polyacrylamide gel electrophoresis
gel electrophoresis and
electrophoresis and autoradiography
This method could
method could be
could be quite
be quite useful
quite useful to
useful to detect
to detect not
detect not only
not only CAG
only CAG repeats
CAG repeats in
repeats in SBMA
in SBMA but
SBMA but also
but also other
also other polymorphic
other polymorphic dinucleotide
polymorphic dinucleotide and
dinucleotide and trinucleotide
and trinucleotide repeats
Cellular immune and
immune and cytokine
and cytokine pathways
cytokine pathways resulting
pathways resulting in
resulting in tissue
in tissue factor
tissue factor expression
factor expression and
expression and relevance
and relevance to
relevance to septic
to septic shock
Cells of monocyte
of monocyte lineage
monocyte lineage serve
lineage serve as
serve as effector
as effector cells
effector cells in
cells in the
in the cellular
the cellular immune
cellular immune response
In addition they
addition they respond
they respond to
respond to LPS
to LPS and
LPS and cytokines
and cytokines with
cytokines with activation
with activation and
activation and expression
and expression of
expression of inflammatory
of inflammatory effector
inflammatory effector gene
effector gene products
gene products similar
products similar to
similar to those
to those elicited
those elicited by
elicited by the
by the antigen
the antigen driven
antigen driven response
The response to
response to antigen
to antigen proceeds
antigen proceeds at
proceeds at the
at the T
the T helper
T helper cell
helper cell level
cell level through
level through two
through two independent
two independent forms
independent forms of
forms of cellular
of cellular collaboration
cellular collaboration contact
collaboration contact and
contact and lymphokine
We review the
review the control
the control of
control of expression
of expression of
expression of the
of the Tissue
the Tissue Factor
Tissue Factor TF
Factor TF gene
TF gene and
gene and the
and the function
the function of
function of the
of the TF
the TF protein
The enhanced initiation
enhanced initiation of
initiation of transcription
of transcription of
transcription of the
of the TF
the TF gene
TF gene appears
gene appears to
appears to require
to require engagement
require engagement of
engagement of a
of a 56
a 56 bp
56 bp LPS
bp LPS Response
LPS Response Element
Response Element an
Element an enhancer
an enhancer that
enhancer that is
that is engaged
is engaged by
engaged by both
by both AP-1
both AP-1 type
AP-1 type heterodimeric
type heterodimeric complexes
heterodimeric complexes as
complexes as well
as well as
well as NF
as NF kappa
NF kappa B
kappa B like
B like heterodimeric
like heterodimeric complexes
Dissociation of NF
of NF kappa
NF kappa B
kappa B from
B from Ig
from Ig kappa
Ig kappa B
kappa B by
B by cytokine
by cytokine and
cytokine and LPS
and LPS stimulation
LPS stimulation and
stimulation and possibly
and possibly activated
possibly activated T
activated T cells
T cells may
cells may represent
may represent a
represent a common
a common pathway
common pathway to
pathway to induction
to induction of
induction of the
of the TF
the TF and
TF and other
and other inflammatory
other inflammatory genes
Enhancement of expression
of expression of
expression of TF
of TF is
TF is observed
is observed upon
observed upon adhesion
upon adhesion of
adhesion of Mo
of Mo to
Mo to endothelial
to endothelial cells
endothelial cells and
cells and extracellular
and extracellular matrix
extracellular matrix proteins
matrix proteins as
proteins as well
as well as
well as upon
as upon engagement
upon engagement of
engagement of leukocyte
of leukocyte integrins
The biological effects
biological effects that
effects that follow
that follow from
follow from expression
from expression of
expression of TF
of TF by
TF by vascular
by vascular cells
vascular cells have
cells have been
have been resolved
been resolved by
resolved by analysis
by analysis of
analysis of function
of function aided
function aided by
aided by the
by the use
the use of
use of recombinant
of recombinant full
recombinant full length
full length TF
length TF and
TF and truncated
and truncated surface
truncated surface domain
surface domain of
domain of TF
The rules of
rules of assembly
of assembly of
assembly of the
of the cognate
the cognate ligands
cognate ligands of
ligands of TF
of TF namely
TF namely the
namely the zymogen
the zymogen plasma
zymogen plasma factors
plasma factors VII
factors VII and
VII and the
and the serine
the serine protease
serine protease factor
protease factor VIIa
factor VIIa with
VIIa with the
with the soluble
the soluble surface
soluble surface domain
surface domain of
domain of TF
of TF in
TF in free
in free solution
free solution in
solution in the
in the presence
the presence of
presence of phospholipid
of phospholipid surfaces
phospholipid surfaces and
surfaces and cell
and cell surface
cell surface and
surface and of
and of the
of the anchored
the anchored TF
anchored TF molecule
TF molecule have
molecule have been
have been described
It is evident
is evident that
evident that assembly
that assembly of
assembly of the
of the surface
the surface domain
surface domain of
domain of TF
of TF with
TF with VIIa
with VIIa to
VIIa to form
to form the
form the binary
the binary TFVIIa
binary TFVIIa complex
TFVIIa complex induces
complex induces a
induces a significant
a significant increase
significant increase in
increase in the
in the Kcat
the Kcat of
Kcat of the
of the catalytic
the catalytic domain
catalytic domain of
domain of VIIa
of VIIa for
VIIa for small
for small peptidyl
small peptidyl substrates
peptidyl substrates and
substrates and more
and more profoundly
more profoundly for
profoundly for protein
for protein substrate
This provides substantial
provides substantial evidence
substantial evidence for
evidence for an
for an allosteric
an allosteric effect
allosteric effect on
effect on the
on the catalytic
the catalytic cleft
catalytic cleft of
cleft of VIIa
of VIIa that
VIIa that is
that is imparted
is imparted by
imparted by binding
by binding to
binding to TF
to TF its
TF its cognate
its cognate catalytic
cognate catalytic cofactor
It is also
is also evident
also evident that
evident that the
that the TFVIIa
the TFVIIa complex
TFVIIa complex is
complex is proteolytically
is proteolytically active
proteolytically active and
active and can
and can activate
can activate the
activate the zymogen
the zymogen plasma
zymogen plasma factor
plasma factor X
factor X to
X to the
to the serine
the serine protease
serine protease Xa
protease Xa in
Xa in free
in free solution
free solution inferring
solution inferring that
inferring that extended
that extended substrate
extended substrate recognition
substrate recognition by
recognition by induced
by induced structural
induced structural loci
structural loci of
loci of the
of the TFVIIa
the TFVIIa complex
TFVIIa complex are
complex are created
are created from
created from either
from either or
either or both
or both proteins
both proteins to
proteins to constitute
to constitute a
constitute a new
a new recognition
new recognition structure
It is also
is also evident
also evident that
evident that association
that association of
association of X
of X with
X with charged
with charged phospholipid
charged phospholipid surfaces
phospholipid surfaces enhances
surfaces enhances the
enhances the proteolytic
the proteolytic activation
proteolytic activation of
activation of this
of this zymogen
this zymogen by
zymogen by increasing
by increasing recognition
increasing recognition and
recognition and susceptibility
and susceptibility of
susceptibility of the
of the sessile
the sessile peptide
sessile peptide bond
peptide bond deduced
bond deduced from
deduced from the
from the markedly
the markedly decreased
markedly decreased Km
decreased Km and
Km and increased
and increased Kcat
Phorbol ester reduces
ester reduces constitutive
reduces constitutive nuclear
constitutive nuclear NF
nuclear NF kappa
NF kappa B
kappa B and
B and inhibits
and inhibits HIV-1
inhibits HIV-1 production
HIV-1 production in
production in mature
in mature human
mature human monocytic
human monocytic cells
NF kappa B
kappa B is
B is a
is a potent
a potent mediator
potent mediator of
mediator of specific
of specific gene
specific gene expression
gene expression in
expression in human
in human monocytes
human monocytes and
monocytes and has
and has been
has been shown
been shown to
shown to play
to play a
play a role
a role in
role in transcription
in transcription of
transcription of the
of the HIV-1
the HIV-1 genome
HIV-1 genome in
genome in promonocytic
in promonocytic leukemias
There is little
is little information
little information available
information available on
available on the
on the response
the response of
response of NF
of NF kappa
NF kappa B
kappa B to
B to cytokines
to cytokines in
cytokines in normal
in normal human
normal human monocytes
We have used
have used a
used a 32P-labeled
a 32P-labeled oligonucleotide
32P-labeled oligonucleotide derived
oligonucleotide derived from
derived from human
from human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV-1
virus HIV-1 long
HIV-1 long terminal
long terminal repeat
terminal repeat which
repeat which contains
which contains a
contains a tandem
a tandem repeat
tandem repeat of
repeat of the
of the NF
the NF kappa
NF kappa B
kappa B binding
B binding sequence
binding sequence as
sequence as a
as a probe
a probe in
probe in a
in a gel
a gel retardation
gel retardation assay
retardation assay to
assay to study
to study this
study this transcription
this transcription factor
Using this assay
this assay we
assay we have
we have detected
have detected NF
detected NF kappa
NF kappa B
kappa B in
B in extracts
in extracts of
extracts of nuclei
of nuclei from
nuclei from normal
from normal human
normal human monocytes
Treatment of normal
of normal monocytes
normal monocytes with
monocytes with 12-0-tetradecanoyl
with 12-0-tetradecanoyl phorbol-13-acetate
12-0-tetradecanoyl phorbol-13-acetate TPA
phorbol-13-acetate TPA for
TPA for 4-24
for 4-24 h
4-24 h caused
h caused the
caused the complete
the complete disappearance
complete disappearance of
disappearance of NF
of NF kappa
NF kappa B
kappa B from
B from nuclear
from nuclear extracts
nuclear extracts of
extracts of monocytes
A similar result
similar result was
result was obtained
was obtained with
obtained with the
with the mature
the mature monocytic
mature monocytic leukemia
monocytic leukemia cell
leukemia cell line
cell line THP-1
The constitutive transcription
constitutive transcription factor
transcription factor SP1
factor SP1 was
SP1 was unaffected
was unaffected by
unaffected by addition
by addition of
addition of TPA
The disappearance of
disappearance of NF
of NF kappa
NF kappa B
kappa B from
B from the
from the nucleus
the nucleus was
nucleus was concentration
was concentration dependent
concentration dependent between
dependent between 10
between 10 and
10 and 50
and 50 ng/ml
50 ng/ml of
ng/ml of phorbol
of phorbol ester
In THP-1 cells
THP-1 cells TPA
cells TPA also
TPA also induced
also induced a
induced a new
a new faster-migrating
new faster-migrating NF
faster-migrating NF kappa
NF kappa B
kappa B species
B species not
species not induced
not induced in
induced in monocytes
Protein kinase C
kinase C inhibitor
C inhibitor staurosporine
inhibitor staurosporine but
staurosporine but not
but not cyclic
not cyclic nucleotide-dependent
cyclic nucleotide-dependent protein
nucleotide-dependent protein kinase
protein kinase inhibitor
kinase inhibitor HA-1004
inhibitor HA-1004 also
HA-1004 also dramatically
also dramatically reduced
dramatically reduced constitutive
reduced constitutive levels
constitutive levels of
levels of nuclear
of nuclear NF
nuclear NF kappa
NF kappa B
Finally TPA addition
TPA addition to
addition to monocytes
to monocytes infected
monocytes infected with
infected with HIV-1
with HIV-1 inhibited
HIV-1 inhibited HIV-1
inhibited HIV-1 replication
HIV-1 replication as
replication as determined
as determined by
determined by reverse
by reverse transcriptase
reverse transcriptase assays
transcriptase assays in
assays in a
in a concentration-dependent
a concentration-dependent manner
These results are
results are in
are in striking
in striking contrast
striking contrast to
contrast to the
to the increase
the increase in
increase in nuclear
in nuclear NF
nuclear NF kappa
NF kappa B
kappa B and
B and HIV-1
and HIV-1 replication
HIV-1 replication induced
replication induced by
induced by phorbol
by phorbol esters
phorbol esters in
esters in promonocytic
in promonocytic leukemia
promonocytic leukemia cells
leukemia cells U937
cells U937 and
U937 and HL-60
and HL-60 and
HL-60 and emphasize
and emphasize the
emphasize the importance
the importance of
importance of studying
of studying cytokine
studying cytokine regulation
cytokine regulation of
regulation of HIV-1
of HIV-1 in
HIV-1 in normal
in normal monocytes
A mechanism for
mechanism for the
for the antiinflammatory
the antiinflammatory effects
antiinflammatory effects of
effects of corticosteroids:
of corticosteroids: the
corticosteroids: the glucocorticoid
the glucocorticoid receptor
glucocorticoid receptor regulates
receptor regulates leukocyte
regulates leukocyte adhesion
leukocyte adhesion to
adhesion to endothelial
to endothelial cells
endothelial cells and
cells and expression
and expression of
expression of endothelial-leukocyte
of endothelial-leukocyte adhesion
endothelial-leukocyte adhesion molecule
adhesion molecule 1
molecule 1 and
1 and intercellular
and intercellular adhesion
intercellular adhesion molecule
adhesion molecule 1
Corticosteroids are the
are the preeminent
the preeminent antiinflammatory
preeminent antiinflammatory agents
antiinflammatory agents although
agents although the
although the molecular
the molecular mechanisms
molecular mechanisms that
mechanisms that impart
that impart their
impart their efficacy
their efficacy have
efficacy have not
have not been
not been defined
The endothelium plays
endothelium plays a
plays a critical
a critical role
critical role in
role in inflammation
in inflammation by
inflammation by directing
by directing circulating
directing circulating leukocytes
circulating leukocytes into
leukocytes into extravascular
into extravascular tissues
extravascular tissues by
tissues by expressing
by expressing adhesive
expressing adhesive molecules
adhesive molecules for
molecules for leukocytes
for leukocytes [eg
leukocytes [eg endothelial-leukocyte
[eg endothelial-leukocyte adhesion
endothelial-leukocyte adhesion molecule
adhesion molecule 1
molecule 1 ELAM-1
1 ELAM-1 and
ELAM-1 and intercellular
and intercellular adhesion
intercellular adhesion molecule
adhesion molecule 1
molecule 1 ICAM-1]
We therefore determined
therefore determined whether
determined whether corticosteroids
whether corticosteroids suppress
corticosteroids suppress inflammation
suppress inflammation by
inflammation by inhibiting
by inhibiting endothelial
inhibiting endothelial expression
endothelial expression of
expression of adhesion
of adhesion molecules
adhesion molecules for
molecules for neutrophils
for neutrophils polymorphonuclear
neutrophils polymorphonuclear leukocytes
Preincubation of endothelial
of endothelial cells
endothelial cells with
cells with endotoxin
with endotoxin [lipopolysaccharide
endotoxin [lipopolysaccharide LPS
[lipopolysaccharide LPS 1
LPS 1 microgram/ml]
1 microgram/ml] led
microgram/ml] led to
led to a
to a 4-fold
a 4-fold increase
4-fold increase in
increase in subsequent
in subsequent adherence
subsequent adherence of
adherence of polymorphonuclear
of polymorphonuclear leukocytes
polymorphonuclear leukocytes P
leukocytes P <
P < 00001
< 00001 n
00001 n =
n = 10
= 10 to
10 to endothelial
to endothelial cells
endothelial cells an
cells an increase
an increase that
increase that was
that was markedly
was markedly attenuated
markedly attenuated when
attenuated when endothelial
when endothelial cells
endothelial cells were
cells were treated
were treated with
treated with dexamethasone
with dexamethasone IC50
dexamethasone IC50 <
IC50 < 1
< 1 nM
1 nM P
nM P <
P < 00001
< 00001 n
00001 n =
n = 6
= 6 or
6 or 7
or 7 during
7 during preincubation
during preincubation with
preincubation with LPS
Moreover the steroid
the steroid receptor
steroid receptor agonist
receptor agonist cortisol
agonist cortisol 10
cortisol 10 microM
10 microM but
microM but not
but not its
not its inactive
its inactive metabolite
inactive metabolite tetrahydrocortisol
metabolite tetrahydrocortisol 10
tetrahydrocortisol 10 microM
10 microM diminished
microM diminished LPS-induced
diminished LPS-induced endothelial
LPS-induced endothelial cell
endothelial cell adhesiveness
Further evidence that
evidence that the
that the action
the action of
action of dexamethasone
of dexamethasone was
dexamethasone was mediated
was mediated through
mediated through ligation
through ligation of
ligation of corticosteroid
of corticosteroid receptors
corticosteroid receptors [human
receptors [human glucocorticoid
[human glucocorticoid receptors
glucocorticoid receptors hGRs]
receptors hGRs] was
hGRs] was provided
was provided by
provided by experiments
by experiments utilizing
experiments utilizing the
utilizing the steroid
the steroid antagonist
steroid antagonist RU-486
RU-486 10 microM
10 microM which
microM which prevents
which prevents translocation
prevents translocation of
translocation of ligated
of ligated hGR
ligated hGR to
hGR to the
to the nucleus
the nucleus by
nucleus by inhibiting
by inhibiting dissociation
inhibiting dissociation of
dissociation of hGR
of hGR from
hGR from heat
from heat shock
heat shock protein
shock protein 90
protein 90 completely
90 completely aborted
completely aborted the
aborted the effect
the effect of
effect of dexamethasone
of dexamethasone on
dexamethasone on adhesiveness
on adhesiveness of
adhesiveness of endothelial
of endothelial cells
endothelial cells P
cells P <
P < 00005
< 00005 n
00005 n =
n = 3
Treatment of endothelial
of endothelial cells
endothelial cells with
cells with LPS
with LPS 1
LPS 1 microgram/ml
1 microgram/ml stimulated
microgram/ml stimulated transcription
stimulated transcription of
transcription of ELAM-1
of ELAM-1 as
ELAM-1 as shown
as shown by
shown by Northern
by Northern blot
Northern blot analysis
blot analysis and
analysis and expression
and expression of
expression of membrane-associated
of membrane-associated ELAM-1
membrane-associated ELAM-1 and
ELAM-1 and ICAM-1
and ICAM-1 as
ICAM-1 as shown
as shown by
shown by quantitative
by quantitative immunofluorescence
quantitative immunofluorescence both
immunofluorescence both P
both P <
P < 0001
< 0001 n
0001 n =
n = 9
Dexamethasone markedly inhibited
markedly inhibited LPS-stimulated
inhibited LPS-stimulated accumulation
LPS-stimulated accumulation of
accumulation of mRNA
of mRNA for
mRNA for ELAM-1
for ELAM-1 and
ELAM-1 and expression
and expression of
expression of ELAM-1
of ELAM-1 and
ELAM-1 and ICAM-1
and ICAM-1 IC50
ICAM-1 IC50 <
IC50 < 10
< 10 nM
10 nM both
nM both P
both P <
P < 0001
< 0001 n
0001 n =
n = 4-9;
= 4-9; inhibition
4-9; inhibition of
inhibition of expression
of expression by
expression by dexamethasone
by dexamethasone was
dexamethasone was reversed
was reversed by
reversed by RU-486
by RU-486 both
RU-486 both P
both P <
P < 0005
< 0005 n
0005 n =
n = 4-6
As in the
in the adhesion
the adhesion studies
adhesion studies cortisol
studies cortisol but
cortisol but not
but not tetrahydrocortisol
not tetrahydrocortisol inhibited
tetrahydrocortisol inhibited expression
inhibited expression of
expression of ELAM-1
of ELAM-1 and
ELAM-1 and ICAM-1
and ICAM-1 both
ICAM-1 both P
both P <
P < 0005
< 0005 n
0005 n =
n = 3
= 3 or
3 or 4
In contrast sodium
contrast sodium salicylate
sodium salicylate 1
salicylate 1 mM
1 mM inhibited
mM inhibited neither
inhibited neither adhesion
neither adhesion nor
adhesion nor expression
nor expression of
expression of these
of these adhesion
these adhesion molecules
These studies suggest
studies suggest that
suggest that antagonism
that antagonism by
antagonism by dexamethasone
by dexamethasone of
dexamethasone of endotoxin-induced
of endotoxin-induced inflammation
endotoxin-induced inflammation is
inflammation is a
is a specific
a specific instance
specific instance of
instance of the
of the general
the general biological
general biological principle
biological principle that
principle that the
that the glucocorticoid
the glucocorticoid receptor
glucocorticoid receptor is
receptor is a
is a hormone-dependent
a hormone-dependent regulator
hormone-dependent regulator of
regulator of transcription
Pax-5 encodes the
encodes the transcription
the transcription factor
transcription factor BSAP
factor BSAP and
BSAP and is
and is expressed
is expressed in
expressed in B
in B lymphocytes
B lymphocytes the
lymphocytes the developing
the developing CNS
developing CNS and
CNS and adult
and adult testis
BSAP has been
has been identified
been identified previously
identified previously as
previously as a
as a transcription
a transcription factor
transcription factor that
factor that is
that is expressed
is expressed at
expressed at early
at early but
early but not
but not late
not late stages
late stages of
stages of B-cell
of B-cell differentiation
Biochemical purification and
purification and cDNA
and cDNA cloning
cDNA cloning has
cloning has now
has now revealed
now revealed that
revealed that BSAP
that BSAP belongs
BSAP belongs to
belongs to the
to the family
the family of
family of paired
of paired domain
paired domain proteins
BSAP is encoded
is encoded by
encoded by the
by the Pax-5
the Pax-5 gene
Pax-5 gene and
gene and has
and has been
has been highly
been highly conserved
highly conserved between
conserved between human
between human and
human and mouse
An intact paired
intact paired domain
paired domain was
domain was shown
was shown to
shown to be
to be both
be both necessary
both necessary and
necessary and sufficient
and sufficient for
sufficient for DNA
for DNA binding
DNA binding of
binding of BSAP
Binding studies with
studies with several
with several BSAP
several BSAP recognition
BSAP recognition sequences
recognition sequences demonstrated
sequences demonstrated that
demonstrated that the
that the sequence
the sequence specificity
sequence specificity of
specificity of BSAP
of BSAP differs
BSAP differs from
differs from that
from that of
that of the
of the distantly
the distantly related
distantly related paired
related paired domain
paired domain protein
domain protein Pax-1
During embryogenesis the
embryogenesis the BSAP
the BSAP gene
BSAP gene is
gene is transiently
is transiently expressed
transiently expressed in
expressed in the
in the mesencephalon
the mesencephalon and
mesencephalon and spinal
and spinal cord
spinal cord with
cord with a
with a spatial
a spatial and
spatial and temporal
and temporal expression
temporal expression pattern
expression pattern that
pattern that is
that is distinct
is distinct from
distinct from that
from that of
that of other
of other Pax
other Pax genes
Pax genes in
genes in the
in the developing
the developing central
developing central nervous
central nervous system
nervous system CNS
Later the expression
the expression of
expression of the
of the BSAP
the BSAP gene
BSAP gene shifts
gene shifts to
shifts to the
to the fetal
the fetal liver
fetal liver where
liver where it
where it correlates
it correlates with
correlates with the
with the onset
the onset of
onset of B
of B lymphopoiesis
BSAP expression persists
expression persists in
persists in B
in B lymphocytes
B lymphocytes and
lymphocytes and is
and is also
is also seen
also seen in
seen in the
in the testis
the testis of
testis of the
of the adult
the adult mouse
All of this
of this evidence
this evidence indicates
evidence indicates that
indicates that the
that the transcription
the transcription factor
transcription factor BSAP
factor BSAP may
BSAP may not
may not only
not only play
only play an
play an important
an important role
important role in
role in B-cell
in B-cell differentiation
B-cell differentiation but
differentiation but also
but also in
also in neural
in neural development
neural development and
development and spermatogenesis
Cell cycle-dependent initiation
cycle-dependent initiation and
initiation and lineage-dependent
and lineage-dependent abrogation
lineage-dependent abrogation of
abrogation of GATA-1
of GATA-1 expression
GATA-1 expression in
expression in pure
in pure differentiating
pure differentiating hematopoietic
differentiating hematopoietic progenitors
The programmed activation/repression
programmed activation/repression of
activation/repression of transcription
of transcription factors
transcription factors in
factors in early
in early hematopoietic
early hematopoietic differentiation
hematopoietic differentiation has
differentiation has not
has not yet
not yet been
yet been explored
The DNA-binding protein
DNA-binding protein GATA-1
protein GATA-1 is
GATA-1 is required
is required for
required for normal
for normal erythroid
normal erythroid development
erythroid development and
development and regulates
and regulates erythroid-expressed
regulates erythroid-expressed genes
erythroid-expressed genes in
genes in maturing
in maturing erythroblasts
We analyzed GATA-1
analyzed GATA-1 expression
GATA-1 expression in
expression in early
in early human
early human adult
human adult hematopoiesis
adult hematopoiesis by
hematopoiesis by using
by using an
using an in
an in vitro
in vitro system
vitro system in
system in which
in which "pure"
which "pure" early
"pure" early hematopoietic
early hematopoietic progenitors
hematopoietic progenitors are
progenitors are induced
are induced to
induced to gradual
to gradual and
gradual and synchronized
and synchronized differentiation
synchronized differentiation selectively
differentiation selectively along
selectively along the
along the erythroid
the erythroid or
erythroid or granulocyte-macrophage
or granulocyte-macrophage pathway
granulocyte-macrophage pathway by
pathway by differential
by differential treatment
differential treatment with
treatment with hematopoietic
with hematopoietic growth
hematopoietic growth factors
The GATA-1 gene
GATA-1 gene though
gene though virtually
though virtually silent
virtually silent in
silent in quiescent
in quiescent progenitors
quiescent progenitors is
progenitors is activated
is activated after
activated after entrance
after entrance into
entrance into the
into the cell
the cell cycle
cell cycle upon
cycle upon stimulation
upon stimulation with
stimulation with hematopoietic
with hematopoietic growth
hematopoietic growth factors
Subsequently increasing expression
increasing expression along
expression along the
along the erythroid
the erythroid pathway
erythroid pathway contrasts
pathway contrasts with
contrasts with an
with an abrupt
an abrupt downregulation
abrupt downregulation in
downregulation in the
in the granulocyte-macrophage
the granulocyte-macrophage lineage
These results suggest
results suggest a
suggest a microenvironment-directed
a microenvironment-directed two-step
microenvironment-directed two-step model
two-step model for
model for GATA-1
for GATA-1 expression
GATA-1 expression in
expression in differentiating
in differentiating hematopoietic
differentiating hematopoietic progenitors
hematopoietic progenitors that
progenitors that involves
that involves i
involves i cycle-dependent
i cycle-dependent initiation
cycle-dependent initiation and
initiation and ii
and ii lineage-dependent
ii lineage-dependent maintenance
lineage-dependent maintenance or
maintenance or suppression
Hypothetically on/off switches
on/off switches of
switches of lineage-restricted
of lineage-restricted transactivators
lineage-restricted transactivators may
transactivators may underlie
may underlie the
underlie the binary
the binary fate
binary fate decisions
fate decisions of
decisions of hematopoietic
of hematopoietic progenitors
Specific NF-kappa B
NF-kappa B subunits
B subunits act
subunits act in
act in concert
in concert with
concert with Tat
with Tat to
Tat to stimulate
to stimulate human
stimulate human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 transcription
NF-kappa B is
B is a
is a protein
a protein complex
protein complex which
complex which functions
which functions in
functions in concert
in concert with
concert with the
with the tat-I
the tat-I gene
tat-I gene product
gene product to
product to stimulate
to stimulate human
stimulate human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV transcription
To determine whether
determine whether specific
whether specific members
specific members of
members of the
of the NF-kappa
the NF-kappa B
NF-kappa B family
B family contribute
family contribute to
contribute to this
to this effect
this effect we
effect we have
we have examined
have examined the
examined the abilities
the abilities of
abilities of different
of different NF-kappa
different NF-kappa B
NF-kappa B subunits
B subunits to
subunits to act
to act with
act with Tat-I
with Tat-I to
Tat-I to stimulate
to stimulate transcription
stimulate transcription of
transcription of HIV
of HIV in
HIV in Jurkat
in Jurkat T-leukemia
Jurkat T-leukemia cells
We have found
have found that
found that the
that the p49100
the p49100 DNA
p49100 DNA binding
DNA binding subunit
binding subunit together
subunit together with
together with p65
with p65 can
p65 can act
can act in
act in concert
in concert with
concert with Tat-I
with Tat-I to
Tat-I to stimulate
to stimulate the
stimulate the expression
the expression of
expression of HIV-CAT
of HIV-CAT plasmid
Little effect was
effect was observed
was observed with
observed with 50-kDa
with 50-kDa forms
50-kDa forms of
forms of p105
of p105 NF-kappa
p105 NF-kappa B
NF-kappa B or
B or rel
or rel in
rel in combination
in combination with
combination with p65
with p65 or
p65 or full-length
or full-length c-rel
full-length c-rel which
c-rel which do
which do not
do not stimulate
not stimulate the
stimulate the HIV
the HIV enhancer
HIV enhancer in
enhancer in these
in these cells
These findings suggest
findings suggest that
suggest that the
that the combination
the combination of
combination of p49100
of p49100 and
p49100 and p65
and p65 NF-kappa
p65 NF-kappa B
NF-kappa B can
B can act
can act in
act in concert
in concert with
concert with the
with the tat-I
the tat-I gene
tat-I gene product
gene product to
product to stimulate
to stimulate the
stimulate the synthesis
the synthesis of
synthesis of HIV
of HIV RNA
Stable expression of
expression of HB24
of HB24 a
HB24 a diverged
a diverged human
diverged human homeobox
human homeobox gene
homeobox gene in
gene in T
in T lymphocytes
T lymphocytes induces
lymphocytes induces genes
induces genes involved
genes involved in
involved in T
in T cell
T cell activation
cell activation and
activation and growth
A diverged homeobox
diverged homeobox gene
homeobox gene HB24
gene HB24 which
HB24 which is
which is known
is known to
known to be
to be induced
be induced following
induced following lymphocyte
following lymphocyte activation
lymphocyte activation was
activation was introduced
was introduced into
introduced into Jurkat
into Jurkat T
Jurkat T cells
T cells under
cells under the
under the control
the control of
control of a
of a constitutive
a constitutive promoter
Stable transfectants of
transfectants of HB24
of HB24 were
HB24 were established
were established that
established that expressed
that expressed high
expressed high levels
high levels of
levels of HB24
of HB24 mRNA
HB24 mRNA and
mRNA and possessed
and possessed an
possessed an altered
an altered phenotype
altered phenotype suggestive
phenotype suggestive of
suggestive of activated
of activated T
activated T cells
A number of
number of genes
of genes known
genes known to
known to be
to be induced
be induced following
induced following T
following T cell
T cell activation
cell activation and
activation and associated
and associated with
associated with cell
with cell growth
cell growth were
growth were increased
were increased in
increased in the
in the transfectants
the transfectants including
transfectants including c-fos
including c-fos c-myc
c-fos c-myc c-myb
c-myc c-myb HLA-DR
c-myb HLA-DR lck
HLA-DR lck NF-kappa
lck NF-kappa B
NF-kappa B interleukin-2
B interleukin-2 and
interleukin-2 and interleukin-2
and interleukin-2 receptor
interleukin-2 receptor alpha
receptor alpha IL-2R
alpha IL-2R alpha
Analysis of IL-2R
of IL-2R alpha
IL-2R alpha expression
alpha expression by
expression by transient
by transient transfection
transient transfection of
transfection of IL-2R
of IL-2R alpha
IL-2R alpha promoter
alpha promoter constructs
promoter constructs into
constructs into the
into the HB24
the HB24 transfectants
HB24 transfectants revealed
transfectants revealed constitutive
revealed constitutive expression
constitutive expression about
expression about 60%
about 60% of
60% of phytohemagglutinin-
of phytohemagglutinin- and
phytohemagglutinin- and phorbol
and phorbol ester-activated
phorbol ester-activated Jurkat
ester-activated Jurkat cells
Jurkat cells that
cells that was
that was dependent
was dependent on
dependent on the
on the kappa
the kappa B
kappa B site
B site in
site in the
in the IL-2R
the IL-2R alpha
IL-2R alpha promoter
Furthermore as a
as a consequence
a consequence of
consequence of the
of the increased
the increased HB24
increased HB24 mRNA
HB24 mRNA levels
mRNA levels the
levels the Jurkat
the Jurkat HB24
Jurkat HB24 transfectants
HB24 transfectants proliferated
transfectants proliferated more
proliferated more rapidly
more rapidly than
rapidly than control
than control cell
control cell lines
Thus stable expression
stable expression of
expression of HB24
of HB24 confers
HB24 confers an
confers an activation
an activation phenotype
activation phenotype on
phenotype on a
on a human
a human T
human T cell
T cell line
cell line implicating
line implicating this
implicating this gene
this gene as
gene as an
as an important
an important transcriptional
important transcriptional factor
transcriptional factor during
factor during T
during T cell
T cell activation
cell activation and
activation and growth
Functional interaction between
interaction between the
between the two
the two zinc
two zinc finger
zinc finger domains
finger domains of
domains of the
of the v-erb
the v-erb A
v-erb A oncoprotein
The v-erb A
v-erb A oncogene
A oncogene of
oncogene of avian
of avian erythroblastosis
avian erythroblastosis virus
erythroblastosis virus is
virus is a
is a mutated
a mutated and
mutated and virally
and virally transduced
virally transduced copy
transduced copy of
copy of a
of a host
a host cell
host cell gene
cell gene encoding
gene encoding a
encoding a thyroid
a thyroid hormone
thyroid hormone receptor
The protein expressed
protein expressed by
expressed by the
by the v-erb
the v-erb A
v-erb A oncogene
A oncogene binds
oncogene binds to
binds to DNA
to DNA and
DNA and acts
and acts as
acts as a
as a dominant
a dominant negative
dominant negative inhibitor
negative inhibitor of
inhibitor of both
of both the
both the thyroid
the thyroid hormone
thyroid hormone receptor
hormone receptor and
receptor and the
and the closely
the closely related
closely related retinoic
related retinoic acid
retinoic acid receptor
The v-erb A
v-erb A protein
A protein has
protein has sustained
has sustained two
sustained two amino
two amino acid
amino acid alterations
acid alterations within
alterations within its
within its DNA-binding
its DNA-binding domain
DNA-binding domain relative
domain relative to
relative to that
to that of
that of c-erb
of c-erb A
c-erb A one
A one of
one of which
of which at
which at serine
at serine 61
serine 61 is
61 is known
is known to
known to be
to be important
be important for
important for v-erb
for v-erb A
v-erb A function
A function in
function in the
in the neoplastic
the neoplastic cell
We report here
report here that
here that the
that the second
the second alteration
second alteration at
alteration at threonine
at threonine 78
threonine 78 also
78 also plays
also plays an
plays an important
an important although
important although more
although more indirect
more indirect role:
indirect role: alteration
role: alteration of
alteration of the
of the sequence
the sequence at
sequence at threonine
at threonine 78
threonine 78 such
78 such that
such that it
that it resembles
it resembles that
resembles that of
that of c-erb
of c-erb A
c-erb A can
A can act
can act as
act as an
as an intragenic
an intragenic suppressor
intragenic suppressor and
suppressor and can
and can partially
can partially restore
partially restore function
restore function to
function to a
to a v-erb
a v-erb A
v-erb A protein
A protein rendered
protein rendered defective
rendered defective due
defective due to
due to a
to a mutation
a mutation at
mutation at position
at position 61
Threonine 78 lies
78 lies within
lies within the
within the D-box
the D-box of
D-box of the
of the v-erb
the v-erb A
v-erb A protein
A protein a
protein a region
a region thought
region thought to
thought to mediate
to mediate receptor-receptor
mediate receptor-receptor dimerizations
receptor-receptor dimerizations and
dimerizations and is
and is not
is not in
not in physical
in physical proximity
physical proximity to
proximity to the
to the serine
the serine at
serine at position
at position 61
It therefore appears
therefore appears that
appears that an
that an indirect
an indirect interaction
indirect interaction occurs
interaction occurs between
occurs between these
between these two
these two sites
two sites and
sites and that
and that this
that this interaction
this interaction is
interaction is crucial
is crucial for
crucial for v-erb
for v-erb A
v-erb A function
cis-acting sequences required
sequences required for
required for inducible
for inducible interleukin-2
inducible interleukin-2 enhancer
interleukin-2 enhancer function
enhancer function bind
function bind a
bind a novel
a novel Ets-related
novel Ets-related protein
Ets-related protein Elf-1
The recent definition
recent definition of
definition of a
of a consensus
a consensus DNA
consensus DNA binding
DNA binding sequence
binding sequence for
sequence for the
for the Ets
the Ets family
Ets family of
family of transcription
of transcription factors
transcription factors has
factors has allowed
has allowed the
allowed the identification
the identification of
identification of potential
of potential Ets
potential Ets binding
Ets binding sites
binding sites in
sites in the
in the promoters
the promoters and
promoters and enhancers
and enhancers of
enhancers of many
of many inducible
many inducible T-cell
inducible T-cell genes
In the studies
the studies described
studies described in
described in this
in this report
this report we
report we have
we have identified
have identified two
identified two potential
two potential Ets
potential Ets binding
Ets binding sites
binding sites EBS1
sites EBS1 and
EBS1 and EBS2
and EBS2 which
EBS2 which are
which are conserved
are conserved in
conserved in both
in both the
both the human
the human and
human and murine
and murine interleukin-2
murine interleukin-2 enhancers
Within the human
the human enhancer
human enhancer these
enhancer these two
these two sites
two sites are
sites are located
are located within
located within the
within the previously
the previously defined
previously defined DNase
defined DNase I
DNase I footprints
I footprints NFAT-1
footprints NFAT-1 and
NFAT-1 and NFIL-2B
and NFIL-2B respectively
Electrophoretic mobility shift
mobility shift and
shift and methylation
and methylation interference
methylation interference analyses
interference analyses demonstrated
analyses demonstrated that
demonstrated that EBS1
that EBS1 and
EBS1 and EBS2
and EBS2 are
EBS2 are essential
are essential for
essential for the
for the formation
the formation of
formation of the
of the NFAT-1
the NFAT-1 and
NFAT-1 and NFIL-2B
and NFIL-2B nuclear
NFIL-2B nuclear protein
nuclear protein complexes
Furthermore in vitro
in vitro mutagenesis
vitro mutagenesis experiments
mutagenesis experiments demonstrated
experiments demonstrated that
demonstrated that inducible
that inducible interleukin-2
inducible interleukin-2 enhancer
interleukin-2 enhancer function
enhancer function requires
function requires the
requires the presence
the presence of
presence of either
of either EBS1
either EBS1 or
EBS1 or EBS2
Two well-characterized Ets
well-characterized Ets family
Ets family members
family members Ets-1
members Ets-1 and
Ets-1 and Ets-2
and Ets-2 are
Ets-2 are reciprocally
are reciprocally expressed
reciprocally expressed during
expressed during T-cell
during T-cell activation
Surprisingly however neither
however neither of
neither of these
of these proteins
these proteins bound
proteins bound in
bound in vitro
in vitro to
vitro to EBS1
to EBS1 or
EBS1 or EBS2
We therefore screened
therefore screened a
screened a T-cell
a T-cell cDNA
T-cell cDNA library
cDNA library under
library under low-stringency
under low-stringency conditions
low-stringency conditions with
conditions with a
with a probe
a probe from
probe from the
from the DNA
the DNA binding
DNA binding domain
binding domain of
domain of Ets-1
of Ets-1 and
Ets-1 and isolated
and isolated a
isolated a novel
a novel Ets
novel Ets family
Ets family member
family member Elf-1
Elf-1 contains a
contains a DNA
a DNA binding
DNA binding domain
binding domain that
domain that is
that is nearly
is nearly identical
nearly identical to
identical to that
to that of
that of E74
of E74 the
E74 the ecdysone-inducible
the ecdysone-inducible Drosophila
ecdysone-inducible Drosophila transcription
Drosophila transcription factor
transcription factor required
factor required for
required for metamorphosis
for metamorphosis hence
metamorphosis hence the
hence the name
the name Elf-1
name Elf-1 for
Elf-1 for E74-like
for E74-like factor
E74-like factor 1
Elf-1 bound specifically
bound specifically to
specifically to both
to both EBS1
both EBS1 and
EBS1 and EBS2
and EBS2 in
EBS2 in electrophoretic
in electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
It also bound
also bound to
bound to the
to the purine-rich
the purine-rich CD3R
purine-rich CD3R element
CD3R element from
element from the
from the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 2
type 2 long
2 long terminal
long terminal repeat
terminal repeat which
repeat which is
which is required
is required for
required for inducible
for inducible virus
inducible virus expression
virus expression in
expression in response
in response to
response to signalling
to signalling through
signalling through the
through the T-cell
the T-cell receptor
Taken together these
together these results
these results demonstrate
results demonstrate that
demonstrate that multiple
that multiple Ets
multiple Ets family
Ets family members
family members with
members with apparently
with apparently distinct
apparently distinct DNA
distinct DNA binding
DNA binding specificities
binding specificities regulate
specificities regulate differential
regulate differential gene
differential gene expression
gene expression in
expression in resting
in resting and
resting and activated
and activated T
activated T cells
Binding of erythroid
of erythroid and
erythroid and non-erythroid
and non-erythroid nuclear
non-erythroid nuclear proteins
nuclear proteins to
proteins to the
to the silencer
the silencer of
silencer of the
of the human
the human epsilon-globin-encoding
human epsilon-globin-encoding gene
To clarify the
clarify the molecular
the molecular mechanisms
molecular mechanisms involved
mechanisms involved in
involved in the
in the developmental
the developmental control
developmental control of
control of hemoglobin-encoding
of hemoglobin-encoding genes
hemoglobin-encoding genes we
genes we have
we have been
have been studying
been studying the
studying the expression
the expression of
expression of these
of these genes
these genes in
genes in human
in human cells
human cells in
cells in continuous
in continuous culture
We have previously
have previously reported
previously reported the
reported the presence
the presence of
presence of a
of a transcriptional
a transcriptional control
transcriptional control element
control element with
element with the
with the properties
the properties of
properties of a
of a silencer
a silencer extending
silencer extending from
extending from -392
from -392 to
-392 to -177
to -177 bp
-177 bp relative
bp relative to
relative to the
to the cap
the cap site
cap site of
site of the
of the human
the human epsilon-globin-encoding
human epsilon-globin-encoding gene
epsilon-globin-encoding gene [Cao
gene [Cao et
[Cao et al
et al ProcNatlAcadSciUSA
al ProcNatlAcadSciUSA 86
ProcNatlAcadSciUSA 86 1989
86 1989 5306-5309]
We also showed
also showed that
showed that this
that this silencer
this silencer has
silencer has stronger
has stronger inhibitory
stronger inhibitory activity
inhibitory activity in
activity in HeLa
in HeLa cells
HeLa cells as
cells as compared
as compared to
compared to K562
to K562 human
K562 human erythroleukemia
human erythroleukemia cells
Using deletion mutants
deletion mutants and
mutants and cis-cloned
and cis-cloned synthetic
cis-cloned synthetic oligodeoxyribonucleotides
synthetic oligodeoxyribonucleotides in
oligodeoxyribonucleotides in transient
in transient expression
transient expression assays
expression assays nucleotide
assays nucleotide sequences
nucleotide sequences responsible
sequences responsible for
responsible for this
for this effect
this effect have
effect have now
have now been
now been further
been further delimited
further delimited to
delimited to 44
to 44 bp
44 bp located
bp located from
located from -294
from -294 to
-294 to -251
to -251 bp
Gel electrophoresis mobility
electrophoresis mobility shift
mobility shift assays
shift assays and
assays and DNaseI
and DNaseI footprinting
DNaseI footprinting assays
footprinting assays demonstrate
assays demonstrate that
demonstrate that these
that these negative
these negative regulatory
negative regulatory sequences
regulatory sequences are
sequences are recognized
are recognized differently
recognized differently by
differently by proteins
by proteins present
proteins present in
present in nuclear
in nuclear extracts
nuclear extracts obtained
extracts obtained from
obtained from HeLa
from HeLa and
HeLa and K562
and K562 cells
Two binding proteins
binding proteins are
proteins are detected
are detected in
detected in K562
in K562 nuclear
K562 nuclear extracts
nuclear extracts while
extracts while only
while only one
only one is
one is found
is found in
found in extracts
in extracts from
extracts from HeLa
from HeLa cells
Possible mechanisms by
mechanisms by which
by which these
which these proteins
these proteins may
proteins may regulate
may regulate transcription
regulate transcription of
transcription of the
of the epsilon-globin-encoding
the epsilon-globin-encoding gene
epsilon-globin-encoding gene in
gene in erythroid
in erythroid and
erythroid and non-erythroid
and non-erythroid cells
non-erythroid cells are
cells are discussed
Calcitriol: a hematolymphopoietrope?
a hematolymphopoietrope? [editorial]
A MEDLINE search
MEDLINE search of
search of the
of the English-language
the English-language literature
English-language literature was
literature was conducted
was conducted using
conducted using the
using the indexing
the indexing terms
indexing terms 'immunology
terms 'immunology calcitriol
'immunology calcitriol and
calcitriol and vitamin
and vitamin D'
vitamin D' to
D' to identify
to identify studies
identify studies indicating
studies indicating a
indicating a role
a role for
role for calcitriol
for calcitriol as
calcitriol as a
as a primary
a primary immunomodulator
Sixty-six papers published
papers published between
published between January
between January 1956
January 1956 and
1956 and June
and June 1991
June 1991 were
1991 were identified
Forty-five of these
of these reports
these reports are
reports are cited
are cited in
cited in this
in this review
The data strongly
data strongly suggest
strongly suggest an
suggest an endocrine
an endocrine autocrine
endocrine autocrine and/or
autocrine and/or paracrine
and/or paracrine role
paracrine role for
role for calcitriol
for calcitriol in
calcitriol in immune
in immune regulation
No unifying hypothesis
unifying hypothesis has
hypothesis has yet
has yet emerged
yet emerged explaining
emerged explaining this
explaining this collection
this collection of
collection of data
This paper provides
paper provides a
provides a brief
a brief review
brief review of
review of immune
of immune properties
immune properties currently
properties currently attributed
currently attributed to
attributed to calcitriol
Transcription of the
of the hypersensitive
the hypersensitive site
hypersensitive site HS2
site HS2 enhancer
HS2 enhancer in
enhancer in erythroid
in erythroid cells
In the human
the human genome
human genome the
genome the erythroid-specific
the erythroid-specific hypersensitive
erythroid-specific hypersensitive site
hypersensitive site HS2
site HS2 enhancer
HS2 enhancer regulates
enhancer regulates the
regulates the transcription
the transcription of
transcription of the
of the downstream
the downstream beta-like
downstream beta-like globin
beta-like globin genes
globin genes 10-50
genes 10-50 kilobases
10-50 kilobases away
The mechanism of
mechanism of HS2
of HS2 enhancer
HS2 enhancer function
enhancer function is
function is not
is not known
The present study
present study employs
study employs RNA
employs RNA protection
RNA protection assays
protection assays to
assays to analyze
to analyze the
analyze the transcriptional
the transcriptional status
transcriptional status of
status of the
of the HS2
the HS2 enhancer
HS2 enhancer in
enhancer in transfected
in transfected recombinant
transfected recombinant chloramphenicol
recombinant chloramphenicol acetyltransferase
chloramphenicol acetyltransferase CAT
acetyltransferase CAT plasmids
In erythroid K562
erythroid K562 cells
K562 cells in
cells in which
in which the
which the HS2
the HS2 enhancer
HS2 enhancer is
enhancer is active
is active the
active the HS2
the HS2 sequence
HS2 sequence directs
sequence directs the
directs the synthesis
the synthesis of
synthesis of long
of long enhancer
long enhancer transcripts
enhancer transcripts that
transcripts that are
that are initiated
are initiated apparently
initiated apparently from
apparently from within
from within the
within the enhancer
the enhancer and
enhancer and elongated
and elongated through
elongated through the
through the intervening
the intervening DNA
intervening DNA into
DNA into the
into the cis-linked
the cis-linked CAT
cis-linked CAT gene
In nonerythroid HL-60
nonerythroid HL-60 cells
HL-60 cells in
cells in which
in which the
which the HS2
the HS2 enhancer
HS2 enhancer is
enhancer is inactive
is inactive long
inactive long enhancer
long enhancer transcripts
enhancer transcripts are
transcripts are not
are not detectable
Splitting the HS2
the HS2 enhancer
HS2 enhancer between
enhancer between two
between two tandem
two tandem Ap1
tandem Ap1 sites
Ap1 sites abolishes
sites abolishes the
abolishes the synthesis
the synthesis of
synthesis of a
of a group
a group of
group of long
of long enhancer
long enhancer transcripts
enhancer transcripts and
transcripts and results
and results in
results in loss
in loss of
loss of enhancer
of enhancer function
enhancer function and
function and transcriptional
and transcriptional silencing
transcriptional silencing of
silencing of the
of the cis-linked
the cis-linked CAT
cis-linked CAT gene
In directing the
directing the synthesis
the synthesis of
synthesis of RNA
of RNA through
RNA through the
through the intervening
the intervening DNA
intervening DNA and
DNA and the
and the gene
the gene by
gene by a
by a tracking
a tracking and
tracking and transcription
and transcription mechanism
transcription mechanism the
mechanism the HS2
the HS2 enhancer
HS2 enhancer may
enhancer may i
may i open
i open up
open up the
up the chromatin
the chromatin structure
chromatin structure of
structure of a
of a gene
a gene domain
gene domain and
domain and ii
and ii deliver
ii deliver enhancer
deliver enhancer binding
enhancer binding proteins
binding proteins to
proteins to the
to the promoter
the promoter sequence
promoter sequence where
sequence where they
where they may
they may stimulate
may stimulate the
stimulate the transcription
the transcription of
transcription of the
of the gene
the gene at
gene at the
at the cap
the cap site
Characterization of a
of a novel
a novel T
novel T lymphocyte
T lymphocyte protein
lymphocyte protein which
protein which binds
which binds to
binds to a
to a site
a site related
site related to
related to steroid/thyroid
to steroid/thyroid hormone
steroid/thyroid hormone receptor
hormone receptor response
receptor response elements
response elements in
elements in the
in the negative
the negative regulatory
negative regulatory sequence
regulatory sequence of
sequence of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus long
virus long terminal
long terminal repeat
We have previously
have previously identified
previously identified a
identified a T
a T lymphocyte
T lymphocyte protein
lymphocyte protein which
protein which binds
which binds to
binds to a
to a site
a site within
site within the
within the LTR
the LTR of
LTR of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 and
HIV-1 and exerts
and exerts an
exerts an inhibitory
an inhibitory effect
inhibitory effect on
effect on virus
on virus gene
virus gene expression
The palindromic site
palindromic site site
site site B
site B recognized
B recognized by
recognized by this
by this protein
this protein is
protein is related
is related to
related to the
to the palindromic
the palindromic binding
palindromic binding sites
binding sites of
sites of members
of members of
members of the
of the steroid/thyroid
the steroid/thyroid hormone
steroid/thyroid hormone receptor
hormone receptor family
Here we characterize
we characterize the
characterize the T
the T cell
T cell protein
cell protein binding
protein binding to
binding to this
to this site
this site as
site as a
as a 100
a 100 kD
100 kD protein
kD protein which
protein which is
which is most
is most abundant
most abundant in
abundant in T
in T cells
T cells and
cells and which
and which binds
which binds to
binds to site
to site B
site B as
B as a
as a 200
a 200 kD
200 kD complex
This protein is
protein is distinct
is distinct from
distinct from other
from other members
other members of
members of the
of the steroid/thyroid
the steroid/thyroid hormone
steroid/thyroid hormone receptor
hormone receptor family
receptor family including
family including the
including the COUP
the COUP protein
COUP protein which
protein which has
which has a
has a closely
a closely related
closely related DNA
related DNA binding
DNA binding specificity
TAR-independent transactivation by
transactivation by Tat
by Tat in
Tat in cells
in cells derived
cells derived from
derived from the
from the CNS:
the CNS: a
CNS: a novel
a novel mechanism
novel mechanism of
mechanism of HIV-1
of HIV-1 gene
HIV-1 gene regulation
The Tat protein
Tat protein of
protein of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 is
HIV-1 is essential
is essential for
essential for productive
for productive infection
productive infection and
infection and is
and is a
is a potential
a potential target
potential target for
target for antiviral
for antiviral therapy
Tat a potent
a potent activator
potent activator of
activator of HIV-1
of HIV-1 gene
HIV-1 gene expression
gene expression serves
expression serves to
serves to greatly
to greatly increase
greatly increase the
increase the rate
the rate of
rate of transcription
of transcription directed
transcription directed by
directed by the
by the viral
the viral promoter
This induction which
induction which seems
which seems to
seems to be
to be an
be an important
an important component
important component in
component in the
in the progression
the progression of
progression of acquired
of acquired immune
acquired immune deficiency
immune deficiency syndrome
deficiency syndrome AIDS
syndrome AIDS may
AIDS may be
may be due
be due to
due to increased
to increased transcriptional
increased transcriptional initiation
transcriptional initiation increased
initiation increased transcriptional
increased transcriptional elongation
transcriptional elongation or
elongation or a
or a combination
a combination of
combination of these
of these processes
Much attention has
attention has been
has been focused
been focused on
focused on the
on the interaction
the interaction of
interaction of Tat
of Tat with
Tat with a
with a specific
a specific RNA
specific RNA target
RNA target termed
target termed TAR
termed TAR transactivation
TAR transactivation responsive
transactivation responsive which
responsive which is
which is present
is present in
present in the
in the leader
the leader sequence
leader sequence of
sequence of all
of all HIV-1
all HIV-1 mRNAs
This interaction is
interaction is believed
is believed to
believed to be
to be an
be an important
an important component
important component of
component of the
of the mechanism
the mechanism of
mechanism of transactivation
In this report
this report we
report we demonstrate
we demonstrate that
demonstrate that in
that in certain
in certain CNS-derived
certain CNS-derived cells
CNS-derived cells Tat
cells Tat is
Tat is capable
is capable of
capable of activating
of activating HIV-1
activating HIV-1 through
HIV-1 through a
through a TAR-independent
a TAR-independent pathway
A Tat-responsive element
Tat-responsive element is
element is found
is found upstream
found upstream within
upstream within the
within the viral
the viral promoter
viral promoter that
promoter that in
that in glial-derived
in glial-derived cell
glial-derived cell lines
cell lines allows
lines allows transactivation
allows transactivation in
transactivation in the
in the absence
the absence of
absence of TAR
Deletion mapping and
mapping and hybrid
and hybrid promoter
hybrid promoter constructs
promoter constructs demonstrate
constructs demonstrate that
demonstrate that the
that the newly
the newly identified
newly identified Tat-responsive
identified Tat-responsive element
Tat-responsive element corresponds
element corresponds to
corresponds to a
to a sequence
a sequence within
sequence within the
within the viral
the viral long
viral long terminal
long terminal repeat
terminal repeat LTR
repeat LTR previously
LTR previously identified
previously identified as
identified as the
as the HIV-1
the HIV-1 enhancer
HIV-1 enhancer or
enhancer or NF-kappa
or NF-kappa B
NF-kappa B domain
DNA band-shift analysis
band-shift analysis reveals
analysis reveals NF-kappa
reveals NF-kappa B
NF-kappa B binding
B binding activity
binding activity in
activity in glial
in glial cells
glial cells that
cells that differs
that differs from
differs from that
from that present
that present in
present in T
in T lymphoid
T lymphoid cells
Further we observe
we observe that
observe that TAR-deleted
that TAR-deleted mutants
TAR-deleted mutants of
mutants of HIV-1
of HIV-1 demonstrate
HIV-1 demonstrate normal
demonstrate normal late
normal late gene
late gene expression
gene expression in
expression in glial
in glial cells
glial cells as
cells as evidenced
as evidenced by
evidenced by syncytia
by syncytia formation
syncytia formation and
formation and production
and production of
production of viral
of viral p24
viral p24 antigen
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Transcription factor AP-2
factor AP-2 activates
AP-2 activates gene
activates gene expression
gene expression of
expression of HTLV-I
The HTLV-I LTR
HTLV-I LTR contains
LTR contains three
contains three conserved
three conserved regulatory
conserved regulatory elements
regulatory elements known
elements known as
known as 21
as 21 base
21 base pair
base pair repeats
pair repeats which
repeats which are
which are required
are required for
required for stimulation
for stimulation of
stimulation of gene
of gene expression
gene expression by
expression by the
by the transactivator
the transactivator protein
transactivator protein tax
Mutagenesis indicates that
indicates that the
that the 21
the 21 bp
21 bp repeats
bp repeats can
repeats can be
can be subdivided
be subdivided into
subdivided into three
into three motifs
three motifs A
motifs A B
A B and
B and C
and C each
C each of
each of which
of which influences
which influences the
influences the level
the level of
level of tax
of tax activation
The A site
A site in
site in the
in the 21
the 21 bp
21 bp repeat
bp repeat has
repeat has strong
has strong homology
strong homology with
homology with previously
with previously described
previously described binding
described binding sites
binding sites for
sites for the
for the transcription
the transcription factor
transcription factor AP-2
We demonstrated that
demonstrated that AP-2
that AP-2 mRNA
AP-2 mRNA was
mRNA was present
was present in
present in T-lymphocytes
in T-lymphocytes and
T-lymphocytes and that
and that cellular
that cellular factors
cellular factors from
factors from both
from both non-transformed
both non-transformed and
non-transformed and transformed
and transformed T-lymphocytes
transformed T-lymphocytes specifically
T-lymphocytes specifically bound
specifically bound to
bound to the
to the consensus
the consensus motif
consensus motif for
motif for AP-2
for AP-2 in
AP-2 in each
in each 21
each 21 bp
To determine the
determine the role
the role of
role of AP-2
of AP-2 in
AP-2 in the
in the regulation
the regulation of
regulation of the
of the HTLV-I
the HTLV-I LTR
HTLV-I LTR gene
LTR gene expression
gene expression we
expression we used
we used an
used an AP-2
an AP-2 cDNA
AP-2 cDNA in
cDNA in DNA
in DNA binding
DNA binding and
binding and transient
and transient expression
transient expression assays
Gel retardation and
retardation and methylation
and methylation interference
methylation interference studies
interference studies revealed
studies revealed that
revealed that bacterially
that bacterially produced
bacterially produced AP-2
produced AP-2 bound
AP-2 bound specifically
bound specifically and
specifically and with
and with high
with high affinity
high affinity to
affinity to all
to all three
all three 21
three 21 bp
21 bp repeats
bp repeats and
repeats and that
and that it
that it required
it required the
required the core
the core sequence
core sequence AGGC
sequence AGGC for
AGGC for specific
for specific binding
Binding of AP-2
of AP-2 prevented
AP-2 prevented the
prevented the subsequent
the subsequent binding
subsequent binding of
binding of members
of members of
members of the
of the CREB/ATF
the CREB/ATF family
CREB/ATF family to
family to an
to an adjacent
an adjacent regulatory
adjacent regulatory motif
regulatory motif in
motif in the
in the 21
the 21 bp
21 bp repeat
Transfection of an
of an AP-2
an AP-2 expression
AP-2 expression construct
expression construct into
construct into T-lymphocytes
into T-lymphocytes activated
T-lymphocytes activated gene
activated gene expression
gene expression from
expression from the
from the HTLV-I
the HTLV-I LTR
At least two
least two 21
two 21 bp
21 bp repeats
bp repeats were
repeats were required
were required for
required for high
for high levels
high levels of
levels of AP-2
of AP-2 activation
AP-2 activation and
activation and mutagenesis
and mutagenesis of
mutagenesis of the
of the AP-2
the AP-2 consensus
AP-2 consensus binding
consensus binding sequences
binding sequences in
sequences in the
in the 21
the 21 bp
21 bp repeats
bp repeats eliminate
repeats eliminate this
eliminate this activation
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Activation of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 enhancer
1 enhancer is
enhancer is not
is not dependent
not dependent on
dependent on NFAT-1
The function of
function of a
of a putative
a putative NFAT-1
putative NFAT-1 site
NFAT-1 site in
site in the
in the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 enhancer
1 enhancer has
enhancer has been
has been analyzed
Activation by the
by the T-cell
the T-cell antigen
T-cell antigen receptor
antigen receptor is
receptor is minimal
is minimal in
minimal in Jurkat
in Jurkat cells
Jurkat cells and
cells and is
and is mediated
is mediated by
mediated by the
by the kappa
the kappa B
kappa B sites
The putative NFAT-1
putative NFAT-1 region
NFAT-1 region is
region is not
is not required
not required for
required for the
for the response
the response to
response to anti-CD3
to anti-CD3 or
anti-CD3 or to
or to mitogens
to mitogens in
mitogens in T-cell
in T-cell B-cell
T-cell B-cell or
B-cell or monocyte/macrophage
or monocyte/macrophage leukemia
monocyte/macrophage leukemia lines
leukemia lines nor
lines nor is
nor is it
is it a
it a cis-acting
a cis-acting negative
cis-acting negative regulatory
negative regulatory element
The B cell-specific
B cell-specific nuclear
cell-specific nuclear factor
nuclear factor OTF-2
factor OTF-2 positively
OTF-2 positively regulates
positively regulates transcription
regulates transcription of
transcription of the
of the human
the human class
human class II
class II transplantation
II transplantation gene
transplantation gene DRA
The promoter of
promoter of the
of the major
the major histocompatibility
major histocompatibility class
histocompatibility class II
class II gene
II gene DRA
gene DRA contains
DRA contains an
contains an octamer
an octamer element
octamer element ATTTGCAT
element ATTTGCAT that
ATTTGCAT that is
that is required
is required for
required for efficient
for efficient DRA
efficient DRA expression
DRA expression in
expression in B
in B cells
Several DNA-binding proteins
DNA-binding proteins are
proteins are known
are known to
known to bind
to bind this
bind this sequence
The best characterized
best characterized are
characterized are the
are the B
the B cell-specific
B cell-specific OTF-2
cell-specific OTF-2 and
OTF-2 and the
and the ubiquitous
the ubiquitous OTF-1
This report directly
report directly demonstrates
directly demonstrates that
demonstrates that OTF-2
that OTF-2 but
OTF-2 but not
but not OTF-1
not OTF-1 regulates
OTF-1 regulates the
regulates the DRA
the DRA gene
In vitro transcription
vitro transcription analysis
transcription analysis using
analysis using protein
using protein fractions
protein fractions enriched
fractions enriched for
enriched for the
for the octamer-binding
the octamer-binding protein
octamer-binding protein OTF-2
protein OTF-2 demonstrate
OTF-2 demonstrate a
demonstrate a positive
a positive functional
positive functional role
functional role for
role for OTF-2
for OTF-2 in
OTF-2 in DRA
in DRA gene
DRA gene transcription
In contrast OTF-1-enriched
contrast OTF-1-enriched protein
OTF-1-enriched protein fractions
protein fractions did
fractions did not
did not affect
not affect DRA
affect DRA gene
DRA gene transcription
gene transcription although
transcription although it
although it functionally
it functionally enhanced
functionally enhanced the
enhanced the transcription
the transcription of
transcription of another
of another gene
Recombinant OTF-2 protein
OTF-2 protein produced
protein produced by
produced by in
by in vitro
in vitro transcription/translation
vitro transcription/translation could
transcription/translation could also
could also enhance
also enhance DRA
enhance DRA gene
DRA gene transcription
gene transcription in
transcription in vitro
In vivo transient
vivo transient transfection
transient transfection studies
transfection studies utilizing
studies utilizing an
utilizing an OTF-2
an OTF-2 expression
OTF-2 expression vector
expression vector resulted
vector resulted in
resulted in similar
in similar findings:
similar findings: that
findings: that OTF-2
that OTF-2 protein
OTF-2 protein enhanced
protein enhanced DRA
enhanced DRA gene
DRA gene transcription
gene transcription and
transcription and that
and that this
that this effect
this effect requires
effect requires an
requires an intact
an intact octamer
intact octamer element
Together these results
these results constitute
results constitute the
constitute the first
the first direct
first direct evidence
direct evidence of
evidence of a
of a positive
a positive role
positive role for
role for the
for the lymphoid-specific
the lymphoid-specific octamer-binding
lymphoid-specific octamer-binding factor
octamer-binding factor in
factor in DRA
in DRA gene
DRA gene transcription
Interferon-gamma potentiates the
potentiates the antiviral
the antiviral activity
antiviral activity and
activity and the
and the expression
the expression of
expression of interferon-stimulated
of interferon-stimulated genes
interferon-stimulated genes induced
genes induced by
induced by interferon-alpha
by interferon-alpha in
interferon-alpha in U937
in U937 cells
Binding of type
of type I
type I interferon
I interferon IFN-alpha/beta
interferon IFN-alpha/beta to
IFN-alpha/beta to specific
to specific receptors
specific receptors results
receptors results in
results in the
in the rapid
the rapid transcriptional
rapid transcriptional activation
transcriptional activation independent
activation independent of
independent of protein
of protein synthesis
protein synthesis of
synthesis of IFN-alpha-stimulated
of IFN-alpha-stimulated genes
IFN-alpha-stimulated genes ISGs
genes ISGs in
ISGs in human
in human fibroblasts
human fibroblasts and
fibroblasts and HeLa
and HeLa and
HeLa and Daudi
and Daudi cell
Daudi cell lines
The binding of
binding of ISGF3
of ISGF3 IFN-stimulated
ISGF3 IFN-stimulated gene
IFN-stimulated gene factor
gene factor 3
factor 3 to
3 to the
to the conserved
the conserved IFN-stimulated
conserved IFN-stimulated response
IFN-stimulated response element
response element ISRE
element ISRE results
ISRE results in
results in transcriptional
in transcriptional activation
This factor is
factor is composed
is composed of
composed of a
of a DNA-binding
a DNA-binding protein
DNA-binding protein ISGF3
protein ISGF3 gamma
ISGF3 gamma which
gamma which normally
which normally is
normally is present
is present in
present in the
in the cytoplasm
the cytoplasm and
cytoplasm and other
and other IFN-alpha-activated
other IFN-alpha-activated proteins
IFN-alpha-activated proteins which
proteins which preexist
which preexist as
preexist as latent
as latent cytoplasmic
latent cytoplasmic precursors
cytoplasmic precursors ISGF3
precursors ISGF3 alpha
We have found
have found that
found that ISG
that ISG expression
ISG expression in
expression in the
in the monocytic
the monocytic U937
monocytic U937 cell
U937 cell line
cell line differs
line differs from
differs from most
from most cell
most cell lines
cell lines previously
lines previously examined
U937 cells express
cells express both
express both type
both type I
type I and
I and type
and type II
type II IFN
II IFN receptors
IFN receptors but
receptors but only
but only IFN-alpha
only IFN-alpha is
IFN-alpha is capable
is capable of
capable of inducing
of inducing antiviral
inducing antiviral protection
antiviral protection in
protection in these
in these cells
Pretreatment with IFN-gamma
with IFN-gamma potentiates
IFN-gamma potentiates the
potentiates the IFN-alpha-induced
the IFN-alpha-induced protection
IFN-alpha-induced protection but
protection but IFN-gamma
but IFN-gamma alone
IFN-gamma alone does
alone does not
does not have
not have any
have any antiviral
any antiviral activity
ISG15 mRNA accumulation
mRNA accumulation in
accumulation in U937
in U937 cells
U937 cells is
cells is not
is not detectable
not detectable before
detectable before 6
before 6 h
6 h of
h of IFN-alpha
of IFN-alpha treatment
IFN-alpha treatment peaks
treatment peaks at
peaks at 24
at 24 h
24 h and
h and requires
and requires protein
requires protein synthesis
Although IFN-gamma alone
IFN-gamma alone does
alone does not
does not induce
not induce ISG
induce ISG expression
ISG expression IFN-gamma
expression IFN-gamma pretreatment
IFN-gamma pretreatment markedly
pretreatment markedly increases
markedly increases and
increases and hastens
and hastens ISG
hastens ISG expression
ISG expression and
expression and transcriptional
and transcriptional induction
Nuclear extracts assayed
extracts assayed for
assayed for the
for the presence
the presence of
presence of ISRE
of ISRE binding
ISRE binding factors
binding factors by
factors by electrophoretic
by electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
shift assays show
assays show that
show that ISGF3
that ISGF3 is
ISGF3 is induced
is induced by
induced by IFN-alpha
by IFN-alpha within
IFN-alpha within 6
within 6 h
6 h from
h from undetectable
from undetectable basal
undetectable basal levels
basal levels in
levels in untreated
in untreated U937
untreated U937 cells
Activation of ISGF3
of ISGF3 alpha
ISGF3 alpha the
alpha the latent
the latent component
latent component of
component of ISGF3
of ISGF3 occurs
ISGF3 occurs rapidly
However the increase
the increase in
increase in ISGF3
in ISGF3 activity
ISGF3 activity ultimately
activity ultimately correlates
ultimately correlates with
correlates with the
with the accumulation
the accumulation of
accumulation of ISGF3
of ISGF3 gamma
ISGF3 gamma induced
gamma induced by
induced by IFN-alpha
by IFN-alpha or
IFN-alpha or IFN-gamma
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Single point estimation
point estimation of
estimation of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in lymphocytes
in lymphocytes of
lymphocytes of normal
of normal subjects
normal subjects and
subjects and of
and of children
of children under
children under long
under long term
long term glucocorticoid
term glucocorticoid treatment
A single point
single point assay
point assay of
assay of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors GR
receptors GR in
GR in human
in human lymphocytes
human lymphocytes based
lymphocytes based on
based on the
on the measurement
the measurement of
measurement of specific
of specific dexamethasone
specific dexamethasone binding
dexamethasone binding has
binding has been
has been developed
been developed and
developed and compared
and compared with
compared with a
with a common
a common multi-point
common multi-point Scatchard
multi-point Scatchard analysis
The assay conditions-concentration
assay conditions-concentration of
conditions-concentration of the
of the ligand
the ligand 20
ligand 20 nmol/l
20 nmol/l incubation
nmol/l incubation time
incubation time 2
time 2 h
2 h and
h and the
and the cell
the cell count
cell count 2-6
count 2-6 mil
cells/tube in the
in the assay
the assay volume
assay volume 025
volume 025 ml
025 ml were
ml were found
were found to
found to be
to be optimal
An attempt was
attempt was also
was also undertaken
also undertaken to
undertaken to use
to use a
use a cell
a cell harvester
cell harvester for
harvester for the
for the separation
the separation of
separation of cells
of cells from
cells from unbound
from unbound ligand
Though specifically bound
specifically bound dexamethasone
bound dexamethasone measured
dexamethasone measured by
measured by whole-cell
by whole-cell assay
whole-cell assay and
assay and that
and that using
that using cell
using cell harvester
cell harvester correlated
harvester correlated well
correlated well almost
well almost by
almost by one
by one order
one order lower
order lower values
lower values obtained
values obtained with
obtained with the
with the latter
the latter method
latter method render
method render it
render it non-applicable
it non-applicable for
non-applicable for receptor
for receptor quantitation
The results from
results from 9
from 9 healthy
9 healthy volunteers
healthy volunteers average
volunteers average GR
average GR concentration
GR concentration 7131
concentration 7131 +/-
7131 +/- 1256
+/- 1256 sites/cell
1256 sites/cell correlated
sites/cell correlated excellently
correlated excellently with
excellently with those
with those obtained
those obtained by
obtained by the
by the Scatchard
the Scatchard analysis
The single point
single point assay
point assay has
assay has been
has been also
been also applied
also applied for
applied for determination
for determination of
determination of GH
of GH in
GH in 10
in 10 children
10 children treated
children treated with
treated with large
with large doses
large doses of
doses of prednisone
The average values
average values from
values from healthy
from healthy volunteers
healthy volunteers did
volunteers did not
did not differ
not differ significantly
differ significantly from
significantly from those
from those found
those found in
found in these
in these children
these children though
children though much
though much broader
much broader range
broader range was
range was found
was found in
found in patients
Glucocorticoid receptor and
receptor and inhibition
and inhibition of
inhibition of 3-O-methyl-D-glucose
of 3-O-methyl-D-glucose uptake
3-O-methyl-D-glucose uptake by
uptake by glucocorticoids
by glucocorticoids in
glucocorticoids in peripheral
in peripheral blood
peripheral blood leukocytes
blood leukocytes from
leukocytes from normal
from normal humans:
normal humans: correlation
humans: correlation between
correlation between receptor
between receptor level
receptor level and
level and hormone
and hormone effect
hormone effect in
effect in vitro
We have measured
have measured the
measured the glucocorticoid
the glucocorticoid receptor
glucocorticoid receptor concentration
receptor concentration in
concentration in mononuclear
in mononuclear and
mononuclear and polymorphonuclear
and polymorphonuclear leukocytes
polymorphonuclear leukocytes both
leukocytes both of
both of which
of which were
which were isolated
were isolated from
isolated from peripheral
from peripheral blood
peripheral blood from
blood from ten
from ten healthy
ten healthy male
healthy male volunteers
In parallel the
parallel the inhibitory
the inhibitory effect
inhibitory effect of
effect of dexamethasone
of dexamethasone on
dexamethasone on 3-O-methyl-D-glucose
on 3-O-methyl-D-glucose uptake
3-O-methyl-D-glucose uptake was
uptake was assayed
was assayed in
assayed in the
in the corresponding
the corresponding mononuclear
corresponding mononuclear leukocytes
The glucocorticoid receptor
glucocorticoid receptor levels
receptor levels in
levels in mononuclear
in mononuclear leukocytes
mononuclear leukocytes correlated
leukocytes correlated with
correlated with those
with those in
those in polymorphonuclear
in polymorphonuclear leukocytes
polymorphonuclear leukocytes and
leukocytes and there
and there was
there was a
was a linear
a linear relationship
linear relationship between
relationship between the
between the cellular
the cellular glucocorticoid
cellular glucocorticoid receptor
glucocorticoid receptor levels
receptor levels and
levels and glucocorticoid-mediated
and glucocorticoid-mediated inhibition
glucocorticoid-mediated inhibition of
inhibition of the
of the uptake
the uptake of
uptake of 3-O-methyl-D-glucose
of 3-O-methyl-D-glucose in
3-O-methyl-D-glucose in mononuclear
in mononuclear leukocytes
When mononuclear leukocytes
mononuclear leukocytes were
leukocytes were incubated
were incubated in
incubated in the
in the presence
the presence of
presence of 8-bromo-cAMP
of 8-bromo-cAMP cellular
8-bromo-cAMP cellular glucocorticoid
cellular glucocorticoid receptor
glucocorticoid receptor levels
receptor levels increased
levels increased and
increased and a
and a more
a more pronounced
more pronounced inhibitory
pronounced inhibitory effect
inhibitory effect of
effect of dexamethasone
of dexamethasone was
dexamethasone was observed
was observed on
observed on the
on the transport
the transport of
transport of 3-O-methyl-D-glucose
We conclude that
conclude that the
that the cellular
the cellular glucocorticoid
cellular glucocorticoid receptor
glucocorticoid receptor levels
receptor levels in
levels in peripheral
in peripheral blood
peripheral blood leukocytes
blood leukocytes reflect
leukocytes reflect in
reflect in vitro
in vitro responsiveness
vitro responsiveness to
responsiveness to glucocorticoids
to glucocorticoids in
glucocorticoids in mononuclear
in mononuclear leukocytes
mononuclear leukocytes from
leukocytes from healthy
from healthy males
healthy males and
males and that
and that the
that the individual
the individual responsiveness
individual responsiveness may
responsiveness may alter
may alter upon
alter upon changes
upon changes in
changes in the
in the cellular
the cellular levels
cellular levels of
levels of glucocorticoid
of glucocorticoid receptor
Transcription factor activation
factor activation and
activation and functional
and functional stimulation
functional stimulation of
stimulation of human
of human monocytes
Activation of expression
of expression of
expression of genes
of genes encoding
genes encoding transcription
encoding transcription factors:
transcription factors: c-fos
factors: c-fos and
c-fos and c-jun
and c-jun and
c-jun and formation
and formation of
formation of AP1
of AP1 transcriptional
AP1 transcriptional complex
transcriptional complex in
complex in human
in human monocytes
human monocytes was
monocytes was investigated
It was found
was found that
found that lipopolysaccharide
that lipopolysaccharide induced
lipopolysaccharide induced strongly
induced strongly both
strongly both c-fos
both c-fos and
c-fos and c-jun
and c-jun expression
c-jun expression as
expression as well
as well as
well as AP1
as AP1 formation
Interferon gamma activated
gamma activated strongly
activated strongly c-fos
strongly c-fos and
c-fos and weakly
and weakly c-jun
weakly c-jun and
c-jun and AP1
Tumor necrosis factor
necrosis factor induced
factor induced slightly
induced slightly c-fos
slightly c-fos and
c-fos and had
and had almost
had almost no
almost no effect
no effect on
effect on c-jun
on c-jun and
c-jun and AP1
The data suggest
data suggest that
suggest that differences
that differences in
differences in functional
in functional responses
functional responses elicited
responses elicited in
elicited in monocytes
in monocytes by
monocytes by all
by all three
all three factors
three factors may
factors may be
may be dependent
be dependent on
dependent on different
on different routes
different routes on
routes on nuclear
on nuclear signalling
nuclear signalling employed
signalling employed by
employed by the
by the factors
Regulation of interleukin-1
of interleukin-1 beta
interleukin-1 beta production
beta production by
production by glucocorticoids
by glucocorticoids in
glucocorticoids in human
in human monocytes:
human monocytes: the
monocytes: the mechanism
the mechanism of
mechanism of action
of action depends
action depends on
depends on the
on the activation
the activation signal
Glucocorticoids are known
are known to
known to downregulate
to downregulate interleukin-1
downregulate interleukin-1 beta
interleukin-1 beta production
beta production in
production in monocytic
in monocytic cells
monocytic cells by
cells by two
by two different
two different mechanims:
different mechanims: direct
mechanims: direct inhibition
direct inhibition of
inhibition of the
of the gene
the gene transcription
gene transcription and
transcription and destabilization
and destabilization of
destabilization of the
of the preformed
the preformed interleukin-1
preformed interleukin-1 beta
interleukin-1 beta mRNA
Now we have
we have examined
have examined the
examined the effect
the effect of
effect of the
of the nature
the nature of
nature of the
of the monocyte
the monocyte activating
monocyte activating signal
activating signal on
signal on these
on these two
these two inhibitory
two inhibitory mechanims
When human monocytes
human monocytes were
monocytes were preincubated
were preincubated with
preincubated with dexamethasone
with dexamethasone for
dexamethasone for 1
for 1 hour
1 hour and
hour and then
and then stimulated
then stimulated either
stimulated either with
either with bacterial
with bacterial lipopolysaccharide
bacterial lipopolysaccharide or
lipopolysaccharide or phorbol
or phorbol myristate
phorbol myristate it
myristate it was
it was found
was found that
found that dexamethasone
that dexamethasone inhibited
dexamethasone inhibited the
inhibited the lipopolysaccharide-induced
the lipopolysaccharide-induced interleukin-1
lipopolysaccharide-induced interleukin-1 beta
interleukin-1 beta protein
beta protein production
protein production but
production but the
but the phorbol
the phorbol myristate-induced
phorbol myristate-induced production
myristate-induced production was
production was increased
was increased 3-10
increased 3-10 fold
This difference was
difference was also
was also seen
also seen at
seen at the
at the mRNA
the mRNA level
When dexamethasone was
dexamethasone was added
was added to
added to the
to the cultures
the cultures 3
cultures 3 hours
3 hours after
hours after the
after the stimulators
the stimulators it
stimulators it clearly
it clearly decreased
clearly decreased the
decreased the interleukin-1
the interleukin-1 beta
interleukin-1 beta mRNA
beta mRNA levels
mRNA levels regardless
levels regardless of
regardless of the
of the stimulator
the stimulator used
stimulator used although
used although the
although the effect
the effect was
effect was clearly
was clearly weaker
clearly weaker on
weaker on the
on the PMA-induced
the PMA-induced mRNA
Thus these data
these data suggest
data suggest that
suggest that the
that the phorbol
the phorbol myristate-induced
phorbol myristate-induced signal
myristate-induced signal prolonged
signal prolonged protein
prolonged protein kinase
protein kinase C
kinase C activation?
C activation? cannot
activation? cannot be
cannot be inhibited
be inhibited by
inhibited by prior
by prior incubation
prior incubation with
incubation with dexamethasone
with dexamethasone and
dexamethasone and it
and it also
it also protects
also protects the
protects the induced
the induced mRNA
induced mRNA for
mRNA for the
for the degradative
the degradative action
degradative action of
action of dexamethasone
Nuclear transcription factors
transcription factors that
factors that bind
that bind to
bind to elements
to elements of
elements of the
of the IL-2
the IL-2 promoter
Induction requirements in
requirements in primary
in primary human
primary human T
human T cells
Prior studies have
studies have identified
have identified several
identified several elements
several elements that
elements that contribute
that contribute to
contribute to the
to the activity
the activity of
activity of the
of the IL-2
the IL-2 promoter
IL-2 promoter in
promoter in the
in the stimulated
the stimulated T
stimulated T cell
T cell line
cell line Jurkat
The sites and
sites and their
and their corresponding
their corresponding nuclear
corresponding nuclear binding
nuclear binding factors
binding factors include:
factors include: NF-kappa
include: NF-kappa B
NF-kappa B AP-1
B AP-1 AP-3
AP-1 AP-3 OCT-1
AP-3 OCT-1 and
OCT-1 and NF-AT
The latter "nuclear
latter "nuclear factor
"nuclear factor for
factor for activated
for activated T
activated T cells"
T cells" likely
cells" likely contributes
likely contributes to
contributes to the
to the tissue
the tissue specificity
tissue specificity of
specificity of IL-2
of IL-2 gene
IL-2 gene expression
Using electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
shift assays we
assays we have
we have studied
have studied these
studied these transcription
these transcription factors
transcription factors in
factors in primary
in primary T
primary T cells
T cells from
cells from human
from human blood
human blood to
blood to verify
to verify their
verify their presence
their presence in
presence in a
in a physiologic
a physiologic setting
physiologic setting and
setting and to
and to identify
to identify the
identify the signals
the signals that
signals that stimulate
that stimulate factor
stimulate factor activity
All factors are
factors are induced
are induced in
induced in the
in the nuclei
the nuclei of
nuclei of T
of T cells
T cells upon
cells upon activation
upon activation with
activation with mitogens
with mitogens but
mitogens but not
but not with
not with exogenous
with exogenous IL-2
exogenous IL-2 growth
IL-2 growth factor
However the signaling
the signaling requirements
signaling requirements and
requirements and sensitivity
and sensitivity to
sensitivity to protein
to protein synthesis
protein synthesis inhibitors
synthesis inhibitors differ
inhibitors differ considerably
Only the activities
the activities for
activities for NF-AT
for NF-AT and
NF-AT and AP-1
and AP-1 sites
AP-1 sites require
sites require two
require two signals
two signals for
signals for optimal
for optimal induction
optimal induction ie
induction ie PMA
ie PMA plus
PMA plus either
plus either lectin
either lectin or
lectin or antibody
or antibody to
antibody to the
to the CD3
the CD3 or
CD3 or CD28
or CD28 surface
CD28 surface molecules
Other factors are
factors are induced
are induced by
induced by lectin
by lectin antibody
lectin antibody and/or
antibody and/or PMA
and/or PMA alone
After appropriate stimulation
appropriate stimulation both
stimulation both NF-AT
both NF-AT and
NF-AT and AP-1
and AP-1 are
AP-1 are peculiarly
are peculiarly sensitive
peculiarly sensitive to
sensitive to the
to the protein
the protein synthesis
protein synthesis inhibitor
synthesis inhibitor anisomycin
Our data correlate
data correlate the
correlate the activity
the activity of
activity of NF-AT
of NF-AT and
NF-AT and AP-1
and AP-1 in
AP-1 in gel
in gel shift
gel shift assays
shift assays with
assays with the
with the two
the two signals
two signals requirements
signals requirements for
requirements for IL-2
for IL-2 gene
IL-2 gene expression
NF-kappa B activity
B activity in
activity in T
in T cells
T cells stably
cells stably expressing
stably expressing the
expressing the Tax
the Tax protein
Tax protein of
protein of human
of human T
human T cell
T cell lymphotropic
cell lymphotropic virus
lymphotropic virus type
virus type I
The effect of
effect of constitutive
of constitutive Tax
constitutive Tax expression
Tax expression on
expression on the
on the interaction
the interaction of
interaction of NF-kappa
of NF-kappa B
NF-kappa B with
B with its
with its recognition
its recognition sequence
recognition sequence and
sequence and on
and on NF-kappa
on NF-kappa B-dependent
NF-kappa B-dependent gene
B-dependent gene expression
gene expression was
expression was examined
was examined in
examined in T
in T lymphoid
T lymphoid Jurkat
lymphoid Jurkat cell
Jurkat cell lines
cell lines 19D
lines 19D and
19D and 9J
and 9J stably
9J stably transformed
stably transformed with
transformed with a
with a Tax
a Tax expression
Tax expression vector
Tax expressing T
expressing T cell
T cell lines
cell lines contained
lines contained a
contained a constitutive
a constitutive level
constitutive level of
level of NF-kappa
of NF-kappa B
NF-kappa B binding
B binding activity
binding activity detectable
activity detectable by
detectable by mobility
by mobility shift
mobility shift assay
shift assay and
assay and uv
and uv cross-linking
uv cross-linking using
cross-linking using a
using a palindromic
a palindromic NF-kappa
palindromic NF-kappa B
NF-kappa B probe
B probe homologous
probe homologous to
homologous to the
to the interferon
the interferon beta
interferon beta PRDII
beta PRDII site
In Jurkat and
Jurkat and NC210
and NC210 induction
NC210 induction with
induction with phorbol
with phorbol esters
phorbol esters resulted
esters resulted in
resulted in the
in the appearance
the appearance of
appearance of new
of new DNA
new DNA binding
DNA binding proteins
binding proteins of
proteins of 85
of 85 75
85 75 and
75 and 54
and 54 kDa
54 kDa whereas
kDa whereas in
whereas in Tax
in Tax expressing
Tax expressing cells
expressing cells the
cells the 85-kDa
the 85-kDa protein
85-kDa protein and
protein and a
and a 92-kDa
a 92-kDa DNA
92-kDa DNA binding
DNA binding protein
binding protein were
protein were constitutively
were constitutively induced
Expression of Tax
of Tax protein
Tax protein in
protein in 19D
in 19D and
19D and 9J
and 9J resulted
9J resulted in
resulted in transcription
in transcription of
transcription of the
of the endogenous
the endogenous NF-kappa
endogenous NF-kappa B-dependent
NF-kappa B-dependent granulocyte-macrophage
B-dependent granulocyte-macrophage colony
granulocyte-macrophage colony stimulating
colony stimulating factor
stimulating factor gene
factor gene and
gene and increased
and increased basal
increased basal level
basal level expression
level expression of
expression of transfected
of transfected NF-kappa
transfected NF-kappa B-regulated
NF-kappa B-regulated promoters
Nonetheless transcription of
transcription of both
of both the
both the endogenous
the endogenous and
endogenous and the
and the transfected
the transfected gene
transfected gene was
gene was inducible
was inducible by
inducible by PMA
by PMA treatment
Tax expression in
expression in Jurkat
in Jurkat T
Jurkat T cells
T cells may
cells may alter
may alter the
alter the stoichiometry
the stoichiometry of
stoichiometry of NF-kappa
of NF-kappa B
NF-kappa B DNA
B DNA binding
DNA binding proteins
binding proteins and
proteins and thus
and thus change
thus change the
change the expression
the expression of
expression of NF-kappa
of NF-kappa B-regulated
NF-kappa B-regulated promoters
A nuclear factor
nuclear factor NF-GM2
factor NF-GM2 that
NF-GM2 that interacts
that interacts with
interacts with a
with a regulatory
a regulatory region
regulatory region of
region of the
of the GM-CSF
the GM-CSF gene
GM-CSF gene essential
gene essential for
essential for its
for its induction
its induction in
induction in responses
in responses to
responses to T-cell
to T-cell activation:
T-cell activation: purification
activation: purification from
purification from human
from human T-cell
human T-cell leukemia
T-cell leukemia line
leukemia line Jurkat
line Jurkat cells
Jurkat cells and
cells and similarity
and similarity to
similarity to NF-kappa
to NF-kappa B
Activation of T
of T cells
T cells by
cells by antigen
by antigen lectin
antigen lectin or
lectin or a
or a combination
a combination of
combination of phorbol-12-myristate
of phorbol-12-myristate acetate
phorbol-12-myristate acetate PMA
acetate PMA and
PMA and calcium
and calcium ionophore
calcium ionophore A23187
ionophore A23187 leads
A23187 leads to
leads to the
to the induction
the induction of
induction of genes
of genes for
genes for a
for a set
a set of
set of lymphokines
of lymphokines including
lymphokines including granulocyte-macrophage
including granulocyte-macrophage colony-stimulating
granulocyte-macrophage colony-stimulating factor
colony-stimulating factor GM-CSF
We demonstrated in
demonstrated in earlier
in earlier studies
earlier studies that
studies that the
that the upstream
the upstream region
upstream region of
region of the
of the mouse
the mouse GM-CSF
mouse GM-CSF promoter
GM-CSF promoter at
promoter at positions
at positions between
positions between -95
between -95 and
-95 and -73
and -73 is
-73 is essential
is essential for
essential for transcriptional
for transcriptional activation
transcriptional activation in
activation in response
in response to
response to PMA/A23187
This region contains
region contains two
contains two DNA-binding
two DNA-binding motifs
DNA-binding motifs GM2
motifs GM2 and
GM2 and GC-box
The GM2 sequence
GM2 sequence GGTAGTTCCC
sequence GGTAGTTCCC is
GGTAGTTCCC is recognized
is recognized by
recognized by an
by an inducible
an inducible factor
inducible factor NF-GM2;
factor NF-GM2; the
NF-GM2; the other
the other CCGCCC
other CCGCCC by
CCGCCC by constitutive
by constitutive factors
constitutive factors A1
factors A1 A2
A1 A2 and
A2 and B
To elucidate the
elucidate the mechanism
the mechanism of
mechanism of GM-CSF
of GM-CSF gene
GM-CSF gene activation
gene activation we
activation we have
we have purified
have purified the
purified the inducible
the inducible factor
inducible factor NF-GM2
factor NF-GM2 from
NF-GM2 from the
from the nuclear
the nuclear extract
nuclear extract of
extract of stimulated
of stimulated Jurkat
stimulated Jurkat cells
Jurkat cells on
cells on the
on the basis
the basis of
basis of specific
of specific DNA-binding
specific DNA-binding activity
The purified NF-GM2
purified NF-GM2 consists
NF-GM2 consists of
consists of 50
of 50 p50
50 p50 and
p50 and 65
and 65 kDa
65 kDa p65
kDa p65 polypeptides
p65 polypeptides and
polypeptides and has
and has a
has a binding
a binding activity
binding activity specific
activity specific for
specific for both
for both the
both the GM-CSF
the GM-CSF and
GM-CSF and immunoglobulin
and immunoglobulin kappa
immunoglobulin kappa GGAAAGTCCC
kappa GGAAAGTCCC enhancers
Electrophoretically purified p50
purified p50 alone
p50 alone can
alone can form
can form a
form a protein-DNA
a protein-DNA complex
protein-DNA complex but
complex but in
but in the
in the mixture
the mixture p50
mixture p50 associates
p50 associates preferentially
associates preferentially with
preferentially with p65
with p65 to
p65 to form
to form the
form the NF-GM2
the NF-GM2 complex
In addition p65
addition p65 gave
p65 gave per
gave per se
per se with
se with low
with low affinity
low affinity a
affinity a protein-DNA
a protein-DNA complex
protein-DNA complex that
complex that migrated
that migrated more
migrated more slowly
more slowly than
slowly than native
than native NF-GM2
native NF-GM2 complex
Furthermore an antiserum
an antiserum against
antiserum against KBF1
against KBF1 identical
KBF1 identical to
identical to 50
to 50 kDa
50 kDa NF-kappa
kDa NF-kappa B
NF-kappa B protein
B protein reacted
protein reacted with
reacted with the
with the p50
the p50 of
p50 of NF-GM2
of NF-GM2 indicating
NF-GM2 indicating that
indicating that the
that the NF-GM2
the NF-GM2 polypeptide
NF-GM2 polypeptide cannot
polypeptide cannot be
cannot be immunologically
be immunologically differentiated
immunologically differentiated from
differentiated from the
from the 50
the 50 kDa
50 kDa subunit
kDa subunit of
subunit of NF-kappa
of NF-kappa B
The purified NF-GM2
purified NF-GM2 activated
NF-GM2 activated in
activated in vitro
in vitro transcription
vitro transcription from
transcription from the
from the kappa
the kappa B
kappa B enhancer
B enhancer while
enhancer while it
while it failed
it failed to
failed to stimulate
to stimulate transcription
stimulate transcription from
transcription from the
from the GM-CSF
the GM-CSF promoter
GM-CSF promoter harboring
promoter harboring the
harboring the GM2
the GM2 sequence
This suggests that
suggests that the
that the activation
the activation mechanism
activation mechanism of
mechanism of the
of the GM-CSF
the GM-CSF gene
GM-CSF gene through
gene through the
through the GM2/GC-box
the GM2/GC-box sequence
GM2/GC-box sequence is
sequence is different
is different from
different from that
from that of
that of genes
of genes carrying
genes carrying the
carrying the kappa
the kappa B
kappa B enhancer
B enhancer alone
Characterization of an
of an immediate-early
an immediate-early gene
immediate-early gene induced
gene induced in
induced in adherent
in adherent monocytes
adherent monocytes that
monocytes that encodes
that encodes I
encodes I kappa
I kappa B-like
kappa B-like activity
We have cloned
have cloned a
cloned a group
a group of
group of cDNAs
of cDNAs representing
cDNAs representing mRNAs
representing mRNAs that
mRNAs that are
that are rapidly
are rapidly induced
rapidly induced following
induced following adherence
following adherence of
adherence of human
of human monocytes
One of the
of the induced
the induced transcripts
induced transcripts MAD-3
transcripts MAD-3 encodes
MAD-3 encodes a
encodes a protein
a protein of
protein of 317
of 317 amino
317 amino acids
amino acids with
acids with one
with one domain
one domain containing
domain containing five
containing five tandem
five tandem repeats
tandem repeats of
repeats of the
of the cdc10/ankyrin
the cdc10/ankyrin motif
cdc10/ankyrin motif which
motif which is
which is 60%
is 60% similar
60% similar 46%
similar 46% identical
46% identical to
identical to the
to the ankyrin
the ankyrin repeat
ankyrin repeat region
repeat region of
region of the
of the precursor
the precursor of
precursor of NF-kappa
of NF-kappa B/KBF1
NF-kappa B/KBF1 p50
The C-terminus has
C-terminus has a
has a putative
a putative protein
putative protein kinase
protein kinase C
kinase C phosphorylation
C phosphorylation site
In vitro translated
vitro translated MAD-3
translated MAD-3 protein
MAD-3 protein was
protein was found
was found to
found to specifically
to specifically inhibit
specifically inhibit the
inhibit the DNA-binding
the DNA-binding activity
DNA-binding activity of
activity of the
of the p50/p65
the p50/p65 NF-kappa
p50/p65 NF-kappa B
NF-kappa B complex
B complex but
complex but not
but not that
not that of
that of the
of the p50/p50
the p50/p50 KBF1
p50/p50 KBF1 factor
KBF1 factor or
factor or of
or of other
of other DNA-binding
other DNA-binding proteins
The MAD-3 cDNA
MAD-3 cDNA encodes
cDNA encodes an
encodes an I
an I kappa
I kappa B-like
kappa B-like protein
B-like protein that
protein that is
that is likely
is likely to
likely to be
to be involved
be involved in
involved in regulation
in regulation of
regulation of transcriptional
of transcriptional responses
transcriptional responses to
responses to NF-kappa
to NF-kappa B
NF-kappa B including
B including adhesion-dependent
including adhesion-dependent pathways
adhesion-dependent pathways of
pathways of monocyte
of monocyte activation
Cortivazol mediated induction
mediated induction of
induction of glucocorticoid
of glucocorticoid receptor
glucocorticoid receptor messenger
receptor messenger ribonucleic
messenger ribonucleic acid
ribonucleic acid in
acid in wild-type
in wild-type and
wild-type and dexamethasone-resistant
and dexamethasone-resistant human
dexamethasone-resistant human leukemic
human leukemic CEM
leukemic CEM cells
Cortivazol is a
is a phenylpyrazolo
a phenylpyrazolo glucocorticoid
phenylpyrazolo glucocorticoid of
glucocorticoid of high
of high potency
high potency and
potency and unusual
and unusual structure
In both wild-type
both wild-type and
wild-type and highly
and highly dexamethasonedex-resistant
highly dexamethasonedex-resistant clones
dexamethasonedex-resistant clones of
clones of the
of the human
the human leukemic
human leukemic cell
leukemic cell line
cell line CEM
line CEM exposure
CEM exposure to
exposure to cortivazol
to cortivazol leads
cortivazol leads to
leads to cell
to cell death
It has been
has been shown
been shown recently
shown recently that
recently that in
that in wild-type
in wild-type CEM
wild-type CEM cells
CEM cells but
cells but not
but not in
not in a
in a dex-resistant
a dex-resistant glucocorticoid
dex-resistant glucocorticoid receptorGR-defective
glucocorticoid receptorGR-defective clone
receptorGR-defective clone ICR-27
clone ICR-27 TK-3
ICR-27 TK-3 dex
TK-3 dex induces
dex induces GR
induces GR mRNA
To test the
test the hypothesis
the hypothesis that
hypothesis that cortivazol
that cortivazol acts
cortivazol acts in
acts in dex-resistant
in dex-resistant cells
dex-resistant cells by
cells by making
by making use
making use of
use of the
of the residual
the residual GR
residual GR found
GR found there
found there wild-type
there wild-type and
wild-type and dex-resistant
and dex-resistant clones
dex-resistant clones were
clones were treated
were treated with
treated with various
with various concentrations
various concentrations of
concentrations of cortivazol
of cortivazol and
cortivazol and induction
and induction of
induction of GR
of GR mRNA
GR mRNA was
mRNA was studied
Cortivazol significantly induced
significantly induced GR
induced GR mRNA
GR mRNA in
mRNA in the
in the normal
the normal CEM-C7
normal CEM-C7 as
CEM-C7 as well
as well as
well as in
as in two
in two classes
two classes of
classes of dex-resistant
of dex-resistant clones
dex-resistant clones although
clones although the
although the dex-resistant
the dex-resistant clones
dex-resistant clones needed
clones needed at
needed at least
at least 10
least 10 times
10 times more
times more cortivazol
more cortivazol than
cortivazol than the
than the normal
the normal cells
normal cells for
cells for significant
for significant GR
significant GR mRNA
GR mRNA induction
Increased levels of
levels of GR
of GR mRNA
GR mRNA were
mRNA were noticed
were noticed as
noticed as early
as early as
early as 3
as 3 h
3 h after
h after treatment
A general correlation
general correlation between
correlation between induction
between induction of
induction of GR
of GR mRNA
GR mRNA and
mRNA and lysis
and lysis of
lysis of the
of the normal
the normal and
normal and dex-resistant
and dex-resistant cells
dex-resistant cells was
cells was found
Positive induction of
induction of GR
of GR mRNA
GR mRNA might
mRNA might be
might be one
be one of
one of the
of the earliest
the earliest crucial
earliest crucial steps
crucial steps in
steps in the
in the lysis
the lysis of
lysis of normal
of normal and
normal and dex-resistant
and dex-resistant CEM
dex-resistant CEM cells
CEM cells or
cells or might
or might serve
might serve as
serve as a
as a marker
a marker for
marker for the
for the process
However the lysis
the lysis pathway
lysis pathway in
pathway in the
in the dex-resistant
the dex-resistant cells
dex-resistant cells is
cells is defective
is defective in
defective in that
in that dex-resistant
that dex-resistant clones
dex-resistant clones needed
clones needed significantly
needed significantly more
significantly more cortivazol
more cortivazol than
cortivazol than the
than the normal
the normal cells
normal cells for
cells for lysis
for lysis of
lysis of the
of the cells
HIV enhancer activity
enhancer activity perpetuated
activity perpetuated by
perpetuated by NF-kappa
by NF-kappa B
NF-kappa B induction
B induction on
induction on infection
on infection of
infection of monocytes
of monocytes [see
monocytes [see comments]
Permissiveness to replication
to replication of
replication of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV differs
HIV differs in
differs in T
in T lymphocytes
T lymphocytes and
lymphocytes and macrophages
In T cells
T cells HIV
cells HIV transcription
HIV transcription is
transcription is poorly
is poorly detected
poorly detected in
detected in vivo
Cloned normal T
normal T lymphocytes
T lymphocytes show
lymphocytes show very
show very little
very little if
little if any
if any basal
any basal activity
basal activity of
activity of the
of the HIV
the HIV enhancer
HIV enhancer and
enhancer and low
and low nuclear
low nuclear expression
nuclear expression of
expression of NF-kappa
of NF-kappa B
NF-kappa B a
B a potent
a potent transcriptional
potent transcriptional activator
transcriptional activator of
activator of the
of the HIV
the HIV enhancer
In contrast fixed
contrast fixed tissue
fixed tissue macrophages
tissue macrophages express
macrophages express detectable
express detectable HIV
detectable HIV proteins
HIV proteins indicating
proteins indicating permanent
indicating permanent virus
permanent virus transcription
One explanation for
explanation for the
for the perpetuation
the perpetuation of
perpetuation of virus
of virus infection
virus infection in
infection in macrophages
in macrophages could
macrophages could be
could be sustained
be sustained nuclear
sustained nuclear NF-kappa
nuclear NF-kappa B
NF-kappa B expression
However the U937
the U937 monocytic
U937 monocytic cell
monocytic cell line
cell line which
line which is
which is fully
is fully permissive
fully permissive to
permissive to HIV
to HIV replication
HIV replication is
replication is known
is known to
known to express
to express only
express only low
only low levels
low levels of
levels of nuclear
of nuclear NF-kappa
nuclear NF-kappa B
We show here
show here that
here that chronic
that chronic HIV
chronic HIV infection
HIV infection results
infection results in
results in both
in both induction
both induction of
induction of a
of a nuclear
a nuclear factor
nuclear factor with
factor with antigenic
with antigenic properties
antigenic properties indistinguishable
properties indistinguishable from
indistinguishable from those
from those of
those of NF-kappa
of NF-kappa B
NF-kappa B and
B and permanently
and permanently increased
permanently increased HIV
increased HIV enhancer
HIV enhancer activity
This phenomenon which
phenomenon which is
which is independent
is independent of
independent of tumour
of tumour necrosis
tumour necrosis factor
necrosis factor is
factor is associated
is associated with
associated with HIV
with HIV replication
HIV replication and
replication and is
and is thus
is thus likely
thus likely to
likely to explain
to explain at
explain at least
at least in
least in part
in part the
part the perpetuation
the perpetuation of
perpetuation of HIV
of HIV infection
HIV infection in
infection in monocytes
Isolation of a
of a rel-related
a rel-related human
rel-related human cDNA
human cDNA that
cDNA that potentially
that potentially encodes
potentially encodes the
encodes the 65-kD
the 65-kD subunit
65-kD subunit of
subunit of NF-kappa
of NF-kappa B
NF-kappa B [published
B [published erratum
[published erratum appears
erratum appears in
appears in Science
in Science 1991
Science 1991 Oct
1991 Oct 4;2545028:11]
A DNA probe
DNA probe that
probe that spanned
that spanned a
spanned a domain
a domain conserved
domain conserved among
conserved among the
among the proto-oncogene
the proto-oncogene c-rel
proto-oncogene c-rel the
c-rel the Drosophila
the Drosophila morphogen
Drosophila morphogen dorsal
morphogen dorsal and
dorsal and the
and the p50
the p50 DNA
p50 DNA binding
DNA binding subunit
binding subunit of
subunit of NF-kappa
of NF-kappa B
NF-kappa B was
B was generated
was generated from
generated from Jurkat
from Jurkat T
Jurkat T cell
T cell complementary
cell complementary DNA
complementary DNA with
DNA with the
with the polymerase
the polymerase chain
polymerase chain reaction
chain reaction PCR
reaction PCR and
PCR and degenerate
and degenerate oligonucleotides
This probe was
probe was used
was used to
used to identify
to identify a
identify a rel-related
a rel-related complementary
rel-related complementary DNA
complementary DNA that
DNA that hybridized
that hybridized to
hybridized to a
to a 26-kilobase
a 26-kilobase messenger
26-kilobase messenger RNA
messenger RNA present
RNA present in
present in human
in human T
human T and
T and B
and B lymphocytes
In vitro transcription
vitro transcription and
transcription and translation
and translation of
translation of the
of the complementary
the complementary DNA
complementary DNA resulted
DNA resulted in
resulted in the
in the synthesis
the synthesis of
synthesis of a
of a protein
a protein with
protein with an
with an apparent
an apparent molecular
apparent molecular size
molecular size of
size of 65
of 65 kilodaltons
65 kilodaltons kD
The translated protein
translated protein showed
protein showed weak
showed weak DNA
weak DNA binding
DNA binding with
binding with a
with a specificity
a specificity for
specificity for the
for the kappa
the kappa B
kappa B binding
B binding motif
This protein-DNA complex
protein-DNA complex comigrated
complex comigrated with
comigrated with the
with the complex
the complex obtained
complex obtained with
obtained with the
with the purified
the purified human
purified human p65
human p65 NF-kappa
p65 NF-kappa B
NF-kappa B subunit
B subunit and
subunit and binding
and binding was
binding was inhibited
was inhibited by
inhibited by I
by I kappa
I kappa B-alpha
kappa B-alpha and
B-alpha and -beta
and -beta proteins
In addition the
addition the 65-kD
the 65-kD protein
65-kD protein associated
protein associated with
associated with the
with the p50
the p50 subunit
p50 subunit of
subunit of NF-kappa
of NF-kappa B
NF-kappa B and
B and the
and the kappa
the kappa B
kappa B probe
B probe to
probe to form
to form a
form a complex
a complex with
complex with the
with the same
the same electrophoretic
same electrophoretic mobility
electrophoretic mobility as
mobility as the
as the NF-kappa
the NF-kappa B-DNA
NF-kappa B-DNA complex
Therefore the rel-related
the rel-related 65-kD
rel-related 65-kD protein
65-kD protein may
protein may represent
may represent the
represent the p65
the p65 subunit
p65 subunit of
subunit of the
of the active
the active NF-kappa
active NF-kappa B
NF-kappa B transcription
B transcription factor
transcription factor complex
The human myelomonocytic
human myelomonocytic cell
myelomonocytic cell line
cell line U-937
line U-937 as
U-937 as a
as a model
a model for
model for studying
for studying alterations
studying alterations in
alterations in steroid-induced
in steroid-induced monokine
steroid-induced monokine gene
monokine gene expression:
gene expression: marked
expression: marked enhancement
marked enhancement of
enhancement of lipopolysaccharide-stimulated
of lipopolysaccharide-stimulated interleukin-1
lipopolysaccharide-stimulated interleukin-1 beta
interleukin-1 beta messenger
beta messenger RNA
messenger RNA levels
RNA levels by
levels by 125-dihydroxyvitamin
by 125-dihydroxyvitamin D3
The active metabolite
active metabolite of
metabolite of vitamin
of vitamin D
vitamin D 125-dihydroxyvitamin
D 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 [125-OH2D3]
D3 [125-OH2D3] is
[125-OH2D3] is a
is a potent
a potent regulator
potent regulator of
regulator of human
of human monocyte/macrophage
human monocyte/macrophage function
monocyte/macrophage function in
function in vitro
To establish a
establish a model
a model for
model for 125-OH2D3
for 125-OH2D3 regulation
125-OH2D3 regulation of
regulation of human
of human monocyte
human monocyte monokine
monocyte monokine synthesis
monokine synthesis three
synthesis three human
three human cell
human cell lines
cell lines U-937
lines U-937 THP-1
U-937 THP-1 and
THP-1 and HL-60
and HL-60 were
HL-60 were examined
were examined for:
examined for: 1
for: 1 the
1 the presence
the presence of
presence of functional
of functional 125-OH2D3
functional 125-OH2D3 receptors;
125-OH2D3 receptors; 2
receptors; 2 the
2 the accumulation
the accumulation of
accumulation of interleukin-1
of interleukin-1 beta
interleukin-1 beta IL-1
beta IL-1 beta
IL-1 beta mRNA
beta mRNA and
mRNA and IL-1
and IL-1 beta
IL-1 beta protein
beta protein in
protein in response
in response to
response to lipopolysaccharide
to lipopolysaccharide LPS;
lipopolysaccharide LPS; and
LPS; and 3
and 3 the
3 the regulation
the regulation of
regulation of this
of this response
this response by
response by 125-OH2D3
All three cell
three cell lines
cell lines expressed
lines expressed vitamin
expressed vitamin D
vitamin D receptor
D receptor and
receptor and had
and had increased
had increased levels
increased levels of
levels of IL-1
of IL-1 beta
IL-1 beta mRNA
beta mRNA in
mRNA in response
in response to
response to LPS
Preincubation of cells
of cells with
cells with 125-OH2D3
with 125-OH2D3 augmented
125-OH2D3 augmented IL-1
augmented IL-1 beta
IL-1 beta mRNA
beta mRNA levels
mRNA levels only
levels only in
only in U-937
in U-937 and
U-937 and HL-60
and HL-60 cells
From these data
these data and
data and taking
and taking into
taking into consideration
into consideration their
consideration their state
their state of
state of differentiation
of differentiation and
differentiation and relative
and relative ease
relative ease of
ease of culture
of culture U-937
culture U-937 was
U-937 was chosen
was chosen over
chosen over HL-60
over HL-60 and
HL-60 and THP-1
and THP-1 as
THP-1 as the
as the cell
the cell line
cell line we
line we further
we further characterized
In U-937 cells
U-937 cells optimum
cells optimum time
optimum time and
time and dose
and dose of
dose of pretreatment
of pretreatment with
pretreatment with 125-OH2D3
with 125-OH2D3 were
125-OH2D3 were determined
were determined to
determined to be
to be 12-24
be 12-24 h
12-24 h at
h at a
at a receptor
a receptor saturating
receptor saturating concentration
saturating concentration of
concentration of 125-OH2D3
of 125-OH2D3 10
125-OH2D3 10 nM
Preincubation of cells
of cells with
cells with 125-OH2D3
with 125-OH2D3 had
125-OH2D3 had no
had no effect
no effect on
effect on the
on the time
the time course
time course of
course of IL-1
of IL-1 beta
IL-1 beta mRNA
beta mRNA appearance
mRNA appearance in
appearance in response
in response to
response to LPS
However exposure of
exposure of U-937
of U-937 cells
U-937 cells to
cells to 125-OH2D3
to 125-OH2D3 increased
125-OH2D3 increased by
increased by 200%
by 200% the
200% the level
the level of
level of IL-1
of IL-1 beta
IL-1 beta mRNA
beta mRNA detected
mRNA detected and
detected and decreased
and decreased by
decreased by three
by three orders
three orders of
orders of magnitude
of magnitude the
magnitude the concentration
the concentration of
concentration of LPS
of LPS required
LPS required to
required to achieve
to achieve steady
achieve steady state
steady state mRNA
state mRNA levels
mRNA levels equivalent
levels equivalent to
equivalent to those
to those observed
those observed in
observed in U-937
in U-937 cells
U-937 cells not
cells not preincubated
not preincubated with
preincubated with the
with the hormone2+o
Regulation of M-CSF
of M-CSF expression
M-CSF expression by
expression by M-CSF:
by M-CSF: role
M-CSF: role of
role of protein
of protein kinase
protein kinase C
kinase C and
C and transcription
and transcription factor
transcription factor NF
factor NF kappa
NF kappa B
Macrophage-colony-stimulating factor M-CSF
factor M-CSF also
M-CSF also referred
also referred to
referred to as
to as CSF-1
as CSF-1 regulates
CSF-1 regulates the
regulates the survival
the survival growth
survival growth differentiation
growth differentiation and
differentiation and functional
and functional activity
functional activity of
activity of monocytes
of monocytes by
monocytes by binding
by binding to
binding to a
to a single
a single class
single class of
class of high-affinity
of high-affinity cell
high-affinity cell surface
cell surface receptors
surface receptors known
receptors known to
known to be
to be the
be the product
the product of
product of the
of the c-fms
the c-fms protooncogene
The detection of
detection of both
of both M-CSF
both M-CSF and
M-CSF and c-fms
and c-fms expression
c-fms expression by
expression by cells
by cells of
cells of the
of the monocyte
the monocyte lineage
monocyte lineage has
lineage has suggested
has suggested that
suggested that M-CSF
that M-CSF may
M-CSF may act
may act by
act by an
by an autocrine
an autocrine mechanism
Interestingly it has
it has been
has been shown
been shown that
shown that M-CSF
that M-CSF can
M-CSF can induce
can induce the
induce the expression
the expression of
expression of its
of its own
its own gene
Although sensitivity to
sensitivity to M-CSF
to M-CSF can
M-CSF can be
can be modulated
be modulated by
modulated by regulation
by regulation of
regulation of receptor
of receptor expression
receptor expression and
expression and function
and function M-CSF
function M-CSF responsiveness
M-CSF responsiveness is
responsiveness is largely
is largely determined
largely determined at
determined at a
at a postreceptor
a postreceptor level
To date little
date little is
little is known
is known about
known about the
about the intracellular
the intracellular pathway
intracellular pathway of
pathway of M-CSF
of M-CSF signal
M-CSF signal transduction
We have therefore
have therefore investigated
therefore investigated the
investigated the changes
the changes in
changes in protein
in protein kinase
protein kinase C
kinase C PKC
C PKC activity
PKC activity upon
activity upon exposure
upon exposure of
exposure of monocytes
of monocytes to
monocytes to M-CSF
We show that
show that M-CSF
that M-CSF activates
M-CSF activates and
activates and translocates
and translocates PKC
Inhibition of PKC
of PKC by
PKC by the
by the isoquinoline
the isoquinoline derivative
isoquinoline derivative H7
derivative H7 abolishes
H7 abolishes induction
abolishes induction of
induction of M-CSF
of M-CSF by
M-CSF by M-CSF
Furthermore activation of
activation of PKC
of PKC was
PKC was pertussis-toxin-sensitive
was pertussis-toxin-sensitive and
pertussis-toxin-sensitive and was
and was associated
was associated with
associated with the
with the detection
the detection of
detection of an
of an NF
an NF kappa
NF kappa B
kappa B protein
B protein in
protein in nuclear
in nuclear extracts
nuclear extracts of
extracts of M-CSF-induced
of M-CSF-induced blood
M-CSF-induced blood monocytes
blood monocytes but
monocytes but not
but not in
not in monocytes
in monocytes exposed
monocytes exposed to
exposed to medium
to medium treatment
medium treatment only
The results suggest
results suggest that
suggest that M-CSF
that M-CSF induction
M-CSF induction of
induction of M-CSF
of M-CSF involves
M-CSF involves G
involves G proteins
G proteins PKC
proteins PKC and
PKC and NF
and NF kappa
NF kappa B
Clone pAT 133
pAT 133 identifies
133 identifies a
identifies a gene
a gene that
gene that encodes
that encodes another
encodes another human
another human member
human member of
member of a
of a class
a class of
class of growth
of growth factor-induced
growth factor-induced genes
factor-induced genes with
genes with almost
with almost identical
almost identical zinc-finger
identical zinc-finger domains
We report the
report the structure
the structure and
structure and regulation
and regulation of
regulation of a
of a gene
a gene represented
gene represented by
represented by clone
by clone pAT
clone pAT 133
pAT 133 which
133 which is
which is induced
is induced upon
induced upon transition
upon transition from
transition from a
from a resting
a resting state
resting state G0
state G0 through
G0 through the
through the early
the early phase
early phase of
phase of the
of the cell
the cell cycle
cell cycle G1
The pAT 133
pAT 133 gene
133 gene is
gene is immediately
is immediately induced
immediately induced with
induced with FOS-like
with FOS-like kinetics
FOS-like kinetics in
kinetics in human
in human T
human T cells
T cells and
cells and in
and in fibroblasts
Primary structure analysis
structure analysis showed
analysis showed that
showed that the
that the encoded
the encoded protein
encoded protein contains
protein contains three
contains three tandem
three tandem zinc-finger
tandem zinc-finger sequences
zinc-finger sequences of
sequences of the
of the type
the type Cys2-Xaa12-His2
This zinc-finger region
zinc-finger region which
region which is
which is thought
is thought to
thought to bind
to bind DNA
bind DNA in
DNA in a
in a sequence-specific
a sequence-specific manner
sequence-specific manner is
manner is similar
is similar greater
similar greater than
greater than 80%
than 80% on
80% on the
on the amino
the amino acid
amino acid level
acid level to
level to two
to two previously
two previously described
previously described transcription
described transcription factors
transcription factors pAT
factors pAT 225/EGR1
pAT 225/EGR1 and
225/EGR1 and pAT
and pAT 591/EGR2
Except for the
for the conserved
the conserved zinc-finger
conserved zinc-finger domains
zinc-finger domains the
domains the amino
the amino acid
amino acid sequences
acid sequences of
sequences of the
of the three
the three proteins
three proteins are
proteins are distinct
This structural similarity
structural similarity suggests
similarity suggests that
suggests that the
that the pAT
the pAT 133
pAT 133 gene
133 gene encodes
gene encodes a
encodes a transcription
a transcription factor
transcription factor with
factor with a
with a specific
a specific biological
specific biological function
Comparing the regulation
the regulation of
regulation of these
of these related
these related zinc-finger-encoding
related zinc-finger-encoding genes
zinc-finger-encoding genes showed
genes showed coordinate
showed coordinate induction
coordinate induction upon
induction upon mitogenic
upon mitogenic stimulation
mitogenic stimulation of
stimulation of resting
of resting T
resting T lymphocytes
T lymphocytes and
lymphocytes and of
and of resting
of resting fibroblasts
However upon transition
upon transition from
transition from a
from a proliferating
a proliferating G1
proliferating G1 to
G1 to a
to a resting
a resting state
resting state of
state of the
of the cell
the cell cycle
cell cycle the
cycle the three
the three genes
three genes were
genes were differently
were differently regulated
In human histiocytic
human histiocytic U937
histiocytic U937 cells
U937 cells mRNA
cells mRNA of
mRNA of clone
of clone pAT
clone pAT 133
pAT 133 was
133 was constitutively
was constitutively expressed
constitutively expressed whereas
expressed whereas mRNA
whereas mRNA of
mRNA of pAT
of pAT 225/EGR1
pAT 225/EGR1 was
225/EGR1 was induced
was induced upon
induced upon induction
upon induction of
induction of terminal
of terminal differentiation
In contrast mRNA
contrast mRNA representing
mRNA representing pAT
representing pAT 591/EGR2
pAT 591/EGR2 was
591/EGR2 was not
was not expressed
not expressed in
expressed in these
in these cells
This difference in
difference in gene
in gene regulation
gene regulation suggests
regulation suggests distinct
suggests distinct biological
distinct biological roles
biological roles in
roles in the
in the control
the control of
control of cell
of cell proliferation
cell proliferation for
proliferation for the
for the respective
the respective proteins
v-erbA overexpression is
overexpression is required
is required to
required to extinguish
to extinguish c-erbA
extinguish c-erbA function
c-erbA function in
function in erythroid
in erythroid cell
erythroid cell differentiation
cell differentiation and
differentiation and regulation
and regulation of
regulation of the
of the erbA
the erbA target
erbA target gene
target gene CAII
The v-erbA oncoprotein
v-erbA oncoprotein represents
oncoprotein represents a
represents a retrovirus-transduced
a retrovirus-transduced oncogenic
retrovirus-transduced oncogenic version
oncogenic version of
version of the
of the thyroid
the thyroid hormone
thyroid hormone T3/T4
hormone T3/T4 receptor
T3/T4 receptor c-erbA
receptor c-erbA type
c-erbA type alpha
It contributes to
contributes to virus-induced
to virus-induced erythroleukemia
virus-induced erythroleukemia by
erythroleukemia by efficiently
by efficiently arresting
efficiently arresting differentiation
arresting differentiation of
differentiation of red
of red cell
red cell progenitors
cell progenitors and
progenitors and by
and by suppressing
by suppressing transcription
suppressing transcription of
transcription of erythrocyte-specific
of erythrocyte-specific genes
Here we show
we show that
show that v-erbA
that v-erbA and
v-erbA and c-erbA
and c-erbA bind
c-erbA bind directly
bind directly to
directly to sequences
to sequences within
sequences within the
within the promoter
the promoter of
promoter of the
of the erythrocyte-specific
the erythrocyte-specific carbonic
erythrocyte-specific carbonic anhydrase
carbonic anhydrase II
anhydrase II CAII
II CAII a
CAII a gene
a gene whose
gene whose transcription
whose transcription is
transcription is efficiently
is efficiently suppressed
efficiently suppressed by
suppressed by v-erbA
This erbA-binding site
erbA-binding site confers
site confers thyroid
confers thyroid hormone
thyroid hormone responsiveness
hormone responsiveness to
responsiveness to a
to a heterologous
a heterologous promoter
heterologous promoter in
promoter in transient
in transient expression
transient expression experiments
expression experiments and
experiments and is
and is a
is a target
a target for
target for efficient
for efficient down-regulation
efficient down-regulation of
down-regulation of CAII
of CAII transcription
CAII transcription by
transcription by the
by the v-erbA
the v-erbA oncoprotein
In stably transformed
stably transformed erythroblasts
transformed erythroblasts coexpressing
erythroblasts coexpressing the
coexpressing the v-erbA
the v-erbA oncoprotein
v-erbA oncoprotein and
oncoprotein and the
and the c-erbA/T3
the c-erbA/T3 receptor
c-erbA/T3 receptor at
receptor at an
at an approximately
an approximately equimolar
approximately equimolar ratio
equimolar ratio c-erbA
ratio c-erbA activity
c-erbA activity is
activity is dominant
is dominant over
dominant over v-erbA
T3 efficiently induced
efficiently induced erythroid
induced erythroid differentiation
erythroid differentiation in
differentiation in these
in these cells
these cells thus
cells thus overcoming
thus overcoming the
overcoming the v-erbA-mediated
the v-erbA-mediated differentiation
v-erbA-mediated differentiation arrest
Likewise T3 activated
T3 activated CAII
activated CAII transcription
CAII transcription as
transcription as well
as well as
well as transient
as transient expression
transient expression of
expression of a
of a T3-responsive
a T3-responsive reporter
T3-responsive reporter gene
reporter gene containing
gene containing the
containing the CAII-specific
the CAII-specific erbA-binding
CAII-specific erbA-binding site
The c-erbA-dependent activation
c-erbA-dependent activation of
activation of this
of this CAII
this CAII reporter
CAII reporter construct
reporter construct could
construct could only
could only be
only be suppressed
be suppressed by
suppressed by very
by very high
very high amounts
high amounts of
amounts of v-erbA
Our results suggest
results suggest that
suggest that overexpression
that overexpression of
overexpression of v-erbA
of v-erbA is
v-erbA is required
is required for
required for its
for its function
its function as
function as an
as an oncoprotein
Anti-CD2 receptor antibodies
receptor antibodies activate
antibodies activate the
activate the HIV
the HIV long
HIV long terminal
long terminal repeat
terminal repeat in
repeat in T
in T lymphocytes
The CD2 T
CD2 T lymphocyte
T lymphocyte glycoprotein
lymphocyte glycoprotein surface
glycoprotein surface molecule
surface molecule mediates
molecule mediates both
mediates both cell
both cell to
cell to cell
to cell adhesion
cell adhesion and
adhesion and T
and T cell
T cell activation
cell activation two
activation two processes
two processes that
processes that are
that are involved
are involved in
involved in the
in the spread
the spread of
spread of HIV
of HIV infection
Treatment of chronically
of chronically HIV-infected
chronically HIV-infected PBMC
HIV-infected PBMC with
PBMC with anti-CD2
with anti-CD2 mAb
anti-CD2 mAb has
mAb has been
has been shown
been shown to
shown to induce
to induce the
induce the expression
the expression of
expression of infectious
of infectious virus
infectious virus from
virus from these
from these cultures
In this study
this study we
study we investigated
we investigated the
investigated the mechanisms
the mechanisms whereby
mechanisms whereby anti-CD2
whereby anti-CD2 antibodies
anti-CD2 antibodies stimulate
antibodies stimulate viral
stimulate viral production
We demonstrate that
demonstrate that treatment
that treatment of
treatment of transiently
of transiently transfected
transiently transfected T
transfected T lymphocytes
T lymphocytes with
lymphocytes with anti-CD2
with anti-CD2 antibodies
anti-CD2 antibodies results
antibodies results in
results in activation
in activation of
activation of the
of the HIV
the HIV long
HIV long terminal
long terminal repeat
Furthermore CAT assays
CAT assays using
assays using mutated
using mutated HIV
mutated HIV long
HIV long terminal
long terminal repeat-CAT
terminal repeat-CAT constructs
repeat-CAT constructs and
constructs and gel
and gel shift
gel shift assays
shift assays demonstrate
assays demonstrate that
demonstrate that this
that this activation
this activation is
activation is dependent
is dependent on
dependent on the
on the NF-kappa
the NF-kappa B
NF-kappa B enhancer
These studies suggest
studies suggest that
suggest that interaction
that interaction of
interaction of CD2
of CD2 with
CD2 with its
with its natural
its natural ligand
natural ligand LFA-3
ligand LFA-3 may
LFA-3 may play
may play a
play a role
a role in
role in regulation
in regulation of
regulation of HIV
of HIV expression
Reactive oxygen intermediates
oxygen intermediates as
intermediates as apparently
as apparently widely
apparently widely used
widely used messengers
used messengers in
messengers in the
in the activation
the activation of
activation of the
of the NF-kappa
the NF-kappa B
NF-kappa B transcription
B transcription factor
transcription factor and
factor and HIV-1
Hydrogen peroxide and
peroxide and oxygen
and oxygen radicals
oxygen radicals are
radicals are agents
are agents commonly
agents commonly produced
commonly produced during
produced during inflammatory
during inflammatory processes
In this study
this study we
study we show
we show that
show that micromolar
that micromolar concentrations
micromolar concentrations of
concentrations of H2O2
of H2O2 can
H2O2 can induce
can induce the
induce the expression
the expression and
expression and replication
and replication of
replication of HIV-1
of HIV-1 in
HIV-1 in a
in a human
a human T
human T cell
T cell line
The effect is
effect is mediated
is mediated by
mediated by the
by the NF-kappa
the NF-kappa B
NF-kappa B transcription
B transcription factor
transcription factor which
factor which is
which is potently
is potently and
potently and rapidly
and rapidly activated
rapidly activated by
activated by an
by an H2O2
an H2O2 treatment
H2O2 treatment of
treatment of cells
of cells from
cells from its
from its inactive
its inactive cytoplasmic
inactive cytoplasmic form
N-acetyl-L-cysteine NAC a
NAC a well
a well characterized
well characterized antioxidant
characterized antioxidant which
antioxidant which counteracts
which counteracts the
counteracts the effects
the effects of
effects of reactive
of reactive oxygen
reactive oxygen intermediates
oxygen intermediates ROI
intermediates ROI in
ROI in living
in living cells
living cells prevented
cells prevented the
prevented the activation
the activation of
activation of NF-kappa
of NF-kappa B
NF-kappa B by
B by H2O2
NAC and other
and other thiol
other thiol compounds
thiol compounds also
compounds also blocked
also blocked the
blocked the activation
the activation of
activation of NF-kappa
of NF-kappa B
NF-kappa B by
B by cycloheximide
by cycloheximide double-stranded
cycloheximide double-stranded RNA
double-stranded RNA calcium
RNA calcium ionophore
calcium ionophore TNF-alpha
ionophore TNF-alpha active
TNF-alpha active phorbol
active phorbol ester
phorbol ester interleukin-1
ester interleukin-1 lipopolysaccharide
interleukin-1 lipopolysaccharide and
lipopolysaccharide and lectin
This suggests that
suggests that diverse
that diverse agents
diverse agents thought
agents thought to
thought to activate
to activate NF-kappa
activate NF-kappa B
NF-kappa B by
B by distinct
by distinct intracellular
distinct intracellular pathways
intracellular pathways might
pathways might all
might all act
all act through
act through a
through a common
a common mechanism
common mechanism involving
mechanism involving the
involving the synthesis
the synthesis of
synthesis of ROI
ROI appear to
appear to serve
to serve as
serve as messengers
as messengers mediating
messengers mediating directly
mediating directly or
directly or indirectly
or indirectly the
indirectly the release
the release of
release of the
of the inhibitory
the inhibitory subunit
inhibitory subunit I
subunit I kappa
I kappa B
kappa B from
B from NF-kappa
from NF-kappa B
Inhibition of transcription
of transcription factors
transcription factors belonging
factors belonging to
belonging to the
to the rel/NF-kappa
the rel/NF-kappa B
rel/NF-kappa B family
B family by
family by a
by a transdominant
a transdominant negative
transdominant negative mutant
The KBF1 factor
KBF1 factor which
factor which binds
which binds to
binds to the
to the enhancer
the enhancer A
enhancer A located
A located in
located in the
in the promoter
the promoter of
promoter of the
of the mouse
the mouse MHC
mouse MHC class
MHC class I
class I gene
I gene H-2Kb
gene H-2Kb is
H-2Kb is indistinguishable
is indistinguishable from
indistinguishable from the
from the p50
the p50 DNA
p50 DNA binding
DNA binding subunit
binding subunit of
subunit of the
of the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B which
B which regulates
which regulates a
regulates a series
a series of
series of genes
of genes involved
genes involved in
involved in immune
in immune and
immune and inflammatory
and inflammatory responses
The KBF1/p50 factor
KBF1/p50 factor binds
factor binds as
binds as a
as a homodimer
a homodimer but
homodimer but can
but can also
can also form
also form heterodimers
form heterodimers with
heterodimers with the
with the products
the products of
products of other
of other members
other members of
members of the
of the same
the same family
same family like
family like the
like the c-rel
the c-rel and
c-rel and v-rel
and v-rel protooncogenes
The dimerization domain
dimerization domain of
domain of KBF1/p50
of KBF1/p50 is
KBF1/p50 is contained
is contained between
contained between amino
between amino acids
amino acids 201
acids 201 and
201 and 367
A mutant of
mutant of KBF1/p50
of KBF1/p50 delta
KBF1/p50 delta SP
delta SP unable
SP unable to
unable to bind
to bind to
bind to DNA
to DNA but
DNA but able
but able to
able to form
to form homo-
form homo- or
homo- or heterodimers
or heterodimers has
heterodimers has been
has been constructed
This protein reduces
protein reduces or
reduces or abolishes
or abolishes in
abolishes in vitro
in vitro the
vitro the DNA
the DNA binding
DNA binding activity
binding activity of
activity of wild-type
of wild-type proteins
wild-type proteins of
proteins of the
of the same
the same family
same family KBF1/p50
family KBF1/p50 c-
KBF1/p50 c- and
c- and v-rel
This mutant also
mutant also functions
also functions in
functions in vivo
in vivo as
vivo as a
as a trans-acting
a trans-acting dominant
trans-acting dominant negative
dominant negative regulator:
negative regulator: the
regulator: the transcriptional
the transcriptional inducibility
transcriptional inducibility of
inducibility of the
of the HIV
the HIV long
HIV long terminal
long terminal repeat
terminal repeat which
repeat which contains
which contains two
contains two potential
two potential NF-kappa
potential NF-kappa B
NF-kappa B binding
B binding sites
binding sites by
sites by phorbol
by phorbol ester
phorbol ester PMA
ester PMA is
PMA is inhibited
is inhibited when
inhibited when it
when it is
it is co-transfected
is co-transfected into
co-transfected into CD4+
into CD4+ T
CD4+ T cells
T cells with
cells with the
with the delta
the delta SP
delta SP mutant
Similarly the basal
the basal as
basal as well
as well as
well as TNF
as TNF or
TNF or IL1-induced
or IL1-induced activity
IL1-induced activity of
activity of the
of the MHC
the MHC class
MHC class I
class I H-2Kb
I H-2Kb promoter
H-2Kb promoter can
promoter can be
can be inhibited
be inhibited by
inhibited by this
by this mutant
this mutant in
mutant in two
in two different
two different cell
different cell lines
These results constitute
results constitute the
constitute the first
the first formal
first formal demonstration
formal demonstration that
demonstration that these
that these genes
these genes are
genes are regulated
are regulated by
regulated by members
by members of
members of the
of the rel/NF-kappa
the rel/NF-kappa B
rel/NF-kappa B family
Tissue-specific expression of
expression of the
of the platelet
the platelet GPIIb
platelet GPIIb gene
One of the
of the major
the major objectives
major objectives in
objectives in the
in the study
the study of
study of thrombogenesis
of thrombogenesis is
thrombogenesis is to
is to determine
to determine the
determine the mechanisms
the mechanisms by
mechanisms by which
by which a
which a hematopoietic
a hematopoietic progenitor
hematopoietic progenitor is
progenitor is activated
is activated and
activated and committed
and committed to
committed to the
to the megakaryocytic
the megakaryocytic lineage
Recent development of
development of primary
of primary cultures
primary cultures of
cultures of human
of human megakaryocytes
human megakaryocytes and
megakaryocytes and the
and the molecular
the molecular cloning
molecular cloning of
cloning of genes
of genes that
genes that are
that are specific
are specific to
specific to this
to this lineage
this lineage offer
lineage offer the
offer the possibility
the possibility of
possibility of getting
of getting some
getting some insights
some insights into
insights into the
into the genetic
the genetic mechanisms
genetic mechanisms that
mechanisms that control
that control megakaryocytopoiesis
One gene of
gene of interest
of interest is
interest is the
is the glycoprotein
the glycoprotein IIb
glycoprotein IIb GPIIb
IIb GPIIb gene;
GPIIb gene; GPIIb
gene; GPIIb the
GPIIb the alpha
the alpha subunit
alpha subunit of
subunit of the
of the platelet
the platelet cytoadhesin
platelet cytoadhesin GPIIb-IIIa
cytoadhesin GPIIb-IIIa is
GPIIb-IIIa is produced
is produced in
produced in megakaryocytes
in megakaryocytes at
megakaryocytes at an
at an early
an early stage
early stage of
stage of the
of the differentiation
the differentiation whereas
differentiation whereas the
whereas the other
the other subunit
other subunit of
subunit of this
of this complex
this complex GPIIIa
complex GPIIIa is
GPIIIa is expressed
is expressed in
expressed in other
in other cells
For these reasons
these reasons the
reasons the 5'-flanking
the 5'-flanking region
5'-flanking region of
region of the
of the GPIIb
the GPIIb gene
GPIIb gene was
gene was used
was used to
used to identify
to identify the
identify the regions
the regions that
regions that interact
that interact with
interact with DNA-binding
with DNA-binding nuclear
DNA-binding nuclear factors
A fragment extending
fragment extending from
extending from -643
from -643 to
-643 to +33
to +33 is
+33 is capable
is capable of
capable of controlling
of controlling the
controlling the tissue-specific
the tissue-specific expression
tissue-specific expression of
expression of the
of the CAT
the CAT gene
CAT gene in
gene in transfection
in transfection experiments
Within this region
this region we
region we have
we have identified
have identified several
identified several sequences
several sequences that
sequences that are
that are implicated
are implicated in
implicated in DNA
in DNA protein
DNA protein interactions
protein interactions as
interactions as shown
as shown in
shown in DNAse
in DNAse I
DNAse I footprints
I footprints and
footprints and gel
and gel mobility
gel mobility shift
mobility shift assays
One region centered
region centered at
centered at -54
at -54 is
-54 is similar
is similar to
similar to a
to a nuclear
a nuclear factor
nuclear factor E1-binding
factor E1-binding site
E1-binding site and
site and a
and a region
a region located
region located at
located at position
at position -233
position -233 contains
-233 contains a
contains a CCAAT
a CCAAT motif
Two domains centered
domains centered at
centered at positions
at positions -345
positions -345 and
-345 and -540
and -540 respectively
-540 respectively bind
respectively bind proteins
bind proteins that
proteins that are
that are present
are present in
present in megakaryocytic
in megakaryocytic cells
megakaryocytic cells and
cells and nonrelated
and nonrelated cells
nonrelated cells as
cells as well
Finally two other
two other domains
other domains located
domains located at
located at positions
at positions -460
positions -460 and
-460 and -510
and -510 interact
-510 interact with
interact with proteins
with proteins that
proteins that are
that are only
are only present
only present in
present in megakaryocytic
in megakaryocytic cells
In addition deletion
addition deletion of
deletion of the
of the region
the region containing
region containing these
containing these two
these two domains
two domains results
domains results in
results in a
in a significant
a significant decrease
significant decrease of
decrease of the
of the promoter
the promoter activity
It is very
is very likely
very likely that
likely that these
that these domains
these domains bind
domains bind megakaryocyte-specific
bind megakaryocyte-specific nuclear
megakaryocyte-specific nuclear proteins
nuclear proteins acting
proteins acting as
acting as positive
as positive transcription
positive transcription factors
Lymphocyte glucocorticoid receptor
glucocorticoid receptor binding
receptor binding during
binding during depression
during depression and
depression and after
and after clinical
after clinical recovery
Lymphocyte glucocorticoid receptor
glucocorticoid receptor binding
receptor binding parameters
binding parameters were
parameters were studied
were studied in
studied in 15
in 15 severely
15 severely depressed
severely depressed patients
depressed patients during
patients during depression
during depression and
depression and after
and after clinical
after clinical recovery
clinical recovery and
recovery and in
and in 15
in 15 healthy
15 healthy controls
There was no
was no difference
no difference in
difference in glucocorticoid
in glucocorticoid receptor
glucocorticoid receptor number
receptor number or
number or affinity
or affinity between
affinity between depressed
between depressed patients
depressed patients and
patients and recovered
and recovered or
recovered or control
or control subjects
Afternoon ACTH and
ACTH and cortisol
and cortisol concentrations
cortisol concentrations did
concentrations did not
did not differ
not differ significantly
differ significantly between
significantly between the
between the three
the three groups
No relationship could
relationship could be
could be established
be established between
established between glucocorticoid
between glucocorticoid receptor
glucocorticoid receptor binding
receptor binding and
binding and antidepressant
and antidepressant medication
These data support
data support the
support the view
the view of
view of an
of an impaired
an impaired ligand-induced
impaired ligand-induced plasticity
ligand-induced plasticity of
plasticity of glucocorticoid
of glucocorticoid receptor
glucocorticoid receptor regulation
receptor regulation rather
regulation rather than
rather than the
than the hypothesis
the hypothesis of
hypothesis of decreased
of decreased glucocorticoid
decreased glucocorticoid receptor
glucocorticoid receptor numbers
receptor numbers during
numbers during depression
Every enhancer works
enhancer works with
works with every
with every promoter
every promoter for
promoter for all
for all the
all the combinations
the combinations tested:
combinations tested: could
tested: could new
could new regulatory
new regulatory pathways
regulatory pathways evolve
pathways evolve by
evolve by enhancer
by enhancer shuffling?
The promoters and
promoters and enhancers
and enhancers of
enhancers of cell
of cell type-specific
cell type-specific genes
type-specific genes are
genes are often
are often conserved
often conserved in
conserved in evolution
in evolution and
evolution and hence
and hence one
hence one might
one might expect
might expect that
expect that a
that a given
a given enhancer
given enhancer has
enhancer has evolved
has evolved to
evolved to work
to work best
work best with
best with its
with its own
its own promoter
While this expectation
this expectation may
expectation may be
may be realized
be realized in
realized in some
in some cases
some cases we
cases we have
we have not
have not found
not found evidence
found evidence for
evidence for it
A total of
total of 27
of 27 combinations
27 combinations of
combinations of different
of different promoters
different promoters and
promoters and enhancers
and enhancers were
enhancers were tested
were tested by
tested by transfection
by transfection into
transfection into cultured
into cultured cells
We found that
found that the
that the relative
the relative efficiency
relative efficiency of
efficiency of the
of the enhancers
the enhancers is
enhancers is approximately
is approximately the
approximately the same
the same irrespective
same irrespective of
irrespective of the
of the type
the type of
type of promoter
of promoter used
promoter used ie
used ie there
ie there was
there was no
was no strong
no strong preference
strong preference for
preference for any
for any given
any given enhancer/promoter
given enhancer/promoter combination
Notably we do
we do not
do not see
not see particularly
see particularly strong
particularly strong transcription
strong transcription when
transcription when the
when the immunoglobulin
the immunoglobulin kappa
immunoglobulin kappa enhancer
kappa enhancer or
enhancer or the
or the immunoglobulin
the immunoglobulin heavy
immunoglobulin heavy chain
heavy chain enhancer
chain enhancer is
enhancer is used
is used to
used to activate
to activate a
activate a kappa
a kappa gene
kappa gene promoter
We propose that
propose that a
that a generally
a generally permissive
generally permissive enhancer/promoter
permissive enhancer/promoter interaction
enhancer/promoter interaction is
interaction is of
is of evolutionary
of evolutionary benefit
evolutionary benefit for
benefit for higher
for higher eukaryotes:
higher eukaryotes: by
eukaryotes: by enhancer
by enhancer shuffling
enhancer shuffling genes
shuffling genes could
genes could be
could be easily
be easily brought
easily brought under
brought under a
under a new
a new type
new type of
type of inducibility/cell
of inducibility/cell type
inducibility/cell type specificity
Towards a molecular
a molecular understanding
molecular understanding of
understanding of T-cell
of T-cell differentiation
Lymphoid differentiation is
differentiation is one
is one of
one of the
of the best
the best studied
best studied examples
studied examples of
examples of mammalian
of mammalian development
Here Hans Clevers
Hans Clevers and
Clevers and Michael
and Michael Owen
Michael Owen describe
Owen describe how
describe how the
how the cloning
the cloning of
cloning of the
of the genes
the genes that
genes that encode
that encode T-cell-specific
encode T-cell-specific membrane
T-cell-specific membrane proteins
membrane proteins allows
proteins allows the
allows the identification
the identification of
identification of transcription
of transcription factors
transcription factors that
factors that control
that control the
control the expression
the expression of
expression of these
of these T-cell
these T-cell genes
Such transcription factors
transcription factors play
factors play a
play a key
a key role
key role in
role in the
in the development
the development of
development of the
of the mature
the mature T-cell
mature T-cell phenotype
T-cell phenotype by
phenotype by functioning
by functioning as
functioning as 'master
as 'master regulators
'master regulators of
regulators of T-cell
of T-cell differentiation'
A study on
study on the
on the circadian
the circadian rhythm
circadian rhythm of
rhythm of glucocorticoid
of glucocorticoid receptor
Circadian rhythm in
rhythm in glucocorticoid
in glucocorticoid receptor
glucocorticoid receptor GR
receptor GR was
GR was studied
was studied in
studied in the
in the rat
the rat liver
rat liver and
liver and human
and human peripheral
human peripheral leukocytes
For rats exposed
rats exposed to
exposed to a
to a natural
a natural environmental
natural environmental photic
environmental photic cycle
photic cycle or
cycle or a
or a 12L:12D
a 12L:12D artificial
12L:12D artificial light
artificial light regime
light regime peak
regime peak values
peak values of
values of hepatic
of hepatic GR
hepatic GR were
GR were detected
were detected between
detected between 23:00
between 23:00 and
23:00 and 02:00
and 02:00 h
Except for a
for a 4-hour
a 4-hour advancement
4-hour advancement of
advancement of the
of the peak
the peak a
peak a similar
a similar circadian
similar circadian rhythm
circadian rhythm of
rhythm of hepatic
of hepatic GR
hepatic GR was
GR was detected
was detected in
detected in rats
in rats reared
rats reared under
reared under a
under a reversed
a reversed lighting
reversed lighting regimen
lighting regimen 12D:12L;
regimen 12D:12L; lights
12D:12L; lights on
lights on between
on between 18:30
between 18:30 and
18:30 and 06:30
and 06:30 h
In human leukocytes
human leukocytes the
leukocytes the peak
the peak value
peak value of
value of GR
of GR was
GR was found
was found to
found to parallel
to parallel that
parallel that of
that of plasma
of plasma cortisol
plasma cortisol with
cortisol with high
with high and
high and low
and low values
low values detected
values detected at
detected at 04:00-08:00
at 04:00-08:00 h
04:00-08:00 h and
h and 23:00-24:00
and 23:00-24:00 h
23:00-24:00 h respectively
In patients suffering
patients suffering from
suffering from Cushing's
from Cushing's syndrome
Cushing's syndrome the
syndrome the circadian
the circadian rhythm
circadian rhythm of
rhythm of plasma
of plasma cortisol
plasma cortisol either
cortisol either disappeared
either disappeared or
disappeared or was
or was inverted
was inverted while
inverted while that
while that of
that of GR
of GR did
GR did not
did not significantly
not significantly deviate
significantly deviate from
deviate from the
from the normal
the normal subjects
For apoplexic patients
apoplexic patients with
patients with lesions
with lesions localized
lesions localized to
localized to the
to the base
the base of
base of the
of the brain
the brain as
brain as indicated
as indicated by
indicated by computerized
by computerized tomography
computerized tomography the
tomography the diurnal
the diurnal variation
diurnal variation of
variation of GR
of GR was
GR was abolished
Conversely diurnal rhythmicity
diurnal rhythmicity persisted
rhythmicity persisted in
persisted in apoplexy
in apoplexy patients
apoplexy patients whose
patients whose lesions
whose lesions were
lesions were in
were in the
in the cerebral
the cerebral cortex
Thus we postulated
we postulated that
postulated that the
that the circadian
the circadian modification
circadian modification of
modification of GR
of GR was
GR was independent
was independent of
independent of the
of the diurnal
the diurnal fluctuations
diurnal fluctuations in
fluctuations in plasma
in plasma cortisol
plasma cortisol level
cortisol level or
level or the
or the circadian
the circadian variations
circadian variations in
variations in environmental
in environmental lighting
environmental lighting and
lighting and that
and that the
that the rhythmicity
the rhythmicity might
rhythmicity might be
might be regulated
be regulated by
regulated by the
by the 'circadian
the 'circadian pacemaker'
'circadian pacemaker' located
pacemaker' located in
located in the
in the human
the human basal
human basal brain
These diurnal variations
diurnal variations in
variations in GR
in GR might
GR might serve
might serve to
serve to coordinate
to coordinate the
coordinate the reactivity
the reactivity of
reactivity of the
of the target
the target cells
target cells to
cells to cortisol
to cortisol because
cortisol because the
because the diurnal
the diurnal rhythms
diurnal rhythms of
rhythms of a
of a GR-mediated
a GR-mediated response
GR-mediated response the
response the fractional
the fractional inhibition
fractional inhibition of
inhibition of chemotactic
of chemotactic migration
chemotactic migration rate
migration rate of
rate of polymorphonuclear
of polymorphonuclear leukocytes
polymorphonuclear leukocytes by
leukocytes by cortisol
by cortisol were
cortisol were found
were found to
found to be
to be synchronous
be synchronous with
synchronous with those
with those of
those of GR
Transcription factor requirements
factor requirements for
requirements for U2
for U2 snRNA-encoding
U2 snRNA-encoding gene
snRNA-encoding gene activation
gene activation in
activation in B
in B lymphoid
B lymphoid cells
Transcription of a
of a human
a human U2
human U2 small
U2 small nuclear
small nuclear RNAsnRNA-encoding
nuclear RNAsnRNA-encoding gene
RNAsnRNA-encoding gene in
gene in HeLa
in HeLa cells
HeLa cells requires
cells requires a
requires a distal
a distal enhancer
distal enhancer element
enhancer element which
element which is
which is composed
is composed of
composed of one
of one octamer
one octamer motif
octamer motif Oct
motif Oct and
Oct and three
and three Sp
three Sp 1-binding
Sp 1-binding sites
To study the
study the transcription
the transcription factor
transcription factor requirement
factor requirement in
requirement in B-cells
in B-cells different
B-cells different U2
different U2 enhancer
U2 enhancer constructions
enhancer constructions were
constructions were transfected
were transfected into
transfected into the
into the lymphoid
the lymphoid cell
lymphoid cell line
cell line BJA-B
The results showed
results showed that
showed that the
that the activation
the activation of
activation of U2
of U2 snRNA
U2 snRNA transcription
snRNA transcription in
transcription in B-cells
in B-cells also
B-cells also requires
also requires an
requires an enhancer
an enhancer comprising
enhancer comprising both
comprising both the
both the Oct
the Oct and
Oct and at
and at least
at least one
least one Sp
one Sp 1-binding
Sp 1-binding site
Deletion of all
of all the
all the Sp
the Sp 1-binding
Sp 1-binding sites
1-binding sites from
sites from the
from the enhancer
the enhancer reduces
enhancer reduces transcription
reduces transcription by
transcription by 80-90%
by 80-90% in
80-90% in HeLa
in HeLa as
HeLa as well
as well as
well as in
as in BJA-B
in BJA-B cells
BJA-B cells whereas
cells whereas the
whereas the removal
the removal of
removal of the
of the octamer-binding
the octamer-binding site
octamer-binding site reduces
site reduces transcription
reduces transcription to
transcription to levels
to levels below
levels below detection
below detection in
detection in both
in both cell
both cell types
Enhancers containing a
containing a single
a single Oct
single Oct have
Oct have nevertheless
have nevertheless the
nevertheless the capacity
the capacity to
capacity to partially
to partially activate
partially activate U2
activate U2 snRNA
U2 snRNA transcription
snRNA transcription in
transcription in both
in both HeLa
both HeLa cells
HeLa cells in
cells in which
in which only
which only OTF-1
only OTF-1 is
OTF-1 is expressed
is expressed and
expressed and in
and in BJA-B
in BJA-B cells
BJA-B cells in
cells in which
in which OTF-2
which OTF-2 is
OTF-2 is the
is the predominantly
the predominantly expressed
predominantly expressed octamer-binding
expressed octamer-binding factor
The most likely
most likely interpretation
likely interpretation of
interpretation of our
of our results
our results is
results is that
is that both
that both the
both the ubiquitous
the ubiquitous transcription
ubiquitous transcription factor
transcription factor OTF-1
factor OTF-1 and
OTF-1 and the
and the B-cell-specific
the B-cell-specific transcription
B-cell-specific transcription factor
transcription factor OTF-2
factor OTF-2 can
OTF-2 can activate
can activate U2
activate U2 snRNA
U2 snRNA transcription
The results also
results also revealed
also revealed a
revealed a similar
a similar functional
similar functional cooperation
functional cooperation between
cooperation between the
between the transcription
the transcription factors
transcription factors which
factors which bind
which bind to
bind to the
to the Oct
the Oct and
Oct and the
and the adjacent
the adjacent Sp
adjacent Sp 1-binding
Sp 1-binding site
1-binding site in
site in BJA-B
in BJA-B cells
BJA-B cells as
cells as has
as has been
has been observed
been observed in
observed in HeLa
in HeLa cells
HeLa cells since
cells since a
since a template
a template which
template which contains
which contains a
contains a weak
a weak binding
weak binding site
binding site for
site for OTFs
for OTFs expresses
OTFs expresses wild-type
expresses wild-type levels
wild-type levels of
levels of U2
of U2 snRNA
U2 snRNA in
snRNA in both
in both cell
both cell types
cell types when
types when the
when the weak
the weak octamer-binding
weak octamer-binding site
octamer-binding site is
site is combined
is combined with
combined with a
with a Sp
a Sp 1-binding
Sp 1-binding site
One base pair
base pair change
pair change abolishes
change abolishes the
abolishes the T
the T cell-restricted
T cell-restricted activity
cell-restricted activity of
activity of a
of a kB-like
a kB-like proto-enhancer
kB-like proto-enhancer element
proto-enhancer element from
element from the
from the interleukin
the interleukin 2
interleukin 2 promoter
The inducible T
inducible T cell-specific
T cell-specific enhancers
cell-specific enhancers of
enhancers of murine
of murine and
murine and human
and human Interleukin
human Interleukin 2
Interleukin 2 Il-2
2 Il-2 genes
Il-2 genes contain
genes contain the
contain the kB-like
the kB-like sequence
kB-like sequence GGGATTTCACC
sequence GGGATTTCACC as
GGGATTTCACC as an
as an essential
an essential cis-acting
essential cis-acting enhancer
cis-acting enhancer motif
When cloned in
cloned in multiple
in multiple copies
multiple copies this
copies this so-called
this so-called TCEd
so-called TCEd distal
TCEd distal T
distal T cell
T cell element
cell element acts
element acts as
acts as an
as an inducible
an inducible proto-enhancer
inducible proto-enhancer element
proto-enhancer element in
element in E14
in E14 T
E14 T lymphoma
T lymphoma cells
lymphoma cells but
cells but not
but not in
not in HeLa
in HeLa cells
In extracts of
extracts of induced
of induced Il-2
induced Il-2 secreting
Il-2 secreting El4
secreting El4 cells
El4 cells three
cells three individual
three individual protein
individual protein factors
protein factors bind
factors bind to
bind to TCEd
to TCEd DNA
The binding of
binding of the
of the most
the most prominent
most prominent factor
prominent factor named
factor named TCF-1
named TCF-1 T
TCF-1 T cell
T cell factor
cell factor 1
factor 1 is
1 is correlated
is correlated with
correlated with the
with the proto-enhancer
the proto-enhancer activity
proto-enhancer activity of
activity of TCEd
TCF-1 consists of
consists of two
of two polypeptides
two polypeptides of
polypeptides of about
of about 50
about 50 kD
50 kD and
kD and 105
and 105 kD;
105 kD; the
kD; the former
the former seems
former seems to
seems to be
to be related
be related to
related to the
to the 50
the 50 kD
50 kD polypeptide
kD polypeptide of
polypeptide of NF-kB
Purified NF-kB is
NF-kB is also
is also able
also able to
able to bind
to bind to
bind to the
to the TCEd
the TCEd but
TCEd but TCF-1
but TCF-1 binds
TCF-1 binds stronger
binds stronger than
stronger than NF-kB
than NF-kB to
NF-kB to TCEd
to TCEd DNA
The conversion of
conversion of the
of the TCEd
the TCEd to
TCEd to a
to a 'perfect'
a 'perfect' NF-kB
'perfect' NF-kB binding
NF-kB binding site
binding site leads
site leads to
leads to a
to a tighter
a tighter binding
tighter binding of
binding of NF-kB
of NF-kB to
NF-kB to TCEd
to TCEd DNA
TCEd DNA and
DNA and as
and as a
as a functional
a functional consequence
functional consequence to
consequence to the
to the activity
the activity of
activity of the
of the 'converted'
the 'converted' TCEd
'converted' TCEd motifs
TCEd motifs in
motifs in HeLa
in HeLa cells
Thus the substitution
the substitution of
substitution of the
of the underlined
the underlined A
underlined A residue
A residue to
residue to a
to a C
a C within
C within the
within the GGGATTTCACC
the GGGATTTCACC motif
GGGATTTCACC motif abolishes
motif abolishes its
abolishes its T
its T cell-restricted
T cell-restricted activity
cell-restricted activity and
activity and leads
and leads to
leads to its
to its functioning
its functioning in
functioning in both
in both El4
both El4 cells
El4 cells and
cells and HeLa
and HeLa cells
These results indicate
results indicate that
indicate that lymphocyte-specific
that lymphocyte-specific factors
lymphocyte-specific factors binding
factors binding to
binding to the
to the TCEd
the TCEd are
TCEd are involved
are involved in
involved in the
in the control
the control of
control of T
of T cell
T cell specific-transcription
cell specific-transcription of
specific-transcription of the
of the Il-2
the Il-2 gene
An erythroid specific
erythroid specific enhancer
specific enhancer upstream
enhancer upstream to
upstream to the
to the gene
the gene encoding
gene encoding the
encoding the cell-type
the cell-type specific
cell-type specific transcription
specific transcription factor
transcription factor GATA-1
The transcription factor
transcription factor GATA-1
factor GATA-1 is
GATA-1 is expressed
is expressed in
expressed in a
in a subset
a subset of
subset of hemopoietic
of hemopoietic cells
hemopoietic cells where
cells where it
where it mediates
it mediates the
mediates the cell-type
the cell-type specific
cell-type specific expression
specific expression of
expression of several
of several genes
We have cloned
have cloned the
cloned the mouse
the mouse and
mouse and human
and human GATA-1
human GATA-1 genes
A region upstream
region upstream to
upstream to the
to the first
the first exon
first exon and
exon and highly
and highly conserved
highly conserved between
conserved between mouse
between mouse and
mouse and man
and man acts
man acts as
acts as an
as an erythroid
an erythroid specific
erythroid specific enhancer
specific enhancer in
enhancer in transient
in transient assays
transient assays if
assays if linked
if linked to
linked to the
to the GATA-1
the GATA-1 or
GATA-1 or to
or to the
to the SV40
the SV40 promoter
The activity of
activity of the
of the enhancer
the enhancer is
enhancer is almost
is almost completely
almost completely dependent
completely dependent on
dependent on the
on the integrity
the integrity of
integrity of a
of a dimeric
a dimeric GATA-1
dimeric GATA-1 binding
GATA-1 binding site
Demonstration of a
of a 125-dihydroxyvitamin
a 125-dihydroxyvitamin D3-responsive
125-dihydroxyvitamin D3-responsive protein
D3-responsive protein in
protein in human
in human lymphocytes:
human lymphocytes: immunologic
lymphocytes: immunologic crossreactivity
immunologic crossreactivity and
crossreactivity and inverse
and inverse regulation
inverse regulation with
regulation with the
with the vitamin
the vitamin D
vitamin D receptor
Using Western blot
Western blot analysis
blot analysis with
analysis with a
with a monoclonal
a monoclonal antibody
monoclonal antibody recognizing
antibody recognizing a
recognizing a 17-amino
a 17-amino acid
17-amino acid epitope
acid epitope of
epitope of the
of the 125-dihydroxyvitamin
the 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 [125OH2D3]receptor
D3 [125OH2D3]receptor we
[125OH2D3]receptor we have
we have detected
have detected two
detected two crossreacting
two crossreacting proteins
crossreacting proteins in
proteins in activated
in activated normal
activated normal human
normal human lymphocytes
The smaller of
smaller of the
of the two
the two proteins
two proteins 50
proteins 50 kDa
50 kDa was
kDa was indistinguishable
was indistinguishable from
indistinguishable from the
from the classical
the classical 125OH2D3
classical 125OH2D3 receptor
125OH2D3 receptor and
receptor and similar
and similar to
similar to the
to the classical
the classical 125OH2D3
classical 125OH2D3 receptor
125OH2D3 receptor was
receptor was upregulated
was upregulated in
upregulated in a
in a dose-dependent
a dose-dependent fashion
dose-dependent fashion by
fashion by 125OH2D3
The larger crossreacting
larger crossreacting protein
crossreacting protein exhibited
protein exhibited an
exhibited an electrophoretic
an electrophoretic mobility
electrophoretic mobility of
mobility of 80
of 80 kDa
80 kDa was
kDa was localized
was localized in
localized in the
in the cell
the cell cytosol
cell cytosol and
cytosol and appeared
and appeared to
appeared to be
to be specific
be specific for
specific for activated
for activated lymphocytes
activated lymphocytes since
lymphocytes since it
since it was
it was not
was not detected
not detected in
detected in several
in several other
several other human
other human cells
human cells including
cells including monocytes
More strikingly the
strikingly the 80-kDa
the 80-kDa protein
80-kDa protein was
protein was downregulated
was downregulated in
downregulated in a
in a dose-dependent
a dose-dependent fashion
dose-dependent fashion by
fashion by 125OH2D3;
by 125OH2D3; this
125OH2D3; this effect
this effect was
effect was independent
was independent of
independent of the
of the mode
the mode of
mode of lymphocyte
of lymphocyte activation
lymphocyte activation and
activation and specific
and specific for
specific for the
for the 125OH2D3
the 125OH2D3 metabolite
125OH2D3 metabolite of
metabolite of vitamin
of vitamin D3
However two potent
two potent immunosuppressive
potent immunosuppressive agents
immunosuppressive agents glucocorticoids
agents glucocorticoids and
glucocorticoids and cyclosporin
and cyclosporin A
cyclosporin A also
A also inhibited
also inhibited the
inhibited the 80-kDa
the 80-kDa protein
Regulation of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in human
in human mononuclear
human mononuclear cells:
mononuclear cells: effects
cells: effects of
effects of glucocorticoid
of glucocorticoid treatment
glucocorticoid treatment Cushing's
treatment Cushing's disease
Cushing's disease and
disease and ketoconazole
Glucocorticoid receptors GcR
receptors GcR were
GcR were determined
were determined by
determined by a
by a whole
a whole cell
whole cell assay
cell assay in
assay in human
in human mononulear
human mononulear leukocytes
mononulear leukocytes hMNL
leukocytes hMNL from
hMNL from control
from control subjects
control subjects patients
subjects patients receiving
patients receiving glucocorticoid
receiving glucocorticoid therapy
glucocorticoid therapy for
therapy for systemic
for systemic diseases
systemic diseases and
diseases and Cushing's
and Cushing's disease
Cushing's disease patients
disease patients with
patients with or
with or without
or without ketoconazole
without ketoconazole therapy
Prolonged corticosteroid treatment
corticosteroid treatment resulted
treatment resulted in
resulted in down-regulation
in down-regulation of
down-regulation of GcR
of GcR while
GcR while the
while the mean
the mean level
mean level of
level of GcR
of GcR in
GcR in Cushing's
in Cushing's disease
Cushing's disease was
disease was normal
In this group
this group however
group however receptor
however receptor levels
receptor levels and
levels and morning
and morning plasma
morning plasma cortisol
plasma cortisol values
cortisol values showed
values showed a
showed a negative
a negative correlation
negative correlation indicating
correlation indicating a
indicating a subtle
a subtle down-regulatory
subtle down-regulatory effect
Furthermore GcR were
GcR were unaltered
were unaltered after
unaltered after these
after these patients
these patients received
patients received ketoconazole
received ketoconazole in
ketoconazole in spite
in spite of
spite of a
of a marked
a marked reduction
marked reduction in
reduction in morning
in morning plasma
morning plasma cortisol
plasma cortisol and
cortisol and urinary
and urinary free
urinary free cortisol
We also observed
also observed that
observed that ketoconazole
that ketoconazole was
ketoconazole was a
was a weak
a weak competitor
weak competitor of
competitor of GcR
of GcR in
GcR in intact
in intact cells
intact cells although
cells although it
although it significantly
it significantly inhibited
significantly inhibited [3H]
inhibited [3H] dexamethasone
[3H] dexamethasone binding
dexamethasone binding in
binding in cytosolic
in cytosolic preparations
cytosolic preparations from
preparations from rat
from rat tissues
The results suggested
results suggested that
suggested that GcR
that GcR in
GcR in hMNL
in hMNL are
hMNL are down-regulated
are down-regulated by
down-regulated by synthetic
by synthetic steroids
synthetic steroids given
steroids given in
given in vivo
in vivo but
vivo but they
but they showed
they showed very
showed very mild
very mild down-regulation
mild down-regulation in
down-regulation in hypercortisolemic
in hypercortisolemic patients
hypercortisolemic patients suffering
patients suffering from
suffering from Cushing's
from Cushing's disease
Finally we did
we did not
did not observed
not observed either
observed either up-regulation
either up-regulation or
up-regulation or antagonism
or antagonism of
antagonism of GcR
of GcR by
GcR by ketoconazole
by ketoconazole treatment
ketoconazole treatment at
treatment at the
at the time
the time that
time that cortisol
that cortisol levels
cortisol levels of
levels of patients
of patients with
patients with Cushing's
with Cushing's disease
Cushing's disease were
disease were reduced
This indicates that
indicates that the
that the beneficial
the beneficial effects
beneficial effects of
effects of ketoconazole
of ketoconazole in
ketoconazole in Cushing's
in Cushing's disease
Cushing's disease are
disease are due
are due to
due to adrenal
to adrenal cortisol
adrenal cortisol suppression
cortisol suppression and
suppression and not
and not to
not to interaction
to interaction with
interaction with GcR
with GcR of
GcR of target
of target cells
target cells and
cells and that
and that the
that the process
the process of
process of GcR
of GcR regulation
GcR regulation in
regulation in hMNL
in hMNL is
hMNL is a
is a complex
a complex phenomenon
complex phenomenon awaiting
phenomenon awaiting further
awaiting further elucidation
HTLV-1 Tax induces
Tax induces expression
induces expression of
expression of various
of various immediate
various immediate early
immediate early serum
early serum responsive
serum responsive genes
Human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type 1
type 1 HTLV-1
1 HTLV-1 is
HTLV-1 is an
is an etiological
an etiological agent
etiological agent of
agent of adult
of adult T-cell
adult T-cell leukemia
T-cell leukemia ATL
We showed here
showed here by
here by mobility-shift
by mobility-shift assay
mobility-shift assay that
assay that T-cell
that T-cell lines
T-cell lines transformed
lines transformed with
transformed with the
with the virus
the virus contained
virus contained high
contained high levels
high levels of
levels of AP-1
of AP-1 activities
Consistent with this
with this result
this result these
result these cell
these cell lines
cell lines expressed
lines expressed increased
expressed increased levels
increased levels of
levels of mRNAs
of mRNAs encoding
mRNAs encoding the
encoding the AP-1
the AP-1 proteins
AP-1 proteins c-Fos
proteins c-Fos Fra-1
c-Fos Fra-1 c-Jun
Fra-1 c-Jun JunB
c-Jun JunB and
JunB and JunD
Previously transcription of
transcription of the
of the c-fos
the c-fos gene
c-fos gene has
gene has been
has been reported
been reported to
reported to be
to be transactivated
be transactivated by
transactivated by the
by the viral
the viral transcription
viral transcription factor
transcription factor Tax1
By using the
using the human
the human T-cell
human T-cell line
T-cell line JPX-9
line JPX-9 in
JPX-9 in which
in which expression
which expression of
expression of the
of the Tax1
the Tax1 is
Tax1 is inducible
is inducible we
inducible we showed
we showed that
showed that expression
that expression of
expression of mRNAs
of mRNAs for
mRNAs for Fra-1
for Fra-1 c-Jun
Fra-1 c-Jun and
c-Jun and JunD
and JunD was
JunD was also
was also transactivated
also transactivated by
transactivated by Tax1
Moreover Tax1 activated
Tax1 activated expression
activated expression of
expression of two
of two other
two other transcription
other transcription factors
transcription factors having
factors having zinc
having zinc finger
zinc finger motifs
finger motifs Egr-1
motifs Egr-1 and
Egr-1 and Egr-2
and Egr-2 in
Egr-2 in the
in the same
the same cells
The Tax1-inducible transcription
Tax1-inducible transcription factors
transcription factors identified
factors identified here
identified here are
here are encoded
are encoded by
encoded by the
by the members
the members of
members of immediate
of immediate early
immediate early genes
early genes under
genes under the
under the control
the control of
control of growth
of growth signals
Thus Tax1 was
Tax1 was suggested
was suggested to
suggested to replace
to replace growth
replace growth signals
growth signals at
signals at least
at least in
least in part
in part by
part by this
by this mechanism
Glucocorticoid receptor characteristics
receptor characteristics in
characteristics in monocytes
in monocytes of
monocytes of patients
of patients with
patients with corticosteroid-resistant
with corticosteroid-resistant bronchial
corticosteroid-resistant bronchial asthma
The mechanism of
mechanism of corticosteroid
of corticosteroid resistance
corticosteroid resistance in
resistance in bronchial
in bronchial asthma
bronchial asthma has
asthma has been
has been studied
been studied by
studied by determining
by determining the
determining the rank
the rank order
rank order of
order of potency
of potency for
potency for different
for different corticosteroids
different corticosteroids in
corticosteroids in inhibiting
in inhibiting the
inhibiting the generation
the generation of
generation of a
of a 3
a 3 kD
3 kD molecule
kD molecule from
molecule from peripheral
from peripheral blood
peripheral blood monocytes
blood monocytes isolated
monocytes isolated from
isolated from corticosteroid-sensitive
from corticosteroid-sensitive CS
corticosteroid-sensitive CS and
CS and corticosteroid-resistant
and corticosteroid-resistant CR
corticosteroid-resistant CR asthmatic
CR asthmatic subjects
asthmatic subjects which
subjects which augments
which augments leukotriene
augments leukotriene B4
leukotriene B4 LTB4
B4 LTB4 generation
LTB4 generation by
generation by human
by human neutrophils
human neutrophils PMN
neutrophils PMN stimulated
PMN stimulated by
stimulated by calcium
by calcium ionophore
In addition binding
addition binding studies
binding studies with
studies with 3H
with 3H dexamethasone
3H dexamethasone have
dexamethasone have been
have been performed
been performed to
performed to determine
to determine the
determine the dissociation
the dissociation constant
dissociation constant Kd
constant Kd and
Kd and receptor
and receptor numbers
receptor numbers Ro
numbers Ro in
Ro in the
in the monocytes
the monocytes of
monocytes of these
of these two
these two groups
two groups of
groups of subjects
The concentration of
concentration of corticosteroid
of corticosteroid producing
corticosteroid producing 50%
producing 50% inhibition
50% inhibition IC50
inhibition IC50 was
IC50 was 600
was 600 nM
600 nM 70
nM 70 nM
70 nM and
nM and 05
and 05 nM
05 nM for
nM for hydrocortisone
for hydrocortisone methylprednisolone
hydrocortisone methylprednisolone and
methylprednisolone and dexamethasone
and dexamethasone respectively
dexamethasone respectively in
respectively in monocytes
in monocytes from
monocytes from CS
from CS individuals
There was only
was only weak
only weak inhibition
weak inhibition of
inhibition of the
of the generation
the generation of
generation of enhancing
of enhancing activity
enhancing activity by
activity by the
by the corticosteroids
the corticosteroids in
corticosteroids in the
in the CR
the CR asthmatic
CR asthmatic individuals
The dexamethasone Kd
dexamethasone Kd was
Kd was 245
was 245 +/-
245 +/- 058
+/- 058 nM
058 nM mean
nM mean +/-
mean +/- SEM
+/- SEM n
SEM n =
n = 6
= 6 in
6 in the
in the CS
the CS group
CS group and
group and 16
and 16 +/-
16 +/- 035
+/- 035 nM
035 nM mean
nM mean +/-
mean +/- SEM
+/- SEM n
SEM n =
n = 6
= 6 in
6 in the
in the CR
the CR group
CR group of
group of patients
of patients p
patients p =
p = 014
The Ro in
Ro in the
in the CS
the CS group
CS group was
group was 3605
was 3605 +/-
3605 +/- 984
+/- 984 binding
984 binding sites
binding sites per
sites per nucleus
per nucleus mean
nucleus mean +/-
mean +/- SEM
+/- SEM n
SEM n =
n = 6
= 6 and
6 and 4757
and 4757 +/-
4757 +/- 692
+/- 692 binding
692 binding sites
binding sites per
sites per nucleus
per nucleus mean
nucleus mean +/-
mean +/- SEM
+/- SEM n
SEM n =
n = 6
= 6 in
6 in the
in the CR
the CR group
CR group p
group p =
p = 023
These findings indicate
findings indicate that
indicate that corticosteroid
that corticosteroid resistance
corticosteroid resistance in
resistance in bronchial
in bronchial asthma
bronchial asthma cannot
asthma cannot be
cannot be explained
be explained by
explained by abnormalities
by abnormalities in
abnormalities in corticosteroid
in corticosteroid receptor
corticosteroid receptor characteristics
Vitamin D receptor
D receptor expression
receptor expression in
expression in human
in human lymphocytes
Signal requirements and
requirements and characterization
and characterization by
characterization by western
by western blots
western blots and
blots and DNA
and DNA sequencing
The signals controlling
signals controlling the
controlling the expression
the expression of
expression of the
of the receptor
the receptor protein
receptor protein for
protein for 1
for 1 alpha25-dihydroxyvitamin
1 alpha25-dihydroxyvitamin D3
alpha25-dihydroxyvitamin D3 in
D3 in normal
in normal human
normal human lymphocytes
human lymphocytes and
lymphocytes and the
and the relationship
the relationship of
relationship of this
of this protein
this protein to
protein to the
to the classical
the classical vitamin
classical vitamin D
vitamin D receptor
D receptor were
receptor were examined
Lymphocytes activated with
activated with the
with the OKT3
the OKT3 antibody
OKT3 antibody to
antibody to the
to the T-cell
the T-cell antigen
T-cell antigen receptor
antigen receptor expressed
receptor expressed fewer
expressed fewer binding
fewer binding sites
binding sites as
sites as compared
as compared to
compared to lymphocytes
to lymphocytes that
lymphocytes that were
that were activated
were activated by
activated by the
by the polyclonal
the polyclonal activator
polyclonal activator phytohemagglutinin
activator phytohemagglutinin PHA
However combination of
combination of OKT3
of OKT3 and
OKT3 and phorbol
and phorbol myristate
phorbol myristate acetate
myristate acetate produced
acetate produced a
produced a concentration
a concentration of
concentration of binding
of binding sites
binding sites similar
sites similar to
similar to the
to the PHA-activated
the PHA-activated cells
The receptor from
receptor from OKT3
from OKT3 and
OKT3 and OKT3
and OKT3 +
OKT3 + phorbol
+ phorbol myristate
phorbol myristate acetate-activated
myristate acetate-activated lymphocytes
acetate-activated lymphocytes exhibited
lymphocytes exhibited decreased
exhibited decreased binding
decreased binding to
binding to DNA-cellulose
to DNA-cellulose compared
DNA-cellulose compared to
compared to PHA-activated
to PHA-activated lymphocytes
In lymphocytes activated
lymphocytes activated either
activated either by
either by PHA
by PHA or
PHA or OKT3
or OKT3 but
OKT3 but not
but not in
not in resting
in resting cells
resting cells a
cells a 50-kDa
a 50-kDa species
50-kDa species cross-reacting
species cross-reacting with
cross-reacting with a
with a monoclonal
a monoclonal antibody
monoclonal antibody against
antibody against the
against the intestinal
the intestinal vitamin
intestinal vitamin D
vitamin D receptor
D receptor was
receptor was detected
Finally RNA from
RNA from activated
from activated lymphocytes
activated lymphocytes was
lymphocytes was amplified
was amplified by
amplified by polymerase
by polymerase chain
polymerase chain reaction
chain reaction using
reaction using oligonucleotide
using oligonucleotide primers
oligonucleotide primers flanking
primers flanking the
flanking the 196
the 196 base
196 base pair
base pair long
pair long region
long region encoding
region encoding the
encoding the DNA-binding
the DNA-binding domain
DNA-binding domain of
domain of the
of the human
the human intestinal
human intestinal receptor
The amplified product
amplified product showed
product showed an
showed an identical
an identical nucleotide
identical nucleotide sequence
nucleotide sequence to
sequence to the
to the DNA-binding
the DNA-binding domain
DNA-binding domain of
domain of the
of the human
the human intestinal
human intestinal receptor
These findings suggest
findings suggest that
suggest that expression
that expression of
expression of the
of the 125-OH2D3
the 125-OH2D3 receptor
125-OH2D3 receptor in
receptor in lymphocytes
in lymphocytes is
lymphocytes is triggered
is triggered by
triggered by distinct
by distinct and
distinct and contingent
and contingent signals
contingent signals and
signals and that
and that the
that the protein
the protein and
protein and the
and the mRNA
the mRNA encoding
mRNA encoding it
encoding it are
it are identical
are identical to
identical to the
to the classical
the classical vitamin
classical vitamin D
vitamin D receptor
Comparison of constitutive
of constitutive and
constitutive and inducible
and inducible transcriptional
inducible transcriptional enhancement
transcriptional enhancement mediated
enhancement mediated by
mediated by kappa
by kappa B-related
kappa B-related sequences:
B-related sequences: modulation
sequences: modulation of
modulation of activity
of activity in
activity in B
in B cells
B cells by
cells by human
by human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type I
type I tax
I tax gene
The kappa B
kappa B sequence
B sequence GGGACTTTCC
sequence GGGACTTTCC binds
GGGACTTTCC binds a
binds a factor
a factor NF-kappa
factor NF-kappa B
NF-kappa B that
B that is
that is constitutively
is constitutively found
constitutively found in
found in its
in its functional
its functional DNA
functional DNA binding
DNA binding form
binding form only
form only in
only in B
in B lymphocytes
A factor with
factor with apparently
with apparently indistinguishable
apparently indistinguishable sequence
indistinguishable sequence specificity
sequence specificity can
specificity can be
can be induced
be induced in
induced in many
in many other
many other cell
other cell types
cell types where
types where it
where it is
it is used
is used to
used to regulate
to regulate inducible
regulate inducible gene
inducible gene expression
For example kappa
example kappa B-related
kappa B-related sequences
B-related sequences have
sequences have been
have been shown
been shown to
shown to be
to be important
be important for
important for the
for the transcription
the transcription of
transcription of a
of a few
a few inducible
few inducible genes
inducible genes such
genes such as
such as the
as the interleukin
the interleukin 2
interleukin 2 receptor
2 receptor alpha-chain
receptor alpha-chain gene
alpha-chain gene and
gene and the
and the beta-interferon
the beta-interferon gene
However these genes
these genes are
genes are not
are not constitutively
not constitutively active
constitutively active in
active in B
in B lymphocytes
B lymphocytes suggesting
lymphocytes suggesting that
suggesting that other
that other regulatory
other regulatory mechanisms
regulatory mechanisms must
mechanisms must play
must play a
play a role
a role in
role in determining
in determining the
determining the patterns
the patterns of
patterns of expression
We have investigated
have investigated the
investigated the constitutive
the constitutive and
constitutive and inducible
and inducible transcriptional
inducible transcriptional activity
transcriptional activity mediated
activity mediated by
mediated by five
by five kappa
five kappa B-related
kappa B-related sequence
B-related sequence elements
sequence elements in
elements in two
in two different
two different cell
different cell types
We show that
show that in
that in S194
in S194 plasma
S194 plasma cells
plasma cells the
cells the activity
the activity of
activity of each
of each element
each element correlates
element correlates well
correlates well with
well with the
with the relative
the relative affinity
relative affinity of
affinity of B-cell-derived
of B-cell-derived NF-kappa
B-cell-derived NF-kappa B
NF-kappa B for
B for that
for that element
This leads to
leads to significantly
to significantly lower
significantly lower transcription
lower transcription enhancement
transcription enhancement by
enhancement by sites
by sites derived
sites derived from
derived from the
from the interleukin
the interleukin 2
interleukin 2 receptor
2 receptor or
receptor or T-cell
or T-cell receptor
T-cell receptor genes
receptor genes in
genes in S194
in S194 cells
However in either
in either EL-4
either EL-4 T
EL-4 T cells
T cells or
cells or S194
or S194 cells
S194 cells both
cells both lower-affinity
both lower-affinity sites
lower-affinity sites can
sites can be
can be significantly
be significantly induced
significantly induced by
induced by the
by the tax
the tax gene
tax gene product
gene product of
product of human
of human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type I
type I showing
I showing that
showing that NF-kappa
that NF-kappa B
NF-kappa B activity
B activity can
activity can be
can be modulated
be modulated even
modulated even in
even in a
in a B-cell
a B-cell line
B-cell line that
line that constitutively
that constitutively expresses
constitutively expresses this
expresses this factor
Specific depletion of
depletion of the
of the B-cell
the B-cell population
B-cell population induced
population induced by
induced by aberrant
by aberrant expression
aberrant expression of
expression of human
of human interferon
human interferon regulatory
interferon regulatory factor
regulatory factor 1
factor 1 gene
1 gene in
gene in transgenic
in transgenic mice
Interferons IFNs are
IFNs are well
are well known
well known both
known both as
both as antiviral
as antiviral proteins
antiviral proteins and
proteins and as
and as potent
as potent regulators
potent regulators of
regulators of cell
of cell growth
cell growth and
growth and differentiation
In fact IFNs
fact IFNs inhibit
IFNs inhibit growth
inhibit growth of
growth of various
of various normal
various normal and
normal and transformed
and transformed cell
transformed cell types
Previously a nuclear
a nuclear factor
nuclear factor IRF-1
factor IRF-1 interferon
IRF-1 interferon regulatory
interferon regulatory factor
regulatory factor 1
factor 1 which
1 which binds
which binds to
binds to type
to type I
type I IFN
I IFN and
IFN and some
and some IFN-inducible
some IFN-inducible gene
IFN-inducible gene promoters
gene promoters was
promoters was identified
was identified and
identified and cloned
Since the IRF-1
the IRF-1 gene
IRF-1 gene is
gene is both
is both virus
both virus and
virus and IFN
and IFN inducible
IFN inducible an
inducible an intriguing
an intriguing issue
intriguing issue is
issue is raised
is raised as
raised as to
as to whether
to whether the
whether the IRF-1
the IRF-1 gene
IRF-1 gene is
gene is functioning
is functioning in
functioning in IFN-mediated
in IFN-mediated regulation
IFN-mediated regulation of
regulation of cell
of cell growth
cell growth and
growth and differentiation
In this study
this study we
study we generated
we generated transgenic
generated transgenic mice
transgenic mice carrying
mice carrying the
carrying the human
the human IRF-1
human IRF-1 gene
IRF-1 gene linked
gene linked to
linked to the
to the human
the human immunoglobulin
human immunoglobulin heavy-chain
immunoglobulin heavy-chain enhancer
In the transgenic
the transgenic mice
transgenic mice all
mice all the
all the lymphoid
the lymphoid tissues
lymphoid tissues examined
tissues examined showed
examined showed a
showed a dramatic
a dramatic reduction
dramatic reduction in
reduction in the
in the number
the number of
number of B
of B lymphocytes
B lymphocytes B
lymphocytes B cells
Preparation and analysis
and analysis of
analysis of bone
of bone marrow
bone marrow cells
marrow cells from
cells from the
from the chimeric
the chimeric mice
chimeric mice indicated
mice indicated that
indicated that the
that the bone
the bone marrow
bone marrow is
marrow is the
is the effective
the effective site
effective site for
site for specific
for specific depletion
specific depletion of
depletion of the
of the B-cell
the B-cell population
In fact transgenic
fact transgenic bone
transgenic bone marrow
bone marrow cells
marrow cells cocultured
cells cocultured with
cocultured with a
with a bone
a bone marrow-derived
bone marrow-derived stromal
marrow-derived stromal cell
stromal cell line
cell line revealed
line revealed an
revealed an altered
an altered B-cell
altered B-cell maturation
B-cell maturation pattern
Characterization of a
of a cofactor
a cofactor that
cofactor that regulates
that regulates dimerization
regulates dimerization of
dimerization of a
of a mammalian
a mammalian homeodomain
mammalian homeodomain protein
Dimerization among transcription
among transcription factors
transcription factors has
factors has become
has become a
become a recurrent
a recurrent theme
recurrent theme in
theme in the
in the regulation
the regulation of
regulation of eukaryotic
of eukaryotic gene
eukaryotic gene expression
Hepatocyte nuclear factor-1
nuclear factor-1 alpha
factor-1 alpha HNF-1
alpha HNF-1 alpha
HNF-1 alpha is
alpha is a
is a homeodomain-containing
a homeodomain-containing protein
homeodomain-containing protein that
protein that functions
that functions as
functions as a
as a dimer
A dimerization cofactor
dimerization cofactor of
cofactor of HNF-1
of HNF-1 alpha
HNF-1 alpha DCoH
alpha DCoH was
DCoH was identified
was identified that
identified that displayed
that displayed a
displayed a restricted
a restricted tissue
restricted tissue distribution
tissue distribution and
distribution and did
and did not
did not bind
not bind to
bind to DNA
to DNA but
DNA but rather
but rather selectively
rather selectively stabilized
selectively stabilized HNF-1
stabilized HNF-1 alpha
HNF-1 alpha dimers
The formation of
formation of a
of a stable
a stable tetrameric
stable tetrameric DCoH-HNF-1
tetrameric DCoH-HNF-1 alpha
DCoH-HNF-1 alpha complex
alpha complex which
complex which required
which required the
required the dimerization
the dimerization domain
dimerization domain of
domain of HNF-1
of HNF-1 alpha
HNF-1 alpha did
alpha did not
did not change
not change the
change the DNA
the DNA binding
DNA binding characteristics
binding characteristics of
characteristics of HNF-1
of HNF-1 alpha
HNF-1 alpha but
alpha but enhanced
but enhanced its
enhanced its transcriptional
its transcriptional activity
However DCoH did
DCoH did not
did not confer
not confer transcriptional
confer transcriptional activation
transcriptional activation to
activation to the
to the GAL4
the GAL4 DNA
GAL4 DNA binding
DNA binding domain
These results indicate
results indicate that
indicate that DCoH
that DCoH regulates
DCoH regulates formation
regulates formation of
formation of transcriptionally
of transcriptionally active
transcriptionally active tetrameric
active tetrameric complexes
tetrameric complexes and
complexes and may
and may contribute
may contribute to
contribute to the
to the developmental
the developmental specificity
developmental specificity of
specificity of the
of the complex
Glucocorticoid resistance in
resistance in chronic
in chronic asthma
Glucocorticoid pharmacokinetics glucocorticoid
pharmacokinetics glucocorticoid receptor
glucocorticoid receptor characteristics
receptor characteristics and
characteristics and inhibition
and inhibition of
inhibition of peripheral
of peripheral blood
peripheral blood T
blood T cell
T cell proliferation
cell proliferation by
proliferation by glucocorticoids
by glucocorticoids in
glucocorticoids in vitro
A total of
total of 37
of 37 chronic
37 chronic severe
chronic severe nonsmoking
severe nonsmoking asthmatic
nonsmoking asthmatic patients
asthmatic patients with
patients with documented
with documented reversible
documented reversible airways
reversible airways obstruction
airways obstruction were
obstruction were classified
were classified as
classified as glucocorticoid-sensitive
as glucocorticoid-sensitive or
glucocorticoid-sensitive or -resistant
or -resistant on
-resistant on the
on the basis
the basis of
basis of changes
of changes in
changes in FEV1
in FEV1 FVC
FEV1 FVC and
FVC and peak
and peak expiratory
peak expiratory flow
expiratory flow PEF
flow PEF after
PEF after oral
after oral prednisolone
The resistant patients
resistant patients showed
patients showed no
showed no significant
no significant improvements
significant improvements in
improvements in airflow
in airflow limitation
Phytohemagglutinin PHA-induced proliferation
PHA-induced proliferation of
proliferation of peripheral
of peripheral blood
peripheral blood T
blood T lymphocytes
T lymphocytes from
lymphocytes from the
from the sensitive
the sensitive but
sensitive but not
but not the
not the resistant
the resistant asthmatic
resistant asthmatic patients
asthmatic patients was
patients was significantly
was significantly p
significantly p less
p less than
less than 001
than 001 inhibited
001 inhibited by
inhibited by dexamethasone
by dexamethasone 10-7
dexamethasone 10-7 mol/L
10-7 mol/L reflecting
mol/L reflecting a
reflecting a shift
a shift of
shift of the
of the dose-response
the dose-response curve
When all the
all the asthmatic
the asthmatic patients
asthmatic patients were
patients were analyzed
were analyzed together
analyzed together there
together there was
there was a
was a significant
a significant correlation
significant correlation between
correlation between the
between the degree
the degree of
degree of sensitivity
of sensitivity of
sensitivity of T
of T cells
T cells to
cells to dexamethasone
to dexamethasone and
dexamethasone and the
and the clinical
the clinical responsiveness
clinical responsiveness to
responsiveness to prednisolone
to prednisolone p
prednisolone p less
p less than
less than 001
No differences were
differences were observed
were observed between
observed between six
between six of
six of the
of the sensitive
the sensitive and
sensitive and resistant
and resistant patients
resistant patients in
patients in the
in the clearance
the clearance of
clearance of plasma
of plasma prednisolone
plasma prednisolone derived
prednisolone derived from
derived from orally
from orally administered
orally administered prednisone
Peripheral blood mononuclear
blood mononuclear cell
mononuclear cell glucocorticoid
cell glucocorticoid receptors
glucocorticoid receptors were
receptors were also
were also characterized
also characterized in
characterized in five
in five sensitive
five sensitive and
sensitive and seven
and seven resistant
seven resistant patients
The numbers and
numbers and binding
and binding affinities
binding affinities of
affinities of these
of these receptors
these receptors could
receptors could not
could not account
not account for
account for the
for the observed
the observed difference
observed difference in
difference in the
in the susceptibility
the susceptibility of
susceptibility of these
of these cells
these cells to
cells to functional
to functional inhibition
functional inhibition by
inhibition by dexamethasone
by dexamethasone in
dexamethasone in vitro
These results suggest
results suggest that
suggest that clinical
that clinical glucocorticoid
clinical glucocorticoid resistance
glucocorticoid resistance in
resistance in chronic
in chronic asthma
chronic asthma does
asthma does not
does not reflect
not reflect abnormal
reflect abnormal glucocorticoid
abnormal glucocorticoid clearance
glucocorticoid clearance but
clearance but may
but may be
may be due
be due at
due at least
at least partly
least partly to
partly to a
to a relative
a relative insensitivity
relative insensitivity of
insensitivity of T
of T lymphocytes
T lymphocytes to
lymphocytes to glucocorticoids
This lack of
lack of sensitivity
of sensitivity is
sensitivity is unexplained
is unexplained but
unexplained but is
but is not
is not attributable
not attributable to
attributable to abnormalities
to abnormalities of
abnormalities of cellular
of cellular glucocorticoid
cellular glucocorticoid receptors
Inhibition of phorbol
of phorbol ester-induced
phorbol ester-induced monocytic
ester-induced monocytic differentiation
monocytic differentiation by
differentiation by dexamethasone
by dexamethasone is
dexamethasone is associated
is associated with
associated with down-regulation
with down-regulation of
down-regulation of c-fos
of c-fos and
c-fos and c-jun
and c-jun AP-1
Previous studies have
studies have shown
have shown that
shown that treatment
that treatment of
treatment of human
of human myeloid
human myeloid leukemia
myeloid leukemia cells
leukemia cells with
cells with 12-O-tetradecanoylphorbol-13-acetate
with 12-O-tetradecanoylphorbol-13-acetate TPA
12-O-tetradecanoylphorbol-13-acetate TPA is
TPA is associated
is associated with
associated with induction
with induction of
induction of monocytic
of monocytic differentiation
monocytic differentiation and
differentiation and expression
and expression of
expression of the
of the c-jun
the c-jun and
c-jun and c-fos
and c-fos early
c-fos early response
early response genes
The present work
present work demonstrates
work demonstrates that
demonstrates that the
that the glucocorticoid
the glucocorticoid dexamethasone
glucocorticoid dexamethasone inhibits
dexamethasone inhibits TPA-induced
inhibits TPA-induced increases
TPA-induced increases in
increases in c-jun
in c-jun and
c-jun and c-fos
and c-fos mRNA
c-fos mRNA levels
mRNA levels in
levels in U-937
in U-937 leukemia
U-937 leukemia cells
These findings were
findings were associated
were associated with
associated with a
with a block
a block in
block in appearance
in appearance of
appearance of the
of the monocytic
the monocytic phenotype
monocytic phenotype including
phenotype including inhibition
including inhibition of
inhibition of TPA-induced
of TPA-induced increases
TPA-induced increases in
increases in lamin
in lamin A
lamin A lamin
A lamin C
lamin C and
C and vimentin
and vimentin transcripts
Other studies have
studies have demonstrated
have demonstrated that
demonstrated that TPA-induced
that TPA-induced monocytic
TPA-induced monocytic differentiation
monocytic differentiation and
differentiation and expression
and expression of
expression of the
of the c-jun
the c-jun and
c-jun and c-fos
and c-fos genes
c-fos genes in
genes in myeloid
in myeloid leukemia
myeloid leukemia cells
leukemia cells are
cells are regulated
are regulated by
regulated by protein
by protein kinase
protein kinase C
kinase C PKC
The finding that
finding that dexamethasone
that dexamethasone has
dexamethasone has no
has no effect
no effect on
effect on TPA-induced
on TPA-induced activation
TPA-induced activation of
activation of PKC
of PKC suggests
PKC suggests that
suggests that this
that this glucocorticoid
this glucocorticoid inhibits
glucocorticoid inhibits signals
inhibits signals downstream
signals downstream or
downstream or parallel
or parallel to
parallel to this
to this enzyme
Nuclear run-on assays
run-on assays demonstrate
assays demonstrate that:
demonstrate that: 1
that: 1 induction
1 induction of
induction of c-jun
of c-jun and
c-jun and c-fos
and c-fos expression
c-fos expression by
expression by TPA
by TPA is
TPA is regulated
is regulated by
regulated by transcriptional
by transcriptional mechanisms
transcriptional mechanisms 2
mechanisms 2 TPA-induced
2 TPA-induced expression
TPA-induced expression of
expression of c-jun
of c-jun and
c-jun and c-fos
and c-fos does
c-fos does not
does not require
not require protein
require protein synthesis
protein synthesis and
synthesis and 3
and 3 TPA-induced
3 TPA-induced expression
TPA-induced expression of
expression of both
of both genes
both genes is
genes is inhibited
is inhibited at
inhibited at the
at the transcriptional
the transcriptional level
transcriptional level by
level by dexamethasone
To further define
further define the
define the effects
the effects of
effects of dexamethasone
of dexamethasone at
dexamethasone at the
at the molecular
the molecular level
molecular level we
level we prepared
we prepared a
prepared a series
a series of
series of deleted
of deleted c-jun
deleted c-jun promoter
c-jun promoter fragments
promoter fragments linked
fragments linked to
linked to the
to the chloramphenicol
the chloramphenicol acetyltransferase
chloramphenicol acetyltransferase CAT
acetyltransferase CAT gene
Increases in CAT
in CAT activity
CAT activity during
activity during transient
during transient expression
transient expression of
expression of these
of these constructs
these constructs in
constructs in TPA-treated
in TPA-treated U-937
TPA-treated U-937 cells
U-937 cells could
cells could be
could be assigned
be assigned to
assigned to the
to the region
the region -97
region -97 to
-97 to -20
to -20 of
-20 of the
of the promoter
the promoter that
promoter that contains
that contains the
contains the AP-1
the AP-1 binding
AP-1 binding site
This induction of
induction of CAT
of CAT activity
CAT activity was
activity was sensitive
was sensitive to
sensitive to dexamethasone
These findings suggest
findings suggest that
suggest that dexamethasone
that dexamethasone down-regulates
dexamethasone down-regulates TPA-induced
down-regulates TPA-induced transcription
TPA-induced transcription of
transcription of the
of the c-jun
the c-jun gene
c-jun gene during
gene during monocytic
during monocytic differentiation
monocytic differentiation by
differentiation by inhibiting
by inhibiting activation
inhibiting activation of
activation of the
of the AP-1
the AP-1 site
Tumor necrosis factor-alpha
necrosis factor-alpha mRNA
factor-alpha mRNA accumulation
mRNA accumulation in
accumulation in human
in human myelomonocytic
human myelomonocytic cell
myelomonocytic cell lines
Role of transcriptional
of transcriptional regulation
transcriptional regulation by
regulation by DNA
by DNA sequence
DNA sequence motifs
sequence motifs and
motifs and mRNA
and mRNA stabilization
The cytokine TNF
cytokine TNF mediates
TNF mediates many
mediates many of
many of the
of the pathologic
the pathologic signs
pathologic signs of
signs of cachexia
of cachexia inflammation
cachexia inflammation and
inflammation and sepsis
The current work
current work describes
work describes the
describes the regulation
the regulation of
regulation of TNF
of TNF in
TNF in human
in human myelomonocytic
human myelomonocytic cell
myelomonocytic cell lines
cell lines after
lines after PMA
after PMA stimulation
The cell lines
cell lines exhibit
lines exhibit a
exhibit a low
a low level
low level of
level of constitutive
of constitutive TNF
constitutive TNF mRNA
TNF mRNA expression
Within 2 to
2 to 4
to 4 h
4 h of
h of PMA
of PMA exposure
PMA exposure steady
exposure steady state
steady state levels
state levels of
levels of TNF
of TNF mRNA
TNF mRNA are
mRNA are markedly
are markedly elevated
markedly elevated in
elevated in all
in all myelomonocytic
all myelomonocytic cell
myelomonocytic cell lines
cell lines studied
This rise is
rise is due
is due to
due to increased
to increased mRNA
increased mRNA stability
mRNA stability which
stability which increased
which increased by
increased by almost
by almost twofold
almost twofold and
twofold and to
and to an
to an overall
an overall increase
overall increase in
increase in transcription
in transcription which
transcription which rises
which rises by
rises by more
by more than
more than sixfold
At the level
the level of
level of the
of the genomic
the genomic TNF
genomic TNF gene
TNF gene a
gene a DNase
a DNase I
DNase I hypersensitive
I hypersensitive site
hypersensitive site is
site is detected
is detected within
detected within the
within the TNF
the TNF promoter
TNF promoter between
promoter between -200
between -200 to
-200 to -100
to -100 bp
-100 bp relative
bp relative to
relative to the
to the transcription
the transcription initiation
transcription initiation site
Although absent in
absent in nonexpressing
in nonexpressing erythroleukemia
nonexpressing erythroleukemia cell
erythroleukemia cell lines
cell lines the
lines the DNase
the DNase I
DNase I site
I site is
site is present
is present in
present in uninduced
in uninduced myelomonocytic
uninduced myelomonocytic cell
myelomonocytic cell lines
cell lines and
lines and is
and is not
is not changed
not changed after
changed after PMA
after PMA induction
The PMA induction
PMA induction of
induction of c-fos
of c-fos mRNA
c-fos mRNA correlated
mRNA correlated well
correlated well with
well with TNF
with TNF gene
TNF gene induction;
gene induction; expression
induction; expression of
expression of genes
of genes encoding
genes encoding other
encoding other proteins
other proteins in
proteins in the
in the AP-1
the AP-1 complex
AP-1 complex junB
complex junB and
junB and junD
and junD were
junD were also
were also induced
also induced by
induced by PMA
The nuclear extracts
nuclear extracts from
extracts from resting
from resting and
resting and induced
and induced ML-1
induced ML-1 cells
ML-1 cells contain
cells contain proteins
contain proteins binding
proteins binding specifically
binding specifically to
specifically to the
to the AP-1
the AP-1 AP-2
AP-1 AP-2 and
AP-2 and NF
and NF kappa
NF kappa B
kappa B sequence
B sequence located
sequence located within
located within the
within the TNF
the TNF promoter
PMA induction increases
induction increases the
increases the level
the level of
level of a
of a number
a number of
number of specific
of specific binding
specific binding complexes
binding complexes relative
complexes relative to
relative to the
to the resting
the resting cells
The regulatory mechanisms
regulatory mechanisms of
mechanisms of the
of the human
the human and
human and murine
and murine TNF
murine TNF genes
TNF genes are
genes are discussed
Enhancement of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus 1
virus 1 replication
1 replication in
replication in monocytes
in monocytes by
monocytes by 125-dihydroxycholecalciferol
Human immunodeficiency virus
immunodeficiency virus HIV
virus HIV expression
HIV expression and
expression and replication
and replication are
replication are under
are under tight
under tight regulatory
tight regulatory control
We demonstrate that
demonstrate that 125-dihydroxycholecalciferol
that 125-dihydroxycholecalciferol [125-OH2D3]
125-dihydroxycholecalciferol [125-OH2D3] enhances
[125-OH2D3] enhances the
enhances the replication
the replication of
replication of monocyte-
of monocyte- and
monocyte- and lymphocyte-tropic
and lymphocyte-tropic strains
lymphocyte-tropic strains of
strains of HIV-1
of HIV-1 up
HIV-1 up to
up to 10000-fold
to 10000-fold in
10000-fold in monocyte
in monocyte cell
monocyte cell lines
cell lines peripheral
lines peripheral blood
peripheral blood monocytes
blood monocytes and
monocytes and unfractionated
and unfractionated peripheral
unfractionated peripheral blood
peripheral blood mononuclear
blood mononuclear cells
125OH2D3 is therefore
is therefore one
therefore one of
one of the
of the most
the most potent
most potent regulators
potent regulators of
regulators of HIV-1
of HIV-1 replication
HIV-1 replication described
replication described to
described to date
Precursors of 125OH2D3
of 125OH2D3 enhance
125OH2D3 enhance HIV-1
enhance HIV-1 replication
HIV-1 replication in
replication in proportion
in proportion to
proportion to their
to their affinity
their affinity for
affinity for the
for the 125OH2D3
the 125OH2D3 intracellular
125OH2D3 intracellular receptor
intracellular receptor suggesting
receptor suggesting that
suggesting that 125OH2D3
that 125OH2D3 influences
125OH2D3 influences HIV-1
influences HIV-1 replication
HIV-1 replication by
replication by mechanisms
by mechanisms involving
mechanisms involving this
involving this receptor
These studies may
studies may have
may have important
have important implications
important implications for
implications for the
for the design
the design of
design of effective
of effective therapy
effective therapy of
therapy of HIV-1
of HIV-1 infection
Transforming growth factor-beta
growth factor-beta suppresses
factor-beta suppresses human
suppresses human B
human B lymphocyte
B lymphocyte Ig
lymphocyte Ig production
Ig production by
production by inhibiting
by inhibiting synthesis
inhibiting synthesis and
synthesis and the
and the switch
the switch from
switch from the
from the membrane
the membrane form
membrane form to
form to the
to the secreted
the secreted form
secreted form of
form of Ig
of Ig mRNA
Transforming growth factor-beta
growth factor-beta TGF-beta
factor-beta TGF-beta inhibits
TGF-beta inhibits B
inhibits B cell
B cell Ig
cell Ig secretion
Ig secretion and
secretion and reduces
and reduces B
reduces B cell
B cell membrane
cell membrane Ig
membrane Ig expression
The addition of
addition of TGF-beta
of TGF-beta to
TGF-beta to human
to human B
human B lymphocyte
B lymphocyte cultures
lymphocyte cultures stimulated
cultures stimulated with
stimulated with Staphylococcus
with Staphylococcus aureus
Staphylococcus aureus Cowan
aureus Cowan strain
Cowan strain I
strain I and
I and IL-2
and IL-2 completely
IL-2 completely inhibited
completely inhibited B
inhibited B cell
B cell Ig
cell Ig secretion
Ig secretion greater
secretion greater than
greater than 90%
than 90% and
90% and decreased
and decreased B
decreased B cell
B cell surface
cell surface IgM
surface IgM IgD
IgM IgD kappa
IgD kappa L
kappa L chain
L chain and
chain and lambda
and lambda L
lambda L chain
L chain expression
In contrast TGF-beta
contrast TGF-beta had
TGF-beta had only
had only minimal
only minimal effects
minimal effects on
effects on two
on two other
two other B
other B cell
B cell membrane
cell membrane proteins
membrane proteins HLA-DR
proteins HLA-DR and
HLA-DR and CD20
Internal labeling with
labeling with [35S]methionine
with [35S]methionine and
[35S]methionine and immunoprecipitation
and immunoprecipitation with
immunoprecipitation with anti-IgM
with anti-IgM anti-kappa
anti-IgM anti-kappa and
anti-kappa and anti-lambda
and anti-lambda antibodies
anti-lambda antibodies revealed
antibodies revealed a
revealed a striking
a striking reduction
striking reduction in
reduction in kappa
in kappa L
kappa L chain
L chain in
chain in the
in the presence
the presence of
presence of TGF-beta
A less pronounced
less pronounced reduction
pronounced reduction in
reduction in lambda
in lambda L
lambda L chain
L chain and
chain and microH
and microH chain
microH chain was
chain was also
was also noted
Northern blot analysis
blot analysis of
analysis of RNA
of RNA purified
RNA purified from
purified from B
from B cells
B cells treated
cells treated with
treated with TGF-beta
with TGF-beta for
TGF-beta for varying
for varying time
varying time intervals
time intervals revealed
intervals revealed a
revealed a significant
a significant decrease
significant decrease in
decrease in steady
in steady state
steady state kappa
state kappa and
kappa and lambda
and lambda L
lambda L chain
L chain mRNA
chain mRNA levels
Furthermore a significant
a significant decrease
significant decrease in
decrease in the
in the switch
the switch from
switch from the
from the membrane
the membrane forms
membrane forms of
forms of mu
of mu and
mu and gamma
and gamma to
gamma to their
to their respective
their respective secreted
respective secreted forms
secreted forms was
forms was noted
was noted in
noted in the
in the presence
the presence of
presence of TGF-beta
Nuclear run-on experiments
run-on experiments demonstrated
experiments demonstrated decreased
demonstrated decreased transcription
decreased transcription of
transcription of kappa
of kappa L
kappa L chain
The effects of
effects of TGF-beta
of TGF-beta on
TGF-beta on two
on two transcriptional
two transcriptional regulatory
transcriptional regulatory factors
regulatory factors Oct-2
factors Oct-2 and
Oct-2 and nuclear
and nuclear factor
nuclear factor NF
factor NF kappa
NF kappa B
kappa B known
B known to
known to be
to be important
be important in
important in Ig
in Ig gene
Ig gene transcription
gene transcription were
transcription were examined
Oct-2 mRNA levels
mRNA levels and
levels and both
and both Oct-2
both Oct-2 and
Oct-2 and NF-kappa
and NF-kappa B
NF-kappa B proteins
B proteins in
proteins in nuclear
in nuclear extracts
nuclear extracts were
extracts were not
were not altered
not altered by
altered by treatment
by treatment with
treatment with TGF-beta
In contrast levels
contrast levels of
levels of the
of the transcriptional
the transcriptional factor
transcriptional factor AP-1
factor AP-1 which
AP-1 which is
which is not
is not known
not known to
known to be
to be important
be important in
important in B
in B cell
B cell Ig
cell Ig production
Ig production were
production were reduced
were reduced by
reduced by TGF-beta
These findings demonstrate
findings demonstrate that
demonstrate that TGF-beta
that TGF-beta decreases
TGF-beta decreases B
decreases B lymphocyte
B lymphocyte Ig
lymphocyte Ig secretion
Ig secretion by
secretion by inhibiting
by inhibiting the
inhibiting the synthesis
the synthesis of
synthesis of Ig
of Ig mRNA
Ig mRNA and
mRNA and inhibiting
and inhibiting the
inhibiting the switch
the switch from
switch from the
from the membrane
the membrane form
membrane form to
form to the
to the secreted
the secreted forms
secreted forms of
forms of mu
of mu and
mu and gamma
and gamma mRNA
The mechanism by
mechanism by which
by which TGF-beta
which TGF-beta inhibits
TGF-beta inhibits Ig
inhibits Ig chain
Ig chain synthesis
chain synthesis is
synthesis is unclear
is unclear although
unclear although it
although it does
it does not
does not involve
not involve inhibition
involve inhibition of
inhibition of the
of the binding
the binding of
binding of NF-kappa
of NF-kappa B
NF-kappa B or
B or Oct-2
or Oct-2 to
Oct-2 to their
to their respective
their respective target
respective target sequences
Murine and human
and human T-lymphocyte
human T-lymphocyte GATA-3
T-lymphocyte GATA-3 factors
GATA-3 factors mediate
factors mediate transcription
mediate transcription through
transcription through a
through a cis-regulatory
a cis-regulatory element
cis-regulatory element within
element within the
within the human
the human T-cell
human T-cell receptor
T-cell receptor delta
receptor delta gene
delta gene enhancer
A family of
family of transcriptional
of transcriptional activators
transcriptional activators has
activators has recently
has recently been
recently been identified
been identified in
identified in chickens;
in chickens; these
chickens; these transcriptional
these transcriptional activators
transcriptional activators recognize
activators recognize a
recognize a common
a common consensus
common consensus motif
consensus motif WGATAR
motif WGATAR through
WGATAR through a
through a conserved
a conserved C4
conserved C4 zinc
C4 zinc finger
zinc finger DNA-binding
finger DNA-binding domain
One of the
of the members
the members of
members of this
of this multigene
this multigene family
multigene family cGATA-3
family cGATA-3 is
cGATA-3 is most
is most abundantly
most abundantly expressed
abundantly expressed in
expressed in the
in the T-lymphocyte
the T-lymphocyte cell
T-lymphocyte cell lineage
Analysis of human
of human and
human and murine
and murine GATA-3
murine GATA-3 factors
GATA-3 factors shows
factors shows a
shows a striking
a striking degree
striking degree of
degree of amino
of amino acid
amino acid sequence
acid sequence identity
sequence identity and
identity and similar
and similar patterns
similar patterns of
patterns of tissue
of tissue specificity
tissue specificity of
specificity of expression
of expression in
expression in these
in these three
these three organisms
The murine and
murine and human
and human factors
human factors are
factors are abundantly
are abundantly expressed
abundantly expressed in
expressed in a
in a variety
a variety of
variety of human
of human and
human and murine
and murine T-cell
murine T-cell lines
T-cell lines and
lines and can
and can activate
can activate transcription
activate transcription through
transcription through a
through a tissue-specific
a tissue-specific GATA-binding
tissue-specific GATA-binding site
GATA-binding site identified
site identified within
identified within the
within the human
the human T-cell
human T-cell receptor
T-cell receptor delta
receptor delta gene
delta gene enhancer
We infer that
infer that the
that the murine
the murine and
murine and human
and human GATA-3
human GATA-3 proteins
GATA-3 proteins play
proteins play a
play a central
a central and
central and highly
and highly conserved
highly conserved role
conserved role in
role in vertebrate
in vertebrate T-cell-specific
vertebrate T-cell-specific transcriptional
T-cell-specific transcriptional regulation
Processing of the
of the precursor
the precursor of
precursor of NF-kappa
of NF-kappa B
NF-kappa B by
B by the
by the HIV-1
the HIV-1 protease
HIV-1 protease during
protease during acute
during acute infection
Transcription of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type-1
virus type-1 HIV-1
type-1 HIV-1 genome
HIV-1 genome is
genome is regulated
is regulated in
regulated in part
in part by
part by cellular
by cellular factors
cellular factors and
factors and is
and is stimulated
is stimulated by
stimulated by activation
by activation of
activation of latently
of latently infected
latently infected T
infected T cells
T-cell activation also
activation also correlates
also correlates with
correlates with the
with the induction
the induction of
induction of the
of the factor
the factor NF-kappa
factor NF-kappa B
NF-kappa B which
B which binds
which binds to
binds to two
to two adjacent
two adjacent sites
adjacent sites in
sites in the
in the HIV-1
the HIV-1 long
HIV-1 long terminal
long terminal repeat
This factor consists
factor consists of
consists of two
of two DNA-binding
two DNA-binding subunits
DNA-binding subunits of
subunits of relative
of relative molecular
relative molecular mass
molecular mass 50000
mass 50000 50K
50000 50K associated
50K associated with
associated with two
with two 65K
two 65K subunits
It is located
is located in
located in the
in the nucleus
the nucleus in
nucleus in mature
in mature B
mature B cells
B cells but
cells but is
but is present
is present in
present in other
in other cell
other cell types
cell types as
types as an
as an inactive
an inactive cytoplasmic
inactive cytoplasmic complex
External stimuli including
stimuli including those
including those that
those that activate
that activate T
activate T cells
T cells result
cells result in
result in nuclear
in nuclear translocation
nuclear translocation of
translocation of active
of active NF-kappa
active NF-kappa B
The cloning of
cloning of the
of the complementary
the complementary DNA
complementary DNA for
DNA for the
for the 50K
the 50K subunit
50K subunit helped
subunit helped to
helped to identify
to identify an
identify an exclusively
an exclusively cytoplasmic
exclusively cytoplasmic 105K
cytoplasmic 105K precursor
105K precursor p105
precursor p105 VB
p105 VB PK
VB PK and
PK and AI
and AI manuscript
AI manuscript submitted
The expression of
expression of active
of active NF-kappa
active NF-kappa B
NF-kappa B might
B might therefore
might therefore also
therefore also be
also be regulated
be regulated by
regulated by the
by the extent
the extent of
extent of processing
of processing of
processing of p105
Because HIV-1 requires
HIV-1 requires active
requires active NF-kappa
active NF-kappa B
NF-kappa B for
B for efficient
for efficient transcription
efficient transcription we
transcription we tested
we tested the
tested the effect
the effect of
effect of HIV-1
of HIV-1 infection
HIV-1 infection on
infection on the
on the processing
the processing of
processing of the
of the human
the human 105K
human 105K precursor
We show here
show here that
here that the
that the HIV-1
the HIV-1 protease
HIV-1 protease can
protease can process
can process p105
process p105 and
p105 and increases
and increases levels
increases levels of
levels of active
of active nuclear
active nuclear NF-kappa
nuclear NF-kappa B
NF-kappa B complex
125-Dihydroxyvitamin D3 receptor
D3 receptor RNA:
receptor RNA: expression
RNA: expression in
expression in hematopoietic
in hematopoietic cells
125-Dihydroxyvitamin D3 [125OH2D3]
D3 [125OH2D3] induces
[125OH2D3] induces differentiation
induces differentiation and
differentiation and inhibits
and inhibits proliferation
inhibits proliferation of
proliferation of myeloid
of myeloid leukemic
myeloid leukemic cells
leukemic cells from
cells from various
from various lines
various lines and
lines and patients;
and patients; these
patients; these effects
these effects are
effects are probably
are probably mediated
probably mediated through
mediated through the
through the 125OH2D3
the 125OH2D3 receptor
Little is known
is known of
known of expression
of expression of
expression of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA in
RNA in hematopoietic
in hematopoietic cells
We examined the
examined the expression
the expression and
expression and modulation
and modulation of
modulation of expression
of expression of
expression of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA in
RNA in various
in various proliferating
various proliferating and
proliferating and nonproliferating
and nonproliferating hematopoietic
nonproliferating hematopoietic cells
Constitutive expression of
expression of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA was
RNA was detected
was detected in
detected in various
in various kinds
various kinds of
kinds of hematopoietic
of hematopoietic cells
hematopoietic cells including
cells including macrophages
including macrophages and
macrophages and activated
and activated T
activated T lymphocytes
T lymphocytes as
lymphocytes as well
as well as
well as in
as in cell
in cell lines
cell lines KG-1
lines KG-1 myeloblasts
KG-1 myeloblasts HL-60
myeloblasts HL-60 promyelocytes
HL-60 promyelocytes ML-3
promyelocytes ML-3 myelomonoblasts
ML-3 myelomonoblasts U937
myelomonoblasts U937 THP-1
U937 THP-1 monoblasts
THP-1 monoblasts K562
monoblasts K562 erythroblasts
K562 erythroblasts and
erythroblasts and S-LB1
and S-LB1 HTLV-1-transfected
S-LB1 HTLV-1-transfected T
HTLV-1-transfected T lymphocytes
Receptor transcripts were
transcripts were 46
were 46 kilobases
46 kilobases kb
kilobases kb and
kb and no
and no variant
no variant sizes
variant sizes were
sizes were observed
All cell lines
cell lines examined
lines examined in
examined in this
in this group
this group also
group also expressed
also expressed 125OH2D3
expressed 125OH2D3 receptors
Most B lymphocyte
B lymphocyte lines
lymphocyte lines expressed
lines expressed negligible
expressed negligible levels
negligible levels of
levels of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA and
RNA and protein;
and protein; however;
protein; however; analysis
however; analysis of
analysis of a
of a lymphoid/myeloid
a lymphoid/myeloid somatic
lymphoid/myeloid somatic hybrid
somatic hybrid suggested
hybrid suggested that
suggested that suppression
that suppression of
suppression of expression
of expression of
expression of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA in
RNA in B
in B lymphocytes
B lymphocytes may
lymphocytes may be
may be a
be a dominant
a dominant characteristic
HL-60 cells were
cells were cultured
were cultured with
cultured with 10-7
with 10-7 mol/L
10-7 mol/L 125OH2D3
mol/L 125OH2D3 for
125OH2D3 for 24
for 24 to
24 to 72
to 72 hours
72 hours and
hours and levels
and levels of
levels of expression
of expression of
expression of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor and
receptor and its
and its RNA
its RNA were
RNA were examined
Levels of RNA
of RNA coding
RNA coding for
coding for the
for the receptor
the receptor were
receptor were not
were not modulated
not modulated by
modulated by exposure
by exposure to
exposure to high
to high levels
high levels of
levels of ligand
Levels of occupied
of occupied 125OH2D3
occupied 125OH2D3 receptor
125OH2D3 receptor protein
receptor protein increased
protein increased in
increased in these
in these HL-60
these HL-60 cells;
HL-60 cells; but
cells; but the
but the total
the total number
total number of
number of 125OH2D3
of 125OH2D3 receptors
125OH2D3 receptors decreased
receptors decreased about
decreased about 50%
about 50% at
50% at 24
at 24 hours
24 hours and
hours and returned
and returned toward
returned toward normal
toward normal at
normal at 72
at 72 hours
Steady-state levels of
levels of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA were
RNA were not
were not affected
not affected by
affected by terminal
by terminal differentiation
terminal differentiation of
differentiation of HL-60
of HL-60 toward
HL-60 toward either
toward either granulocytes
either granulocytes or
granulocytes or macrophages
Nondividing macrophages from
macrophages from normal
from normal individuals
normal individuals also
individuals also expressed
also expressed 125OH2D3
expressed 125OH2D3 receptor
125OH2D3 receptor RNA
In contrast nondividing
contrast nondividing peripheral
nondividing peripheral blood
peripheral blood lymphocytes
blood lymphocytes from
lymphocytes from normal
from normal individuals
normal individuals did
individuals did not
did not express
not express 125OH2D3
express 125OH2D3 receptor
125OH2D3 receptor RNA;
receptor RNA; with
RNA; with stimulation
with stimulation of
stimulation of proliferation
of proliferation of
proliferation of these
of these cells
these cells accumulation
cells accumulation of
accumulation of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA increased
RNA increased markedly
Half-life t1/2 of
t1/2 of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA in
RNA in T
in T lymphocytes
T lymphocytes was
lymphocytes was short
was short 1
short 1 hour
1 hour as
hour as determined
as determined by
determined by measuring
by measuring decay
measuring decay of
decay of the
of the message
the message after
message after addition
after addition of
addition of actinomycin
of actinomycin D
Consistent with this
with this short
this short t1/2
short t1/2 accumulation
t1/2 accumulation of
accumulation of 125OH2D3
of 125OH2D3 receptor
125OH2D3 receptor RNA
receptor RNA increased
RNA increased in
increased in cells
in cells as
cells as their
as their protein
their protein synthesis
protein synthesis was
synthesis was inhibited
Further studies are
studies are required
are required to
required to understand
to understand the
understand the physiologic
the physiologic role
physiologic role of
role of 125OH2D3
of 125OH2D3 receptors
125OH2D3 receptors in
receptors in myeloid
in myeloid cells
myeloid cells and
cells and proliferating
and proliferating T
proliferating T lymphocytes
Expression of c-jun
of c-jun jun
c-jun jun B
jun B and
B and jun
and jun D
jun D proto-oncogenes
D proto-oncogenes in
proto-oncogenes in human
in human peripheral-blood
human peripheral-blood granulocytes
We have found
have found that
found that purified
that purified human
purified human peripheral-blood
human peripheral-blood granulocytes
peripheral-blood granulocytes express
granulocytes express constitutively
express constitutively significant
constitutively significant levels
significant levels of
levels of proto-oncogenes
of proto-oncogenes c-jun
proto-oncogenes c-jun jun
c-jun jun B
jun B and
B and jun
and jun D
jun D mRNA
Upon functional activation
functional activation of
activation of granulocytes
of granulocytes by
granulocytes by 4
by 4 beta-phorbol
4 beta-phorbol 12-myristate
beta-phorbol 12-myristate 13-acetate
12-myristate 13-acetate PMA
13-acetate PMA the
PMA the levels
the levels of
levels of c-jun
of c-jun jun
c-jun jun B
jun B and
B and jun
and jun D
jun D transcripts
D transcripts were
transcripts were increased
The three jun
three jun genes
jun genes showed
genes showed a
showed a similar
a similar time
similar time course
time course in
course in their
in their induction
their induction by
induction by PMA
by PMA maximal
PMA maximal mRNA
maximal mRNA levels
mRNA levels being
levels being reached
being reached after
reached after 60
after 60 min
60 min of
min of induction
These results suggest
results suggest that
suggest that expression
that expression of
expression of c-jun
of c-jun jun
c-jun jun B
jun B and
B and jun
and jun D
jun D genes
D genes might
genes might be
might be involved
be involved in
involved in terminal
in terminal granulocyte
terminal granulocyte differentiation
granulocyte differentiation or
differentiation or in
or in regulating
in regulating granulocyte
regulating granulocyte functionality
The 29-kDa proteins
29-kDa proteins phosphorylated
proteins phosphorylated in
phosphorylated in thrombin-activated
in thrombin-activated human
thrombin-activated human platelets
human platelets are
platelets are forms
are forms of
forms of the
of the estrogen
the estrogen receptor-related
estrogen receptor-related 27-kDa
receptor-related 27-kDa heat
27-kDa heat shock
heat shock protein
Thrombin plays a
plays a critical
a critical role
critical role in
role in platelet
in platelet activation
platelet activation hemostasis
activation hemostasis and
hemostasis and thrombosis
Cellular activation by
activation by thrombin
by thrombin leads
thrombin leads to
leads to the
to the phosphorylation
the phosphorylation of
phosphorylation of multiple
of multiple proteins
multiple proteins most
proteins most of
most of which
of which are
which are unidentified
We have characterized
have characterized several
characterized several 29-kDa
several 29-kDa proteins
29-kDa proteins that
proteins that are
that are rapidly
are rapidly phosphorylated
rapidly phosphorylated following
phosphorylated following exposure
following exposure of
exposure of intact
of intact human
intact human platelets
human platelets to
platelets to thrombin
A murine monoclonal
murine monoclonal antibody
monoclonal antibody raised
antibody raised to
raised to an
to an unidentified
an unidentified estrogen
unidentified estrogen receptor-related
estrogen receptor-related 29-kDa
receptor-related 29-kDa protein
29-kDa protein selectively
protein selectively recognized
selectively recognized these
recognized these proteins
these proteins as
proteins as well
as well as
well as a
as a more
a more basic
more basic unphosphorylated
basic unphosphorylated 27-kDa
unphosphorylated 27-kDa protein
Cellular activation by
activation by thrombin
by thrombin led
thrombin led to
led to a
to a marked
a marked shift
marked shift in
shift in the
in the proportion
the proportion of
proportion of protein
of protein from
protein from the
from the 27-kDa
the 27-kDa unphosphorylated
27-kDa unphosphorylated form
unphosphorylated form to
form to the
to the 29-kDa
the 29-kDa phosphoprotein
29-kDa phosphoprotein species
Using this antibody
this antibody we
antibody we isolated
we isolated and
isolated and sequenced
and sequenced a
sequenced a human
a human cDNA
human cDNA clone
cDNA clone encoding
clone encoding a
encoding a protein
a protein that
protein that was
that was identical
was identical to
identical to the
to the mammalian
the mammalian 27-kDa
mammalian 27-kDa heat
27-kDa heat shock
heat shock protein
shock protein HSP27
protein HSP27 a
HSP27 a protein
a protein of
protein of uncertain
of uncertain function
uncertain function that
function that is
that is known
is known to
known to be
to be phosphorylated
be phosphorylated to
phosphorylated to several
to several forms
several forms and
forms and to
and to be
to be transcriptionally
be transcriptionally induced
transcriptionally induced by
induced by estrogen
The 29-kDa proteins
29-kDa proteins were
proteins were confirmed
were confirmed to
confirmed to be
to be phosphorylated
be phosphorylated forms
phosphorylated forms of
forms of HSP27
of HSP27 by
HSP27 by immunoprecipitation
by immunoprecipitation studies
Thus the "estrogen
the "estrogen receptor-related
"estrogen receptor-related protein"
receptor-related protein" is
protein" is HSP27
is HSP27 and
HSP27 and the
and the three
the three major
three major 29-kDa
major 29-kDa proteins
29-kDa proteins phosphorylated
proteins phosphorylated in
phosphorylated in thrombin-activated
in thrombin-activated platelets
thrombin-activated platelets are
platelets are forms
are forms of
forms of HSP27
These data suggest
data suggest a
suggest a role
a role for
role for HSP27
for HSP27 in
HSP27 in the
in the signal
the signal transduction
signal transduction events
transduction events of
events of platelet
of platelet activation
Isolation of a
of a candidate
a candidate repressor/activator
candidate repressor/activator NF-E1
repressor/activator NF-E1 YY-1
NF-E1 YY-1 delta
YY-1 delta that
delta that binds
that binds to
binds to the
to the immunoglobulin
the immunoglobulin kappa
immunoglobulin kappa 3'
kappa 3' enhancer
3' enhancer and
enhancer and the
and the immunoglobulin
the immunoglobulin heavy-chain
immunoglobulin heavy-chain mu
heavy-chain mu E1
mu E1 site
We have determined
have determined that
determined that the
that the developmental
the developmental control
developmental control of
control of immunoglobulin
of immunoglobulin kappa
immunoglobulin kappa 3'
kappa 3' enhancer
3' enhancer kappa
enhancer kappa E3'
kappa E3' activity
E3' activity is
activity is the
is the result
the result of
result of the
of the combined
the combined influence
combined influence of
influence of positive-
of positive- and
positive- and negative-acting
and negative-acting elements
We show that
show that a
that a central
a central core
central core in
core in the
in the kappa
the kappa E3'
kappa E3' enhancer
E3' enhancer is
enhancer is active
is active at
active at the
at the pre-B-cell
the pre-B-cell stage
pre-B-cell stage but
stage but is
but is repressed
is repressed by
repressed by flanking
by flanking negative-acting
flanking negative-acting elements
The negative-acting sequences
negative-acting sequences repress
sequences repress enhancer
repress enhancer activity
enhancer activity in
activity in a
in a position-
a position- and
position- and orientation-independent
and orientation-independent manner
orientation-independent manner at
manner at the
at the pre-B-cell
the pre-B-cell stage
We have isolated
have isolated a
isolated a human
a human cDNA
human cDNA clone
cDNA clone encoding
clone encoding a
encoding a zinc
a zinc finger
zinc finger protein
finger protein NF-E1
protein NF-E1 that
NF-E1 that binds
that binds to
binds to the
to the negative-acting
the negative-acting segment
negative-acting segment of
segment of the
of the kappa
the kappa E3'
kappa E3' enhancer
This protein also
protein also binds
also binds to
binds to the
to the immunoglobulin
the immunoglobulin heavy-chain
immunoglobulin heavy-chain enhancer
heavy-chain enhancer mu
enhancer mu E1
mu E1 site
NF-E1 is encoded
is encoded by
encoded by the
by the same
the same gene
same gene as
gene as the
as the YY-1
the YY-1 protein
YY-1 protein which
protein which binds
which binds to
binds to the
to the adeno-associated
the adeno-associated virus
adeno-associated virus P5
virus P5 promoter
NF-E1 is also
is also the
also the human
the human homologue
human homologue of
homologue of the
of the mouse
the mouse delta
mouse delta protein
delta protein which
protein which binds
which binds to
binds to ribosomal
to ribosomal protein
ribosomal protein gene
protein gene promoters
The predicted amino
predicted amino acid
amino acid sequence
acid sequence of
sequence of this
of this protein
this protein contains
protein contains features
contains features characteristic
features characteristic of
characteristic of transcriptional
of transcriptional activators
transcriptional activators as
activators as well
as well as
well as transcriptional
as transcriptional repressors
Cotransfection studies with
studies with this
with this cDNA
this cDNA indicate
cDNA indicate that
indicate that it
that it can
it can repress
can repress basal
repress basal promoter
basal promoter activity
The apparent dual
apparent dual function
dual function of
function of this
of this protein
this protein is
protein is discussed
A human putative
human putative lymphocyte
putative lymphocyte G0/G1
lymphocyte G0/G1 switch
G0/G1 switch gene
switch gene containing
gene containing a
containing a CpG-rich
a CpG-rich island
CpG-rich island encodes
island encodes a
encodes a small
a small basic
small basic protein
basic protein with
protein with the
with the potential
the potential to
potential to be
to be phosphorylated
Genes actively involved
actively involved in
involved in the
in the G0/G1
the G0/G1 switch
G0/G1 switch G0S
switch G0S genes
G0S genes may
genes may be
may be differentially
be differentially expressed
differentially expressed during
expressed during the
during the lectin-induced
the lectin-induced switch
lectin-induced switch of
switch of lymphocytes
of lymphocytes from
lymphocytes from the
from the G0
the G0 to
G0 to the
to the G1
the G1 phases
G1 phases of
phases of the
of the cell
the cell cycle
This paper presents
paper presents studies
presents studies of
studies of G0S2
of G0S2 a
G0S2 a member
a member of
member of a
of a set
a set of
set of putative
of putative G0S
putative G0S genes
G0S genes for
genes for which
for which cDNAs
which cDNAs were
cDNAs were cloned
were cloned and
cloned and selected
and selected on
selected on the
on the basis
the basis of
basis of differential
of differential cDNA
differential cDNA hybridization
G0S2 mRNA increases
mRNA increases transiently
increases transiently within
transiently within 1-2
within 1-2 hr
1-2 hr of
hr of the
of the addition
the addition of
addition of lectin
of lectin or
lectin or cycloheximide
or cycloheximide to
cycloheximide to cultured
to cultured blood
cultured blood mononuclear
blood mononuclear cells
Comparison of a
of a nearly
a nearly full-length
nearly full-length cDNA
full-length cDNA sequence
cDNA sequence with
sequence with the
with the corresponding
the corresponding genomic
corresponding genomic sequence
genomic sequence reveals
sequence reveals one
reveals one small
one small intron
small intron and
intron and an
and an open
an open reading
open reading frame
reading frame in
frame in the
in the second
the second exon
The derived 103-amino-acid
derived 103-amino-acid basic
103-amino-acid basic protein
basic protein has
protein has two
has two potential
two potential alpha-helical
potential alpha-helical domains
alpha-helical domains separated
domains separated by
separated by a
by a hydrophobic
a hydrophobic region
hydrophobic region with
region with the
with the potential
the potential to
potential to generate
to generate turns
generate turns and
turns and assume
and assume a
assume a beta-sheet
a beta-sheet conformation
Consistent with involvement
with involvement in
involvement in the
in the G0/G1
the G0/G1 switch
G0/G1 switch the
switch the protein
the protein contains
protein contains potential
contains potential sites
potential sites for
sites for phosphorylation
for phosphorylation by
phosphorylation by protein
by protein kinase
protein kinase C
kinase C and
C and casein
and casein kinase
casein kinase II
The gene contains
gene contains a
contains a CpG-rich
a CpG-rich island
CpG-rich island suggesting
island suggesting expression
suggesting expression in
expression in the
in the germ
the germ line
An upstream segment
upstream segment contains
segment contains tandem
contains tandem dinucleotide
tandem dinucleotide repeats
dinucleotide repeats CT19/CA16
There is a
is a suitably
a suitably located
suitably located TATA
located TATA box
TATA box but
box but potential
but potential sites
potential sites for
sites for CCAAT-box
for CCAAT-box binding
CCAAT-box binding factors
binding factors are
factors are far
are far upstream
far upstream embedded
upstream embedded in
embedded in a
in a 42-nucleotide
a 42-nucleotide repeat
42-nucleotide repeat element
Potential sites for
sites for transcription
for transcription factors
transcription factors AP1
factors AP1 AP2
AP1 AP2 and
AP2 and AP3
and AP3 are
AP3 are consistent
are consistent with
consistent with rapid
with rapid transcriptional
rapid transcriptional activation
transcriptional activation in
activation in response
in response to
response to inducing
to inducing agents
USF-related transcription factor
transcription factor HIV-TF1
factor HIV-TF1 stimulates
HIV-TF1 stimulates transcription
stimulates transcription of
transcription of human
of human immunodeficiency
human immunodeficiency virus-1
The transcription factor
transcription factor HIV-TF1
factor HIV-TF1 which
HIV-TF1 which binds
which binds to
binds to a
to a region
a region about
region about 60
about 60 bp
60 bp upstream
bp upstream from
upstream from the
from the enhancer
the enhancer of
enhancer of the
of the human
the human immunodeficiency
human immunodeficiency virus-1
immunodeficiency virus-1 HIV-1
virus-1 HIV-1 was
HIV-1 was purified
was purified from
purified from human
from human B
human B cells
HIV-TF1 had a
had a molecular
a molecular weight
molecular weight of
weight of 39000
Binding of HIV-TF1
of HIV-TF1 to
HIV-TF1 to the
to the HIV
the HIV long
HIV long terminal
long terminal repeat
terminal repeat LTR
repeat LTR activated
LTR activated transcription
activated transcription from
transcription from the
from the HIV
the HIV promoter
HIV promoter in
promoter in vitro
The HIV-TF1-binding site
HIV-TF1-binding site in
site in HIV
in HIV LTR
HIV LTR was
LTR was similar
was similar to
similar to the
to the site
the site recognized
site recognized by
recognized by upstream
by upstream stimulatory
upstream stimulatory factor
stimulatory factor USF
factor USF in
USF in the
in the adenovirus
the adenovirus major
adenovirus major late
major late promoter
DNA-binding properties of
properties of HIV-TF1
of HIV-TF1 suggested
HIV-TF1 suggested that
suggested that HIV-TF1
that HIV-TF1 might
HIV-TF1 might be
might be identical
be identical or
identical or related
or related to
related to USF
Interestingly treatment of
treatment of purified
of purified HIV-TF1
purified HIV-TF1 by
HIV-TF1 by phosphatase
by phosphatase greatly
phosphatase greatly reduced
greatly reduced its
reduced its DNA-binding
its DNA-binding activity
DNA-binding activity suggesting
activity suggesting that
suggesting that phosphorylation
that phosphorylation of
phosphorylation of HIV-TF1
of HIV-TF1 was
HIV-TF1 was essential
was essential for
essential for DNA
for DNA binding
The disruption of
disruption of HIV-TF1-binding
of HIV-TF1-binding site
HIV-TF1-binding site induced
site induced a
induced a 60%
a 60% decrease
60% decrease in
decrease in the
in the level
the level of
level of transcription
of transcription from
transcription from the
from the HIV
the HIV promoter
HIV promoter in
promoter in vivo
These results suggest
results suggest that
suggest that HIV-TF1
that HIV-TF1 is
HIV-TF1 is involved
is involved in
involved in transcriptional
in transcriptional regulation
transcriptional regulation of
regulation of HIV-1
Severe 5-fluorouracil toxicity
5-fluorouracil toxicity secondary
toxicity secondary to
secondary to dihydropyrimidine
to dihydropyrimidine dehydrogenase
dihydropyrimidine dehydrogenase deficiency
A potentially more
potentially more common
more common pharmacogenetic
common pharmacogenetic syndrome
This study describes
study describes the
describes the inheritance
the inheritance of
inheritance of a
of a defect
a defect in
defect in pyrimidine
in pyrimidine catabolism
pyrimidine catabolism and
catabolism and its
and its association
its association with
association with drug-induced
with drug-induced toxicity
drug-induced toxicity in
toxicity in a
in a patient
a patient receiving
patient receiving 5-fluorouracil
receiving 5-fluorouracil FUra
5-fluorouracil FUra as
FUra as adjuvant
as adjuvant chemotherapy
adjuvant chemotherapy for
chemotherapy for breast
for breast carcinoma
The study population
study population included
population included the
included the affected
the affected patient
affected patient proband
patient proband nine
proband nine of
nine of her
of her blood
her blood relatives
blood relatives and
relatives and seven
and seven healthy
seven healthy volunteers
The activity of
activity of dihydropyrimidine
of dihydropyrimidine dehydrogenase
dihydropyrimidine dehydrogenase DPD
dehydrogenase DPD the
DPD the initial
the initial enzyme
initial enzyme of
enzyme of pyrimidine
of pyrimidine and
pyrimidine and FUra
and FUra catabolism
FUra catabolism in
catabolism in peripheral
in peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells was
cells was measured
was measured in
measured in each
in each subject
each subject by
subject by a
by a specific
a specific radiometric
specific radiometric assay
radiometric assay using
assay using FUra
using FUra as
FUra as the
as the substrate
The proband had
proband had no
had no detectable
no detectable DPD
detectable DPD activity
When enzyme levels
enzyme levels in
levels in the
in the proband
the proband and
proband and relatives
and relatives were
relatives were compared
were compared with
compared with that
with that in
that in controls
in controls an
controls an autosomal
an autosomal recessive
autosomal recessive pattern
recessive pattern of
pattern of inheritance
of inheritance was
inheritance was demonstrated
This is the
is the third
the third patient
third patient with
patient with severe
with severe FUra
severe FUra toxicity
FUra toxicity secondary
toxicity secondary to
secondary to an
to an alteration
an alteration in
alteration in pyrimidine
in pyrimidine catabolism
pyrimidine catabolism and
catabolism and the
and the second
the second from
second from our
from our clinic
our clinic population
clinic population suggesting
population suggesting that
suggesting that the
that the frequency
the frequency of
frequency of this
of this genetic
this genetic defect
genetic defect may
defect may be
may be greater
be greater than
greater than previously
than previously thought
Monitoring DPD activity
DPD activity may
activity may be
may be important
be important in
important in the
in the management
the management of
management of patients
of patients experiencing
patients experiencing severe
experiencing severe toxicity
severe toxicity secondary
toxicity secondary to
secondary to FUra
to FUra chemotherapy
Transactivation of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus promoter
virus promoter by
promoter by human
by human herpesvirus
human herpesvirus 6
herpesvirus 6 HHV-6
6 HHV-6 strains
HHV-6 strains GS
strains GS and
GS and Z-29
and Z-29 in
Z-29 in primary
in primary human
primary human T
human T lymphocytes
T lymphocytes and
lymphocytes and identification
and identification of
identification of transactivating
of transactivating HHV-6GS
transactivating HHV-6GS gene
HHV-6GS gene fragments
Human herpesvirus 6
herpesvirus 6 HHV-6
6 HHV-6 can
HHV-6 can activate
can activate the
activate the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV promoter
HIV promoter and
promoter and accelerate
and accelerate cytopathic
accelerate cytopathic effects
cytopathic effects in
effects in HIV-infected
in HIV-infected human
HIV-infected human T
human T cells
This study examines
study examines the
examines the regions
the regions of
regions of the
of the HIV
the HIV promoter
HIV promoter required
promoter required for
required for HHV-6
for HHV-6 transactivation
HHV-6 transactivation in
transactivation in a
in a heterogeneous
a heterogeneous population
heterogeneous population of
population of primary
of primary human
primary human T
human T lymphocytes
T lymphocytes with
lymphocytes with or
with or without
or without antigenic
without antigenic stimulation
Two different strains
different strains of
strains of HHV-6
of HHV-6 GS
HHV-6 GS and
GS and Z29
and Z29 transactivated
Z29 transactivated the
transactivated the HIV
the HIV promoter
The GS strain
GS strain transactivated
strain transactivated the
transactivated the promoter
the promoter in
promoter in both
in both stimulated
both stimulated and
stimulated and resting
and resting T
resting T cells
T cells while
cells while the
while the Z29
the Z29 strain
Z29 strain increased
strain increased HIV
increased HIV promoter
HIV promoter activity
promoter activity only
activity only in
only in stimulated
in stimulated T
stimulated T cells
Three DNA clones
DNA clones containing
clones containing HHV-6GS
containing HHV-6GS genomic
HHV-6GS genomic fragments
genomic fragments transactivated
fragments transactivated the
transactivated the HIV
the HIV promoter
HIV promoter in
promoter in cotransfected
in cotransfected T
cotransfected T cells
A 214-kb DNA
214-kb DNA clone
DNA clone pZVB70
clone pZVB70 showed
pZVB70 showed the
showed the highest
the highest transactivating
highest transactivating ability
transactivating ability while
ability while two
while two other
two other DNA
other DNA fragments
DNA fragments pZVB10
fragments pZVB10 62
pZVB10 62 kb
62 kb and
kb and pZVH14
and pZVH14 87
pZVH14 87 kb
87 kb showed
kb showed lower
showed lower activity
One of these
of these clones
these clones pZVH14
clones pZVH14 activated
pZVH14 activated the
activated the HIV
the HIV promoter
HIV promoter construct
promoter construct containing
construct containing a
containing a mutation
a mutation in
mutation in the
in the NF
the NF kappa
NF kappa B
kappa B site
However this mutated
this mutated NF
mutated NF kappa
NF kappa B
kappa B promoter
B promoter was
promoter was not
was not transactivated
not transactivated during
transactivated during HHV-6GS
during HHV-6GS infection
HHV-6GS infection or
infection or after
or after cotransfection
after cotransfection with
cotransfection with pZVB70
with pZVB70 or
pZVB70 or pZVB10
These data indicate
data indicate that
indicate that the
that the NF
the NF kappa
NF kappa B
kappa B sites
B sites of
sites of the
of the HIV
the HIV promoter
HIV promoter are
promoter are essential
are essential for
essential for its
for its transactivation
its transactivation during
transactivation during HHV-6GS
during HHV-6GS infection
By increasing HIV
increasing HIV promoter
HIV promoter activity
promoter activity in
activity in primary
in primary T
primary T lymphocytes
T lymphocytes HHV-6
lymphocytes HHV-6 may
HHV-6 may consequently
may consequently increase
consequently increase HIV
increase HIV replication
HIV replication leading
replication leading to
leading to an
to an increase
an increase in
increase in the
in the cytopathic
the cytopathic effect
cytopathic effect on
effect on coinfected
on coinfected human
coinfected human T
human T cells
Inhibition of HIV-1
of HIV-1 replication
HIV-1 replication and
replication and NF-kappa
and NF-kappa B
NF-kappa B activity
B activity by
activity by cysteine
by cysteine and
cysteine and cysteine
and cysteine derivatives
HIV-1 proviral DNA
proviral DNA contains
DNA contains two
contains two binding
two binding sites
binding sites for
sites for the
for the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
HIV-1-infected individuals have
individuals have on
have on average
on average abnormally
average abnormally high
abnormally high levels
high levels of
levels of tumour
of tumour necrosis
tumour necrosis factor
necrosis factor alpha
factor alpha TNF
alpha TNF alpha
TNF alpha and
alpha and abnormally
and abnormally low
abnormally low plasma
low plasma cysteine
plasma cysteine levels
We therefore investigated
therefore investigated the
investigated the effects
the effects of
effects of cysteine
of cysteine and
cysteine and related
and related thiols
related thiols on
thiols on HIV-1
on HIV-1 replication
HIV-1 replication and
replication and NF-kappa
and NF-kappa B
NF-kappa B expression
The experiments in
experiments in this
in this report
this report show
report show that
show that cysteine
that cysteine or
cysteine or N-acetylcysteine
or N-acetylcysteine NAC
N-acetylcysteine NAC raise
NAC raise the
raise the intracellular
the intracellular glutathione
intracellular glutathione GSH
glutathione GSH level
GSH level and
level and inhibit
and inhibit HIV-1
inhibit HIV-1 replication
HIV-1 replication in
replication in persistently
in persistently infected
persistently infected Molt-4
infected Molt-4 and
Molt-4 and U937
and U937 cells
However inhibition of
inhibition of HIV-1
of HIV-1 replication
HIV-1 replication appears
replication appears not
appears not to
not to be
to be directly
be directly correlated
directly correlated with
correlated with GSH
with GSH levels
Cysteine and NAC
and NAC also
NAC also inhibit
also inhibit NF-kappa
inhibit NF-kappa B
NF-kappa B activity
B activity as
activity as determined
as determined by
determined by electrophoretic
by electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
shift assays and
assays and chloramphenicol
and chloramphenicol acetyl-transferase
chloramphenicol acetyl-transferase CAT
acetyl-transferase CAT gene
CAT gene expression
gene expression under
expression under control
under control of
control of NF-kappa
of NF-kappa B
NF-kappa B binding
B binding sites
binding sites in
sites in uninfected
in uninfected cells
This suggests that
suggests that the
that the cysteine
the cysteine deficiency
cysteine deficiency in
deficiency in HIV-1-infected
in HIV-1-infected individuals
HIV-1-infected individuals may
individuals may cause
may cause an
cause an over-expression
an over-expression of
over-expression of NF-kappa
of NF-kappa B-dependent
NF-kappa B-dependent genes
B-dependent genes and
genes and enhance
and enhance HIV-1
enhance HIV-1 replication
NAC may be
may be considered
be considered for
considered for the
for the treatment
the treatment of
treatment of HIV-1-infected
of HIV-1-infected individuals
A thymus-specific member
thymus-specific member of
member of the
of the HMG
the HMG protein
HMG protein family
protein family regulates
family regulates the
regulates the human
the human T
human T cell
T cell receptor
cell receptor C
receptor C alpha
C alpha enhancer
The human T
human T cell-specific
T cell-specific transcription
cell-specific transcription factor
transcription factor TCF-1
factor TCF-1 alpha
TCF-1 alpha plays
alpha plays a
plays a key
a key role
key role in
role in the
in the tissue-specific
the tissue-specific activation
tissue-specific activation of
activation of the
of the T
the T cell
T cell receptor
cell receptor TCR
receptor TCR C
TCR C alpha
C alpha enhancer
alpha enhancer and
enhancer and binds
and binds to
binds to pyrimidine-rich
to pyrimidine-rich elements
pyrimidine-rich elements 5'-PyCTTTG-3'
elements 5'-PyCTTTG-3' present
5'-PyCTTTG-3' present in
present in a
in a variety
a variety of
variety of other
of other T
other T cell-specific
T cell-specific control
cell-specific control regions
Using amino acid
amino acid sequence
acid sequence information
sequence information derived
information derived from
derived from the
from the DNA
the DNA affinity-purified
DNA affinity-purified protein
affinity-purified protein we
protein we have
we have now
have now isolated
now isolated cDNA
isolated cDNA clones
cDNA clones encoding
clones encoding TCF-1
encoding TCF-1 alpha
The TCF-1 alpha
TCF-1 alpha cDNA
alpha cDNA contains
cDNA contains a
contains a single
a single 68-amino-acid
single 68-amino-acid domain
68-amino-acid domain that
domain that is
that is homologous
is homologous to
homologous to a
to a region
a region conserved
region conserved among
conserved among high-mobility
among high-mobility group
high-mobility group HMG
group HMG and
HMG and nonhistone
and nonhistone chromosomal
nonhistone chromosomal proteins
Expression of full-length
of full-length and
full-length and mutant
and mutant cDNA
mutant cDNA clones
cDNA clones in
clones in bacteria
in bacteria reveal
bacteria reveal that
reveal that the
that the single
the single HMG
single HMG motif
HMG motif which
motif which is
which is predicted
is predicted to
predicted to contain
to contain two
contain two extended
two extended alpha-helical
extended alpha-helical segments
alpha-helical segments is
segments is sufficient
is sufficient to
sufficient to direct
to direct the
direct the sequence-specific
the sequence-specific binding
sequence-specific binding of
binding of TCF-1
of TCF-1 alpha
TCF-1 alpha to
alpha to DNA
Northern blot experiments
blot experiments demonstrate
experiments demonstrate further
demonstrate further that
further that TCF-1
that TCF-1 alpha
TCF-1 alpha mRNA
alpha mRNA is
mRNA is highly
is highly tissue
highly tissue specific
tissue specific found
specific found primarily
found primarily in
primarily in the
in the thymus
the thymus or
thymus or T
or T cell
T cell lines
The immature CEM
immature CEM T
CEM T cell
T cell line
cell line expresses
line expresses relatively
expresses relatively low
relatively low levels
low levels of
levels of TCF-1
of TCF-1 alpha
TCF-1 alpha mRNA
alpha mRNA which
mRNA which are
which are increased
are increased upon
increased upon activation
upon activation of
activation of these
of these cells
these cells by
cells by phorbol
by phorbol esters
Interestingly the cloned
the cloned TCF-1
cloned TCF-1 alpha
TCF-1 alpha protein
alpha protein is
protein is a
is a potent
a potent transcriptional
potent transcriptional activator
transcriptional activator of
activator of the
of the human
the human TCR
human TCR alpha
TCR alpha enhancer
alpha enhancer in
enhancer in nonlymphoid
in nonlymphoid cell
nonlymphoid cell lines
cell lines whereas
lines whereas the
whereas the activity
the activity of
activity of the
of the endogenous
the endogenous protein
endogenous protein in
protein in T
in T cell
T cell lines
cell lines is
lines is strongly
is strongly dependent
strongly dependent on
dependent on an
on an additional
an additional T
additional T cell-specific
T cell-specific protein
cell-specific protein that
protein that interacts
that interacts with
interacts with the
with the core
the core enhancer
TCF-1 alpha is
alpha is currently
is currently unique
currently unique among
unique among the
among the newly
the newly emerging
newly emerging family
emerging family of
family of DNA-binding
of DNA-binding regulatory
DNA-binding regulatory proteins
regulatory proteins that
proteins that share
that share the
share the HMG
the HMG motif
HMG motif in
motif in that
in that it
that it is
it is a
is a highly
a highly tissue-specific
highly tissue-specific RNA
tissue-specific RNA polymerase
RNA polymerase II
polymerase II transcription
II transcription factor
A novel HIV-1
novel HIV-1 isolate
HIV-1 isolate containing
isolate containing alterations
containing alterations affecting
alterations affecting the
affecting the NF-kappa
the NF-kappa B
NF-kappa B element
Three molecular clones
molecular clones of
clones of HIV-1
of HIV-1 derived
HIV-1 derived from
derived from a
from a single
a single isolate
single isolate AL1
isolate AL1 exhibited
AL1 exhibited distinct
exhibited distinct replicative
distinct replicative and
replicative and cytopathic
and cytopathic properties
cytopathic properties during
properties during propagation
during propagation in
propagation in a
in a human
a human T
human T cell
T cell line
The phenotypic differences
phenotypic differences observed
differences observed were
observed were attributable
were attributable in
attributable in large
in large part
large part to
part to changes
to changes affecting
changes affecting the
affecting the viral
the viral LTR
Nucleotide sequence and
sequence and PCR
and PCR analyses
PCR analyses demonstrated
analyses demonstrated the
demonstrated the presence
the presence of
presence of novel
of novel duplications
novel duplications or
duplications or deletions
or deletions involving
deletions involving the
involving the NF-kappa
the NF-kappa B
NF-kappa B motif
These changes in
changes in the
in the enhancer
the enhancer element
enhancer element were
element were identified
were identified in
identified in the
in the original
the original AL1
original AL1 virus
AL1 virus stock
Subcloning of the
of the variant
the variant NF-kappa
variant NF-kappa B
NF-kappa B segments
B segments into
segments into LTR-driven
into LTR-driven CAT
LTR-driven CAT expression
CAT expression vectors
expression vectors confirmed
vectors confirmed a
confirmed a correlation
a correlation between
correlation between promoter
between promoter activity
promoter activity and
activity and replicative/cytopathic
and replicative/cytopathic capacity
Multiple Oct2 isoforms
Oct2 isoforms are
isoforms are generated
are generated by
generated by alternative
by alternative splicing
The interaction of
interaction of the
of the Oct2
the Oct2 transcription
Oct2 transcription factor
transcription factor with
factor with the
with the cognate
the cognate octamer
cognate octamer motif
octamer motif ATGCAAAT
motif ATGCAAAT is
ATGCAAAT is a
is a critical
a critical determinant
critical determinant of
determinant of the
of the lymphoid-specific
the lymphoid-specific expression
lymphoid-specific expression of
expression of immunoglobulin
of immunoglobulin genes
Ectopic expression of
expression of cloned
of cloned Oct2
cloned Oct2 cDNA
Oct2 cDNA was
cDNA was shown
was shown to
shown to be
to be sufficient
be sufficient to
sufficient to reconstitute
to reconstitute at
reconstitute at least
at least some
least some aspects
some aspects of
aspects of this
of this regulation
this regulation in
regulation in non-lymphoid
in non-lymphoid cells
We describe the
describe the isolation
the isolation and
isolation and characterization
and characterization of
characterization of multiple
of multiple cDNAs
multiple cDNAs encoding
cDNAs encoding mouse
encoding mouse Oct2
mouse Oct2 from
Oct2 from a
from a mature
a mature B-cell
mature B-cell line
B-cell line and
line and we
and we show
we show that
show that a
that a variety
a variety of
variety of isoforms
of isoforms of
isoforms of this
of this transcription
this transcription factor
transcription factor is
factor is generated
is generated from
generated from a
from a single
a single gene
single gene by
gene by an
by an alternative
an alternative splicing
alternative splicing mechanism
All the isoforms
the isoforms retain
isoforms retain the
retain the previously
the previously characterized
previously characterized POU-domain
characterized POU-domain and
POU-domain and are
and are therefore
are therefore able
therefore able to
able to bind
to bind to
bind to the
to the octamer
the octamer motif
Different amounts of
amounts of the
of the various
the various isoforms
various isoforms are
isoforms are present
are present within
present within the
within the same
the same B-cell
same B-cell regardless
B-cell regardless of
regardless of the
of the developmental
the developmental stage
developmental stage of
stage of B-cell
of B-cell differentiation
B-cell differentiation and
differentiation and at
and at least
at least some
least some of
some of the
of the isoforms
the isoforms are
isoforms are conserved
are conserved between
conserved between mouse
between mouse and
mouse and humans
In cotransfection experiments
cotransfection experiments we
experiments we show
we show that
show that all
that all the
all the isoforms
the isoforms are
isoforms are able
are able to
able to activate
to activate an
activate an octamer
an octamer containing
octamer containing promoter
containing promoter element
promoter element in
element in fibroblasts
in fibroblasts revealing
fibroblasts revealing an
revealing an unexpected
an unexpected functional
unexpected functional redundancy
Finally we show
we show that
show that one
that one of
one of the
of the isoforms
the isoforms encodes
isoforms encodes the
encodes the previously
the previously described
previously described lymphoid-specific
described lymphoid-specific Oct2B
lymphoid-specific Oct2B protein
Oct2B protein which
protein which has
which has been
has been suggested
been suggested to
suggested to be
to be involved
be involved in
involved in the
in the function
the function of
function of the
of the octamer
the octamer motif
octamer motif in
motif in the
in the context
the context of
context of the
of the immunoglobulin
the immunoglobulin heavy-chain
immunoglobulin heavy-chain IgH
heavy-chain IgH enhancer
[Regulation of intracellular
of intracellular cholesterol
intracellular cholesterol synthesis
cholesterol synthesis in
synthesis in hypercholesterolemia
in hypercholesterolemia by
hypercholesterolemia by glucocorticoids]
The rate of
rate of endogenous
of endogenous cholesterol
endogenous cholesterol synthesis
cholesterol synthesis in
synthesis in blood
in blood lymphocytes
blood lymphocytes and
lymphocytes and skin
and skin fibroblasts
skin fibroblasts from
fibroblasts from patients
from patients with
patients with type
with type IIa
type IIa hyperlipidemia
IIa hyperlipidemia was
hyperlipidemia was found
was found to
found to be
to be increased
be increased in
increased in comparison
in comparison with
comparison with healthy
with healthy donors
The cells of
cells of hyperlipidemic
of hyperlipidemic patients
hyperlipidemic patients had
patients had lowered
had lowered levels
lowered levels of
levels of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors concomitantly
receptors concomitantly with
concomitantly with a
with a partial
a partial loss
partial loss of
loss of their
of their sensitivity
their sensitivity to
sensitivity to glucocorticoids
In fibroblasts from
fibroblasts from patients
from patients with
patients with hereditary
with hereditary hypercholesteremia
hereditary hypercholesteremia of
hypercholesteremia of homozygous
of homozygous type
homozygous type the
type the number
the number of
number of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors did
receptors did not
did not exceed
not exceed 10%
exceed 10% of
10% of their
of their content
their content in
content in normal
in normal cells
The decrease of
decrease of the
of the number
the number of
number of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in patients
in patients with
patients with type
with type IIa
type IIa hyperlipidemia
IIa hyperlipidemia seems
hyperlipidemia seems to
seems to be
to be a
be a compensatory
a compensatory response
compensatory response of
response of cells
of cells culminating
cells culminating in
culminating in activation
in activation of
activation of endogenous
of endogenous cholesterol
endogenous cholesterol synthesis
Negative regulation of
regulation of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 expression
1 expression in
expression in monocytes:
in monocytes: role
monocytes: role of
role of the
of the 65-kDa
the 65-kDa plus
65-kDa plus 50-kDa
plus 50-kDa NF-kappa
50-kDa NF-kappa B
NF-kappa B dimer
Although monocytic cells
monocytic cells can
cells can provide
can provide a
provide a reservoir
a reservoir for
reservoir for viral
for viral production
viral production in
production in vivo
in vivo their
vivo their regulation
their regulation of
regulation of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 transcription
HIV-1 transcription can
transcription can be
can be either
be either latent
either latent restricted
latent restricted or
restricted or productive
These differences in
differences in gene
in gene expression
gene expression have
expression have not
have not been
not been molecularly
been molecularly defined
In THP-1 cells
THP-1 cells with
cells with restricted
with restricted HIV
restricted HIV expression
HIV expression there
expression there is
there is an
is an absence
an absence of
absence of DNA-protein
of DNA-protein binding
DNA-protein binding complex
binding complex formation
complex formation with
formation with the
with the HIV-1
the HIV-1 promoter-enhancer
HIV-1 promoter-enhancer associated
promoter-enhancer associated with
associated with markedly
with markedly less
markedly less viral
less viral RNA
viral RNA production
This absence of
absence of binding
of binding was
binding was localized
was localized to
localized to the
to the NF-kappa
the NF-kappa B
NF-kappa B region
B region of
region of the
of the HIV-1
the HIV-1 enhancer;
HIV-1 enhancer; the
enhancer; the 65-kDa
the 65-kDa plus
65-kDa plus 50-kDa
plus 50-kDa NF-kappa
50-kDa NF-kappa B
NF-kappa B heterodimer
B heterodimer was
heterodimer was preferentially
was preferentially lost
Adding purified NF-kappa
purified NF-kappa B
NF-kappa B protein
B protein to
protein to nuclear
to nuclear extracts
nuclear extracts from
extracts from cells
from cells with
cells with restricted
with restricted expression
restricted expression overcomes
expression overcomes this
overcomes this lack
this lack of
lack of binding
In addition treatment
addition treatment of
treatment of these
of these nuclear
these nuclear extracts
nuclear extracts with
extracts with sodium
with sodium deoxycholate
sodium deoxycholate restored
deoxycholate restored their
restored their ability
their ability to
ability to form
to form the
form the heterodimer
the heterodimer suggesting
heterodimer suggesting the
suggesting the presence
the presence of
presence of an
of an inhibitor
an inhibitor of
inhibitor of NF-kappa
of NF-kappa B
NF-kappa B activity
Furthermore treatment of
treatment of nuclear
of nuclear extracts
nuclear extracts from
extracts from these
from these cells
these cells that
cells that had
that had restricted
had restricted expression
restricted expression with
expression with lipopolysaccharide
with lipopolysaccharide increased
lipopolysaccharide increased viral
increased viral production
viral production and
production and NF-kappa
and NF-kappa B
NF-kappa B activity
Antiserum specific for
specific for NF-kappa
for NF-kappa B
NF-kappa B binding
B binding proteins
binding proteins but
proteins but not
but not c-rel-specific
not c-rel-specific antiserum
c-rel-specific antiserum disrupted
antiserum disrupted heterodimer
disrupted heterodimer complex
heterodimer complex formation
Thus both NF-kappa
both NF-kappa B-binding
NF-kappa B-binding complexes
B-binding complexes are
complexes are needed
are needed for
needed for optimal
for optimal viral
optimal viral transcription
Binding of the
of the 65-kDa
the 65-kDa plus
65-kDa plus 50-kDa
plus 50-kDa heterodimer
50-kDa heterodimer to
heterodimer to the
to the HIV-1
the HIV-1 enhancer
HIV-1 enhancer can
enhancer can be
can be negatively
be negatively regulated
negatively regulated in
regulated in monocytes
in monocytes providing
monocytes providing one
providing one mechanism
one mechanism restricting
mechanism restricting HIV-1
restricting HIV-1 gene
HIV-1 gene expression
Glucocorticoid receptors in
receptors in normal
in normal leukocytes:
normal leukocytes: effects
leukocytes: effects of
effects of age
of age gender
age gender season
gender season and
season and plasma
and plasma cortisol
plasma cortisol concentrations
We measured glucocorticoid
measured glucocorticoid receptors
glucocorticoid receptors GR
receptors GR in
GR in mononuclear
in mononuclear leukocytes
mononuclear leukocytes MNL
leukocytes MNL isolated
MNL isolated from
isolated from peripheral
from peripheral blood
peripheral blood of
blood of 145
of 145 apparently
145 apparently healthy
apparently healthy volunteers
healthy volunteers 86
volunteers 86 men
86 men and
men and 59
and 59 women
An age-related decrease
age-related decrease in
decrease in the
in the number
the number of
number of GR
of GR was
GR was suggested
was suggested between
suggested between subjects
between subjects younger
subjects younger than
younger than 20
than 20 years
20 years and
years and elderly
and elderly subjects;
elderly subjects; there
subjects; there was
there was no
was no apparent
no apparent seasonal
apparent seasonal variation
seasonal variation in
variation in GR
Gender difference in
difference in the
in the number
the number of
number of GR
of GR was
GR was not
was not significant
not significant although
significant although women
although women showed
women showed slightly
showed slightly fewer
slightly fewer GR
Eight patients with
patients with dermatomyositis/polymyositis
with dermatomyositis/polymyositis were
dermatomyositis/polymyositis were examined
were examined to
examined to determine
to determine whether
determine whether the
whether the number
the number of
number of GR
of GR in
GR in MNL
in MNL could
MNL could be
could be down-regulated
be down-regulated by
down-regulated by their
by their cognate
their cognate ligands
The number of
number of GR
of GR in
GR in MNL
in MNL from
MNL from these
from these patients
these patients was
patients was significantly
was significantly decreased
significantly decreased one
decreased one month
one month after
month after the
after the initiation
the initiation of
initiation of prednisolone
of prednisolone therapy
However in normal
in normal subjects
normal subjects the
subjects the GR
the GR in
GR in MNL
in MNL did
MNL did not
did not demonstrate
not demonstrate circadian
demonstrate circadian variation
circadian variation in
variation in contrast
in contrast to
contrast to concentrations
to concentrations of
concentrations of plasma
of plasma cortisol
Synergism between two
between two distinct
two distinct elements
distinct elements of
elements of the
of the HTLV-I
the HTLV-I enhancer
HTLV-I enhancer during
enhancer during activation
during activation by
activation by the
by the trans-activator
the trans-activator of
trans-activator of HTLV-I
We have conducted
have conducted functional
conducted functional studies
functional studies of
studies of the
of the enhancer
the enhancer elements
enhancer elements of
elements of human
of human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type I
type I HTLV-I
I HTLV-I using
HTLV-I using the
using the human
the human T-cell
human T-cell lines
T-cell lines Jurkat
lines Jurkat and
Jurkat and MOLT
and MOLT 4
MOLT 4 which
4 which are
which are negative
are negative for
negative for HTLV-I
for HTLV-I and
HTLV-I and MT-2
and MT-2 and
MT-2 and TL-Mor
and TL-Mor which
TL-Mor which carry
which carry the
carry the proviral
the proviral genome
proviral genome of
genome of HTLV-I
Two distinct elements
distinct elements have
elements have been
have been implicated
been implicated in
implicated in function
in function of
function of the
of the HTLV-I
the HTLV-I enhancer
One is the
is the 21-base-pair
the 21-base-pair bp
21-base-pair bp core
bp core element
core element that
element that is
that is responsible
is responsible for
responsible for trans-activation
for trans-activation by
trans-activation by the
by the HTLV-I
the HTLV-I trans-activator
HTLV-I trans-activator p40tax
trans-activator p40tax and
p40tax and that
and that has
that has the
has the ability
the ability to
ability to bind
to bind to
bind to cyclic-AMP
to cyclic-AMP responsive
cyclic-AMP responsive element
responsive element binding
element binding factor
binding factor CREB-like
factor CREB-like factors
The other is
other is a
is a region
a region interposed
region interposed between
interposed between the
between the 21-bp
the 21-bp elements
In this study
this study we
study we demonstrate
we demonstrate that
demonstrate that a
that a subfragment
a subfragment C26
subfragment C26 in
C26 in the
in the region
the region between
region between the
between the 21-bp
the 21-bp elements
21-bp elements is
elements is involved
is involved in
involved in trans-activation
in trans-activation by
trans-activation by p40tax
by p40tax possibly
p40tax possibly through
possibly through binding
through binding to
binding to an
to an NF-kappa
an NF-kappa B-like
NF-kappa B-like nuclear
B-like nuclear factor
nuclear factor or
factor or factors
Formation of the
of the protein-DNA
the protein-DNA complex
protein-DNA complex with
complex with the
with the C26
the C26 subfragment
C26 subfragment was
subfragment was positively
was positively affected
positively affected by
affected by p40tax
The C26 element
C26 element conferred
element conferred partial
conferred partial responsiveness
partial responsiveness to
responsiveness to p40tax
to p40tax when
p40tax when linked
when linked to
linked to one
to one copy
one copy of
copy of the
of the 21-bp
the 21-bp element
21-bp element that
element that by
that by itself
by itself showed
itself showed little
showed little activation
little activation in
activation in response
in response to
response to p40tax
However the C26
the C26 element
C26 element alone
element alone even
alone even when
even when repeated
when repeated could
repeated could not
could not be
not be activated
be activated by
activated by p40tax
by p40tax unlike
p40tax unlike other
unlike other NF-kappa
other NF-kappa B-binding
NF-kappa B-binding elements
In contrast the
contrast the C26
the C26 element
C26 element itself
element itself was
itself was profoundly
was profoundly activated
profoundly activated upon
activated upon stimulation
upon stimulation with
stimulation with 12-O-tetradecanoylphorbol-13-acetate
These findings therefore
findings therefore suggest
therefore suggest that
suggest that the
that the HTLV-I
the HTLV-I enhancer
HTLV-I enhancer contains
enhancer contains multiple
contains multiple functional
multiple functional elements
functional elements including
elements including binding
including binding sites
binding sites for
sites for at
for at least
at least CREB-
least CREB- and
CREB- and NF-kappa
and NF-kappa B-like
NF-kappa B-like factors
B-like factors which
factors which synergistically
which synergistically cooperate
synergistically cooperate in
cooperate in activation
in activation of
activation of the
of the HTLV-I
the HTLV-I enhancer
HTLV-I enhancer in
enhancer in response
in response to
response to p40tax
Our results also
results also demonstrate
also demonstrate that
demonstrate that TPA-dependent
that TPA-dependent activation
TPA-dependent activation of
activation of the
of the HTLV-I
the HTLV-I enhancer
HTLV-I enhancer may
enhancer may be
may be mediated
be mediated through
mediated through the
through the C26
the C26 element
Human tumor necrosis
tumor necrosis factor
necrosis factor alpha
factor alpha gene
alpha gene regulation
gene regulation in
regulation in phorbol
in phorbol ester
phorbol ester stimulated
ester stimulated T
stimulated T and
T and B
and B cell
B cell lines
The minimal region
minimal region of
region of the
of the human
the human tumor
human tumor necrosis
tumor necrosis factor
necrosis factor alpha
factor alpha TNF-alpha
alpha TNF-alpha gene
TNF-alpha gene promoter
gene promoter necessary
promoter necessary for
necessary for its
for its transcriptional
its transcriptional induction
transcriptional induction by
induction by phorbol
by phorbol esters
phorbol esters PMA
esters PMA in
PMA in human
in human T
human T and
T and B
and B lymphocyte
B lymphocyte cell
lymphocyte cell lines
cell lines has
lines has been
has been localized
been localized between
localized between -52
between -52 and
-52 and +89
and +89 nucleotides
+89 nucleotides nt
nucleotides nt relative
nt relative to
relative to the
to the gene's
the gene's transcriptional
gene's transcriptional start
transcriptional start site
Comparison of these
of these sequences
these sequences to
sequences to those
to those required
those required to
required to mediate
to mediate virus
mediate virus or
virus or lipopolysaccharide
or lipopolysaccharide LPS
lipopolysaccharide LPS induction
LPS induction of
induction of the
of the gene
the gene reveal
gene reveal significant
reveal significant differences
significant differences and
differences and thus
and thus the
thus the sequence
the sequence requirements
sequence requirements for
requirements for PMA
for PMA induction
PMA induction are
induction are distinct
are distinct from
distinct from those
from those that
those that mediate
that mediate induction
mediate induction by
induction by virus
by virus or
virus or LPS
Although three sites
three sites in
sites in the
in the TNF-alpha
the TNF-alpha promoter
TNF-alpha promoter kappa
promoter kappa 1
kappa 1 kappa
1 kappa 2
kappa 2 and
2 and kappa
and kappa 3
kappa 3 specifically
3 specifically bind
specifically bind the
bind the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B in
B in lymphoid
in lymphoid nuclear
lymphoid nuclear extracts
nuclear extracts TNF-alpha
extracts TNF-alpha mRNA
TNF-alpha mRNA induction
mRNA induction by
induction by PMA
by PMA does
PMA does not
does not correlate
not correlate with
correlate with NF-kappa
with NF-kappa B
NF-kappa B binding
B binding activities
binding activities displayed
activities displayed by
displayed by different
by different T
different T and
T and B
and B cell
B cell lines
Moreover kappa 1-kappa
kappa 1-kappa 3
1-kappa 3 can
3 can each
can each be
each be deleted
be deleted from
deleted from the
from the TNF-alpha
the TNF-alpha promoter
TNF-alpha promoter with
promoter with little
with little effect
little effect on
effect on the
on the gene's
the gene's inducibility
gene's inducibility by
inducibility by PMA
Therefore TNF-alpha mRNA
TNF-alpha mRNA induction
mRNA induction by
induction by PMA
by PMA like
PMA like its
like its induction
its induction by
induction by virus
by virus and
virus and LPS
and LPS is
LPS is not
is not primarily
not primarily mediated
primarily mediated by
mediated by NF-kappa
by NF-kappa B
NF-kappa B but
B but rather
but rather is
rather is mediated
is mediated through
mediated through other
through other sequences
other sequences and
sequences and protein
and protein factors
Surprisingly multimers of
multimers of kappa
of kappa 1-kappa
kappa 1-kappa 3
1-kappa 3 can
3 can confer
can confer PMA
confer PMA inducibility
PMA inducibility on
inducibility on a
on a heterologous
a heterologous promoter
heterologous promoter in
promoter in a
in a B
a B Raji
B Raji but
Raji but not
but not a
not a T
a T HUT78
T HUT78 cell
HUT78 cell line
However they are
they are not
are not functional
not functional on
functional on a
on a truncated
a truncated TNF-alpha
truncated TNF-alpha promoter
TNF-alpha promoter indicating
promoter indicating that
indicating that promoter
that promoter context
promoter context and
context and cell
and cell type
cell type specificity
type specificity influence
specificity influence the
influence the PMA
the PMA inducible
PMA inducible function
inducible function of
function of these
of these NF-kappa
these NF-kappa B
NF-kappa B binding
B binding sites
Differentiation-associated expression of
expression of the
of the Epstein-Barr
the Epstein-Barr virus
Epstein-Barr virus BZLF1
virus BZLF1 transactivator
BZLF1 transactivator protein
transactivator protein in
protein in oral
in oral hairy
oral hairy leukoplakia
The BZLF1 protein
BZLF1 protein of
protein of Epstein-Barr
of Epstein-Barr virus
Epstein-Barr virus EBV
virus EBV is
EBV is a
is a key
a key immediate-early
key immediate-early protein
immediate-early protein which
protein which has
which has been
has been shown
been shown to
shown to disrupt
to disrupt virus
disrupt virus latency
virus latency in
latency in EBV-infected
in EBV-infected B
EBV-infected B cells
We have generated
have generated a
generated a monoclonal
a monoclonal antibody
monoclonal antibody BZ1
antibody BZ1 to
BZ1 to BZLF1
to BZLF1 which
BZLF1 which reacts
which reacts in
reacts in immunohistology
in immunohistology immunoblotting
immunohistology immunoblotting and
immunoblotting and immunoprecipitation
and immunoprecipitation and
immunoprecipitation and which
and which recognizes
which recognizes both
recognizes both the
both the active
the active dimeric
active dimeric form
dimeric form and
form and the
and the inactive
the inactive monomeric
inactive monomeric form
monomeric form of
form of the
of the protein
Biopsies of oral
of oral hairy
oral hairy leukoplakia
hairy leukoplakia an
leukoplakia an AIDS-associated
an AIDS-associated lesion
AIDS-associated lesion characterized
lesion characterized by
characterized by high-level
by high-level EBV
high-level EBV replication
EBV replication were
replication were examined
were examined by
examined by immunohistochemistry
by immunohistochemistry using
immunohistochemistry using the
using the BZ1
the BZ1 monoclonal
BZ1 monoclonal antibody
A differentiation-associated pattern
differentiation-associated pattern of
pattern of BZLF1
of BZLF1 expression
BZLF1 expression was
expression was observed
was observed BZ1
observed BZ1 reacting
BZ1 reacting with
reacting with nuclei
with nuclei of
nuclei of the
of the upper
the upper spinous
upper spinous layer
spinous layer of
layer of the
of the lesion
This finding suggests
finding suggests that
suggests that the
that the BZLF1
the BZLF1 promoter
BZLF1 promoter may
promoter may be
may be regulated
be regulated by
regulated by the
by the degree
the degree of
degree of squamous
of squamous differentiation
A comparison of
comparison of in
of in situ
in situ hybridization
situ hybridization to
hybridization to EBV
to EBV DNA
EBV DNA and
DNA and viral
and viral capsid
viral capsid antigen
capsid antigen staining
antigen staining with
staining with BZ1
with BZ1 reactivity
BZ1 reactivity suggested
reactivity suggested that
suggested that BZLF1
that BZLF1 expression
BZLF1 expression precedes
expression precedes rampant
precedes rampant virus
rampant virus replication
The inability to
inability to detect
to detect EBV
detect EBV in
EBV in the
in the lower
the lower epithelial
lower epithelial layers
epithelial layers of
layers of oral
of oral hairy
oral hairy leukoplakia
hairy leukoplakia raises
leukoplakia raises questions
raises questions concerning
questions concerning the
concerning the nature
the nature of
nature of EBV
of EBV latency
EBV latency and
latency and persistence
and persistence in
persistence in stratified
in stratified squamous
stratified squamous epithelium
[Changes in levels
in levels of
levels of leucocytic
of leucocytic estrogen
leucocytic estrogen receptor
estrogen receptor in
receptor in patients
in patients with
patients with menopausal
with menopausal type
menopausal type II
type II diabetes
II diabetes and
diabetes and its
and its significance]
The number of
number of estrogen
of estrogen receptors
estrogen receptors ER
receptors ER in
ER in human
in human peripheral
human peripheral leucocytes
peripheral leucocytes in
leucocytes in 12
in 12 women
12 women with
women with menopausal
with menopausal type
menopausal type II
type II diabetes
II diabetes was
diabetes was measured
was measured with
measured with radio-ligand
with radio-ligand binding
radio-ligand binding method
The results were
results were compared
were compared with
compared with those
with those of
those of 12
of 12 menopausal
12 menopausal women
menopausal women without
women without diabetes
without diabetes and
diabetes and 12
and 12 normal
12 normal women
normal women of
women of childbearing
of childbearing age
It was found
was found that
found that the
that the number
the number of
number of ER
of ER in
ER in the
in the patients
the patients was
patients was significantly
was significantly decreased
Our data indicate
data indicate that
indicate that decrease
that decrease of
decrease of ER
of ER level
ER level in
level in leukocytes
in leukocytes may
leukocytes may be
may be related
be related to
related to the
to the pathogenesis
the pathogenesis of
pathogenesis of type
of type II
type II diabetes
II diabetes in
diabetes in menopausal
in menopausal period
Lymphocyte glucocorticoid receptor
glucocorticoid receptor number
receptor number in
number in posttraumatic
in posttraumatic stress
posttraumatic stress disorder
OBJECTIVE: The authors'
The authors' objective
authors' objective was
objective was to
was to investigate
to investigate the
investigate the possibility
the possibility that
possibility that glucocorticoid
that glucocorticoid receptor
glucocorticoid receptor changes
receptor changes may
changes may be
may be involved
be involved in
involved in the
in the dysregulation
the dysregulation of
dysregulation of the
of the hypothalamic-pituitary-adrenal
the hypothalamic-pituitary-adrenal HPA
hypothalamic-pituitary-adrenal HPA axis
HPA axis in
axis in posttraumatic
in posttraumatic stress
posttraumatic stress disorder
stress disorder PTSD
METHOD: They measured
They measured the
measured the number
the number of
number of lymphocyte
of lymphocyte cytosolic
lymphocyte cytosolic glucocorticoid
cytosolic glucocorticoid receptors
glucocorticoid receptors and
receptors and plasma
and plasma cortisol
plasma cortisol concentrations
cortisol concentrations in
concentrations in 15
in 15 consecutively
15 consecutively admitted
consecutively admitted male
admitted male combat
male combat Vietnam
combat Vietnam veterans
Vietnam veterans with
veterans with PTSD
with PTSD and
PTSD and in
and in a
in a normal
a normal comparison
normal comparison group
comparison group of
group of 11
of 11 subjects
RESULTS: Both the
Both the patients
the patients and
patients and the
and the normal
the normal comparison
normal comparison subjects
comparison subjects showed
subjects showed a
showed a morning-to-afternoon
a morning-to-afternoon decline
morning-to-afternoon decline in
decline in glucocorticoid
in glucocorticoid receptor
glucocorticoid receptor concentrations
receptor concentrations paralleling
concentrations paralleling the
paralleling the normal
the normal diurnal
normal diurnal decline
diurnal decline in
decline in cortisol
in cortisol levels
The number of
number of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors was
receptors was 63%
was 63% greater
63% greater in
greater in the
in the morning
the morning and
morning and 26%
and 26% greater
26% greater in
greater in the
in the afternoon
the afternoon in
afternoon in the
in the patients
the patients with
patients with PTSD
with PTSD than
PTSD than in
than in the
in the normal
the normal subjects
No group differences
group differences in
differences in cortisol
in cortisol levels
cortisol levels were
levels were observed
were observed nor
observed nor were
nor were glucocorticoid
were glucocorticoid receptor
glucocorticoid receptor number
receptor number and
number and cortisol
and cortisol levels
cortisol levels correlated
The number of
number of morning
of morning glucocorticoid
morning glucocorticoid receptors
glucocorticoid receptors was
receptors was positively
was positively correlated
positively correlated with
correlated with symptoms
with symptoms of
symptoms of PTSD
of PTSD and
PTSD and anxiety
CONCLUSIONS: These results
These results provide
results provide further
provide further evidence
further evidence for
evidence for a
for a dysregulation
a dysregulation of
dysregulation of the
of the HPA
the HPA axis
HPA axis in
axis in PTSD
The finding that
finding that patients
that patients with
patients with PTSD
with PTSD had
PTSD had a
had a substantially
a substantially greater
substantially greater number
greater number of
number of lymphocyte
of lymphocyte glucocorticoid
lymphocyte glucocorticoid receptors
glucocorticoid receptors than
receptors than normal
than normal comparison
normal comparison subjects
comparison subjects is
subjects is consistent
is consistent with
consistent with the
with the authors'
the authors' previous
authors' previous observations
previous observations of
observations of low
of low 24-hour
low 24-hour urinary
24-hour urinary cortisol
urinary cortisol excretion
cortisol excretion in
excretion in subjects
in subjects with
subjects with PTSD
Furthermore the receptor
the receptor changes
receptor changes observed
changes observed are
observed are opposite
are opposite of
opposite of those
of those reported
those reported in
reported in major
in major depressive
major depressive disorder
The present data
present data along
data along with
along with other
with other findings
other findings of
findings of HPA
of HPA abnormalities
HPA abnormalities in
abnormalities in PTSD
in PTSD support
PTSD support the
support the possibility
the possibility of
possibility of a
of a greater
a greater negative
greater negative feedback
negative feedback sensitivity
feedback sensitivity at
sensitivity at one
at one or
one or more
or more levels
more levels of
levels of the
of the HPA
the HPA axis
Induction of NF-kappa
of NF-kappa B
NF-kappa B during
B during monocyte
during monocyte differentiation
monocyte differentiation is
differentiation is associated
is associated with
associated with activation
with activation of
activation of HIV-gene
of HIV-gene expression
Cells of the
of the monocyte-macrophage
the monocyte-macrophage lineage
monocyte-macrophage lineage are
lineage are important
are important targets
important targets of
targets of HIV
of HIV infection
We report here
report here that
here that the
that the phenotypic
the phenotypic differentiation
phenotypic differentiation of
differentiation of monocyte
of monocyte cell
monocyte cell lines
cell lines induced
lines induced by
induced by phorbol
by phorbol esters
phorbol esters or
esters or tumour
or tumour necrosis
tumour necrosis factor
necrosis factor alpha
factor alpha TNF
alpha TNF alpha
TNF alpha is
alpha is associated
is associated with
associated with expression
with expression of
expression of nuclear
of nuclear factor
nuclear factor kappa
factor kappa B
kappa B NF-kappa
B NF-kappa B
In parallel with
parallel with such
with such differentiation
such differentiation HIV
differentiation HIV transcription
HIV transcription monitored
transcription monitored using
monitored using an
using an HIV
an HIV long
HIV long terminal
long terminal repeat
terminal repeat reporter
repeat reporter gene
reporter gene construct
gene construct is
construct is activated
is activated in
activated in such
in such cells
such cells under
cells under the
under the influence
the influence of
influence of enhanced
of enhanced NF-kappa
enhanced NF-kappa B
NF-kappa B expression
Also in a
in a promonocyte
a promonocyte cell
promonocyte cell line
cell line chronically
line chronically infected
chronically infected with
infected with HIV
with HIV NF-kappa
HIV NF-kappa B
NF-kappa B expression
B expression and
expression and HIV
and HIV transcription
HIV transcription were
transcription were enhanced
were enhanced on
enhanced on stimulation
on stimulation with
stimulation with phorbol
with phorbol ester
phorbol ester or
ester or TNF
or TNF alpha
Thus stimulation of
stimulation of monocyte
of monocyte cell
monocyte cell lines
cell lines by
lines by phorbol
by phorbol esters
phorbol esters or
esters or TNF
or TNF alpha
TNF alpha induces
alpha induces cell
induces cell differentiation
cell differentiation and
differentiation and activates
and activates HIV
activates HIV transcription
Such a process
a process may
process may have
may have fundamental
have fundamental implications
fundamental implications in
implications in AIDS
in AIDS pathogenesis
AIDS pathogenesis in
pathogenesis in vivo
in vivo and
vivo and may
and may be
may be important
be important in
important in disease
in disease progression
disease progression induced
progression induced by
induced by opportunistic
by opportunistic infections
opportunistic infections directly
infections directly or
directly or indirectly
or indirectly involving
indirectly involving macrophages
Demonstration of estrogen
of estrogen and
estrogen and progesterone
and progesterone receptors
progesterone receptors as
receptors as well
as well as
well as Ki-67
as Ki-67 and
Ki-67 and p-145
and p-145 antigens
p-145 antigens in
antigens in single
in single tumor
single tumor cells
tumor cells from
cells from blood
from blood and
blood and pleural
and pleural effusions
pleural effusions using
effusions using a
using a slide
a slide assay
We describe a
describe a slide
a slide assay
slide assay that
assay that allows
that allows the
allows the demonstration
the demonstration of
demonstration of antigens
of antigens localized
antigens localized in
localized in the
in the nucleus
the nucleus from
nucleus from isolated
from isolated white
isolated white blood
white blood cells
blood cells as
cells as well
as well as
well as from
as from single
from single tumor
single tumor cells
tumor cells derived
cells derived from
derived from malignant
from malignant effusions
With the antibodies
the antibodies Ki-67
antibodies Ki-67 and
Ki-67 and anti-p-145
and anti-p-145 an
anti-p-145 an increased
an increased rate
increased rate of
rate of nuclear
of nuclear and
nuclear and nucleolar
and nucleolar staining
nucleolar staining resulted
staining resulted in
resulted in cells
in cells from
cells from highly
from highly malignant
highly malignant lymphomas
An almost identical
almost identical reaction
identical reaction was
reaction was obtained
was obtained when
obtained when tumor
when tumor cells
tumor cells from
cells from malignant
from malignant effusions
malignant effusions were
effusions were tested
Cells isolated from
isolated from the
from the blood
the blood of
blood of patients
of patients with
patients with leukemic
with leukemic spread
leukemic spread of
spread of lymphomas
of lymphomas of
lymphomas of low
of low malignancy
low malignancy yielded
malignancy yielded a
yielded a weak
a weak staining
weak staining comparable
staining comparable to
comparable to that
to that of
that of normal
of normal mesothelial
normal mesothelial cells
mesothelial cells from
cells from non-tumorous
from non-tumorous cavity
non-tumorous cavity fluids
The detection of
detection of estrogen
of estrogen and
estrogen and progesterone
and progesterone receptors
progesterone receptors ER
receptors ER and
ER and PR
and PR localized
PR localized in
localized in the
in the cell
the cell nucleus
cell nucleus can
nucleus can be
can be achieved
be achieved by
achieved by the
by the same
the same assay
The reaction is
reaction is enhanced
is enhanced by
enhanced by incubation
by incubation of
incubation of the
of the tumor
the tumor cells
tumor cells for
cells for 30
for 30 min
30 min at
min at 37
at 37 degrees
37 degrees C
degrees C prior
C prior to
prior to fixation
Pleural effusions from
effusions from 20
from 20 patients
20 patients with
patients with breast
with breast cancer
breast cancer were
cancer were tested
ER was positive
was positive in
positive in 13
in 13 and
13 and PR
and PR was
PR was positive
was positive in
positive in 12
in 12 of
12 of the
of the 20
the 20 samples
In 5 cases
5 cases there
cases there was
there was a
was a divergent
a divergent reaction
divergent reaction with
reaction with ER
with ER and
ER and PR
and PR antibody
The hormone receptors
hormone receptors of
receptors of the
of the primary
the primary tumor
primary tumor were
tumor were known
were known in
known in 15
in 15 ER
15 ER and
ER and 14
and 14 PR
14 PR patients
PR patients respectively
In each cohort
each cohort there
cohort there was
there was only
was only one
only one case
one case with
case with a
with a negative
a negative reaction
negative reaction of
reaction of the
of the primary
the primary tumor
primary tumor and
tumor and a
and a positive
a positive reaction
positive reaction with
reaction with the
with the isolated
the isolated tumor
isolated tumor cells
tumor cells from
cells from the
from the pleural
the pleural effusions
These results indicate
results indicate that
indicate that the
that the demonstration
the demonstration of
demonstration of hormone
of hormone receptor
hormone receptor proteins
receptor proteins in
proteins in cells
in cells from
cells from malignant
from malignant effusions
malignant effusions is
effusions is possible
is possible and
possible and that
and that there
that there is
there is a
is a correlation
a correlation with
correlation with the
with the status
the status of
status of the
of the primary
the primary site
primary site of
site of cancer
Constitutive activation of
activation of NF-kB
of NF-kB in
NF-kB in human
in human thymocytes
NF-kB is a
is a eukaryotic
a eukaryotic transcription
eukaryotic transcription regulatory
transcription regulatory factor
In T cells
T cells and
cells and T
and T cell
T cell lines
cell lines NF-kB
lines NF-kB is
NF-kB is bound
is bound to
bound to a
to a cytoplasmic
a cytoplasmic proteic
cytoplasmic proteic inhibitor
proteic inhibitor the
inhibitor the IkB
Treatment of T
of T cells
T cells with
cells with mitogens
with mitogens phorbol
mitogens phorbol esters
phorbol esters or
esters or cytokines
or cytokines TNF
cytokines TNF alpha
TNF alpha induces
alpha induces NF-kB
induces NF-kB nuclear
NF-kB nuclear translocation
nuclear translocation and
translocation and the
and the subsequent
the subsequent expression
subsequent expression of
expression of NF-kB
of NF-kB dependent
NF-kB dependent T
dependent T cell
T cell genes
Here we examined
we examined the
examined the activation
the activation of
activation of NF-kB
of NF-kB in
NF-kB in human
in human T
human T cell
T cell thymic
cell thymic progenitors
We report differences
report differences in
differences in Ca2+i
in Ca2+i requirement
Ca2+i requirement for
requirement for NF-kB
for NF-kB activation
NF-kB activation in
activation in thymocytes
in thymocytes as
thymocytes as compared
as compared to
compared to mature
to mature T
mature T cells
Furthermore our results
our results indicated
results indicated that
indicated that thymocytes
that thymocytes have
thymocytes have a
have a constitutively
a constitutively active
constitutively active form
active form of
form of NF-kB
of NF-kB suggesting
NF-kB suggesting that
suggesting that they
that they are
they are activated
are activated in
activated in vivo
TCF-1 a T
a T cell-specific
T cell-specific transcription
cell-specific transcription factor
transcription factor of
factor of the
of the HMG
the HMG box
HMG box family
box family interacts
family interacts with
interacts with sequence
with sequence motifs
sequence motifs in
motifs in the
in the TCR
the TCR beta
TCR beta and
beta and TCR
and TCR delta
TCR delta enhancers
We have recently
have recently identified
recently identified and
identified and cloned
and cloned TCF-1
cloned TCF-1 a
TCF-1 a T
a T cell-specific
T cell-specific transcription
cell-specific transcription factor
transcription factor with
factor with specificity
with specificity for
specificity for the
for the AACAAAG
the AACAAAG motif
AACAAAG motif in
motif in the
in the CD3
the CD3 epsilon
CD3 epsilon enhancer
epsilon enhancer and
enhancer and for
and for the
for the TTCAAAG
the TTCAAAG motif
TTCAAAG motif in
motif in the
in the TCR
the TCR alpha
TCR alpha enhancer
TCF-1 belongs to
belongs to the
to the family
the family of
family of transcription-regulating
of transcription-regulating proteins
transcription-regulating proteins which
proteins which share
which share a
share a region
a region of
region of homology
of homology termed
homology termed the
termed the HMG-box
Here we show
we show by
show by gel
by gel retardation
gel retardation analysis
retardation analysis that
analysis that TCF-1
that TCF-1 specifically
TCF-1 specifically recognizes
specifically recognizes the
recognizes the T
the T beta
T beta 5
beta 5 element
5 element of
element of the
of the TCR
the TCR beta
TCR beta enhancer
beta enhancer and
enhancer and the
and the T
the T delta
T delta 7
delta 7 element
7 element of
element of the
of the TCR
the TCR delta
TCR delta enhancer
Comparison of the
of the sequences
the sequences of
sequences of all
of all elements
all elements recognized
elements recognized by
recognized by TCF-1
by TCF-1 defines
TCF-1 defines a
defines a consensus
a consensus motif
consensus motif A/T
motif A/T A/T
A/T A/T C
A/T C A
C A A/G
A A/G A
A/G A G
These observations imply
observations imply that
imply that TCF-1
that TCF-1 is
TCF-1 is involved
is involved in
involved in the
in the control
the control of
control of several
of several T
several T cell-specific
T cell-specific genes
cell-specific genes and
genes and might
and might thus
might thus play
thus play an
play an important
an important role
important role in
role in the
in the establishment
the establishment and
establishment and maintenance
and maintenance of
maintenance of the
of the mature
the mature T
mature T cell
T cell phenotype
[Regulatory effect of
effect of insulin
of insulin on
insulin on glucocorticoid
on glucocorticoid receptor
glucocorticoid receptor in
receptor in human
in human peripheral
human peripheral leukocytes]
The regulatory effect
regulatory effect of
effect of insulin
of insulin on
insulin on the
on the specific
the specific binding
specific binding power
binding power of
power of glucocorticoid
of glucocorticoid receptor
glucocorticoid receptor GR
receptor GR of
GR of human
of human leukocytes
human leukocytes was
leukocytes was assessed
was assessed by
assessed by the
by the unoccupied
the unoccupied receptor
unoccupied receptor sites
receptor sites capable
sites capable of
capable of combining
of combining with
combining with [3H]
with [3H] labelled
[3H] labelled dexamethasone
labelled dexamethasone measured
dexamethasone measured at
measured at 3
at 3 and
3 and 24
and 24 h
24 h after
h after incubation
after incubation with
incubation with various
with various concentrations
various concentrations of
concentrations of insulin
of insulin added
insulin added to
added to the
to the medium
After 3 h
3 h incubation
h incubation the
incubation the specific
the specific binding
specific binding power
binding power with
power with [3H]
with [3H] Dex
[3H] Dex was
Dex was decreased
was decreased by
decreased by 233
by 233 +/-
233 +/- 100
+/- 100 322
100 322 +/-
322 +/- 132
+/- 132 and
132 and 543
and 543 +/-
543 +/- 92%
+/- 92% P
92% P greater
P greater than
greater than 005
than 005 P
005 P greater
P greater than
greater than 005
than 005 and
005 and P
and P less
P less than
less than 001
than 001 as
001 as compared
as compared with
compared with the
with the control
the control value
control value of
value of 100
of 100 in
100 in the
in the absence
the absence of
absence of insulin
of insulin respectively
insulin respectively in
respectively in the
in the presence
the presence of
presence of 20
of 20 mU/L
20 mU/L physiological
mU/L physiological testing
physiological testing concentration
testing concentration 200
concentration 200 mU/L
200 mU/L physiological
mU/L physiological upper
physiological upper limit
upper limit and
limit and 2000
and 2000 mU/L
2000 mU/L pharmacological
mU/L pharmacological concentration
pharmacological concentration insulin
concentration insulin in
insulin in the
in the incubation
the incubation medium
After 24 h
24 h incubation
h incubation the
incubation the decrease
the decrease of
decrease of these
of these values
these values increased
values increased respectively
increased respectively to
respectively to 435
to 435 +/-
435 +/- 190
+/- 190 561
190 561 +/-
561 +/- 207
+/- 207 and
207 and 802
and 802 +/-
802 +/- 155
+/- 155 P
155 P less
P less than
less than 005
than 005 P
005 P less
P less than
less than 001
than 001 and
001 and P
and P less
P less than
less than 001
than 001 compared
001 compared with
compared with control
Thus the inhibitory
the inhibitory effect
inhibitory effect of
effect of insulin
of insulin on
insulin on the
on the GR
the GR binding
GR binding power
binding power is
power is both
is both dose-
both dose- and
dose- and time-dependent
and time-dependent which
time-dependent which strongly
which strongly suggests
strongly suggests that
suggests that GR
that GR is
GR is tonically
is tonically controlled
tonically controlled by
controlled by insulin
by insulin concentration
insulin concentration change
concentration change under
change under physiological
under physiological conditions
The effect of
effect of toremifene
of toremifene therapy
toremifene therapy on
therapy on serum
on serum immunoglobulin
serum immunoglobulin levels
immunoglobulin levels in
levels in breast
in breast cancer
Estrogens and anti-estrogens
and anti-estrogens enhance
anti-estrogens enhance the
enhance the number
the number of
number of immunoglobulin
of immunoglobulin Ig-secreting
immunoglobulin Ig-secreting cells
Ig-secreting cells in
cells in pokeweed
in pokeweed mitogen
pokeweed mitogen PWM-stimulated
mitogen PWM-stimulated lymphocyte
PWM-stimulated lymphocyte cultures
Lymphocytes from patients
from patients who
patients who have
who have received
have received anti-estrogen
received anti-estrogen therapy
anti-estrogen therapy show
therapy show similar
show similar enhancement
similar enhancement of
enhancement of Ig-secreting
of Ig-secreting cells
Ig-secreting cells after
cells after PWM
after PWM stimulation
In this study
this study the
study the effect
the effect of
effect of anti-estrogen
of anti-estrogen toremifene
anti-estrogen toremifene therapy
toremifene therapy on
therapy on serum
on serum immunoglobulin
serum immunoglobulin IgA
immunoglobulin IgA IgM
IgA IgM IgG
IgM IgG levels
IgG levels in
levels in breast
in breast cancer
breast cancer patients
cancer patients was
patients was investigated
Serum Ig levels
Ig levels were
levels were followed
were followed up
followed up to
up to two
to two years
two years after
years after or
after or during
or during the
during the therapy
An unexpected finding
unexpected finding was
finding was that
was that the
that the Ig
the Ig levels
Ig levels decreased
levels decreased during
decreased during the
during the follow-up
the follow-up period
This decrease was
decrease was seen
was seen in
seen in patients
in patients who
patients who responded
who responded to
responded to the
to the therapy
the therapy as
therapy as well
as well as
well as in
as in those
in those who
those who did
who did not
Human erythroid 5-aminolevulinate
erythroid 5-aminolevulinate synthase:
5-aminolevulinate synthase: promoter
synthase: promoter analysis
promoter analysis and
analysis and identification
and identification of
identification of an
of an iron-responsive
an iron-responsive element
iron-responsive element in
element in the
in the mRNA
5-Aminolevulinate synthase ALAS
synthase ALAS catalyzes
ALAS catalyzes the
catalyzes the first
the first step
first step of
step of the
of the heme
the heme biosynthetic
heme biosynthetic pathway
cDNA clones for
clones for the
for the human
the human erythroid
human erythroid ALAS
erythroid ALAS isozyme
ALAS isozyme were
isozyme were isolated
were isolated from
isolated from a
from a fetal
a fetal liver
fetal liver library
It can be
can be deduced
be deduced that
deduced that the
that the erythroid
the erythroid ALAS
erythroid ALAS precursor
ALAS precursor protein
precursor protein has
protein has a
has a molecular
a molecular weight
molecular weight of
weight of 646
of 646 kd
646 kd and
kd and is
and is similar
is similar in
similar in size
in size to
size to the
to the previously
the previously isolated
previously isolated human
isolated human housekeeping
human housekeeping ALAS
housekeeping ALAS precursor
ALAS precursor of
precursor of molecular
of molecular weight
molecular weight 706
weight 706 kd
The mature mitochondrial
mature mitochondrial forms
mitochondrial forms of
forms of the
of the erythroid
the erythroid and
erythroid and housekeeping
and housekeeping ALAS
housekeeping ALAS isozymes
ALAS isozymes are
isozymes are predicted
are predicted to
predicted to have
to have molecular
have molecular weights
molecular weights of
weights of 595
of 595 kd
595 kd and
kd and 646
and 646 kd
646 kd respectively
The two isozymes
two isozymes show
isozymes show little
show little amino
little amino acid
amino acid identity
acid identity in
identity in their
in their N-terminal
their N-terminal signal
N-terminal signal sequences
signal sequences but
sequences but have
but have considerable
have considerable sequence
considerable sequence identity
sequence identity in
identity in the
in the C-terminal
the C-terminal two-thirds
C-terminal two-thirds of
two-thirds of their
of their proteins
An analysis of
analysis of the
of the immediate
the immediate promoter
immediate promoter of
promoter of the
of the human
the human erythroid
human erythroid ALAS
erythroid ALAS gene
ALAS gene revealed
gene revealed several
revealed several putative
several putative erythroid-specific
putative erythroid-specific cis-acting
erythroid-specific cis-acting elements
cis-acting elements including
elements including both
including both a
both a GATA-1
a GATA-1 and
GATA-1 and an
and an NF-E2
an NF-E2 binding
NF-E2 binding site
An iron-responsive element
iron-responsive element IRE
element IRE motif
IRE motif has
motif has been
has been identified
been identified in
identified in the
in the 5'-untranslated
the 5'-untranslated region
5'-untranslated region of
region of the
of the human
the human erythroid
human erythroid ALAS
erythroid ALAS mRNA
ALAS mRNA but
mRNA but is
but is not
is not present
not present in
present in the
in the housekeeping
the housekeeping ALAS
housekeeping ALAS mRNA
Gel retardation experiments
retardation experiments established
experiments established that
established that this
that this IRE
this IRE motif
IRE motif formed
motif formed a
formed a protein
a protein -
protein - RNA
- RNA complex
RNA complex with
complex with cytosolic
with cytosolic extracts
cytosolic extracts from
extracts from human
from human K562
human K562 cells
K562 cells and
cells and this
and this binding
this binding was
binding was strongly
was strongly competed
strongly competed with
competed with IRE
with IRE transcripts
IRE transcripts from
transcripts from ferritin
from ferritin or
ferritin or transferrin
or transferrin receptor
transferrin receptor mRNAs
A transcript of
transcript of the
of the ALAS
the ALAS IRE
ALAS IRE mutated
IRE mutated in
mutated in the
in the conserved
the conserved loop
conserved loop of
loop of the
of the IRE
the IRE did
IRE did not
did not readily
not readily form
readily form this
form this protein
this protein -
protein - RNA
- RNA complex
These results suggest
results suggest that
suggest that the
that the IRE
the IRE motif
IRE motif in
motif in the
in the ALAS
the ALAS mRNA
ALAS mRNA is
mRNA is functional
is functional and
functional and imply
and imply that
imply that translation
that translation of
translation of the
of the mRNA
the mRNA is
mRNA is controlled
is controlled by
controlled by cellular
by cellular iron
cellular iron availability
iron availability during
availability during erythropoiesis
Regulation of jun
of jun and
jun and fos
and fos gene
fos gene expression
gene expression in
expression in human
in human monocytes
human monocytes by
monocytes by the
by the macrophage
the macrophage colony-stimulating
macrophage colony-stimulating factor
The macrophage colony-stimulating
macrophage colony-stimulating factor
colony-stimulating factor M-CSF
factor M-CSF is
M-CSF is required
is required for
required for the
for the growth
the growth and
growth and differentiation
and differentiation of
differentiation of mononuclear
of mononuclear phagocytes
However the signaling
the signaling events
signaling events responsible
events responsible for
responsible for these
for these effects
these effects remain
effects remain unclear
The present studies
present studies have
studies have examined
have examined the
examined the effects
the effects of
effects of M-CSF
of M-CSF on
M-CSF on potential
on potential signaling
potential signaling pathways
signaling pathways involving
pathways involving expression
involving expression of
expression of the
of the jun
the jun and
jun and fos
and fos early
fos early response
early response genes
Low levels of
levels of c-jun
of c-jun transcripts
c-jun transcripts were
transcripts were detectable
were detectable in
detectable in resting
in resting human
resting human peripheral
human peripheral blood
peripheral blood monocytes
Treatment of these
of these cells
these cells with
cells with 103
with 103 units/ml
103 units/ml human
units/ml human recombinant
human recombinant M-CSF
recombinant M-CSF was
M-CSF was associated
was associated with
associated with rapid
with rapid and
rapid and transient
and transient increases
transient increases in
increases in c-jun
in c-jun mRNA
c-jun mRNA levels
Nuclear run-on assays
run-on assays and
assays and mRNA
and mRNA stability
mRNA stability studies
stability studies demonstrated
studies demonstrated that
demonstrated that M-CSF
that M-CSF regulates
M-CSF regulates c-jun
regulates c-jun expression
c-jun expression by
expression by both
by both an
both an increase
an increase in
increase in transcription
in transcription rate
transcription rate and
rate and a
and a prolongation
a prolongation in
prolongation in the
in the half-life
the half-life of
half-life of c-jun
of c-jun transcripts
M-CSF treatment was
treatment was also
was also associated
also associated with
associated with a
with a rapid
a rapid induction
rapid induction of
induction of the
of the jun-B
the jun-B gene
jun-B gene although
gene although expression
although expression of
expression of this
of this gene
this gene was
gene was prolonged
was prolonged compared
prolonged compared to
compared to that
to that of
that of c-jun
We further demonstrate
further demonstrate that
demonstrate that M-CSF
that M-CSF increases
M-CSF increases c-fos
increases c-fos mRNA
c-fos mRNA levels
mRNA levels in
levels in human
in human monocytes
human monocytes through
monocytes through control
through control at
control at both
at both the
both the transcriptional
the transcriptional and
transcriptional and posttranscriptional
and posttranscriptional levels
Maximal induction of
induction of the
of the c-fos
the c-fos gene
c-fos gene was
gene was followed
was followed by
followed by that
by that for
that for the
for the fos-B
the fos-B gene
Moreover M-CSF-induced expression
M-CSF-induced expression of
expression of the
of the fos-related
the fos-related gene
fos-related gene fra-1
gene fra-1 was
fra-1 was delayed
was delayed compared
delayed compared to
compared to that
to that for
that for both
for both c-fos
both c-fos and
c-fos and fos-B
Taken together the
together the results
the results indicate
results indicate that
indicate that M-CSF
that M-CSF treatment
M-CSF treatment is
treatment is associated
is associated with
associated with differential
with differential activation
differential activation of
activation of multiple
of multiple members
multiple members of
members of the
of the jun/fos
the jun/fos family
jun/fos family and
family and that
and that expression
that expression of
expression of these
of these genes
these genes could
genes could contribute
could contribute to
contribute to nuclear
to nuclear signaling
nuclear signaling mechanisms
signaling mechanisms that
mechanisms that regulate
that regulate a
regulate a specific
a specific program
specific program of
program of monocyte
of monocyte differentiation
Glucocorticoid receptors in
receptors in systemic
in systemic lupus
systemic lupus erythematosus
Glucocorticosteroids remain the
remain the major
the major treatment
major treatment modality
treatment modality for
modality for systemic
for systemic lupus
systemic lupus erythematosus
lupus erythematosus SLE
erythematosus SLE but
SLE but their
but their mechanism
their mechanism of
mechanism of action
of action is
action is unclear
Over the past
the past decade
past decade it
decade it has
it has become
has become clear
become clear that
clear that glucocorticosteroid
that glucocorticosteroid receptors
glucocorticosteroid receptors play
receptors play a
play a significant
a significant role
significant role in
role in the
in the mechanism
the mechanism of
mechanism of glucocorticosteroid
of glucocorticosteroid action
We studied glucocorticosteroid
studied glucocorticosteroid receptor
glucocorticosteroid receptor density
receptor density and
density and affinity
and affinity on
affinity on peripheral
on peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells by
cells by the
by the glucocorticosteroid
the glucocorticosteroid binding
glucocorticosteroid binding assay
binding assay in
assay in 33
in 33 patients
33 patients with
patients with SLE
with SLE who
SLE who had
who had taken
had taken no
taken no glucocorticosteroid
no glucocorticosteroid for
glucocorticosteroid for the
for the previous
the previous 6
previous 6 months
6 months and
months and in
and in 32
in 32 healthy
32 healthy controls
Patients' disease activity
disease activity was
activity was measured
was measured by
measured by the
by the SLE
the SLE Disease
SLE Disease Activity
Disease Activity Index
Activity Index SLEDAI
Glucocorticosteroid receptors on
receptors on leukocytes
on leukocytes of
leukocytes of patients
of patients with
patients with SLE
with SLE were
SLE were significantly
were significantly higher
significantly higher than
higher than in
than in healthy
in healthy controls
healthy controls 4419
controls 4419 +/-
4419 +/- 306
+/- 306 vs
306 vs 3369
vs 3369 +/-
3369 +/- 196
+/- 196 p
196 p less
p less than
less than 0005
The binding affinity
binding affinity was
affinity was not
was not different
not different between
different between patients
between patients and
patients and controls
There was no
was no correlation
no correlation between
correlation between glucocorticosteroid
between glucocorticosteroid receptor
glucocorticosteroid receptor number
receptor number and
number and SLE
and SLE disease
SLE disease activity
Kappa B binding
B binding proteins
binding proteins are
proteins are constitutively
are constitutively expressed
constitutively expressed in
expressed in an
in an IL-2
an IL-2 autocrine
IL-2 autocrine human
autocrine human T
human T cell
T cell line
The IL-2 and
IL-2 and the
and the IL-2-R
the IL-2-R alpha
IL-2-R alpha genes
alpha genes are
genes are both
are both expressed
both expressed transiently
expressed transiently in
transiently in normal
in normal T
normal T lymphocytes
T lymphocytes after
lymphocytes after Ag
after Ag or
Ag or mitogen
or mitogen activation
In contrast the
contrast the human
the human T
human T cell
T cell line
cell line IARC
line IARC 301
IARC 301 expresses
301 expresses these
expresses these two
these two genes
two genes constitutively
genes constitutively and
constitutively and we
and we have
we have previously
have previously demonstrated
previously demonstrated that
demonstrated that its
that its growth
its growth depends
growth depends on
depends on the
on the autocrine
the autocrine production
autocrine production of
production of this
of this T
this T cell
T cell growth
cell growth factor
growth factor and
factor and high
and high affinity
high affinity IL-2R
To dissect the
dissect the molecular
the molecular basis
molecular basis for
basis for the
for the unusual
the unusual persistent
unusual persistent expression
persistent expression of
expression of the
of the IL-2
the IL-2 and
IL-2 and IL-2-R
and IL-2-R alpha
IL-2-R alpha genes
alpha genes in
genes in these
in these IARC
these IARC 301
IARC 301 T
301 T cells
T cells we
cells we have
we have analyzed
have analyzed the
analyzed the interactions
the interactions of
interactions of constitutively
of constitutively expressed
constitutively expressed nuclear
expressed nuclear proteins
nuclear proteins with
proteins with the
with the 5'
the 5' flanking
5' flanking regions
flanking regions of
regions of the
of the IL-2
the IL-2 and
IL-2 and IL-2-R
and IL-2-R alpha
IL-2-R alpha genes
alpha genes using
genes using both
using both DNase
both DNase I
DNase I footprinting
I footprinting and
footprinting and gel
and gel retardation
gel retardation techniques
We have found
have found that
found that a
that a region
a region in
region in both
in both genes
both genes -276
genes -276 to
-276 to -250
to -250 for
-250 for IL-2-R
for IL-2-R alpha
IL-2-R alpha and
alpha and -203
and -203 to
-203 to -183
to -183 for
-183 for IL-2
for IL-2 which
IL-2 which corresponds
which corresponds to
corresponds to a
to a kappa
a kappa B
kappa B enhancer
B enhancer element
enhancer element is
element is specifically
is specifically protected
specifically protected by
protected by nuclear
by nuclear proteins
nuclear proteins from
proteins from IARC
from IARC 301
In agreement with
agreement with this
with this finding
this finding both
finding both the
both the IL-2
the IL-2 and
IL-2 and IL-2-R
and IL-2-R alpha
IL-2-R alpha promoters
alpha promoters are
promoters are active
are active in
active in transient
in transient transfection
transient transfection assays
transfection assays in
assays in IARC
in IARC 301
IARC 301 cells
In contrast mutation
contrast mutation of
mutation of the
of the kappa
the kappa B
kappa B enhancer
B enhancer results
enhancer results in
results in markedly
in markedly attenuated
markedly attenuated activities
attenuated activities of
activities of both
of both promoters
Two proteins binding
proteins binding the
binding the kappa
the kappa B
kappa B sequence
B sequence NF-kappa
sequence NF-kappa B
NF-kappa B and
B and KBF1
and KBF1 are
KBF1 are constitutively
are constitutively expressed
constitutively expressed in
expressed in IARC
in IARC 301
IARC 301 nuclei
301 nuclei and
nuclei and induced
and induced by
induced by PMA
by PMA and
PMA and PHA
and PHA in
PHA in Jurkat
They bind to
bind to the
to the kappa
the kappa B
kappa B motifs
B motifs with
motifs with different
with different relative
different relative affinities
relative affinities that
affinities that may
that may reflect
may reflect their
reflect their different
their different contribution
different contribution in
contribution in the
in the expression
the expression of
expression of various
of various promoters
HIV1 infection of
infection of human
of human monocytes
human monocytes and
monocytes and macrophages
and macrophages promotes
macrophages promotes induction
promotes induction or
induction or translocation
or translocation of
translocation of NF-KB-related
of NF-KB-related factors
In 1991 we
1991 we demonstrated
we demonstrated using
demonstrated using electrophoretic
using electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
shift assays that
assays that 3
that 3 different
3 different factors
different factors termed
factors termed B1
termed B1 B2
B1 B2 and
B2 and B3
and B3 with
B3 with affinity
with affinity for
affinity for the
for the KB-enhancer
the KB-enhancer target
KB-enhancer target sequence
target sequence were
sequence were specifically
were specifically detected
specifically detected in
detected in nuclear
in nuclear extracts
nuclear extracts from
extracts from HIV1-infected
from HIV1-infected monocytes
HIV1-infected monocytes and
monocytes and macrophages
The B2 factor
B2 factor was
factor was induced
was induced in
induced in the
in the nuclei
the nuclei of
nuclei of these
of these cells
these cells only
cells only upon
only upon HIV1
upon HIV1 infection
The B3 factor
B3 factor was
factor was only
was only slightly
only slightly evident
slightly evident in
evident in nuclei
in nuclei of
nuclei of uninfected
of uninfected cells
uninfected cells but
cells but was
but was readily
was readily detectable
readily detectable in
detectable in nuclei
in nuclei of
nuclei of infected
of infected monocytes
Its expression remained
expression remained very
remained very low
very low in
low in nuclei
in nuclei of
nuclei of HIV1-infected
of HIV1-infected macrophages
In this paper
this paper we
paper we demonstrate
we demonstrate that
demonstrate that the
that the B2
the B2 factor
B2 factor is
factor is expressed
is expressed in
expressed in the
in the cytosol
the cytosol of
cytosol of monocytes
of monocytes and
monocytes and macrophages
and macrophages as
macrophages as a
as a DNA-binding
a DNA-binding protein
DNA-binding protein indicating
protein indicating that
indicating that it
that it is
it is not
is not associated
not associated with
associated with an
with an inhibitor
an inhibitor IKB
This factor remained
factor remained clustered
remained clustered in
clustered in the
in the cytosol
the cytosol and
cytosol and was
and was translocated
was translocated to
translocated to the
to the nuclei
the nuclei only
nuclei only after
only after HIV1
after HIV1 infection
The B3 factor
B3 factor is
factor is detected
is detected in
detected in the
in the cytosol
the cytosol only
cytosol only when
only when cells
when cells are
cells are HIV1-infected
The role of
role of HIV1
of HIV1 infection
HIV1 infection in
infection in the
in the expression
the expression and
expression and the
and the translocation
the translocation of
translocation of these
of these factors
these factors is
factors is discussed
Identification and cloning
and cloning of
cloning of TCF-1
of TCF-1 a
TCF-1 a T
a T lymphocyte-specific
T lymphocyte-specific transcription
lymphocyte-specific transcription factor
transcription factor containing
factor containing a
containing a sequence-specific
a sequence-specific HMG
sequence-specific HMG box
CD3-epsilon expression is
expression is controlled
is controlled by
controlled by a
by a downstream
a downstream T
downstream T lymphocyte-specific
T lymphocyte-specific enhancer
lymphocyte-specific enhancer element
We report the
report the identification
the identification of
identification of a
of a T
a T cell-specific
T cell-specific transcription
cell-specific transcription factor
transcription factor TCF-1
factor TCF-1 binding
TCF-1 binding to
binding to this
to this element
The multimerized recognition
multimerized recognition motif
recognition motif of
motif of TCF-1
of TCF-1 constituted
TCF-1 constituted a
constituted a T
a T cell-specific
T cell-specific enhancer
Subsequent cloning of
cloning of TCF-1
of TCF-1 identified
TCF-1 identified three
identified three splice
three splice alternatives
TCF-1 contained a
contained a single
a single DNA-binding
single DNA-binding HMG
DNA-binding HMG box
HMG box most
box most closely
most closely related
closely related to
related to similar
to similar boxes
similar boxes in
boxes in the
in the putative
the putative mammalian
putative mammalian sex-determining
mammalian sex-determining gene
sex-determining gene SRY
gene SRY and
SRY and in
and in the
in the Schizosaccharomyces
the Schizosaccharomyces pombe
Schizosaccharomyces pombe Mc
pombe Mc mating
Mc mating type
mating type gene
TCF-1 mRNA was
mRNA was expressed
was expressed uniquely
expressed uniquely in
uniquely in T
in T lymphocytes
Upon cotransfection into
cotransfection into non-T
into non-T cells
non-T cells TCF-1
cells TCF-1 could
TCF-1 could transactivate
could transactivate through
transactivate through its
through its cognate
its cognate motif
These results identify
results identify TCF-1
identify TCF-1 as
TCF-1 as a
as a T
a T cell-specific
T cell-specific transcription
cell-specific transcription factor
transcription factor which
factor which might
which might play
might play a
play a role
a role in
role in the
in the establishment
the establishment of
establishment of the
of the mature
the mature T
mature T cell
T cell phenotype
Identification of transcriptional
of transcriptional suppressor
transcriptional suppressor proteins
suppressor proteins that
proteins that bind
that bind to
bind to the
to the negative
the negative regulatory
negative regulatory element
regulatory element of
element of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
Two different proteins
different proteins which
proteins which independently
which independently bound
independently bound to
bound to neighboring
to neighboring sequences
neighboring sequences within
sequences within the
within the negative
the negative regulatory
negative regulatory element
regulatory element NRE
element NRE of
NRE of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 were
HIV-1 were detected
were detected in
detected in the
in the nuclear
the nuclear extract
nuclear extract of
extract of a
of a virus-infected
a virus-infected human
virus-infected human T
human T cell
T cell line
One of the
of the factors
the factors bound
factors bound to
bound to a
to a novel
a novel dyad
novel dyad symmetrical
dyad symmetrical sequence
This sequence is
sequence is well
is well conserved
well conserved in
conserved in various
in various HIV-1
various HIV-1 isolates
HIV-1 isolates and
isolates and partial
and partial homology
partial homology was
homology was found
was found with
found with the
with the promoter
the promoter region
promoter region of
region of the
of the human
the human retinoblastoma
human retinoblastoma gene
Similar DNA binding
DNA binding activity
binding activity was
activity was detected
was detected in
detected in a
in a variety
a variety of
variety of virus-uninfected
of virus-uninfected human
virus-uninfected human T
human T cell
T cell lines
cell lines and
lines and HeLa
and HeLa cells
HeLa cells by
cells by means
by means of
means of a
of a gel
a gel mobility
gel mobility shift
mobility shift assay
The other factor
other factor bound
factor bound to
bound to a
to a putative
a putative AP-1
putative AP-1 recognition
AP-1 recognition sequence
recognition sequence predicted
sequence predicted for
predicted for the
for the HIV-1
the HIV-1 NRE
However this factor
this factor did
factor did not
did not bind
not bind to
bind to a
to a typical
a typical AP-1
typical AP-1 site
The insertion of
insertion of multiple
of multiple copies
multiple copies of
copies of the
of the binding
the binding site
binding site for
site for the
for the former
the former or
former or latter
or latter factor
latter factor into
factor into a
into a heterologous
a heterologous promoter
heterologous promoter reduced
promoter reduced the
reduced the promoter
the promoter activity
promoter activity to
activity to one-tenth
to one-tenth or
one-tenth or one-third
or one-third respectively
Thus each factor
each factor may
factor may function
may function as
function as a
as a novel
a novel negative
novel negative regulator
negative regulator of
regulator of transcription
Protein kinase C
kinase C activation
C activation and
activation and protooncogene
and protooncogene expression
protooncogene expression in
expression in differentiation/retrodifferentiation
in differentiation/retrodifferentiation of
differentiation/retrodifferentiation of human
of human U-937
human U-937 leukemia
U-937 leukemia cells
Human U-937 leukemia
U-937 leukemia cells
leukemia cells differentiate
cells differentiate along
differentiate along the
along the monocytic
the monocytic lineage
monocytic lineage following
lineage following 3-day
following 3-day exposures
3-day exposures to
exposures to 12-O-tetradecanoylphorbol-13-acetate
to 12-O-tetradecanoylphorbol-13-acetate TPA
This induction of
induction of differentiation
of differentiation is
differentiation is accompanied
is accompanied by
accompanied by adherence
by adherence and
adherence and loss
and loss of
loss of proliferation
of proliferation as
proliferation as well
as well as
well as expression/repression
as expression/repression of
expression/repression of differentiation-associated
of differentiation-associated genes
Long term culture
term culture of
culture of TPA-differentiated
of TPA-differentiated U-937
TPA-differentiated U-937 cells
U-937 cells in
cells in the
in the absence
the absence of
absence of phorbol
of phorbol ester
phorbol ester for
ester for 32-36
for 32-36 days
32-36 days resulted
days resulted in
resulted in a
in a process
a process of
process of retrodifferentiation
The retrodifferentiated cells
retrodifferentiated cells detached
cells detached from
detached from the
from the substrate
the substrate and
substrate and reinitiated
and reinitiated proliferation
Other cellular parameters
cellular parameters such
parameters such as
such as glycosidase
as glycosidase activities
glycosidase activities cytokine
activities cytokine release
cytokine release and
release and filament
and filament expression
filament expression returned
expression returned to
returned to levels
to levels similar
levels similar to
similar to that
to that observed
that observed in
observed in uninduced
in uninduced cells
Treatment of U-937
of U-937 cells
U-937 cells with
cells with TPA
with TPA resulted
TPA resulted in
resulted in a
in a rapid
a rapid translocation
rapid translocation of
translocation of protein
of protein kinase
protein kinase C
kinase C PKC
C PKC from
PKC from the
from the cytosol
the cytosol to
cytosol to cell
to cell membrane
cell membrane fractions
membrane fractions within
fractions within 2-8
within 2-8 min
Increased levels of
levels of membrane-associated
of membrane-associated PKC
membrane-associated PKC activity
PKC activity persisted
activity persisted until
persisted until 17-29
until 17-29 days
However longer periods
longer periods of
periods of incubation
of incubation were
incubation were associated
were associated with
associated with a
with a return
a return to
return to the
to the distribution
the distribution of
distribution of PKC
of PKC in
PKC in control
in control cells
Activation of PKC
of PKC has
PKC has been
has been implicated
been implicated in
implicated in the
in the regulation
the regulation of
regulation of certain
of certain immediate
certain immediate early
immediate early response
early response genes
response genes and
genes and in
and in the
in the present
the present studies
present studies TPA
studies TPA rapidly
TPA rapidly induced
rapidly induced c-fos
induced c-fos and
c-fos and c-jun
and c-jun gene
c-jun gene expression
Levels of c-fos
of c-fos and
c-fos and c-jun
and c-jun transcripts
c-jun transcripts remained
transcripts remained elevated
remained elevated during
elevated during periods
during periods of
periods of PKC
of PKC activation
PKC activation and
activation and also
and also returned
also returned to
returned to levels
to levels observed
levels observed in
observed in control
in control cells
control cells by
cells by 30-36
by 30-36 days
30-36 days when
days when the
when the cells
the cells entered
cells entered retrodifferentiation
Staurosporine a nonspecific
a nonspecific inhibitor
nonspecific inhibitor of
inhibitor of PKC
of PKC partially
PKC partially blocked
partially blocked TPA-induced
blocked TPA-induced adherence
TPA-induced adherence and
adherence and growth
and growth inhibition
growth inhibition and
inhibition and concomitantly
and concomitantly prevented
concomitantly prevented TPA-induced
prevented TPA-induced c-fos
TPA-induced c-fos and
c-fos and c-jun
and c-jun gene
c-jun gene expression
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Kappa B-specific DNA
B-specific DNA binding
DNA binding proteins
binding proteins are
proteins are differentially
are differentially inhibited
differentially inhibited by
inhibited by enhancer
by enhancer mutations
enhancer mutations and
mutations and biological
and biological oxidation
Kappa B kappa
B kappa B
kappa B enhancer
B enhancer binding
enhancer binding proteins
binding proteins isolated
proteins isolated from
isolated from the
from the nuclei
the nuclei of
nuclei of activated
of activated human
activated human T
human T cells
T cells produce
cells produce two
produce two distinct
two distinct nucleoprotein
distinct nucleoprotein complexes
nucleoprotein complexes when
complexes when incubated
when incubated with
incubated with the
with the kappa
the kappa B
kappa B element
B element from
element from the
from the interleukin-2
the interleukin-2 receptor-alpha
interleukin-2 receptor-alpha IL-2R
receptor-alpha IL-2R alpha
IL-2R alpha gene
These two DNA-protein
two DNA-protein complexes
DNA-protein complexes are
complexes are composed
are composed of
composed of at
of at least
at least four
least four host
four host proteins
host proteins p50
proteins p50 p55
p50 p55 p75
p55 p75 p85
p75 p85 each
p85 each of
each of which
of which shares
which shares structural
shares structural similarity
structural similarity with
similarity with the
with the v-rel
the v-rel oncogene
v-rel oncogene product
Nuclear expression of
expression of these
of these proteins
these proteins is
proteins is induced
is induced with
induced with distinctly
with distinctly biphasic
distinctly biphasic kinetics
biphasic kinetics following
kinetics following phorbol
following phorbol ester
phorbol ester activation
ester activation of
activation of T
of T cells
T cells p55/p75
cells p55/p75 early
p55/p75 early and
early and p50/p85
and p50/p85 late
DNA-protein crosslinking studies
crosslinking studies have
studies have revealed
have revealed that
revealed that the
that the more
the more rapidly
more rapidly migrating
rapidly migrating B2
migrating B2 complex
B2 complex contains
complex contains both
contains both p50
both p50 and
p50 and p55
and p55 while
p55 while the
while the more
the more slowly
more slowly migrating
slowly migrating B1
migrating B1 complex
B1 complex is
complex is composed
is composed of
composed of p50
of p50 p55
p50 p55 p75
p55 p75 and
p75 and p85
Site-directed mutagenesis of
mutagenesis of the
of the wild-type
the wild-type IL-2R
wild-type IL-2R alpha
IL-2R alpha kappa
alpha kappa B
kappa B enhancer
B enhancer GGGGAATCTCCC
enhancer GGGGAATCTCCC has
GGGGAATCTCCC has revealed
has revealed that
revealed that the
that the binding
the binding of
binding of p50
of p50 and
p50 and p55
and p55 B2
p55 B2 complex
B2 complex is
complex is particularly
is particularly sensitive
particularly sensitive to
sensitive to alteration
to alteration of
alteration of the
of the 5'
the 5' triplet
5' triplet of
triplet of deoxyguanosine
of deoxyguanosine residues
In contrast formation
contrast formation of
formation of the
of the B1
the B1 complex
B1 complex reflecting
complex reflecting the
reflecting the binding
the binding of
binding of p75
of p75 and
p75 and p85
and p85 critically
p85 critically depends
critically depends upon
depends upon the
upon the more
the more 3'
more 3' sequences
3' sequences of
sequences of this
of this enhancer
this enhancer element
DNA binding by
binding by all
by all four
all four of
four of these
of these Rel-related
these Rel-related factors
Rel-related factors is
factors is blocked
is blocked by
blocked by selective
by selective chemical
selective chemical modification
chemical modification of
modification of lysine
of lysine and
lysine and arginine
and arginine residues
arginine residues suggesting
residues suggesting that
suggesting that both
that both of
both of these
of these basic
these basic amino
basic amino acids
amino acids are
acids are required
are required for
required for binding
for binding to
binding to the
to the kappa
the kappa B
kappa B element
Similarly covalent modification
covalent modification of
modification of free
of free sulfhydryl
free sulfhydryl groups
sulfhydryl groups with
groups with diamide
with diamide reversible
diamide reversible or
reversible or N-ethylmaleimide
or N-ethylmaleimide irreversible
N-ethylmaleimide irreversible results
irreversible results in
results in a
in a complete
a complete loss
complete loss of
loss of DNA
of DNA binding
DNA binding activity
In contrast mild
contrast mild oxidation
mild oxidation with
oxidation with glucose
with glucose oxidase
glucose oxidase selectively
oxidase selectively inhibits
selectively inhibits p75
inhibits p75 and
p75 and p85
and p85 binding
p85 binding while
binding while not
while not blocking
not blocking p50
blocking p50 and
p50 and p55
and p55 interactions
These findings suggest
findings suggest that
suggest that reduced
that reduced cysteine
reduced cysteine thiols
cysteine thiols play
thiols play an
play an important
an important role
important role in
role in the
in the DNA
the DNA binding
DNA binding activity
binding activity of
activity of this
of this family
this family of
family of Rel-related
of Rel-related transcription
Rel-related transcription factors
[Changes in leucocytic
in leucocytic estrogen
leucocytic estrogen receptor
estrogen receptor levels
receptor levels in
levels in patients
in patients with
patients with climacteric
with climacteric syndrome
climacteric syndrome and
syndrome and therapeutic
and therapeutic effect
therapeutic effect of
effect of liuwei
of liuwei dihuang
liuwei dihuang pills]
The numbers of
numbers of estrogen
of estrogen receptor
estrogen receptor ER
receptor ER in
ER in human
in human peripheral
human peripheral leucocytes
peripheral leucocytes in
leucocytes in 22
in 22 women
22 women with
women with climacteric
with climacteric syndrome
climacteric syndrome were
syndrome were measured
were measured by
measured by radioligand
by radioligand method
The results were
results were compared
were compared with
compared with those
with those of
those of 12
of 12 normal
12 normal child-bearing-age
normal child-bearing-age women
It wat found
wat found that
found that the
that the contents
the contents of
contents of leucocytic
of leucocytic ER
leucocytic ER in
ER in climacteric
in climacteric syndrome
climacteric syndrome patients
syndrome patients were
patients were significantly
were significantly lower
significantly lower than
lower than normal
than normal child-bearing-age
normal child-bearing-age women
The authors used
authors used a
used a Chinese
a Chinese prescription--Liuwei
Chinese prescription--Liuwei Dihuang
prescription--Liuwei Dihuang Pills
Dihuang Pills LDP
Pills LDP to
LDP to treat
to treat the
treat the patients
the patients for
patients for 2
for 2 months
The numbers of
numbers of leucocytic
of leucocytic ER
leucocytic ER were
ER were significantly
were significantly increased
significantly increased after
increased after treatment
The data indicate
data indicate that
indicate that decrease
that decrease of
decrease of ER
of ER levels
ER levels in
levels in cell
in cell may
cell may involve
may involve in
involve in the
in the pathogenesis
the pathogenesis of
pathogenesis of climacteric
of climacteric syndrome
LDP not only
not only increases
only increases plasma
increases plasma estradiol
plasma estradiol levels
estradiol levels but
levels but also
but also increases
also increases the
increases the leucocytic
the leucocytic ER
leucocytic ER levels
This may be
may be the
be the basis
the basis of
basis of the
of the therapeutic
the therapeutic effect
therapeutic effect on
effect on the
on the disease
Evaluation of the
of the role
the role of
role of ligand
of ligand and
ligand and thermal
and thermal activation
thermal activation of
activation of specific
of specific DNA
specific DNA binding
DNA binding by
binding by in
by in vitro
in vitro synthesized
vitro synthesized human
synthesized human glucocorticoid
human glucocorticoid receptor
We have used
have used a
used a DNA-binding/immunoprecipitation
a DNA-binding/immunoprecipitation assay
DNA-binding/immunoprecipitation assay to
assay to analyze
to analyze the
analyze the capacity
the capacity of
capacity of human
of human glucocorticoid
human glucocorticoid receptor
glucocorticoid receptor hGR
receptor hGR generated
hGR generated in
generated in rabbit
in rabbit reticulocyte
rabbit reticulocyte lysates
reticulocyte lysates to
lysates to bind
to bind DNA
In vitro translated
vitro translated hGR
translated hGR was
hGR was indistinguishable
was indistinguishable from
indistinguishable from native
from native hGR
native hGR as
hGR as determined
as determined by
determined by migration
by migration on
migration on sodium
on sodium dodecyl
sodium dodecyl sulfate-polyacrylamide
dodecyl sulfate-polyacrylamide gels
sulfate-polyacrylamide gels sedimentation
gels sedimentation on
sedimentation on sucrose
on sucrose density
sucrose density gradients
density gradients and
gradients and reactivity
and reactivity with
reactivity with antipeptide
with antipeptide antibodies
antipeptide antibodies generated
antibodies generated against
generated against hGR
In addition cell-free
addition cell-free synthesized
cell-free synthesized hGR
synthesized hGR was
hGR was capable
was capable of
capable of specific
of specific binding
specific binding to
binding to glucocorticoid
to glucocorticoid response
glucocorticoid response element
response element GRE-containing
element GRE-containing DNA
GRE-containing DNA fragments
Using this assay
this assay system
assay system we
system we have
we have evaluated
have evaluated the
evaluated the contributions
the contributions of
contributions of ligand
of ligand binding
ligand binding and
binding and heat
and heat activation
heat activation to
activation to DNA
to DNA binding
DNA binding by
binding by these
by these glucocorticoid
these glucocorticoid receptors
In vitro translated
vitro translated hGR
translated hGR was
hGR was capable
was capable of
capable of selective
of selective DNA
selective DNA binding
DNA binding even
binding even in
even in the
in the absence
the absence of
absence of glucocorticoid
Treatment with dexamethasone
with dexamethasone or
dexamethasone or the
or the antiglucocorticoid
the antiglucocorticoid RU486
antiglucocorticoid RU486 had
RU486 had no
had no additional
no additional effect
additional effect on
effect on the
on the DNA-binding
the DNA-binding capacity
DNA-binding capacity when
capacity when receptor
when receptor preparations
receptor preparations were
preparations were maintained
were maintained at
maintained at 0
at 0 C
0 C no
C no activation
In contrast addition
contrast addition of
addition of either
of either ligand
either ligand or
ligand or antagonist
or antagonist in
antagonist in combination
in combination with
combination with a
with a heat
a heat activation
heat activation step
activation step promoted
step promoted DNA
promoted DNA binding
DNA binding by
binding by approximately
by approximately 3-fold
approximately 3-fold over
3-fold over that
over that of
that of heat-activated
of heat-activated unliganded
heat-activated unliganded receptors
Agonist dexamethasone was
dexamethasone was slightly
was slightly more
slightly more effective
more effective in
effective in supporting
in supporting specific
supporting specific DNA
specific DNA binding
DNA binding than
binding than antagonist
than antagonist RU486
DNA binding by
binding by in
by in vitro
in vitro synthesized
vitro synthesized GR
synthesized GR was
GR was blocked
was blocked by
blocked by the
by the addition
the addition of
addition of sodium
of sodium molybdate
sodium molybdate to
molybdate to the
to the receptor
the receptor preparations
receptor preparations before
preparations before steroid
before steroid addition
steroid addition and
addition and thermal
and thermal activation
Addition of KCl
of KCl resulted
KCl resulted in
resulted in less
in less DNA
less DNA binding
DNA binding either
binding either due
either due to
due to blockage
to blockage of
blockage of DNA-receptor
of DNA-receptor complex
DNA-receptor complex formation
complex formation or
formation or disruption
or disruption of
disruption of the
of the complexes
The specificity of
specificity of DNA
of DNA binding
DNA binding by
binding by cell-free
by cell-free synthesized
cell-free synthesized hGR
synthesized hGR was
hGR was analyzed
was analyzed further
analyzed further by
further by examining
by examining the
examining the abilities
the abilities of
abilities of various
of various DNAs
various DNAs to
DNAs to compete
to compete for
compete for binding
for binding to
binding to a
to a naturally
a naturally occurring
naturally occurring GRE
occurring GRE found
GRE found in
found in the
in the mouse
the mouse mammary
mouse mammary tumor
mammary tumor virus-long
tumor virus-long terminal
virus-long terminal repeat
Oligonucleotides containing the
containing the consensus
the consensus GRE
consensus GRE were
GRE were the
were the most
the most efficient
most efficient competitors
efficient competitors and
competitors and fragments
and fragments containing
fragments containing regulatory
containing regulatory sequences
regulatory sequences from
sequences from glucocorticoid-repressible
from glucocorticoid-repressible genes
glucocorticoid-repressible genes were
genes were somewhat
were somewhat competitive
somewhat competitive whereas
competitive whereas single
whereas single stranded
single stranded oligonucleotides
stranded oligonucleotides were
oligonucleotides were unable
were unable to
unable to compete
to compete for
compete for mouse
for mouse mammary
mouse mammary tumor
mammary tumor virus-long
tumor virus-long terminal
virus-long terminal repeat
terminal repeat DNA
repeat DNA binding
DNA binding except
binding except when
except when competitor
when competitor was
competitor was present
was present at
present at extremely
at extremely high
extremely high concentrations
Together these studies
these studies indicate
studies indicate that
indicate that hGR
that hGR synthesized
hGR synthesized in
synthesized in rabbit
in rabbit reticulocyte
rabbit reticulocyte lysates
reticulocyte lysates displays
lysates displays many
displays many of
many of the
of the same
the same properties
same properties including
properties including GRE-specific
including GRE-specific DNA
GRE-specific DNA binding
DNA binding observed
binding observed for
observed for glucocorticoid
for glucocorticoid receptor
glucocorticoid receptor present
receptor present in
present in cytosolic
in cytosolic extracts
cytosolic extracts of
extracts of mammalian
of mammalian cells
mammalian cells and
cells and tissues
Similarities between the
between the effects
the effects of
effects of dexamethasone
of dexamethasone and
dexamethasone and RU486
and RU486 suggest
RU486 suggest that
suggest that the
that the antiglucocorticoid
the antiglucocorticoid properties
antiglucocorticoid properties of
properties of RU486
of RU486 do
RU486 do not
do not occur
not occur at
occur at the
at the level
the level of
level of specific
of specific DNA
specific DNA binding
Expression of 125OH2D3
of 125OH2D3 receptors
125OH2D3 receptors on
receptors on alveolar
on alveolar lymphocytes
alveolar lymphocytes from
lymphocytes from patients
from patients with
patients with pulmonary
with pulmonary granulomatous
pulmonary granulomatous diseases
125OH2D3 is known
is known to
known to be
to be produced
be produced at
produced at sites
at sites of
sites of granulomatous
of granulomatous reactions
In order to
order to characterize
to characterize the
characterize the cell
the cell types
cell types that
types that are
that are targets
are targets for
targets for this
for this immunoregulatory
this immunoregulatory hormone
immunoregulatory hormone we
hormone we have
we have evaluated
have evaluated the
evaluated the expression
the expression of
expression of 125OH2D3
of 125OH2D3 receptors
125OH2D3 receptors on
receptors on peripheral
on peripheral blood
peripheral blood T-lymphocytes
blood T-lymphocytes and
T-lymphocytes and those
and those recovered
those recovered from
recovered from the
from the lung
the lung by
lung by bronchoalveolar
by bronchoalveolar lavage
bronchoalveolar lavage from
lavage from patients
from patients with
patients with pulmonary
with pulmonary granulomatous
pulmonary granulomatous diseases
granulomatous diseases tuberculosis
diseases tuberculosis and
tuberculosis and sarcoidosis
and sarcoidosis and
sarcoidosis and from
and from normal
from normal control
normal control subjects
control subjects using
subjects using combined
using combined autoradiographic
combined autoradiographic and
autoradiographic and immunohistochemical
and immunohistochemical techniques
Lavage T-lymphocytes from
T-lymphocytes from patients
from patients with
patients with tuberculosis
with tuberculosis or
tuberculosis or with
or with sarcoidosis
with sarcoidosis but
sarcoidosis but not
but not those
not those from
those from normal
from normal control
normal control subjects
control subjects expressed
subjects expressed 125OH2D3
expressed 125OH2D3 receptors
125OH2D3 receptors as
receptors as demonstrated
as demonstrated by
demonstrated by binding
by binding of
binding of [3H]125OH2D3
of [3H]125OH2D3 which
[3H]125OH2D3 which was
which was inhibited
was inhibited by
inhibited by the
by the presence
the presence of
presence of excess
of excess unlabeled
excess unlabeled 125OH2D3
unlabeled 125OH2D3 but
125OH2D3 but not
but not by
not by the
by the presence
the presence of
presence of unlabeled
of unlabeled 25OHD3
unlabeled 25OHD3 receptor-positive
25OHD3 receptor-positive lymphocytes:
receptor-positive lymphocytes: sarcoidosis
lymphocytes: sarcoidosis 20
sarcoidosis 20 +/-
20 +/- 12%;
+/- 12%; tuberculosis
12%; tuberculosis 31
tuberculosis 31 +/-
31 +/- 17%
In contrast blood
contrast blood lymphocytes
blood lymphocytes from
lymphocytes from patients
from patients with
patients with granulomatous
with granulomatous diseases
granulomatous diseases did
diseases did not
did not express
not express detectable
express detectable 125OH2D3
detectable 125OH2D3 receptors
The percentage of
percentage of lavage
of lavage T-lymphocytes
lavage T-lymphocytes expressing
T-lymphocytes expressing 125OH2D3
expressing 125OH2D3 receptors
125OH2D3 receptors was
receptors was significantly
was significantly greater
significantly greater for
greater for patients
for patients with
patients with tuberculosis
with tuberculosis presenting
tuberculosis presenting with
presenting with isolated
with isolated hilar
isolated hilar adenopathy
hilar adenopathy than
adenopathy than for
than for patients
for patients with
patients with pulmonary
with pulmonary infiltrates
pulmonary infiltrates and/or
infiltrates and/or cavities
125OH2D3 receptors were
receptors were expressed
were expressed to
expressed to a
to a greater
a greater extent
greater extent on
extent on CD8+
on CD8+ T-lymphocytes
CD8+ T-lymphocytes than
T-lymphocytes than on
than on CD4+
on CD4+ T-lymphocytes
CD4+ T-lymphocytes in
T-lymphocytes in sarcoidosis
in sarcoidosis whereas
sarcoidosis whereas a
whereas a greater
a greater proportion
greater proportion of
proportion of CD4+
of CD4+ than
CD4+ than of
than of CD8+
of CD8+ T-lymphocytes
CD8+ T-lymphocytes from
T-lymphocytes from patients
from patients with
patients with tuberculosis
with tuberculosis were
tuberculosis were receptor-positive
These findings support
findings support the
support the conclusion
the conclusion that
conclusion that the
that the interaction
the interaction of
interaction of 125OH2D3
of 125OH2D3 with
125OH2D3 with its
with its receptor
its receptor on
receptor on T-lymphocytes
on T-lymphocytes may
T-lymphocytes may play
may play an
play an important
an important role
important role in
role in the
in the regulation
the regulation of
regulation of granulomatous
of granulomatous reactions
granulomatous reactions but
reactions but because
but because these
because these receptors
these receptors are
receptors are expressed
are expressed on
expressed on different
on different lymphocyte
different lymphocyte populations
lymphocyte populations the
populations the net
the net effect
net effect of
effect of this
of this potent
this potent immunoregulatory
potent immunoregulatory molecule
immunoregulatory molecule is
molecule is likely
is likely different
likely different in
different in sarcoidosis
in sarcoidosis and
sarcoidosis and tuberculosis
Role for the
for the Epstein-Barr
the Epstein-Barr virus
Epstein-Barr virus nuclear
virus nuclear antigen
nuclear antigen 2
antigen 2 in
2 in viral
in viral promoter
viral promoter switching
promoter switching during
switching during initial
during initial stages
initial stages of
stages of infection
During latent Epstein-Barr
latent Epstein-Barr virus
Epstein-Barr virus EBV
virus EBV infection
EBV infection of
infection of human
of human B
human B lymphocytes
B lymphocytes six
lymphocytes six viral
six viral nuclear
viral nuclear antigen
nuclear antigen EBNAs
antigen EBNAs are
EBNAs are expressed
are expressed from
expressed from long
from long primary
long primary transcripts
primary transcripts by
transcripts by means
by means of
means of alternative
of alternative splicing
alternative splicing and
splicing and alternative
and alternative polyadenylylation
alternative polyadenylylation sites
These transcripts initiate
transcripts initiate from
initiate from one
from one of
one of two
of two promoters
two promoters Cp
promoters Cp or
Cp or Wp
or Wp that
Wp that function
that function in
function in a
in a mutually
a mutually exclusive
mutually exclusive fashion
Wp is exclusively
is exclusively utilized
exclusively utilized during
utilized during the
during the initial
the initial stages
initial stages of
stages of infection
of infection of
infection of primary
of primary B
primary B lymphocytes
B lymphocytes followed
lymphocytes followed by
followed by a
by a switch
a switch to
switch to Cp
to Cp usage
These studies have
studies have been
have been extended
been extended to
extended to show
to show that
show that i
that i a
i a mutant
a mutant EBV
mutant EBV strain
EBV strain lacking
strain lacking the
lacking the gene
the gene encoding
gene encoding EBNA
encoding EBNA 2
EBNA 2 fails
2 fails to
fails to switch
to switch from
switch from Wp
from Wp to
Wp to Cp
to Cp usage
Cp usage in
usage in primary
in primary B
primary B lymphocytes
B lymphocytes although
lymphocytes although the
although the virus
the virus contains
virus contains a
contains a functional
a functional Cp;
functional Cp; ii
Cp; ii a
ii a region
a region from
region from -429
from -429 to
-429 to -245
to -245 base
-245 base pairs
base pairs upstream
pairs upstream of
upstream of Cp
of Cp is
Cp is essential
is essential for
essential for Cp
for Cp activity
Cp activity in
activity in B
in B lymphocytes
B lymphocytes but
lymphocytes but only
but only in
only in the
in the context
the context of
context of upstream
of upstream and
upstream and downstream
and downstream sequences;
downstream sequences; iii
sequences; iii this
iii this region
this region contains
region contains an
contains an EBNA
an EBNA 2-dependent
EBNA 2-dependent enhancer;
2-dependent enhancer; and
enhancer; and iv
and iv DNase
iv DNase I
DNase I protection
I protection employing
protection employing nuclear
employing nuclear extracts
nuclear extracts from
extracts from B
from B and
B and T
and T lymphocytes
T lymphocytes revealed
lymphocytes revealed a
revealed a B-cell-specific
a B-cell-specific footprint
B-cell-specific footprint in
footprint in the
in the region
the region of
region of the
of the EBNA
the EBNA 2-dependent
EBNA 2-dependent enhancer
These results support
results support a
support a model
a model for
model for viral
for viral promoter
viral promoter switching
promoter switching during
switching during the
during the initial
the initial stages
initial stages of
stages of infection
of infection in
infection in which
in which Wp
which Wp activity
Wp activity leads
activity leads to
leads to the
to the expression
the expression of
expression of EBNA
of EBNA 2
EBNA 2 followed
2 followed by
followed by activation
by activation of
activation of Cp
of Cp through
Cp through the
through the EBNA
the EBNA 2-dependent
EBNA 2-dependent enhancer
Immune response of
response of peripheral
of peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells to
cells to HBx-antigen
to HBx-antigen of
HBx-antigen of hepatitis
of hepatitis B
hepatitis B virus
The hepatitis B
hepatitis B virus
B virus genome
virus genome encodes
genome encodes a
encodes a transcriptional
a transcriptional transactivator
transcriptional transactivator protein
transactivator protein designated
protein designated HBxAg
We have investigated
have investigated whether
investigated whether this
whether this antigen
this antigen is
antigen is a
is a target
a target structure
target structure for
structure for human
for human T-lymphocytes
Using recombinant HBxAg
recombinant HBxAg protein
HBxAg protein we
protein we found
we found HBxAg-specific
found HBxAg-specific stimulation
HBxAg-specific stimulation of
stimulation of peripheral
of peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells in
cells in patients
in patients with
patients with acute
with acute hepatitis
acute hepatitis B
hepatitis B virus
B virus infection
virus infection 6
infection 6 of
6 of 6
of 6 and
6 and chronic
and chronic hepatitis
chronic hepatitis B
hepatitis B virus
B virus infection
virus infection 6
infection 6 of
6 of 17
of 17 but
17 but not
but not in
not in healthy
in healthy individuals
With HBxAg-specific synthetic
HBxAg-specific synthetic polypeptides
synthetic polypeptides several
polypeptides several T-cell
several T-cell epitopes
T-cell epitopes were
epitopes were identified
Most were located
were located in
located in the
in the carboxyterminal
the carboxyterminal half
carboxyterminal half of
half of the
of the HBxAg
the HBxAg protein
Five T-cell clones
T-cell clones specific
clones specific for
specific for a
for a T-cell
a T-cell epitope
T-cell epitope located
epitope located at
located at the
at the carboxyterminal
the carboxyterminal region
carboxyterminal region of
region of HBxAg
of HBxAg were
HBxAg were established
were established and
established and found
and found to
found to belong
to belong to
belong to the
to the CD2/CD4-positive
the CD2/CD4-positive CD8-negative
CD2/CD4-positive CD8-negative subtype
These data establish
data establish for
establish for the
for the first
the first time
first time HBxAg
time HBxAg as
HBxAg as an
as an antigen
an antigen in
antigen in the
in the cellular
the cellular immune
cellular immune response
[Changes in leucocytic
in leucocytic estrogen
leucocytic estrogen receptor
estrogen receptor levels
receptor levels in
levels in patients
in patients with
patients with gynecomastia]
The number of
number of estrogen
of estrogen receptor
estrogen receptor ER
receptor ER in
ER in human
in human peripheral
human peripheral leucocytes
peripheral leucocytes in
leucocytes in 13
in 13 men
13 men with
men with gynecomastia
with gynecomastia were
gynecomastia were measured
were measured by
measured by radioligand
by radioligand binding
radioligand binding method
binding method The
method The results
The results were
results were compared
were compared with
compared with those
with those of
those of 13
of 13 sex-and
13 sex-and age-matched
sex-and age-matched healthy
age-matched healthy subjects
It was found
was found that
found that the
that the number
the number of
number of ER
of ER in
ER in leucocytes
in leucocytes was
leucocytes was significantly
was significantly increased
significantly increased in
increased in gynecomastia
in gynecomastia Rs
gynecomastia Rs of
Rs of leucocytes
of leucocytes were
leucocytes were 1054
were 1054 +/-
1054 +/- 254
+/- 254 sites/cell
It suggested that
suggested that increase
that increase of
increase of ER
of ER levels
ER levels play
levels play an
play an important
an important role
important role in
role in the
in the pathogenesis
the pathogenesis of
pathogenesis of gynecomastia
The NF kappa
NF kappa B
kappa B independent
B independent cis-acting
independent cis-acting sequences
cis-acting sequences in
sequences in HIV-1
in HIV-1 LTR
HIV-1 LTR responsive
LTR responsive to
responsive to T-cell
to T-cell activation
The rate of
rate of transcription
of transcription initiation
transcription initiation directed
initiation directed by
directed by the
by the long
the long terminal
long terminal repeat
terminal repeat LTR
repeat LTR of
LTR of HIV-1
of HIV-1 increases
HIV-1 increases in
increases in response
in response to
response to mitogenic
to mitogenic stimuli
mitogenic stimuli of
stimuli of T
of T cells
Here we show
we show that
show that the
that the response
the response of
response of the
of the HIV-1
the HIV-1 LTR
HIV-1 LTR may
LTR may be
may be governed
be governed by
governed by two
by two independent
two independent sequences
independent sequences located
sequences located 5'
located 5' to
5' to the
to the site
the site of
site of transcription
of transcription initiation
transcription initiation sequences
initiation sequences that
sequences that bind
that bind either
bind either NFAT-1
either NFAT-1 or
NFAT-1 or NF
or NF kappa
NF kappa B
The rate of
rate of LTR-directed
of LTR-directed gene
LTR-directed gene expression
gene expression increased
expression increased in
increased in response
in response to
response to treatment
to treatment with
treatment with either
with either a
either a phorbol
a phorbol ester
phorbol ester or
ester or tumor
or tumor necrosis
tumor necrosis factor
necrosis factor alpha
factor alpha if
alpha if either
if either the
either the NFAT-1
the NFAT-1 or
NFAT-1 or NF
or NF kappa
NF kappa B
kappa B binding
B binding sites
binding sites were
sites were deleted
were deleted but
deleted but failed
but failed to
failed to respond
to respond to
respond to these
to these mitogenic
these mitogenic stimuli
mitogenic stimuli if
stimuli if both
if both sequences
both sequences were
sequences were absent
The HIV-1 mutant
HIV-1 mutant virus
mutant virus containing
virus containing both
containing both NF
both NF kappa
NF kappa B
kappa B and
B and NFAT-1
and NFAT-1 deletion
NFAT-1 deletion was
deletion was able
was able to
able to replicate
to replicate although
replicate although at
although at a
at a much
a much decreased
much decreased growth
decreased growth rate
growth rate while
rate while the
while the deletion
the deletion of
deletion of NFAT-1
of NFAT-1 alone
NFAT-1 alone increased
alone increased the
increased the viral
the viral growth
viral growth rate
growth rate in
rate in Jurkat
in Jurkat cells
Neither deletion of
deletion of NF
of NF kappa
NF kappa B
kappa B nor
B nor deletion
nor deletion of
deletion of NFAT-1
of NFAT-1 decreased
NFAT-1 decreased activation
decreased activation of
activation of viral
of viral replication
viral replication by
replication by phorbol
by phorbol ester
cAMP-dependent regulation of
regulation of proenkephalin
of proenkephalin by
proenkephalin by JunD
by JunD and
JunD and JunB:
and JunB: positive
JunB: positive and
positive and negative
and negative effects
negative effects of
effects of AP-1
of AP-1 proteins
We demonstrate that
demonstrate that JunD
that JunD a
JunD a component
a component of
component of the
of the AP-1
the AP-1 transcription
AP-1 transcription factor
transcription factor complex
factor complex activates
complex activates transcription
activates transcription of
transcription of the
of the human
the human proenkephalin
human proenkephalin gene
proenkephalin gene in
gene in a
in a fashion
a fashion that
fashion that is
that is completely
is completely dependent
completely dependent upon
dependent upon the
upon the cAMP-dependent
the cAMP-dependent protein
cAMP-dependent protein kinase
protein kinase protein
kinase protein kinase
protein kinase A
Activation of proenkephalin
of proenkephalin transcription
proenkephalin transcription by
transcription by JunD
by JunD is
JunD is dependent
is dependent upon
dependent upon a
upon a previously
a previously characterized
previously characterized cAMP-
characterized cAMP- phorbol
cAMP- phorbol ester-
phorbol ester- and
ester- and Ca2+-inducible
and Ca2+-inducible enhancer
Ca2+-inducible enhancer and
enhancer and JunD
and JunD is
JunD is shown
is shown to
shown to bind
to bind the
bind the enhancer
the enhancer as
enhancer as a
as a homodimer
Another component of
component of the
of the AP-1
the AP-1 transcription
AP-1 transcription complex
transcription complex JunB
complex JunB is
JunB is shown
is shown to
shown to inhibit
to inhibit activation
inhibit activation mediated
activation mediated by
mediated by JunD
As a homodimer
a homodimer JunB
homodimer JunB is
JunB is unable
is unable to
unable to bind
to bind the
bind the enhancer;
the enhancer; however
enhancer; however in
however in the
in the presence
the presence of
presence of c-Fos
of c-Fos high-affinity
c-Fos high-affinity binding
high-affinity binding is
binding is observed
Furthermore JunD is
JunD is shown
is shown to
shown to activate
to activate transcription
activate transcription of
transcription of genes
of genes linked
genes linked to
linked to both
to both cAMP
both cAMP and
cAMP and phorbol
and phorbol ester
phorbol ester response
ester response elements
response elements in
elements in a
in a protein
a protein kinase
protein kinase A-dependent
kinase A-dependent fashion
A-dependent fashion further
fashion further blurring
further blurring the
blurring the distinction
the distinction between
distinction between these
between these response
these response elements
These results demonstrate
results demonstrate that
demonstrate that the
that the transcriptional
the transcriptional activity
transcriptional activity of
activity of an
of an AP-1-related
an AP-1-related protein
AP-1-related protein is
protein is regulated
is regulated by
regulated by the
by the cAMP-dependent
the cAMP-dependent second-messenger
cAMP-dependent second-messenger pathway
second-messenger pathway and
pathway and suggest
and suggest that
suggest that JunD
that JunD and
JunD and other
and other AP-1-related
other AP-1-related proteins
AP-1-related proteins may
proteins may play
may play an
play an important
an important role
important role in
role in the
in the regulation
the regulation of
regulation of gene
of gene expression
gene expression by
expression by cAMP-dependent
by cAMP-dependent intracellular
cAMP-dependent intracellular signaling
intracellular signaling pathways
[Plasma cortisol concentration
cortisol concentration and
concentration and blood
and blood leukocyte
blood leukocyte content
leukocyte content of
content of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in patients
in patients with
patients with deficiency-cold
with deficiency-cold vs
deficiency-cold vs deficiency-heat
vs deficiency-heat syndromes]
Plasma cortisol concentration
cortisol concentration and
concentration and blood
and blood leukocyte
blood leukocyte content
leukocyte content of
content of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors GCR
receptors GCR were
GCR were assayed
were assayed in
assayed in 20
in 20 patients
20 patients with
patients with deficiency
with deficiency syndromes
deficiency syndromes 10
syndromes 10 cold
10 cold in
cold in property
in property deficiency-cold
property deficiency-cold the
deficiency-cold the other
the other 10
other 10 hot
10 hot in
hot in property
in property deficiency-heat
property deficiency-heat and
deficiency-heat and also
and also in
also in 10
in 10 healthy
10 healthy individuals
healthy individuals as
individuals as normal
as normal control
normal control for
control for the
for the purpose
the purpose of
purpose of investigating
of investigating the
investigating the nature
the nature of
nature of cold
of cold and
cold and heat
and heat syndromes
As a result
a result the
result the cases
the cases of
cases of deficiency-cold
of deficiency-cold syndrome
deficiency-cold syndrome DCS
syndrome DCS had
DCS had a
had a normal
a normal concentration
normal concentration of
concentration of plasma
of plasma cortisol
plasma cortisol but
cortisol but a
but a lowered
a lowered content
lowered content of
content of GCR
of GCR in
GCR in leukocytes
in leukocytes when
leukocytes when compared
when compared with
compared with the
with the normal
the normal control
normal control P
control P less
P less than
less than 005;
than 005; the
005; the cases
the cases of
cases of deficiency-heat
of deficiency-heat syndrome
deficiency-heat syndrome DHS
syndrome DHS had
DHS had a
had a higher
a higher concentration
higher concentration of
concentration of plasma
of plasma cortisol
plasma cortisol than
cortisol than the
than the normal
the normal control
normal control P
control P less
P less than
less than 005
than 005 and
005 and a
and a slightly
a slightly higher
slightly higher content
higher content of
content of GCR
of GCR in
GCR in leukocytes
It was concluded
was concluded that
concluded that the
that the DCS
the DCS is
DCS is characterized
is characterized by
characterized by diminished
by diminished biological
diminished biological effects
biological effects of
effects of adrenocortical
of adrenocortical activity
adrenocortical activity while
activity while the
while the DHS
the DHS by
DHS by augmented
by augmented biological
augmented biological effects
biological effects of
effects of adrenocortical
of adrenocortical activity
The role of
role of jun
of jun and
jun and fos
and fos gene
fos gene family
gene family members
family members in
members in 12-O-tetradecanoylphorbol-13-acetate
in 12-O-tetradecanoylphorbol-13-acetate induced
12-O-tetradecanoylphorbol-13-acetate induced hemopoietic
induced hemopoietic differentiation
Terminal differentiation of
differentiation of the
of the leukemic
the leukemic cell
leukemic cell lines
cell lines U-937
lines U-937 and
U-937 and HL-60
and HL-60 by
HL-60 by 12-O-tetradecanoylphorbol-13-acetate
by 12-O-tetradecanoylphorbol-13-acetate is
12-O-tetradecanoylphorbol-13-acetate is accompanied
is accompanied by
accompanied by marked
by marked changes
marked changes in
changes in gene
in gene expression
In this study
this study we
study we demonstrate
we demonstrate that
demonstrate that the
that the expression
the expression of
expression of jun
of jun and
jun and fos
and fos gene
fos gene family
gene family members
family members is
members is induced
is induced with
induced with variable
with variable kinetics
variable kinetics during
kinetics during 12-O-tetradecanoylphorbol-13-acetate
during 12-O-tetradecanoylphorbol-13-acetate induced
12-O-tetradecanoylphorbol-13-acetate induced differentiation
induced differentiation with
differentiation with c-jun
with c-jun expression
c-jun expression best
expression best paralleling
best paralleling differentiation
The generation of
generation of AP-1
of AP-1 complexes
AP-1 complexes as
complexes as measured
as measured by
measured by DNA
by DNA binding
DNA binding activity
binding activity closely
activity closely parallels
closely parallels morphological
parallels morphological differentiation
Furthermore the ability
the ability of
ability of these
of these complexes
these complexes to
complexes to regulate
to regulate gene
regulate gene expression
gene expression is
expression is demonstrated
is demonstrated by
demonstrated by increased
by increased transcription
increased transcription from
transcription from an
from an AP-1
an AP-1 driven
AP-1 driven reporter
driven reporter construct
reporter construct and
construct and marked
and marked increases
marked increases in
increases in the
in the expression
the expression of
expression of endogenous
of endogenous AP-1
endogenous AP-1 regulated
AP-1 regulated genes
Differentiation assays using
assays using water
using water soluble
water soluble phorbol
soluble phorbol esters
phorbol esters reveal
esters reveal that
reveal that differentiation
that differentiation becomes
differentiation becomes irreversible
becomes irreversible soon
irreversible soon after
soon after AP-1
after AP-1 appears
This tight correlation
tight correlation between
correlation between c-jun
between c-jun expression
c-jun expression the
expression the generation
the generation of
generation of AP-1
of AP-1 activity
AP-1 activity and
activity and differentiation
and differentiation suggests
differentiation suggests a
suggests a critical
a critical role
critical role for
role for this
for this gene
this gene and
gene and transcriptional
and transcriptional complex
transcriptional complex during
complex during this
during this process
Nuclear association of
association of a
of a T-cell
a T-cell transcription
T-cell transcription factor
transcription factor blocked
factor blocked by
blocked by FK-506
by FK-506 and
FK-506 and cyclosporin
and cyclosporin A
cyclosporin A [see
A [see comments]
Cyclosporin A and
A and FK506
and FK506 inhibit
FK506 inhibit T-
inhibit T- and
T- and B-cell
and B-cell activation
B-cell activation and
activation and other
and other processes
other processes essential
processes essential to
essential to an
to an effective
an effective immune
effective immune response
In T lymphocytes
T lymphocytes these
lymphocytes these drugs
these drugs disrupt
drugs disrupt an
disrupt an unknown
an unknown step
unknown step in
step in the
in the transmission
the transmission of
transmission of signals
of signals from
signals from the
from the T-cell
the T-cell antigen
T-cell antigen receptor
antigen receptor to
receptor to cytokine
to cytokine genes
cytokine genes that
genes that coordinate
that coordinate the
coordinate the immune
the immune response
The putative intracellular
putative intracellular receptors
intracellular receptors for
receptors for FK506
for FK506 and
FK506 and cyclosporin
and cyclosporin are
cyclosporin are cis-trans
are cis-trans prolyl
cis-trans prolyl isomerases
Binding of the
of the drug
the drug inhibits
drug inhibits isomerase
inhibits isomerase activity
isomerase activity but
activity but studies
but studies with
studies with other
with other prolyl
other prolyl isomerase
prolyl isomerase inhibitors
isomerase inhibitors and
inhibitors and analysis
and analysis of
analysis of cyclosporin-resistant
of cyclosporin-resistant mutants
cyclosporin-resistant mutants in
mutants in yeast
in yeast suggest
yeast suggest that
suggest that the
that the effects
the effects of
effects of the
of the drug
the drug result
drug result from
result from the
from the formation
the formation of
formation of an
of an inhibitory
an inhibitory complex
inhibitory complex between
complex between the
between the drug
the drug and
drug and isomerase
and isomerase and
isomerase and not
and not from
not from inhibition
from inhibition of
inhibition of isomerase
of isomerase activity
A transcription factor
transcription factor NF-AT
factor NF-AT which
NF-AT which is
which is essential
is essential for
essential for early
for early T-cell
early T-cell gene
T-cell gene activation
gene activation seems
activation seems to
seems to be
to be a
be a specific
a specific target
specific target of
target of cyclosporin
of cyclosporin A
cyclosporin A and
A and FK506
and FK506 action
FK506 action because
action because transcription
because transcription directed
transcription directed by
directed by this
by this protein
this protein is
protein is blocked
is blocked in
blocked in T
in T cells
T cells treated
cells treated with
treated with these
with these drugs
these drugs with
drugs with little
with little or
little or no
or no effect
no effect on
effect on other
on other transcription
other transcription factors
transcription factors such
factors such as
such as AP-1
as AP-1 and
AP-1 and NF-kappa
and NF-kappa B
Here we demonstrate
we demonstrate that
demonstrate that NF-AT
that NF-AT is
NF-AT is formed
is formed when
formed when a
when a signal
a signal from
signal from the
from the antigen
the antigen receptor
antigen receptor induces
receptor induces a
induces a pre-existing
a pre-existing cytoplasmic
pre-existing cytoplasmic subunit
cytoplasmic subunit to
subunit to translocate
to translocate to
translocate to the
to the nucleus
the nucleus and
nucleus and combine
and combine with
combine with a
with a newly
a newly synthesized
newly synthesized nuclear
synthesized nuclear subunit
nuclear subunit of
subunit of NF-AT
FK506 and cyclosporin
and cyclosporin A
cyclosporin A block
A block translocation
block translocation of
translocation of the
of the cytoplasmic
the cytoplasmic component
cytoplasmic component without
component without affecting
without affecting synthesis
affecting synthesis of
synthesis of the
of the nuclear
the nuclear subunit
Glucocorticoid receptors in
receptors in lymphocytes
in lymphocytes in
lymphocytes in anorexia
in anorexia nervosa
OBJECTIVE: The aim
The aim was
aim was to
was to explore
to explore the
explore the down-regulation
the down-regulation of
down-regulation of the
of the glucocorticoid
the glucocorticoid receptors
glucocorticoid receptors during
receptors during hypercortisolaemia
during hypercortisolaemia in
hypercortisolaemia in anorexia
in anorexia nervosa
DESIGN: Urine and
Urine and plasma
and plasma samples
plasma samples were
samples were obtained
were obtained for
obtained for cortisol
for cortisol determination
cortisol determination and
determination and blood
and blood lymphocytes
blood lymphocytes were
lymphocytes were isolated
were isolated for
isolated for receptor
for receptor binding
receptor binding studies
PATIENTS: Sixteen anorexic
Sixteen anorexic patients
anorexic patients aged
patients aged 16-27
aged 16-27 years
16-27 years with
years with a
with a mean
a mean +/-
mean +/- SEM
+/- SEM body
SEM body mass
body mass index
mass index of
index of 142
of 142 +/-
142 +/- 20
+/- 20 ranging
20 ranging from
ranging from 111
from 111 to
111 to 174
to 174 and
174 and 15
and 15 normal
15 normal women
normal women were
women were studied
Six patients were
patients were reinvestigated
were reinvestigated after
reinvestigated after a
after a significant
a significant weight
significant weight gain
MEASUREMENTS: The binding
The binding capacity
binding capacity and
capacity and affinity
and affinity of
affinity of the
of the glucocorticoid
the glucocorticoid receptors
glucocorticoid receptors were
receptors were measured
were measured with
measured with dexamethasone
with dexamethasone as
dexamethasone as ligand
as ligand on
ligand on lymphocytes
RESULTS: In patients
In patients both
patients both total
both total and
total and free
and free plasma
free plasma cortisol
plasma cortisol concentrations
cortisol concentrations were
concentrations were higher
were higher than
higher than in
than in the
in the normal
the normal women
normal women as
women as was
as was their
was their urinary
their urinary free
urinary free cortisol;
free cortisol; the
cortisol; the number
the number of
number of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors per
receptors per cell
per cell Ro
cell Ro and
Ro and the
and the binding
the binding affinity
binding affinity Kd
affinity Kd for
Kd for dexamethasone
for dexamethasone were
dexamethasone were however
were however not
however not significantly
not significantly different
significantly different Ro:
different Ro: 7687
Ro: 7687 +/-
7687 +/- 1750
+/- 1750 vs
1750 vs 7347
vs 7347 +/-
7347 +/- 1285
+/- 1285 sites/cell;
1285 sites/cell; Kd:
sites/cell; Kd: 77
Kd: 77 +/-
77 +/- 24
+/- 24 vs
24 vs 74
vs 74 +/-
74 +/- 17
+/- 17 nM
17 nM at
nM at 24
at 24 degrees
24 degrees C
After weight gain
weight gain 14
gain 14 +/-
14 +/- 2
+/- 2 to
2 to 16
to 16 +/-
16 +/- 2
+/- 2 kg/m2
2 kg/m2 receptor
kg/m2 receptor numbers
receptor numbers were
numbers were 8421
were 8421 +/-
8421 +/- 2126
+/- 2126 pre
2126 pre and
pre and 9011
and 9011 +/-
9011 +/- 500
+/- 500 post
500 post sites/cell
post sites/cell which
sites/cell which are
which are not
are not significantly
not significantly different
significantly different P
different P greater
P greater than
greater than 02;
than 02; the
02; the Kd
the Kd was
Kd was unchanged
was unchanged 93
unchanged 93 +/-
93 +/- 26
+/- 26 vs
26 vs 92
vs 92 +/-
92 +/- 24
+/- 24 nM
CONCLUSIONS Hypercortisolaemia does
Hypercortisolaemia does not
does not down-regulate
not down-regulate the
down-regulate the lymphocyte
the lymphocyte glucocorticoid
lymphocyte glucocorticoid receptors
glucocorticoid receptors in
receptors in anorexia
in anorexia nervosa
anorexia nervosa and
nervosa and a
and a post-receptor
a post-receptor defect
post-receptor defect might
defect might be
might be involved
be involved in
involved in peripheral
in peripheral tissue
peripheral tissue resistance
tissue resistance to
resistance to the
to the effects
the effects of
effects of glucocorticoid
of glucocorticoid hormones
glucocorticoid hormones in
hormones in undernutrition
Inhibition of protein
of protein phosphatases
protein phosphatases by
phosphatases by okadaic
by okadaic acid
okadaic acid induces
acid induces AP1
induces AP1 in
AP1 in human
in human T
human T cells
To examine the
examine the role
the role of
role of protein
of protein phosphatases
protein phosphatases in
phosphatases in T
in T cell
T cell activation
cell activation Jurkat
activation Jurkat cells
Jurkat cells were
cells were treated
were treated with
treated with okadaic
with okadaic acid
okadaic acid an
acid an inhibitor
an inhibitor of
inhibitor of type
of type 1
type 1 and
1 and 2A
and 2A phosphatases
2A phosphatases and
phosphatases and nuclear
and nuclear extracts
nuclear extracts were
extracts were examined
were examined for
examined for the
for the presence
the presence of
presence of AP1
of AP1 as
AP1 as a
as a measure
a measure of
measure of early
of early T
early T cell
T cell activation
Okadaic acid was
acid was found
was found to
found to be
to be a
be a potent
a potent inducer
potent inducer of
inducer of AP1
In contrast to
contrast to phorbol
to phorbol esters
phorbol esters such
esters such as
such as phorbol
as phorbol myristate
phorbol myristate acetate
myristate acetate PMA
acetate PMA the
PMA the induction
the induction of
induction of AP1
of AP1 by
AP1 by okadaic
by okadaic acid
okadaic acid occurs
acid occurs predominantly
occurs predominantly by
predominantly by transcriptional
by transcriptional activation
transcriptional activation of
activation of the
of the jun
the jun and
jun and fos
and fos family
fos family of
family of proto-oncogenes
Surprisingly while the
while the addition
the addition of
addition of phytohemagglutinin
of phytohemagglutinin further
phytohemagglutinin further enhanced
further enhanced the
enhanced the induction
the induction of
induction of AP1
of AP1 the
AP1 the addition
the addition of
addition of PMA
of PMA inhibited
PMA inhibited it
Okadaic acid treatment
acid treatment was
treatment was found
was found to
found to dramatically
to dramatically increase
dramatically increase mRNA
increase mRNA transcripts
mRNA transcripts of
transcripts of the
of the jun
the jun family
jun family of
family of proto-oncogenes
of proto-oncogenes including
proto-oncogenes including c-jun
including c-jun junD
c-jun junD and
junD and junB
and junB and
junB and to
and to a
to a lesser
a lesser extent
lesser extent the
extent the fos
the fos family
fos family including
family including c-fos
including c-fos and
c-fos and fra-1
By comparison PMA
comparison PMA is
PMA is a
is a very
a very inefficient
very inefficient inducer
inefficient inducer of
inducer of the
of the jun
the jun gene
jun gene family
gene family in
family in Jurkat
in Jurkat cells
Similar to its
to its effect
its effect on
effect on the
on the induction
the induction of
induction of AP1
of AP1 by
AP1 by okadaic
by okadaic acid
okadaic acid PMA
acid PMA inhibits
PMA inhibits the
inhibits the induction
the induction of
induction of c-jun
of c-jun mRNA
c-jun mRNA by
mRNA by okadaic
by okadaic acid
Transfection of c-jun
of c-jun promoter
c-jun promoter constructs
promoter constructs confirmed
constructs confirmed the
confirmed the marked
the marked difference
marked difference between
difference between PMA
between PMA and
PMA and okadaic
and okadaic acid
okadaic acid in
acid in inducing
in inducing c-jun
inducing c-jun transcription
The induction of
induction of AP1
of AP1 by
AP1 by okadaic
by okadaic acid
okadaic acid suggests
acid suggests that
suggests that protein
that protein phosphatases
protein phosphatases 1
phosphatases 1 and
1 and 2A
and 2A PP1
2A PP1 and
PP1 and PP2A
and PP2A may
PP2A may be
may be involved
be involved in
involved in T
in T cell
T cell activation
cell activation as
activation as important
as important negative
important negative regulators
negative regulators of
regulators of the
of the transcription
the transcription factor
transcription factor AP1
Cloning of murine
of murine TCF-1
murine TCF-1 a
TCF-1 a T
a T cell-specific
T cell-specific transcription
cell-specific transcription factor
transcription factor interacting
factor interacting with
interacting with functional
with functional motifs
functional motifs in
motifs in the
in the CD3-epsilon
the CD3-epsilon and
CD3-epsilon and T
and T cell
T cell receptor
cell receptor alpha
receptor alpha enhancers
CD3-epsilon gene expression
gene expression is
expression is confined
is confined to
confined to the
to the T
the T cell
T cell lineage
We have recently
have recently identified
recently identified and
identified and cloned
and cloned a
cloned a human
a human transcription
human transcription factor
transcription factor TCF-1
factor TCF-1 that
TCF-1 that binds
that binds to
binds to a
to a functional
a functional element
functional element in
element in the
in the T
the T lymphocyte-specific
T lymphocyte-specific enhancer
lymphocyte-specific enhancer of
enhancer of CD3-epsilon
In a panel
a panel of
panel of human
of human cell
human cell lines
cell lines TCF-1
lines TCF-1 expression
TCF-1 expression was
expression was restricted
was restricted to
restricted to T
to T lineage
T lineage cells
TCF-1 belonged to
belonged to a
to a novel
a novel family
novel family of
family of genes
of genes that
genes that contain
that contain the
contain the so-called
the so-called high
so-called high mobility
high mobility group
mobility group 1
group 1 HMG
1 HMG box
Here we report
we report the
report the cloning
the cloning of
cloning of murine
of murine TCF-1
Two splice alternatives
splice alternatives were
alternatives were identified
were identified that
identified that were
that were not
were not previously
not previously observed
previously observed in
observed in human
in human TCF-1
Murine and human
and human TCF-1
human TCF-1 displayed
TCF-1 displayed a
displayed a 955%
a 955% overall
955% overall amino
overall amino acid
amino acid homology
Recombinant murine and
murine and human
and human TCF-1
human TCF-1 recognized
TCF-1 recognized the
recognized the same
the same sequence
same sequence motif
sequence motif in
motif in the
in the CD3-epsilon
the CD3-epsilon enhancer
CD3-epsilon enhancer as
enhancer as judged
as judged by
judged by gel
by gel retardation
gel retardation and
retardation and methylation
and methylation interference
methylation interference assays
With the murine
the murine cDNA
murine cDNA clones
cDNA clones several
clones several aspects
several aspects of
aspects of TCF-1
of TCF-1 were
TCF-1 were analyzed
First deletion analysis
deletion analysis revealed
analysis revealed that
revealed that a
that a region
a region of
region of TCF-1
of TCF-1 containing
TCF-1 containing the
containing the HMG
the HMG box
HMG box was
box was sufficient
was sufficient for
sufficient for sequence-specific
for sequence-specific binding
Second by high
by high stringency
high stringency Northern
stringency Northern blotting
Northern blotting and
blotting and in
and in situ
in situ hybridization
situ hybridization TCF-1
hybridization TCF-1 expression
TCF-1 expression was
expression was shown
was shown to
shown to be
to be confined
be confined to
confined to the
to the thymus
the thymus and
thymus and to
and to the
to the T
the T cell
T cell areas
cell areas of
areas of the
of the spleen
Third TCF-1 bound
TCF-1 bound specifically
bound specifically to
specifically to a
to a functional
a functional T
functional T cell-specific
T cell-specific element
cell-specific element in
element in the
in the T
the T cell
T cell receptor
cell receptor alpha
receptor alpha TCR-alpha
alpha TCR-alpha enhancer
The T lineage-specific
T lineage-specific expression
lineage-specific expression and
expression and the
and the affinity
the affinity for
affinity for functional
for functional motifs
functional motifs in
motifs in the
in the TCR-alpha
the TCR-alpha and
TCR-alpha and CD3-epsilon
and CD3-epsilon enhancers
CD3-epsilon enhancers imply
enhancers imply an
imply an important
an important role
important role for
role for TCF-1
for TCF-1 in
TCF-1 in the
in the establishment
the establishment of
establishment of the
of the mature
the mature T
mature T cell
T cell phenotype
Cloning of a
of a human
a human homeobox
human homeobox gene
homeobox gene that
gene that resembles
that resembles a
resembles a diverged
a diverged Drosophila
diverged Drosophila homeobox
Drosophila homeobox gene
homeobox gene and
gene and is
and is expressed
is expressed in
expressed in activated
in activated lymphocytes
A new homeobox
new homeobox gene
homeobox gene HB24
gene HB24 has
HB24 has been
has been isolated
been isolated from
isolated from a
from a human
a human B-lymphocyte
human B-lymphocyte cDNA
B-lymphocyte cDNA library
Northern blot analysis
blot analysis of
analysis of polyadenylated
of polyadenylated RNA
polyadenylated RNA purified
RNA purified from
purified from activated
from activated human
activated human B
human B cells
B cells revealed
cells revealed a
revealed a single
a single mRNA
single mRNA transcript
mRNA transcript of
transcript of approximately
of approximately 23
approximately 23 kb
Two cDNA clones
cDNA clones were
clones were sequenced
were sequenced and
sequenced and provided
and provided 2250
provided 2250 nucleotides
2250 nucleotides nt
nucleotides nt of
nt of DNA
of DNA sequence
DNA sequence information
There is a
is a single
a single methionine
single methionine codon-initiated
methionine codon-initiated open
codon-initiated open reading
open reading frame
reading frame of
frame of 1458
of 1458 nt
1458 nt in
nt in frame
in frame with
frame with a
with a homeobox
a homeobox and
homeobox and a
and a CAX
a CAX repeat
CAX repeat and
repeat and the
and the open
the open reading
open reading frame
reading frame is
frame is predicted
is predicted to
predicted to encode
to encode a
encode a protein
a protein of
protein of 51659
of 51659 daltons
When the homeodomain
the homeodomain from
homeodomain from HB24
from HB24 was
HB24 was compared
was compared to
compared to known
to known mammalian
known mammalian and
mammalian and Drosophila
and Drosophila homeodomains
Drosophila homeodomains it
homeodomains it was
it was found
was found to
found to be
to be only
be only moderately
only moderately conserved
moderately conserved but
conserved but when
but when it
when it was
it was compared
was compared to
compared to a
to a highly
a highly diverged
highly diverged Drosophila
diverged Drosophila homeodomain
Drosophila homeodomain H20
homeodomain H20 it
H20 it was
it was found
was found to
found to be
to be 80%
be 80% identical
The HB24 mRNA
HB24 mRNA was
mRNA was absent
was absent or
absent or present
or present at
present at low
at low levels
low levels in
levels in normal
in normal B
normal B and
B and T
and T lymphocytes;
T lymphocytes; however
lymphocytes; however with
however with the
with the appropriate
the appropriate activation
appropriate activation signal
activation signal HB24
signal HB24 mRNA
HB24 mRNA was
mRNA was induced
was induced within
induced within several
within several hours
several hours even
hours even in
even in the
in the presence
the presence of
presence of cycloheximide
Characterization of HB24
of HB24 expression
HB24 expression in
expression in lymphoid
in lymphoid and
lymphoid and select
and select developing
select developing tissues
developing tissues was
tissues was performed
was performed by
performed by in
by in situ
in situ hybridization
Positive hybridization was
hybridization was found
was found in
found in thymus
in thymus tonsil
thymus tonsil bone
tonsil bone marrow
bone marrow developing
marrow developing vessels
developing vessels and
vessels and in
and in fetal
in fetal brain
HB24 is likely
is likely to
likely to have
to have an
have an important
an important role
important role in
role in lymphocytes
in lymphocytes as
lymphocytes as well
as well as
well as in
as in certain
in certain developing
certain developing tissues
Platelet-activating factor induces
factor induces phospholipid
induces phospholipid turnover
phospholipid turnover calcium
turnover calcium flux
calcium flux arachidonic
flux arachidonic acid
arachidonic acid liberation
acid liberation eicosanoid
liberation eicosanoid generation
eicosanoid generation and
generation and oncogene
and oncogene expression
oncogene expression in
expression in a
in a human
a human B
human B cell
B cell line
Platelet-activating factor is
factor is a
is a potent
a potent mediator
potent mediator of
mediator of the
of the inflammatory
the inflammatory response
Studies of the
of the actions
the actions of
actions of platelet-activating
of platelet-activating factor
platelet-activating factor have
factor have centered
have centered mainly
centered mainly around
mainly around neutrophils
around neutrophils monocytes
neutrophils monocytes and
monocytes and platelets
In this report
this report we
report we begin
we begin to
begin to uncover
to uncover the
uncover the influence
the influence of
influence of platelet-activating
of platelet-activating factor
platelet-activating factor on
factor on B
on B lymphocytes
Employing the EBV-transformed
the EBV-transformed human
EBV-transformed human B
human B cell
B cell line
cell line SKW64
line SKW64 we
SKW64 we demonstrate
we demonstrate that
demonstrate that platelet-activating
that platelet-activating factor
platelet-activating factor significantly
factor significantly alters
significantly alters membrane
alters membrane phospholipid
membrane phospholipid metabolism
phospholipid metabolism indicated
metabolism indicated by
indicated by the
by the incorporation
the incorporation of
incorporation of 32P
of 32P into
32P into phosphatidylcholine
into phosphatidylcholine phosphatidylinositol
phosphatidylcholine phosphatidylinositol and
phosphatidylinositol and phosphatidic
and phosphatidic acid
phosphatidic acid but
acid but not
but not significantly
not significantly into
significantly into phosphatidylethanolamine
into phosphatidylethanolamine at
phosphatidylethanolamine at concentrations
at concentrations ranging
concentrations ranging from
ranging from 10-9
from 10-9 to
10-9 to 10-6
to 10-6 M
The inactive precursor
inactive precursor lyso-platelet-activating
precursor lyso-platelet-activating factor
lyso-platelet-activating factor at
factor at a
at a concentration
a concentration as
concentration as high
as high as
high as 10-7
as 10-7 M
10-7 M had
M had no
had no effect
no effect on
effect on any
on any of
any of the
of the membrane
the membrane phospholipids
We also show
also show that
show that platelet-activating
that platelet-activating factor
platelet-activating factor from
factor from 10-12
from 10-12 to
10-12 to 10-6
to 10-6 M
10-6 M induced
M induced rapid
induced rapid and
rapid and significant
and significant elevation
significant elevation in
elevation in intracellular
in intracellular calcium
intracellular calcium levels
calcium levels whereas
levels whereas lyso-platelet-activating
whereas lyso-platelet-activating factor
lyso-platelet-activating factor was
factor was again
was again ineffective
We further demonstrate
further demonstrate the
demonstrate the impact
the impact of
impact of platelet-activating
of platelet-activating factor
platelet-activating factor binding
factor binding to
binding to B
to B cells
B cells by
cells by measuring
by measuring platelet-activating
measuring platelet-activating factor
platelet-activating factor induced
factor induced arachidonic
induced arachidonic acid
arachidonic acid release
acid release and
release and 5-hydroxyeicosatetraenoic
and 5-hydroxyeicosatetraenoic acid
5-hydroxyeicosatetraenoic acid production
Moreover platelet-activating factor
platelet-activating factor was
factor was capable
was capable of
capable of inducing
of inducing transcription
inducing transcription of
transcription of the
of the nuclear
the nuclear proto-oncogenes
nuclear proto-oncogenes c-fos
proto-oncogenes c-fos and
c-fos and c-jun
Finally we explored
we explored the
explored the possible
the possible role
possible role of
role of 5-hydroxyeicosatetraenoic
of 5-hydroxyeicosatetraenoic acid
5-hydroxyeicosatetraenoic acid as
acid as a
as a regulator
a regulator of
regulator of arachidonic
of arachidonic acid
arachidonic acid liberation
acid liberation demonstrating
liberation demonstrating that
demonstrating that endogenous
that endogenous 5-lipoxygenase
endogenous 5-lipoxygenase activity
5-lipoxygenase activity modulates
activity modulates platelet-activating
modulates platelet-activating factor
platelet-activating factor induced
factor induced arachidonic
induced arachidonic acid
arachidonic acid release
acid release perhaps
release perhaps acting
perhaps acting at
acting at the
at the level
the level of
level of phospholipase
of phospholipase A2
In summary platelet-activating
summary platelet-activating factor
platelet-activating factor is
factor is shown
is shown here
shown here to
here to have
to have a
have a direct
a direct and
direct and profound
and profound effect
profound effect on
effect on a
on a pure
a pure B
pure B cell
B cell line
Positive and negative
and negative regulation
negative regulation of
regulation of immunoglobulin
of immunoglobulin gene
immunoglobulin gene expression
gene expression by
expression by a
by a novel
a novel B-cell-specific
novel B-cell-specific enhancer
B-cell-specific enhancer element
A new B-cell-specific
new B-cell-specific enhancer
B-cell-specific enhancer element
enhancer element has
element has been
has been identified
been identified 3'
identified 3' of
3' of E4
of E4 and
E4 and the
and the octamerlike
the octamerlike motifs
octamerlike motifs in
motifs in the
in the human
the human immunoglobulin
human immunoglobulin heavy-chain
immunoglobulin heavy-chain gene
heavy-chain gene enhancer
Tandem copies of
copies of this
of this 67-bp
this 67-bp MnlI-AluI
67-bp MnlI-AluI fragment
MnlI-AluI fragment when
fragment when fused
when fused to
fused to the
to the chloramphenicol
the chloramphenicol acetyltransferase
chloramphenicol acetyltransferase gene
acetyltransferase gene driven
gene driven by
driven by the
by the conalbumin
the conalbumin promoter
conalbumin promoter stimulated
promoter stimulated transcription
stimulated transcription in
transcription in B
in B cells
B cells but
cells but not
but not in
not in Jurkat
in Jurkat T
Jurkat T cells
T cells or
cells or HeLa
or HeLa cells
Footprinting analysis revealed
analysis revealed that
revealed that the
that the identical
the identical sequence
identical sequence CCGAAACTGAAAAGG
sequence CCGAAACTGAAAAGG designated
CCGAAACTGAAAAGG designated E6
designated E6 was
E6 was protected
was protected by
protected by nuclear
by nuclear extracts
nuclear extracts from
extracts from B
from B cells
B cells T
cells T cells
T cells or
cells or HeLa
or HeLa cells
Gel mobility shift
mobility shift assays
shift assays using
assays using a
using a synthetic
a synthetic E6
synthetic E6 motif
E6 motif detected
motif detected a
detected a B-cell-specific
a B-cell-specific complex
B-cell-specific complex in
complex in addition
in addition to
addition to a
to a ubiquitous
a ubiquitous band
ubiquitous band found
band found also
found also in
also in T
in T cells
T cells and
cells and HeLa
and HeLa cells
In agreement with
agreement with the
with the results
the results of
results of gel
of gel retardation
gel retardation assays
retardation assays tandem
assays tandem copies
tandem copies of
copies of the
of the E6
the E6 motif
E6 motif stimulated
motif stimulated transcription
stimulated transcription in
transcription in ARH77
in ARH77 and
ARH77 and Raji
and Raji cells
Raji cells but
cells but not
but not in
not in Jurkat
in Jurkat or
Jurkat or HeLa
or HeLa cells
Furthermore a mutant
a mutant E6
mutant E6 motif
E6 motif lost
motif lost both
lost both in
both in vitro
in vitro binding
vitro binding activity
binding activity and
activity and in
and in vivo
in vivo enhancer
vivo enhancer activity
In striking contrast
striking contrast to
contrast to the
to the mouse
the mouse Ig
mouse Ig heavy-chain
Ig heavy-chain enhancer
heavy-chain enhancer in
enhancer in which
in which the
which the octamer
the octamer motif
octamer motif acts
motif acts as
acts as a
as a B-cell-specific
a B-cell-specific enhancer
B-cell-specific enhancer element
enhancer element the
element the human
the human enhancer
human enhancer contains
enhancer contains an
contains an octamerlike
an octamerlike sequence
octamerlike sequence with
sequence with one
with one base
one base substitution
base substitution which
substitution which bound
which bound octamer-binding
bound octamer-binding proteins
octamer-binding proteins with
proteins with only
with only very
only very low
very low affinity
low affinity and
affinity and showed
and showed no
showed no enhancer
no enhancer activity
enhancer activity of
activity of its
of its own
Interestingly the MnlI-AluI
the MnlI-AluI fragment
MnlI-AluI fragment could
fragment could suppress
could suppress the
suppress the basal-level
the basal-level activity
basal-level activity of
activity of the
of the conalbumin
the conalbumin promoter
conalbumin promoter in
promoter in both
in both Jurkat
both Jurkat and
Jurkat and HeLa
and HeLa cells
Moreover simian virus
simian virus 40
virus 40 enhancer
40 enhancer activity
enhancer activity was
activity was blocked
was blocked by
blocked by the
by the MnlI-AluI
the MnlI-AluI fragment
MnlI-AluI fragment in
fragment in HeLa
in HeLa cells
HeLa cells but
cells but not
but not in
not in B
in B cells
Thus the novel
the novel enhancer
novel enhancer element
enhancer element identified
element identified in
identified in this
in this study
this study is
study is probably
is probably a
probably a target
a target site
target site for
site for both
for both positive
both positive and
positive and negative
and negative factors
Charybdotoxin-sensitive Ca2+-dependent membrane
Ca2+-dependent membrane potential
membrane potential changes
potential changes are
changes are not
are not involved
not involved in
involved in human
in human T
human T or
T or B
or B cell
B cell activation
cell activation and
activation and proliferation
The involvement of
involvement of ion
of ion channels
ion channels in
channels in B
in B and
B and T
and T lymphocyte
T lymphocyte activation
lymphocyte activation is
activation is supported
is supported by
supported by many
by many reports
many reports of
reports of changes
of changes in
changes in ion
in ion fluxes
ion fluxes and
fluxes and membrane
and membrane potential
membrane potential after
potential after mitogen
after mitogen binding
Human T and
T and B
and B lymphocytes
B lymphocytes demonstrate
lymphocytes demonstrate an
demonstrate an early
an early and
early and transient
and transient hyperpolarization
transient hyperpolarization after
hyperpolarization after ligand
after ligand binding
Inasmuch as the
as the change
the change in
change in membrane
in membrane potential
membrane potential is
potential is dependent
is dependent on
dependent on elevation
on elevation of
elevation of free
of free cytosolic
free cytosolic calcium
cytosolic calcium the
calcium the hyperpolarization
the hyperpolarization is
hyperpolarization is presumably
is presumably through
presumably through opening
through opening of
opening of Ca2+-stimulated
of Ca2+-stimulated K+
Ca2+-stimulated K+ channels
We have used
have used charybdotoxin
used charybdotoxin a
charybdotoxin a known
a known inhibitor
known inhibitor of
inhibitor of Ca2+-dependent
of Ca2+-dependent K+
Ca2+-dependent K+ channels
K+ channels to
channels to study
to study the
study the role
the role of
role of these
of these channels
these channels in
channels in lymphocyte
in lymphocyte activation
lymphocyte activation and
activation and mitogenesis
We demonstrate that
demonstrate that charybdotoxin
that charybdotoxin inhibits
charybdotoxin inhibits the
inhibits the ligand-induced
the ligand-induced transient
ligand-induced transient membrane
transient membrane hyperpolarization
membrane hyperpolarization in
hyperpolarization in B
in B and
B and T
and T cells
T cells in
cells in a
in a dose-dependent
a dose-dependent fashion
dose-dependent fashion without
fashion without affecting
without affecting changes
affecting changes in
changes in cytosolic
in cytosolic Ca2+
However blockade of
blockade of the
of the Ca2+-activated
the Ca2+-activated K+
Ca2+-activated K+ channel
K+ channel is
channel is not
is not associated
not associated with
associated with changes
with changes in
changes in cell-cycle
in cell-cycle gene
cell-cycle gene activation
gene activation IL-2
activation IL-2 production
IL-2 production IL-2R
production IL-2R expression
IL-2R expression or
expression or B
or B and
B and T
and T cell
T cell mitogenesis
These results imply
results imply that
imply that membrane
that membrane potential
membrane potential changes
potential changes secondary
changes secondary to
secondary to the
to the ligand-dependent
the ligand-dependent opening
ligand-dependent opening of
opening of Ca2+-activated
of Ca2+-activated K+
Ca2+-activated K+ channels
K+ channels are
channels are not
are not involved
not involved in
involved in B
in B and
B and T
and T lymphocyte
T lymphocyte activation
lymphocyte activation and
activation and mitogenesis
Activity of the
of the kappa
the kappa B
kappa B enhancer
B enhancer of
enhancer of the
of the interleukin-2
the interleukin-2 receptor
interleukin-2 receptor alpha
receptor alpha chain
alpha chain in
chain in somatic
in somatic cell
somatic cell hybrids
cell hybrids is
hybrids is accompanied
is accompanied by
accompanied by the
by the nuclear
the nuclear localization
nuclear localization of
localization of NF-kappa
of NF-kappa B
The two nuclear
two nuclear proteins
nuclear proteins NF-kappa
proteins NF-kappa B
NF-kappa B consisting
B consisting of
consisting of subunits
of subunits p50
subunits p50 an
p50 an dp65
an dp65 and
dp65 and the
and the DNA-binding
the DNA-binding subunit
DNA-binding subunit of
subunit of NF-kappa
of NF-kappa B
NF-kappa B p50
B p50 by
p50 by itself
by itself also
itself also called
also called KBF1
called KBF1 are
KBF1 are constitutively
are constitutively expressed
constitutively expressed and
expressed and localized
and localized in
localized in the
in the nucleus
the nucleus of
nucleus of the
of the human
the human T-cell
human T-cell line
T-cell line IARC
line IARC 3015
In order to
order to define
to define the
define the roles
the roles of
roles of these
of these two
these two factors
two factors which
factors which bind
which bind to
bind to the
to the same
the same kappa
same kappa B
kappa B enhancers
B enhancers in
enhancers in transcription
in transcription activation
transcription activation we
activation we have
we have prepared
have prepared somatic
prepared somatic cell
somatic cell hybrids
cell hybrids between
hybrids between IARC
between IARC 3015
IARC 3015 and
3015 and a
and a murine
a murine myeloma
Most hybrids express
hybrids express both
express both KBF1
both KBF1 and
KBF1 and NF-kappa
and NF-kappa B
NF-kappa B in
B in their
in their nuclei
their nuclei but
nuclei but one
but one hybrid
one hybrid expresses
hybrid expresses only
expresses only KBF1
The kappa B
kappa B enhancer
B enhancer of
enhancer of the
of the gene
the gene encoding
gene encoding the
encoding the interleukin-2
the interleukin-2 IL-2
interleukin-2 IL-2 receptor
IL-2 receptor alpha
receptor alpha chain
alpha chain IL-2R
chain IL-2R alpha
IL-2R alpha is
alpha is functional
is functional only
functional only in
only in the
in the hybrids
the hybrids expressing
hybrids expressing nuclear
expressing nuclear NF-kappa
nuclear NF-kappa B
These findings show
findings show that
show that nuclear
that nuclear NF-kappa
nuclear NF-kappa B
NF-kappa B is
B is necessary
is necessary to
necessary to activate
to activate the
activate the kappa
the kappa B
kappa B enhancer
B enhancer while
enhancer while KBF1
while KBF1 by
KBF1 by itself
by itself is
itself is not
is not sufficient
We propose that
propose that KBF1
that KBF1 is
KBF1 is a
is a competitive
a competitive inhibitor
competitive inhibitor of
inhibitor of NF-kappa
of NF-kappa B
NF-kappa B and
B and discuss
and discuss how
discuss how these
how these factors
these factors may
factors may be
may be involved
be involved in
involved in the
in the transient
the transient expression
transient expression of
expression of IL-2
of IL-2 and
IL-2 and IL-2
and IL-2 alpha
IL-2 alpha genes
alpha genes during
genes during the
during the immune
the immune response
T-helper-cell determinants in
determinants in protein
in protein antigens
protein antigens are
antigens are preferentially
are preferentially located
preferentially located in
located in cysteine-rich
in cysteine-rich antigen
cysteine-rich antigen segments
antigen segments resistant
segments resistant to
resistant to proteolytic
to proteolytic cleavage
proteolytic cleavage by
cleavage by cathepsin
by cathepsin B
cathepsin B L
B L and
L and D
We report on
report on a
on a computer
a computer algorithm
computer algorithm capable
algorithm capable of
capable of predicting
of predicting the
predicting the location
the location of
location of T-helper-cell
of T-helper-cell epitopes
T-helper-cell epitopes in
epitopes in protein
in protein antigen
protein antigen Ag
antigen Ag by
Ag by analysing
by analysing the
analysing the Ag
the Ag amino
Ag amino acid
amino acid sequence
The algorithm was
algorithm was constructed
was constructed with
constructed with the
with the aim
the aim of
aim of identifying
of identifying segments
identifying segments in
segments in Ag
in Ag which
Ag which are
which are resistant
are resistant to
resistant to proteolytic
to proteolytic degradation
proteolytic degradation by
degradation by the
by the enzymes
the enzymes cathepsin
enzymes cathepsin B
cathepsin B L
B L and
L and D
These are prominent
are prominent enzymes
prominent enzymes in
enzymes in the
in the endocytic
the endocytic pathway
endocytic pathway through
pathway through which
through which soluble
which soluble protein
soluble protein Ag
protein Ag enter
Ag enter APC
enter APC and
APC and resistant
and resistant segments
resistant segments in
segments in Ag
in Ag may
Ag may therefore
may therefore be
therefore be expected
be expected to
expected to contain
to contain more
contain more T-cell
more T-cell determinants
T-cell determinants than
determinants than susceptible
than susceptible segments
From information available
information available in
available in the
in the literature
the literature on
literature on the
on the substrate
the substrate specificity
substrate specificity of
specificity of the
of the three
the three enzymes
three enzymes it
enzymes it is
it is clear
is clear that
clear that a
that a cysteine
a cysteine is
cysteine is not
is not accepted
not accepted in
accepted in any
in any of
any of the
of the S2
the S2 S1
S2 S1 S1'
S1 S1' and
S1' and S2'
and S2' subsites
S2' subsites of
subsites of cathepsin
of cathepsin B
cathepsin B and
B and L
and L and
L and not
and not in
not in the
in the S1
the S1 and
S1 and S1'
and S1' subsites
S1' subsites of
subsites of cathepsin
of cathepsin D
Moreover we have
we have noticed
have noticed that
noticed that cysteine-containing
that cysteine-containing T-cell
cysteine-containing T-cell determinants
T-cell determinants in
determinants in a
in a number
a number of
number of protein
of protein Ag
protein Ag are
Ag are particularly
are particularly rich
particularly rich in
rich in the
in the amino
the amino acids
amino acids alanine
acids alanine glycine
alanine glycine lysine
glycine lysine leucine
lysine leucine serine
leucine serine threonine
serine threonine and
threonine and valine
By searching protein
searching protein Ag
protein Ag for
Ag for clusters
for clusters of
clusters of amino
of amino acids
amino acids containing
acids containing cysteine
containing cysteine and
cysteine and two
and two of
two of the
of the other
the other amino
other amino acids
amino acids we
acids we were
we were able
were able to
able to predict
to predict 17
predict 17 out
17 out of
out of 23
of 23 empirically
23 empirically known
empirically known T-cell
known T-cell determinants
T-cell determinants in
determinants in the
in the Ag
the Ag with
Ag with a
with a relatively
a relatively low
relatively low number
low number of
number of false
of false positive
false positive predictions
Furthermore we present
we present a
present a new
a new principle
new principle for
principle for searching
for searching Ag
searching Ag for
Ag for potential
for potential amphipatic
potential amphipatic alpha-helical
amphipatic alpha-helical protein
alpha-helical protein segments
Such segments accord
segments accord well
accord well with
well with empirically
with empirically known
empirically known T-cell
known T-cell determinants
T-cell determinants and
determinants and our
and our algorithm
our algorithm produces
algorithm produces a
produces a lower
a lower number
lower number of
number of false
of false positive
false positive predictions
positive predictions than
predictions than the
than the principle
the principle based
principle based on
based on discrete
on discrete Fourier
discrete Fourier transformations
Fourier transformations previously
transformations previously described
Contribution of NF-kappa
of NF-kappa B
NF-kappa B and
B and Sp1
and Sp1 binding
Sp1 binding motifs
binding motifs to
motifs to the
to the replicative
the replicative capacity
replicative capacity of
capacity of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1:
type 1: distinct
1: distinct patterns
distinct patterns of
patterns of viral
of viral growth
viral growth are
growth are determined
are determined by
determined by T-cell
by T-cell types
Starting with a
with a replication-incompetent
a replication-incompetent molecular
replication-incompetent molecular clone
molecular clone of
clone of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 lacking
1 lacking all
lacking all the
all the NF-kappa
the NF-kappa B
NF-kappa B and
B and Sp1
and Sp1 binding
Sp1 binding sites
binding sites present
sites present in
present in the
in the native
the native long
native long terminal
long terminal repeat
terminal repeat LTR
repeat LTR proviruses
LTR proviruses containing
proviruses containing reconstructed
containing reconstructed LTRs
reconstructed LTRs with
LTRs with individual
with individual or
individual or combinations
or combinations of
combinations of NF-kappa
of NF-kappa B
NF-kappa B and
B and Sp1
and Sp1 elements
Sp1 elements were
elements were generated
were generated and
generated and evaluated
and evaluated for
evaluated for their
for their capacity
their capacity to
capacity to produce
to produce virus
produce virus progeny
virus progeny following
progeny following transfection-cocultivation
Virus stocks obtained
stocks obtained from
obtained from these
from these experiments
these experiments exhibited
experiments exhibited a
exhibited a continuum
a continuum of
continuum of replicative
of replicative capacities
replicative capacities in
capacities in different
in different human
different human T-cell
human T-cell types
T-cell types depending
types depending on
depending on which
on which elements
which elements was
elements was present
was present in
present in the
in the LTR
For example in
example in experiments
in experiments involving
experiments involving proviral
involving proviral clones
proviral clones with
clones with LTRs
with LTRs containing
LTRs containing one
containing one or
one or two
or two NF-kappa
two NF-kappa B
NF-kappa B elements
B elements and
elements and no
and no Sp1
no Sp1 binding
Sp1 binding sites
binding sites a
sites a hierarchy
a hierarchy of
hierarchy of cellular
of cellular permissivity
cellular permissivity to
permissivity to virus
to virus replication
virus replication peripheral
replication peripheral blood
peripheral blood lymphocytes
blood lymphocytes =
lymphocytes = MT4
= MT4 greater
MT4 greater than
greater than H9
than H9 greater
H9 greater than
greater than CEM
than CEM greater
CEM greater than
greater than Jurkat
than Jurkat was
Jurkat was observed
Of note was
note was the
was the associated
the associated emergence
associated emergence of
emergence of second-site
of second-site LTR
second-site LTR revertants
LTR revertants which
revertants which involved
which involved an
involved an alteration
an alteration of
alteration of the
of the TATA
the TATA box
These results suggest
results suggest that
suggest that the
that the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 LTR
1 LTR possesses
LTR possesses functional
possesses functional redundancy
functional redundancy which
redundancy which ensures
which ensures virus
ensures virus replication
virus replication in
replication in different
in different T-cell
different T-cell types
T-cell types and
types and is
and is capable
is capable of
capable of changing
of changing depending
changing depending on
depending on the
on the particular
the particular combination
particular combination of
combination of transcriptional
of transcriptional factors
transcriptional factors present
Stimulation of interferon
of interferon beta
interferon beta gene
beta gene transcription
gene transcription in
transcription in vitro
in vitro by
vitro by purified
by purified NF-kappa
purified NF-kappa B
NF-kappa B and
B and a
and a novel
a novel TH
novel TH protein
The human interferon
human interferon beta
interferon beta IFN-beta
beta IFN-beta regulatory
IFN-beta regulatory element
regulatory element consists
element consists of
consists of multiple
of multiple enhanson
multiple enhanson domains
enhanson domains which
domains which are
which are targets
are targets for
targets for transcription
for transcription factors
transcription factors involved
factors involved in
involved in inducible
in inducible expression
inducible expression of
expression of the
of the promoter
To further characterize
further characterize the
characterize the protein-DNA
the protein-DNA interactions
protein-DNA interactions mediating
interactions mediating IFN-beta
mediating IFN-beta induction
IFN-beta induction positive
induction positive regulatory
positive regulatory domain
regulatory domain PRD
domain PRD II
PRD II binding
II binding proteins
binding proteins were
proteins were purified
were purified from
purified from phorbol
from phorbol ester
phorbol ester induced
ester induced Jurkat
induced Jurkat T-cells
Jurkat T-cells and
T-cells and from
and from IFN
from IFN primed
IFN primed cycloheximide/polyinosinic-polycytidylic
primed cycloheximide/polyinosinic-polycytidylic acid
cycloheximide/polyinosinic-polycytidylic acid treated
acid treated HeLa
treated HeLa S3
HeLa S3 cells
From HeLa cells
HeLa cells two
cells two major
two major proteins
major proteins of
proteins of 52
of 52 and
52 and 45
and 45 kilodaltons
45 kilodaltons kD
kilodaltons kD copurified
kD copurified with
copurified with DNA
with DNA binding
DNA binding activity
binding activity whereas
activity whereas from
whereas from T-cells
from T-cells four
T-cells four proteins--a
four proteins--a major
proteins--a major protein
major protein of
protein of 52
of 52 kD
52 kD and
kD and three
and three minor
three minor proteins
minor proteins of
proteins of 82
of 82 67
82 67 and
67 and 43-47
and 43-47 kD--were
43-47 kD--were purified
Also an induction
an induction specific
induction specific DNA
specific DNA binding
DNA binding protein
binding protein was
protein was purified
was purified from
purified from HeLa
from HeLa cells
HeLa cells that
cells that interacted
that interacted with
interacted with the
with the AAGTGA4
the AAGTGA4 tetrahexamer
AAGTGA4 tetrahexamer sequence
tetrahexamer sequence and
sequence and the
and the PRDI
the PRDI domain
This protein is
protein is immunologically
is immunologically distinct
immunologically distinct from
distinct from IRF-1/ISGF2
Uninduced or Sendai
or Sendai virus
Sendai virus induced
virus induced HeLa
induced HeLa extracts
HeLa extracts were
extracts were used
were used to
used to examine
to examine transcription
examine transcription in
transcription in vitro
in vitro using
vitro using a
using a series
a series of
series of IFN
of IFN beta
IFN beta promoter
beta promoter deletions
Deletions upstream of
upstream of the
of the PRDII
the PRDII element
PRDII element increased
element increased transcription
increased transcription in
transcription in the
in the uninduced
the uninduced extract
uninduced extract indicating
extract indicating predominantly
indicating predominantly negative
predominantly negative regulation
negative regulation of
regulation of the
of the promoter
A 2-4-fold increase
2-4-fold increase in
increase in IFN-beta
in IFN-beta promoter
IFN-beta promoter transcription
promoter transcription was
transcription was observed
was observed in
observed in Sendai
in Sendai virus
Sendai virus induced
virus induced extracts
induced extracts and
extracts and deletion
and deletion of
deletion of PRDI
of PRDI and
PRDI and PRDII
and PRDII elements
PRDII elements decreased
elements decreased this
decreased this induced
this induced level
induced level of
level of transcription
When purified PRDII
purified PRDII and
PRDII and tetrahexamer
and tetrahexamer binding
tetrahexamer binding proteins
binding proteins were
proteins were added
were added to
added to the
to the induced
the induced extract
induced extract a
extract a 4-fold
a 4-fold increase
4-fold increase in
increase in transcription
in transcription was
transcription was observed
These experiments demonstrate
experiments demonstrate that
demonstrate that it
that it is
it is possible
is possible to
possible to modulate
to modulate IFN-beta
modulate IFN-beta transcription
IFN-beta transcription in
transcription in vitro
in vitro but
vitro but indicate
but indicate that
indicate that additional
that additional proteins
additional proteins may
proteins may be
may be required
be required to
required to fully
to fully activate
fully activate IFN-beta
activate IFN-beta transcription
The rhombotin family
rhombotin family of
family of cysteine-rich
of cysteine-rich LIM-domain
cysteine-rich LIM-domain oncogenes:
LIM-domain oncogenes: distinct
oncogenes: distinct members
distinct members are
members are involved
are involved in
involved in T-cell
in T-cell translocations
T-cell translocations to
translocations to human
to human chromosomes
human chromosomes 11p15
chromosomes 11p15 and
11p15 and 11p13
A chromosomal translocation
chromosomal translocation in
translocation in a
in a T-cell
a T-cell leukemia
T-cell leukemia involving
leukemia involving the
involving the short
the short arm
short arm of
arm of human
of human chromosome
human chromosome 11
chromosome 11 at
11 at band
at band 11p15
band 11p15 disrupts
11p15 disrupts the
disrupts the rhombotin
the rhombotin gene
This gene encodes
gene encodes a
encodes a protein
a protein with
protein with duplicated
with duplicated cysteine-rich
duplicated cysteine-rich regions
cysteine-rich regions called
regions called LIM
called LIM domains
LIM domains which
domains which show
which show homology
show homology to
homology to zinc-binding
to zinc-binding proteins
zinc-binding proteins and
proteins and to
and to iron-sulfur
to iron-sulfur centers
iron-sulfur centers of
centers of ferredoxins
Two homologues of
homologues of the
of the rhombotin
the rhombotin gene
rhombotin gene have
gene have now
have now been
now been isolated
One of these
of these designated
these designated Rhom-2
designated Rhom-2 is
Rhom-2 is located
is located on
located on human
on human chromosome
human chromosome 11
chromosome 11 at
11 at band
at band 11p13
band 11p13 where
11p13 where a
where a cluster
a cluster of
cluster of T-cell
of T-cell leukemia-specific
T-cell leukemia-specific translocations
leukemia-specific translocations occur;
translocations occur; all
occur; all translocation
all translocation breakpoints
translocation breakpoints at
breakpoints at 11p13
at 11p13 are
11p13 are upstream
are upstream of
upstream of the
of the Rhom-2
the Rhom-2 gene
Human and mouse
and mouse Rhom-2
mouse Rhom-2 are
Rhom-2 are highly
are highly conserved
highly conserved and
conserved and like
and like rhombotin
like rhombotin encode
rhombotin encode two
encode two tandem
two tandem cysteine-rich
tandem cysteine-rich LIM
cysteine-rich LIM domains
Rhom-2 mRNA is
mRNA is expressed
is expressed in
expressed in early
in early mouse
early mouse development
mouse development in
development in central
in central nervous
central nervous system
nervous system lung
system lung kidney
lung kidney liver
kidney liver and
liver and spleen
and spleen but
spleen but only
but only very
only very low
very low levels
low levels occur
levels occur in
occur in thymus
The other gene
other gene designated
gene designated Rhom-3
designated Rhom-3 is
Rhom-3 is not
is not on
not on chromosome
on chromosome 11
chromosome 11 but
11 but also
but also retains
also retains homology
retains homology to
homology to the
to the LIM
the LIM domain
LIM domain of
domain of rhombotin
Since the Rhom-2
the Rhom-2 gene
Rhom-2 gene is
gene is such
is such a
such a common
a common site
common site of
site of chromosomal
of chromosomal damage
chromosomal damage in
damage in T-cell
in T-cell tumors
T-cell tumors the
tumors the consistency
the consistency of
consistency of translocations
of translocations near
translocations near the
near the rhombotin
the rhombotin gene
rhombotin gene was
gene was further
was further examined
A second translocation
second translocation adjacent
translocation adjacent to
adjacent to rhombotin
to rhombotin was
rhombotin was found
was found and
found and at
and at the
at the same
the same position
same position as
position as in
as in the
in the previous
the previous example
Therefore chromosome bands
chromosome bands 11p15
bands 11p15 rhombotin
11p15 rhombotin and
rhombotin and 11p13
and 11p13 Rhom-2
11p13 Rhom-2 are
Rhom-2 are consistent
are consistent sites
consistent sites of
sites of chromosome
of chromosome translocation
chromosome translocation in
translocation in T-cell
in T-cell leukemia
T-cell leukemia with
leukemia with the
with the 11p15
the 11p15 target
11p15 target more
target more rarely
more rarely involved
The results define
results define the
define the rhombotin
the rhombotin gene
rhombotin gene family
gene family as
family as a
as a class
a class of
class of T-cell
of T-cell oncogenes
T-cell oncogenes with
oncogenes with duplicated
with duplicated cysteine-rich
duplicated cysteine-rich LIM
cysteine-rich LIM domains
NF-kappa B activation
B activation by
activation by tumor
by tumor necrosis
tumor necrosis factor
necrosis factor alpha
factor alpha in
alpha in the
in the Jurkat
the Jurkat T
Jurkat T cell
T cell line
cell line is
line is independent
is independent of
independent of protein
of protein kinase
protein kinase A
kinase A protein
A protein kinase
protein kinase C
kinase C and
C and Ca2+-regulated
and Ca2+-regulated kinases
NF-kappa B is
B is a
is a DNA-binding
a DNA-binding regulatory
DNA-binding regulatory factor
regulatory factor able
factor able to
able to control
to control transcription
control transcription of
transcription of a
of a number
a number of
number of genes
of genes including
genes including human
including human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV genes
In T cells
T cells NF-kappa
cells NF-kappa B
NF-kappa B is
B is activated
is activated upon
activated upon cellular
upon cellular treatment
cellular treatment by
treatment by phorbol
by phorbol esters
phorbol esters and
esters and the
and the cytokine
the cytokine tumor
cytokine tumor necrosis
tumor necrosis factor
necrosis factor alpha
factor alpha TNF
alpha TNF alpha
In the present
the present work
present work we
work we investigated
we investigated the
investigated the molecular
the molecular events
molecular events leading
events leading to
leading to NF-kappa
to NF-kappa B
NF-kappa B activation
B activation by
activation by TNF
by TNF alpha
TNF alpha in
alpha in a
in a human
a human T
human T cell
T cell line
cell line Jurkat
line Jurkat and
Jurkat and its
and its subclone
its subclone JCT6
subclone JCT6 which
JCT6 which presents
which presents a
presents a deficiency
a deficiency in
deficiency in the
in the PKA
the PKA transduction
PKA transduction pathway
We found that
found that in
that in both
in both cell
both cell lines
cell lines both
lines both phorbol
both phorbol ester
phorbol ester and
ester and TNF
and TNF alpha
TNF alpha were
alpha were able
were able to
able to activate
to activate NF-kappa
activate NF-kappa B
Phorbol activation was
activation was positively
was positively modulated
positively modulated by
modulated by Ca2+
by Ca2+ influx
Ca2+ influx while
influx while TNF
while TNF alpha
TNF alpha activation
alpha activation was
activation was not
Furthermore while PMA
while PMA activation
PMA activation was
activation was inhibited
was inhibited by
inhibited by the
by the PKC
the PKC inhibitor
PKC inhibitor staurosporin
inhibitor staurosporin the
staurosporin the TNF
the TNF alpha
TNF alpha effect
alpha effect was
effect was unchanged
TNF alpha did
alpha did not
did not activate
not activate cAMP
activate cAMP production
cAMP production and
production and its
and its signal
its signal was
signal was not
was not modulated
not modulated by
modulated by cAMP
by cAMP activators
Moreover cAMP activators
cAMP activators did
activators did not
did not activate
not activate NF-kappa
activate NF-kappa B
NF-kappa B in
B in Jurkat
in Jurkat cells
Thus TNF alpha-induced
TNF alpha-induced NF-kappa
alpha-induced NF-kappa B
NF-kappa B activation
B activation was
activation was found
was found to
found to be
to be mediated
be mediated by
mediated by none
by none of
none of the
of the major
the major signal-mediating
major signal-mediating kinases
signal-mediating kinases such
kinases such as
such as protein
as protein kinase
protein kinase C
kinase C PKC
C PKC protein
PKC protein kinase
protein kinase A
kinase A or
A or Ca2+-regulated
or Ca2+-regulated kinases
Furthermore we found
we found that
found that cytoplasmic
that cytoplasmic acidification
cytoplasmic acidification facilitated
acidification facilitated NF-kappa
facilitated NF-kappa B
NF-kappa B activation
B activation by
activation by both
by both TNF
both TNF alpha
TNF alpha and
alpha and PKC
and PKC by
PKC by a
by a mechanism
a mechanism that
mechanism that increases
that increases NF-kappa
increases NF-kappa B/I
NF-kappa B/I kappa
B/I kappa B
kappa B dissociation
B dissociation without
dissociation without affecting
without affecting the
affecting the NF-kappa
the NF-kappa B
NF-kappa B translocation
B translocation step
The functional domains
functional domains of
domains of the
of the murine
the murine Thy-1
murine Thy-1 gene
Thy-1 gene promoter
The Thy-1 gene
Thy-1 gene promoter
gene promoter resembles
promoter resembles a
resembles a "housekeeping"
a "housekeeping" promoter
"housekeeping" promoter in
promoter in that
in that it
that it is
it is located
is located within
located within a
within a methylation-free
a methylation-free island
methylation-free island lacks
island lacks a
lacks a canonical
a canonical TATA
canonical TATA box
TATA box and
box and displays
and displays heterogeneity
displays heterogeneity in
heterogeneity in the
in the 5'-end
the 5'-end termini
5'-end termini of
termini of the
of the mRNA
Using transgenic mice
transgenic mice we
mice we show
we show that
show that this
that this promoter
this promoter does
promoter does not
does not confer
not confer any
confer any tissue
any tissue specificity
tissue specificity and
specificity and is
and is active
is active only
active only in
only in a
in a position-dependent
a position-dependent manner
It can only
can only be
only be activated
be activated in
activated in a
in a tissue-specific
a tissue-specific manner
tissue-specific manner by
manner by elements
by elements that
elements that lie
that lie downstream
lie downstream of
downstream of the
of the initiation
the initiation site
We have analyzed
have analyzed the
analyzed the functional
the functional domains
functional domains of
domains of the
of the minimal
the minimal Thy-1
minimal Thy-1 promoter
Thy-1 promoter and
promoter and show
and show that
show that the
that the dominant
the dominant promoter
dominant promoter elements
promoter elements consist
elements consist of
consist of multiple
of multiple binding
multiple binding sites
binding sites for
sites for the
for the transcription
the transcription factor
transcription factor Sp1
factor Sp1 an
Sp1 an inverted
an inverted CCAAT
inverted CCAAT box
CCAAT box and
box and sequences
and sequences proximal
sequences proximal to
proximal to the
to the transcription
the transcription start
transcription start site
DNase I and
I and gel
and gel mobility
gel mobility shift
mobility shift assays
shift assays show
assays show the
show the binding
the binding of
binding of a
of a number
a number of
number of nuclear
of nuclear factors
nuclear factors to
factors to these
to these elements
these elements including
elements including Sp1
including Sp1 and
Sp1 and CP1
Our results show
results show that
show that the
that the structure
the structure of
structure of this
of this promoter
this promoter only
promoter only permits
only permits productive
permits productive interactions
productive interactions of
interactions of the
of the two
the two transcription
two transcription factors
transcription factors Sp1
factors Sp1 and
Sp1 and CP1
and CP1 with
CP1 with the
with the basal
the basal transcription
basal transcription machinery
transcription machinery in
machinery in the
in the presence
the presence of
presence of enhancer
of enhancer sequences
Nuclear factor kappa
factor kappa B
kappa B activates
B activates proenkephalin
activates proenkephalin transcription
proenkephalin transcription in
transcription in T
in T lymphocytes
Upon activation T
activation T lymphocytes
T lymphocytes accumulate
lymphocytes accumulate high
accumulate high levels
high levels of
levels of the
of the neuropeptide
the neuropeptide enkephalin
neuropeptide enkephalin which
enkephalin which correlate
which correlate with
correlate with high
with high levels
high levels of
levels of proenkephalin
of proenkephalin mRNA
proenkephalin mRNA in
mRNA in the
in the cells
Here we investigated
we investigated the
investigated the transcriptional
the transcriptional basis
transcriptional basis for
basis for these
for these changes
The proenkephalin promoter
proenkephalin promoter contains
promoter contains a
contains a sequence
a sequence GGGGACGTCCCC
sequence GGGGACGTCCCC named
GGGGACGTCCCC named B2
named B2 which
B2 which is
which is similar
is similar to
similar to the
to the kappa
the kappa B
kappa B sequence
B sequence GGGGACTTTCC
sequence GGGGACTTTCC the
GGGGACTTTCC the binding
the binding site
binding site of
site of the
of the transcription
the transcription factor
transcription factor nuclear
factor nuclear factor
nuclear factor NF-kappa
factor NF-kappa B
Activation of T
of T lymphocytes
T lymphocytes induces
lymphocytes induces an
induces an NF-kappa
an NF-kappa B-like
NF-kappa B-like binding
B-like binding activity
binding activity to
activity to the
to the B2
the B2 site
B2 site concomitant
site concomitant with
concomitant with activation
with activation of
activation of the
of the proenkephalin
the proenkephalin promoter
Mutations at the
at the B2
the B2 site
B2 site abolish
site abolish this
abolish this transcriptional
this transcriptional activation
The purified homodimer
purified homodimer two
homodimer two p50s
two p50s of
p50s of the
of the DNA-binding
the DNA-binding subunit
DNA-binding subunit of
subunit of NF-kappa
of NF-kappa B
NF-kappa B binds
B binds the
binds the B2
the B2 site
B2 site of
site of proenkephalin
of proenkephalin relatively
proenkephalin relatively better
relatively better than
better than does
than does the
does the heterotetramer
the heterotetramer two
heterotetramer two p65s
two p65s plus
p65s plus two
plus two p50s
two p50s form
p50s form of
form of the
of the factor
Thus it appears
it appears that
appears that the
that the T-cell-specific
the T-cell-specific activation
T-cell-specific activation of
activation of the
of the proenkephalin
the proenkephalin promoter
proenkephalin promoter is
promoter is mediated
is mediated by
mediated by NF-kappa
by NF-kappa B
However as NF-kappa
as NF-kappa B
NF-kappa B is
B is ubiquitous
is ubiquitous and
ubiquitous and the
and the transcriptional
the transcriptional activation
transcriptional activation through
activation through the
through the B2
the B2 site
B2 site is
site is T
is T cell
T cell specific
cell specific yet
specific yet another
yet another T-cell-specific
another T-cell-specific factor
T-cell-specific factor which
factor which synergizes
which synergizes with
synergizes with NF-kappa
with NF-kappa B
NF-kappa B should
B should be
should be considered
Induction of NF-KB
of NF-KB during
NF-KB during monocyte
during monocyte differentiation
monocyte differentiation by
differentiation by HIV
by HIV type
HIV type 1
type 1 infection
The production of
production of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 progeny
HIV-1 progeny was
progeny was followed
was followed in
followed in the
in the U937
the U937 promonocytic
U937 promonocytic cell
promonocytic cell line
cell line after
line after stimulation
after stimulation either
stimulation either with
either with retinoic
with retinoic acid
retinoic acid or
acid or PMA
or PMA and
PMA and in
and in purified
in purified human
purified human monocytes
human monocytes and
monocytes and macrophages
Electrophoretic mobility shift
mobility shift assays
shift assays and
assays and Southwestern
and Southwestern blotting
Southwestern blotting experiments
blotting experiments were
experiments were used
were used to
used to detect
to detect the
detect the binding
the binding of
binding of cellular
of cellular transactivation
cellular transactivation factor
transactivation factor NF-KB
factor NF-KB to
NF-KB to the
to the double
the double repeat-KB
double repeat-KB enhancer
repeat-KB enhancer sequence
enhancer sequence located
sequence located in
located in the
in the long
the long terminal
long terminal repeat
PMA treatment and
treatment and not
and not retinoic
not retinoic acid
retinoic acid treatment
acid treatment of
treatment of the
of the U937
the U937 cells
U937 cells acts
cells acts in
acts in inducing
in inducing NF-KB
inducing NF-KB expression
NF-KB expression in
expression in the
in the nuclei
In nuclear extracts
nuclear extracts from
extracts from monocytes
from monocytes or
monocytes or macrophages
or macrophages induction
macrophages induction of
induction of NF-KB
of NF-KB occurred
NF-KB occurred only
occurred only if
only if the
if the cells
the cells were
cells were previously
were previously infected
previously infected with
infected with HIV-1
When U937 cells
U937 cells were
cells were infected
were infected with
infected with HIV-1
with HIV-1 no
HIV-1 no induction
no induction of
induction of NF-KB
of NF-KB factor
NF-KB factor was
factor was detected
was detected whereas
detected whereas high
whereas high level
high level of
level of progeny
of progeny virions
progeny virions was
virions was produced
was produced suggesting
produced suggesting that
suggesting that this
that this factor
this factor was
factor was not
was not required
not required for
required for viral
for viral replication
These results indicate
results indicate that
indicate that in
that in monocytic
in monocytic cell
monocytic cell lineage
cell lineage HIV-1
lineage HIV-1 could
HIV-1 could mimic
could mimic some
mimic some differentiation/activation
some differentiation/activation stimuli
differentiation/activation stimuli allowing
stimuli allowing nuclear
allowing nuclear NF-KB
nuclear NF-KB expression
Disruption of the
of the human
the human SCL
human SCL locus
SCL locus by
locus by "illegitimate"
by "illegitimate" V-D-J
"illegitimate" V-D-J recombinase
V-D-J recombinase activity
A fusion complementary
fusion complementary DNA
complementary DNA in
DNA in the
in the T
the T cell
T cell line
cell line HSB-2
line HSB-2 elucidates
HSB-2 elucidates a
elucidates a provocative
a provocative mechanism
provocative mechanism for
mechanism for the
for the disruption
the disruption of
disruption of the
of the putative
the putative hematopoietic
putative hematopoietic transcription
hematopoietic transcription factor
transcription factor SCL
The fusion cDNA
fusion cDNA results
cDNA results from
results from an
from an interstitial
an interstitial deletion
interstitial deletion between
deletion between a
between a previously
a previously unknown
previously unknown locus
unknown locus SIL
locus SIL SCL
SIL SCL interrupting
SCL interrupting locus
interrupting locus and
locus and the
and the 5'
the 5' untranslated
5' untranslated region
untranslated region of
region of SCL
Similar to 1;14
to 1;14 translocations
1;14 translocations this
translocations this deletion
this deletion disrupts
deletion disrupts the
disrupts the SCL
the SCL 5'
SCL 5' regulatory
5' regulatory region
This event is
event is probably
is probably mediated
probably mediated by
mediated by V-D-J
by V-D-J recombinase
V-D-J recombinase activity
recombinase activity although
activity although neither
although neither locus
neither locus is
locus is an
is an immunoglobulin
an immunoglobulin or
immunoglobulin or a
or a T
a T cell
T cell receptor
Two other T
other T cell
T cell lines
cell lines CEM
lines CEM and
CEM and RPMI
and RPMI 8402
RPMI 8402 have
8402 have essentially
have essentially identical
essentially identical deletions
Thus in lymphocytes
in lymphocytes growth-affecting
lymphocytes growth-affecting genes
growth-affecting genes other
genes other than
other than immune
than immune receptors
immune receptors risk
receptors risk rearrangements
Thyroid hormone receptors
hormone receptors form
receptors form distinct
form distinct nuclear
distinct nuclear protein-dependent
nuclear protein-dependent and
protein-dependent and independent
and independent complexes
independent complexes with
complexes with a
with a thyroid
a thyroid hormone
thyroid hormone response
hormone response element
We have examined
have examined the
examined the binding
the binding of
binding of nuclear
of nuclear proteins
nuclear proteins and
proteins and recombinant
and recombinant thyroid
recombinant thyroid hormone
thyroid hormone receptors
hormone receptors TRs
receptors TRs to
TRs to the
to the palindromic
the palindromic thyroid
palindromic thyroid hormone
thyroid hormone responsive
hormone responsive element
responsive element AGGTCATGACCT
element AGGTCATGACCT TREp
AGGTCATGACCT TREp using
TREp using a
using a gel
a gel electrophoretic
gel electrophoretic mobility
electrophoretic mobility shift
mobility shift assay
Four specific protein-DNA
specific protein-DNA complexes
protein-DNA complexes were
complexes were detected
were detected after
detected after incubation
after incubation of
incubation of nuclear
of nuclear extracts
nuclear extracts NE
extracts NE from
NE from T3-responsive
from T3-responsive pituitary
T3-responsive pituitary GH3
pituitary GH3 cells
GH3 cells with
cells with a
with a TREp-containing
a TREp-containing DNA
TREp-containing DNA fragment
This was compared
was compared with
compared with the
with the TREp
the TREp binding
TREp binding of
binding of reticulocyte
of reticulocyte lysate-synthesized
reticulocyte lysate-synthesized TRs
TR alpha 1
alpha 1 and
1 and TR
and TR beta
TR beta 2
beta 2 each
2 each formed
each formed a
formed a single
a single major
single major TR:TREp
major TR:TREp complex
TR:TREp complex which
complex which comigrated
which comigrated with
comigrated with the
with the least
the least retarded
least retarded complex
retarded complex formed
complex formed by
formed by GH3
by GH3 NE
GH3 NE while
NE while TR
while TR beta
TR beta 1
beta 1 formed
1 formed multiple
formed multiple complexes
multiple complexes suggesting
complexes suggesting that
suggesting that it
that it can
it can bind
can bind to
bind to TREp
to TREp as
TREp as an
as an oligomer
Interestingly coincubation of
coincubation of 35S-TR
of 35S-TR alpha
35S-TR alpha 1
alpha 1 GH3
1 GH3 NE
GH3 NE and
NE and unlabeled
and unlabeled TREp
unlabeled TREp resulted
TREp resulted in
resulted in not
in not only
not only the
only the 35S-TR:TREp
the 35S-TR:TREp complex
35S-TR:TREp complex but
complex but in
but in two
in two additional
two additional more
additional more greatly
more greatly retarded
greatly retarded complexes
retarded complexes containing
complexes containing 35S-TR
containing 35S-TR alpha
35S-TR alpha 1
alpha 1 and
1 and comigrating
and comigrating with
comigrating with those
with those formed
those formed by
formed by GH3
by GH3 extract
GH3 extract alone
Incubation of each
of each of
each of the
of the TRs
the TRs with
TRs with NE
with NE from
NE from COS-7
from COS-7 cells
COS-7 cells which
cells which do
which do not
do not possess
not possess sufficient
possess sufficient endogenous
sufficient endogenous TRs
endogenous TRs to
TRs to mediate
to mediate T3-responses
mediate T3-responses resulted
T3-responses resulted in
resulted in formation
in formation of
formation of a
of a new
a new more
new more greatly
more greatly shifted
greatly shifted complex
A similar heat
similar heat labile
heat labile activity
labile activity which
activity which altered
which altered mobility
altered mobility of
mobility of the
of the TR:TRE
the TR:TRE complex
TR:TRE complex was
complex was also
was also present
also present in
present in NE
in NE from
NE from T3-unresponsive
from T3-unresponsive JEG-3
T3-unresponsive JEG-3 cells
At high concentration
high concentration of
concentration of NE
of NE all
NE all of
all of the
of the TR
the TR bound
TR bound to
bound to TREp
to TREp was
TREp was more
was more greatly
more greatly retarded
greatly retarded than
retarded than in
than in the
in the absence
the absence of
absence of NE
Truncation of TR
of TR alpha
TR alpha 1
alpha 1 at
1 at amino
at amino acid
amino acid 210
acid 210 prevented
210 prevented additional
prevented additional complex
additional complex formation
complex formation in
formation in the
in the presence
the presence of
presence of NE
of NE without
NE without affecting
without affecting DNA
affecting DNA binding
DNA binding suggesting
binding suggesting that
suggesting that the
that the carboxyl-terminus
the carboxyl-terminus of
carboxyl-terminus of the
of the TRs
the TRs is
TRs is essential
is essential for
essential for interaction
for interaction with
interaction with nuclear
with nuclear proteins
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Cell-specific differences in
differences in activation
in activation of
activation of NF-kappa
of NF-kappa B
NF-kappa B regulatory
B regulatory elements
regulatory elements of
elements of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus and
virus and beta
and beta interferon
beta interferon promoters
interferon promoters by
promoters by tumor
by tumor necrosis
tumor necrosis factor
Three aspects of
aspects of the
of the involvement
the involvement of
involvement of tumor
of tumor necrosis
tumor necrosis factor
necrosis factor in
factor in human
in human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV pathogenesis
HIV pathogenesis were
pathogenesis were examined
Tumor necrosis factor
necrosis factor alpha
factor alpha TNF-alpha
alpha TNF-alpha mRNA
TNF-alpha mRNA production
mRNA production was
production was analyzed
was analyzed by
analyzed by polymerase
by polymerase chain
polymerase chain reaction
chain reaction amplification
reaction amplification in
amplification in monocytic
in monocytic U937
monocytic U937 cells
U937 cells and
cells and in
and in a
in a chronically
a chronically HIV
chronically HIV infected
HIV infected U937
infected U937 cell
U937 cell line
cell line U9-IIIB
TNF-alpha RNA was
RNA was undetectable
was undetectable in
undetectable in U937
in U937 cells
U937 cells whereas
cells whereas a
whereas a low
a low constitutive
low constitutive level
constitutive level was
level was detected
was detected in
detected in U9-IIIB
in U9-IIIB cells
Paramyxovirus infection induced
infection induced a
induced a 5-
a 5- to
5- to 10-fold
to 10-fold increase
10-fold increase in
increase in the
in the steady-state
the steady-state level
steady-state level of
level of TNF-alpha
of TNF-alpha RNA
TNF-alpha RNA in
RNA in U9-IIIB
in U9-IIIB cells
U9-IIIB cells compared
cells compared with
compared with U937
with U937 cells
U937 cells suggesting
cells suggesting that
suggesting that HIV-infected
that HIV-infected monocytic
HIV-infected monocytic cells
monocytic cells produced
cells produced higher
produced higher levels
higher levels of
levels of TNF-alpha
of TNF-alpha than
TNF-alpha than did
than did normal
did normal cells
normal cells after
cells after a
after a secondary
a secondary virus
secondary virus infection
The effects of
effects of TNF-alpha
of TNF-alpha on
TNF-alpha on gene
on gene expression
gene expression were
expression were examined
were examined by
examined by transient
by transient expression
transient expression assays
expression assays using
assays using reporter
using reporter chloramphenicol
reporter chloramphenicol acetyltransferase
chloramphenicol acetyltransferase plasmids
acetyltransferase plasmids linked
plasmids linked to
linked to regulatory
to regulatory elements
regulatory elements from
elements from the
from the HIV
the HIV long
HIV long terminal
long terminal repeat
terminal repeat LTR
repeat LTR and
LTR and the
and the beta
the beta interferon
beta interferon promoter
In U937 and
U937 and Jurkat
and Jurkat T
Jurkat T lymphoid
T lymphoid cells
lymphoid cells the
cells the inducibility
the inducibility of
inducibility of the
of the different
the different hybrid
different hybrid promoters
hybrid promoters by
promoters by TNF-alpha
by TNF-alpha or
TNF-alpha or phorbol
or phorbol ester
phorbol ester varied
ester varied in
varied in a
in a cell
a cell type-
cell type- and
type- and promoter
and promoter context-specific
promoter context-specific manner;
context-specific manner; the
manner; the levels
the levels of
levels of gene
of gene activity
gene activity of
activity of NF-kappa
of NF-kappa B-containing
NF-kappa B-containing plasmids
B-containing plasmids correlated
plasmids correlated directly
correlated directly with
directly with induction
with induction of
induction of NF-kappa
of NF-kappa B
NF-kappa B DNA-binding
B DNA-binding activity
Although the intact
the intact beta
intact beta interferon
beta interferon promoter
interferon promoter was
promoter was only
was only weakly
only weakly stimulated
weakly stimulated by
stimulated by phorbol
by phorbol ester
phorbol ester or
ester or TNF-alpha
or TNF-alpha multimers
TNF-alpha multimers of
multimers of the
of the PRDII
the PRDII NF-kappa
PRDII NF-kappa B-binding
NF-kappa B-binding domain
B-binding domain were
domain were inducible
were inducible by
inducible by both
by both agents
TNF-alpha was able
was able to
able to increase
to increase expression
increase expression of
expression of the
of the HIV
the HIV LTR
HIV LTR in
LTR in T
in T cells
T cells but
cells but in
but in monocytic
in monocytic cells
monocytic cells TNF-alpha
cells TNF-alpha did
TNF-alpha did not
did not induce
not induce the
induce the HIV
the HIV LTR
HIV LTR above
LTR above a
above a constitutive
a constitutive level
constitutive level of
level of activity
This level of
level of NF-kappa
of NF-kappa B-independent
NF-kappa B-independent activity
B-independent activity appears
activity appears to
appears to be
to be sufficient
be sufficient for
sufficient for virus
for virus multiplication
virus multiplication since
multiplication since TNF-alpha
since TNF-alpha treatment
TNF-alpha treatment had
treatment had no
had no effect
no effect on
effect on the
on the kinetics
the kinetics of
kinetics of de
of de novo
de novo HIV
novo HIV type
HIV type 1
type 1 HIV-1
1 HIV-1 infection
HIV-1 infection and
infection and viral
and viral RNA
viral RNA production
RNA production in
production in U937
in U937 cells
However in Jurkat
in Jurkat cells
Jurkat cells TNF-alpha
cells TNF-alpha dramatically
TNF-alpha dramatically enhanced
dramatically enhanced the
enhanced the spread
the spread of
spread of HIV-1
of HIV-1 through
HIV-1 through the
through the cell
the cell population
cell population and
population and increased
and increased viral
increased viral RNA
viral RNA synthesis
RNA synthesis indicating
synthesis indicating that
indicating that in
that in T
in T cells
T cells HIV-1
cells HIV-1 multiplication
HIV-1 multiplication was
multiplication was stimulated
was stimulated by
stimulated by TNF-alpha
by TNF-alpha treatment
Functional analysis of
analysis of cis-linked
of cis-linked regulatory
cis-linked regulatory sequences
regulatory sequences in
sequences in the
in the HLA
the HLA DRA
HLA DRA promoter
DRA promoter by
promoter by transcription
by transcription in
transcription in vitro
Two consensus sequences
consensus sequences called
sequences called X
called X and
X and Y
and Y boxes
Y boxes capable
boxes capable of
capable of binding
of binding nuclear
binding nuclear proteins
nuclear proteins and
proteins and regulating
and regulating expression
regulating expression in
expression in B
in B cells
B cells have
cells have been
have been defined
been defined within
defined within the
within the immediate
the immediate upstream
immediate upstream region
upstream region of
region of major
of major histocompatibility
major histocompatibility complex
histocompatibility complex MHC
complex MHC class
MHC class II
class II promoters
Unlike other class
other class II
class II promoters
II promoters the
promoters the HLA-DR
the HLA-DR alpha
HLA-DR alpha DRA
alpha DRA promoter
DRA promoter also
promoter also contains
also contains one
contains one element
one element identical
element identical to
identical to the
to the "octamer"
the "octamer" motif
"octamer" motif of
motif of immunoglobulin
of immunoglobulin variable
immunoglobulin variable region
variable region promoters
region promoters that
promoters that is
that is responsible
is responsible for
responsible for B
for B cell-specific
B cell-specific transcription
This "octamer" in
"octamer" in the
in the context
the context of
context of DRA
of DRA appears
DRA appears capable
appears capable of
capable of binding
of binding both
binding both the
both the ubiquitous
the ubiquitous OTF-1
ubiquitous OTF-1 and
OTF-1 and lymphoid-specific
and lymphoid-specific OTF-2
lymphoid-specific OTF-2 "octamer"
OTF-2 "octamer" binding
"octamer" binding proteins
binding proteins but
proteins but at
but at least
at least one
least one other
one other distinct
other distinct "octamer"
distinct "octamer" complex
"octamer" complex was
complex was found
In order to
order to characterize
to characterize the
characterize the function
the function of
function of cis-acting
of cis-acting elements
cis-acting elements we
elements we have
we have developed
have developed an
developed an in
an in vitro
in vitro system
vitro system in
system in which
in which a
which a DRA
a DRA promoter
DRA promoter construct
promoter construct is
construct is transcribed
is transcribed more
transcribed more efficiently
more efficiently in
efficiently in extracts
in extracts from
extracts from B
from B cells
B cells than
cells than in
than in extracts
in extracts from
extracts from class
from class II-negative
class II-negative HeLa
II-negative HeLa cells
5' deletion constructs
deletion constructs which
constructs which lacked
which lacked the
lacked the Y
the Y box
Y box but
box but retained
but retained the
retained the "octamer"
the "octamer" motif
"octamer" motif and
motif and TATA
and TATA box
TATA box were
box were completely
were completely inactive
completely inactive and
inactive and internal
and internal deletion
internal deletion of
deletion of the
of the Y
the Y box
Y box reduced
box reduced transcription
reduced transcription by
transcription by 95%
Using supercoiled but
supercoiled but not
but not linear
not linear templates
linear templates we
templates we observed
we observed differences
observed differences in
differences in transcription
in transcription efficiencies
transcription efficiencies from
efficiencies from templates
from templates lacking
templates lacking or
lacking or disrupting
or disrupting the
disrupting the X
the X consensus
X consensus element
consensus element that
element that reflect
that reflect effects
reflect effects of
effects of random
of random replacement
random replacement of
replacement of X
of X box
X box sequences
box sequences in
sequences in transient
in transient expression
transient expression assays
Demonstration of the
of the complete
the complete dependence
complete dependence on
dependence on the
on the Y
the Y box
Y box in
box in this
in this system
this system suggests
system suggests that
suggests that despite
that despite its
despite its demonstrated
its demonstrated importance
demonstrated importance in
importance in the
in the DRA
the DRA promoter
DRA promoter the
promoter the DRA
the DRA "octamer"
DRA "octamer" does
"octamer" does not
does not utilize
not utilize OTF-2
utilize OTF-2 in
OTF-2 in a
in a manner
a manner analogous
manner analogous to
analogous to immunoglobulin
to immunoglobulin promoters
immunoglobulin promoters in
promoters in B
in B cells
Lipopolysaccharide is a
is a potent
a potent monocyte/macrophage-specific
potent monocyte/macrophage-specific stimulator
monocyte/macrophage-specific stimulator of
stimulator of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 expression
Lipopolysaccharide LPS potently
LPS potently stimulates
potently stimulates human
stimulates human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1-long
type 1-long terminal
1-long terminal repeat
terminal repeat HIV-1-LTR
repeat HIV-1-LTR CAT
HIV-1-LTR CAT constructs
CAT constructs transfected
constructs transfected into
transfected into monocyte/macrophage-like
into monocyte/macrophage-like cell
monocyte/macrophage-like cell lines
cell lines but
lines but not
but not a
not a T
a T cell
T cell line
This effect appears
effect appears to
appears to be
to be mediated
be mediated through
mediated through the
through the induction
the induction of
induction of nuclear
of nuclear factor
nuclear factor kappa
factor kappa B
kappa B NF-kappa
B NF-kappa B
Electrophoretic mobility shift
mobility shift assays
shift assays demonstrate
assays demonstrate that
demonstrate that LPS
that LPS induces
LPS induces a
induces a DNA
a DNA binding
DNA binding activity
binding activity indistinguishable
activity indistinguishable from
indistinguishable from NF-kappa
from NF-kappa B
NF-kappa B in
B in U937
in U937 and
U937 and THP-1
and THP-1 cells
LPS is also
is also shown
also shown to
shown to dramatically
to dramatically increase
dramatically increase HIV-1
increase HIV-1 production
HIV-1 production from
production from a
from a chronically
a chronically infected
chronically infected monocyte/macrophage-like
infected monocyte/macrophage-like cloned
monocyte/macrophage-like cloned cell
cloned cell line
cell line U1
line U1 which
U1 which produces
which produces very
produces very low
very low levels
low levels of
levels of HIV-1
of HIV-1 at
HIV-1 at baseline
The stimulation of
stimulation of viral
of viral production
viral production from
production from this
from this cell
this cell line
cell line occurs
line occurs only
occurs only if
only if these
if these cells
these cells are
cells are treated
are treated with
treated with granulocyte/macrophage
with granulocyte/macrophage colony-stimulating
granulocyte/macrophage colony-stimulating factor
colony-stimulating factor GM-CSF
factor GM-CSF before
GM-CSF before treatment
before treatment with
treatment with LPS
This stimulation of
stimulation of HIV-1
of HIV-1 production
HIV-1 production is
production is correlated
is correlated with
correlated with an
with an increase
an increase in
increase in the
in the level
the level of
level of HIV-1
of HIV-1 RNA
HIV-1 RNA and
RNA and and
and and activation
and activation of
activation of NF-kappa
of NF-kappa B
LPS is not
is not able
not able to
able to induce
to induce HIV-1
induce HIV-1 production
HIV-1 production in
production in a
in a cloned
a cloned T
cloned T cell
T cell line
The effect of
effect of LPS
of LPS on
LPS on HIV-1
on HIV-1 replication
HIV-1 replication occurs
replication occurs at
occurs at picogram
at picogram per
picogram per milliliter
per milliliter concentrations
milliliter concentrations and
concentrations and may
and may be
may be clinically
be clinically significant
clinically significant in
significant in understanding
in understanding the
understanding the variability
the variability of
variability of the
of the natural
the natural history
natural history of
history of HIV-1
of HIV-1 infection
Steroid dose sparing:
dose sparing: pharmacodynamic
sparing: pharmacodynamic responses
pharmacodynamic responses to
responses to single
to single versus
single versus divided
versus divided doses
divided doses of
doses of methylprednisolone
of methylprednisolone in
methylprednisolone in man
Inhibitory drug interactions
drug interactions affecting
interactions affecting the
affecting the metabolism
the metabolism of
metabolism of methylprednisolone
of methylprednisolone MP
methylprednisolone MP may
MP may produce
may produce either
produce either steroid
either steroid sparing
steroid sparing or
sparing or adverse
or adverse effects
adverse effects partly
effects partly by
partly by increasing
by increasing the
increasing the exposure
the exposure time
exposure time to
time to the
to the steroid
This phenomenon can
phenomenon can be
can be mimicked
be mimicked by
mimicked by administering
by administering MP
administering MP in
MP in divided
in divided doses
Two types of
types of responses
of responses were
responses were compared
were compared after
compared after a
after a single
a single MP
single MP dose
MP dose 40
dose 40 mg
40 mg bolus
mg bolus and
bolus and a
and a divided
a divided regimen
divided regimen 20
regimen 20 mg
20 mg bolus
mg bolus and
bolus and a
and a 5
a 5 mg
5 mg bolus
mg bolus 8
bolus 8 hours
8 hours later
hours later in
later in six
in six healthy
six healthy male
healthy male volunteers
The suppression of
suppression of basophils
of basophils measured
basophils measured as
measured as whole
as whole blood
whole blood histamine
blood histamine and
histamine and plasma
and plasma cortisol
plasma cortisol concentrations
cortisol concentrations was
concentrations was assessed
was assessed during
assessed during 32
during 32 hours
The 375% reduction
375% reduction in
reduction in dose
in dose produced
dose produced a
produced a 23%
a 23% overall
23% overall decreased
overall decreased blood
decreased blood histamine
blood histamine response
A pharmacodynamic model
pharmacodynamic model for
model for basophil
for basophil cell
basophil cell distribution
cell distribution to
distribution to and
to and from
and from an
from an extravascular
an extravascular compartment
extravascular compartment describes
compartment describes the
describes the effects
the effects of
effects of MP
of MP after
MP after both
after both regimens
A slower initial
slower initial decline
initial decline in
decline in blood
in blood histamine
blood histamine after
histamine after the
after the divided
the divided regimen
divided regimen may
regimen may be
may be related
be related to
related to incomplete
to incomplete suppression
incomplete suppression of
suppression of basophil
of basophil cell
basophil cell return
cell return to
return to blood
The 50% inhibitory
50% inhibitory concentrations
inhibitory concentrations of
concentrations of MP
of MP of
MP of about
of about 5
about 5 ng/ml
5 ng/ml were
ng/ml were similar
were similar for
similar for both
for both regimens
The decline and
decline and return
and return of
return of cortisol
of cortisol concentrations
cortisol concentrations were
concentrations were similar
were similar between
similar between MP
between MP treatments
MP treatments with
treatments with suppression
with suppression continuing
suppression continuing for
continuing for 24
for 24 hours
The 50% inhibitory
50% inhibitory concentrations
inhibitory concentrations of
concentrations of MP
of MP values
MP values for
values for adrenal
for adrenal suppression
adrenal suppression were
suppression were about
were about 1
about 1 ng/ml
Pharmacodynamic modeling is
modeling is useful
is useful in
useful in quantitating
in quantitating corticosteroid
quantitating corticosteroid responses
corticosteroid responses and
responses and generally
and generally predicted
generally predicted the
predicted the "dose-sparing"
the "dose-sparing" effects
"dose-sparing" effects that
effects that were
that were achieved
were achieved by
achieved by prolonging
by prolonging MP
prolonging MP plasma
MP plasma concentrations
This study supports
study supports previous
supports previous clinical
previous clinical observations
clinical observations that
observations that patients
that patients may
patients may require
may require morning
require morning through
morning through evening
through evening exposure
evening exposure to
exposure to MP
to MP to
MP to optimize
to optimize efficacy
optimize efficacy while
efficacy while adrenal
while adrenal suppression
adrenal suppression is
suppression is being
is being minimized
125OH2D2 production by
production by T
by T lymphocytes
T lymphocytes and
lymphocytes and alveolar
and alveolar macrophages
alveolar macrophages recovered
macrophages recovered by
recovered by lavage
by lavage from
lavage from normocalcemic
from normocalcemic patients
normocalcemic patients with
patients with tuberculosis
To compare extra-renal
compare extra-renal 125OH2D3
extra-renal 125OH2D3 production
125OH2D3 production in
production in different
in different types
different types of
types of granulomatous
of granulomatous disease
granulomatous disease and
disease and to
and to identify
to identify the
identify the cell
the cell types
cell types responsible
types responsible we
responsible we have
we have evaluated
have evaluated the
evaluated the conversion
the conversion of
conversion of 25OHD3
of 25OHD3 in
25OHD3 in 125OH2D3
in 125OH2D3 by
125OH2D3 by uncultured
by uncultured cells
uncultured cells recovered
cells recovered by
recovered by bronchoalveolar
by bronchoalveolar lavage
bronchoalveolar lavage and
lavage and blood
and blood mononuclear
blood mononuclear cells
mononuclear cells from
cells from normocalcemic
from normocalcemic patients
normocalcemic patients with
patients with sarcoidosis
with sarcoidosis and
sarcoidosis and tuberculosis
125OH2D3 was produced
was produced both
produced both by
both by lavage
by lavage cells
lavage cells 12/12
cells 12/12 tuberculosis
12/12 tuberculosis patients
tuberculosis patients 2/6
patients 2/6 sarcoidosis
2/6 sarcoidosis patients
sarcoidosis patients and
patients and blood
and blood mononuclear
blood mononuclear cells
mononuclear cells 3/5
cells 3/5 tuberculosis
3/5 tuberculosis patients
tuberculosis patients 0/3
patients 0/3 sarcoidosis
0/3 sarcoidosis patients
sarcoidosis patients from
patients from patients
from patients but
patients but not
but not controls
not controls but
controls but significantly
but significantly greater
significantly greater amounts
greater amounts were
amounts were produced
were produced by
produced by lavage
by lavage cells
lavage cells from
cells from tuberculosis
from tuberculosis patients
tuberculosis patients than
patients than those
than those of
those of sarcoidosis
of sarcoidosis patients
sarcoidosis patients P
patients P less
P less than
less than 0001
125OH2D3 production by
production by lavage
by lavage cells
lavage cells from
cells from tuberculosis
from tuberculosis patients
tuberculosis patients correlated
patients correlated with
correlated with the
with the number
the number of
number of CD8+
of CD8+ T
CD8+ T lymphocytes
T lymphocytes present
lymphocytes present but
present but not
but not other
not other cell
other cell types
T lymphocytes appeared
lymphocytes appeared to
appeared to be
to be an
be an important
an important source
important source of
source of 125OH2D3
of 125OH2D3 production
125OH2D3 production since
production since purified
since purified T
purified T lymphocytes
T lymphocytes from
lymphocytes from all
from all patients
all patients with
patients with tuberculosis
with tuberculosis produced
tuberculosis produced 125OH2D3
produced 125OH2D3 and
125OH2D3 and 125OH2D3
and 125OH2D3 production
125OH2D3 production by
production by these
by these cells
these cells correlated
cells correlated closely
correlated closely with
closely with that
with that produced
that produced by
produced by unseparated
by unseparated lavage
unseparated lavage cells
Because 125OH2D3 can
125OH2D3 can improve
can improve the
improve the capacity
the capacity of
capacity of macrophages
of macrophages to
macrophages to kill
to kill mycobacteria
kill mycobacteria our
mycobacteria our results
our results support
results support the
support the conclusion
the conclusion that
conclusion that macrophage-lymphocyte
that macrophage-lymphocyte interactions
macrophage-lymphocyte interactions mediated
interactions mediated at
mediated at least
at least in
least in part
in part by
part by 125OH2D3
by 125OH2D3 may
125OH2D3 may be
may be an
be an important
an important component
important component of
component of a
of a successful
a successful antituberculous
successful antituberculous immune
antituberculous immune response
Megakaryocytic and erythrocytic
and erythrocytic lineages
erythrocytic lineages share
lineages share specific
share specific transcription
specific transcription factors
Erythroid-specific genes contain
genes contain binding
contain binding sites
binding sites for
sites for NF-E1
for NF-E1 also
NF-E1 also called
also called GF-1
called GF-1 and
GF-1 and Eryf-1;
and Eryf-1; refs
Eryf-1; refs 1-3
refs 1-3 respectively
1-3 respectively the
respectively the principal
the principal DNA-binding
principal DNA-binding protein
DNA-binding protein of
protein of the
of the erythrocytic
the erythrocytic lineage
NF-E1 expression seems
expression seems to
seems to be
to be restricted
be restricted to
restricted to the
to the erythrocytic
the erythrocytic lineage
A closely related
closely related if
related if not
if not identical
not identical protein
identical protein is
protein is found
is found in
found in both
in both a
both a human
a human megakaryocytic
human megakaryocytic cell
megakaryocytic cell line
cell line and
line and purified
and purified human
purified human megakaryocytes;
human megakaryocytes; it
megakaryocytes; it binds
it binds to
binds to promoter
to promoter regions
promoter regions of
regions of two
of two megakaryocytic-specific
two megakaryocytic-specific genes
The binding sites
binding sites and
sites and partial
and partial proteolysis
partial proteolysis profile
proteolysis profile of
profile of this
of this protein
this protein are
protein are indistinguishable
are indistinguishable from
indistinguishable from those
from those of
those of the
of the erythroid
the erythroid protein;
erythroid protein; also
protein; also NF-E1
also NF-E1 messenger
NF-E1 messenger RNA
messenger RNA is
RNA is the
is the same
the same size
same size in
size in both
in both the
both the megakaryocytic
the megakaryocytic and
megakaryocytic and erythroid
and erythroid cell
erythroid cell lines
Furthermore point mutations
point mutations that
mutations that abolish
that abolish binding
abolish binding of
binding of NF-E1
of NF-E1 result
NF-E1 result in
result in a
in a 70%
a 70% decrease
70% decrease in
decrease in the
in the transcriptional
the transcriptional activity
transcriptional activity of
activity of a
of a megakaryocytic-specific
a megakaryocytic-specific promoter
We also find
also find that
find that NF-E2
that NF-E2 another
NF-E2 another trans-acting
another trans-acting factor
trans-acting factor of
factor of the
of the erythrocytic
the erythrocytic lineage
erythrocytic lineage is
lineage is present
is present in
present in megakaryocytes
Transcriptional effects in
effects in both
in both lineages
both lineages might
lineages might then
might then be
then be mediated
be mediated in
mediated in part
in part by
part by the
by the same
the same specific
same specific trans-acting
specific trans-acting factors
Our data strengthen
data strengthen the
strengthen the idea
the idea of
idea of a
of a close
a close association
close association between
association between the
between the erythrocytic
the erythrocytic and
erythrocytic and the
and the megakaryocytic
the megakaryocytic lineages
megakaryocytic lineages and
lineages and could
and could also
could also explain
also explain the
explain the expression
the expression of
expression of markers
of markers specific
markers specific to
specific to the
to the erythrocytic
the erythrocytic and
erythrocytic and megakaryocytic
and megakaryocytic lineages
megakaryocytic lineages in
lineages in most
in most erythroblastic
most erythroblastic and
erythroblastic and megakaryoblastic
and megakaryoblastic permanent
megakaryoblastic permanent cell
permanent cell lines
Transcriptional down-regulation of
down-regulation of c-myc
of c-myc expression
c-myc expression by
expression by protein
by protein synthesis-dependent
protein synthesis-dependent and
synthesis-dependent and -independent
and -independent pathways
-independent pathways in
pathways in a
in a human
a human T
human T lymphoblastic
T lymphoblastic tumor
lymphoblastic tumor cell
tumor cell line
We show that
show that in
that in the
in the human
the human T
human T lymphoblastic
T lymphoblastic tumor
lymphoblastic tumor cell
tumor cell line
cell line Molt4
line Molt4 c-myc
Molt4 c-myc mRNA
c-myc mRNA and
mRNA and protein
and protein expression
protein expression is
expression is down-regulated
is down-regulated after
down-regulated after exposure
after exposure to
exposure to dimethyl
to dimethyl sulfoxide
dimethyl sulfoxide to
sulfoxide to phorbol
to phorbol myristate
phorbol myristate acetate
myristate acetate or
acetate or to
or to the
to the calcium
the calcium ionophore
calcium ionophore A23187
ionophore A23187 which
A23187 which raises
which raises the
raises the intracellular
the intracellular calcium
intracellular calcium concentration
A block to
block to RNA
to RNA elongation
RNA elongation is
elongation is largely
is largely responsible
largely responsible for
responsible for decreased
for decreased c-myc
decreased c-myc transcription
Although negative regulation
negative regulation by
regulation by dimethyl
by dimethyl sulfoxide
dimethyl sulfoxide takes
sulfoxide takes place
takes place even
place even when
even when protein
when protein synthesis
protein synthesis is
synthesis is inhibited
is inhibited by
inhibited by cycloheximide
by cycloheximide the
cycloheximide the phorbol
the phorbol myristate
phorbol myristate acetate
myristate acetate effect
acetate effect is
effect is blocked
is blocked to
blocked to some
to some extent
some extent only
extent only by
only by cycloheximide
The calcium ionophore-induced
calcium ionophore-induced c-myc
ionophore-induced c-myc suppression
c-myc suppression however
suppression however strictly
however strictly requires
strictly requires de
requires de novo
de novo protein
novo protein synthesis
Therefore two different
two different negative
different negative regulatory
negative regulatory pathways
regulatory pathways are
pathways are involved
are involved in
involved in c-myc
in c-myc regulation:
c-myc regulation: one
regulation: one which
one which is
which is independent
is independent and
independent and one
and one which
one which depends
which depends on
depends on de
on de novo
de novo protein
novo protein synthesis
The latter one
latter one appears
one appears to
appears to be
to be mediated
be mediated by
mediated by a
by a rapidly
a rapidly calcium-dependent
rapidly calcium-dependent induced
calcium-dependent induced gene
induced gene product
Oestrogen receptor ER
receptor ER analysis
ER analysis in
analysis in B-cell
in B-cell chronic
B-cell chronic lymphocytic
chronic lymphocytic leukemia:
lymphocytic leukemia: correlation
leukemia: correlation of
correlation of biochemical
of biochemical and
biochemical and immunocytochemical
and immunocytochemical methods
Oestrogen receptors ER
receptors ER are
ER are present
are present in
present in neoplastic
in neoplastic lymphoid
neoplastic lymphoid cells
lymphoid cells and
cells and have
and have been
have been considered
been considered a
considered a physiological
a physiological marker
physiological marker of
marker of growth
of growth rate
growth rate or
rate or differentiation
Tamoxifen an oestrogen
an oestrogen antagonist
oestrogen antagonist has
antagonist has been
has been given
been given in
given in some
in some patients
some patients with
patients with CLL
with CLL and
CLL and Hodgkin's
and Hodgkin's disease
Hodgkin's disease with
disease with dramatic
with dramatic response
dramatic response in
response in single
in single cases
Until now ER
now ER status
ER status has
status has been
has been assessed
been assessed using
assessed using a
using a steroid
a steroid binding
steroid binding assay
binding assay SBA
assay SBA which
SBA which has
which has many
has many inherent
many inherent problems
Recently the development
the development of
development of monoclonal
of monoclonal antibodies
monoclonal antibodies directed
antibodies directed against
directed against ER
against ER has
ER has been
has been applied
been applied to
applied to the
to the study
the study of
study of breast
of breast carcinomas
breast carcinomas and
carcinomas and results
and results obtained
results obtained show
obtained show good
show good correlation
good correlation with
correlation with the
with the quantitative
the quantitative SBA
We studied 49
studied 49 cases
49 cases of
cases of B-cell
of B-cell chronic
B-cell chronic lymphocytic
chronic lymphocytic leukemia
lymphocytic leukemia CLL
leukemia CLL using
CLL using immunostaining
using immunostaining of
immunostaining of cytospin
of cytospin preparations
In 30 of
30 of these
of these cases
these cases ER
cases ER enzyme
ER enzyme immunoassay
enzyme immunoassay ER-EIA
immunoassay ER-EIA was
ER-EIA was also
was also performed
Cultured MCF-7 cells
MCF-7 cells derived
cells derived from
derived from a
from a pleural
a pleural effusion
pleural effusion of
effusion of a
of a breast
a breast cancer
breast cancer patient
cancer patient known
patient known to
known to contain
to contain high
contain high levels
high levels of
levels of ER
of ER were
ER were used
were used as
used as a
as a positive
a positive control
positive control 40-48%
control 40-48% ER
40-48% ER positive
ER positive cells
positive cells by
cells by immunocytochemistry;
by immunocytochemistry; 200
immunocytochemistry; 200 fmol/mg
200 fmol/mg protein
fmol/mg protein by
protein by EIA
All of the
of the CLL
the CLL cases
CLL cases except
cases except two
except two 96%
two 96% were
96% were negative
were negative for
negative for ER
for ER less
ER less than
less than 1%
than 1% staining;
1% staining; less
staining; less than
less than 4
than 4 fmol/mg
4 fmol/mg protein
The two positive
two positive cases
positive cases expressed
cases expressed granular
expressed granular ER
granular ER staining
ER staining over
staining over the
over the nucleus
the nucleus 92
nucleus 92 and
92 and 121%
and 121% positive
121% positive cells
positive cells and
cells and were
and were positive
were positive by
positive by EIA
by EIA and
EIA and SBA
It is concluded
is concluded that
concluded that i
that i patients
i patients with
patients with CLL
with CLL rarely
CLL rarely express
rarely express ER
express ER and
ER and ii
and ii immunocytochemical
ii immunocytochemical staining
immunocytochemical staining of
staining of cytospin
of cytospin preparations
cytospin preparations is
preparations is a
is a valid
a valid technique
valid technique for
technique for the
for the measurement
the measurement of
measurement of ER
It is of
is of interest
of interest that
interest that one
that one of
one of the
of the positive
the positive cases
positive cases was
cases was diagnosed
was diagnosed as
diagnosed as CLL
as CLL with
CLL with Richter's
with Richter's transformation
Richter's transformation confirming
transformation confirming earlier
confirming earlier findings
Type-II estrogen binding
estrogen binding sites
binding sites in
sites in a
in a lymphoblastoid
a lymphoblastoid cell
lymphoblastoid cell line
cell line and
line and growth-inhibitory
and growth-inhibitory effect
growth-inhibitory effect of
effect of estrogen
of estrogen anti-estrogen
estrogen anti-estrogen and
anti-estrogen and bioflavonoids
Type-II estrogen-binding sites
estrogen-binding sites type-II
sites type-II EBS
type-II EBS have
EBS have been
have been demonstrated
been demonstrated in
demonstrated in the
in the human
the human lymphoblastoid
human lymphoblastoid cell
lymphoblastoid cell line
cell line IM-9
line IM-9 using
IM-9 using a
using a whole-cell
a whole-cell assay
whole-cell assay with
assay with 67-3H
with 67-3H estradiol
67-3H estradiol 3H-E2
estradiol 3H-E2 as
3H-E2 as tracer
Competition analysis showed
analysis showed that
showed that the
that the anti-estrogen
the anti-estrogen tamoxifen
anti-estrogen tamoxifen and
tamoxifen and the
and the flavonoids
the flavonoids quercetin
flavonoids quercetin and
quercetin and rutin
and rutin competed
rutin competed for
competed for 3H-E2
for 3H-E2 binding
3H-E2 binding to
binding to type-II
to type-II EBS
Growth experiments demonstrated
experiments demonstrated that
demonstrated that diethylstilbestrol
that diethylstilbestrol DES
diethylstilbestrol DES tamoxifen
DES tamoxifen TAM
tamoxifen TAM quercetin
TAM quercetin and
quercetin and rutin
and rutin exerted
rutin exerted a
exerted a reversible
a reversible dose-dependent
reversible dose-dependent inhibition
dose-dependent inhibition of
inhibition of cell
of cell proliferation
cell proliferation in
proliferation in the
in the range
the range of
range of concentrations
of concentrations between
concentrations between 10
between 10 nM
10 nM and
nM and 10
and 10 microM
The relative binding
relative binding affinity
binding affinity of
affinity of quercetin
of quercetin rutin
quercetin rutin DES
rutin DES and
DES and TAM
and TAM for
TAM for type-II
for type-II EBS
type-II EBS correlated
EBS correlated well
correlated well with
well with their
with their potency
their potency as
potency as cell
as cell growth
cell growth inhibitors
Moreover hesperidin a
hesperidin a flavonoid
a flavonoid which
flavonoid which does
which does not
does not bind
not bind to
bind to type-II
to type-II EBS
type-II EBS was
EBS was ineffective
was ineffective in
ineffective in inhibiting
in inhibiting cell
inhibiting cell growth
Cell-cycle analysis showed
analysis showed that
showed that the
that the growth-inhibitory
the growth-inhibitory effect
growth-inhibitory effect of
effect of DES
of DES TAM
DES TAM or
TAM or quercetin
or quercetin was
quercetin was due
was due to
due to a
to a blocking
a blocking effect
blocking effect in
effect in the
in the G0-G1
the G0-G1 phases
Our results suggest
results suggest that
suggest that high
that high estrogen
high estrogen and
estrogen and anti-estrogen
and anti-estrogen concentrations
anti-estrogen concentrations and
concentrations and flavonoids
and flavonoids may
flavonoids may regulate
may regulate IM-9
regulate IM-9 cell
IM-9 cell growth
cell growth through
growth through a
through a common
a common mechanism
common mechanism involving
mechanism involving a
involving a binding
a binding interaction
binding interaction with
interaction with type-II
with type-II EBS
[Glucocorticoid receptors in
receptors in peripheral
in peripheral blood
peripheral blood lymphocytes
blood lymphocytes of
lymphocytes of patients
of patients with
patients with bronchial
with bronchial asthma]
Quantitation of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors GCR
receptors GCR and
GCR and the
and the study
the study of
study of their
of their affinity
their affinity for
affinity for glucocorticosteroids
for glucocorticosteroids GCS
glucocorticosteroids GCS were
GCS were made
were made in
made in peripheral
in peripheral blood
peripheral blood lymphocytes
blood lymphocytes of
lymphocytes of bronchial
of bronchial asthma
bronchial asthma BA
asthma BA patients
BA patients in
patients in consideration
in consideration of
consideration of GCR
of GCR treatment
GCR treatment and
treatment and serum
and serum levels
serum levels of
levels of endogenous
of endogenous cortisol
It is stated
is stated that
stated that GCR
that GCR of
GCR of healthy
of healthy controls
healthy controls and
controls and GCS-untreated
and GCS-untreated patients
GCS-untreated patients outnumbered
patients outnumbered those
outnumbered those of
those of cortisol-dependent
of cortisol-dependent BA
cortisol-dependent BA patients
BA patients on
patients on hormone
on hormone therapy
Following discontinuation of
discontinuation of glucocorticoid
of glucocorticoid drugs
glucocorticoid drugs GCR
drugs GCR count
GCR count in
count in cortisol-dependent
in cortisol-dependent BA
cortisol-dependent BA tends
BA tends to
tends to rise
Endogenous cortisol has
cortisol has no
has no effect
no effect on
effect on GCR
on GCR level
GCR level estimated
level estimated by
estimated by 3H-triamcinolone
by 3H-triamcinolone acetonide
Two glucocorticoid binding
glucocorticoid binding sites
binding sites on
sites on the
on the human
the human glucocorticoid
human glucocorticoid receptor
Glucocorticoids are known
are known to
known to have
to have a
have a lytic
a lytic effect
lytic effect in
effect in leukemic
in leukemic cells
leukemic cells via
cells via interactions
via interactions with
interactions with the
with the glucocorticoid
the glucocorticoid receptor
glucocorticoid receptor GR
Cortisol and various
and various synthetic
various synthetic glucocorticoids
synthetic glucocorticoids bind
glucocorticoids bind to
bind to the
to the GR
the GR with
GR with one-site
with one-site kinetics
Cortivazol CVZ is
CVZ is a
is a unique
a unique high
unique high potency
high potency synthetic
potency synthetic glucocorticoid
synthetic glucocorticoid which
glucocorticoid which has
which has a
has a phenylpyrazol
a phenylpyrazol fused
phenylpyrazol fused to
fused to the
to the A-ring
the A-ring of
A-ring of the
of the steroid
the steroid nucleus
steroid nucleus and
nucleus and displays
and displays binding
displays binding consistent
binding consistent with
consistent with two
with two or
two or more
or more sites
more sites in
sites in the
in the cytosol
the cytosol from
cytosol from CEM
from CEM C7
CEM C7 cells
C7 cells a
cells a human
a human acute
human acute lymphoblastic
acute lymphoblastic T-cell
lymphoblastic T-cell line
It has previously
has previously been
previously been shown
been shown that
shown that the
that the lower
the lower affinity
lower affinity class
affinity class of
class of sites
of sites are
sites are similar
are similar in
similar in affinity
in affinity and
affinity and site
and site molarity
site molarity to
molarity to those
to those recognized
those recognized by
recognized by dexamethasone
The higher affinity
higher affinity sites
affinity sites bind
sites bind CVZ
bind CVZ with
CVZ with 20-
with 20- to
20- to 50-fold
to 50-fold greater
50-fold greater affinity
greater affinity consistent
affinity consistent with
consistent with CVZ's
with CVZ's enhanced
CVZ's enhanced biological
enhanced biological effects
In mutant leukemic
mutant leukemic cells
leukemic cells resistant
cells resistant to
resistant to the
to the lytic
the lytic effects
lytic effects of
effects of dexamethasone
of dexamethasone CVZ
dexamethasone CVZ both
CVZ both lyses
both lyses the
lyses the cells
the cells and
cells and recognizes
and recognizes a
recognizes a single
a single class
single class of
class of sites
of sites similar
sites similar to
similar to the
to the high
the high affinity
high affinity site
affinity site in
site in CEM
in CEM C7
CEM C7 cells
We have carried
have carried out
carried out experiments
out experiments to
experiments to define
to define the
define the nature
the nature of
nature of the
of the higher
the higher affinity
higher affinity CVZ
affinity CVZ binding
CVZ binding site
We now show
now show that:
show that: 1
that: 1 CVZ
1 CVZ has
CVZ has more
has more than
more than one
than one binding
one binding site
binding site in
site in a
in a second
a second independent
second independent B-cell
independent B-cell line
B-cell line IM-9;
line IM-9; 2
IM-9; 2 the
2 the antiglucocorticoid
the antiglucocorticoid RU
antiglucocorticoid RU 38486
RU 38486 is
38486 is able
is able to
able to block
to block both
block both CVZ's
both CVZ's higher
CVZ's higher and
higher and lower
and lower affinity
lower affinity sites;
affinity sites; 3
sites; 3 all
3 all of
all of CVZ's
of CVZ's binding
CVZ's binding sites
binding sites are
sites are on
are on a
on a protein
a protein immunologically
protein immunologically indistinguishable
immunologically indistinguishable from
indistinguishable from the
from the human
the human GR;
human GR; and
GR; and 4
and 4 freshly
4 freshly isolated
freshly isolated clones
isolated clones of
clones of CVZ-resistant
of CVZ-resistant cells
CVZ-resistant cells have
cells have lost
have lost all
lost all binding
all binding sites
binding sites for
sites for CVZ
These data indicate
data indicate that
indicate that CVZ
that CVZ is
CVZ is recognizing
is recognizing two
recognizing two glucocorticoid
two glucocorticoid binding
glucocorticoid binding sites
binding sites on
sites on the
on the human
the human GR
human GR or
GR or a
or a protein
a protein very
protein very similar
very similar to
similar to it
Retroviral mediated transfer
mediated transfer and
transfer and expression
and expression of
expression of exogenous
of exogenous genes
exogenous genes in
genes in primary
in primary lymphoid
primary lymphoid cells:
lymphoid cells: assaying
cells: assaying for
assaying for a
for a viral
a viral transactivator
viral transactivator activity
transactivator activity in
activity in normal
in normal and
normal and malignant
and malignant cells
In this report
this report we
report we describe
we describe the
describe the use
the use of
use of recombinant
of recombinant retroviruses
recombinant retroviruses to
retroviruses to characterize
to characterize the
characterize the activity
the activity of
activity of an
of an exogenous
an exogenous promoter
exogenous promoter in
promoter in primary
in primary cells
primary cells obtained
cells obtained from
obtained from patients
from patients with
patients with lymphoproliferative
with lymphoproliferative disorders
The infection of
infection of a
of a variety
a variety of
variety of cultured
of cultured and
cultured and primary
and primary lymphoid
primary lymphoid cells
lymphoid cells with
cells with a
with a recombinant
a recombinant retrovirus
recombinant retrovirus containing
retrovirus containing a
containing a histone
a histone promoter-driven
histone promoter-driven beta-galactosidase
promoter-driven beta-galactosidase gene
beta-galactosidase gene is
gene is shown
is shown to
shown to result
to result in
result in the
in the expression
the expression of
expression of beta-galactosidase
of beta-galactosidase in
beta-galactosidase in 50%
in 50% to
50% to 100%
to 100% of
100% of the
of the cells
A similar infection
similar infection with
infection with a
with a recombinant
a recombinant retrovirus
recombinant retrovirus containing
retrovirus containing the
containing the beta-galactosidase
the beta-galactosidase gene
beta-galactosidase gene with
gene with an
with an adenovirus
an adenovirus E2
adenovirus E2 promoter
E2 promoter results
promoter results in
results in beta-galactosidase
in beta-galactosidase activity
beta-galactosidase activity in
activity in a
in a limited
a limited number
limited number of
number of cultured
of cultured and
cultured and primary
and primary cells
Since the adenovirus
the adenovirus E2
adenovirus E2 promoter
E2 promoter has
promoter has been
has been well
been well characterized
well characterized and
characterized and is
and is known
is known to
known to be
to be regulated
be regulated by
regulated by transactivators
by transactivators encoded
transactivators encoded by
encoded by many
by many viruses
many viruses the
viruses the activity
the activity of
activity of this
of this promoter
this promoter in
promoter in specific
in specific cell
specific cell types
cell types is
types is discussed
is discussed in
discussed in reference
in reference to
reference to both
to both the
both the biology
the biology of
biology of the
of the cell
the cell and
cell and the
and the possible
the possible presence
possible presence of
presence of as
of as yet
as yet undetected
yet undetected viral
undetected viral gene
viral gene products
[The effect of
effect of 2425-dihydroxyvitamin
of 2425-dihydroxyvitamin D3
2425-dihydroxyvitamin D3 dioxyvit
D3 dioxyvit on
dioxyvit on Ca
on Ca metabolism
Ca metabolism and
metabolism and immune
and immune status
immune status during
status during chronic
during chronic kidney
chronic kidney failure]
Active metabolite of
metabolite of vitamin
of vitamin D3
vitamin D3 24R25
D3 24R25 OH2D3
24R25 OH2D3 dioxyvit
OH2D3 dioxyvit was
dioxyvit was used
was used at
used at a
at a daily
a daily dose
daily dose of
dose of 100
of 100 micrograms
100 micrograms in
micrograms in treatment
in treatment of
treatment of children
of children affected
children affected with
affected with tubulointerstitial
with tubulointerstitial disease
tubulointerstitial disease of
disease of kidney
of kidney and
kidney and with
and with chronic
with chronic glomerulonephritis
chronic glomerulonephritis under
glomerulonephritis under conditions
under conditions of
conditions of kidney
of kidney insufficiency
The drug exhibited
drug exhibited distinct
exhibited distinct normalizing
distinct normalizing effect
normalizing effect on
effect on patterns
on patterns of
patterns of calcium
of calcium metabolism:
calcium metabolism: increase
metabolism: increase of
increase of total
of total and
total and ionized
and ionized Ca2+
ionized Ca2+ and
Ca2+ and of
and of 25-OHD
of 25-OHD decrease
25-OHD decrease in
decrease in concentration
in concentration of
concentration of parath
of parath hormone
parath hormone and
hormone and osteocalcine
and osteocalcine in
osteocalcine in blood
in blood serum
blood serum as
serum as well
as well as
well as on
as on immunological
on immunological parameters:
immunological parameters: restoration
parameters: restoration of
restoration of decreased
of decreased content
decreased content of
content of T-
of T- and
T- and 0-lymphocytes
Concentration of receptors
of receptors of
receptors of hormonal
of hormonal form
hormonal form of
form of 125OH2D3
of 125OH2D3 was
125OH2D3 was found
was found to
found to be
to be minimal
be minimal in
minimal in lymphocytes
in lymphocytes under
lymphocytes under conditions
under conditions of
conditions of chronic
of chronic kidney
chronic kidney insufficiency
kidney insufficiency while
insufficiency while their
while their expression
their expression after
expression after the
after the dioxyvit
the dioxyvit action
dioxyvit action was
action was detected
was detected only
detected only in
only in patients
in patients with
patients with glomerulonephritis
Specific calcitropic effect
calcitropic effect of
effect of dioxyvit
of dioxyvit with
dioxyvit with simultaneous
with simultaneous correction
simultaneous correction of
correction of vitamin
of vitamin D
vitamin D deficiency
D deficiency were
deficiency were apparently
were apparently responsible
apparently responsible for
responsible for high
for high efficacy
high efficacy of
efficacy of the
of the drug
the drug in
drug in treatment
in treatment of
treatment of calcium
of calcium metabolism
calcium metabolism and
metabolism and immunity
and immunity impairments
immunity impairments in
impairments in children
in children with
children with renal
with renal deteriorations
renal deteriorations at
deteriorations at the
at the step
the step of
step of chronic
of chronic kidney
chronic kidney insufficiency
[The role of
role of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors and
receptors and HLA
and HLA antigens
HLA antigens in
antigens in the
in the pathogenesis
the pathogenesis of
pathogenesis of Cushing's
of Cushing's syndrome]
Lymphocytic levels of
levels of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors were
receptors were evaluated
were evaluated in
evaluated in 114
in 114 patients
114 patients suffering
patients suffering from
suffering from Icenko-Cushing's
from Icenko-Cushing's syndrome
Incidence of HLA
of HLA antigens
HLA antigens was
antigens was determined
was determined in
determined in 94
in 94 of
94 of them
A significant rise
significant rise of
rise of A10
of A10 and
A10 and B27
and B27 antigen
B27 antigen incidence
antigen incidence compared
incidence compared to
compared to that
to that in
that in normal
in normal subjects
normal subjects allows
subjects allows these
allows these antigens
these antigens to
antigens to be
to be considered
be considered genetic
considered genetic markers
genetic markers of
markers of Icenko-Cushing's
of Icenko-Cushing's syndrome
The levels of
levels of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in lymphocytes
in lymphocytes of
lymphocytes of the
of the patients
the patients are
patients are lower
are lower than
lower than in
than in normal
in normal subjects
normal subjects both
subjects both in
both in the
in the active
the active stage
active stage of
stage of the
of the disease
the disease and
disease and following
and following bilateral
following bilateral total
bilateral total adrenalectomy
The patients carrying
patients carrying B27
carrying B27 antigen
B27 antigen had
antigen had lymphocytic
had lymphocytic receptor
lymphocytic receptor concentrations
receptor concentrations under
concentrations under the
under the levels
the levels of
levels of such
of such in
such in patients
in patients free
patients free of
free of the
of the antigen
the antigen carriage
Antigen B27 seems
B27 seems to
seems to be
to be a
be a cause
a cause of
cause of lower
of lower levels
lower levels of
levels of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in blood
in blood lymphocytes
Effects of 1
of 1 alpha
1 alpha 25-dihydroxyvitamin
alpha 25-dihydroxyvitamin D3
25-dihydroxyvitamin D3 on
D3 on the
on the human
the human chronic
human chronic myelogenous
chronic myelogenous leukemia
myelogenous leukemia cell
leukemia cell line
cell line RWLeu-4
The effects of
effects of 1
of 1 alpha
1 alpha 25-dihydroxyvitamin
alpha 25-dihydroxyvitamin D3
25-dihydroxyvitamin D3 VD3
D3 VD3 on
VD3 on proliferation
on proliferation differentiation
proliferation differentiation and
differentiation and macromolecular
and macromolecular synthesis
macromolecular synthesis in
synthesis in the
in the new
the new Philadelphia
new Philadelphia chromosome-positive
Philadelphia chromosome-positive chronic
chromosome-positive chronic myelogenous
chronic myelogenous leukemia
myelogenous leukemia cell
leukemia cell line
cell line RWLeu-4
line RWLeu-4 were
RWLeu-4 were investigated
Binding of [3H]VD3
of [3H]VD3 was
[3H]VD3 was saturable
was saturable with
saturable with approximately
with approximately 2000-3000
approximately 2000-3000 sites/cell
2000-3000 sites/cell and
sites/cell and half-maximal
and half-maximal binding
half-maximal binding occurring
binding occurring at
occurring at 021-033
at 021-033 nM
Treatment of RWLeu-4
of RWLeu-4 cells
RWLeu-4 cells with
cells with VD3
with VD3 induced
VD3 induced 24R-hydroxylase
induced 24R-hydroxylase activity
24R-hydroxylase activity a
activity a marker
a marker of
marker of vitamin
of vitamin D3
vitamin D3 responsiveness
D3 responsiveness in
responsiveness in many
in many tissues
Exposure of RWLeu-4
of RWLeu-4 cells
RWLeu-4 cells to
cells to VD3
to VD3 also
VD3 also inhibited
also inhibited proliferation
inhibited proliferation and
proliferation and DNA
and DNA synthesis
DNA synthesis with
synthesis with a
with a 50%
a 50% effective
50% effective dose
effective dose of
dose of 35-10
of 35-10 nM
35-10 nM within
nM within 72
within 72 h;
72 h; in
h; in addition
in addition protein
addition protein and
protein and RNA
and RNA synthesis
RNA synthesis were
synthesis were inhibited
were inhibited by
inhibited by VD3
by VD3 treatment
Exposure of RWLeu-4
of RWLeu-4 cells
RWLeu-4 cells to
cells to 5
to 5 nM
5 nM VD3
nM VD3 for
VD3 for 72
for 72 h
72 h caused
h caused 50%
caused 50% of
50% of the
of the cells
the cells to
cells to differentiate
to differentiate into
differentiate into macrophage/monocyte
into macrophage/monocyte type
macrophage/monocyte type cells
type cells as
cells as judged
as judged by
judged by nitroblue
by nitroblue tetrazolium
nitroblue tetrazolium staining
tetrazolium staining and
staining and adherence
and adherence to
adherence to plastic
Progressive expression of
expression of cell
of cell surface
cell surface maturation-specific
surface maturation-specific antigens
maturation-specific antigens of
antigens of the
of the monocyte/macrophage
the monocyte/macrophage lineage
monocyte/macrophage lineage was
lineage was induced
was induced by
induced by treatment
by treatment of
treatment of RWLeu-4
of RWLeu-4 cells
RWLeu-4 cells with
cells with VD3
with VD3 for
VD3 for 24
for 24 to
24 to 72
to 72 h
72 h at
h at doses
at doses that
doses that inhibited
that inhibited cellular
inhibited cellular proliferation
c-myc RNA which
RNA which is
which is constitutively
is constitutively expressed
constitutively expressed in
expressed in RWLeu-4
in RWLeu-4 cells
RWLeu-4 cells increased
cells increased after
increased after 05
after 05 h
05 h of
h of treatment
of treatment with
treatment with 50
with 50 nM
50 nM VD3
nM VD3 and
VD3 and then
and then rapidly
then rapidly decreased
rapidly decreased to
decreased to barely
to barely detectable
barely detectable levels
detectable levels after
levels after 4
after 4 h
4 h of
h of treatment
Finally the in
the in vitro
in vitro tyrosine
vitro tyrosine kinase
tyrosine kinase activity
kinase activity associated
activity associated with
associated with the
with the p210bcr-abl
the p210bcr-abl oncogene
p210bcr-abl oncogene product
oncogene product was
product was decreased
was decreased approximately
decreased approximately 50%
approximately 50% by
50% by VD3
by VD3 treatment
Because of the
of the presence
the presence of
presence of a
of a functional
a functional receptor-effector
functional receptor-effector system
receptor-effector system for
system for VD3
for VD3 and
VD3 and multiple
and multiple biological
multiple biological responses
biological responses to
responses to the
to the hormone
the hormone these
hormone these cells
these cells provide
cells provide a
provide a unique
a unique model
unique model system
model system with
system with which
with which to
which to probe
to probe the
probe the specific
the specific effects
specific effects of
effects of VD3
of VD3 on
VD3 on cell
on cell growth
cell growth and
growth and differentiation
and differentiation in
differentiation in chronic
in chronic myelogenous
chronic myelogenous leukemia
A new member
new member of
member of the
of the leucine
the leucine zipper
leucine zipper class
zipper class of
class of proteins
of proteins that
proteins that binds
that binds to
binds to the
to the HLA
the HLA DR
HLA DR alpha
DR alpha promoter
Several mutants derived
mutants derived from
derived from transformed
from transformed human
transformed human B
human B cell
B cell lines
cell lines are
lines are defective
are defective in
defective in expressing
in expressing major
expressing major histocompatibility
major histocompatibility complex
histocompatibility complex MHC
complex MHC class
MHC class II
class II genes
The failure to
failure to express
to express a
express a class
a class II
class II gene
II gene in
gene in at
in at least
at least one
least one such
one such mutant
such mutant line
mutant line has
line has been
has been mapped
been mapped to
mapped to the
to the MHC
the MHC class
MHC class II
class II X
II X box
X box a
box a conserved
a conserved transcriptional
conserved transcriptional element
transcriptional element in
element in the
in the promoter
the promoter region
A complementary DNA
complementary DNA encoding
DNA encoding a
encoding a DNA-binding
a DNA-binding protein
DNA-binding protein human
protein human X
human X box
X box binding
box binding protein
binding protein hXBP-1
protein hXBP-1 whose
hXBP-1 whose target
whose target is
target is the
is the human
the human DR
human DR alpha
DR alpha X
alpha X box
X box and
box and the
and the 3'
the 3' flanking
3' flanking region
flanking region has
region has now
has now been
now been cloned
This complementary DNA
complementary DNA encoded
DNA encoded a
encoded a protein
a protein with
protein with structural
with structural similarities
structural similarities to
similarities to the
to the c-jun
the c-jun proto-oncogene
c-jun proto-oncogene product
proto-oncogene product and
product and its
and its target
its target sequence
target sequence was
sequence was closely
was closely related
closely related to
related to the
to the palindromic
the palindromic target
palindromic target sequence
target sequence of
sequence of c-jun
Mutation of the
of the hXBP-1
the hXBP-1 DNA
hXBP-1 DNA target
DNA target sequence
target sequence decreased
sequence decreased DR
decreased DR alpha
DR alpha promoter
alpha promoter activity
promoter activity in
activity in vivo
These studies suggest
studies suggest that
suggest that the
that the hXBP-1
the hXBP-1 protein
hXBP-1 protein acts
protein acts as
acts as a
as a transcription
a transcription factor
transcription factor in
factor in B
in B cells
Pseudohypoaldosteronism in eight
in eight families:
eight families: different
families: different forms
different forms of
forms of inheritance
of inheritance are
inheritance are evidence
are evidence for
evidence for various
for various genetic
various genetic defects
Pseudohypoaldosteronism is a
is a rare
a rare hereditary
rare hereditary disorder
hereditary disorder presenting
disorder presenting in
presenting in early
in early infancy
early infancy with
infancy with renal
with renal salt
renal salt loss
salt loss leading
loss leading to
leading to hyponatremia
to hyponatremia and
hyponatremia and hyperkalemia
and hyperkalemia despite
hyperkalemia despite high
despite high levels
high levels of
levels of plasma
of plasma aldosterone
The patients are
patients are insensitive
are insensitive to
insensitive to mineralocorticoids;
to mineralocorticoids; however
mineralocorticoids; however sodium
however sodium supplementation
sodium supplementation is
supplementation is able
is able to
able to correct
to correct electrolyte
correct electrolyte abnormalities
Absent or greatly
or greatly diminished
greatly diminished type
diminished type I
type I aldosterone
I aldosterone receptors
aldosterone receptors in
receptors in peripheral
in peripheral mononuclear
peripheral mononuclear leucocytes
mononuclear leucocytes have
leucocytes have been
have been recently
been recently demonstrated
recently demonstrated and
demonstrated and explain
and explain the
explain the lack
the lack of
lack of response
of response to
response to mineralocorticoids
We have studied
have studied the
studied the mode
the mode of
mode of inheritance
of inheritance in
inheritance in eight
in eight families
eight families with
families with a
with a total
a total of
total of nine
of nine patients
There was evidence
was evidence for
evidence for an
for an autosomal
an autosomal recessive
autosomal recessive form
recessive form of
form of inheritance
of inheritance in
inheritance in four
in four families
four families while
families while the
while the other
the other four
other four families
four families appeared
families appeared to
appeared to have
to have an
have an autosomal
an autosomal dominant
autosomal dominant mode
dominant mode of
mode of transmission
In three families
three families the
families the autosomal
the autosomal recessive
autosomal recessive form
recessive form was
form was characterized
was characterized by
characterized by normal
by normal receptor
normal receptor as
receptor as well
as well as
well as hormone
as hormone data
hormone data in
data in both
in both parents
both parents while
parents while in
while in one
in one family
one family receptor
family receptor levels
receptor levels in
levels in both
in both parents
both parents were
parents were greatly
were greatly reduced
greatly reduced but
reduced but hormone
but hormone levels
hormone levels were
levels were normal
In the four
the four families
four families with
families with an
with an autosomal
an autosomal dominant
autosomal dominant mode
dominant mode of
mode of transmission
of transmission there
transmission there was
there was always
was always one
always one parent
one parent with
parent with reduced
with reduced receptor
reduced receptor binding
receptor binding in
binding in peripheral
in peripheral mononuclear
peripheral mononuclear leucocytes
mononuclear leucocytes and
leucocytes and elevated
and elevated serum
elevated serum hormone
serum hormone levels
These parents were
parents were entirely
were entirely asymptomatic
In an extended
an extended family
extended family we
family we were
we were able
were able to
able to study
to study an
study an aunt
an aunt and
aunt and her
and her newborn
her newborn daughter
newborn daughter who
daughter who were
who were both
were both also
both also biochemically
also biochemically affected
biochemically affected but
affected but clinically
but clinically asymptomatic
It therefore appears
therefore appears that
appears that this
that this dual
this dual pattern
dual pattern of
pattern of genetic
of genetic transmission
genetic transmission may
transmission may indicate
may indicate differing
indicate differing genetic
differing genetic defects
genetic defects which
defects which cause
which cause the
cause the same
the same clinical
same clinical picture
clinical picture of
picture of pseudohypoaldosteronism
Perceived social support
social support and
support and tumor
and tumor estrogen/progesterone
tumor estrogen/progesterone receptor
estrogen/progesterone receptor status
receptor status as
status as predictors
as predictors of
predictors of natural
of natural killer
natural killer cell
killer cell activity
cell activity in
activity in breast
in breast cancer
breast cancer patients
This report is
report is concerned
is concerned with
concerned with the
with the prediction
the prediction of
prediction of natural
of natural killer
natural killer NK
killer NK cell
NK cell activity
cell activity in
activity in 61
in 61 Stage
61 Stage I
Stage I and
I and II
and II breast
II breast cancer
breast cancer patients
cancer patients between
patients between the
between the ages
the ages of
ages of 25
of 25 and
25 and 70
and 70 who
70 who were
who were accrued
were accrued to
accrued to this
to this project
All baseline interview
baseline interview and
interview and testing
and testing data
testing data were
data were obtained
were obtained either
obtained either just
either just before
just before patients
before patients were
patients were discharged
were discharged from
discharged from the
from the hospital
the hospital or
hospital or at
or at their
at their first
their first outpatient
first outpatient visit
outpatient visit within
visit within two
within two weeks
two weeks of
weeks of discharge
A major interest
major interest of
interest of this
of this project
this project is
project is the
is the predictive
the predictive value
predictive value of
value of perceived
of perceived social
perceived social support
social support as
support as a
as a potential
a potential "stress"
potential "stress" buffer
"stress" buffer related
buffer related to
related to NK
to NK activity
In the main
the main model
main model reported
model reported here
reported here we
here we found
we found that
found that a
that a significant
a significant amount
significant amount of
amount of NK
of NK activity
NK activity variance
activity variance could
variance could be
could be explained
be explained by
explained by five
by five variables
Higher NK activity
NK activity could
activity could be
could be predicted
be predicted by
predicted by the
by the perception
the perception of
perception of high
of high quality
high quality emotional
quality emotional support
emotional support from
support from a
from a spouse
a spouse or
spouse or intimate
or intimate other
intimate other perceived
other perceived social
perceived social support
social support from
support from the
from the patient's
the patient's physician
patient's physician estrogen
physician estrogen receptor-negative
estrogen receptor-negative tumor
receptor-negative tumor status
tumor status having
status having an
having an excisional
an excisional biopsy
excisional biopsy as
biopsy as surgical
as surgical treatment
surgical treatment and
treatment and actively
and actively seeking
actively seeking social
seeking social support
social support as
support as a
as a major
a major coping
major coping strategy
coping strategy R2
strategy R2 =
R2 = 033
= 033 F555
033 F555 =
F555 = 55
= 55 p
55 p less
p less than
less than 00004
Findings are discussed
are discussed in
discussed in terms
in terms of
terms of host
of host interaction
host interaction with
interaction with tumor
with tumor endocrine
tumor endocrine status
endocrine status and
status and the
and the role
the role that
role that social
that social support
social support might
support might play
might play in
play in modulating
in modulating such
modulating such activity
[Estrogen receptor content
receptor content of
content of peripheral
of peripheral blood
peripheral blood lymphocytes
blood lymphocytes in
lymphocytes in patients
in patients with
patients with systemic
with systemic lupus
systemic lupus erythematosus]
ER content in
content in lymphocytes
in lymphocytes of
lymphocytes of peripheral
of peripheral blood
peripheral blood from
blood from 27
from 27 SLE
27 SLE patients
SLE patients and
patients and 20
and 20 healthy
20 healthy controls
healthy controls were
controls were determined
were determined by
determined by dextran-coated
by dextran-coated charcoal
dextran-coated charcoal assay
ER content in
content in lymphocytes
in lymphocytes of
lymphocytes of each
of each sample
each sample was
sample was expressed
was expressed by
expressed by both
by both fmol/mg
both fmol/mg of
fmol/mg of lymphocyte
of lymphocyte cytosolic
lymphocyte cytosolic protein
cytosolic protein and
protein and fmol/micrograms
and fmol/micrograms of
fmol/micrograms of lymphocyte
of lymphocyte DNA
The results showed
results showed that
showed that there
that there was
there was no
was no significant
no significant difference
significant difference between
difference between the
between the ER
the ER content
ER content of
content of lymphocytes
of lymphocytes from
lymphocytes from the
from the controls
the controls and
controls and that
and that from
that from patients
from patients with
patients with SLE
But the logarithmic
the logarithmic mean
logarithmic mean of
mean of ER
of ER content
ER content in
content in lymphocytes
in lymphocytes expressed
lymphocytes expressed by
expressed by fmol/mg
by fmol/mg of
fmol/mg of cytosolic
of cytosolic protein
cytosolic protein in
protein in 14
in 14 patients
14 patients with
patients with active
with active SLE
active SLE 09356
SLE 09356 +/-
09356 +/- 031
+/- 031 was
031 was significantly
was significantly higher
significantly higher than
higher than that
than that in
that in 13
in 13 patients
13 patients with
patients with inactive
with inactive SLE
inactive SLE 02979
SLE 02979 +/-
02979 +/- 023
+/- 023 P
023 P less
P less than
less than 0001
than 0001 and
0001 and in
and in the
in the controls
the controls 06204
controls 06204 +/-
06204 +/- 052
+/- 052 P
052 P less
P less than
less than 0001
The normal upper
normal upper limit
upper limit of
limit of ER
of ER content
ER content in
content in lymphocytes
in lymphocytes expressed
lymphocytes expressed by
expressed by fmol/micrograms
by fmol/micrograms of
fmol/micrograms of DNA
of DNA was
DNA was 0136
The elevated rate
elevated rate of
rate of ER
of ER content
ER content in
content in lymphocytes
in lymphocytes in
lymphocytes in 14
in 14 active
14 active SLE
active SLE 929%
SLE 929% was
929% was also
was also higher
also higher than
higher than that
than that in
that in quieiescent
in quieiescent patients
quieiescent patients 231%
patients 231% P
231% P less
P less than
less than 0001
than 0001 and
0001 and in
and in the
in the controls
the controls 10%
controls 10% P
10% P less
P less than
less than 0001
Moreover the elevated
the elevated level
elevated level of
level of ER
of ER content
ER content was
content was found
was found to
found to be
to be related
be related to
related to the
to the positive
the positive antidsDNA
positive antidsDNA antibody
antidsDNA antibody and
antibody and hypocomplementemia
An in vitro
in vitro globin
vitro globin gene
globin gene switching
gene switching model
switching model based
model based on
based on differentiated
on differentiated embryonic
differentiated embryonic stem
embryonic stem cells
We used mouse
used mouse embryonic
mouse embryonic stem
embryonic stem ES
stem ES cells
ES cells to
cells to study
to study globin
study globin gene
globin gene expression
gene expression and
expression and switching
and switching in
switching in vitro
We show that
show that ES-derived
that ES-derived embryoid
ES-derived embryoid bodies
embryoid bodies express
bodies express the
express the full
the full complement
full complement of
complement of mouse
of mouse embryonic
mouse embryonic globin
embryonic globin genes
globin genes in
genes in the
in the correct
the correct temporal
correct temporal order
temporal order and
order and that
and that on
that on further
on further differentiation
further differentiation a
differentiation a switch
a switch occurs
switch occurs to
occurs to the
to the fetal/adult
the fetal/adult genes
In addition the
addition the erythroid-specific
the erythroid-specific transcription
erythroid-specific transcription factor
transcription factor NF-E1
factor NF-E1 was
NF-E1 was shown
was shown to
shown to be
to be expressed
be expressed coordinately
expressed coordinately with
coordinately with that
with that of
that of globin
of globin in
globin in embryoid
in embryoid bodies
We conclude from
conclude from these
from these experiments
these experiments that
experiments that the
that the ES
the ES cell
ES cell system
cell system provides
system provides a
provides a good
a good model
good model to
model to study
to study hematopoietic
study hematopoietic development
When the human
the human epsilon-
human epsilon- or
epsilon- or beta-globin
or beta-globin genes
beta-globin genes driven
genes driven by
driven by the
by the dominant
the dominant control
dominant control region
control region DCR
region DCR are
DCR are introduced
are introduced into
introduced into this
into this system
this system the
system the human
the human epsilon-globin
human epsilon-globin gene
epsilon-globin gene in
gene in contrast
in contrast to
contrast to the
to the beta-globin
the beta-globin gene
beta-globin gene is
gene is not
is not deregulated
not deregulated by
deregulated by the
by the presence
the presence of
presence of the
of the DCR
the DCR and
DCR and is
and is expressed
is expressed strictly
expressed strictly as
strictly as an
as an embryonic
an embryonic gene
We conclude from
conclude from this
from this that
this that the
that the epsilon-globin
the epsilon-globin gene
epsilon-globin gene is
gene is not
is not regulated
not regulated by
regulated by competition
by competition with
competition with other
with other genes
other genes in
genes in the
in the human
the human beta-globin
human beta-globin locus
Cloning of a
of a mitogen-inducible
a mitogen-inducible gene
mitogen-inducible gene encoding
gene encoding a
encoding a kappa
a kappa B
kappa B DNA-binding
B DNA-binding protein
DNA-binding protein with
protein with homology
with homology to
homology to the
to the rel
the rel oncogene
rel oncogene and
oncogene and to
and to cell-cycle
to cell-cycle motifs
We have cloned
have cloned and
cloned and characterized
and characterized a
characterized a mitogen-inducible
a mitogen-inducible gene
mitogen-inducible gene isolated
gene isolated from
isolated from human
from human T
human T cells
T cells that
cells that predicts
that predicts a
predicts a protein
a protein of
protein of 968
of 968 amino
968 amino acids
The amino-terminal domain
amino-terminal domain has
domain has regions
has regions homologous
regions homologous to
homologous to the
to the oncogene
the oncogene rel
oncogene rel and
rel and to
and to the
to the developmentally
the developmentally important
developmentally important gene
important gene dorsal
gene dorsal of
dorsal of Drosophila
The carboxy-terminal domain
carboxy-terminal domain contains
domain contains repeat
contains repeat structures
repeat structures found
structures found in
found in a
in a variety
a variety of
variety of proteins
of proteins that
proteins that are
that are involved
are involved in
involved in cell-cycle
in cell-cycle control
cell-cycle control of
control of yeast
of yeast and
yeast and in
and in tissue
in tissue differentiation
tissue differentiation in
differentiation in Drosophila
in Drosophila and
Drosophila and Ceanorhabditis
and Ceanorhabditis elegans
Ceanorhabditis elegans as
elegans as well
as well as
well as in
as in the
in the putative
the putative human
putative human oncogene
human oncogene bcl-3
oncogene bcl-3 and
bcl-3 and in
and in the
in the ankyrin
the ankyrin protein
A truncated form
truncated form of
form of the
of the product
the product of
product of this
of this gene
this gene translated
gene translated in
translated in vitro
in vitro is
vitro is a
is a DNA-binding
a DNA-binding protein
DNA-binding protein which
protein which interacts
which interacts specifically
interacts specifically with
specifically with the
with the kappa
the kappa B
kappa B binding
B binding site
binding site found
site found in
found in many
in many inducible
many inducible genes
inducible genes including
genes including the
including the enhancer
the enhancer in
enhancer in human
in human immunodeficiency
human immunodeficiency virus
This gene is
gene is yet
is yet another
yet another in
another in a
in a growing
a growing list
growing list of
list of important
of important regulatory
important regulatory molecules
regulatory molecules whose
molecules whose expression
whose expression is
expression is transcriptionally
is transcriptionally induced
transcriptionally induced upon
induced upon cellular
upon cellular activation
Extrarenal receptor-effector-mechanisms for
receptor-effector-mechanisms for aldosterone:
for aldosterone: the
aldosterone: the sequence
the sequence of
sequence of effects
of effects on
effects on the
on the cellular
the cellular electrolyte
cellular electrolyte transport
electrolyte transport in
transport in human
in human lymphocytes
human lymphocytes and
lymphocytes and their
and their implications
their implications for
implications for disorders
for disorders of
disorders of the
of the water
the water and
water and electrolyte
and electrolyte balances
High affinity aldosterone
affinity aldosterone binding
aldosterone binding sites
binding sites have
sites have not
have not only
not only been
only been described
been described in
described in the
in the classic
the classic target
classic target tissues
target tissues such
tissues such as
such as the
as the renal
the renal tubules
renal tubules but
tubules but also
but also in
also in non-classic
in non-classic target
non-classic target tissues
target tissues such
tissues such as
such as the
as the hippocampus
the hippocampus mammary
hippocampus mammary gland
mammary gland endothelial
gland endothelial cells
endothelial cells and
cells and recently
and recently human
recently human mononuclear
human mononuclear leukocytes
An in vitro
in vitro effect
vitro effect of
effect of aldosterone
of aldosterone on
aldosterone on intracellular
on intracellular sodium
intracellular sodium potassium
sodium potassium and
potassium and calcium
and calcium concentrations
calcium concentrations and
concentrations and cell
and cell volume
cell volume was
volume was shown
was shown in
shown in human
in human mononuclear
human mononuclear leukocytes
In the absence
the absence of
absence of aldosterone
of aldosterone the
aldosterone the intracellular
the intracellular Na+
intracellular Na+ K+
Na+ K+ and
K+ and Ca2+
and Ca2+ concentrations
Ca2+ concentrations and
concentrations and the
and the cell
the cell volume
cell volume decreased
volume decreased significantly
decreased significantly but
significantly but remained
but remained constant
remained constant when
constant when aldosterone
when aldosterone 14
aldosterone 14 nmol/l
14 nmol/l was
nmol/l was added
was added to
added to the
to the incubation
the incubation medium
These effects of
effects of aldosterone
of aldosterone were
aldosterone were blocked
were blocked by
blocked by the
by the aldosterone
the aldosterone antagonist
aldosterone antagonist canrenone
antagonist canrenone 140
canrenone 140 nmol/l
The sodium/proton exchanger
sodium/proton exchanger of
exchanger of the
of the cell
the cell membrane
cell membrane could
membrane could be
could be identified
be identified as
identified as the
as the primary
the primary target
primary target of
target of the
of the aldosterone
the aldosterone action
aldosterone action possibly
action possibly non-genomically
possibly non-genomically mediated
non-genomically mediated through
mediated through membrane
through membrane receptors
The clinical significance
clinical significance of
significance of this
of this model
this model was
model was underlined
was underlined by
underlined by the
by the demonstration
the demonstration of
demonstration of absent
of absent or
absent or a
or a decreased
a decreased number
decreased number of
number of mineralocorticoid
of mineralocorticoid receptors
mineralocorticoid receptors and
receptors and the
and the lack
the lack of
lack of electrolyte
of electrolyte response
electrolyte response to
response to aldosterone
to aldosterone in
aldosterone in human
in human mononuclear
human mononuclear leukocytes
mononuclear leukocytes of
leukocytes of patients
of patients with
patients with pseudohypoaldosteronism
with pseudohypoaldosteronism and
pseudohypoaldosteronism and aldosteronism
Additionally an abnormal
an abnormal effector
abnormal effector mechanism
effector mechanism could
mechanism could be
could be demonstrated
be demonstrated in
demonstrated in human
in human mononuclear
human mononuclear leukocytes
mononuclear leukocytes from
leukocytes from essential
from essential hypertensives
These studies are
studies are the
are the first
the first to
first to demonstrate
to demonstrate the
demonstrate the significance
the significance of
significance of extrarenal
of extrarenal nonepithelial
extrarenal nonepithelial mineralocorticoid
nonepithelial mineralocorticoid receptors
mineralocorticoid receptors and
receptors and the
and the related
the related effector
related effector mechanism
effector mechanism in
mechanism in different
in different disorders
different disorders of
disorders of the
of the water
the water and
water and electrolyte
and electrolyte balance
electrolyte balance in
balance in man
Immunohistochemical study of
study of steroid
of steroid hormones
steroid hormones and
hormones and an
and an estrogen
an estrogen binding
estrogen binding assay
binding assay in
assay in malignant
in malignant soft
malignant soft tissue
soft tissue tumors
Immunohistochemically the immunoreaction
the immunoreaction against
immunoreaction against 5
against 5 steroid
5 steroid hormone
steroid hormone anti-sera
hormone anti-sera estradiol
anti-sera estradiol estriol
estradiol estriol cortisol
estriol cortisol progesterone
cortisol progesterone and
progesterone and testosterone
and testosterone was
testosterone was examined
was examined in
examined in 39
in 39 cases
39 cases with
cases with the
with the malignant
the malignant soft
malignant soft tissue
soft tissue tumors
tissue tumors fibrosarcoma:
tumors fibrosarcoma: 8
fibrosarcoma: 8 malignant
8 malignant fibrous
malignant fibrous histiocytoma:
fibrous histiocytoma: 6
histiocytoma: 6 rhabdomyosarcoma:
6 rhabdomyosarcoma: 10
rhabdomyosarcoma: 10 leiomyosarcoma:
10 leiomyosarcoma: 10
leiomyosarcoma: 10 liposarcoma:
10 liposarcoma: 5
Seventeen cases revealed
cases revealed distinct
revealed distinct immunostaining
distinct immunostaining against
immunostaining against at
against at least
at least 1
least 1 of
1 of the
of the 5
the 5 steroid
5 steroid hormones
Immunostained tumor cells
tumor cells were
cells were more
were more frequently
more frequently distributed
frequently distributed in
distributed in the
in the area
the area where
area where tumor
where tumor cell
tumor cell infiltration
cell infiltration was
infiltration was more
was more invasive
The majority of
majority of the
of the positive
the positive cases
positive cases occurred
cases occurred in
occurred in female
in female cases
Furthermore the existence
the existence of
existence of estrogen
of estrogen receptor
estrogen receptor estrogen
receptor estrogen binding
estrogen binding activity
binding activity was
activity was examined
was examined histochemically
examined histochemically in
histochemically in 39
in 39 cases
39 cases and
cases and it
and it was
it was detected
was detected in
detected in 8
We concluded that
concluded that steroid
that steroid hormones
steroid hormones might
hormones might be
might be closely
be closely related
closely related to
related to tumor
to tumor cell
tumor cell infiltration
cell infiltration of
infiltration of some
of some malignant
some malignant soft
malignant soft tissue
soft tissue tumors
Involvement of cyclic
of cyclic AMP-dependent
cyclic AMP-dependent protein
AMP-dependent protein kinases
protein kinases in
kinases in the
in the signal
the signal transduction
signal transduction pathway
transduction pathway for
pathway for interleukin-1
Expression of a
of a highly
a highly specific
highly specific protein
specific protein inhibitor
protein inhibitor for
inhibitor for cyclic
for cyclic AMP-dependent
cyclic AMP-dependent protein
AMP-dependent protein kinases
protein kinases in
kinases in interleukin-1
in interleukin-1 IL-1-responsive
interleukin-1 IL-1-responsive cells
IL-1-responsive cells blocked
cells blocked IL-1-induced
blocked IL-1-induced gene
IL-1-induced gene transcription
gene transcription that
transcription that was
that was driven
was driven by
driven by the
by the kappa
the kappa immunoglobulin
kappa immunoglobulin enhancer
immunoglobulin enhancer or
enhancer or the
or the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus long
virus long terminal
long terminal repeat
This inhibitor did
inhibitor did not
did not affect
not affect protein
affect protein kinase
protein kinase C-mediated
kinase C-mediated gene
C-mediated gene transcription
gene transcription suggesting
transcription suggesting that
suggesting that cyclic
that cyclic AMP-dependent
cyclic AMP-dependent protein
AMP-dependent protein kinases
protein kinases are
kinases are involved
are involved in
involved in the
in the signal
the signal transduction
signal transduction pathway
transduction pathway for
pathway for IL-1
for IL-1 in
IL-1 in a
in a number
a number of
number of responsive
of responsive cell
responsive cell types
The Epstein-Barr virus
Epstein-Barr virus EBV
virus EBV ORI1yt
EBV ORI1yt enhancer
ORI1yt enhancer is
enhancer is not
is not B-cell
not B-cell specific
B-cell specific and
specific and does
and does not
does not respond
not respond synergistically
respond synergistically to
synergistically to the
to the EBV
the EBV transcription
EBV transcription factors
transcription factors R
factors R and
R and Z
The Epstein-Barr virus
Epstein-Barr virus DR
virus DR promoter
DR promoter is
promoter is located
is located upstream
located upstream of
upstream of the
of the PstI
the PstI repeats
PstI repeats and
repeats and in
and in addition
in addition to
addition to the
to the TATA
the TATA box
TATA box it
box it contains
it contains an
contains an upstream
an upstream region
upstream region positions
region positions -69
positions -69 to
-69 to -220
to -220 responsive
-220 responsive to
responsive to EB1
to EB1 Z
EB1 Z the
Z the BZLF1-encoded
the BZLF1-encoded transcription
BZLF1-encoded transcription factor
transcription factor and
factor and an
and an enhancer
an enhancer with
enhancer with two
with two functionally
two functionally distinct
functionally distinct domains
distinct domains A
domains A and
A and B
Domain B has
B has been
has been described
been described as
described as a
as a B-cell-specific
a B-cell-specific EB1-responsive
B-cell-specific EB1-responsive element
EB1-responsive element PMLieberman
element PMLieberman JMHardwick
PMLieberman JMHardwick and
JMHardwick and SDHayward
and SDHayward JVirol63:3040-3050
SDHayward JVirol63:3040-3050 1989
JVirol63:3040-3050 1989 activated
1989 activated synergistically
activated synergistically by
synergistically by EB1
by EB1 and
EB1 and R
and R an
R an EBV
an EBV early
EBV early product
early product encoded
product encoded by
encoded by the
by the open
the open reading
open reading frame
reading frame BRLF1
frame BRLF1 MA
BRLF1 MA Cox
MA Cox JLeahy
Cox JLeahy and
JLeahy and JMHardwick
and JMHardwick JVirol64:313-321
JMHardwick JVirol64:313-321 1990
We show here
show here that
here that domain
that domain B
domain B is
B is an
is an R-responsive
an R-responsive element
R-responsive element in
element in HeLa
in HeLa cells
HeLa cells and
cells and is
and is therefore
is therefore not
therefore not an
not an EB1-responsive
an EB1-responsive B-cell-specific
EB1-responsive B-cell-specific element
However there is
there is an
is an EB1-binding
an EB1-binding site
EB1-binding site ZRE-B
site ZRE-B located
ZRE-B located within
located within the
within the R-responsive
the R-responsive enhancer
R-responsive enhancer region
ZRE-B can be
can be deleted
be deleted without
deleted without affecting
without affecting the
affecting the R-dependent
the R-dependent enhancer
R-dependent enhancer activity
Moreover there is
there is no
is no cooperation
no cooperation or
cooperation or synergy
or synergy between
synergy between R
between R and
R and EB1
and EB1 when
EB1 when activating
when activating the
activating the B
the B domain
B domain ZRE-B
domain ZRE-B plus
ZRE-B plus the
plus the R-responsive
the R-responsive element
R-responsive element positioned
element positioned as
positioned as an
as an enhancer
ZRE-B is therefore
is therefore not
therefore not part
not part of
part of the
of the R-
the R- inducible
R- inducible enhancer
We have tested
have tested several
tested several subregions
several subregions of
subregions of the
of the DR
the DR enhancer
DR enhancer B
enhancer B domain
B domain either
domain either alone
either alone or
alone or in
or in combination
in combination for
combination for their
for their capacity
their capacity to
capacity to transmit
to transmit the
transmit the R-activating
the R-activating signal
R-activating signal to
signal to the
to the rabbit
the rabbit beta-globin
rabbit beta-globin promoter
We found that
found that the
that the R-responsive
the R-responsive element
R-responsive element is
element is composed
is composed of
composed of four
of four protoenhancers
four protoenhancers that
protoenhancers that span
that span the
span the whole
the whole B
whole B domain
These protoenhancers alone
protoenhancers alone are
alone are weakly
are weakly or
weakly or not
or not responsive
not responsive to
responsive to R
One of the
of the protoenhancers
the protoenhancers contains
protoenhancers contains the
contains the overlapping
the overlapping palindromes
overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3'
However one palindrome
one palindrome either
palindrome either alone
either alone or
alone or duplicated
or duplicated or
duplicated or the
or the overlapping
the overlapping palindromes
overlapping palindromes did
palindromes did not
did not respond
not respond to
respond to R
Nuclear 353'-triiodothyronine receptors
353'-triiodothyronine receptors T3R
receptors T3R of
T3R of circulating
of circulating human
circulating human lymphocytes
human lymphocytes in
lymphocytes in hyper-
in hyper- and
hyper- and hypothyroidism
and hypothyroidism and
hypothyroidism and nonthyroidal
and nonthyroidal diseases
The clinical implications
clinical implications of
implications of nuclear
of nuclear T3R
nuclear T3R alterations
T3R alterations of
alterations of circulating
of circulating lymphocytes
circulating lymphocytes in
lymphocytes in hyperthyroidism
in hyperthyroidism hypothyroidism
hyperthyroidism hypothyroidism and
hypothyroidism and nonthyroidal
and nonthyroidal diseases
nonthyroidal diseases were
diseases were investigated
Nuclear T3R in
T3R in lymphocytes
in lymphocytes was
lymphocytes was determined
was determined by
determined by radio-ligand
by radio-ligand binding
radio-ligand binding analysis
The results showed
results showed that
showed that in
that in hyper-
in hyper- and
hyper- and hypothyroid
and hypothyroid patients
hypothyroid patients the
patients the nuclear
the nuclear affinity
nuclear affinity Ka
affinity Ka for
Ka for T3
for T3 was
T3 was similar
was similar to
similar to that
to that of
that of normal
of normal subjects
In hyperthyroidism nuclear
hyperthyroidism nuclear T3
nuclear T3 maximal
T3 maximal binding
maximal binding capacity
binding capacity MBC
capacity MBC was
MBC was unaltered
was unaltered whereas
unaltered whereas in
whereas in hypothyroidism
in hypothyroidism the
hypothyroidism the MBC
the MBC was
MBC was significantly
was significantly increased
In the patients
the patients with
patients with diabetes
with diabetes mellitus
diabetes mellitus chronic
mellitus chronic renal
chronic renal failure
renal failure and
failure and hepatic
and hepatic cirrhosis
hepatic cirrhosis the
cirrhosis the nuclear
the nuclear T3R
nuclear T3R MBC
T3R MBC of
MBC of lymphocytes
of lymphocytes was
lymphocytes was about
was about 15-16
about 15-16 times
15-16 times of
times of the
of the normal
the normal controls
It was concluded
was concluded that
concluded that there
that there existed
there existed hormonal
existed hormonal regulation
hormonal regulation of
regulation of nuclear
of nuclear T3R
nuclear T3R and
T3R and up-regulation
and up-regulation was
up-regulation was seen
was seen in
seen in hypothyroidism
in hypothyroidism and
hypothyroidism and low
and low T3
low T3 syndrome
Lymphocyte cell lines
cell lines from
lines from vitamin
from vitamin D-dependent
vitamin D-dependent rickets
D-dependent rickets type
rickets type II
type II show
II show functional
show functional defects
functional defects in
defects in the
in the 1
the 1 alpha25-dihydroxyvitamin
1 alpha25-dihydroxyvitamin D3
alpha25-dihydroxyvitamin D3 receptor
Lymphocyte cell lines
cell lines were
lines were established
were established from
established from five
from five patients
five patients with
patients with vitamin
with vitamin D-dependent
vitamin D-dependent rickets
D-dependent rickets type
rickets type II
type II VDDR-II
These lines were
lines were established
were established by
established by infection
by infection with
infection with human
with human T-lymphotrophic
human T-lymphotrophic virus
T-lymphotrophic virus type
virus type I
type I HTLV-I
Binding of [3H]1
of [3H]1 alpha25-dihydroxyvitamin
[3H]1 alpha25-dihydroxyvitamin D3
alpha25-dihydroxyvitamin D3 125OH2D3
D3 125OH2D3 to
125OH2D3 to its
to its receptor
its receptor in
receptor in these
in these cell
these cell lines
cell lines was
lines was compared
was compared to
compared to binding
to binding studies
binding studies using
studies using a
using a T-lymphocyte
a T-lymphocyte cell
T-lymphocyte cell line
cell line S-LB1
line S-LB1 from
S-LB1 from a
from a normal
a normal individual
The 125OH2D3 receptor
125OH2D3 receptor of
receptor of S-LB1
of S-LB1 was
S-LB1 was comparable
was comparable to
comparable to the
to the well-characterized
the well-characterized chick
well-characterized chick intestinal
chick intestinal 125OH2D3
intestinal 125OH2D3 receptor
125OH2D3 receptor in
receptor in terms
in terms of
terms of its
of its ligand
its ligand binding
ligand binding affinity
binding affinity and
affinity and capacity
and capacity its
capacity its mobility
its mobility on
mobility on 5-20%
on 5-20% sucrose
5-20% sucrose gradients
sucrose gradients and
gradients and its
and its adsorption
its adsorption to
adsorption to and
to and elution
and elution properties
elution properties from
properties from DNA-cellulose
Three cell lines
cell lines established
lines established from
established from patients
from patients with
patients with VDDR-II
with VDDR-II Rh-VDR
VDDR-II Rh-VDR Sh-VDR
Rh-VDR Sh-VDR and
Sh-VDR and Ab-VDR
and Ab-VDR showed
Ab-VDR showed no
showed no specific
no specific binding
specific binding of
binding of 125OH2D3
of 125OH2D3 to
125OH2D3 to a
to a receptor
a receptor and
receptor and treatment
and treatment of
treatment of the
of the cultured
the cultured cells
cultured cells with
cells with 125OH2D3
with 125OH2D3 did
125OH2D3 did not
did not stimulate
not stimulate production
stimulate production of
production of 2425-dihydroxy-vitamin
of 2425-dihydroxy-vitamin D3
2425-dihydroxy-vitamin D3 2425OH2D3
D3 2425OH2D3 a
2425OH2D3 a response
a response which
response which is
which is diagnostic
is diagnostic of
diagnostic of the
of the presence
the presence of
presence of a
of a functional
a functional 125OH2D3
functional 125OH2D3 receptor
In a fourth
a fourth cell
fourth cell line
cell line A1-VDR
line A1-VDR the
A1-VDR the receptor
the receptor for
receptor for 125OH2D3
for 125OH2D3 had
125OH2D3 had a
had a low
a low binding
low binding capacity
binding capacity and
capacity and 25OHD3-24-hydroxylase
and 25OHD3-24-hydroxylase activity
25OHD3-24-hydroxylase activity was
activity was not
was not detectable
Induction of 2425-OH2D3
of 2425-OH2D3 synthesis
2425-OH2D3 synthesis by
synthesis by 125OH2D3
by 125OH2D3 was
125OH2D3 was observed
was observed in
observed in the
in the fifth
the fifth cell
fifth cell line
cell line designated
line designated Ro-VDR
designated Ro-VDR although
Ro-VDR although the
although the sensitivity
the sensitivity to
sensitivity to hormone
to hormone treatment
hormone treatment was
treatment was lower
was lower than
lower than in
than in the
in the control
the control cell
control cell line
cell line from
line from a
from a normal
a normal donor
The capacity of
capacity of the
of the receptor
the receptor for
receptor for 125OH2D3
for 125OH2D3 was
125OH2D3 was low
was low in
low in Ro-VDR
In all cell
all cell lines
cell lines where
lines where 125OH2D3
where 125OH2D3 binding
125OH2D3 binding to
binding to a
to a receptor
a receptor was
receptor was detectable
was detectable the
detectable the receptor
the receptor had
receptor had the
had the typical
the typical sedimentation
typical sedimentation coefficient
sedimentation coefficient of
coefficient of 37
of 37 S
37 S on
S on sucrose
on sucrose density
sucrose density gradient
density gradient analysis
Binding and elution
and elution properties
elution properties to
properties to DNA-cellulose
to DNA-cellulose however
DNA-cellulose however differed
however differed from
differed from normal
from normal in
normal in both
in both Ro-VDR
both Ro-VDR and
Ro-VDR and A1-VDR
and A1-VDR cells
A1-VDR cells where
cells where elution
where elution from
elution from DNA-cellulose
from DNA-cellulose occurred
DNA-cellulose occurred at
occurred at a
at a lower
a lower salt
lower salt concentration
salt concentration than
concentration than is
than is typical
is typical of
typical of the
of the 125OH2D3
the 125OH2D3 receptor
While Ro-VDR cells
Ro-VDR cells showed
cells showed typical
showed typical nuclear
typical nuclear localization
nuclear localization of
localization of the
of the unoccupied
the unoccupied 125OH2D3
unoccupied 125OH2D3 receptor
125OH2D3 receptor neither
receptor neither the
neither the unoccupied
the unoccupied nor
unoccupied nor the
nor the occupied
the occupied receptor
occupied receptor from
receptor from A1-VDR
from A1-VDR cells
A1-VDR cells was
cells was completely
was completely localized
completely localized in
localized in the
in the nucleus
In a series
a series of
series of functional
of functional studies
functional studies we
studies we found
we found that
found that modulation
that modulation of
modulation of the
of the level
the level of
level of the
of the mRNAs
the mRNAs coding
mRNAs coding for
coding for both
for both the
both the c-myc
the c-myc oncogene
c-myc oncogene and
oncogene and the
and the growth
the growth factor
growth factor known
factor known as
known as granulocyte-monocyte
as granulocyte-monocyte colony
granulocyte-monocyte colony stimulating
colony stimulating activity
stimulating activity by
activity by 125OH2D3
by 125OH2D3 correlated
125OH2D3 correlated with
correlated with the
with the 125OH2D3
the 125OH2D3 receptor
125OH2D3 receptor status
receptor status of
status of these
of these cells
Use of these
of these cell
these cell lines
cell lines will
lines will facilitate
will facilitate further
facilitate further study
further study of
study of the
of the molecular
the molecular defects
molecular defects in
defects in the
in the receptor
the receptor for
receptor for 125OH2D3
for 125OH2D3 in
125OH2D3 in vitamin
in vitamin D-dependent
vitamin D-dependent rickets
D-dependent rickets type
rickets type II
type II and
II and will
and will allow
will allow a
allow a correlation
a correlation with
correlation with impairment
with impairment of
impairment of cellular
of cellular functions
Transcriptional and post-transcriptional
and post-transcriptional regulation
post-transcriptional regulation of
regulation of c-jun
of c-jun expression
c-jun expression during
expression during monocytic
during monocytic differentiation
monocytic differentiation of
differentiation of human
of human myeloid
human myeloid leukemic
myeloid leukemic cells
AP-1 the polypeptide
the polypeptide product
polypeptide product of
product of c-jun
of c-jun recognizes
c-jun recognizes and
recognizes and binds
and binds to
binds to specific
to specific DNA
specific DNA sequences
DNA sequences and
sequences and stimulates
and stimulates transcription
stimulates transcription of
transcription of genes
of genes responsive
genes responsive to
responsive to certain
to certain growth
certain growth factors
growth factors and
factors and phorbol
and phorbol esters
phorbol esters such
esters such as
such as 12-O-tetradecanoylphorbol-13-acetate
as 12-O-tetradecanoylphorbol-13-acetate TPA
We studied the
studied the effects
the effects of
effects of TPA
of TPA on
TPA on the
on the regulation
the regulation of
regulation of c-jun
of c-jun gene
c-jun gene expression
gene expression in
expression in HL-60
in HL-60 cells
HL-60 cells during
cells during monocytic
during monocytic differentiation
Low levels of
levels of c-jun
of c-jun transcripts
c-jun transcripts were
transcripts were detectable
were detectable in
detectable in untreated
in untreated HL-60
untreated HL-60 leukemic
HL-60 leukemic cells
leukemic cells increased
cells increased significantly
increased significantly by
significantly by 6
by 6 h
6 h and
h and reached
and reached near
reached near maximal
near maximal levels
maximal levels by
levels by 24
by 24 h
24 h of
h of exposure
of exposure to
exposure to 32
to 32 nM
32 nM TPA
Similar kinetics of
kinetics of c-jun
of c-jun induction
c-jun induction by
induction by TPA
by TPA were
TPA were observed
were observed in
observed in human
in human U-937
human U-937 and
U-937 and THP-1
and THP-1 monocytic
THP-1 monocytic leukemia
monocytic leukemia cells
Similar findings were
findings were obtained
were obtained with
obtained with bryostatin
with bryostatin 1
bryostatin 1 10
1 10 nM
10 nM another
nM another activator
another activator of
activator of protein
of protein kinase
protein kinase C
kinase C and
C and inducer
and inducer of
inducer of monocytic
of monocytic differentiation
Furthermore 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 05
D3 05 microM
05 microM a
microM a structurally
a structurally distinct
structurally distinct agent
distinct agent which
agent which also
which also induces
also induces HL-60
induces HL-60 monocytic
HL-60 monocytic differentiation
monocytic differentiation increased
differentiation increased c-jun
increased c-jun expression
TPA treatment of
treatment of HL-60
of HL-60 cells
HL-60 cells in
cells in the
in the presence
the presence of
presence of cycloheximide
of cycloheximide was
cycloheximide was associated
was associated with
associated with superinduction
with superinduction of
superinduction of c-jun
of c-jun transcripts
Run-on analysis demonstrated
analysis demonstrated detectable
demonstrated detectable levels
detectable levels of
levels of c-jun
of c-jun gene
c-jun gene transcription
gene transcription in
transcription in untreated
in untreated HL-60
untreated HL-60 cells
HL-60 cells and
cells and that
and that exposure
that exposure to
exposure to TPA
to TPA increases
TPA increases this
increases this rate
this rate 33-fold
Treatment of HL-60
of HL-60 cells
HL-60 cells with
cells with both
with both TPA
both TPA and
TPA and cycloheximide
and cycloheximide had
cycloheximide had no
had no effect
no effect on
effect on the
on the rates
the rates of
rates of c-jun
of c-jun transcription
The half-life of
half-life of c-jun
of c-jun RNA
c-jun RNA as
RNA as determined
as determined by
determined by treating
by treating HL-60
treating HL-60 cells
HL-60 cells with
cells with TPA
with TPA and
TPA and actinomycin
and actinomycin D
actinomycin D was
D was 30
was 30 min
In contrast the
contrast the half-life
the half-life of
half-life of c-jun
of c-jun RNA
c-jun RNA in
RNA in TPA-treated
in TPA-treated HL-60
TPA-treated HL-60 cells
HL-60 cells exposed
cells exposed to
exposed to cycloheximide
to cycloheximide and
cycloheximide and actinomycin
and actinomycin D
actinomycin D was
D was greater
was greater than
greater than 2
than 2 h
These findings suggested
findings suggested that
suggested that the
that the increase
the increase in
increase in c-jun
in c-jun RNA
c-jun RNA observed
RNA observed during
observed during TPA-induced
during TPA-induced monocytic
TPA-induced monocytic differentiation
monocytic differentiation is
differentiation is mediated
is mediated by
mediated by both
by both transcriptional
both transcriptional and
transcriptional and post-transcriptional
and post-transcriptional mechanisms
[Hormonal interactions and
interactions and glucocorticoid
and glucocorticoid receptors
glucocorticoid receptors in
receptors in patients
in patients with
patients with the
with the nephrotic
the nephrotic syndrome]
As many as
many as 27
as 27 children
27 children aged
children aged 6
aged 6 to
6 to 15
to 15 years
15 years with
years with morphologically
with morphologically verified
morphologically verified nephropathies
verified nephropathies were
nephropathies were examined
Four variants of
variants of changes
of changes in
changes in the
in the thyroid
the thyroid status
thyroid status characteristic
status characteristic of
characteristic of children
of children with
children with different
with different variants
different variants of
variants of nephrotic
of nephrotic syndrome
nephrotic syndrome were
syndrome were distinguished:
were distinguished: 1
distinguished: 1 biochemical
1 biochemical signs
biochemical signs of
signs of primary
of primary hypothyroidism
primary hypothyroidism 2
hypothyroidism 2 biochemical
2 biochemical signs
biochemical signs of
signs of secondary
of secondary hypothyroidism
secondary hypothyroidism 3
hypothyroidism 3 low
3 low content
low content of
content of T3
of T3 4
T3 4 dysfunction
4 dysfunction of
dysfunction of the
of the hypophyseal
the hypophyseal and
hypophyseal and thyroid
and thyroid system
It is shown
is shown that
shown that the
that the low
the low level
low level of
level of steroid
of steroid receptors
steroid receptors thyroid
receptors thyroid hormones
thyroid hormones that
hormones that the
that the low
the low level
low level of
level of steroid
of steroid receptors
steroid receptors thyroid
receptors thyroid hormones
thyroid hormones T3
hormones T3 and
T3 and T4
and T4 and
T4 and cortisol
and cortisol is
cortisol is typical
is typical of
typical of children
of children with
children with the
with the signs
the signs of
signs of renal
of renal dysplasia
It is assumed
is assumed that
assumed that superaddition
that superaddition under
superaddition under such
under such conditions
such conditions of
conditions of immune
of immune glomerulopathy
immune glomerulopathy glomerulonephritis
glomerulopathy glomerulonephritis and
glomerulonephritis and nephrotic
and nephrotic syndrome
nephrotic syndrome gives
syndrome gives rise
gives rise to
rise to the
to the resistance
the resistance to
resistance to the
to the treatment
the treatment with
treatment with glucocorticoids
Lymphoid specific gene
specific gene expression
gene expression of
expression of the
of the adenovirus
the adenovirus early
adenovirus early region
early region 3
region 3 promoter
3 promoter is
promoter is mediated
is mediated by
mediated by NF-kappa
by NF-kappa B
NF-kappa B binding
B binding motifs
A primary site
primary site of
site of infection
of infection by
infection by human
by human adenoviruses
human adenoviruses is
adenoviruses is lymphoid
is lymphoid cells
However analysis of
analysis of the
of the viral
the viral control
viral control elements
control elements and
elements and the
and the cellular
the cellular factors
cellular factors that
factors that regulate
that regulate adenoviral
regulate adenoviral gene
adenoviral gene expression
gene expression in
expression in lymphocytes
in lymphocytes has
lymphocytes has not
has not been
not been reported
The adenovirus early
adenovirus early region
early region 3
region 3 ES
3 ES gene
ES gene products
gene products are
products are involved
are involved in
involved in the
in the maintenance
the maintenance of
maintenance of viral
of viral persistence
viral persistence by
persistence by complexing
by complexing with
complexing with the
with the class
the class I
class I MHC
I MHC antigens
MHC antigens thus
antigens thus preventing
thus preventing their
preventing their cell
their cell surface
cell surface expression
surface expression with
expression with a
with a resultant
a resultant decrease
resultant decrease in
decrease in host
in host immunologic
host immunologic destruction
To determine whether
determine whether different
whether different cellular
different cellular factors
cellular factors were
factors were involved
were involved in
involved in E3
in E3 regulation
E3 regulation in
regulation in lymphocytes
in lymphocytes as
lymphocytes as compared
as compared with
compared with HeLa
with HeLa cells
HeLa cells both
cells both DNA
both DNA binding
DNA binding and
binding and transfection
and transfection analysis
transfection analysis with
analysis with the
with the E3
the E3 promoter
E3 promoter in
promoter in both
in both cell
both cell types
cell types were
types were performed
These studies detected
studies detected two
detected two novel
two novel domains
novel domains referred
domains referred to
referred to as
to as L1
as L1 and
L1 and L2
and L2 with
L2 with a
with a variety
a variety of
variety of lymphoid
of lymphoid but
lymphoid but not
but not HeLa
not HeLa extracts
Each of these
of these domains
these domains possessed
domains possessed strong
possessed strong homology
strong homology to
homology to motifs
to motifs previously
motifs previously found
previously found to
found to bind
to bind the
bind the cellular
the cellular factor
cellular factor NF-kappa
factor NF-kappa B
Transfections of E3
of E3 constructs
E3 constructs linked
constructs linked to
linked to the
to the chloramphenicol
the chloramphenicol acetyltransferase
chloramphenicol acetyltransferase gene
acetyltransferase gene revealed
gene revealed that
revealed that mutagenesis
that mutagenesis of
mutagenesis of the
of the distal
the distal NF-kappa
distal NF-kappa B
NF-kappa B motif
B motif L2
motif L2 had
L2 had minimal
had minimal effects
minimal effects on
effects on promoter
on promoter expression
promoter expression in
expression in HeLa
in HeLa cells
HeLa cells but
cells but resulted
but resulted in
resulted in dramatic
in dramatic decreases
dramatic decreases in
decreases in expression
in expression by
expression by lymphoid
by lymphoid cells
In contrast mutagenesis
contrast mutagenesis of
mutagenesis of proximal
of proximal NF-kappa
proximal NF-kappa B
NF-kappa B motif
B motif L1
motif L1 had
L1 had minimal
had minimal effects
minimal effects on
effects on gene
on gene expression
gene expression in
expression in both
in both HeLa
both HeLa cells
HeLa cells and
cells and lymphoid
and lymphoid cells
lymphoid cells but
cells but resulted
but resulted in
resulted in a
in a small
a small but
small but reproducible
but reproducible increase
reproducible increase in
increase in gene
in gene expression
gene expression in
expression in lymphoid
in lymphoid cells
lymphoid cells when
cells when coupled
when coupled to
coupled to the
to the L2
the L2 mutation
Reversing the position
the position and
position and subsequent
and subsequent mutagenesis
subsequent mutagenesis of
mutagenesis of the
of the L1
the L1 and
L1 and L2
and L2 domains
L2 domains indicated
domains indicated that
indicated that the
that the primary
the primary sequence
primary sequence of
sequence of these
of these motifs
these motifs rather
motifs rather than
rather than their
than their position
their position in
position in the
in the E3
the E3 promoter
E3 promoter was
promoter was critical
was critical for
critical for regulating
for regulating gene
regulating gene expression
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Characterization of defensin
of defensin resistance
defensin resistance phenotypes
resistance phenotypes associated
phenotypes associated with
associated with mutations
with mutations in
mutations in the
in the phoP
the phoP virulence
phoP virulence regulon
virulence regulon of
regulon of Salmonella
of Salmonella typhimurium
The defensin sensitivities
defensin sensitivities of
sensitivities of Salmonella
of Salmonella typhimurium
Salmonella typhimurium strains
typhimurium strains with
strains with mutations
with mutations in
mutations in the
in the phoP/phoQ
the phoP/phoQ two-component
phoP/phoQ two-component virulence
two-component virulence regulon
virulence regulon were
regulon were tested
were tested by
tested by using
by using purified
using purified defensins
purified defensins NP-1
defensins NP-1 and
NP-1 and NP-2
Strains with mutations
with mutations in
mutations in either
in either gene
either gene of
gene of the
of the regulatory
the regulatory pair
regulatory pair phoP
pair phoP [transcriptional
phoP [transcriptional activator]
[transcriptional activator] or
activator] or phoQ
or phoQ [membrane
phoQ [membrane sensor
[membrane sensor kinase]
sensor kinase] had
kinase] had increased
had increased sensitivities
increased sensitivities to
sensitivities to defensin
The predicted periplasmic
predicted periplasmic domain
periplasmic domain of
domain of the
of the PhoQ
the PhoQ protein
PhoQ protein contained
protein contained a
contained a markedly
a markedly anionic
markedly anionic domain
anionic domain that
domain that could
that could interact
could interact with
interact with cationic
with cationic proteins
cationic proteins and
proteins and that
and that could
that could be
could be responsible
be responsible for
responsible for resistance
for resistance to
resistance to defensin
Because insertion mutations
insertion mutations in
mutations in phoP
in phoP are
phoP are polar
are polar on
polar on phoQ
on phoQ we
phoQ we constructed
we constructed strains
constructed strains that
strains that expressed
that expressed the
expressed the PhoQ
the PhoQ protein
PhoQ protein in
protein in the
in the absence
the absence of
absence of PhoP
of PhoP to
PhoP to test
to test whether
test whether resistance
whether resistance to
resistance to defensin
to defensin requires
defensin requires only
requires only the
only the phoQ
the phoQ gene
phoQ gene product
We found that
found that resistance
that resistance to
resistance to defensin
to defensin requires
defensin requires the
requires the function
the function of
function of both
of both components
both components of
components of this
of this regulatory
this regulatory system
regulatory system because
system because strains
because strains expressing
strains expressing PhoQ
expressing PhoQ without
PhoQ without PhoP
without PhoP were
PhoP were still
were still markedly
still markedly sensitive
markedly sensitive to
sensitive to defensins
This implied that
implied that a
that a pag
a pag phoP-activated
pag phoP-activated gene
phoP-activated gene product
gene product is
product is responsible
is responsible for
responsible for defensin
for defensin resistance
We also tested
also tested for
tested for the
for the ability
the ability of
ability of defensins
of defensins NP-1
defensins NP-1 NP-5
NP-1 NP-5 and
NP-5 and HNP-1
and HNP-1 to
HNP-1 to activate
to activate pag
activate pag expression
pag expression and
expression and found
and found that
found that these
that these peptides
these peptides have
peptides have no
have no effect
Defensin resistance is
resistance is not
is not the
not the only
the only virulence
only virulence characteristic
virulence characteristic controlled
characteristic controlled by
controlled by the
by the PhoP-PhoQ
the PhoP-PhoQ regulon
PhoP-PhoQ regulon because
regulon because mutations
because mutations in
mutations in pagC
in pagC as
pagC as well
as well as
well as ones
as ones in
ones in the
in the phoP
the phoP locus
phoP locus that
locus that resulted
that resulted in
resulted in constitutive
in constitutive pag
constitutive pag activation
pag activation phenotype
activation phenotype PhoPc
phenotype PhoPc had
PhoPc had no
had no effect
no effect on
effect on defensin
on defensin resistance
defensin resistance even
resistance even though
even though they
though they rendered
they rendered the
rendered the organism
the organism avirulent
organism avirulent and
avirulent and deficient
and deficient in
deficient in survival
in survival within
survival within macrophages
The virulence defect
virulence defect conferred
defect conferred by
conferred by mutations
by mutations in
mutations in the
in the phoP-phoQ
the phoP-phoQ two-component
phoP-phoQ two-component regulatory
two-component regulatory system
regulatory system is
system is not
is not completely
not completely explained
completely explained by
explained by alterations
by alterations in
alterations in resistance
in resistance to
resistance to cationic
to cationic proteins
cationic proteins and
proteins and involves
and involves the
involves the control
the control of
control of other
of other proteins
other proteins necessary
proteins necessary for
necessary for S
for S typhimurium
S typhimurium survival
typhimurium survival within
survival within macrophages
Stimulation of a
of a human
a human T-cell
human T-cell clone
T-cell clone with
clone with anti-CD3
with anti-CD3 or
anti-CD3 or tumor
or tumor necrosis
tumor necrosis factor
necrosis factor induces
factor induces NF-kappa
induces NF-kappa B
NF-kappa B translocation
B translocation but
translocation but not
but not human
not human immunodeficiency
human immunodeficiency virus
immunodeficiency virus 1
virus 1 enhancer-dependent
1 enhancer-dependent transcription
The expression of
expression of transiently
of transiently transfected
transiently transfected expression
transfected expression vectors
expression vectors under
vectors under the
under the control
the control of
control of the
of the long
the long terminal
long terminal repeat
terminal repeat LTR
repeat LTR of
LTR of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV or
HIV or its
or its enhancer
its enhancer sequence
enhancer sequence and
sequence and the
and the translocation
the translocation of
translocation of the
of the HIV
the HIV enhancer-binding
HIV enhancer-binding protein
enhancer-binding protein NF-kappa
protein NF-kappa B
NF-kappa B were
B were analyzed
were analyzed in
analyzed in two
in two human
two human T-cell
human T-cell clones
T-cell clones stimulated
clones stimulated through
stimulated through their
through their T-cell
their T-cell receptor
T-cell receptor complex
receptor complex or
complex or by
or by tumor
by tumor necrosis
tumor necrosis factor
necrosis factor or
factor or phorbol
or phorbol 12-myristate
phorbol 12-myristate 13-acetate
We found a
found a dissociation
a dissociation of
dissociation of NF-kappa
of NF-kappa B
NF-kappa B translocation
B translocation from
translocation from transactivation
from transactivation of
transactivation of either
of either the
either the HIV
the HIV LTR
HIV LTR or
LTR or the
or the HIV
the HIV enhancer
Interleukin 2 induced
2 induced proliferation
induced proliferation but
proliferation but not
but not NF-kappa
not NF-kappa B
NF-kappa B translocation
B translocation or
translocation or LTR
or LTR transactivation
Phorbol ester or
ester or specific
or specific antigen
specific antigen recognition
antigen recognition induced
recognition induced HIV
induced HIV LTR
HIV LTR transactivation
LTR transactivation whereas
transactivation whereas stimulation
whereas stimulation with
stimulation with tumor
with tumor necrosis
tumor necrosis factor
necrosis factor or
factor or antibody
or antibody to
antibody to CD3
to CD3 did
CD3 did not
The two latter
two latter signals
latter signals were
signals were nevertheless
were nevertheless able
nevertheless able to
able to induce
to induce NF-kappa
induce NF-kappa B
NF-kappa B translocation
B translocation with
translocation with a
with a pattern
a pattern in
pattern in the
in the band-shift
the band-shift assay
band-shift assay indistinguishable
assay indistinguishable from
indistinguishable from that
from that observed
that observed using
observed using phorbol
using phorbol ester
Our finding that
finding that induction
that induction of
induction of NF-kappa
of NF-kappa B
NF-kappa B by
B by tumor
by tumor necrosis
tumor necrosis factor
necrosis factor or
factor or antibody
or antibody to
antibody to CD3
to CD3 is
CD3 is not
is not sufficient
not sufficient to
sufficient to induce
to induce HIV
induce HIV enhancer-dependent
HIV enhancer-dependent transcription
enhancer-dependent transcription in
transcription in cloned
in cloned T
cloned T cells
T cells contrasts
cells contrasts with
contrasts with results
with results obtained
results obtained in
obtained in most
in most lymphoblastoid
most lymphoblastoid T-cell
lymphoblastoid T-cell lines
T-cell lines and
lines and indicates
and indicates that
indicates that normal
that normal T
normal T lymphocytes
T lymphocytes differ
lymphocytes differ from
differ from tumoral
from tumoral T
tumoral T cells
T cells in
cells in terms
in terms of
terms of requirements
of requirements for
requirements for HIV
for HIV LTR
HIV LTR activation
Furthermore our results
our results suggest
results suggest that
suggest that events
that events linked
events linked to
linked to T-cell
to T-cell activation
T-cell activation in
activation in addition
in addition to
addition to NF-kappa
to NF-kappa B
NF-kappa B translocation
B translocation per
translocation per se
per se induce
se induce functional
induce functional interactions
functional interactions of
interactions of the
of the NF-kappa
the NF-kappa B
NF-kappa B complex
B complex with
complex with the
with the HIV
the HIV enhancer
Decreased concentration of
concentration of 125-dihydroxyvitamin
of 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 receptors
D3 receptors in
receptors in peripheral
in peripheral mononuclear
peripheral mononuclear cells
mononuclear cells of
cells of patients
of patients with
patients with X-linked
with X-linked hypophosphatemic
X-linked hypophosphatemic rickets:
hypophosphatemic rickets: effect
rickets: effect of
effect of phosphate
of phosphate supplementation
Abnormal renal tubular
renal tubular phosphate
tubular phosphate transport
phosphate transport is
transport is considered
is considered to
considered to be
to be the
be the primary
the primary defect
primary defect in
defect in X-linked
in X-linked hypophosphatemic
X-linked hypophosphatemic rickets
hypophosphatemic rickets XLH
However the resistance
the resistance to
resistance to vitamin
to vitamin D
vitamin D treatment
D treatment in
treatment in XLH
in XLH cannot
XLH cannot be
cannot be explained
be explained by
explained by hypophosphatemia
by hypophosphatemia alone
Since most of
most of the
of the actions
the actions of
actions of vitamin
of vitamin D
vitamin D are
D are mediated
are mediated by
mediated by its
by its receptors
its receptors VDR
receptors VDR abnormalities
VDR abnormalities of
abnormalities of VDR
of VDR have
VDR have been
have been postulated
been postulated in
postulated in XLH
In order to
order to investigate
to investigate this
investigate this possibility
this possibility we
possibility we measured
we measured the
measured the concentration
the concentration of
concentration of VDR
of VDR in
VDR in PHA-activated
in PHA-activated peripheral
PHA-activated peripheral mononuclear
peripheral mononuclear cells
mononuclear cells from
cells from 10
from 10 XLH
10 XLH patients
Patients without phosphate
without phosphate supplementation
phosphate supplementation showed
supplementation showed significantly
showed significantly lower
significantly lower concentration
lower concentration 217
concentration 217 +/-
217 +/- 51
+/- 51 fmol/mg
51 fmol/mg protein
fmol/mg protein mean
protein mean +/-
mean +/- SEM
+/- SEM compared
SEM compared to
compared to the
to the normal
the normal controls
normal controls 607
controls 607 +/-
607 +/- 40
On the contrary
the contrary there
contrary there was
there was no
was no significant
no significant difference
significant difference between
difference between the
between the phosphate-supplemented
the phosphate-supplemented patients
phosphate-supplemented patients 583
patients 583 +/-
583 +/- 27
+/- 27 and
27 and controls
There was a
was a significant
a significant positive
significant positive correlation
positive correlation between
correlation between VDR
between VDR concentration
VDR concentration and
concentration and serum
and serum phosphate
serum phosphate P
phosphate P less
P less than
less than 005
In two patients
two patients VDR
patients VDR was
VDR was increased
was increased after
increased after daily
after daily phosphate
daily phosphate supplementation
phosphate supplementation was
supplementation was started
These results indicate
results indicate that
indicate that a
that a decreased
a decreased concentration
decreased concentration of
concentration of VDR
of VDR secondary
VDR secondary to
secondary to persistent
to persistent hypophosphatemia
persistent hypophosphatemia is
hypophosphatemia is one
is one of
one of the
of the causes
the causes of
causes of vitamin
of vitamin D
vitamin D resistance
D resistance in
resistance in XLH
Two distinct forms
distinct forms of
forms of active
of active transcription
active transcription factor
transcription factor CREB
factor CREB cAMP
CREB cAMP response
cAMP response element
response element binding
element binding protein
Mammalian cells express
cells express two
express two distinct
two distinct forms
distinct forms of
forms of transcription
of transcription factor
transcription factor CREB
factor CREB cAMP
CREB cAMP response
cAMP response element
response element binding
element binding protein
binding protein that
protein that are
that are apparently
are apparently the
apparently the products
the products of
products of alternative
of alternative splicing
alternative splicing of
splicing of the
of the CREB
the CREB gene
CREB gene transcript
The two proteins
two proteins differ
proteins differ by
differ by a
by a 14-amino
a 14-amino acid
14-amino acid serine-rich
acid serine-rich insertion
serine-rich insertion present
insertion present in
present in one
in one of
one of the
of the CREB
the CREB isoforms
We show that
show that both
that both CREB
both CREB isoforms
CREB isoforms are
isoforms are expressed
are expressed in
expressed in many
in many cell
many cell types
cell types and
types and mammalian
and mammalian species
Both encode proteins
encode proteins that
proteins that bind
that bind specifically
bind specifically to
specifically to a
to a cAMP
a cAMP response
cAMP response element
response element in
element in vitro
As expected for
expected for proteins
for proteins of
proteins of this
of this class
this class the
class the CREB
the CREB proteins
CREB proteins bind
proteins bind DNA
bind DNA as
DNA as dimers
Both proteins impart
proteins impart cAMP-regulated
impart cAMP-regulated transcriptional
cAMP-regulated transcriptional activity
transcriptional activity to
activity to a
to a heterologous
a heterologous DNA-binding
heterologous DNA-binding domain
DNA-binding domain showing
domain showing that
showing that cAMP
that cAMP directly
cAMP directly modulates
directly modulates the
modulates the transcriptional
the transcriptional stimulatory
transcriptional stimulatory activity
stimulatory activity of
activity of CREB
The presence of
presence of multiple
of multiple CREB
multiple CREB isoforms
CREB isoforms with
isoforms with identical
with identical DNA-binding
identical DNA-binding specificities
DNA-binding specificities but
specificities but differences
but differences in
differences in the
in the presumed
the presumed regulatory
presumed regulatory domain
regulatory domain raises
domain raises the
raises the possibility
the possibility that
possibility that CREB
that CREB proteins
CREB proteins may
proteins may be
may be able
be able to
able to integrate
to integrate distinct
integrate distinct regulatory
distinct regulatory signals
regulatory signals at
signals at the
at the level
the level of
level of gene
of gene transcription
Human immunodeficiency virus
immunodeficiency virus vpr
virus vpr product
vpr product is
product is a
is a virion-associated
a virion-associated regulatory
virion-associated regulatory protein
The vpr product
vpr product of
product of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 acts
HIV-1 acts in
acts in trans
in trans to
trans to accelerate
to accelerate virus
accelerate virus replication
virus replication and
replication and cytopathic
and cytopathic effect
cytopathic effect in
effect in T
in T cells
Here it is
it is shown
is shown that
shown that the
that the HIV-1
the HIV-1 viral
HIV-1 viral particle
viral particle contains
particle contains multiple
contains multiple copies
multiple copies of
copies of the
of the vpr
the vpr protein
The vpr product
vpr product is
product is the
is the first
the first regulatory
first regulatory protein
regulatory protein of
protein of HIV-1
of HIV-1 to
HIV-1 to be
to be found
be found in
found in the
in the virus
the virus particle
This observation raises
observation raises the
raises the possibility
the possibility that
possibility that vpr
that vpr acts
vpr acts to
acts to facilitate
to facilitate the
facilitate the early
the early steps
early steps of
steps of infection
of infection before
infection before de
before de novo
de novo viral
novo viral protein
viral protein synthesis
protein synthesis occurs
A novel B-cell
novel B-cell lineage-specific
B-cell lineage-specific transcription
lineage-specific transcription factor
transcription factor present
factor present at
present at early
at early but
early but not
but not late
not late stages
late stages of
stages of differentiation
A novel B-cell-specific
novel B-cell-specific transcription
B-cell-specific transcription factor
transcription factor BSAP
factor BSAP was
BSAP was identified
was identified as
identified as a
as a mammalian
a mammalian homolog
mammalian homolog of
homolog of the
of the sea
the sea urchin
sea urchin protein
urchin protein TSAP
protein TSAP which
TSAP which interacts
which interacts with
interacts with the
with the promoters
the promoters of
promoters of four
of four tissue-specific
four tissue-specific late
tissue-specific late histone
late histone H2A-2
histone H2A-2 and
H2A-2 and H2B-2
and H2B-2 genes
As shown by
shown by mobility-shift
by mobility-shift methylation
mobility-shift methylation interference
methylation interference and
interference and mutational
and mutational analyses
mutational analyses the
analyses the mammalian
the mammalian protein
mammalian protein BSAP
protein BSAP recognizes
BSAP recognizes all
recognizes all four
all four sea
four sea urchin
sea urchin binding
urchin binding sites
binding sites in
sites in a
in a manner
a manner indistinguishable
manner indistinguishable from
indistinguishable from TSAP;
from TSAP; however
TSAP; however the
however the two
the two proteins
two proteins differ
proteins differ in
differ in molecular
in molecular weight
BSAP is exclusively
is exclusively restricted
exclusively restricted to
restricted to the
to the B-cell
the B-cell lineage
B-cell lineage of
lineage of lymphoid
of lymphoid differentiation
Its expression appears
expression appears to
appears to be
to be activated
be activated during
activated during pro-B-cell
during pro-B-cell development
pro-B-cell development is
development is abundant
is abundant at
abundant at the
at the pre-B-
the pre-B- and
pre-B- and mature
and mature B-cell
mature B-cell stages
B-cell stages but
stages but is
but is absent
is absent in
absent in terminally
in terminally differentiated
terminally differentiated plasma
differentiated plasma cells
Moreover BSAP is
BSAP is clearly
is clearly a
clearly a B-cell-specific
a B-cell-specific transcription
B-cell-specific transcription factor
transcription factor as
factor as a
as a wild-type
a wild-type but
wild-type but not
but not a
not a mutant
a mutant TSAP-binding
mutant TSAP-binding site
TSAP-binding site of
site of the
of the sea
the sea urchin
sea urchin functions
urchin functions only
functions only in
only in transfected
in transfected B
transfected B cells
B cells as
cells as an
as an upstream
an upstream promoter
upstream promoter element
Competition experiments did
experiments did not
did not reveal
not reveal any
reveal any high-affinity
any high-affinity binding
high-affinity binding site
binding site for
site for BSAP
for BSAP in
BSAP in known
in known regulatory
known regulatory regions
regulatory regions of
regions of immunoglobulin
of immunoglobulin and
immunoglobulin and class
and class II
class II major
II major histocompatibility
major histocompatibility MHC
histocompatibility MHC genes
MHC genes suggesting
genes suggesting that
suggesting that BSAP
that BSAP is
BSAP is a
is a regulator
a regulator of
regulator of a
of a different
a different set
different set of
set of B-lymphoid-specific
of B-lymphoid-specific genes
Octamer transcription factors
transcription factors and
factors and the
and the cell
the cell type-specificity
cell type-specificity of
type-specificity of immunoglobulin
of immunoglobulin gene
immunoglobulin gene expression
Antibodies are produced
are produced exclusively
produced exclusively in
exclusively in B
in B lymphocytes
The expression of
expression of the
of the antibody-encoding
the antibody-encoding genes
antibody-encoding genes the
genes the immunoglobulin
the immunoglobulin Ig
immunoglobulin Ig genes
Ig genes is
genes is also
is also restricted
also restricted to
restricted to B
to B cells
The octamer sequence
octamer sequence ATGCAAAT
sequence ATGCAAAT is
ATGCAAAT is present
is present in
present in the
in the promoter
the promoter and
promoter and the
and the enhancer
the enhancer of
enhancer of Ig
of Ig genes
Ig genes and
genes and plays
and plays an
plays an important
an important role
important role in
role in its
in its tissue-specific
its tissue-specific expression
This sequence motif
sequence motif is
motif is a
is a binding
a binding site
binding site for
site for nuclear
for nuclear proteins
nuclear proteins the
proteins the so-called
the so-called octamer
so-called octamer transcription
octamer transcription factors
transcription factors Oct
factors Oct or
Oct or OTF
or OTF factors
The Oct-1 protein
Oct-1 protein is
protein is present
is present in
present in all
in all cell
all cell types
cell types analyzed
types analyzed so
analyzed so far
so far whereas
far whereas Oct-2A
whereas Oct-2A and
Oct-2A and Oct-2B
and Oct-2B are
Oct-2B are found
are found mainly
found mainly in
mainly in B
in B lymphocytes
All three proteins
three proteins show
proteins show the
show the same
the same sequence
same sequence specificity
sequence specificity and
specificity and binding
and binding affinity
It appears that
appears that the
that the B
the B cell-specific
B cell-specific expression
cell-specific expression of
expression of Ig
of Ig genes
Ig genes is
genes is mediated
is mediated at
mediated at least
at least in
least in part
in part by
part by cell
by cell type-specific
cell type-specific Oct
type-specific Oct factors
Oct factors and
factors and that
and that there
that there are
there are both
are both quantitative
both quantitative and
quantitative and qualitative
and qualitative differences
qualitative differences between
differences between Oct-1
between Oct-1 and
Oct-1 and Oct-2
and Oct-2 factors
Recently a number
a number of
number of other
of other octamer
other octamer factor
octamer factor variants
factor variants were
variants were identified
Many of these
of these may
these may be
may be created
be created by
created by alternative
by alternative splicing
alternative splicing of
splicing of a
of a primary
a primary transcript
primary transcript of
transcript of one
of one Oct
one Oct factor
Oct factor gene
factor gene and
gene and may
and may serve
may serve a
serve a specific
a specific function
specific function in
function in the
in the fine
the fine tuning
fine tuning of
tuning of gene
of gene expression
A factor known
factor known to
known to bind
to bind to
bind to endogenous
to endogenous Ig
endogenous Ig heavy
Ig heavy chain
heavy chain enhancer
chain enhancer only
enhancer only in
only in lymphocytes
in lymphocytes is
lymphocytes is a
is a ubiquitously
a ubiquitously active
ubiquitously active transcription
active transcription factor
The transcriptional enhancer
transcriptional enhancer located
enhancer located in
located in the
in the first
the first intron
first intron of
intron of the
of the immunoglobulin
the immunoglobulin heavy
immunoglobulin heavy chain
heavy chain constant
chain constant region
constant region is
region is a
is a major
a major determinant
major determinant of
determinant of B-cell-specific
of B-cell-specific expression
B-cell-specific expression of
expression of immunoglobulin
of immunoglobulin genes
Like other enhancers
other enhancers the
enhancers the Ig
the Ig heavy
Ig heavy chain
heavy chain enhancer
chain enhancer contains
enhancer contains several
contains several short
several short sequence
short sequence motifs
sequence motifs that
motifs that bind
that bind specific
bind specific transcription
specific transcription factors
Each binding site
binding site contributes
site contributes to
contributes to the
to the overall
the overall activity
overall activity of
activity of the
of the enhancer
the enhancer however
enhancer however no
however no single
no single element
single element seems
element seems absolutely
seems absolutely required
absolutely required for
required for activity
For a better
a better understanding
better understanding of
understanding of the
of the Ig
the Ig heavy
Ig heavy chain
heavy chain enhancer
chain enhancer components
enhancer components we
components we have
we have cloned
have cloned and
cloned and analyzed
and analyzed individual
analyzed individual sequence
individual sequence elements
We find that
find that the
that the factor
the factor that
factor that binds
that binds to
binds to the
to the E3
the E3 enhancer
E3 enhancer motif
enhancer motif CATGTGGC
motif CATGTGGC is
CATGTGGC is a
is a ubiquitous
a ubiquitous transcription
ubiquitous transcription factor
It is present
is present in
present in an
in an active
an active form
active form in
form in both
in both B
both B cells
B cells and
cells and non-B
and non-B cells
non-B cells where
cells where it
where it can
it can mediate
can mediate transcriptional
mediate transcriptional activation
transcriptional activation in
activation in vitro
in vitro and
vitro and in
and in vivo
However despite its
despite its ability
its ability to
ability to activate
to activate transcription
activate transcription of
transcription of a
of a transfected
a transfected reporter
transfected reporter gene
reporter gene the
gene the factor
the factor is
factor is apparently
is apparently unable
apparently unable to
unable to bind
to bind to
bind to the
to the endogenous
the endogenous Ig
endogenous Ig heavy
Ig heavy chain
heavy chain enhancer
chain enhancer in
enhancer in non-lymphoid
in non-lymphoid cells:
non-lymphoid cells: In
cells: In previous
In previous experiments
previous experiments by
experiments by others
by others the
others the characteristic
the characteristic in
characteristic in vivo
in vivo footprint
vivo footprint of
footprint of this
of this factor
this factor designated
factor designated NF-muE3
designated NF-muE3 was
NF-muE3 was detected
was detected in
detected in B
in B cells
B cells but
cells but not
but not in
not in non-B
in non-B cells
From this and
this and other
and other findings
other findings the
findings the picture
the picture emerges
picture emerges that
emerges that there
that there are
there are at
are at least
at least three
least three categories
three categories of
categories of factors
of factors which
factors which mediate
which mediate cell-type-specific
mediate cell-type-specific transcription
cell-type-specific transcription in
transcription in B
in B lymphocytes:
B lymphocytes: a
lymphocytes: a cell-specific
a cell-specific factors
cell-specific factors such
factors such as
such as Oct-2A
as Oct-2A and
Oct-2A and Oct-2B
and Oct-2B that
Oct-2B that are
that are not
are not expressed
not expressed in
expressed in most
in most other
most other cell
other cell types:
cell types: b
types: b ubiquitous
b ubiquitous factors
ubiquitous factors such
factors such as
such as NF-kappa
as NF-kappa B
NF-kappa B that
B that are
that are constitutively
are constitutively active
constitutively active in
active in B
in B cells
B cells but
cells but are
but are sequestered
are sequestered in
sequestered in an
in an inactive
an inactive form
inactive form in
form in other
in other cells;
other cells; c
cells; c ubiquitously
c ubiquitously active
ubiquitously active factors
active factors exemplified
factors exemplified by
exemplified by the
by the one
the one binding
one binding to
binding to the
to the E3
the E3 sequence
E3 sequence motif
This factor is
factor is present
is present in
present in an
in an active
an active form
active form in
form in a
in a variety
a variety of
variety of cell
of cell types
cell types but
types but is
but is apparently
is apparently unable
apparently unable to
unable to bind
to bind to
bind to the
to the endogenous
the endogenous Ig
endogenous Ig heavy
Ig heavy chain
heavy chain enhancer
chain enhancer in
enhancer in non-B
in non-B cells
non-B cells perhaps
cells perhaps due
perhaps due to
due to a
to a non-permissive
a non-permissive chromatin
non-permissive chromatin structure
chromatin structure of
structure of the
of the Ig
the Ig heavy
Ig heavy chain
heavy chain locus
[Endocrine status changes
status changes in
changes in children
in children with
children with bronchial
with bronchial asthma]
A study was
study was made
was made of
made of adrenocortical
of adrenocortical function
adrenocortical function by
function by measuring
by measuring blood
measuring blood plasma
blood plasma cortisol
plasma cortisol concentration
cortisol concentration and
concentration and amount
and amount of
amount of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in lymphocytes
in lymphocytes as
lymphocytes as well
as well as
well as thyroid
as thyroid function
thyroid function by
function by measuring
by measuring blood
measuring blood plasma
blood plasma triidothyronine
plasma triidothyronine and
triidothyronine and thyroxine
and thyroxine concentration
thyroxine concentration in
concentration in 58
in 58 bronchial
58 bronchial asthma
bronchial asthma children
asthma children aged
children aged 1
aged 1 to
1 to 14
to 14 years
The authors revealed
authors revealed alterations
revealed alterations in
alterations in the
in the functional
the functional activity
functional activity of
activity of the
of the indicated
the indicated endocrine
indicated endocrine glands
endocrine glands depending
glands depending on
depending on the
on the intensity
the intensity of
intensity of bronchial
of bronchial patency
bronchial patency disorders
patency disorders and
disorders and the
and the nature
the nature of
nature of the
of the therapeutic
the therapeutic measures
therapeutic measures carried
measures carried out
TAR independent activation
independent activation of
activation of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus in
virus in phorbol
in phorbol ester
phorbol ester stimulated
ester stimulated T
stimulated T lymphocytes
Multiple regulatory elements
regulatory elements in
elements in the
in the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus long
virus long terminal
long terminal repeat
terminal repeat HIV
repeat HIV LTR
HIV LTR are
LTR are required
are required for
required for activation
for activation of
activation of HIV
of HIV gene
HIV gene expression
Previous transfection studies
transfection studies of
studies of HIV
of HIV LTR
HIV LTR constructs
LTR constructs linked
constructs linked to
linked to the
to the chloramphenicol
the chloramphenicol acetyltransferase
chloramphenicol acetyltransferase gene
acetyltransferase gene indicated
gene indicated that
indicated that multiple
that multiple regulatory
multiple regulatory regions
regulatory regions including
regions including the
including the enhancer
the enhancer SP1
enhancer SP1 TATA
SP1 TATA and
TATA and TAR
and TAR regions
TAR regions were
regions were important
were important for
important for HIV
for HIV gene
HIV gene expression
To characterize these
characterize these regulatory
these regulatory elements
regulatory elements further
elements further mutations
further mutations in
mutations in these
in these regions
these regions were
regions were inserted
were inserted into
inserted into both
into both the
both the 5'
the 5' and
5' and 3'
and 3' HIV
3' HIV LTRs
HIV LTRs and
LTRs and infectious
and infectious proviral
infectious proviral constructs
proviral constructs were
constructs were assembled
These constructs were
constructs were transfected
were transfected into
transfected into either
into either HeLa
either HeLa cells
HeLa cells Jurkat
cells Jurkat cells
Jurkat cells or
cells or U937
or U937 cells
U937 cells in
cells in both
in both the
both the presence
the presence and
presence and absence
and absence of
absence of phorbol
of phorbol esters
phorbol esters which
esters which have
which have previously
have previously been
previously been demonstrated
been demonstrated to
demonstrated to activate
to activate HIV
activate HIV gene
HIV gene expression
Viral gene expression
gene expression was
expression was assayed
was assayed by
assayed by the
by the level
the level of
level of p24
of p24 gag
p24 gag protein
gag protein released
protein released from
released from cultures
from cultures transfected
cultures transfected with
transfected with the
with the proviral
the proviral constructs
Results in all
in all cell
all cell lines
cell lines indicated
lines indicated that
indicated that mutations
that mutations of
mutations of the
of the SP1
the SP1 TATA
SP1 TATA and
TATA and the
and the TAR
the TAR loop
TAR loop and
loop and stem
and stem secondary
stem secondary structure
secondary structure resulted
structure resulted in
resulted in marked
in marked decreases
marked decreases in
decreases in gene
in gene expression
gene expression while
expression while mutations
while mutations of
mutations of the
of the enhancer
the enhancer motif
enhancer motif or
motif or TAR
or TAR primary
TAR primary sequence
primary sequence resulted
sequence resulted in
resulted in only
in only slight
only slight decreases
However viruses containing
viruses containing mutations
containing mutations in
mutations in either
in either the
either the TAR
the TAR loop
TAR loop sequences
loop sequences or
sequences or stem
or stem secondary
stem secondary structure
secondary structure which
structure which were
which were very
were very defective
very defective for
defective for gene
for gene expression
gene expression in
expression in untreated
in untreated Jurkat
untreated Jurkat cells
Jurkat cells gave
cells gave nearly
gave nearly wild-type
nearly wild-type levels
wild-type levels of
levels of gene
of gene expression
gene expression in
expression in phorbol
in phorbol ester-treated
phorbol ester-treated Jurkat
ester-treated Jurkat cells
Jurkat cells but
cells but not
but not in
not in phorbol
in phorbol ester-treated
phorbol ester-treated HeLa
ester-treated HeLa or
HeLa or U937
or U937 cells
High level gene
level gene expression
gene expression of
expression of these
of these TAR
these TAR mutant
TAR mutant constructs
mutant constructs in
constructs in phorbol
in phorbol ester-treated
phorbol ester-treated Jurkat
ester-treated Jurkat cells
Jurkat cells was
cells was eliminated
was eliminated by
eliminated by second
by second site
second site mutations
site mutations in
mutations in the
in the enhancer
the enhancer region
enhancer region or
region or by
or by disruption
by disruption of
disruption of the
of the tat
the tat gene
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
A case of
case of hypersensitivity
of hypersensitivity to
hypersensitivity to thyroid
to thyroid hormones
thyroid hormones with
hormones with normally
with normally functioning
normally functioning thyroid
functioning thyroid gland
thyroid gland and
gland and increased
and increased nuclear
increased nuclear triiodothyronine
nuclear triiodothyronine receptors
A 52-year-old male
52-year-old male presented
male presented himself
presented himself with
himself with tachycardia
with tachycardia crises
tachycardia crises which
crises which appeared
which appeared first
appeared first during
first during childhood
during childhood increased
childhood increased in
increased in frequency
in frequency without
frequency without goiter
without goiter or
goiter or exophthalmos
Cardiac and adrenergic
and adrenergic diseases
adrenergic diseases were
diseases were excluded
The thyroid function
thyroid function was
function was normal
was normal regarding
normal regarding T4
regarding T4 free
T4 free T4
free T4 and
T4 and T3
and T3 TBG
T3 TBG radioiodine
TBG radioiodine uptake
radioiodine uptake TSH
uptake TSH and
TSH and T3
and T3 suppressibility;
T3 suppressibility; however
suppressibility; however the
however the TSH
the TSH response
TSH response to
response to TRH
to TRH was
TRH was decreased
The lymphocyte nuclear
lymphocyte nuclear T3
nuclear T3 receptor
T3 receptor was
receptor was found
was found with
found with an
with an affinity
an affinity close
affinity close to
close to that
to that of
that of normal
of normal volunteers
normal volunteers Ka:
volunteers Ka: 142
Ka: 142 x
142 x 1010
x 1010 M-1
1010 M-1 vs
M-1 vs 195
vs 195 +/-
195 +/- 035
+/- 035 x
035 x 1010
x 1010 M-1
1010 M-1 and
M-1 and a
and a binding
a binding capacity
binding capacity markedly
capacity markedly increased
markedly increased 99
increased 99 vs
99 vs 37
vs 37 +/-
37 +/- 04
+/- 04 fmol
04 fmol T3/100
fmol T3/100 micrograms
T3/100 micrograms DNA
Pindolol was inefficient
was inefficient on
inefficient on the
on the dysrhythmia
the dysrhythmia which
dysrhythmia which disappeared
which disappeared with
disappeared with carbimazole
with carbimazole and
carbimazole and relapsed
and relapsed after
relapsed after withdrawal
after withdrawal of
withdrawal of the
of the antithyroid
the antithyroid drug
Under carbimazole the
carbimazole the plasma
the plasma T4
plasma T4 markedly
T4 markedly decreased
markedly decreased 277
decreased 277 +/-
277 +/- 36
+/- 36 nmol/l
36 nmol/l but
nmol/l but the
but the patient
the patient remained
patient remained euthyroid
The clinical course
clinical course and
course and the
and the laboratory
the laboratory data
laboratory data suggest
data suggest that
suggest that the
that the tachycardia
the tachycardia crises
tachycardia crises are
crises are the
are the consequence
the consequence of
consequence of a
of a hypersensitivity
a hypersensitivity of
hypersensitivity of the
of the heart
the heart to
heart to thyroid
to thyroid hormones
thyroid hormones associated
hormones associated with
associated with an
with an increased
an increased number
increased number of
number of T3
of T3 nuclear
T3 nuclear receptor
nuclear receptor sites
receptor sites in
sites in lymphocytes
Induction of immediate
of immediate early
immediate early response
early response genes
response genes by
genes by macrophage
by macrophage colony-stimulating
macrophage colony-stimulating factor
colony-stimulating factor in
factor in normal
in normal human
normal human monocytes
A group of
group of coordinately
of coordinately induced
coordinately induced protooncogenes
induced protooncogenes cytoskeletal
protooncogenes cytoskeletal and
cytoskeletal and extracellular
and extracellular matrix
extracellular matrix genes
matrix genes have
genes have been
have been termed
been termed immediate
termed immediate early
immediate early response
early response genes
response genes and
genes and their
and their induction
their induction has
induction has been
has been associated
been associated with
associated with growth
with growth factor-stimulated
growth factor-stimulated cell
factor-stimulated cell proliferation
We have investigated
have investigated the
investigated the induction
the induction of
induction of these
of these genes
these genes by
genes by macrophage-CSF
by macrophage-CSF M-CSF
macrophage-CSF M-CSF in
M-CSF in human
in human monocytes
human monocytes that
monocytes that do
that do not
do not proliferate
not proliferate in
proliferate in response
in response to
response to M-CSF
to M-CSF but
M-CSF but require
but require the
require the factor
the factor for
factor for optimal
for optimal cell
optimal cell differentiation
Normal human monocytes
human monocytes were
monocytes were isolated
were isolated carefully
isolated carefully washed
carefully washed and
washed and incubated
and incubated for
incubated for 36
for 36 to
36 to 48
to 48 h
48 h in
h in fetal
in fetal bovine
fetal bovine serum-containing
bovine serum-containing medium
At the end
the end of
end of this
of this incubation
this incubation the
incubation the resting
the resting cells
resting cells were
cells were stimulated
were stimulated with
stimulated with M-CSF
with M-CSF and
M-CSF and RNA
and RNA was
RNA was isolated
was isolated for
isolated for analysis
for analysis by
analysis by Northern
by Northern blotting
RNA from control
from control resting
control resting cells
resting cells contained
cells contained low
contained low to
low to undetectable
to undetectable levels
undetectable levels of
levels of c-jun
of c-jun fibronectin
c-jun fibronectin receptor
fibronectin receptor and
receptor and actin
and actin mRNA
Within 15 to
15 to 30
to 30 min
30 min of
min of addition
of addition of
addition of M-CSF
of M-CSF however
M-CSF however there
however there was
there was a
was a dramatic
a dramatic coordinate
dramatic coordinate induction
coordinate induction of
induction of these
of these genes
The c-jun gene
c-jun gene expression
gene expression was
expression was very
was very transient
very transient and
transient and was
and was not
was not detectable
not detectable by
detectable by 60
by 60 min
60 min after
min after M-CSF
after M-CSF addition
In contrast the
contrast the expression
the expression of
expression of actin
of actin and
actin and fibronectin
and fibronectin receptor
fibronectin receptor mRNA
receptor mRNA was
mRNA was more
was more sustained
more sustained and
sustained and the
and the expression
the expression of
expression of these
of these genes
these genes remained
genes remained elevated
remained elevated at
elevated at 24
at 24 to
24 to 48
to 48 h
48 h after
h after M-CSF
after M-CSF addition
We also observed
also observed the
observed the induction
the induction of
induction of the
of the myelomonocytic
the myelomonocytic specific
myelomonocytic specific tyrosine
specific tyrosine kinase
tyrosine kinase hck
kinase hck gene
hck gene simultaneously
gene simultaneously with
simultaneously with the
with the other
the other immediate
other immediate early
immediate early response
early response genes
The protein synthesis
protein synthesis inhibitor
synthesis inhibitor cycloheximide
inhibitor cycloheximide did
cycloheximide did not
did not block
not block the
block the induction
the induction of
induction of any
of any of
any of these
of these genes
these genes and
genes and in
and in fact
in fact super-induced
fact super-induced the
super-induced the expression
the expression of
expression of c-jun
of c-jun and
c-jun and hck
Nuclear run on
run on transcription
on transcription of
transcription of the
of the c-jun
the c-jun hck
c-jun hck and
hck and actin
and actin genes
Therefore in normal
in normal human
normal human monocytes
human monocytes M-CSF
monocytes M-CSF induces
M-CSF induces immediate
induces immediate early
immediate early response
early response genes
response genes without
genes without inducing
without inducing cell
inducing cell proliferation
These genes may
genes may then
may then play
then play a
play a role
a role in
role in altering
in altering the
altering the physiologic
the physiologic status
physiologic status of
status of the
of the cells
the cells in
cells in response
in response to
response to CSF
Inducible nuclear factor
nuclear factor binding
factor binding to
binding to the
to the kappa
the kappa B
kappa B elements
B elements of
elements of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus enhancer
virus enhancer in
enhancer in T
in T cells
T cells can
cells can be
can be blocked
be blocked by
blocked by cyclosporin
by cyclosporin A
cyclosporin A in
A in a
in a signal-dependent
a signal-dependent manner
Cyclosporin A CsA
A CsA is
CsA is thought
is thought to
thought to exert
to exert its
exert its immunosuppressive
its immunosuppressive effects
immunosuppressive effects by
effects by inhibiting
by inhibiting the
inhibiting the expression
the expression of
expression of a
of a distinct
a distinct set
distinct set of
set of lymphokine
of lymphokine genes
lymphokine genes which
genes which are
which are induced
are induced upon
induced upon T-cell
upon T-cell activation
T-cell activation among
activation among them
among them the
them the gene
the gene coding
gene coding for
coding for interleukin-2
In addition the
addition the activation
the activation of
activation of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV is
HIV is partially
is partially suppressed
To better understand
better understand the
understand the molecular
the molecular mechanisms
molecular mechanisms underlying
mechanisms underlying suppression
underlying suppression by
suppression by CsA
by CsA we
CsA we have
we have investigated
have investigated the
investigated the effects
the effects of
effects of this
of this drug
this drug on
drug on transcription
on transcription factors
transcription factors in
factors in T
in T cells
Here we report
we report that
report that the
that the formation
the formation of
formation of two
of two distinct
two distinct mitogen-inducible
distinct mitogen-inducible DNA-binding
mitogen-inducible DNA-binding complexes
DNA-binding complexes the
complexes the kappa
the kappa B
kappa B complex
B complex within
complex within the
within the HIV
the HIV enhancer
HIV enhancer and
enhancer and the
and the NFAT-1
the NFAT-1 complex
NFAT-1 complex within
complex within the
within the interleukin-2
the interleukin-2 enhancer
interleukin-2 enhancer is
enhancer is inhibited
is inhibited in
inhibited in the
in the presence
the presence of
presence of CsA
The kappa B-binding
kappa B-binding activity
B-binding activity with
activity with the
with the HIV
the HIV enhancer
HIV enhancer is
enhancer is inhibited
is inhibited only
inhibited only if
only if it
if it is
it is activated
is activated via
activated via the
via the mitogen
the mitogen phytohemagglutinin
mitogen phytohemagglutinin whereas
phytohemagglutinin whereas phorbol
whereas phorbol myristate
phorbol myristate acetate-mediated
myristate acetate-mediated activation
acetate-mediated activation is
activation is completely
is completely insensitive
completely insensitive to
insensitive to the
to the drug
This suggests a
suggests a model
a model in
model in which
in which functionally
which functionally indistinguishable
functionally indistinguishable kappa
indistinguishable kappa B
kappa B complexes
B complexes can
complexes can be
can be activated
be activated via
activated via two
via two separate
two separate pathways
separate pathways of
pathways of signal
of signal transduction
signal transduction distinguishable
transduction distinguishable by
distinguishable by CsA
Purification of TCF-1
of TCF-1 alpha
TCF-1 alpha a
alpha a T-cell-specific
a T-cell-specific transcription
T-cell-specific transcription factor
transcription factor that
factor that activates
that activates the
activates the T-cell
the T-cell receptor
T-cell receptor C
receptor C alpha
C alpha gene
alpha gene enhancer
gene enhancer in
enhancer in a
in a context-dependent
a context-dependent manner
The differentiation of
differentiation of T
of T cells
T cells into
cells into functionally
into functionally diverse
functionally diverse subpopulations
diverse subpopulations is
subpopulations is controlled
is controlled in
controlled in part
in part by
part by transcriptional
by transcriptional activation
transcriptional activation and
activation and silencing;
and silencing; however
silencing; however little
however little is
little is known
is known in
known in detail
in detail about
detail about the
about the proteins
the proteins that
proteins that influence
that influence this
influence this developmental
this developmental process
We have purified
have purified a
purified a new
a new T-cell-specific
new T-cell-specific factor
T-cell-specific factor TCF-1
factor TCF-1 alpha
TCF-1 alpha that
alpha that is
that is implicated
is implicated in
implicated in the
in the activation
the activation of
activation of genes
of genes encoding
genes encoding a
encoding a major
a major component
major component of
component of the
of the human
the human T-cell
human T-cell receptor
T-cell receptor TCR
TCF-1 alpha originally
alpha originally identified
originally identified and
identified and purified
and purified through
purified through its
through its binding
its binding sites
binding sites on
sites on the
on the HIV-1
the HIV-1 promoter
HIV-1 promoter was
promoter was found
was found to
found to bind
to bind to
bind to the
to the TCR
the TCR alpha
TCR alpha enhancer
alpha enhancer and
enhancer and to
and to promoters
to promoters for
promoters for several
for several genes
several genes expressed
genes expressed at
expressed at significantly
at significantly earlier
significantly earlier stages
earlier stages of
stages of T-cell
of T-cell development
T-cell development than
development than the
than the TCR
the TCR alpha
TCR alpha gene
alpha gene eg
gene eg p56lck
eg p56lck and
p56lck and CD3
and CD3 delta
Sequences related to
related to the
to the TCF-1
the TCF-1 alpha
TCF-1 alpha binding
alpha binding motif
binding motif 5'-GGCACCCTTTGA-3'
motif 5'-GGCACCCTTTGA-3' are
5'-GGCACCCTTTGA-3' are also
are also found
also found in
found in the
in the human
the human TCR
human TCR delta
TCR delta and
delta and possibly
and possibly TCR
possibly TCR beta
TCR beta enhancers
Southwestern and gel
and gel renaturation
gel renaturation experiments
renaturation experiments with
experiments with the
with the use
the use of
use of purified
of purified protein
purified protein fractions
protein fractions revealed
fractions revealed that
revealed that TCF-1
that TCF-1 alpha
TCF-1 alpha activity
alpha activity is
activity is derived
is derived from
derived from a
from a family
a family of
family of 57-
of 57- to
57- to 53-kD
to 53-kD proteins
53-kD proteins that
proteins that are
that are abundantly
are abundantly expressed
abundantly expressed in
expressed in mature
in mature and
mature and immature
and immature T-cell
immature T-cell lines
T-cell lines Jurkat
lines Jurkat CCRF-CEM
Jurkat CCRF-CEM and
CCRF-CEM and not
and not in
not in mature
in mature B
mature B cells
B cells JY
cells JY Namalwa
JY Namalwa or
Namalwa or nonlymphoid
or nonlymphoid HeLa
nonlymphoid HeLa cell
HeLa cell lines
A small 95-bp
small 95-bp fragment
95-bp fragment of
fragment of the
of the TCR
the TCR alpha
TCR alpha control
alpha control region
control region that
region that contains
that contains the
contains the TCF-1
the TCF-1 alpha
TCF-1 alpha binding
alpha binding site
binding site juxtaposed
site juxtaposed between
juxtaposed between a
between a cAMP-response
a cAMP-response element
cAMP-response element the
element the CRE
the CRE or
CRE or T
or T alpha
T alpha 1
alpha 1 motif
1 motif and
motif and the
and the binding
the binding site
binding site for
site for a
for a distinct
a distinct lymphoid-specific
distinct lymphoid-specific protein
lymphoid-specific protein TCF-2
protein TCF-2 alpha
TCF-2 alpha behaved
alpha behaved as
behaved as a
as a potent
a potent T-cell-specific
potent T-cell-specific enhancer
T-cell-specific enhancer in
enhancer in vivo
Tandem copies of
copies of this
of this enhancer
this enhancer functioned
enhancer functioned synergistically
functioned synergistically in
synergistically in mature
in mature Jurkat
mature Jurkat T-cell
Jurkat T-cell lines
T-cell lines as
lines as well
as well as
well as resting
as resting and
resting and activated
and activated immature
activated immature CCRF-CEM
immature CCRF-CEM T-cell
CCRF-CEM T-cell lines
Mutation of the
of the TCF-1
the TCF-1 alpha
TCF-1 alpha binding
alpha binding site
binding site diminished
site diminished enhancer
diminished enhancer activity
enhancer activity and
activity and disrupted
and disrupted the
disrupted the synergism
the synergism observed
synergism observed in
observed in vivo
in vivo between
vivo between tandem
between tandem enhancer
tandem enhancer repeats
The TCF-1 alpha
TCF-1 alpha binding
alpha binding site
binding site was
site was also
was also required
also required for
required for TCR
for TCR alpha
TCR alpha enhancer
alpha enhancer activity
enhancer activity in
activity in transcriptionally
in transcriptionally active
transcriptionally active extracts
active extracts from
extracts from Jurkat
from Jurkat but
Jurkat but not
but not HeLa
not HeLa cells
HeLa cells confirming
cells confirming that
confirming that TCF-1
that TCF-1 alpha
TCF-1 alpha is
alpha is a
is a T-cell-specific
a T-cell-specific transcription
T-cell-specific transcription factor
Curiously the TCF-1
the TCF-1 alpha
TCF-1 alpha binding
alpha binding element
binding element was
element was inactive
was inactive in
inactive in vivo
in vivo when
vivo when removed
when removed from
removed from its
from its neighboring
its neighboring elements
neighboring elements on
elements on the
on the TCR
the TCR alpha
TCR alpha enhancer
alpha enhancer and
enhancer and positioned
and positioned in
positioned in one
in one or
one or more
or more copies
more copies upstream
copies upstream of
upstream of a
of a heterologous
a heterologous promoter
Thus the transcriptional
the transcriptional activity
transcriptional activity of
activity of TCF-1
of TCF-1 alpha
TCF-1 alpha appears
alpha appears to
appears to depend
to depend on
depend on the
on the TCF-2
the TCF-2 alpha
TCF-2 alpha and
alpha and T
and T alpha
T alpha 1
alpha 1 CREB
1 CREB transcription
CREB transcription factors
transcription factors and
factors and the
and the context
the context of
context of its
of its binding
its binding site
binding site within
site within the
within the TCR
the TCR alpha
TCR alpha enhancer
Tandem AP-1-binding sites
AP-1-binding sites within
sites within the
within the human
the human beta-globin
human beta-globin dominant
beta-globin dominant control
dominant control region
control region function
region function as
function as an
as an inducible
an inducible enhancer
inducible enhancer in
enhancer in erythroid
in erythroid cells
A powerful enhancer
powerful enhancer has
enhancer has been
has been mapped
been mapped to
mapped to an
to an 18-bp
an 18-bp DNA
18-bp DNA segment
DNA segment located
segment located 11
located 11 kb
11 kb 5'
kb 5' to
5' to the
to the human
the human epsilon-globin
human epsilon-globin gene
epsilon-globin gene within
gene within the
within the dominant
the dominant control
dominant control or
control or locus-activating
or locus-activating region
This enhancer is
enhancer is inducible
is inducible in
inducible in K562
in K562 human
K562 human erythroleukemia
human erythroleukemia cells
erythroleukemia cells increasing
cells increasing linked
increasing linked gamma-globin
linked gamma-globin promoter/luciferase
gamma-globin promoter/luciferase gene
promoter/luciferase gene expression
gene expression to
expression to 170-fold
to 170-fold over
170-fold over an
over an enhancerless
an enhancerless construct
The enhancer consists
enhancer consists of
consists of tandem
of tandem AP-1-binding
tandem AP-1-binding sites
AP-1-binding sites phased
sites phased 10
phased 10 bp
10 bp apart
bp apart which
apart which are
which are both
are both required
both required for
required for full
for full activity
DNA-protein binding assays
binding assays with
assays with nuclear
with nuclear extracts
nuclear extracts from
extracts from induced
from induced cells
induced cells demonstrate
cells demonstrate a
demonstrate a high
a high molecular
high molecular weight
molecular weight complex
weight complex on
complex on the
on the enhancer
The formation of
formation of this
of this complex
this complex also
complex also requires
also requires both
requires both AP-1
both AP-1 sites
AP-1 sites and
sites and correlates
and correlates with
correlates with maximal
with maximal enhancer
maximal enhancer activity
Induction of the
of the enhancer
the enhancer may
enhancer may have
may have a
have a role
a role in
role in the
in the increase
the increase in
increase in globin
in globin gene
globin gene transcription
gene transcription that
transcription that characterizes
that characterizes erythroid
characterizes erythroid maturation
Enhancer activity appears
activity appears to
appears to be
to be mediated
be mediated by
mediated by the
by the binding
the binding of
binding of a
of a complex
a complex of
complex of proteins
of proteins from
proteins from the
from the jun
the jun and
jun and fos
and fos families
fos families to
families to tandem
to tandem AP-1
tandem AP-1 consensus
AP-1 consensus sequences
Identification of a
of a novel
a novel factor
novel factor that
factor that interacts
that interacts with
interacts with an
with an immunoglobulin
an immunoglobulin heavy-chain
immunoglobulin heavy-chain promoter
heavy-chain promoter and
promoter and stimulates
and stimulates transcription
stimulates transcription in
transcription in conjunction
in conjunction with
conjunction with the
with the lymphoid
the lymphoid cell-specific
lymphoid cell-specific factor
cell-specific factor OTF2
The tissue-specific expression
tissue-specific expression of
expression of the
of the MOPC
the MOPC 141
MOPC 141 immunoglobulin
141 immunoglobulin heavy-chain
immunoglobulin heavy-chain gene
heavy-chain gene was
gene was studied
was studied by
studied by using
by using in
using in vitro
in vitro transcription
B-cell-specific transcription of
transcription of this
of this gene
this gene was
gene was dependent
was dependent on
dependent on the
on the octamer
the octamer element
octamer element 5'-ATGCAAAG-3'
element 5'-ATGCAAAG-3' located
5'-ATGCAAAG-3' located in
located in the
in the upstream
the upstream region
upstream region of
region of this
of this promoter
this promoter and
promoter and in
and in the
in the promoters
the promoters of
promoters of all
of all other
all other immunoglobulin
other immunoglobulin heavy-
immunoglobulin heavy- and
heavy- and light-chain
and light-chain genes
The interaction of
interaction of purified
of purified octamer
purified octamer transcription
octamer transcription factors
transcription factors 1
factors 1 and
1 and 2
and 2 OTF1
2 OTF1 and
OTF1 and OTF2
and OTF2 with
OTF2 with the
with the MOPC
the MOPC 141
MOPC 141 promoter
141 promoter was
promoter was studied
was studied by
studied by using
by using electrophoretic
using electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
shift assays and
assays and DNase
and DNase I
DNase I footprinting
Purified OTF1 from
OTF1 from HeLa
from HeLa cells
HeLa cells and
cells and OTF1
and OTF1 and
OTF1 and OTF2
and OTF2 from
OTF2 from B
from B cells
B cells bound
cells bound to
bound to identical
to identical sequences
identical sequences within
sequences within the
within the heavy-chain
the heavy-chain promoter
The OTF interactions
OTF interactions we
interactions we observed
we observed extended
observed extended over
extended over the
over the heptamer
the heptamer element
heptamer element 5'-CTCAGGA-3'
element 5'-CTCAGGA-3' and
5'-CTCAGGA-3' and it
and it seems
it seems likely
seems likely that
likely that the
that the binding
the binding of
binding of the
of the purified
the purified factors
purified factors involves
factors involves cooperation
involves cooperation between
cooperation between octamer
between octamer and
octamer and heptamer
and heptamer sites
heptamer sites in
sites in this
in this promoter
In addition to
addition to these
to these elements
these elements we
elements we identified
we identified a
identified a second
a second regulatory
second regulatory element
regulatory element the
element the N
the N element
N element with
element with the
with the sequence
the sequence 5'-GGAACCTCCCCC-3'
The N element
N element could
element could independently
could independently mediate
independently mediate low
mediate low levels
low levels of
levels of transcription
of transcription in
transcription in both
in both B-cell
both B-cell and
B-cell and HeLa-cell
and HeLa-cell extracts
HeLa-cell extracts and
extracts and in
and in conjunction
in conjunction with
conjunction with the
with the octamer
the octamer element
octamer element it
element it can
it can promote
can promote high
promote high levels
high levels of
levels of transcription
of transcription in
transcription in B-cell
in B-cell extracts
The N element
N element bound
element bound a
bound a transcription
a transcription factor
transcription factor NTF
factor NTF that
NTF that is
that is ubiquitous
is ubiquitous in
ubiquitous in cell-type
in cell-type distribution
cell-type distribution and
distribution and NTF
and NTF was
NTF was distinct
was distinct from
distinct from any
from any of
any of the
of the previously
the previously described
previously described proteins
described proteins that
proteins that bind
that bind to
bind to similar
to similar sequences
Based on these
on these results
these results we
results we propose
we propose that
propose that NTF
that NTF and
NTF and OTF2
and OTF2 interactions
OTF2 interactions both
interactions both with
both with their
with their cognate
their cognate DNA
cognate DNA elements
DNA elements and
elements and possibly
and possibly at
possibly at the
at the protein-protein
the protein-protein level
protein-protein level may
level may be
may be critical
be critical to
critical to B-cell-specific
to B-cell-specific expression
B-cell-specific expression and
expression and that
and that these
that these interactions
these interactions provide
interactions provide additional
provide additional pathways
additional pathways for
pathways for regulating
for regulating gene
regulating gene expression
NF-kappa B as
B as inducible
as inducible transcriptional
inducible transcriptional activator
transcriptional activator of
activator of the
of the granulocyte-macrophage
the granulocyte-macrophage colony-stimulating
granulocyte-macrophage colony-stimulating factor
colony-stimulating factor gene
The expression of
expression of the
of the gene
the gene encoding
gene encoding the
encoding the granulocyte-macrophage
the granulocyte-macrophage colony-stimulating
granulocyte-macrophage colony-stimulating factor
colony-stimulating factor GM-CSF
factor GM-CSF is
GM-CSF is induced
is induced upon
induced upon activation
upon activation of
activation of T
of T cells
T cells with
cells with phytohemagglutinin
with phytohemagglutinin and
phytohemagglutinin and active
and active phorbolester
active phorbolester and
phorbolester and upon
and upon expression
upon expression of
expression of tax1
of tax1 a
tax1 a transactivating
a transactivating protein
transactivating protein of
protein of the
of the human
the human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type I
The same agents
same agents induce
agents induce transcription
induce transcription from
transcription from the
from the interleukin-2
the interleukin-2 receptor
interleukin-2 receptor alpha-chain
receptor alpha-chain and
alpha-chain and interleukin-2
and interleukin-2 genes
interleukin-2 genes depending
genes depending on
depending on promoter
on promoter elements
promoter elements that
elements that bind
that bind the
bind the inducible
the inducible transcription
inducible transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B or
B or an
or an NF-kappa
an NF-kappa B-like
NF-kappa B-like factor
We therefore tested
therefore tested the
tested the possibility
the possibility that
possibility that the
that the GM-CSF
the GM-CSF gene
GM-CSF gene is
gene is also
is also regulated
also regulated by
regulated by a
by a cognate
a cognate motif
cognate motif for
motif for the
for the NF-kappa
the NF-kappa B
NF-kappa B transcription
B transcription factor
A recent functional
recent functional analysis
functional analysis by
analysis by Miyatake
by Miyatake et
Miyatake et al
et al S
al S Miyatake
S Miyatake M
Miyatake M Seiki
M Seiki M
Seiki M Yoshida
M Yoshida and
Yoshida and K
and K Arai
K Arai Mol
Arai Mol Cell
Mol Cell Biol
Cell Biol 8:5581-5587
Biol 8:5581-5587 1988
8:5581-5587 1988 described
1988 described a
described a short
a short promoter
short promoter region
promoter region in
region in the
in the GM-CSF
the GM-CSF gene
GM-CSF gene that
gene that conferred
that conferred strong
conferred strong inducibility
strong inducibility by
inducibility by T-cell-activating
by T-cell-activating signals
T-cell-activating signals and
signals and tax1
and tax1 but
tax1 but no
but no NF-kappa
no NF-kappa B-binding
NF-kappa B-binding motifs
B-binding motifs were
motifs were identified
Using electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
shift assays we
assays we showed
we showed binding
showed binding of
binding of purified
of purified human
purified human NF-kappa
human NF-kappa B
NF-kappa B and
B and of
and of the
of the NF-kappa
the NF-kappa B
NF-kappa B activated
B activated in
activated in Jurkat
in Jurkat T
Jurkat T cells
T cells to
cells to an
to an oligonucleotide
an oligonucleotide comprising
oligonucleotide comprising the
comprising the GM-CSF
the GM-CSF promoter
GM-CSF promoter element
promoter element responsible
element responsible for
responsible for mediating
for mediating responsiveness
mediating responsiveness to
responsiveness to T-cell-activating
to T-cell-activating signals
T-cell-activating signals and
signals and tax1
As shown by
shown by a
by a methylation
a methylation interference
methylation interference analysis
interference analysis and
analysis and oligonucleotide
and oligonucleotide competition
oligonucleotide competition experiments
competition experiments purified
experiments purified NF-kappa
purified NF-kappa B
NF-kappa B binds
B binds at
binds at positions
at positions -82
positions -82 to
-82 to -91
to -91 GGGAACTACC
-91 GGGAACTACC of
GGGAACTACC of the
of the GM-CSF
the GM-CSF promoter
GM-CSF promoter sequence
promoter sequence with
sequence with an
with an affinity
an affinity similar
affinity similar to
similar to that
to that with
that with which
with which it
which it binds
it binds to
binds to the
to the biologically
the biologically functional
biologically functional kappa
functional kappa B
kappa B motif
B motif in
motif in the
in the beta
the beta interferon
beta interferon promoter
interferon promoter GGGAAATTCC
Two kappa B-like
kappa B-like motifs
B-like motifs at
motifs at positions
at positions -98
positions -98 to
-98 to -108
to -108 of
-108 of the
of the GM-CSF
the GM-CSF promoter
GM-CSF promoter were
promoter were also
were also recognized
also recognized but
recognized but with
but with much
with much lower
much lower affinities
Our data provide
data provide strong
provide strong evidence
strong evidence that
evidence that the
that the expression
the expression of
expression of the
of the GM-CSF
the GM-CSF gene
GM-CSF gene following
gene following T-cell
following T-cell activation
T-cell activation is
activation is controlled
is controlled by
controlled by binding
by binding of
binding of the
of the NF-kappa
the NF-kappa B
NF-kappa B transcription
B transcription factor
transcription factor to
factor to a
to a high-affinity
a high-affinity binding
high-affinity binding site
binding site in
site in the
in the GM-CSF
the GM-CSF promoter
Effects of mitogenic
of mitogenic agents
mitogenic agents upon
agents upon glucocorticoid
upon glucocorticoid action
glucocorticoid action in
action in human
in human tonsillar
human tonsillar T-lymphocytes
The treatment of
treatment of human
of human tonsillar
human tonsillar T-lymphocytes
tonsillar T-lymphocytes with
T-lymphocytes with 4-phorbol
with 4-phorbol 12-myristate
4-phorbol 12-myristate 13-acetate
12-myristate 13-acetate PMA
13-acetate PMA resulted
PMA resulted in
resulted in about
in about two
about two fold
two fold increase
fold increase in
increase in glucocorticoid
in glucocorticoid receptor
glucocorticoid receptor GR
receptor GR number
GR number without
number without any
without any significant
any significant change
significant change in
change in the
in the receptor
the receptor affinity
This increase disappeared
increase disappeared in
disappeared in the
in the presence
the presence of
presence of cycloheximide
Alone PMA and
PMA and calcium
and calcium ionophore
calcium ionophore A23187
ionophore A23187 did
A23187 did not
did not affect
not affect but
affect but together
but together stimulated
together stimulated like
stimulated like phytohaemagglutinin
like phytohaemagglutinin PHA
phytohaemagglutinin PHA leucine
PHA leucine and
leucine and in
and in particular
in particular thymidine
particular thymidine incorporation
PMA enhanced slightly
enhanced slightly the
slightly the stimulatory
the stimulatory effect
stimulatory effect of
effect of PHA
Alone these agents
these agents failed
agents failed to
failed to alter
to alter the
alter the suppressive
the suppressive effect
suppressive effect of
effect of dexamethasone
of dexamethasone on
dexamethasone on thymidine
on thymidine and
thymidine and leucine
and leucine incorporation;
leucine incorporation; however
incorporation; however PMA-A23187
however PMA-A23187 and
PMA-A23187 and PMA-PHA
and PMA-PHA combinations
PMA-PHA combinations appeared
combinations appeared to
appeared to antagonize
to antagonize the
antagonize the suppression
the suppression by
suppression by dexamethasone
To be or
be or not
or not to
not to be
to be a
be a responder
a responder in
responder in T-cell
in T-cell responses:
T-cell responses: ubiquitous
responses: ubiquitous oligopeptides
ubiquitous oligopeptides in
oligopeptides in all
in all proteins
Amino acid sequences
acid sequences of
sequences of all
of all proteins
all proteins are
proteins are essays
are essays written
essays written in
written in the
in the same
the same language
Accordingly the same
the same set
same set of
set of words
of words and
words and phrases
and phrases oligopeptides
phrases oligopeptides appear
oligopeptides appear in
appear in totally
in totally unrelated
totally unrelated proteins
The reason that
reason that only
that only certain
only certain individuals
certain individuals of
individuals of particular
of particular major
particular major histocompatibility
major histocompatibility complex
histocompatibility complex MHC
complex MHC haplotypes
MHC haplotypes can
haplotypes can mount
can mount T-cell
mount T-cell responses
T-cell responses against
responses against a
against a given
a given antigen
given antigen of
antigen of pathogens
of pathogens is
pathogens is found
is found in
found in the
in the fact
the fact that
fact that T-cell
that T-cell receptors
T-cell receptors are
receptors are designed
are designed to
designed to recognize
to recognize 18-20
recognize 18-20 residue-long
18-20 residue-long peptide
residue-long peptide fragments
peptide fragments sandwiched
fragments sandwiched between
sandwiched between two
between two alpha-helices
two alpha-helices of
alpha-helices of class
of class I
class I or
I or class
or class II
class II MHC
II MHC molecules
At this range
this range of
range of peptide
of peptide lengths
peptide lengths most
lengths most would
most would appear
would appear as
appear as self
as self while
self while nonselfness
while nonselfness of
nonselfness of the
of the remainders
the remainders are
remainders are destined
are destined to
destined to be
to be quite
be quite ambiguous
quite ambiguous hence
ambiguous hence creating
hence creating responders
creating responders and
responders and nonresponders
Two distinct signal
distinct signal transmission
signal transmission pathways
transmission pathways in
pathways in T
in T lymphocytes
T lymphocytes are
lymphocytes are inhibited
are inhibited by
inhibited by complexes
by complexes formed
complexes formed between
formed between an
between an immunophilin
an immunophilin and
immunophilin and either
and either FK506
either FK506 or
FK506 or rapamycin
Proliferation and immunologic
and immunologic function
immunologic function of
function of T
of T lymphocytes
T lymphocytes are
lymphocytes are initiated
are initiated by
initiated by signals
by signals from
signals from the
from the antigen
the antigen receptor
antigen receptor that
receptor that are
that are inhibited
are inhibited by
inhibited by the
by the immunosuppressant
the immunosuppressant FK506
immunosuppressant FK506 but
FK506 but not
but not by
not by its
by its structural
its structural analog
structural analog rapamycin
On the other
the other hand
other hand interleukin
hand interleukin 2
interleukin 2 IL-2-induced
2 IL-2-induced signals
IL-2-induced signals are
signals are blocked
are blocked by
blocked by rapamycin
by rapamycin but
rapamycin but not
but not by
not by FK506
Remarkably these two
these two drugs
two drugs inhibit
drugs inhibit each
inhibit each other's
each other's actions
other's actions raising
actions raising the
raising the possibility
the possibility that
possibility that both
that both act
both act by
act by means
by means of
means of a
of a common
a common immunophilin
common immunophilin immunosuppressant
immunophilin immunosuppressant binding
immunosuppressant binding protein
We find that
find that the
that the dissociation
the dissociation constant
dissociation constant of
constant of rapamycin
of rapamycin to
rapamycin to the
to the FK506
the FK506 binding
FK506 binding protein
binding protein FKBP
protein FKBP Kd
FKBP Kd =
Kd = 02
= 02 nM
02 nM is
nM is close
is close to
close to the
to the dissociation
the dissociation constant
dissociation constant of
constant of FK506
of FK506 to
FK506 to FKBP
to FKBP Kd
FKBP Kd =
Kd = 04
= 04 nM
04 nM and
nM and to
and to their
to their effective
their effective biologic
effective biologic inhibitory
biologic inhibitory concentrations
However an excess
an excess of
excess of rapamycin
of rapamycin is
rapamycin is needed
is needed to
needed to revert
to revert FK506-mediated
revert FK506-mediated inhibition
FK506-mediated inhibition of
inhibition of IL-2
of IL-2 production
IL-2 production apoptosis
production apoptosis and
apoptosis and transcriptional
and transcriptional activation
transcriptional activation of
activation of NF-AT
of NF-AT a
NF-AT a T-cell-specific
a T-cell-specific transcription
T-cell-specific transcription factor
transcription factor necessary
factor necessary for
necessary for IL-2
for IL-2 gene
IL-2 gene activation
Similarly an excess
an excess of
excess of FK506
of FK506 is
FK506 is needed
is needed to
needed to revert
to revert rapamycin-mediated
revert rapamycin-mediated inhibition
rapamycin-mediated inhibition of
inhibition of IL-2-induced
of IL-2-induced proliferation
The drug concentrations
drug concentrations required
concentrations required for
required for antagonism
for antagonism may
antagonism may be
may be explained
be explained by
explained by the
by the relative
the relative affinity
relative affinity of
affinity of the
of the drugs
the drugs to
drugs to and
to and by
and by the
by the abundance
the abundance of
abundance of the
of the immunophilin
the immunophilin FKBP
FKBP has been
has been shown
been shown to
shown to catalyze
to catalyze the
catalyze the interconversion
the interconversion of
interconversion of the
of the cis-
the cis- and
cis- and trans-rotamers
and trans-rotamers of
trans-rotamers of the
of the peptidyl-prolyl
the peptidyl-prolyl amide
peptidyl-prolyl amide bond
amide bond of
bond of peptide
of peptide substrates;
peptide substrates; here
substrates; here we
here we show
we show that
show that rapamycin
that rapamycin like
rapamycin like FK506
like FK506 is
FK506 is a
is a potent
a potent inhibitor
potent inhibitor of
inhibitor of the
of the rotamase
the rotamase activity
rotamase activity of
activity of FKBP
of FKBP Ki
FKBP Ki =
Ki = 02
= 02 nM
Neither FKBP binding
FKBP binding nor
binding nor inhibition
nor inhibition of
inhibition of rotamase
of rotamase activity
rotamase activity of
activity of FKBP
of FKBP alone
FKBP alone is
alone is sufficient
is sufficient to
sufficient to explain
to explain the
explain the biologic
the biologic actions
biologic actions of
actions of these
of these drugs
Rather these findings
these findings suggest
findings suggest that
suggest that immunophilin
that immunophilin bound
immunophilin bound to
bound to FK506
to FK506 interferes
FK506 interferes with
interferes with antigen
with antigen receptor-induced
antigen receptor-induced signals
receptor-induced signals while
signals while rapamycin
while rapamycin bound
rapamycin bound to
bound to the
to the immunophilin
the immunophilin interferes
immunophilin interferes with
interferes with IL-2-induced
with IL-2-induced signals
Adherence-dependent increase in
increase in human
in human monocyte
human monocyte PDGFB
monocyte PDGFB mRNA
PDGFB mRNA is
mRNA is associated
is associated with
associated with increases
with increases in
increases in c-fos
in c-fos c-jun
c-fos c-jun and
c-jun and EGR2
and EGR2 mRNA
Adherence is an
is an important
an important initial
important initial step
initial step in
step in the
in the transition
the transition of
transition of a
of a circulating
a circulating monocyte
circulating monocyte to
monocyte to a
to a tissue
a tissue macrophage
This differentiation is
differentiation is accompanied
is accompanied by
accompanied by an
by an augmented
an augmented capacity
augmented capacity to
capacity to generate
to generate growth
generate growth factors
We hypothesized that
hypothesized that adherence
that adherence itself
adherence itself might
itself might be
might be an
be an important
an important trigger
important trigger for
trigger for a
for a sequence
a sequence of
sequence of gene
of gene activation
gene activation culminating
activation culminating in
culminating in cells
in cells with
cells with increased
with increased mRNA
increased mRNA encoding
mRNA encoding profibrotic
encoding profibrotic growth
profibrotic growth factors
growth factors such
factors such as
such as platelet-derived
as platelet-derived growth
platelet-derived growth factor
growth factor B
factor B subunit
B subunit PDGF[B]
subunit PDGF[B] and
PDGF[B] and transforming
and transforming growth
transforming growth factor-beta
growth factor-beta TGF-beta
After in vitro
in vitro adherence
vitro adherence human
adherence human monocytes
human monocytes had
monocytes had a
had a biphasic
a biphasic increase
biphasic increase in
increase in PDGFB
in PDGFB mRNA
PDGFB mRNA with
mRNA with peaks
with peaks at
peaks at 6
at 6 h
6 h and
h and 13
and 13 d
No increase in
increase in TGF-beta
in TGF-beta mRNA
TGF-beta mRNA was
mRNA was observed
The 6-h increase
6-h increase in
increase in PDGFB
in PDGFB mRNA
PDGFB mRNA was
mRNA was adherence
was adherence dependent
adherence dependent and
dependent and in
and in addition
in addition was
addition was abrogated
was abrogated when
abrogated when the
when the cytoskeletal
the cytoskeletal integrity
cytoskeletal integrity was
integrity was compromised
was compromised by
compromised by cytochalasin
by cytochalasin D
The 6-h increase
6-h increase in
increase in PDGFB
in PDGFB mRNA
PDGFB mRNA was
mRNA was unaltered
was unaltered by
unaltered by adherence
by adherence in
adherence in the
in the presence
the presence of
presence of the
of the monocyte
the monocyte stimulus
monocyte stimulus lipopolysaccharide
Adherence to either
to either fibronectin
either fibronectin or
fibronectin or collagen-coated
or collagen-coated plastic
collagen-coated plastic had
plastic had little
had little consistent
little consistent effect
consistent effect on
effect on PDGFB
on PDGFB mRNA
PDGFB mRNA accumulation
The increased PDGFB
increased PDGFB mRNA
PDGFB mRNA observed
mRNA observed in
observed in adherent
in adherent monocytes
adherent monocytes was
monocytes was accompanied
was accompanied by
accompanied by increases
by increases in
increases in mRNAs
in mRNAs of
mRNAs of the
of the early
the early growth
early growth response
growth response genes
response genes c-fos
genes c-fos maximal
c-fos maximal at
maximal at 20
at 20 min
20 min c-jun
min c-jun and
c-jun and EGR2
and EGR2 maximal
EGR2 maximal at
maximal at 6-24
at 6-24 h
The increase in
increase in c-jun
in c-jun and
c-jun and EGR2
and EGR2 but
EGR2 but not
but not c-fos
not c-fos mRNA
c-fos mRNA was
mRNA was also
was also abrogated
also abrogated by
abrogated by cytochalasin
by cytochalasin D
These observations suggest
observations suggest that
suggest that adherence
that adherence results
adherence results in
results in increases
in increases of
increases of c-fos
of c-fos c-jun
c-fos c-jun EGR2
c-jun EGR2 and
EGR2 and PDGFB
and PDGFB mRNA
In addition the
addition the increases
the increases in
increases in c-jun
in c-jun EGR2
c-jun EGR2 and
EGR2 and PDGFB
and PDGFB may
PDGFB may depend
may depend on
depend on cytoskeletal
on cytoskeletal rearrangement
Modulation of these
of these events
these events at
events at the
at the time
the time of
time of adherence
of adherence offers
adherence offers a
offers a mechanism
a mechanism by
mechanism by which
by which differential
which differential priming
differential priming of
priming of the
of the cells
the cells may
cells may be
may be accomplished
Single cell assay
cell assay of
assay of a
of a transcription
a transcription factor
transcription factor reveals
factor reveals a
reveals a threshold
a threshold in
threshold in transcription
in transcription activated
transcription activated by
activated by signals
by signals emanating
signals emanating from
emanating from the
from the T-cell
the T-cell antigen
T-cell antigen receptor
Stimulation of T
of T lymphocytes
T lymphocytes through
lymphocytes through their
through their antigen
their antigen receptor
antigen receptor leads
receptor leads to
leads to the
to the appearance
the appearance of
appearance of several
of several transcription
several transcription factors
transcription factors including
factors including NF-AT
including NF-AT and
NF-AT and NF-kappa
and NF-kappa B
NF-kappa B which
B which are
which are involved
are involved in
involved in regulating
in regulating genes
regulating genes required
genes required for
required for immunologic
for immunologic activation
To investigate the
investigate the activity
the activity of
activity of a
of a single
a single transcription
single transcription factor
transcription factor in
factor in individual
in individual viable
individual viable cells
viable cells we
cells we have
we have applied
have applied an
applied an assay
an assay that
assay that uses
that uses the
uses the fluorescence-activated
the fluorescence-activated cell
fluorescence-activated cell sorter
cell sorter to
sorter to quantitate
to quantitate beta-galactosidase
quantitate beta-galactosidase beta-gal
We have analyzed
have analyzed the
analyzed the distribution
the distribution of
distribution of NF-AT
of NF-AT transcriptional
NF-AT transcriptional activity
transcriptional activity among
activity among T
among T cells
T cells undergoing
cells undergoing activation
undergoing activation by
activation by using
by using a
using a construct
a construct in
construct in which
in which three
which three tandem
three tandem copies
tandem copies of
copies of the
of the NF-AT-binding
the NF-AT-binding site
NF-AT-binding site directs
site directs transcription
directs transcription of
transcription of the
of the lacZ
the lacZ gene
Unexpectedly stimulation of
stimulation of cloned
of cloned stably
cloned stably transfected
stably transfected Jurkat
transfected Jurkat T
Jurkat T cells
T cells leads
cells leads to
leads to a
to a bimodal
a bimodal pattern
bimodal pattern of
pattern of beta-gal
of beta-gal expression
beta-gal expression in
expression in which
in which some
which some cells
some cells express
cells express no
express no beta-gal
no beta-gal and
beta-gal and others
and others express
others express high
express high levels
This expression pattern
expression pattern cannot
pattern cannot be
cannot be accounted
be accounted for
accounted for by
for by cell-cycle
by cell-cycle position
cell-cycle position or
position or heritable
or heritable variation
Further results in
results in which
in which beta-gal
which beta-gal activity
beta-gal activity is
activity is correlated
is correlated with
correlated with NF-AT-binding
with NF-AT-binding activity
NF-AT-binding activity indicate
activity indicate that
indicate that the
that the concentration
the concentration of
concentration of NF-AT
of NF-AT must
NF-AT must exceed
must exceed a
exceed a critical
a critical threshold
critical threshold before
threshold before transcription
before transcription initiates
This threshold likely
threshold likely reflects
likely reflects the
reflects the NF-AT
the NF-AT concentration-dependent
NF-AT concentration-dependent assembly
concentration-dependent assembly of
assembly of transcription
of transcription complexes
transcription complexes at
complexes at the
at the promoter
Similar constructs controlled
constructs controlled by
controlled by NF-kappa
by NF-kappa B
NF-kappa B or
B or the
or the entire
the entire interleukin-2
entire interleukin-2 enhancer
interleukin-2 enhancer show
enhancer show bimodal
show bimodal expression
bimodal expression patterns
expression patterns during
patterns during induction
during induction suggesting
induction suggesting that
suggesting that thresholds
that thresholds set
thresholds set by
set by the
by the concentration
the concentration of
concentration of transcription
of transcription factors
transcription factors may
factors may be
may be a
be a common
a common property
common property of
property of inducible
of inducible genes
The Epstein-Barr virus
Epstein-Barr virus EBV
virus EBV BMRF1
EBV BMRF1 promoter
BMRF1 promoter for
promoter for early
for early antigen
early antigen EA-D
antigen EA-D is
EA-D is regulated
is regulated by
regulated by the
by the EBV
the EBV transactivators
EBV transactivators BRLF1
transactivators BRLF1 and
BRLF1 and BZLF1
and BZLF1 in
BZLF1 in a
in a cell-specific
a cell-specific manner
The Epstein-Barr virus
Epstein-Barr virus early
virus early antigen
early antigen diffuse
antigen diffuse component
diffuse component EA-D
component EA-D is
EA-D is essential
is essential for
essential for Epstein-Barr
for Epstein-Barr virus
Epstein-Barr virus DNA
virus DNA polymerase
DNA polymerase activity
polymerase activity and
activity and its
and its activity
its activity is
activity is suppressed
is suppressed during
suppressed during latent
during latent infection
We investigated the
investigated the regulation
the regulation of
regulation of the
of the promoter
the promoter BMRF1
promoter BMRF1 for
BMRF1 for this
for this early
this early gene
early gene by
gene by studying
by studying its
studying its responsiveness
its responsiveness in
responsiveness in vitro
in vitro to
vitro to two
to two immediate-early
two immediate-early viral
immediate-early viral transactivators
viral transactivators BZLF1
transactivators BZLF1 Z
BZLF1 Z and
Z and BRLF1
and BRLF1 R
BRLF1 R focusing
R focusing on
focusing on the
on the differences
the differences in
differences in response
in response in
response in lymphoid
in lymphoid cells
lymphoid cells and
cells and epithelial
and epithelial cells
In lymphoid cells
lymphoid cells Z
cells Z or
Z or R
or R alone
R alone produced
alone produced only
produced only small
only small increases
small increases in
increases in EA-D
in EA-D promoter
EA-D promoter activity
promoter activity whereas
activity whereas both
whereas both transactivators
both transactivators together
transactivators together produced
together produced a
produced a large
a large stimulatory
large stimulatory effect
In epithelial cells
epithelial cells the
cells the Z
the Z transactivator
Z transactivator alone
transactivator alone produced
alone produced maximal
produced maximal stimulation
maximal stimulation of
stimulation of the
of the EA-D
the EA-D promoter;
EA-D promoter; the
promoter; the effect
the effect of
effect of R
of R and
R and Z
and Z together
Z together was
together was no
was no greater
no greater than
greater than that
than that of
that of Z
of Z alone
Deletional analysis and
analysis and site-directed
and site-directed mutagenesis
site-directed mutagenesis of
mutagenesis of the
of the EA-D
the EA-D promoter
EA-D promoter demonstrated
promoter demonstrated that
demonstrated that in
that in epithelial
in epithelial cells
epithelial cells the
cells the potential
the potential AP-1
potential AP-1 binding
AP-1 binding site
binding site plays
site plays an
plays an essential
an essential role
essential role in
role in Z
in Z responsiveness
Z responsiveness although
responsiveness although sequences
although sequences further
sequences further upstream
further upstream are
upstream are also
are also important
In lymphoid cells
lymphoid cells only
cells only the
only the upstream
the upstream sequences
upstream sequences are
sequences are required
are required for
required for transactivation
for transactivation by
transactivation by the
by the Z/R
the Z/R combination
Z/R combination and
combination and the
and the AP-1
the AP-1 site
AP-1 site is
site is dispensable
These data suggest
data suggest that
suggest that EA-D
that EA-D BMRF1
EA-D BMRF1 promoter
BMRF1 promoter regulation
promoter regulation by
regulation by Z
by Z and
Z and R
and R is
R is cell
is cell type
cell type specific
type specific and
specific and appears
and appears to
appears to involve
to involve different
involve different mechanisms
different mechanisms in
mechanisms in each
in each cell
each cell type
Complementary DNA encoding
DNA encoding the
encoding the human
the human T-cell
human T-cell FK506-binding
T-cell FK506-binding protein
FK506-binding protein a
protein a peptidylprolyl
a peptidylprolyl cis-trans
peptidylprolyl cis-trans isomerase
cis-trans isomerase distinct
isomerase distinct from
distinct from cyclophilin
The recently discovered
recently discovered macrolide
discovered macrolide FK506
macrolide FK506 has
FK506 has been
has been demonstrated
been demonstrated to
demonstrated to have
to have potent
have potent immunosuppressive
potent immunosuppressive activity
immunosuppressive activity at
activity at concentrations
at concentrations 100-fold
concentrations 100-fold lower
100-fold lower than
lower than cyclosporin
than cyclosporin A
cyclosporin A a
A a cyclic
a cyclic undecapeptide
cyclic undecapeptide that
undecapeptide that is
that is used
is used to
used to prevent
to prevent rejection
prevent rejection after
rejection after transplantation
after transplantation of
transplantation of bone
of bone marrow
bone marrow and
marrow and organs
and organs such
organs such as
such as kidney
as kidney heart
kidney heart and
heart and liver
After the recent
the recent discovery
recent discovery that
discovery that the
that the cyclosporin
the cyclosporin A-binding
cyclosporin A-binding protein
A-binding protein cyclophilin
protein cyclophilin is
cyclophilin is identical
is identical to
identical to peptidylprolyl
to peptidylprolyl cis-trans
peptidylprolyl cis-trans isomerase
cis-trans isomerase a
isomerase a cellular
a cellular binding
cellular binding protein
binding protein for
protein for FK506
for FK506 was
FK506 was found
was found to
found to be
to be distinct
be distinct from
distinct from cyclophilin
from cyclophilin but
cyclophilin but to
but to have
to have the
have the same
the same enzymatic
same enzymatic activity
In this study
this study we
study we isolated
we isolated a
isolated a cDNA
a cDNA coding
cDNA coding for
coding for FK506-binding
for FK506-binding protein
FK506-binding protein FKBP
protein FKBP from
FKBP from human
from human peripheral
human peripheral blood
peripheral blood T
blood T cells
T cells by
cells by using
by using mixed
using mixed 20-mer
mixed 20-mer oligonucleotide
20-mer oligonucleotide probes
oligonucleotide probes synthesized
probes synthesized on
synthesized on the
on the basis
the basis of
basis of the
of the sequence
the sequence Glu-Asp-Gly-Lys-Lys-Phe-Asp
sequence Glu-Asp-Gly-Lys-Lys-Phe-Asp reported
Glu-Asp-Gly-Lys-Lys-Phe-Asp reported for
reported for bovine
for bovine FKBP
The DNA isolated
DNA isolated contained
isolated contained an
contained an open
an open reading
open reading frame
reading frame encoding
frame encoding 108
encoding 108 amino
108 amino acid
amino acid residues
The first 40
first 40 residues
40 residues of
residues of the
of the deduced
the deduced amino
deduced amino acid
amino acid sequence
acid sequence were
sequence were identical
were identical to
identical to those
to those of
those of the
of the reported
the reported amino-terminal
reported amino-terminal sequence
amino-terminal sequence of
sequence of bovine
of bovine FKBP
bovine FKBP indicating
FKBP indicating that
indicating that the
that the DNA
the DNA sequence
DNA sequence isolated
sequence isolated represents
isolated represents the
represents the gene
the gene coding
gene coding for
coding for FKBP
Computer-assisted analysis of
analysis of the
of the deduced
the deduced amino
deduced amino acid
amino acid sequence
acid sequence indicates
sequence indicates that
indicates that FKBP
that FKBP exhibits
FKBP exhibits no
exhibits no internal
no internal homology
internal homology and
homology and does
and does not
does not have
not have significant
have significant sequence
significant sequence similarity
sequence similarity to
similarity to any
to any other
any other amino
other amino acid
amino acid sequences
acid sequences of
sequences of known
of known proteins
known proteins including
proteins including cyclophilin
This result suggests
result suggests that
suggests that two
that two catalytically
two catalytically similar
catalytically similar proteins
similar proteins cyclophilin
proteins cyclophilin and
cyclophilin and FKBP
and FKBP evolved
FKBP evolved independently
In Northern blot
Northern blot analysis
blot analysis mRNA
analysis mRNA species
mRNA species of
species of approximately
of approximately 18
approximately 18 kilobases
18 kilobases that
kilobases that hybridized
that hybridized with
hybridized with human
with human FKBP
human FKBP cDNA
FKBP cDNA were
cDNA were detected
were detected in
detected in polyA+
in polyA+ RNAs
polyA+ RNAs from
RNAs from brain
from brain lung
brain lung liver
lung liver and
liver and placental
and placental cells
placental cells and
cells and leukocytes
Induction of Jurkat
of Jurkat leukemic
Jurkat leukemic T
leukemic T cells
T cells with
cells with phorbol
with phorbol 12-myristate
phorbol 12-myristate 13-acetate
12-myristate 13-acetate and
13-acetate and ionomycin
and ionomycin did
ionomycin did not
did not affect
not affect the
affect the level
the level of
level of FKBP
of FKBP mRNA
Southern blot analysis
blot analysis of
analysis of human
of human genomic
human genomic DNA
genomic DNA digested
DNA digested with
digested with different
with different restriction
different restriction enzymes
restriction enzymes suggests
enzymes suggests the
suggests the existence
the existence of
existence of only
of only a
only a few
a few copies
few copies of
copies of the
of the DNA
the DNA sequence
DNA sequence encoding
sequence encoding FKBP
This is in
is in contrast
in contrast to
contrast to the
to the result
the result that
result that as
that as many
as many as
many as 20
as 20 copies
20 copies of
copies of the
of the cyclophilin
the cyclophilin gene
cyclophilin gene and
gene and possible
and possible pseudogenes
possible pseudogenes may
pseudogenes may be
may be present
be present in
present in the
in the mammalian
the mammalian genome
Involvement of a
of a second
a second lymphoid-specific
second lymphoid-specific enhancer
lymphoid-specific enhancer element
enhancer element in
element in the
in the regulation
the regulation of
regulation of immunoglobulin
of immunoglobulin heavy-chain
immunoglobulin heavy-chain gene
heavy-chain gene expression
To determine whether
determine whether enhancer
whether enhancer elements
enhancer elements in
elements in addition
in addition to
addition to the
to the highly
the highly conserved
highly conserved octamer
conserved octamer OCTA-nucleotide
octamer OCTA-nucleotide motif
OCTA-nucleotide motif are
motif are important
are important for
important for lymphoid-specific
for lymphoid-specific expression
lymphoid-specific expression of
expression of the
of the immunoglobulin
the immunoglobulin heavy-chain
immunoglobulin heavy-chain IgH
heavy-chain IgH gene
IgH gene we
gene we have
we have investigated
have investigated the
investigated the effect
the effect of
effect of mutating
of mutating the
mutating the binding
the binding site
binding site for
site for a
for a putative
a putative additional
putative additional lymphoid-specific
additional lymphoid-specific transcription
lymphoid-specific transcription factor
transcription factor designated
factor designated NF-microB
designated NF-microB in
NF-microB in the
in the murine
the murine IgH
murine IgH enhancer
We demonstrate that
demonstrate that the
that the NF-microB-binding
the NF-microB-binding site
NF-microB-binding site plays
site plays a
plays a critical
a critical role
critical role in
role in the
in the IgH
the IgH enhancer
IgH enhancer because
enhancer because mutation
because mutation of
mutation of the
of the microB
the microB DNA
microB DNA motif
DNA motif decreased
motif decreased transcriptional
decreased transcriptional activity
transcriptional activity of
activity of the
of the IgH
the IgH enhancer
IgH enhancer in
enhancer in cells
in cells of
cells of the
of the B-cell
the B-cell lineage
B-cell lineage but
lineage but not
but not in
not in nonlymphoid
in nonlymphoid cells
This effect was
effect was comparable
was comparable to
comparable to or
to or even
or even stronger
even stronger than
stronger than the
than the effect
the effect of
effect of a
of a mutation
a mutation in
mutation in the
in the OCTA
the OCTA site
Moreover combined mutation
combined mutation of
mutation of both
of both microB
both microB and
microB and OCTA
and OCTA sites
OCTA sites further
sites further reduced
further reduced enhancer
reduced enhancer activity
enhancer activity in
activity in lymphoid
in lymphoid cells
Interestingly alteration of
alteration of either
of either the
either the microB
the microB or
microB or E3
or E3 site
E3 site in
site in a
in a 70-base-pair
a 70-base-pair fragment
70-base-pair fragment of
fragment of the
of the IgH
the IgH enhancer
IgH enhancer that
enhancer that lacks
that lacks the
lacks the binding
the binding site
binding site for
site for OCTA
for OCTA abolished
OCTA abolished enhancer
abolished enhancer activity
enhancer activity in
activity in lymphoid
in lymphoid cells
lymphoid cells completely
Nevertheless a multimer
a multimer of
multimer of the
of the microB
the microB motif
microB motif alone
motif alone showed
alone showed no
showed no enhancer
no enhancer activity
DNase footprinting analysis
footprinting analysis corroborated
analysis corroborated the
corroborated the functional
the functional data
functional data showing
data showing that
showing that a
that a lymphoid-specific
a lymphoid-specific protein
lymphoid-specific protein binds
protein binds to
binds to the
to the microB
the microB DNA
microB DNA motif
Our results suggest
results suggest that
suggest that the
that the microB
the microB element
microB element is
element is a
is a new
a new crucial
new crucial element
crucial element important
element important for
important for lymphoid-specific
for lymphoid-specific expression
lymphoid-specific expression of
expression of the
of the IgH
the IgH gene
IgH gene but
gene but that
but that interaction
that interaction with
interaction with another
with another enhancer
another enhancer element
enhancer element is
element is essential
is essential for
essential for its
for its activity
Stimulation of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 2
type 2 HIV-2
2 HIV-2 gene
HIV-2 gene expression
gene expression by
expression by the
by the cytomegalovirus
the cytomegalovirus and
cytomegalovirus and HIV-2
and HIV-2 transactivator
HIV-2 transactivator gene
Human immunodeficiency virus
immunodeficiency virus HIV
virus HIV often
HIV often causes
often causes latent
causes latent infection
Transactivation by some
by some DNA
some DNA viruses
DNA viruses has
viruses has been
has been implicated
been implicated in
implicated in inducing
in inducing HIV-1
inducing HIV-1 replication
HIV-1 replication and
replication and pathogenesis
The transactivator IE-2
transactivator IE-2 gene
IE-2 gene of
gene of the
of the human
the human cytomegalovirus
human cytomegalovirus CMV
cytomegalovirus CMV can
CMV can enhance
can enhance HIV-2
enhance HIV-2 as
HIV-2 as well
as well as
well as HIV-1
as HIV-1 gene
HIV-1 gene expression
gene expression in
expression in vitro
This inducer can
inducer can act
can act in
act in concert
in concert with
concert with the
with the HIV-2
the HIV-2 tat
HIV-2 tat gene
tat gene and
gene and T-cell
and T-cell activation
T-cell activation in
activation in enhancing
in enhancing gene
enhancing gene expression
gene expression in
expression in human
in human CD4+
human CD4+ lymphocytes
While the HIV-2
the HIV-2 and
HIV-2 and HIV-1
and HIV-1 tat
HIV-1 tat genes
tat genes and
genes and T-cell
and T-cell activators
T-cell activators apparently
activators apparently employ
apparently employ independent
employ independent modes
independent modes of
modes of action
of action the
action the CMV
the CMV transactivator
CMV transactivator in
transactivator in combination
in combination with
combination with the
with the HIV-2
the HIV-2 tat
HIV-2 tat or
tat or T-cell
or T-cell activators
T-cell activators may
activators may employ
may employ a
employ a gene
a gene activation
gene activation pathway
activation pathway with
pathway with some
with some common
some common and
common and some
and some distinct
some distinct components
Both HIV-2 and
HIV-2 and CMV
and CMV transactivators
CMV transactivators enhance
transactivators enhance HIV-2
enhance HIV-2 gene
HIV-2 gene expression
gene expression by
expression by transcriptional
by transcriptional activation
transcriptional activation involving
activation involving transcript
involving transcript initiation
transcript initiation as
initiation as well
as well as
well as elongation
as elongation with
elongation with CMV
with CMV transactivator
CMV transactivator affecting
transactivator affecting elongation
affecting elongation more
elongation more than
more than the
than the initiation
A significant proportion
significant proportion of
proportion of transcripts
of transcripts appear
transcripts appear to
appear to terminate
to terminate prematurely
terminate prematurely in
prematurely in the
in the absence
the absence of
absence of transactivators
Deletion mutation analysis
mutation analysis of
analysis of the
of the HIV-2
the HIV-2 long
HIV-2 long terminal
long terminal repeat
terminal repeat LTR
repeat LTR suggests
LTR suggests that
suggests that the
that the element
the element that
element that responds
that responds to
responds to CMV
to CMV transactivation
CMV transactivation in
transactivation in human
in human CD4+
human CD4+ lymphocytes
CD4+ lymphocytes is
lymphocytes is either
is either a
either a diffuse
a diffuse one
diffuse one or
one or located
or located downstream
located downstream of
downstream of the
of the HIV-2
the HIV-2 enhancer
HIV-2 enhancer element
Quantitative immunohistochemical analysis
immunohistochemical analysis of
analysis of mononuclear
of mononuclear infiltrates
mononuclear infiltrates in
infiltrates in breast
in breast carcinomas--correlation
breast carcinomas--correlation with
carcinomas--correlation with tumour
with tumour differentiation
Inflammatory infiltrates were
infiltrates were analysed
were analysed in
analysed in tissue
in tissue sections
tissue sections of
sections of 76
of 76 breast
76 breast carcinomas
breast carcinomas by
carcinomas by counting
by counting the
counting the percentage
the percentage of
percentage of macrophages
of macrophages IgA+
macrophages IgA+ and
IgA+ and IgG+
and IgG+ plasma
IgG+ plasma cells
plasma cells T
cells T cells
T cells with
cells with their
with their subpopulations
their subpopulations and
subpopulations and natural
and natural killer
natural killer cells
killer cells and
cells and by
and by measuring
by measuring postcapillary
measuring postcapillary venules
postcapillary venules PCVs
venules PCVs found
PCVs found in
found in 12
in 12 cases
12 cases within
cases within the
within the infiltrates
These parameters were
parameters were correlated
were correlated with
correlated with nuclear
with nuclear grade
nuclear grade and
grade and biochemically
and biochemically determined
biochemically determined hormone
determined hormone receptor
hormone receptor status
receptor status known
status known markers
known markers of
markers of tumour
of tumour differentiation
A direct correlation
direct correlation was
correlation was found
was found between
found between the
between the extent
the extent of
extent of inflammation
of inflammation and
inflammation and nuclear
and nuclear grade
nuclear grade P
grade P less
P less than
less than 00001
than 00001 and
00001 and an
and an inverse
an inverse correlation
inverse correlation between
correlation between inflammation
between inflammation and
inflammation and oestrogen
and oestrogen receptor
oestrogen receptor OR
receptor OR positivity
OR positivity P
positivity P less
P less than
less than 005
than 005 as
005 as well
as well as
well as inflammation
as inflammation and
inflammation and progesterone
and progesterone receptor
progesterone receptor PR
receptor PR positivity
PR positivity P
positivity P less
P less than
less than 005
The percentage of
percentage of the
of the OKT8+
the OKT8+ suppressor/cytotoxic
OKT8+ suppressor/cytotoxic T
suppressor/cytotoxic T cells
T cells increased
cells increased when
increased when the
when the inflammation
the inflammation expanded
inflammation expanded from
expanded from scanty
from scanty to
scanty to moderate
to moderate P
moderate P less
P less than
less than 002
The diameter of
diameter of the
of the PCVs
the PCVs also
PCVs also increased
also increased with
increased with increasing
with increasing inflammatory
increasing inflammatory infiltrate
inflammatory infiltrate P
infiltrate P less
P less than
less than 002
In addition a
addition a direct
a direct correlation
direct correlation exists
correlation exists between
exists between the
between the diameter
the diameter of
diameter of the
of the PCVs
the PCVs and
PCVs and both
and both the
both the percentage
the percentage of
percentage of the
of the OKT8+
the OKT8+ T
OKT8+ T cells
T cells P
cells P less
P less than
less than 004
than 004 and
004 and the
and the Leu-7+
the Leu-7+ natural
Leu-7+ natural killer
natural killer cells
killer cells P
cells P less
P less than
less than 003
Reactivity of lymphocytes
of lymphocytes to
lymphocytes to a
to a progesterone
a progesterone receptor-specific
progesterone receptor-specific monoclonal
receptor-specific monoclonal antibody
In this study
this study we
study we present
we present evidence
present evidence for
evidence for reactivity
for reactivity of
reactivity of pregnancy
of pregnancy lymphocytes
pregnancy lymphocytes but
lymphocytes but not
but not nonpregnancy
not nonpregnancy lymphocytes
nonpregnancy lymphocytes with
lymphocytes with the
with the progesterone
the progesterone receptor-specific
progesterone receptor-specific monoclonal
receptor-specific monoclonal antibody
monoclonal antibody mPRI
Using an avidin-biotin
an avidin-biotin peroxidase
avidin-biotin peroxidase detection
peroxidase detection system
detection system we
system we found
we found a
found a nuclear
a nuclear staining
nuclear staining in
staining in 146
in 146 +/-
146 +/- 37%
+/- 37% mean
37% mean +/-
mean +/- SEM
+/- SEM N
SEM N =
N = 27
= 27 of
27 of pregnancy
of pregnancy lymphocytes
pregnancy lymphocytes while
lymphocytes while only
while only 047
only 047 +/-
047 +/- 033%
+/- 033% mean
033% mean +/-
mean +/- SEM
+/- SEM N
SEM N =
N = 15
= 15 of
15 of nonpregnancy
of nonpregnancy lymphocytes
nonpregnancy lymphocytes reacted
lymphocytes reacted with
reacted with the
with the antibody
To characterize the
characterize the receptor-bearing
the receptor-bearing subset
receptor-bearing subset CD8+
subset CD8+ and
CD8+ and CD4+
and CD4+ cells
CD4+ cells were
cells were depleted
were depleted by
depleted by complement-dependent
by complement-dependent lysis
Depletion of CD8+
of CD8+ cells
CD8+ cells was
cells was accompanied
was accompanied by
accompanied by 62
by 62 +/-
62 +/- 18%
+/- 18% loss
18% loss of
loss of progesterone
of progesterone receptor-bearing
progesterone receptor-bearing cells
receptor-bearing cells while
cells while depletion
while depletion of
depletion of CD4+
of CD4+ cells
CD4+ cells resulted
cells resulted in
resulted in a
in a twofold
a twofold increase
twofold increase in
increase in the
in the number
the number of
number of positively
of positively staining
positively staining lymphocytes
In nonpregnancy lymphocytes
nonpregnancy lymphocytes a
lymphocytes a 3-day
a 3-day PHA
3-day PHA treatment
PHA treatment as
treatment as well
as well as
well as allogeneic
as allogeneic stimulation
allogeneic stimulation resulted
stimulation resulted in
resulted in a
in a significant
a significant increase
significant increase in
increase in the
in the number
the number of
number of receptor-containing
of receptor-containing cells
These results suggest
results suggest that
suggest that pregnancy
that pregnancy but
pregnancy but not
but not nonpregnancy
not nonpregnancy lymphocytes
nonpregnancy lymphocytes contain
lymphocytes contain progesterone
contain progesterone binding
progesterone binding structures
binding structures and
structures and that
and that these
that these are
these are inducible
are inducible by
inducible by mitogenic
by mitogenic or
mitogenic or alloantigenic
or alloantigenic stimuli
Activation of human
of human CD4
human CD4 T
CD4 T lymphocytes
Interaction of fibronectin
of fibronectin with
fibronectin with VLA-5
with VLA-5 receptor
VLA-5 receptor on
receptor on CD4
on CD4 cells
CD4 cells induces
cells induces the
induces the AP-1
the AP-1 transcription
AP-1 transcription factor
Fibronectin synergized with
synergized with anti-CD3
with anti-CD3 antibody
anti-CD3 antibody to
antibody to promote
to promote CD4
promote CD4 cell
CD4 cell proliferation
cell proliferation in
proliferation in a
in a serum-free
a serum-free culture
serum-free culture system
culture system whereas
system whereas no
whereas no proliferation
no proliferation was
proliferation was observed
was observed when
observed when CD4
when CD4 cells
CD4 cells were
cells were cultured
were cultured with
cultured with anti-CD3
with anti-CD3 alone
anti-CD3 alone or
alone or fibronectin
or fibronectin alone
In addition anti-CD29
addition anti-CD29 integrin
anti-CD29 integrin beta
integrin beta 1
beta 1 as
1 as well
as well as
well as anti-VLA-5
as anti-VLA-5 human
anti-VLA-5 human fibronectin
human fibronectin receptor
fibronectin receptor antibodies
receptor antibodies blocked
antibodies blocked this
blocked this CD4
this CD4 cell
CD4 cell activation
cell activation in
activation in this
in this system
Although anti-CD3 alone
anti-CD3 alone or
alone or fibronectin
or fibronectin alone
fibronectin alone cannot
alone cannot induce
cannot induce IL-2
induce IL-2 message
IL-2 message by
message by CD4
by CD4 cells
CD4 cells the
cells the combination
the combination of
combination of anti-CD3
of anti-CD3 plus
anti-CD3 plus fibronectin
plus fibronectin induced
fibronectin induced IL-2
induced IL-2 message
IL-2 message by
message by CD4
by CD4 cells
In an analysis
an analysis of
analysis of the
of the molecular
the molecular mechanism
molecular mechanism by
mechanism by which
by which IL-2
which IL-2 message
IL-2 message was
message was generated
was generated we
generated we showed
we showed that
showed that a
that a fibronectin-VLA-5
a fibronectin-VLA-5 fibronectin
fibronectin-VLA-5 fibronectin receptor
fibronectin receptor interaction
receptor interaction may
interaction may contribute
may contribute an
contribute an independent
an independent signal
independent signal distinct
signal distinct from
distinct from the
from the CD3
the CD3 pathway
CD3 pathway of
pathway of activation
of activation by
activation by the
by the induction
the induction of
induction of an
of an AP-1
an AP-1 transcriptional
AP-1 transcriptional factor
Thus the VLA-5
the VLA-5 fibronectin
VLA-5 fibronectin receptor
fibronectin receptor on
receptor on CD4
on CD4 cells
CD4 cells can
cells can play
can play a
play a complementary
a complementary role
complementary role in
role in CD3-TCR-mediated
in CD3-TCR-mediated signal
CD3-TCR-mediated signal transduction
signal transduction through
transduction through its
through its interaction
its interaction with
interaction with fibronectin
Glucocorticoid receptors on
receptors on mononuclear
on mononuclear leukocytes
mononuclear leukocytes in
leukocytes in Alzheimer's
in Alzheimer's disease
Several lines of
lines of evidence
of evidence suggest
evidence suggest disturbances
suggest disturbances of
disturbances of the
of the hypothalamic-pituitary-adrenal
the hypothalamic-pituitary-adrenal HPA
hypothalamic-pituitary-adrenal HPA system
HPA system in
system in Alzheimer's
in Alzheimer's disease
Alzheimer's disease AD
In an exploration
an exploration of
exploration of the
of the potential
the potential role
potential role of
role of the
of the glucocorticoid
the glucocorticoid receptor
glucocorticoid receptor GR
receptor GR in
GR in AD
in AD GR
AD GR density
GR density and
density and affinity
and affinity were
affinity were assessed
were assessed on
assessed on mononuclear
on mononuclear leukocytes
mononuclear leukocytes of
leukocytes of 12
of 12 AD
12 AD patients
AD patients and
patients and 12
and 12 healthy
12 healthy controls
GR binding characteristics
binding characteristics did
characteristics did not
did not differ
not differ between
differ between patients
between patients and
patients and controls
and controls or
controls or between
or between patients
between patients subdivided
patients subdivided according
subdivided according to
according to diagnosis
to diagnosis or
diagnosis or associated
or associated clinical
associated clinical features
These data suggest
data suggest that
suggest that the
that the abnormalities
the abnormalities of
abnormalities of the
of the HPA
the HPA system
HPA system in
system in AD
in AD are
AD are not
are not related
not related to
related to a
to a GR
a GR deficiency
Oncogene amplification correlates
amplification correlates with
correlates with dense
with dense lymphocyte
dense lymphocyte infiltration
lymphocyte infiltration in
infiltration in human
in human breast
human breast cancers:
breast cancers: a
cancers: a role
a role for
role for hematopoietic
for hematopoietic growth
hematopoietic growth factor
growth factor release
factor release by
release by tumor
by tumor cells?
One hundred six
hundred six primary
six primary breast
primary breast cancer
breast cancer samples
cancer samples were
samples were analysed
were analysed for
analysed for c-erbB2
for c-erbB2 int-2
c-erbB2 int-2 and
int-2 and c-myc
and c-myc gene
c-myc gene amplification
Surgically confirmed nodal
confirmed nodal involvement
nodal involvement was
involvement was observed
was observed in
observed in 42%
Level of gene
of gene amplification
gene amplification was
amplification was studied
was studied by
studied by Southern
by Southern and/or
Southern and/or slot
and/or slot blot
slot blot techniques
Amplified c-erbB2 gene
c-erbB2 gene sequences
gene sequences were
sequences were present
were present in
present in 215%
in 215% of
215% of all
of all samples
Int-2 was amplified
was amplified in
amplified in 131%
in 131% and
131% and c-myc
and c-myc was
c-myc was amplified
was amplified in
amplified in 103%
In a non-parametric
a non-parametric test
non-parametric test Kruskal-Wallis
test Kruskal-Wallis a
Kruskal-Wallis a strong
a strong negative
strong negative association
negative association was
association was found
was found between
found between high
between high levels
high levels of
levels of c-erbB2
of c-erbB2 amplification
c-erbB2 amplification and
amplification and absence
and absence of
absence of estrogen
of estrogen receptor
estrogen receptor ER
receptor ER P
ER P =
P = 0009
= 0009 or
0009 or progesterone
or progesterone receptor
progesterone receptor PR
receptor PR P
PR P =
P = 011
= 011 expression
No correlations were
correlations were found
were found between
found between all
between all or
all or high
or high levels
high levels of
levels of amplification
of amplification of
amplification of each
of each oncogene
each oncogene separately
oncogene separately or
separately or combined
or combined with
combined with T
with T N
T N grade
N grade multifocality
grade multifocality of
multifocality of tumor
of tumor or
tumor or associated
or associated carcinoma
associated carcinoma in
carcinoma in situ
There was a
was a trend
a trend approaching
trend approaching statistical
approaching statistical significance
statistical significance for
significance for patients
for patients with
patients with c-erbB2
with c-erbB2 amplifications
c-erbB2 amplifications to
amplifications to have
to have positive
have positive lymph
positive lymph nodes
lymph nodes at
nodes at surgery
at surgery P
surgery P =
P = 009
A somewhat surprising
somewhat surprising finding
surprising finding however
finding however was
however was a
was a very
a very strong
very strong association
strong association between
association between oncogene
between oncogene amplification
oncogene amplification and
amplification and dense
and dense lymphocyte
dense lymphocyte infiltration
lymphocyte infiltration of
infiltration of the
of the tumor
the tumor P
tumor P =
P = 05
= 05 This
05 This correlation
This correlation is
correlation is even
is even stronger
even stronger when
stronger when only
when only high
only high levels
high levels of
levels of amplification
of amplification are
amplification are considered
are considered either
considered either for
either for each
for each oncogene
each oncogene separately
oncogene separately P
separately P =
P = 0048
= 0048 or
0048 or in
or in combination
in combination P
combination P =
P = 0007
We propose that
propose that malignant
that malignant cell
malignant cell cytokine
cell cytokine production
cytokine production may
production may help
may help explain
help explain this
explain this observation
Suppression of signals
of signals required
signals required for
required for activation
for activation of
activation of transcription
of transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B in
B in cells
in cells constitutively
cells constitutively expressing
constitutively expressing the
expressing the HTLV-I
the HTLV-I Tax
HTLV-I Tax protein
Transient short-term expression
short-term expression of
expression of the
of the Tax
the Tax protein
Tax protein of
protein of human
of human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type-I
virus type-I HTLV-I
type-I HTLV-I leads
HTLV-I leads to
leads to activation
to activation of
activation of the
of the pleiotropic
the pleiotropic transcription
pleiotropic transcription factor
transcription factor NF-kappa
factor NF-kappa B
Consistent with findings
with findings obtained
findings obtained with
obtained with transient
with transient expression
transient expression assays
expression assays we
assays we observed
we observed marked
observed marked accumulation
marked accumulation of
accumulation of the
of the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B in
B in the
in the nucleus
the nucleus of
nucleus of Namalwa
of Namalwa B
Namalwa B lymphoid
B lymphoid cells
lymphoid cells which
cells which constitutively
which constitutively express
constitutively express Tax
In contrast NF-kappa
contrast NF-kappa B
NF-kappa B activity
B activity was
activity was not
was not detected
not detected in
detected in the
in the nucleus
the nucleus following
nucleus following long-term
following long-term expression
long-term expression of
expression of Tax
of Tax in
Tax in Jurkat
in Jurkat T
Jurkat T lymphocytes
The ability of
ability of both
of both mitogens
both mitogens and
mitogens and cytokines
and cytokines to
cytokines to activate
to activate NF-kappa
activate NF-kappa B
NF-kappa B was
B was also
was also blocked
also blocked in
blocked in Jurkat
in Jurkat cells
Jurkat cells constitutively
cells constitutively expressing
constitutively expressing Tax
However the activation
the activation of
activation of other
of other mitogen-inducible
other mitogen-inducible transcription
mitogen-inducible transcription factors
transcription factors such
factors such as
such as Fos
as Fos and
Fos and Jun
and Jun was
Jun was unaffected
Thus depending on
depending on the
on the cellular
the cellular environment
cellular environment the
environment the short-
the short- and
short- and long-term
and long-term effects
long-term effects of
effects of Tax
of Tax expression
Tax expression can
expression can be
can be quite
be quite different
Consequently one function
one function of
function of Tax
of Tax in
Tax in cells
in cells infected
cells infected with
infected with HTLV-I
with HTLV-I might
HTLV-I might involve
might involve cell-type-specific
involve cell-type-specific suppression
cell-type-specific suppression as
suppression as opposed
as opposed to
opposed to activation
to activation of
activation of distinct
of distinct signal
distinct signal pathways
The cells lines
cells lines described
lines described here
described here should
here should be
should be useful
be useful for
useful for the
for the delineation
the delineation of
delineation of signaling
of signaling pathways
signaling pathways utilized
pathways utilized in
utilized in the
in the selective
the selective regulation
selective regulation of
regulation of gene
of gene expression
Interferon-gamma and the
and the sexual
the sexual dimorphism
sexual dimorphism of
dimorphism of autoimmunity
The sexual difference
sexual difference in
difference in the
in the incidence
the incidence of
incidence of autoimmune
of autoimmune diseases
autoimmune diseases has
diseases has remained
has remained an
remained an enigma
an enigma for
enigma for many
for many years
In the examination
the examination of
examination of the
of the induction
the induction of
induction of autoimmunity
of autoimmunity in
autoimmunity in transgenic
in transgenic mice
transgenic mice evidence
mice evidence has
evidence has been
has been obtained
been obtained further
obtained further implicating
further implicating the
implicating the lymphokine
the lymphokine interferon-gamma
lymphokine interferon-gamma in
interferon-gamma in the
in the etiology
the etiology of
etiology of autoimmunity
Sex steroid regulation
steroid regulation of
regulation of the
of the production
the production of
production of this
of this molecule
this molecule as
molecule as well
as well as
well as other
as other cytokines
other cytokines may
cytokines may help
may help explain
help explain the
explain the gender-specific
the gender-specific differences
gender-specific differences in
differences in the
in the immune
the immune system
immune system including
system including autoimmunity
Cloning of a
of a transcriptionally
a transcriptionally active
transcriptionally active human
active human TATA
human TATA binding
TATA binding factor
Transcription factor IID
factor IID TFIID
IID TFIID binds
TFIID binds to
binds to the
to the TATA
the TATA box
TATA box promoter
box promoter element
promoter element and
element and regulates
and regulates the
regulates the expression
the expression of
expression of most
of most eukaryotic
most eukaryotic genes
eukaryotic genes transcribed
genes transcribed by
transcribed by RNA
by RNA polymerase
RNA polymerase II
Complementary DNA cDNA
DNA cDNA encoding
cDNA encoding a
encoding a human
a human TFIID
human TFIID protein
TFIID protein has
protein has been
has been cloned
The human TFIID
human TFIID polypeptide
TFIID polypeptide has
polypeptide has 339
has 339 amino
339 amino acids
amino acids and
acids and a
and a molecular
a molecular size
molecular size of
size of 37745
of 37745 daltons
The carboxyl-terminal 181
carboxyl-terminal 181 amino
181 amino acids
amino acids of
acids of the
of the human
the human TFIID
human TFIID protein
TFIID protein shares
protein shares 80%
shares 80% identity
80% identity with
identity with the
with the TFIID
the TFIID protein
TFIID protein from
protein from Saccharomyces
from Saccharomyces cerevisiae
The amino terminus
amino terminus contains
terminus contains an
contains an unusual
an unusual repeat
unusual repeat of
repeat of 38
of 38 consecutive
38 consecutive glutamine
consecutive glutamine residues
glutamine residues and
residues and an
and an X-Thr-Pro
an X-Thr-Pro repeat
Expression of DNA
of DNA in
DNA in reticulocyte
in reticulocyte lysates
reticulocyte lysates or
lysates or in
or in Escherichia
in Escherichia coli
Escherichia coli yielded
coli yielded a
yielded a protein
a protein that
protein that was
that was competent
was competent for
competent for both
for both DNA
both DNA binding
DNA binding and
binding and transcription
and transcription activation
A novel T-cell
novel T-cell trans-activator
T-cell trans-activator that
trans-activator that recognizes
that recognizes a
recognizes a phorbol
a phorbol ester-inducible
phorbol ester-inducible element
ester-inducible element of
element of the
of the interleukin-2
the interleukin-2 promoter
The interleukin 2
interleukin 2 IL-2
2 IL-2 gene
IL-2 gene promoter
gene promoter is
promoter is recognized
is recognized by
recognized by several
by several cell-type-specific
several cell-type-specific and
cell-type-specific and ubiquitous
and ubiquitous transcriptional
ubiquitous transcriptional regulators
transcriptional regulators that
regulators that integrate
that integrate information
integrate information transmitted
information transmitted by
transmitted by various
by various signaling
various signaling systems
signaling systems leading
systems leading to
leading to IL-2
to IL-2 production
IL-2 production and
production and T-cell
and T-cell activation
Using a combination
a combination of
combination of transfection
of transfection protein-DNA
transfection protein-DNA binding
protein-DNA binding and
binding and in
and in vitro
in vitro transcription
vitro transcription methods
transcription methods we
methods we have
we have discovered
have discovered the
discovered the novel
the novel T-cell-specific
novel T-cell-specific transcriptional
T-cell-specific transcriptional activator
transcriptional activator TCF-1
activator TCF-1 for
TCF-1 for T-Cell
for T-Cell Factor-1
T-Cell Factor-1 which
Factor-1 which recognizes
which recognizes a
recognizes a T-cell-specific
a T-cell-specific response
T-cell-specific response element
response element TCE
element TCE located
TCE located within
located within the
within the IL-2
the IL-2 promoter
Although the TCE
the TCE is
TCE is similar
is similar in
similar in sequence
in sequence to
sequence to a
to a consensus
a consensus NF
consensus NF kappa
NF kappa B
kappa B site
B site several
site several criteria
several criteria indicate
criteria indicate that
indicate that TCF-1
that TCF-1 is
TCF-1 is distinct
is distinct from
distinct from NF
from NF kappa
NF kappa B
However like NF
like NF kappa
NF kappa B
kappa B TCF-1
B TCF-1 activity
TCF-1 activity is
activity is induced
is induced by
induced by phorbol
by phorbol esters
phorbol esters and
esters and other
and other T-cell
other T-cell activators
Risk factors for
factors for breast
for breast recurrence
breast recurrence in
recurrence in premenopausal
in premenopausal and
premenopausal and postmenopausal
and postmenopausal patients
postmenopausal patients with
patients with ductal
with ductal cancers
ductal cancers treated
cancers treated by
treated by conservation
by conservation therapy
Risk factors for
factors for local
for local failure
local failure were
failure were evaluated
were evaluated for
evaluated for 496
for 496 clinical
496 clinical Stage
clinical Stage I-II
Stage I-II patients
I-II patients with
patients with infiltrating
with infiltrating ductal
infiltrating ductal carcinomas
ductal carcinomas median
carcinomas median follow-up
median follow-up 71
follow-up 71 months
71 months treated
months treated by
treated by conservative
by conservative surgery
conservative surgery and
surgery and radiotherapy
Monofactorial analysis identified
analysis identified the
identified the following
the following factors
following factors to
factors to be
to be correlated
be correlated with
correlated with increased
with increased risk:
increased risk: moderate/marked
risk: moderate/marked mononuclear
moderate/marked mononuclear cell
mononuclear cell reaction
cell reaction MCR
reaction MCR high
MCR high histologic
high histologic grade
histologic grade G
grade G extensive
G extensive intraductal
extensive intraductal component
intraductal component EIC
component EIC tumor
EIC tumor necrosis
tumor necrosis macroscopic
necrosis macroscopic multiplicity
macroscopic multiplicity estrogen
multiplicity estrogen receptor
estrogen receptor negativity
receptor negativity anatomic
negativity anatomic tumor
anatomic tumor size
tumor size age
size age younger
age younger than
younger than 40
than 40 years
40 years and
years and vascular
and vascular invasion
Only MCR G
MCR G and
G and EIC
and EIC proved
EIC proved significant
proved significant in
significant in Cox
in Cox multivariate
Cox multivariate analysis
These risk factors
risk factors were
factors were highly
were highly age
highly age dependent
age dependent with
dependent with EIC
with EIC markedly
EIC markedly more
markedly more prevalent
more prevalent in
prevalent in women
in women younger
women younger than
younger than 50
than 50 MCR
50 MCR and
MCR and G
and G in
G in women
in women younger
women younger than
younger than 40
Separate Cox analysis
Cox analysis for
analysis for premenopausal
for premenopausal patients
premenopausal patients showed
patients showed that
showed that MCR/EIC
that MCR/EIC determined
MCR/EIC determined risk
determined risk independent
risk independent of
independent of resection
of resection margins:
resection margins: tumors
margins: tumors with
tumors with MCR
with MCR had
MCR had a
had a 28%
a 28% and
28% and with
and with EIC
with EIC a
EIC a 22%
a 22% probability
22% probability of
probability of recurring
of recurring locally
recurring locally by
locally by 5
by 5 years
Premenopausal patients with
patients with neither
with neither risk
neither risk factor
risk factor had
factor had a
had a very
a very low
very low failure
low failure rate
failure rate 26%
rate 26% at
26% at 5
at 5 years
5 years regardless
years regardless of
regardless of age
For postmenopausal patients
postmenopausal patients risk
patients risk of
risk of breast
of breast recurrence
breast recurrence was
recurrence was determined
was determined both
determined both by
both by adequacy
by adequacy of
adequacy of resection
of resection margins
resection margins and
margins and grade
and grade with
grade with a
with a high
a high local
high local failure
local failure rate
failure rate for
rate for patients
for patients having
patients having G3
having G3 tumors
G3 tumors with
tumors with positive
with positive or
positive or indeterminate
or indeterminate margins
indeterminate margins 31%
margins 31% at
31% at 5
at 5 years
The authors conclude
authors conclude that
conclude that the
that the microscopic
the microscopic examination
microscopic examination is
examination is the
is the only
the only useful
only useful tool
useful tool for
tool for assessing
for assessing the
assessing the risk
the risk of
risk of local
of local failure
local failure which
failure which is
which is quite
is quite low
quite low for
low for the
for the majority
the majority of
majority of patients
of patients treated
patients treated with
treated with breast
with breast conservation
High-risk patients can
patients can be
can be recognized
be recognized morphologically
The age dependence
age dependence of
dependence of morphologic
of morphologic risk
morphologic risk factors
risk factors appears
factors appears to
appears to explain
to explain the
explain the high
the high local
high local failure
local failure rate
failure rate seen
rate seen in
seen in patients
in patients younger
patients younger than
younger than 40
Tax-independent binding of
binding of multiple
of multiple cellular
multiple cellular factors
cellular factors to
factors to Tax-response
to Tax-response element
Tax-response element DNA
element DNA of
DNA of HTLV-I
The human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type I
type I HTLV-I
I HTLV-I promoter
HTLV-I promoter contains
promoter contains three
contains three copies
three copies of
copies of imperfect
of imperfect repeats
imperfect repeats of
repeats of a
of a 21-base
a 21-base pair
21-base pair sequence
pair sequence designated
sequence designated here
designated here as
here as TRE
as TRE Tax-response
TRE Tax-response element
Tax-response element that
element that is
that is responsive
is responsive to
responsive to the
to the virally
the virally encoded
virally encoded transactivator
encoded transactivator protein
transactivator protein Tax
We have identified
have identified and
identified and separated
and separated four
separated four nuclear
four nuclear proteins
nuclear proteins from
proteins from C81-66-45
from C81-66-45 cells
C81-66-45 cells an
cells an HTLV-I
an HTLV-I immortalized
HTLV-I immortalized Tax-expressing
immortalized Tax-expressing human
Tax-expressing human T-lymphocyte
human T-lymphocyte line
T-lymphocyte line Salahuddin
line Salahuddin et
Salahuddin et al
et al 1983
al 1983 that
1983 that interact
that interact with
interact with the
with the TRE-DNA
the TRE-DNA none
TRE-DNA none of
none of which
of which are
which are identical
are identical with
identical with the
with the Tax-protein
The proteins identified
proteins identified have
identified have molecular
have molecular weights
molecular weights of
weights of about
of about 32
about 32 36
32 36 to
36 to 42
to 42 50
42 50 and
50 and 110
and 110 kD
Four different methods
different methods were
methods were used
were used to
used to identify
to identify the
identify the proteins
First from different
from different cell
different cell lines
cell lines three
lines three or
three or all
or all four
all four of
four of the
of the nuclear
the nuclear proteins
nuclear proteins were
proteins were specifically
were specifically cross-linked
specifically cross-linked by
cross-linked by UV
by UV irradiation
UV irradiation to
irradiation to the
to the radioactively
the radioactively labeled
radioactively labeled TRE-DNA
labeled TRE-DNA fragment
Second TRE-DNA binding
TRE-DNA binding proteins
binding proteins sedimented
proteins sedimented through
sedimented through a
through a glycerol
a glycerol density
glycerol density gradient
density gradient at
gradient at rates
at rates corresponding
rates corresponding to
corresponding to proteins
to proteins of
proteins of native
of native molecular
native molecular weights
molecular weights of
weights of 35
of 35 to
35 to 50
to 50 kD
50 kD and
kD and 110
and 110 kD
Third only the
only the 50
the 50 kD
50 kD protein
kD protein was
protein was retained
was retained on
retained on a
on a biotinylated
a biotinylated DNA-streptavidin
biotinylated DNA-streptavidin matrix
DNA-streptavidin matrix when
matrix when the
when the DNA
the DNA fragment
DNA fragment contained
fragment contained the
contained the TRE-DNA
Fourth extensive purification
extensive purification by
purification by several
by several cycles
several cycles of
cycles of TRE-DNA
of TRE-DNA affinity
TRE-DNA affinity chromatography
affinity chromatography resulted
chromatography resulted in
resulted in the
in the 32
the 32 36
32 36 to
36 to 42
to 42 and
42 and 110
and 110 kD
110 kD proteins
kD proteins and
proteins and to
and to less
to less extent
less extent the
extent the 50
the 50 kD
50 kD factor
Two abundant proteins
abundant proteins of
proteins of 75
of 75 and
75 and 80
and 80 kD
80 kD were
kD were competed
were competed out
competed out by
out by poly[dI-C]
by poly[dI-C] in
poly[dI-C] in all
in all reactions
The cAMP-response element
cAMP-response element CRE
element CRE TGACGTCA
CRE TGACGTCA present
TGACGTCA present in
present in the
in the 21
the 21 base-pair
21 base-pair sequence
base-pair sequence appears
sequence appears to
appears to be
to be essential
be essential for
essential for specific
for specific protein-TRE-DNA
specific protein-TRE-DNA interactions
protein-TRE-DNA interactions because
interactions because mutation
because mutation of
mutation of the
of the two
the two G's
two G's destroys
G's destroys this
destroys this complex
This result suggests
result suggests that
suggests that the
that the cAMP
the cAMP response
cAMP response element
response element binding
element binding protein
binding protein CREB
protein CREB is
CREB is involved
is involved in
involved in the
in the protein-TRE-DNA
the protein-TRE-DNA complex
protein-TRE-DNA complex and
complex and in
and in mediating
in mediating the
mediating the Tax
the Tax response
Two distinct transcription
distinct transcription factors
transcription factors that
factors that bind
that bind the
bind the immunoglobulin
the immunoglobulin enhancer
immunoglobulin enhancer microE5/kappa
enhancer microE5/kappa 2
microE5/kappa 2 motif
Activity of the
of the immunoglobulin
the immunoglobulin heavy
immunoglobulin heavy and
heavy and kappa
and kappa light
kappa light chain
light chain gene
chain gene enhancers
gene enhancers depends
enhancers depends on
depends on a
on a complex
a complex interplay
complex interplay of
interplay of ubiquitous
of ubiquitous and
ubiquitous and developmentally
and developmentally regulated
developmentally regulated proteins
Two complementary DNAs
complementary DNAs were
DNAs were isolated
were isolated that
isolated that encode
that encode proteins
encode proteins denoted
proteins denoted ITF-1
denoted ITF-1 and
ITF-1 and ITF-2
and ITF-2 that
ITF-2 that are
that are expressed
are expressed in
expressed in a
in a variety
a variety of
variety of cell
of cell types
cell types and
types and bind
and bind the
bind the microE5/kappa
the microE5/kappa 2
microE5/kappa 2 motif
2 motif found
motif found in
found in both
in both heavy
both heavy and
heavy and kappa
and kappa light
kappa light chain
light chain enhancers
The complementary DNAs
complementary DNAs are
DNAs are the
are the products
the products of
products of distinct
of distinct genes
distinct genes yet
genes yet both
yet both ITF-1
both ITF-1 and
ITF-1 and ITF-2
and ITF-2 are
ITF-2 are structurally
are structurally and
structurally and functionally
and functionally similar
The two proteins
two proteins interact
proteins interact with
interact with one
with one another
one another through
another through their
through their putative
their putative helix-loop-helix
putative helix-loop-helix motifs
helix-loop-helix motifs and
motifs and each
and each possesses
each possesses a
possesses a distinct
a distinct domain
distinct domain that
domain that dictates
that dictates transcription
dictates transcription activation
Elevated glucocorticoid receptor
glucocorticoid receptor concentrations
receptor concentrations before
concentrations before and
before and after
and after glucocorticoid
after glucocorticoid therapy
glucocorticoid therapy in
therapy in peripheral
in peripheral mononuclear
peripheral mononuclear leukocytes
mononuclear leukocytes of
leukocytes of patients
of patients with
patients with atopic
with atopic dermatitis
The number and
number and affinity
and affinity of
affinity of glucocorticoid
of glucocorticoid binding
glucocorticoid binding sites
binding sites in
sites in peripheral
in peripheral mononuclear
peripheral mononuclear leukocytes
mononuclear leukocytes of
leukocytes of patients
of patients with
patients with atopic
with atopic dermatitis
atopic dermatitis AD
dermatitis AD and
AD and healthy
and healthy controls
healthy controls were
controls were determined
were determined under
determined under baseline
under baseline conditions
baseline conditions and
conditions and after
and after a
after a defined
a defined oral
defined oral glucocorticoid
oral glucocorticoid treatment
Patients with AD
with AD n
AD n =
n = 15
= 15 exhibited
15 exhibited significantly
exhibited significantly more
significantly more glucocorticoid
more glucocorticoid receptors
glucocorticoid receptors GR
receptors GR per
GR per cell
per cell than
cell than the
than the control
the control group
control group n
group n =
n = 22
= 22 while
22 while the
while the GR
the GR affinity
GR affinity did
affinity did not
did not differ
Methylprednisolone treatment resulted
treatment resulted in
resulted in a
in a significant
a significant reduction
significant reduction of
reduction of the
of the GR
the GR sites
GR sites per
sites per cell
per cell in
cell in the
in the steroid-treated
the steroid-treated control
steroid-treated control group
control group n
group n =
n = 10
= 10 in
10 in contrast
in contrast to
contrast to the
to the patients
The dissociation constant
dissociation constant was
constant was not
was not affected
not affected by
affected by methylprednisolone
by methylprednisolone treatment
methylprednisolone treatment in
treatment in either
in either group
In view of
view of the
of the therapeutic
the therapeutic efficiency
therapeutic efficiency of
efficiency of glucocorticoids
of glucocorticoids in
glucocorticoids in AD
in AD and
AD and findings
and findings of
findings of abnormal
of abnormal cAMP
abnormal cAMP and
cAMP and cAMP-phosphodiesterase
and cAMP-phosphodiesterase activity
cAMP-phosphodiesterase activity the
activity the elevated
the elevated GR
elevated GR concentrations
GR concentrations in
concentrations in AD
in AD lend
AD lend support
lend support to
support to the
to the hypothesis
the hypothesis of
hypothesis of a
of a compensatory
a compensatory GR
compensatory GR upregulation
GR upregulation due
upregulation due to
due to an
to an insufficient
an insufficient action
insufficient action of
action of endogenous
of endogenous cortisol
endogenous cortisol or
cortisol or to
or to altered
to altered cAMP-induced
altered cAMP-induced GR
cAMP-induced GR expression
The actions of
actions of cyclosporin
of cyclosporin A
cyclosporin A and
A and FK506
and FK506 suggest
FK506 suggest a
suggest a novel
a novel step
novel step in
step in the
in the activation
the activation of
activation of T
of T lymphocytes
Cyclosporin A and
A and FK506
and FK506 are
FK506 are immunosuppressive
are immunosuppressive compounds
immunosuppressive compounds that
compounds that have
that have similar
have similar inhibitory
similar inhibitory effects
inhibitory effects on
effects on the
on the expression
the expression of
expression of several
of several lymphokines
several lymphokines produced
lymphokines produced by
produced by T
by T lymphocytes
Despite their similar
their similar effects
similar effects the
effects the drugs
the drugs bind
drugs bind to
bind to two
to two different
two different cytosolic
different cytosolic protein
cytosolic protein cyclophilin
protein cyclophilin and
cyclophilin and FKBP
and FKBP respectively
FKBP respectively which
respectively which raises
which raises the
raises the possibility
the possibility that
possibility that they
that they have
they have different
have different modes
different modes of
modes of action
Using constructs in
constructs in which
in which mRNA
which mRNA production
mRNA production controlled
production controlled by
controlled by a
by a specific
a specific transcription
specific transcription factor
transcription factor could
factor could be
could be readily
be readily measured
readily measured we
measured we found
we found that
found that both
that both cyclosporin
both cyclosporin A
cyclosporin A and
A and FK506
and FK506 completely
FK506 completely inhibited
completely inhibited transcription
inhibited transcription activated
transcription activated by
activated by NF-AT
by NF-AT NFIL2
NF-AT NFIL2 A
NFIL2 A NFIL2
A NFIL2 B
NFIL2 B and
B and partially
and partially inhibited
partially inhibited transcription
inhibited transcription activated
transcription activated by
activated by NF
by NF kappa
NF kappa B
Cyclosporin A and
A and FK506
and FK506 inhibited
FK506 inhibited only
inhibited only transcriptional
only transcriptional activation
transcriptional activation that
activation that was
that was dependent
was dependent on
dependent on Ca2+
on Ca2+ mobilization
However cyclosporin A
cyclosporin A and
A and FK506
and FK506 did
FK506 did not
did not inhibit
not inhibit Ca2+
inhibit Ca2+ mobilization
Ca2+ mobilization dependent
mobilization dependent expression
dependent expression of
expression of c-fos
of c-fos mRNA
c-fos mRNA indicating
mRNA indicating that
indicating that only
that only a
only a subset
a subset of
subset of signalling
of signalling pathways
signalling pathways regulated
pathways regulated by
regulated by Ca2+
by Ca2+ is
Ca2+ is sensitive
is sensitive to
sensitive to these
to these drugs
Furthermore we did
we did not
did not observe
not observe any
observe any qualitative
any qualitative differences
qualitative differences between
differences between the
between the effect
the effect of
effect of cyclosporin
of cyclosporin A
cyclosporin A and
A and FK506
and FK506 on
FK506 on six
on six different
six different transcription
different transcription factors
transcription factors which
factors which suggests
which suggests that
suggests that these
that these drugs
these drugs may
drugs may interfere
may interfere with
interfere with the
with the activity
the activity of
activity of a
of a novel
a novel Ca2+
novel Ca2+ dependent
Ca2+ dependent step
dependent step that
step that regulates
that regulates several
regulates several transcription
several transcription factors
The internal methionine
internal methionine codons
methionine codons of
codons of human
of human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type II
type II rex
II rex gene
rex gene are
gene are not
are not required
not required for
required for p24rex
for p24rex production
p24rex production or
production or virus
or virus replication
virus replication and
replication and transformation
Human T-cell leukemia
T-cell leukemia virus
leukemia virus types
virus types I
types I HTLV-I
I HTLV-I and
HTLV-I and II
and II HTLV-II
II HTLV-II have
HTLV-II have two
have two nonstructural
two nonstructural trans-acting
nonstructural trans-acting regulatory
trans-acting regulatory genes
regulatory genes tax
genes tax and
tax and rex
and rex located
rex located in
located in the
in the 3'
the 3' region
3' region of
region of the
of the viral
the viral genome
The tax gene
tax gene product
gene product HTLV-I
product HTLV-I p40tax
HTLV-I p40tax and
p40tax and HTLV-II
and HTLV-II p37tax
HTLV-II p37tax is
p37tax is the
is the transcriptional
the transcriptional activator
transcriptional activator of
activator of the
of the viral
the viral long
viral long terminal
long terminal repeat
The rex gene
rex gene encodes
gene encodes two
encodes two protein
two protein products
protein products p27rex/p21rex
products p27rex/p21rex and
p27rex/p21rex and p26rex/p24rex
and p26rex/p24rex in
p26rex/p24rex in HTLV-I
in HTLV-I and
HTLV-I and HTLV-II
and HTLV-II respectively
Rex acts posttranscriptionally
acts posttranscriptionally to
posttranscriptionally to facilitate
to facilitate accumulation
facilitate accumulation of
accumulation of full-length
of full-length gag/pol
full-length gag/pol and
gag/pol and singly
and singly spliced
singly spliced env
spliced env mRNA
env mRNA in
mRNA in the
in the cytoplasm
the cytoplasm of
cytoplasm of HTLV-infected
of HTLV-infected cells
Previous studies showed
studies showed that
showed that the
that the first
the first ATG
first ATG of
ATG of the
of the rex
the rex gene
rex gene is
gene is critical
is critical for
critical for Rex
for Rex production
Rex production and
production and function
The importance of
importance of the
of the internal
the internal ATGs
internal ATGs to
ATGs to Rex
to Rex function
Rex function is
function is not
is not known
However in vitro
in vitro mutagenesis
vitro mutagenesis of
mutagenesis of the
of the HTLV-I
the HTLV-I rex
HTLV-I rex gene
rex gene has
gene has provided
has provided indirect
provided indirect evidence
indirect evidence which
evidence which suggests
which suggests that
suggests that p21rex
that p21rex and
p21rex and by
and by analogy
by analogy HTLV-II
analogy HTLV-II p24rex
HTLV-II p24rex results
p24rex results from
results from initiation
from initiation at
initiation at an
at an internal
an internal AUG
internal AUG of
AUG of the
of the tax/rex
the tax/rex mRNA
By using an
using an infectious
an infectious molecular
infectious molecular clone
molecular clone of
clone of HTLV-II
of HTLV-II we
HTLV-II we investigated
we investigated the
investigated the importance
the importance of
importance of the
of the internal
the internal ATGs
internal ATGs of
ATGs of the
of the rex
the rex gene
rex gene on
gene on Rex
on Rex protein
Rex protein production
protein production and
production and function
Our results indicate
results indicate that
indicate that p24rex
that p24rex of
p24rex of HTLV-II
of HTLV-II is
HTLV-II is not
is not initiated
not initiated at
initiated at an
at an internal
an internal AUG
internal AUG and
AUG and that
and that the
that the internal
the internal methionine
internal methionine codons
methionine codons are
codons are not
are not crucial
not crucial to
crucial to the
to the function
the function of
function of the
of the rex
the rex gene
rex gene and
gene and ultimately
and ultimately the
ultimately the transforming
the transforming properties
transforming properties of
properties of the
of the virus
Astrocytes and glioblastoma
and glioblastoma cells
glioblastoma cells express
cells express novel
express novel octamer-DNA
novel octamer-DNA binding
octamer-DNA binding proteins
binding proteins distinct
proteins distinct from
distinct from the
from the ubiquitous
the ubiquitous Oct-1
ubiquitous Oct-1 and
Oct-1 and B
and B cell
B cell type
cell type Oct-2
type Oct-2 proteins
The 'octamer' sequence
'octamer' sequence ATGCAAAT
sequence ATGCAAAT or
ATGCAAAT or its
or its complement
its complement ATTTGCAT
complement ATTTGCAT is
ATTTGCAT is a
is a key
a key element
key element for
element for the
for the transcriptional
the transcriptional regulation
transcriptional regulation of
regulation of immunoglobulin
of immunoglobulin genes
immunoglobulin genes in
genes in B-lymphocytes
in B-lymphocytes as
B-lymphocytes as well
as well as
well as a
as a number
a number of
number of housekeeping
of housekeeping genes
housekeeping genes in
genes in all
in all cell
all cell types
In lymphocytes the
lymphocytes the octamer-binding
the octamer-binding protein
octamer-binding protein Oct-2A
protein Oct-2A and
Oct-2A and variants
and variants thereof
variants thereof are
thereof are thought
are thought to
thought to contribute
to contribute to
contribute to the
to the B-cell
the B-cell specific
B-cell specific gene
specific gene expression
gene expression while
expression while the
while the ubiquitous
the ubiquitous protein
ubiquitous protein Oct-1
protein Oct-1 seems
Oct-1 seems to
seems to control
to control general
control general octamer
general octamer site-dependent
octamer site-dependent transcription
Various other genes
other genes for
genes for example
for example interleukin-1
example interleukin-1 and
interleukin-1 and MHC
and MHC class
MHC class II
class II genes
II genes contain
genes contain an
contain an octamer
an octamer sequence
octamer sequence in
sequence in the
in the promoter
the promoter and
promoter and are
and are expressed
are expressed in
expressed in cells
in cells of
cells of both
of both the
both the immune
the immune and
immune and nervous
and nervous systems
This prompted us
prompted us to
us to analyze
to analyze the
analyze the octamer-binding
the octamer-binding proteins
octamer-binding proteins in
proteins in the
in the latter
the latter cells
Using the electrophoretic
the electrophoretic mobility
electrophoretic mobility shift
mobility shift assay
shift assay at
assay at least
at least six
least six novel
six novel octamer
novel octamer binding
octamer binding proteins
binding proteins were
proteins were detected
were detected in
detected in nuclear
in nuclear extracts
nuclear extracts of
extracts of cultured
of cultured mouse
cultured mouse astrocytes
These proteins are
proteins are differentially
are differentially expressed
differentially expressed in
expressed in human
in human glioblastoma
human glioblastoma and
glioblastoma and neuroblastoma
and neuroblastoma cell
neuroblastoma cell lines
The nervous system-derived
nervous system-derived N-Oct
system-derived N-Oct proteins
N-Oct proteins bound
proteins bound to
bound to the
to the octamer
the octamer DNA
octamer DNA sequence
DNA sequence in
sequence in a
in a manner
a manner which
manner which is
which is indistinguishable
is indistinguishable from
indistinguishable from the
from the Oct-1
the Oct-1 and
Oct-1 and Oct-2A
and Oct-2A proteins
The relationship of
relationship of the
of the N-Oct
the N-Oct proteins
N-Oct proteins to
proteins to Oct-1
to Oct-1 and
Oct-1 and Oct-2A
and Oct-2A was
Oct-2A was analyzed
was analyzed by
analyzed by proteolytic
by proteolytic clipping
proteolytic clipping bandshift
clipping bandshift assays
bandshift assays and
assays and by
and by their
by their reactivity
their reactivity towards
reactivity towards antisera
towards antisera raised
antisera raised against
raised against recombinant
against recombinant Oct-1
recombinant Oct-1 and
Oct-1 and Oct-2A
and Oct-2A proteins
On the basis
the basis of
basis of these
of these assays
these assays all
assays all N-Oct-factors
all N-Oct-factors were
N-Oct-factors were found
were found to
found to be
to be distinct
be distinct from
distinct from the
from the ubiquitous
the ubiquitous Oct-1
ubiquitous Oct-1 and
Oct-1 and the
and the lymphoid-specific
the lymphoid-specific Oct-2A
lymphoid-specific Oct-2A proteins
In melanoma cells
melanoma cells that
cells that contain
that contain the
contain the N-Oct-3
the N-Oct-3 factor
N-Oct-3 factor a
factor a transfected
a transfected lymphocyte-specific
transfected lymphocyte-specific promoter
lymphocyte-specific promoter was
promoter was neither
was neither activated
neither activated nor
activated nor was
nor was it
was it repressed
it repressed upon
repressed upon contransfection
upon contransfection with
contransfection with an
with an Oct-2A
an Oct-2A expression
Oct-2A expression vector
We therefore speculate
therefore speculate that
speculate that N-Oct-3
that N-Oct-3 and
N-Oct-3 and other
and other N-Oct
other N-Oct factors
N-Oct factors have
factors have a
have a specific
a specific role
specific role in
role in gene
in gene expression
gene expression in
expression in cells
in cells of
cells of the
of the nervous
the nervous system
Detection in non-erythroid
in non-erythroid cells
non-erythroid cells of
cells of a
of a factor
a factor with
factor with the
with the binding
the binding characteristics
binding characteristics of
characteristics of the
of the erythroid
the erythroid cell
erythroid cell transcription
cell transcription factor
transcription factor EF1
The erythroid transcription
erythroid transcription factor
transcription factor erythroid
factor erythroid factor-1
erythroid factor-1 EF1
factor-1 EF1 plays
EF1 plays a
plays a critical
a critical role
critical role in
role in the
in the transcription
the transcription of
transcription of erythroid-specific
of erythroid-specific genes
Here we report
we report the
report the presence
the presence of
presence of a
of a factor
a factor with
factor with the
with the mobility
the mobility and
mobility and sequence-specific
and sequence-specific DNA-binding
sequence-specific DNA-binding characteristics
DNA-binding characteristics of
characteristics of EF1
of EF1 at
EF1 at low
at low abundance
low abundance in
abundance in a
in a wide
a wide variety
wide variety of
variety of non-erythroid
of non-erythroid cell
non-erythroid cell types
This is the
is the first
the first report
first report of
report of an
of an EF1-like
an EF1-like activity
EF1-like activity in
activity in non-erythroid
in non-erythroid cells
non-erythroid cells and
cells and indicates
and indicates that
indicates that this
that this factor
this factor may
factor may play
may play a
play a role
a role in
role in the
in the regulation
the regulation of
regulation of genes
of genes expressed
genes expressed in
expressed in such
in such cells
Protein kinase inhibitor
kinase inhibitor H-7
inhibitor H-7 blocks
H-7 blocks accumulation
blocks accumulation of
accumulation of unspliced
of unspliced mRNA
unspliced mRNA of
mRNA of human
of human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type I
type I HTLV-I
Rex the post-transcriptional
the post-transcriptional regulator
post-transcriptional regulator of
regulator of human
of human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type I
type I HTLV-I
I HTLV-I is
HTLV-I is known
is known to
known to induce
to induce accumulation
induce accumulation of
accumulation of the
of the unspliced
the unspliced viral
unspliced viral gag-pol
viral gag-pol mRNA
Rex is a
is a phosphoprotein
a phosphoprotein found
phosphoprotein found in
found in the
in the cell
the cell nucleolus
cell nucleolus whose
nucleolus whose function
whose function may
function may be
may be regulated
be regulated by
regulated by its
by its localization
its localization and
localization and phosphorylation
We have examined
have examined the
examined the role
the role of
role of phosphorylation
of phosphorylation on
phosphorylation on Rex
on Rex function
Rex function by
function by using
by using a
using a protein
a protein kinase
protein kinase inhibitor
kinase inhibitor H-7
inhibitor H-7 [1-5-isoquinolinyl-sulfonyl-2-methylpiperazine]
Treatment of an
of an HTLV-I
an HTLV-I infected
HTLV-I infected human
infected human T-cell
human T-cell line
T-cell line with
line with H-7
with H-7 blocked
H-7 blocked specifically
blocked specifically accumulation
specifically accumulation of
accumulation of the
of the unspliced
the unspliced gag-pol
unspliced gag-pol mRNA
gag-pol mRNA resulting
mRNA resulting in
resulting in the
in the decreased
the decreased Gag
decreased Gag protein
Gag protein synthesis
protein synthesis that
synthesis that corresponds
that corresponds with
corresponds with the
with the decreased
the decreased in
decreased in vivo
in vivo phosphorylation
vivo phosphorylation of
phosphorylation of Rex
In contrast other
contrast other viral
other viral and
viral and cellular
and cellular products
cellular products have
products have not
have not been
not been influenced
been influenced by
influenced by the
by the level
the level of
level of H-7
of H-7 used
Therefore the phosphorylation
the phosphorylation of
phosphorylation of Rex
of Rex is
Rex is required
is required for
required for the
for the viral
the viral RNA
viral RNA partition
RNA partition of
partition of HTLV-I
Increased glucocorticoid responsiveness
glucocorticoid responsiveness of
responsiveness of CD4+
of CD4+ T-cell
CD4+ T-cell clonal
T-cell clonal lines
clonal lines grown
lines grown in
grown in serum-free
in serum-free media
CEM-C7 a human
a human leukemic
human leukemic CD4+
leukemic CD4+ T-lymphocyte
CD4+ T-lymphocyte cell
T-lymphocyte cell line
cell line and
line and three
and three of
three of its
of its subclones
its subclones CEM-4R4
subclones CEM-4R4 CEM-3R43
CEM-4R4 CEM-3R43 and
CEM-3R43 and ICR-27
and ICR-27 previously
ICR-27 previously cultured
previously cultured in
cultured in a
in a medium
a medium supplemented
medium supplemented with
supplemented with 5
with 5 to
5 to 10%
to 10% fetal
10% fetal bovine
fetal bovine serum
bovine serum have
serum have been
have been adapted
been adapted to
adapted to serum-free
to serum-free media
The best medium
best medium of
medium of those
of those tested
those tested was
tested was RPMI
was RPMI 1640
RPMI 1640 supplemented
1640 supplemented with
supplemented with 5
with 5 micrograms/ml
5 micrograms/ml each
micrograms/ml each transferrin
each transferrin and
transferrin and insulin
and insulin +
insulin + 5
+ 5 ng/ml
5 ng/ml sodium
ng/ml sodium selenite
sodium selenite +/-
selenite +/- 01%
+/- 01% bovine
01% bovine serum
bovine serum albumin
While growing either
growing either with
either with or
with or without
or without albumin
without albumin the
albumin the several
the several clonal
several clonal lines
clonal lines of
lines of CEM
of CEM cells
CEM cells displayed
cells displayed growth
displayed growth similar
growth similar to
similar to serum-supplemented
to serum-supplemented cultures
Cell proliferation of
proliferation of CEM-C7
of CEM-C7 cells
CEM-C7 cells cultured
cells cultured in
cultured in both
in both serum-free
both serum-free media
serum-free media has
media has been
has been sustained
been sustained for
sustained for 3
for 3 mo
with culture doubling
culture doubling times
doubling times of
times of about
of about 25
about 25 h
25 h for
h for both
for both serum-supplemented
both serum-supplemented and
serum-supplemented and serum-free
and serum-free cultures
serum-free cultures viability
cultures viability greater
viability greater than
greater than or
than or equal
or equal to
equal to 90%
Cell morphology remained
morphology remained essentially
remained essentially the
essentially the same
the same in
same in serum-free
in serum-free or
serum-free or serum
or serum containing
serum containing media
The expression of
expression of CD4
of CD4 a
CD4 a marker
a marker for
marker for T-derived
for T-derived lymphoid
T-derived lymphoid cells
lymphoid cells was
cells was not
was not significantly
not significantly different
significantly different in
different in serum-free
in serum-free medium
When grown in
grown in serum-free
in serum-free medium
serum-free medium CEM-C7
medium CEM-C7 cells
CEM-C7 cells exhibited
cells exhibited increased
exhibited increased steroid
increased steroid responsiveness
steroid responsiveness as
responsiveness as evidenced
as evidenced by
evidenced by increased
by increased glucocorticoid
increased glucocorticoid receptor
glucocorticoid receptor binding
receptor binding sites
binding sites increased
sites increased induction
increased induction of
induction of glutamine
of glutamine synthetase
glutamine synthetase and
synthetase and cell
and cell lysis
cell lysis at
lysis at lower
at lower concentrations
lower concentrations of
concentrations of steroid
Receptor mutant subclones
mutant subclones of
subclones of CEM-C7
of CEM-C7 which
CEM-C7 which are
which are proven
are proven to
proven to be
to be completely
be completely unresponsive
completely unresponsive to
unresponsive to micromolar
to micromolar concentrations
micromolar concentrations of
concentrations of dexamethasone
of dexamethasone when
dexamethasone when grown
when grown in
grown in serum-supplemented
in serum-supplemented medium
serum-supplemented medium become
medium become partially
become partially sensitive
partially sensitive to
sensitive to the
to the hormone
the hormone after
hormone after growth
after growth in
growth in defined
in defined medium
The increased sensitivity
increased sensitivity of
sensitivity of CEM-C7
of CEM-C7 cells
CEM-C7 cells and
cells and its
and its subclones
its subclones to
subclones to dexamethasone
to dexamethasone in
dexamethasone in serum-free
in serum-free medium
serum-free medium returned
medium returned to
returned to previous
to previous levels
previous levels when
levels when these
when these cells
these cells were
cells were recultured
were recultured in
recultured in serum-containing
in serum-containing medium
Our results suggest
results suggest that
suggest that substances
that substances in
substances in serum
in serum influence
serum influence steroid
influence steroid effects
steroid effects on
effects on these
on these cells
these cells and
cells and that
and that the
that the molecular
the molecular details
molecular details of
details of glucocorticoid
of glucocorticoid hormone
glucocorticoid hormone action
hormone action may
action may be
may be pursued
be pursued more
pursued more precisely
more precisely in
precisely in a
in a clearly
a clearly defined
clearly defined culture
defined culture medium
[Glucocorticoid receptors on
receptors on human
on human peripheral
human peripheral mononuclear
peripheral mononuclear and
mononuclear and polymorphonuclear
and polymorphonuclear leucocytes:
polymorphonuclear leucocytes: changes
leucocytes: changes in
changes in patients
in patients with
patients with yang-deficiency]
It was found
was found that
found that in
that in former
in former works
former works the
works the glucocorticoid
the glucocorticoid receptors
glucocorticoid receptors GCR
receptors GCR on
GCR on peripheral
on peripheral mixed
peripheral mixed leucocytes
mixed leucocytes in
leucocytes in patients
in patients with
patients with Yang-deficiency
with Yang-deficiency were
Yang-deficiency were decreased
In this work
this work the
work the mixed
the mixed leucocytes
mixed leucocytes were
leucocytes were further
were further separated
further separated into
separated into mononuclear
into mononuclear MNL
mononuclear MNL and
MNL and polymorphonuclear
and polymorphonuclear PML
polymorphonuclear PML leucocytes
PML leucocytes and
leucocytes and GCR
and GCR were
GCR were determined
were determined in
determined in each
in each part
each part of
part of leucocytes
GCR on MNL
on MNL and
MNL and PML
and PML in
PML in 6
in 6 Yang
6 Yang deficient
Yang deficient patients
deficient patients were
patients were 3473
were 3473 +/-
3473 +/- 413
+/- 413 and
413 and 4433
and 4433 +/-
4433 +/- 651
+/- 651 sites/cell
651 sites/cell respectively
sites/cell respectively statistically
respectively statistically significant
statistically significant from
significant from the
from the normal
the normal control
normal control group
control group 4462
group 4462 +/-
4462 +/- 962
+/- 962 and
962 and 5622
and 5622 +/-
5622 +/- 782
+/- 782 sites/cell
782 sites/cell respectively
sites/cell respectively P
respectively P less
P less than
less than 005
GCR on MNL
on MNL PML
MNL PML and
PML and mixed
and mixed leucocytes
mixed leucocytes in
leucocytes in 5
in 5 patients
5 patients were
patients were determined
were determined simultaneously
determined simultaneously and
simultaneously and all
and all lowered
all lowered from
lowered from the
from the control
the control group
The results were
results were 3369
were 3369 +/-
3369 +/- 370
+/- 370 4986
370 4986 +/-
4986 +/- 419
+/- 419 and
419 and 4524
and 4524 +/-
4524 +/- 852
+/- 852 sites/cell
852 sites/cell respectively
sites/cell respectively with
respectively with the
with the lowest
the lowest GCR
lowest GCR on
GCR on MNL
on MNL and
MNL and highest
and highest on
highest on PML
The ubiquitous octamer-binding
ubiquitous octamer-binding proteins
octamer-binding proteins is
proteins is sufficient
is sufficient for
sufficient for transcription
for transcription of
transcription of immunoglobulin
of immunoglobulin genes
All immunoglobulin genes
immunoglobulin genes contain
genes contain a
contain a conserved
a conserved octanucleotide
conserved octanucleotide promoter
octanucleotide promoter element
promoter element ATGCAAAT
element ATGCAAAT which
ATGCAAAT which has
which has been
has been shown
been shown to
shown to be
to be required
be required for
required for their
for their normal
their normal B-cell-specific
normal B-cell-specific transcription
Proteins that bind
that bind this
bind this octamer
this octamer have
octamer have been
have been purified
been purified and
purified and cDNAs
and cDNAs encoding
cDNAs encoding octamer-binding
encoding octamer-binding proteins
octamer-binding proteins have
proteins have been
have been cloned
Some of these
of these proteins
these proteins referred
proteins referred to
referred to as
to as OTF-2
as OTF-2 are
OTF-2 are lymphoid
are lymphoid specific
lymphoid specific whereas
specific whereas at
whereas at least
at least one
least one other
one other and
other and possibly
and possibly more
possibly more referred
more referred to
referred to as
to as OTF-1
as OTF-1 is
OTF-1 is found
is found ubiquitously
found ubiquitously in
ubiquitously in all
in all cell
all cell types
The exact role
exact role of
role of these
of these different
these different proteins
different proteins in
proteins in directing
in directing the
directing the tissue-specific
the tissue-specific expression
tissue-specific expression of
expression of immunoglobulin
of immunoglobulin genes
immunoglobulin genes is
genes is unclear
We have identified
have identified two
identified two human
two human pre-B-cell
human pre-B-cell lines
pre-B-cell lines that
lines that contain
that contain extremely
contain extremely low
extremely low levels
low levels of
levels of OTF-2
of OTF-2 yet
OTF-2 yet still
yet still express
still express high
express high levels
high levels of
levels of steady-state
of steady-state immunoglobulin
steady-state immunoglobulin heavy-chain
immunoglobulin heavy-chain mRNA
heavy-chain mRNA in
mRNA in vivo
in vivo and
vivo and efficiently
and efficiently transcribe
efficiently transcribe an
transcribe an immunoglobulin
an immunoglobulin gene
immunoglobulin gene in
gene in vitro
Addition of a
of a highly
a highly enriched
highly enriched preparation
enriched preparation of
preparation of OTF-1
of OTF-1 made
OTF-1 made from
made from one
from one of
one of these
of these pre-B
these pre-B cells
pre-B cells or
cells or from
or from HeLa
from HeLa cells
HeLa cells specifically
cells specifically stimulated
specifically stimulated in
stimulated in vitro
in vitro transcription
vitro transcription of
transcription of an
of an immunoglobulin
an immunoglobulin gene
Furthermore OFT-1 appeared
OFT-1 appeared to
appeared to have
to have approximately
have approximately the
approximately the same
the same transactivation
same transactivation ability
transactivation ability as
ability as OTF-2
as OTF-2 when
OTF-2 when normalized
when normalized for
normalized for binding
for binding activity
These results suggest
results suggest that
suggest that OTF-1
that OTF-1 without
OTF-1 without OTF-2
without OTF-2 is
OTF-2 is sufficient
is sufficient for
sufficient for transcription
for transcription of
transcription of immunoglobulin
of immunoglobulin genes
immunoglobulin genes and
genes and that
and that OTF-2
that OTF-2 alone
OTF-2 alone is
alone is not
is not responsible
not responsible for
responsible for the
for the B-cell-specific
the B-cell-specific regulation
B-cell-specific regulation of
regulation of immunoglobulin
of immunoglobulin gene
immunoglobulin gene expression
Effects of aldosterone
of aldosterone on
aldosterone on intralymphocytic
on intralymphocytic sodium
intralymphocytic sodium and
sodium and potassium
and potassium in
potassium in patients
in patients with
patients with essential
with essential hypertension
In vitro binding
vitro binding of
binding of aldosterone
of aldosterone to
aldosterone to mineralocorticoid
to mineralocorticoid receptors
mineralocorticoid receptors on
receptors on human
on human mononuclear
human mononuclear leukocytes
mononuclear leukocytes HML
leukocytes HML and
HML and its
and its effects
its effects on
effects on the
on the intracellular
the intracellular sodium
intracellular sodium and
sodium and potassium
and potassium concentrations
potassium concentrations of
concentrations of HML
of HML have
HML have already
have already been
already been described
In the present
the present paper
present paper this
paper this easily
this easily accessible
easily accessible human
accessible human cell
human cell model
cell model was
model was investigated
was investigated in
investigated in 13
in 13 patients
13 patients with
patients with essential
with essential hypertension
In only four
only four patients
four patients sodium
patients sodium in
sodium in HML
in HML without
HML without incubation
without incubation was
incubation was elevated
was elevated compared
elevated compared with
compared with the
with the range
the range for
range for normal
for normal persons
A decrease of
decrease of intracellular
of intracellular sodium
intracellular sodium or
sodium or potassium
or potassium occurred
potassium occurred during
occurred during incubation
during incubation without
incubation without aldosterone
without aldosterone P
aldosterone P less
P less than
less than 002
The addition of
addition of 14
of 14 nM
14 nM aldosterone
nM aldosterone did
aldosterone did not
did not prevent
not prevent this
prevent this loss
this loss of
loss of electrolytes
of electrolytes as
electrolytes as observed
as observed in
observed in normal
in normal persons
Plasma renin activity
renin activity and
activity and aldosterone
and aldosterone were
aldosterone were not
were not correlated
not correlated with
correlated with the
with the electrolyte
the electrolyte response
electrolyte response and
response and were
and were within
were within the
within the normal
the normal limits
The number of
number of mineralocorticoid
of mineralocorticoid receptors/cell
mineralocorticoid receptors/cell were
receptors/cell were within
were within or
within or close
or close to
close to the
to the normal
the normal range
normal range n
range n =
n = 9
The independence of
independence of intracellular
of intracellular electrolytes
intracellular electrolytes from
electrolytes from aldosterone
from aldosterone despite
aldosterone despite a
despite a normal
a normal number
normal number of
number of mineralocorticoid
of mineralocorticoid receptors
mineralocorticoid receptors may
receptors may reflect
may reflect an
reflect an impairment
an impairment of
impairment of the
of the mineralocorticoid
the mineralocorticoid effector
mineralocorticoid effector mechanism
effector mechanism in
mechanism in the
in the HML
the HML of
HML of patients
of patients with
patients with essential
with essential hypertension
[Differential diagnostic value
diagnostic value of
value of receptors
of receptors of
receptors of 125-dihydroxyvitamin
of 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 calcitriol
D3 calcitriol determination
calcitriol determination in
determination in lymphocytes
in lymphocytes of
lymphocytes of children
of children with
children with rickets
with rickets and
rickets and rickets-like
and rickets-like diseases]
The authors provide
authors provide the
provide the results
the results of
results of studying
of studying 125-dihydroxyvitamin
studying 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 calcitriol
D3 calcitriol in
calcitriol in lymphocytes
in lymphocytes of
lymphocytes of children
of children with
children with rickets
with rickets and
rickets and rickets-like
and rickets-like diseases
It is proposed
is proposed that
proposed that the
that the character
the character of
character of their
of their expression
their expression under
expression under the
under the influence
the influence of
influence of vitamin
of vitamin D
vitamin D may
D may be
may be used
be used with
used with differential
with differential diagnostic
differential diagnostic purposes
diagnostic purposes in
purposes in view
Regulation of gene
of gene expression
gene expression with
expression with double-stranded
with double-stranded phosphorothioate
double-stranded phosphorothioate oligonucleotides
Alteration of gene
of gene transcription
gene transcription by
transcription by inhibition
by inhibition of
inhibition of specific
of specific transcriptional
specific transcriptional regulatory
transcriptional regulatory proteins
regulatory proteins is
proteins is necessary
is necessary for
necessary for determining
for determining how
determining how these
how these factors
these factors participate
factors participate in
participate in cellular
in cellular differentiation
The functions of
functions of these
of these proteins
these proteins can
proteins can be
can be antagonized
be antagonized by
antagonized by several
by several methods
several methods each
methods each with
each with specific
with specific limitations
Inhibition of sequence-specific
of sequence-specific DNA-binding
sequence-specific DNA-binding proteins
DNA-binding proteins was
proteins was achieved
was achieved with
achieved with double-stranded
with double-stranded ds
double-stranded ds phosphorothioate
ds phosphorothioate oligonucleotides
phosphorothioate oligonucleotides that
oligonucleotides that contained
that contained octamer
contained octamer or
octamer or kappa
or kappa B
kappa B consensus
B consensus sequences
The phosphorothioate oligonucleotides
phosphorothioate oligonucleotides specifically
oligonucleotides specifically bound
specifically bound either
bound either octamer
either octamer transcription
octamer transcription factor
transcription factor or
factor or nuclear
or nuclear factor
nuclear factor NF-kappa
factor NF-kappa B
The modified oligonucleotides
modified oligonucleotides accumulated
oligonucleotides accumulated in
accumulated in cells
in cells more
cells more effectively
more effectively than
effectively than standard
than standard ds
standard ds oligonucleotides
ds oligonucleotides and
oligonucleotides and modulated
and modulated gene
modulated gene expression
gene expression in
expression in a
in a specific
a specific manner
Octamer-dependent activation of
activation of a
of a reporter
a reporter plasmid
reporter plasmid or
plasmid or NF-kappa
or NF-kappa B-dependent
NF-kappa B-dependent activation
B-dependent activation of
activation of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV enhancer
HIV enhancer was
enhancer was inhibited
was inhibited when
inhibited when the
when the appropriate
the appropriate phosphorothioate
appropriate phosphorothioate oligonucleotide
phosphorothioate oligonucleotide was
oligonucleotide was added
was added to
added to a
to a transiently
a transiently transfected
transiently transfected B
transfected B cell
B cell line
Addition of phosphorothioate
of phosphorothioate oligonucleotides
phosphorothioate oligonucleotides that
oligonucleotides that contained
that contained the
contained the octamer
the octamer consensus
octamer consensus to
consensus to Jurkat
to Jurkat T
Jurkat T leukemia
T leukemia cells
leukemia cells inhibited
cells inhibited interleukin-2
inhibited interleukin-2 IL-2
interleukin-2 IL-2 secretion
IL-2 secretion to
secretion to a
to a degree
a degree similar
degree similar to
similar to that
to that observed
that observed with
observed with a
with a mutated
a mutated octamer
mutated octamer site
octamer site in
site in the
in the IL-2
the IL-2 enhancer
The ds phosphorothioate
ds phosphorothioate oligonucleotides
phosphorothioate oligonucleotides probably
oligonucleotides probably compete
probably compete for
compete for binding
for binding of
binding of specific
of specific transcription
specific transcription factors
transcription factors and
factors and may
and may provide
may provide anti-viral
provide anti-viral immunosuppressive
anti-viral immunosuppressive or
immunosuppressive or other
or other therapeutic
other therapeutic effects
[Effect of the
of the regimen
the regimen of
regimen of kidney-tonifying
of kidney-tonifying and
kidney-tonifying and qi-invigorating
and qi-invigorating on
qi-invigorating on aging
on aging changes
aging changes of
changes of glucocorticoid
of glucocorticoid receptor]
The plasma cortisol
plasma cortisol concentration
cortisol concentration and
concentration and the
and the sites
the sites of
sites of glucocorticoid
of glucocorticoid receptor
glucocorticoid receptor GCR
receptor GCR in
GCR in the
in the peripheral
the peripheral lymphocytes
peripheral lymphocytes were
lymphocytes were measured
were measured in
measured in 32
in 32 healthy
32 healthy aged
healthy aged persons
aged persons and
persons and 13
and 13 young
13 young adults
In animal experiment
animal experiment GCR
experiment GCR of
GCR of spleen
of spleen lymphocytic
spleen lymphocytic cell
lymphocytic cell was
cell was also
was also measured
also measured in
measured in 18
in 18 aged
18 aged rats
aged rats and
rats and 9
and 9 young
9 young rats
The results showed
results showed that
showed that GCR
that GCR was
GCR was significantly
was significantly lower
significantly lower in
lower in the
in the aged
the aged persons
aged persons or
persons or rats
or rats than
rats than that
than that in
that in the
in the young
the young while
young while the
while the plasma
the plasma cortisol
plasma cortisol level
cortisol level didn't
level didn't change
didn't change with
change with aging
So we think
we think that
think that GCR
that GCR is
GCR is more
is more sensitive
more sensitive than
sensitive than the
than the plasma
the plasma cortisol
plasma cortisol level
cortisol level to
level to reflect
to reflect the
reflect the aging
the aging change
aging change of
change of the
of the adrenal
the adrenal cortex
adrenal cortex function
After the treatment
the treatment with
treatment with the
with the regimen
the regimen of
regimen of Kidney-tonifying
of Kidney-tonifying and
Kidney-tonifying and Qi-invigorating
and Qi-invigorating the
Qi-invigorating the GCR
the GCR of
GCR of the
of the aged
the aged persons
aged persons and
persons and rats
and rats was
rats was enhanced
was enhanced and
enhanced and in
and in this
in this way
this way the
way the function
the function of
function of the
of the aged
the aged adrenal
aged adrenal cortex
adrenal cortex was
cortex was improved
Interferon affects nuclear
affects nuclear proteins
nuclear proteins in
proteins in cells
in cells of
cells of clinically
of clinically sensitive
clinically sensitive chronic
sensitive chronic myelogenous
chronic myelogenous leukemia
myelogenous leukemia patients
Cytoplasmic protein extracts
protein extracts from
extracts from chronic
from chronic myelogenous
chronic myelogenous leukemia
myelogenous leukemia CML
leukemia CML cells
CML cells contained
cells contained an
contained an activity
an activity that
activity that altered
that altered the
altered the electrophoretic
the electrophoretic mobility
electrophoretic mobility of
mobility of complexes
of complexes formed
complexes formed between
formed between nuclear
between nuclear proteins
nuclear proteins and
proteins and the
and the transcriptional
the transcriptional enhancers
transcriptional enhancers of
enhancers of interferon
of interferon IFN-inducible
interferon IFN-inducible genes
Exposure of CML
of CML cells
CML cells to
cells to IFN-alpha
to IFN-alpha diminished
IFN-alpha diminished the
diminished the effect
the effect of
effect of the
of the CML
the CML cytoplasmic
CML cytoplasmic proteins
cytoplasmic proteins on
proteins on these
on these nuclear
these nuclear protein-DNA
nuclear protein-DNA complexes
The presence of
presence of clinical
of clinical responsiveness
clinical responsiveness to
responsiveness to IFN-alpha
to IFN-alpha correlated
IFN-alpha correlated with
correlated with the
with the sensitivity
the sensitivity to
sensitivity to the
to the IFN-induced
the IFN-induced change
IFN-induced change in
change in the
in the electrophoretic
the electrophoretic mobility
electrophoretic mobility of
mobility of nuclear
of nuclear protein-DNA
nuclear protein-DNA complexes
These data suggest
data suggest that
suggest that the
that the action
the action of
action of IFN-alpha
of IFN-alpha in
IFN-alpha in CML
in CML may
CML may be
may be linked
be linked to
linked to a
to a pathway
a pathway that
pathway that can
that can result
can result in
result in posttranslational
in posttranslational modification
posttranslational modification of
modification of nuclear
of nuclear proteins
Epstein-Barr virus nuclear
virus nuclear antigen
nuclear antigen 2
antigen 2 transactivates
2 transactivates latent
transactivates latent membrane
latent membrane protein
membrane protein LMP1
Several lines of
lines of evidence
of evidence are
evidence are compatible
are compatible with
compatible with the
with the hypothesis
the hypothesis that
hypothesis that Epstein-Barr
that Epstein-Barr virus
Epstein-Barr virus EBV
virus EBV nuclear
EBV nuclear antigen
nuclear antigen 2
antigen 2 EBNA-2
2 EBNA-2 or
EBNA-2 or leader
or leader protein
leader protein EBNA-LP
protein EBNA-LP affects
EBNA-LP affects expression
affects expression of
expression of the
of the EBV
the EBV latent
EBV latent infection
latent infection membrane
infection membrane protein
membrane protein LMP1
We now demonstrate
now demonstrate the
demonstrate the following
i Acute transfection
Acute transfection and
transfection and expression
and expression of
expression of EBNA-2
of EBNA-2 under
EBNA-2 under control
under control of
control of simian
of simian virus
simian virus 40
virus 40 or
40 or Moloney
or Moloney murine
Moloney murine leukemia
murine leukemia virus
leukemia virus promoters
virus promoters resulted
promoters resulted in
resulted in increased
in increased LMP1
increased LMP1 expression
LMP1 expression in
expression in P3HR-1-infected
in P3HR-1-infected Burkitt's
P3HR-1-infected Burkitt's lymphoma
Burkitt's lymphoma cells
lymphoma cells and
cells and the
and the P3HR-1
the P3HR-1 or
P3HR-1 or Daudi
or Daudi cell
Daudi cell line
ii Transfection and
Transfection and expression
and expression of
expression of EBNA-LP
of EBNA-LP alone
EBNA-LP alone had
alone had no
had no effect
no effect on
effect on LMP1
on LMP1 expression
LMP1 expression and
expression and did
and did not
did not act
not act synergistically
act synergistically with
synergistically with EBNA-2
with EBNA-2 to
EBNA-2 to affect
to affect LMP1
affect LMP1 expression
iii LMP1 expression
LMP1 expression in
expression in Daudi
in Daudi and
Daudi and P3HR-1-infected
and P3HR-1-infected cells
P3HR-1-infected cells was
cells was controlled
was controlled at
controlled at the
at the mRNA
the mRNA level
mRNA level and
level and EBNA-2
and EBNA-2 expression
EBNA-2 expression in
expression in Daudi
in Daudi cells
Daudi cells increased
cells increased LMP1
increased LMP1 mRNA
iv No other
No other EBV
other EBV genes
EBV genes were
genes were required
were required for
required for EBNA-2
for EBNA-2 transactivation
EBNA-2 transactivation of
transactivation of LMP1
of LMP1 since
LMP1 since cotransfection
since cotransfection of
cotransfection of recombinant
of recombinant EBNA-2
recombinant EBNA-2 expression
EBNA-2 expression vectors
expression vectors and
vectors and genomic
and genomic LMP1
genomic LMP1 DNA
LMP1 DNA fragments
DNA fragments enhanced
fragments enhanced LMP1
enhanced LMP1 expression
LMP1 expression in
expression in the
in the EBV-negative
the EBV-negative B-lymphoma
EBV-negative B-lymphoma cell
B-lymphoma cell lines
cell lines BJAB
lines BJAB Louckes
BJAB Louckes and
Louckes and BL30
v An EBNA-2-responsive
An EBNA-2-responsive element
EBNA-2-responsive element was
element was found
was found within
found within the
within the -512
the -512 to
-512 to +40
to +40 LMP1
+40 LMP1 DNA
LMP1 DNA since
DNA since this
since this DNA
this DNA linked
DNA linked to
linked to a
to a chloramphenicol
a chloramphenicol acetyltransferase
chloramphenicol acetyltransferase reporter
acetyltransferase reporter gene
reporter gene was
gene was transactivated
was transactivated by
transactivated by cotransfection
by cotransfection with
cotransfection with an
with an EBNA-2
an EBNA-2 expression
EBNA-2 expression vector
vi The EBV
The EBV type
EBV type 2
type 2 EBNA-2
2 EBNA-2 transactivated
EBNA-2 transactivated LMP1
transactivated LMP1 as
LMP1 as well
as well as
well as the
as the EBV
the EBV type
EBV type 1
type 1 EBNA-2
vii Two deletions
Two deletions within
deletions within the
within the EBNA-2
the EBNA-2 gene
EBNA-2 gene which
gene which rendered
which rendered EBV
rendered EBV transformation
EBV transformation incompetent
transformation incompetent did
incompetent did not
did not transactivate
not transactivate LMP1
transactivate LMP1 whereas
LMP1 whereas a
whereas a transformation-competent
a transformation-competent EBNA-2
transformation-competent EBNA-2 deletion
EBNA-2 deletion mutant
deletion mutant did
mutant did transactivate
did transactivate LMP1
LMP1 is a
is a potent
a potent effector
potent effector of
effector of B-lymphocyte
of B-lymphocyte activation
B-lymphocyte activation and
activation and can
and can act
can act synergistically
act synergistically with
synergistically with EBNA-2
with EBNA-2 to
EBNA-2 to induce
to induce cellular
induce cellular CD23
cellular CD23 gene
CD23 gene expression
Thus EBNA-2 transactivation
EBNA-2 transactivation of
transactivation of LMP1
of LMP1 amplifies
LMP1 amplifies the
amplifies the biological
the biological impact
biological impact of
impact of EBNA-2
of EBNA-2 and
EBNA-2 and underscores
and underscores its
underscores its central
its central role
central role in
role in EBV-induced
in EBV-induced growth
EBV-induced growth transformation
The expression of
expression of c-fos
of c-fos c-jun
c-fos c-jun and
c-jun and c-myc
and c-myc genes
c-myc genes is
genes is regulated
is regulated by
regulated by heat
by heat shock
heat shock in
shock in human
in human lymphoid
human lymphoid cells
The effect of
effect of heat
of heat shock
heat shock on
shock on the
on the expression
the expression of
expression of the
of the nuclear
the nuclear protooncogenes
nuclear protooncogenes c-fos
protooncogenes c-fos c-jun
c-fos c-jun and
c-jun and c-myc
and c-myc was
c-myc was studied
was studied in
studied in human
in human lymphoid
human lymphoid cells
Heat shock caused
shock caused an
caused an increase
an increase in
increase in c-fos
in c-fos and
c-fos and c-jun
and c-jun mRNA
c-jun mRNA levels
mRNA levels and
levels and a
and a decrease
a decrease in
decrease in c-myc
in c-myc mRNA
c-myc mRNA levels
mRNA levels in
levels in pre-B
in pre-B Hyon
pre-B Hyon and
Hyon and T
and T DND-41
T DND-41 cell
DND-41 cell lines
cell lines as
lines as well
as well as
well as in
as in freshly
in freshly isolated
freshly isolated normal
isolated normal human
normal human thymocytes
The changes in
changes in the
in the mRNA
the mRNA levels
mRNA levels of
levels of these
of these protooncogenes
these protooncogenes in
protooncogenes in Hyon
in Hyon cells
Hyon cells were
cells were most
were most pronounced
most pronounced at
pronounced at 42
at 42 and
42 and 43
and 43 degrees
43 degrees C;
degrees C; kinetic
C; kinetic analysis
kinetic analysis demonstrated
analysis demonstrated that
demonstrated that the
that the changes
the changes could
changes could be
could be detected
be detected within
detected within 30
within 30 min
30 min of
min of heat
of heat shock
Altered transcription of
transcription of c-fos
of c-fos and
c-fos and c-myc
and c-myc genes
c-myc genes was
genes was the
was the primary
the primary effect
primary effect of
effect of heat
of heat shock
Secondarily heat shock
heat shock of
shock of Hyon
of Hyon cells
Hyon cells stabilized
cells stabilized the
stabilized the c-myc
the c-myc mRNA
c-myc mRNA level
mRNA level by
level by increasing
by increasing its
increasing its half-life
its half-life from
half-life from 24
from 24 to
24 to 45
to 45 min
The overall effect
overall effect of
effect of heat
of heat shock
heat shock on
shock on c-myc
on c-myc mRNA
c-myc mRNA level
mRNA level however
level however was
however was a
was a marked
a marked inhibition
marked inhibition of
inhibition of its
of its transcription
These results demonstrate
results demonstrate that
demonstrate that the
that the transcription
the transcription of
transcription of nuclear
of nuclear protooncogenes
nuclear protooncogenes is
protooncogenes is regulated
is regulated by
regulated by heat
by heat shock
heat shock indicating
shock indicating a
indicating a role
a role for
role for nuclear
for nuclear protooncogenes
nuclear protooncogenes in
protooncogenes in the
in the stress
the stress response
stress response of
response of lymphoid
of lymphoid cells
Mapping of B-cell
of B-cell epitopes
B-cell epitopes of
epitopes of the
of the human
the human hepatitis
human hepatitis B
hepatitis B virus
B virus X
virus X protein
The immune response
immune response to
response to the
to the X
the X protein
X protein of
protein of human
of human hepatitis
human hepatitis B
hepatitis B virus
B virus HBV
virus HBV was
HBV was studied
was studied by
studied by epitope
by epitope mapping
epitope mapping by
mapping by using
by using a
using a set
a set of
set of MS2-HBx
of MS2-HBx fusion
MS2-HBx fusion proteins
fusion proteins and
proteins and synthetic
and synthetic peptides
Antibodies in sera
in sera of
sera of patients
of patients with
patients with acute
with acute and
acute and chronic
and chronic HBV
chronic HBV infection
HBV infection showed
infection showed a
showed a multispecific
a multispecific immune
multispecific immune response
Each serum contained
serum contained antibodies
contained antibodies to
antibodies to a
to a different
a different set
different set of
set of epitopes
of epitopes which
epitopes which taken
which taken together
taken together cover
together cover most
cover most of
most of the
of the HBx
the HBx sequence
Some of the
of the epitopes
the epitopes were
epitopes were detectable
were detectable only
detectable only by
only by immunoblotting
by immunoblotting with
immunoblotting with fusion
with fusion proteins;
fusion proteins; others
proteins; others were
others were detectable
were detectable only
detectable only by
only by an
by an enzyme-linked
an enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
immunosorbent assay ELISA
assay ELISA with
ELISA with synthetic
with synthetic peptides
The carboxy-terminal half
carboxy-terminal half of
half of the
of the HBx
the HBx protein
HBx protein was
protein was preferentially
was preferentially recognized
preferentially recognized by
recognized by antibodies
by antibodies from
antibodies from patients
from patients with
patients with chronic
with chronic hepatitis
chronic hepatitis and
hepatitis and contained
and contained a
contained a short
a short immunodominant
short immunodominant antigenic
immunodominant antigenic region
antigenic region with
region with at
with at least
at least two
least two major
two major nonoverlapping
major nonoverlapping epitopes
Anti-HBx antibody titers
antibody titers as
titers as revealed
as revealed by
revealed by peptide
by peptide ELISAs
peptide ELISAs were
ELISAs were highest
were highest and
highest and most
and most frequent
most frequent in
frequent in patients
in patients with
patients with chronic
with chronic hepatitis
chronic hepatitis and
hepatitis and usually
and usually low
usually low in
low in acutely
in acutely infected
acutely infected patients
infected patients and
patients and asymptomatic
and asymptomatic carriers
The data demonstrate
data demonstrate a
demonstrate a remarkable
a remarkable qualitative
remarkable qualitative and
qualitative and quantitative
and quantitative heterogeneity
quantitative heterogeneity of
heterogeneity of the
of the humoral
the humoral HBx
humoral HBx immune
HBx immune response
immune response which
response which can
which can be
can be monitored
be monitored by
monitored by HBx-specific
by HBx-specific peptide
HBx-specific peptide ELISAs
Such tests may
tests may become
may become useful
become useful diagnostic
useful diagnostic tools
[The inhibitory effect
inhibitory effect of
effect of hydrocortisone
of hydrocortisone on
hydrocortisone on the
on the chemotactic
the chemotactic migration
chemotactic migration of
migration of human
of human leukocytes]
Random migration RM
migration RM and
RM and chemotactic
and chemotactic migration
chemotactic migration ChtM
migration ChtM of
ChtM of human
of human leukocytes
human leukocytes to
leukocytes to yeast
to yeast activated
yeast activated serum
activated serum were
serum were studied
were studied with
studied with the
with the modified
the modified Boyden
modified Boyden chamber
Boyden chamber method
Both RM and
RM and ChtM
and ChtM showed
ChtM showed circadian
showed circadian rhythm
Leukocytes migrated most
migrated most rapidly
most rapidly at
rapidly at night
The difference between
difference between the
between the peak
the peak 0:00
peak 0:00 and
0:00 and trough
and trough values
trough values 8:00
values 8:00 of
8:00 of RM
of RM and
RM and ChtM
and ChtM was
ChtM was significant
was significant statistically
significant statistically P
statistically P less
P less than
less than 001
ChtM was inhibited
was inhibited by
inhibited by hydrocortisone
by hydrocortisone F
hydrocortisone F of
F of physiological
of physiological concentration
physiological concentration 10-9-10-7
concentration 10-9-10-7 mol/L
10-9-10-7 mol/L which
mol/L which was
which was dose-dependent
was dose-dependent and
dose-dependent and completely
and completely antagonized
completely antagonized by
antagonized by the
by the competitive
the competitive antagonist
competitive antagonist RU38486
The inhibitory effect
inhibitory effect was
effect was much
was much more
much more evident
more evident with
evident with higher
with higher dose
higher dose more
dose more than
more than 10-5
than 10-5 mol/L
10-5 mol/L and
mol/L and it
and it was
it was also
was also reversed
also reversed by
reversed by RU38486
by RU38486 but
RU38486 but only
but only partially
It is suggested
is suggested that
suggested that glucocorticoids
that glucocorticoids GC
glucocorticoids GC may
GC may be
may be a
be a physiological
a physiological regulator
physiological regulator of
regulator of the
of the activity
the activity of
activity of leukocytes
of leukocytes and
leukocytes and its
and its inhibitory
its inhibitory action
inhibitory action on
action on ChtM
on ChtM may
ChtM may be
may be involved
be involved in
involved in antiinflammatory
in antiinflammatory mechanisms
antiinflammatory mechanisms of
mechanisms of GC
of GC of
GC of pharmacological
of pharmacological doses
The action of
action of physiological
of physiological and
physiological and pharmacological
and pharmacological concentration
pharmacological concentration of
concentration of GC
of GC may
GC may be
may be mediated
be mediated by
mediated by low
by low affinity
low affinity specific
affinity specific binding
specific binding sites
binding sites of
sites of glucocorticoid
of glucocorticoid receptors
Heterogeneity of antigen
of antigen molecules
antigen molecules recognized
molecules recognized by
recognized by anti-tax1
by anti-tax1 monoclonal
anti-tax1 monoclonal antibody
monoclonal antibody Lt-4
antibody Lt-4 in
Lt-4 in cell
in cell lines
cell lines bearing
lines bearing human
bearing human T
human T cell
T cell leukemia
cell leukemia virus
leukemia virus type
virus type I
type I and
I and related
and related retroviruses
Using a monoclonal
a monoclonal antibody
monoclonal antibody Lt-4
antibody Lt-4 directed
Lt-4 directed against
directed against human
against human T
human T cell
T cell leukemia
cell leukemia virus
leukemia virus type
virus type I
type I HTLV-I
I HTLV-I trans-activator
HTLV-I trans-activator tax1
trans-activator tax1 antigen
tax1 antigen we
antigen we examined
we examined the
examined the expression
the expression of
expression of tax1
of tax1 and
tax1 and related
and related antigens
related antigens in
antigens in a
in a variety
a variety of
variety of T
of T cell
T cell lines
cell lines bearing
lines bearing HTLV-I
bearing HTLV-I and
HTLV-I and related
and related retroviruses
related retroviruses simian
retroviruses simian T
simian T cell
T cell leukemia
cell leukemia virus
leukemia virus type
virus type I
type I STLV-I
I STLV-I and
STLV-I and HTLV-II
and HTLV-II by
HTLV-II by immunofluorescence
by immunofluorescence and
immunofluorescence and immunoblot
and immunoblot assays
Lt-4 reacted with
reacted with all
with all HTLV-I-bearing
all HTLV-I-bearing cell
HTLV-I-bearing cell lines
cell lines tested
lines tested and
tested and five
and five out
five out of
out of eight
of eight simian
eight simian cell
simian cell lines
cell lines bearing
lines bearing STLV-I
bearing STLV-I but
STLV-I but not
but not with
not with an
with an HTLV-II-bearing
an HTLV-II-bearing cell
HTLV-II-bearing cell line
Lt-4 detected 40
detected 40 kd
40 kd tax1
kd tax1 antigen
tax1 antigen molecules
antigen molecules in
molecules in most
in most HTLV-I-bearing
most HTLV-I-bearing cell
HTLV-I-bearing cell lines
cell lines except
lines except one
except one cell
one cell line
cell line that
line that expressed
that expressed 39
expressed 39 kd
39 kd tax1
kd tax1 antigen
In the STLV-I-bearing
the STLV-I-bearing T
STLV-I-bearing T cell
T cell lines
cell lines tax1-related
lines tax1-related antigen
tax1-related antigen molecules
antigen molecules detected
molecules detected by
detected by Lt-4
by Lt-4 were
Lt-4 were heterogeneous
were heterogeneous having
heterogeneous having molecular
having molecular weights
molecular weights in
weights in the
in the range
the range of
range of 36-41
of 36-41 kd
Characterization of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 enhancer-binding
1 enhancer-binding proteins
enhancer-binding proteins from
proteins from the
from the human
the human T-cell
human T-cell line
T-cell line Jurkat
The transcription of
transcription of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 is
HIV-1 is under
is under the
under the control
the control of
control of cellular
of cellular proteins
cellular proteins that
proteins that bind
that bind to
bind to the
to the viral
the viral long
viral long terminal
long terminal repeat
terminal repeat LTR
Among the protein-binding
the protein-binding regions
protein-binding regions of
regions of the
of the HIV-1
the HIV-1 LTR
HIV-1 LTR is
LTR is the
is the transcription-enhancer
the transcription-enhancer region
We show that
show that at
that at least
at least one
least one inducible
one inducible C1
inducible C1 and
C1 and one
and one constitutive
one constitutive C2
constitutive C2 protein
C2 protein can
protein can bind
can bind to
bind to the
to the HIV
the HIV enhancer
HIV enhancer in
enhancer in Jurkat
in Jurkat cells
The two proteins
two proteins differ
proteins differ in
differ in their
in their surface
their surface charge
surface charge since
charge since they
since they are
they are separable
are separable by
separable by anion-exchange
by anion-exchange chromatography
Bivalent cations such
cations such as
such as Mg2+
as Mg2+ and
Mg2+ and Zn2+
and Zn2+ differentially
Zn2+ differentially affect
differentially affect their
affect their binding
their binding to
binding to oligonucleotides
to oligonucleotides which
oligonucleotides which contain
which contain the
contain the HIV-enhancer
the HIV-enhancer domain
Both C1 and
C1 and C2
and C2 proteins
C2 proteins also
proteins also bind
also bind to
bind to a
to a similar
a similar sequence
similar sequence found
sequence found in
found in the
in the interleukin-2-receptor
the interleukin-2-receptor alpha-subunit
interleukin-2-receptor alpha-subunit enhancer
The inducible C1
inducible C1 protein
C1 protein was
protein was partially
was partially purified
partially purified by
purified by three
by three chromatographic
three chromatographic steps
chromatographic steps and
steps and characterized
and characterized by
characterized by uv
by uv cross-linking
uv cross-linking as
cross-linking as a
as a 47
a 47 kDa
47 kDa protein
Differences in transcriptional
in transcriptional enhancers
transcriptional enhancers of
enhancers of HIV-1
of HIV-1 and
HIV-1 and HIV-2
Response to T
to T cell
T cell activation
cell activation signals
T cell activation
cell activation results
activation results in
results in high
in high levels
high levels of
levels of HIV
of HIV replication
HIV replication and
replication and is
and is thought
is thought to
thought to be
to be one
be one mechanism
one mechanism leading
mechanism leading to
leading to the
to the conversion
the conversion from
conversion from latent
from latent to
latent to active
to active viral
active viral infection
In HIV-1 the
HIV-1 the sequences
the sequences that
sequences that respond
that respond to
respond to these
to these signaling
these signaling events
signaling events are
events are found
are found in
found in the
in the long
the long terminal
long terminal repeat
terminal repeat LTR
repeat LTR and
LTR and comprise
and comprise the
comprise the transcriptional
the transcriptional enhancer
transcriptional enhancer which
enhancer which contains
which contains two
contains two conserved
two conserved binding
conserved binding sites
binding sites for
sites for the
for the nuclear
the nuclear factor
nuclear factor kappa
factor kappa B
kappa B NF
B NF kappa
NF kappa B
The corresponding region
corresponding region in
region in the
in the second
the second AIDS
second AIDS retrovirus
AIDS retrovirus HIV-2
retrovirus HIV-2 contains
HIV-2 contains a
contains a conserved
a conserved and
conserved and a
and a divergent
a divergent NF
divergent NF kappa
NF kappa B
kappa B binding
B binding site
We demonstrate that
demonstrate that the
that the HIV-1
the HIV-1 LTR
HIV-1 LTR responds
LTR responds better
responds better than
better than the
than the HIV-2
the HIV-2 LTR
HIV-2 LTR to
LTR to T
to T cell
T cell activation
cell activation signals
These qualitative differences
qualitative differences in
differences in the
in the response
the response to
response to T
to T cell
T cell activation
cell activation are
activation are reproduced
are reproduced not
reproduced not only
not only when
only when HIV-1
when HIV-1 or
HIV-1 or HIV-2
or HIV-2 enhancers
HIV-2 enhancers are
enhancers are placed
are placed upstream
placed upstream of
upstream of a
of a heterologous
a heterologous promoter
heterologous promoter but
promoter but also
but also when
also when these
when these enhancers
these enhancers are
enhancers are switched
are switched between
switched between their
between their respective
their respective LTR
In electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
shift assays NF
assays NF kappa
NF kappa B
kappa B binds
B binds to
binds to both
to both conserved
both conserved sites
conserved sites in
sites in the
in the HIV-1
the HIV-1 transcriptional
HIV-1 transcriptional enhancer
transcriptional enhancer and
enhancer and only
and only to
only to the
to the single
the single conserved
single conserved site
conserved site in
site in the
in the HIV-2
the HIV-2 transcriptional
HIV-2 transcriptional enhancer
Instead of NF
of NF kappa
NF kappa B
kappa B the
B the activator
the activator protein
activator protein 3
protein 3 binds
3 binds to
binds to the
to the divergent
the divergent site
divergent site in
site in HIV-2
In conclusion HIV-1
conclusion HIV-1 and
HIV-1 and HIV-2
and HIV-2 are
HIV-2 are differentially
are differentially regulated
differentially regulated by
regulated by T
by T cell
T cell activation
cell activation signals
activation signals and
signals and this
and this difference
this difference may
difference may account
may account for
account for the
for the longer
the longer period
longer period of
period of viral
of viral latency
viral latency observed
latency observed with
observed with HIV-2
with HIV-2 than
HIV-2 than with
than with HIV-1
with HIV-1 infection
NF-X2 that binds
that binds to
binds to the
to the DRA
the DRA X2-box
DRA X2-box is
X2-box is activator
is activator protein
activator protein 1
Expression cloning of
cloning of c-Jun
Human class II
class II MHC
II MHC Ag
MHC Ag are
Ag are a
are a family
a family of
family of cell
of cell surface
cell surface glycoproteins
Their constitutive expression
constitutive expression is
expression is limited
is limited to
limited to B
to B lymphocytes
B lymphocytes and
lymphocytes and thymic
and thymic epithelial
thymic epithelial cells
In many other
many other cells
other cells their
cells their expression
their expression can
expression can be
can be induced
be induced by
induced by IFN-gamma
Conserved upstream promoter
upstream promoter sequences
promoter sequences regulate
sequences regulate this
regulate this tissue-specific
this tissue-specific expression
tissue-specific expression of
expression of class
of class II
class II genes
In the DRA
the DRA promoter
DRA promoter one
promoter one of
one of these
of these cis-acting
these cis-acting regulatory
cis-acting regulatory motifs
regulatory motifs is
motifs is the
is the X2-box
the X2-box to
X2-box to which
to which nuclear
which nuclear factor
nuclear factor X2
factor X2 NF-X2
X2 NF-X2 binds
Here we present
we present the
present the isolation
the isolation and
isolation and characterization
and characterization of
characterization of the
of the full-length
the full-length cDNA
full-length cDNA clone
cDNA clone encoding
clone encoding NF-X2
This cDNA clone
cDNA clone was
clone was isolated
was isolated by
isolated by expression
by expression cDNA
expression cDNA cloning
cDNA cloning and
cloning and encodes
and encodes the
encodes the human
the human c-Jun
human c-Jun protein
c-Jun protein which
protein which together
which together with
together with c-Fos
with c-Fos forms
c-Fos forms the
forms the heterodimeric
the heterodimeric activator
heterodimeric activator protein-1
activator protein-1 transcription
protein-1 transcription complex
Whereas c-Fos/c-Jun heterodimers
c-Fos/c-Jun heterodimers do
heterodimers do not
do not exist
not exist in
exist in B
in B cells
B cells they
cells they form
they form and
form and bind
and bind to
bind to the
to the X2-box
the X2-box in
X2-box in class
in class II
class II nonexpressing
II nonexpressing cells
Thus c-Fos/c-Jun heterodimers
c-Fos/c-Jun heterodimers might
heterodimers might contribute
might contribute to
contribute to the
to the repression
the repression of
repression of DRA
of DRA gene
DRA gene expression
Synthesis of 419-disubstituted
of 419-disubstituted derivatives
419-disubstituted derivatives of
derivatives of DOC
Radioreceptor assay of
assay of some
of some corticosteroid
some corticosteroid derivatives
corticosteroid derivatives in
derivatives in human
in human mononuclear
human mononuclear leukocytes
Several new 419-substituted
new 419-substituted steroids
419-substituted steroids and
steroids and previously
and previously synthesized
previously synthesized corticosteroids
synthesized corticosteroids were
corticosteroids were assayed
were assayed for
assayed for affinity
for affinity to
affinity to type
to type 1
type 1 receptors
1 receptors in
receptors in human
in human mononuclear
human mononuclear leukocytes
11 beta19-epoxy-421-dihydroxypregn-4-ene-320-dione 2
beta19-epoxy-421-dihydroxypregn-4-ene-320-dione 2 was
2 was hydrogenated
was hydrogenated with
hydrogenated with Pd-C
with Pd-C to
Pd-C to yield
to yield a
yield a mixture
a mixture of
mixture of all
of all four
all four dihydro
four dihydro derivatives
dihydro derivatives 5
derivatives 5 accompanied
5 accompanied by
accompanied by 421-diacetoxy-11
by 421-diacetoxy-11 beta19-epoxy-3-hydroxypregnan-20-one
421-diacetoxy-11 beta19-epoxy-3-hydroxypregnan-20-one 6
beta19-epoxy-3-hydroxypregnan-20-one 6 and
6 and 21-acetoxy-11
and 21-acetoxy-11 beta19-epoxy-4-hydroxypregnane-320-dione
21-acetoxy-11 beta19-epoxy-4-hydroxypregnane-320-dione 7
With hot acetic
hot acetic +
acetic + p-toluenesulfonic
+ p-toluenesulfonic acid
p-toluenesulfonic acid 5
acid 5 underwent
5 underwent rearrangement
underwent rearrangement to
rearrangement to 21-acetoxy-11
to 21-acetoxy-11 beta19-epoxypregn-5-ene-420-dione
21-acetoxy-11 beta19-epoxypregn-5-ene-420-dione 8
beta19-epoxypregn-5-ene-420-dione 8 Pd-C
8 Pd-C hydrogenation
Pd-C hydrogenation of
hydrogenation of 321-diacetoxy-5
of 321-diacetoxy-5 beta19-cyclopregna-2911-diene-420-dione
321-diacetoxy-5 beta19-cyclopregna-2911-diene-420-dione 10
beta19-cyclopregna-2911-diene-420-dione 10 gave
10 gave 321-diacetoxy-5
gave 321-diacetoxy-5 beta19-cyclopregn-5-ene-420-dione
321-diacetoxy-5 beta19-cyclopregn-5-ene-420-dione 11
beta19-cyclopregn-5-ene-420-dione 11 and
11 and the
and the 911-dihydro
the 911-dihydro derivative
911-dihydro derivative of
derivative of the
of the latter
Treatment of 10
of 10 with
10 with warm
with warm HCl
warm HCl furnished
HCl furnished 19-chloro-421-dihydroxypregna-4911-diene-320-dione
furnished 19-chloro-421-dihydroxypregna-4911-diene-320-dione 13
Pd-C hydrogenation of
hydrogenation of its
of its diacetate
its diacetate 14
diacetate 14 afforded
14 afforded the
afforded the 45-dihydro
the 45-dihydro derivative
45-dihydro derivative 18
derivative 18 19-chloro-21-acetoxypregn-911-en-20-one
18 19-chloro-21-acetoxypregn-911-en-20-one 15
19-chloro-21-acetoxypregn-911-en-20-one 15 its
15 its 4-acetoxy
its 4-acetoxy derivative
4-acetoxy derivative 16
derivative 16 and
16 and the
and the 34-diacetoxy
the 34-diacetoxy derivative
34-diacetoxy derivative 17
When tested in
tested in a
in a radioreceptor
a radioreceptor assay
radioreceptor assay in
assay in human
in human mononuclear
human mononuclear leukocytes
mononuclear leukocytes the
leukocytes the synthesized
the synthesized compounds
synthesized compounds showed
compounds showed only
showed only low
only low relative
low relative binding
relative binding affinities
binding affinities RBA
affinities RBA to
RBA to type
to type 1
type 1 receptor
1 receptor the
receptor the highest
the highest being
highest being 072%
being 072% for
072% for 13
for 13 aldosterone
13 aldosterone =
aldosterone = 100%
For comparison other
comparison other RBA
other RBA in
RBA in this
in this system
this system were:
system were: 19-noraldosterone
were: 19-noraldosterone 20%;
19-noraldosterone 20%; 18-deoxyaldosterone
20%; 18-deoxyaldosterone 58%;
18-deoxyaldosterone 58%; 18-deoxy-19-noraldosterone
58%; 18-deoxy-19-noraldosterone 47%;
18-deoxy-19-noraldosterone 47%; 1821-anhydroaldosterone
47%; 1821-anhydroaldosterone 037%;
1821-anhydroaldosterone 037%; 17-isoaldosterone
037%; 17-isoaldosterone 76%
17-isoaldosterone 76% and
76% and apoaldosterone
and apoaldosterone 43%
Cell type specificity
type specificity and
specificity and activation
and activation requirements
activation requirements for
requirements for NFAT-1
for NFAT-1 nuclear
NFAT-1 nuclear factor
nuclear factor of
factor of activated
of activated T-cells
activated T-cells transcriptional
T-cells transcriptional activity
transcriptional activity determined
activity determined by
determined by a
by a new
a new method
new method using
method using transgenic
using transgenic mice
transgenic mice to
mice to assay
to assay transcriptional
assay transcriptional activity
transcriptional activity of
activity of an
of an individual
an individual nuclear
individual nuclear factor
Nuclear factor of
factor of activated
of activated T-cells
activated T-cells NFAT-1
T-cells NFAT-1 is
NFAT-1 is a
is a transcription
a transcription factor
transcription factor which
factor which is
which is considered
is considered to
considered to be
to be an
be an important
an important regulator
important regulator in
regulator in early
in early T-cell
early T-cell activation
We have developed
have developed a
developed a system
a system to
system to monitor
to monitor the
monitor the transcriptional
the transcriptional activity
transcriptional activity of
activity of NFAT-1
of NFAT-1 at
NFAT-1 at the
at the single
the single cell
single cell level
cell level in
level in whole
in whole animals
The system is
system is based
is based on
based on the
on the use
the use of
use of an
of an oligomerized
an oligomerized NFAT-1
oligomerized NFAT-1 binding
NFAT-1 binding motif
binding motif that
motif that directs
that directs transcription
directs transcription of
transcription of SV40
of SV40 T-antigen
SV40 T-antigen in
T-antigen in transgenic
in transgenic mice
This report represents
report represents the
represents the first
the first demonstration
first demonstration that
demonstration that a
that a multimerized
a multimerized short
multimerized short binding
short binding motif
binding motif can
motif can function
can function appropriately
function appropriately in
appropriately in transgenic
in transgenic mice
NFAT-1 activity had
activity had previously
had previously been
previously been thought
been thought to
thought to be
to be confined
be confined to
confined to activated
to activated T-lymphocytes
activated T-lymphocytes upon
T-lymphocytes upon release
upon release of
release of intracellular
of intracellular calcium
By targeting NFAT-1-dependent
targeting NFAT-1-dependent gene
NFAT-1-dependent gene expression
gene expression in
expression in transgenic
in transgenic mice
transgenic mice we
mice we discovered
we discovered new
discovered new sites
new sites of
sites of NFAT-1
of NFAT-1 activity
Besides in T-lymphocytes
in T-lymphocytes NFAT-1
T-lymphocytes NFAT-1 activity
NFAT-1 activity could
activity could also
could also be
also be induced
be induced in
induced in T-lymphocyte-depleted
in T-lymphocyte-depleted spleen
T-lymphocyte-depleted spleen cells
spleen cells and
cells and purified
and purified B-lymphocytes
purified B-lymphocytes and
B-lymphocytes and requires
and requires agents
requires agents that
agents that both
that both release
both release intracellular
release intracellular calcium
intracellular calcium and
calcium and activate
and activate protein
activate protein kinase
protein kinase C
A difference in
difference in the
in the time
the time course
time course of
course of appearance
of appearance of
appearance of NFAT-1
of NFAT-1 activity
NFAT-1 activity between
activity between T-lymphocytes
between T-lymphocytes and
T-lymphocytes and non-T-lymphocytes
and non-T-lymphocytes was
non-T-lymphocytes was revealed
Constitutive expression was
expression was observed
was observed in
observed in a
in a small
a small population
small population of
population of cells
of cells in
cells in the
in the dermis
the dermis and
dermis and some
and some mice
some mice have
mice have developed
have developed skin
developed skin lesions
Interestingly the tissue
the tissue pattern
tissue pattern of
pattern of expression
of expression of
expression of the
of the NFAT-1
the NFAT-1 activity
NFAT-1 activity resembles
activity resembles the
resembles the expression
the expression pattern
expression pattern described
pattern described for
described for HIV-LTR/tat
for HIV-LTR/tat transgenic
HIV-LTR/tat transgenic mice
transgenic mice Vogel
mice Vogel J
Vogel J Hinrichs
J Hinrichs S
Hinrichs S H
S H Reynolds
H Reynolds R
Reynolds R K
R K Luciw
K Luciw P
Luciw P A
P A and
A and Jay
and Jay G
Jay G 1988
G 1988 Nature
1988 Nature 335
Nature 335 606-611
This similarity in
similarity in expression
in expression and
expression and the
and the fact
the fact that
fact that NFAT-1
that NFAT-1 has
NFAT-1 has been
has been shown
been shown to
shown to bind
to bind functional
bind functional sequences
functional sequences in
sequences in HIV-LTR
in HIV-LTR suggest
HIV-LTR suggest a
suggest a role
a role for
role for NFAT-1
for NFAT-1 in
NFAT-1 in dermal
in dermal activation
dermal activation of
activation of the
of the HIV-LTR
A novel T-cell
novel T-cell protein
T-cell protein which
protein which recognizes
which recognizes a
recognizes a palindromic
a palindromic sequence
palindromic sequence in
sequence in the
in the negative
the negative regulatory
negative regulatory element
regulatory element of
element of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus long
virus long terminal
long terminal repeat
Two major protein-binding
major protein-binding sites
protein-binding sites within
sites within the
within the negative
the negative regulatory
negative regulatory element
regulatory element of
element of the
of the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 long
1 long terminal
long terminal repeat
terminal repeat have
repeat have been
have been identified
One site B
site B contained
B contained a
contained a palindromic
a palindromic sequence
palindromic sequence with
sequence with homology
with homology to
homology to steroid/thyroid
to steroid/thyroid hormone
steroid/thyroid hormone response
hormone response elements
response elements but
elements but was
but was distinct
was distinct from
distinct from previously
from previously described
previously described binding
described binding sites
binding sites of
sites of this
of this class
A novel T-cell
novel T-cell protein
T-cell protein recognized
protein recognized the
recognized the palindromic
the palindromic sequence
palindromic sequence within
sequence within site
within site B
site B and
B and also
and also bound
also bound estrogen-
bound estrogen- or
estrogen- or thyroid
or thyroid hormone-response
thyroid hormone-response elements
hormone-response elements with
elements with lower
with lower affinity
A 7-base-pair mutation
7-base-pair mutation in
mutation in the
in the site
the site B
site B palindrome
B palindrome which
palindrome which destroyed
which destroyed protein
destroyed protein binding
protein binding resulted
binding resulted in
resulted in increased
in increased expression
increased expression from
expression from the
from the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 long
1 long terminal
long terminal repeat
terminal repeat in
repeat in T
in T cells
Progesterone suppression of
suppression of pregnancy
of pregnancy lymphocytes
pregnancy lymphocytes is
lymphocytes is not
is not mediated
not mediated by
mediated by glucocorticoid
by glucocorticoid effect
This study investigated
study investigated whether
investigated whether the
whether the suppressive
the suppressive effect
suppressive effect of
effect of progesterone
of progesterone on
progesterone on pregnancy
on pregnancy lymphocytes
pregnancy lymphocytes is
lymphocytes is mediated
is mediated by
mediated by specific
by specific progesterone
specific progesterone receptors
The effects of
effects of a
of a competitive
a competitive progesterone
competitive progesterone antagonist
progesterone antagonist RU486
antagonist RU486 and
RU486 and a
and a specific
a specific glucocorticoid
specific glucocorticoid receptor
glucocorticoid receptor blocker
receptor blocker RU43044
blocker RU43044 were
RU43044 were tested
were tested on
tested on the
on the release
the release of
release of a
of a blocking
a blocking factor
blocking factor by
factor by progesterone-treated
by progesterone-treated pregnancy
progesterone-treated pregnancy lymphocytes
RU 486 tested
486 tested at
tested at an
at an equal
an equal concentration
equal concentration as
concentration as progesterone
as progesterone significantly
progesterone significantly inhibited
significantly inhibited the
inhibited the production
the production of
production of the
of the blocking
the blocking factor
blocking factor while
factor while RU
while RU 43044
RU 43044 was
43044 was without
was without effect
These data suggest
data suggest that
suggest that in
that in pregnancy
in pregnancy lymphocyte
pregnancy lymphocyte progesterone
lymphocyte progesterone acts
progesterone acts on
acts on specific
on specific progesterone
specific progesterone receptors
progesterone receptors and
receptors and glucocorticoid
and glucocorticoid binding
glucocorticoid binding sites
binding sites are
sites are not
are not involved
The 56-59-kilodalton protein
56-59-kilodalton protein identified
protein identified in
identified in untransformed
in untransformed steroid
untransformed steroid receptor
steroid receptor complexes
receptor complexes is
complexes is a
is a unique
a unique protein
unique protein that
protein that exists
that exists in
exists in cytosol
in cytosol in
cytosol in a
in a complex
a complex with
complex with both
with both the
both the 70-
the 70- and
70- and 90-kilodalton
and 90-kilodalton heat
90-kilodalton heat shock
heat shock proteins
It has previously
has previously been
previously been shown
been shown that
shown that 9S
that 9S untransformed
9S untransformed progestin
untransformed progestin estrogen
progestin estrogen androgen
estrogen androgen and
androgen and glucocorticoid
and glucocorticoid receptor
glucocorticoid receptor complexes
receptor complexes in
complexes in rabbit
in rabbit uterine
rabbit uterine and
uterine and liver
and liver cytosols
liver cytosols contain
cytosols contain a
contain a 59-kDa
a 59-kDa protein
59-kDa protein [Tai
protein [Tai PK
[Tai PK Maeda
PK Maeda Y
Maeda Y Nakao
Y Nakao K
Nakao K Wakim
K Wakim NG
Wakim NG Duhring
NG Duhring JL
Duhring JL &
JL & Faber
& Faber LE1986
Faber LE1986 Biochemistry
LE1986 Biochemistry 25
Biochemistry 25 5269-5275]
In this work
this work we
work we show
we show that
show that the
that the monoclonal
the monoclonal antibody
monoclonal antibody KN
antibody KN 382/EC1
KN 382/EC1 raised
382/EC1 raised against
raised against the
against the rabbit
the rabbit 59-kDa
rabbit 59-kDa protein
59-kDa protein reacts
protein reacts with
reacts with 9S
with 9S untransformed
9S untransformed glucocorticoid
untransformed glucocorticoid receptor
glucocorticoid receptor complexes
receptor complexes in
complexes in cytosol
in cytosol prepared
cytosol prepared from
prepared from human
from human IM-9
human IM-9 lymphocytes
IM-9 lymphocytes but
lymphocytes but not
but not with
not with 4S
with 4S salt-transformed
4S salt-transformed receptors
The human protein
human protein recognized
protein recognized by
recognized by the
by the EC1
the EC1 antibody
EC1 antibody is
antibody is a
is a 56-kDa
a 56-kDa protein
56-kDa protein p56
protein p56 of
p56 of moderate
of moderate abundance
moderate abundance located
abundance located predominantly
located predominantly in
predominantly in the
in the cytoplasm
the cytoplasm by
cytoplasm by indirect
by indirect immunofluorescence
There are at
are at least
at least six
least six isomorphs
six isomorphs of
isomorphs of p56
of p56 by
p56 by two-dimensional
by two-dimensional gel
two-dimensional gel analysis
N-Terminal sequencing 20
sequencing 20 amino
20 amino acids
amino acids shows
acids shows that
shows that p56
that p56 is
p56 is a
is a unique
a unique human
unique human protein
When p56 is
p56 is immunoadsorbed
is immunoadsorbed from
immunoadsorbed from IM-9
from IM-9 cell
IM-9 cell cytosol
cell cytosol both
cytosol both the
both the 70-
the 70- and
70- and 90-kDa
and 90-kDa heat
90-kDa heat shock
heat shock proteins
shock proteins are
proteins are coadsorbed
are coadsorbed in
coadsorbed in an
in an immune-specific
an immune-specific manner
Neither heat shock
heat shock protein
shock protein reacts
protein reacts directly
reacts directly with
directly with the
with the EC1
the EC1 antibody
We conclude that
conclude that p56
that p56 exists
p56 exists in
exists in cytosol
in cytosol in
cytosol in a
in a higher
a higher order
higher order complex
order complex containing
complex containing hsp70
containing hsp70 and
hsp70 and hsp90
and hsp90 both
hsp90 both of
both of which
of which in
which in turn
in turn have
turn have been
have been found
been found to
found to be
to be associated
be associated with
associated with untransformed
with untransformed steroid
untransformed steroid receptors
Sequence-specific DNA binding
DNA binding of
binding of the
of the proto-oncoprotein
the proto-oncoprotein ets-1
proto-oncoprotein ets-1 defines
ets-1 defines a
defines a transcriptional
a transcriptional activator
transcriptional activator sequence
activator sequence within
sequence within the
within the long
the long terminal
long terminal repeat
terminal repeat of
repeat of the
of the Moloney
the Moloney murine
Moloney murine sarcoma
murine sarcoma virus
The ets proto-oncogene
ets proto-oncogene family
proto-oncogene family is
family is a
is a group
a group of
group of sequence-related
of sequence-related genes
sequence-related genes whose
genes whose normal
whose normal cellular
normal cellular function
cellular function is
function is unknown
In a study
a study of
study of cellular
of cellular proteins
cellular proteins involved
proteins involved in
involved in the
in the transcriptional
the transcriptional regulation
transcriptional regulation of
regulation of murine
of murine retroviruses
murine retroviruses in
retroviruses in T
in T lymphocytes
T lymphocytes we
lymphocytes we have
we have discovered
have discovered that
discovered that a
that a member
a member of
member of the
of the ets
the ets gene
ets gene family
gene family encodes
family encodes a
encodes a sequence-specific
a sequence-specific DNA-binding
sequence-specific DNA-binding protein
A mouse ets-1
mouse ets-1 cDNA
ets-1 cDNA clone
cDNA clone was
clone was obtained
was obtained by
obtained by screening
by screening a
screening a mouse
a mouse thymus
mouse thymus cDNA
thymus cDNA expression
cDNA expression library
expression library with
library with a
with a double-stranded
a double-stranded oligonucleotide
double-stranded oligonucleotide probe
oligonucleotide probe representing
probe representing 20
representing 20 bp
20 bp of
bp of the
of the Moloney
the Moloney murine
Moloney murine sarcoma
murine sarcoma virus
sarcoma virus MSV
virus MSV long
MSV long terminal
long terminal repeat
terminal repeat LTR
The cDNA sequence
cDNA sequence has
sequence has an
has an 813-bp
an 813-bp open
813-bp open reading
open reading frame
reading frame ORF
frame ORF whose
ORF whose predicted
whose predicted amino
predicted amino acid
amino acid sequence
acid sequence is
sequence is 976%
is 976% identical
976% identical to
identical to the
to the 272
the 272 carboxy-terminal
272 carboxy-terminal amino
carboxy-terminal amino acids
amino acids of
acids of the
of the human
the human ets-1
human ets-1 protein
The ORF was
ORF was expressed
was expressed in
expressed in bacteria
in bacteria and
bacteria and the
and the 30-kD
the 30-kD protein
30-kD protein product
protein product was
product was shown
was shown to
shown to bind
to bind DNA
bind DNA in
DNA in a
in a sequence-specific
a sequence-specific manner
sequence-specific manner by
manner by mobility-shift
by mobility-shift assays
mobility-shift assays Southwestern
assays Southwestern blot
Southwestern blot analysis
blot analysis and
analysis and methylation
and methylation interference
A mutant LTR
mutant LTR containing
LTR containing four
containing four base
four base pair
base pair substitutions
pair substitutions in
substitutions in the
in the ets-1
the ets-1 binding
ets-1 binding site
binding site was
site was constructed
was constructed and
constructed and was
and was shown
was shown to
shown to have
to have reduced
have reduced binding
reduced binding in
binding in vitro
Transcriptional efficiency of
efficiency of the
of the MSV
the MSV LTR
MSV LTR promoter
LTR promoter containing
promoter containing this
containing this disrupted
this disrupted ets-1
disrupted ets-1 binding
ets-1 binding site
binding site was
site was compared
was compared to
compared to the
to the activity
the activity of
activity of a
of a wild-type
a wild-type promoter
wild-type promoter in
promoter in mouse
in mouse T
mouse T lymphocytes
T lymphocytes in
lymphocytes in culture
in culture and
culture and 15-
and 15- to
15- to 20-fold
to 20-fold reduction
20-fold reduction in
reduction in expression
in expression of
expression of a
of a reporter
a reporter gene
reporter gene was
gene was observed
We propose that
propose that ets-1
that ets-1 functions
ets-1 functions as
functions as a
as a transcriptional
a transcriptional activator
transcriptional activator of
activator of mammalian
of mammalian type-C
mammalian type-C retroviruses
type-C retroviruses and
retroviruses and speculate
and speculate that
speculate that ets-related
that ets-related genes
ets-related genes constitute
genes constitute a
constitute a new
a new group
new group of
group of eukaryotic
of eukaryotic DNA-binding
eukaryotic DNA-binding proteins
Type II estrogen
II estrogen binding
estrogen binding sites
binding sites in
sites in human
in human peripheral
human peripheral blood
peripheral blood mononuclear
blood mononuclear cells:
mononuclear cells: variations
cells: variations during
variations during the
during the menstrual
the menstrual cycle
We have previously
have previously reported
previously reported that
reported that human
that human peripheral
human peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells PBMC
cells PBMC contain
PBMC contain type
contain type II
type II estrogen
II estrogen binding
estrogen binding sites
binding sites type
sites type II
type II EBS
In this study
this study the
study the fluctuations
the fluctuations of
fluctuations of type
of type II
type II EBS
II EBS during
EBS during the
during the menstrual
the menstrual cycle
menstrual cycle were
cycle were analyzed
were analyzed in
analyzed in 6
in 6 normally
6 normally menstruating
normally menstruating women
Approximately 3 times
3 times higher
times higher levels
higher levels of
levels of type
of type II
type II EBS
II EBS were
EBS were found
were found in
found in the
in the periovulatory
the periovulatory period
periovulatory period with
period with respect
with respect to
respect to both
to both follicular
both follicular and
follicular and luteal
and luteal phases
In postmenopausal women
postmenopausal women the
women the mean
the mean type
mean type II
type II EBS
II EBS levels
EBS levels were
levels were similar
were similar to
similar to those
to those observed
those observed in
observed in the
in the follicular
the follicular phase
follicular phase of
phase of the
of the cycle
However in 3
in 3 postmenopausal
3 postmenopausal patients
postmenopausal patients a
patients a short
a short course
short course of
course of estrogen
of estrogen or
estrogen or tamoxifen
or tamoxifen resulted
tamoxifen resulted in
resulted in a
in a marked
a marked increase
marked increase of
increase of type
of type II
type II EBS
II EBS levels
Tamoxifen was also
was also found
also found to
found to compete
to compete with
compete with 17
with 17 beta-estradiol
17 beta-estradiol for
beta-estradiol for type
for type II
type II EBS
II EBS in
EBS in PBMC
in PBMC although
PBMC although to
although to a
to a lesser
a lesser extent
lesser extent than
extent than diethylstilbestrol
Mononuclear leukocyte glucocorticoid
leukocyte glucocorticoid receptor
glucocorticoid receptor binding
receptor binding characteristics
binding characteristics and
characteristics and down-regulation
and down-regulation in
down-regulation in major
in major depression
Some patients with
patients with major
with major depressive
major depressive disorder
depressive disorder MDD
disorder MDD have
MDD have elevated
have elevated plasma
elevated plasma cortisol
plasma cortisol concentrations
cortisol concentrations and
concentrations and show
and show failure
show failure to
failure to suppress
to suppress cortisol
suppress cortisol secretion
cortisol secretion upon
secretion upon administration
upon administration of
administration of dexamethasone
of dexamethasone DEX
dexamethasone DEX yet
DEX yet they
yet they do
they do not
do not have
not have Cushingoid
have Cushingoid features
To study whether
study whether this
whether this represents
this represents glucocorticoid
represents glucocorticoid GC
glucocorticoid GC resistance
GC resistance [3H]-DEX-binding
resistance [3H]-DEX-binding assays
[3H]-DEX-binding assays were
assays were used
were used to
used to measure
to measure in
measure in vitro
in vitro the
vitro the GC
the GC receptor
GC receptor affinity
receptor affinity 1/Kd
affinity 1/Kd and
1/Kd and number
and number Bmax
number Bmax in
Bmax in mononuclear
in mononuclear leukocytes
mononuclear leukocytes of
leukocytes of 11
of 11 MDD
11 MDD patients
MDD patients and
patients and 15
and 15 control
15 control subjects
No receptor abnormalities
receptor abnormalities were
abnormalities were detected
were detected in
detected in the
in the MDD
the MDD group;
MDD group; thus
group; thus any
thus any cellular
any cellular defect
cellular defect leading
defect leading to
leading to a
to a lack
a lack of
lack of responsiveness
of responsiveness to
responsiveness to GC
to GC in
GC in the
in the MDD
the MDD patients
MDD patients if
patients if present
if present probably
present probably lies
probably lies beyond
lies beyond the
beyond the initial
the initial receptor
initial receptor binding
DEX 10 mg
10 mg orally
mg orally was
orally was administered
was administered to
administered to study
to study in
study in vivo
in vivo GC
vivo GC receptor
GC receptor down-regulation
Compared to the
to the control
the control group
control group fewer
group fewer depressed
fewer depressed subjects
depressed subjects down-regulated
subjects down-regulated Bmax
down-regulated Bmax after
Bmax after DEX
By paired t-test
paired t-test Bmax
t-test Bmax decreased
Bmax decreased significantly
decreased significantly in
significantly in the
in the control
the control group
control group but
group but not
but not in
not in the
in the depressed
the depressed group
Receptor number on
number on the
on the control
the control day
control day did
day did not
did not correlate
not correlate significantly
correlate significantly with
significantly with the
with the degree
the degree of
degree of receptor
of receptor down-regulation
receptor down-regulation severity
down-regulation severity of
severity of depression
of depression or
depression or cortisol
or cortisol concentrations
cortisol concentrations across
concentrations across all
across all the
all the subjects
These results do
results do not
do not lend
not lend support
lend support to
support to previous
to previous reports
previous reports suggesting
reports suggesting that
suggesting that GC
that GC resistance
GC resistance in
resistance in MDD
in MDD results
MDD results from
results from a
from a GC
a GC receptor-binding
GC receptor-binding abnormality
receptor-binding abnormality and
abnormality and they
and they emphasize
they emphasize the
emphasize the importance
the importance of
importance of considering
of considering receptor
considering receptor studies
receptor studies in
studies in the
in the context
the context of
context of GC-mediated
of GC-mediated cell
GC-mediated cell processes
cell processes in
processes in order
in order to
order to identify
to identify the
identify the exact
the exact cellular
exact cellular defects
cellular defects leading
defects leading to
leading to GC
to GC resistance
Ras-related GTP-binding proteins
GTP-binding proteins and
proteins and leukocyte
and leukocyte signal
leukocyte signal transduction
Many aspects of
aspects of leukocyte
of leukocyte function
leukocyte function are
function are regulated
are regulated by
regulated by both
by both heterotrimeric
both heterotrimeric and
heterotrimeric and Ras-related
and Ras-related GTP-binding
Ras-related GTP-binding proteins
GTP-binding proteins but
proteins but there
but there is
there is little
is little definite
little definite information
definite information about
information about their
about their roles
their roles in
roles in the
in the specialized
the specialized processes
specialized processes utilized
processes utilized by
utilized by leukocytes
by leukocytes for
leukocytes for cell
for cell killing
Recent progress in
progress in understanding
in understanding the
understanding the regulation
the regulation of
regulation of the
of the phagocyte
the phagocyte NADPH
phagocyte NADPH oxidase
NADPH oxidase by
oxidase by the
by the Rac
the Rac GTP-binding
Rac GTP-binding proteins
GTP-binding proteins provides
proteins provides a
provides a basis
a basis for
basis for defining
for defining the
defining the operational
the operational characteristics
operational characteristics of
characteristics of one
of one such
one such phagocyte
such phagocyte system
It is clear
is clear from
clear from various
from various studies
various studies that
studies that the
that the activity
the activity of
activity of the
of the NADPH
the NADPH oxidase
NADPH oxidase can
oxidase can be
can be modulated
be modulated through
modulated through the
through the regulation
the regulation of
regulation of the
of the GTP-GDP
the GTP-GDP state
GTP-GDP state of
state of Rac
Proteins exist in
exist in leukocytes
in leukocytes able
leukocytes able to
able to modify
to modify GTP-binding
modify GTP-binding protein
GTP-binding protein function
protein function in
function in this
in this manner
this manner and
manner and their
and their activity
their activity may
activity may be
may be regulated
be regulated by
regulated by signals
by signals generated
signals generated on
generated on phagocyte
on phagocyte stimulation
Proteins of the
of the Ras
the Ras superfamily
Ras superfamily are
superfamily are likely
are likely to
likely to be
to be involved
be involved in
involved in a
in a variety
a variety of
variety of normal
of normal phagocyte
normal phagocyte functions
phagocyte functions through
functions through their
through their ability
their ability to
ability to modulate
to modulate the
modulate the assembly
the assembly of
assembly of actin
of actin filaments
actin filaments direct
filaments direct vesicle
direct vesicle trafficking
vesicle trafficking and
trafficking and fusion
and fusion and
fusion and so
and so forth
BSAP: a key
a key regulator
key regulator of
regulator of B-cell
of B-cell development
B-cell development and
development and differentiation
B-cell-specific activator protein
activator protein BSAP
protein BSAP is
BSAP is a
is a recently
a recently identified
recently identified member
identified member of
member of the
of the Pax-gene
the Pax-gene family
Pax-gene family of
family of transcription
of transcription factors;
transcription factors; in
factors; in the
in the lymphoid
the lymphoid system
lymphoid system BSAP
system BSAP is
BSAP is produced
is produced only
produced only in
only in B
in B cells
Here Markus Neurath
Markus Neurath Eckhard
Neurath Eckhard Stuber
Eckhard Stuber and
Stuber and Warren
and Warren Strober
Warren Strober describe
Strober describe the
describe the molecular
the molecular structure
molecular structure of
structure of BSAP
of BSAP and
BSAP and focus
and focus on
focus on the
on the ability
the ability of
ability of this
of this protein
this protein to
protein to regulate
to regulate the
regulate the expression
the expression of
expression of B-cell-specific
of B-cell-specific genes
They propose that
propose that BSAP
that BSAP is
BSAP is a
is a key
a key protein
key protein of
protein of B
of B cells
B cells and
cells and that
and that it
that it not
it not only
not only influence
only influence B-cell
influence B-cell development
B-cell development but
development but also
but also influences
also influences the
influences the balance
the balance between
balance between B-cell
between B-cell proliferation
B-cell proliferation and
proliferation and immunoglobulin
and immunoglobulin secretion
immunoglobulin secretion at
secretion at later
at later stages
later stages of
stages of B-cell
of B-cell differentiation
Down-regulation of NF-kappa
of NF-kappa B
NF-kappa B protein
B protein levels
protein levels in
levels in activated
in activated human
activated human lymphocytes
human lymphocytes by
lymphocytes by 125-dihydroxyvitamin
by 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 [published
D3 [published erratum
[published erratum appears
erratum appears in
appears in Proc
in Proc Natl
Proc Natl Acad
Natl Acad Sci
Acad Sci U
Sci U S
U S A
S A 1996
A 1996 Jan
1996 Jan 9;931:524]
The effect of
effect of 125-dihydroxyvitamin
of 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 [125OH2D3]
D3 [125OH2D3] a
[125OH2D3] a steroid
a steroid hormone
steroid hormone with
hormone with immunomodulating
with immunomodulating properties
immunomodulating properties on
properties on nuclear
on nuclear factor
nuclear factor kappa
factor kappa B
kappa B NF-kappa
B NF-kappa B
NF-kappa B proteins
B proteins was
proteins was examined
was examined in
examined in in
in in vitro
in vitro activated
vitro activated normal
activated normal human
normal human lymphocytes
human lymphocytes by
lymphocytes by Western
by Western blot
Western blot analysis
Over a 72-hr
a 72-hr period
72-hr period of
period of activation
of activation the
activation the expression
the expression of
expression of the
of the 50-kDa
the 50-kDa NF-kappa
50-kDa NF-kappa B
NF-kappa B p50
B p50 and
p50 and its
and its precursor
its precursor p105
precursor p105 was
p105 was increased
was increased progressively
When cells were
cells were activated
were activated in
activated in the
in the presence
the presence of
presence of 125OH2D3
of 125OH2D3 the
125OH2D3 the levels
the levels of
levels of the
of the mature
the mature protein
mature protein as
protein as well
as well as
well as its
as its precursor
its precursor were
precursor were decreased
The effect of
effect of the
of the hormone
the hormone on
hormone on the
on the levels
the levels of
levels of p50
of p50 was
p50 was demonstrable
was demonstrable in
demonstrable in the
in the cytosolic
the cytosolic and
cytosolic and nuclear
and nuclear compartments;
nuclear compartments; it
compartments; it required
it required between
required between 4
between 4 and
4 and 8
and 8 hr
8 hr and
hr and was
and was specific
was specific as
specific as 25-hydroxyvitamin
as 25-hydroxyvitamin D3
25-hydroxyvitamin D3 and
D3 and 2425-dihydroxyvitamin
and 2425-dihydroxyvitamin D3
2425-dihydroxyvitamin D3 were
D3 were ineffective
Besides p50 125OH2D3
p50 125OH2D3 decreased
125OH2D3 decreased the
decreased the levels
the levels of
levels of another
of another NF-kappa
another NF-kappa B
NF-kappa B protein
B protein namely
protein namely c-rel
In addition 125OH2D3
addition 125OH2D3 decreased
125OH2D3 decreased the
decreased the abundance
the abundance of
abundance of a
of a specific
a specific DNA-protein
specific DNA-protein complex
DNA-protein complex formed
complex formed upon
formed upon incubation
upon incubation of
incubation of nuclear
of nuclear extracts
nuclear extracts from
extracts from activated
from activated lymphocytes
activated lymphocytes with
lymphocytes with a
with a labeled
a labeled NF-kappa
labeled NF-kappa B
NF-kappa B DNA
B DNA binding
DNA binding motif
Further 125OH2D3 inhibited
125OH2D3 inhibited the
inhibited the transcriptional
the transcriptional activity
transcriptional activity of
activity of NF-kappa
of NF-kappa B
NF-kappa B in
B in Jurkat
in Jurkat cells
Jurkat cells transiently
cells transiently transfected
transiently transfected with
transfected with a
with a construct
a construct containing
construct containing four
containing four tandem
four tandem repeats
tandem repeats of
repeats of the
of the NF-kappa
the NF-kappa B
NF-kappa B binding
B binding sequence
binding sequence of
sequence of the
of the immunoglobulin
the immunoglobulin kappa
immunoglobulin kappa light
kappa light chain
light chain gene
chain gene linked
gene linked to
linked to the
to the chloramphenicol
the chloramphenicol acetyltransferase
chloramphenicol acetyltransferase reporter
acetyltransferase reporter gene
These observations demonstrate
observations demonstrate directly
demonstrate directly that
directly that there
that there is
there is de
is de novo
de novo synthesis
novo synthesis of
synthesis of NF-kappa
of NF-kappa B
NF-kappa B during
B during human
during human lymphocyte
human lymphocyte activation
lymphocyte activation and
activation and suggest
and suggest that
suggest that this
that this process
this process is
process is hormonally
is hormonally regulated
The myeloid zinc
myeloid zinc finger
zinc finger gene
finger gene MZF-1
gene MZF-1 regulates
MZF-1 regulates the
regulates the CD34
the CD34 promoter
CD34 promoter in
promoter in vitro
MZF-1 is a
is a C2H2
a C2H2 zinc
C2H2 zinc finger
zinc finger gene
finger gene encoding
gene encoding a
encoding a putative
a putative transcriptional
putative transcriptional regulator
transcriptional regulator of
regulator of myeloid
of myeloid differentiation
The MZF-1 protein
MZF-1 protein contains
protein contains 13
contains 13 C2H2
13 C2H2 zinc
C2H2 zinc fingers
zinc fingers arranged
fingers arranged in
arranged in bipartite
in bipartite DNA
bipartite DNA binding
DNA binding domains
binding domains containing
domains containing zinc
containing zinc fingers
zinc fingers through
fingers through 4
through 4 and
4 and in
and in the
in the carboxy-terminus
the carboxy-terminus 5
carboxy-terminus 5 through
5 through 13
We previously identified
previously identified the
identified the DNA
the DNA consensus
DNA consensus binding
consensus binding site
binding site recognized
site recognized by
recognized by the
by the two
the two DNA
two DNA binding
DNA binding domains
To assess the
assess the transcription
the transcription regulatory
transcription regulatory function
regulatory function of
function of MZF-1
of MZF-1 the
MZF-1 the full-length
the full-length MZF-1
full-length MZF-1 coding
MZF-1 coding region
coding region was
region was fused
was fused to
fused to the
to the DNA
the DNA binding
DNA binding domain
binding domain of
domain of the
of the yeast
the yeast transactivator
yeast transactivator GAL4
The expression vector
expression vector was
vector was cotransfected
was cotransfected with
cotransfected with the
with the chloramphenicol
the chloramphenicol acetyl
chloramphenicol acetyl transferase
acetyl transferase CAT
transferase CAT reporter
CAT reporter gene
reporter gene regulated
gene regulated by
regulated by the
by the thymidine
the thymidine kinase
thymidine kinase promoter
kinase promoter containing
promoter containing GAL4
containing GAL4 DNA
GAL4 DNA binding
DNA binding sites
binding sites into
sites into NIH
into NIH 3T3
NIH 3T3 293
3T3 293 K562
293 K562 and
K562 and Jurkat
and Jurkat cell
Jurkat cell lines
MZF-1 represses CAT
represses CAT reporter
CAT reporter gene
reporter gene expression
gene expression via
expression via GAL4
via GAL4 binding
GAL4 binding sites
binding sites in
sites in the
in the nonhematopoietic
the nonhematopoietic cell
nonhematopoietic cell lines
cell lines NIH
lines NIH 3T3
NIH 3T3 and
3T3 and 293
In contrast MZF-1
contrast MZF-1 activates
MZF-1 activates CAT
activates CAT reporter
CAT reporter gene
reporter gene expression
gene expression in
expression in the
in the hematopoietic
the hematopoietic cell
hematopoietic cell lines
cell lines K562
lines K562 and
K562 and Jurkat
The MZF-1 binding
MZF-1 binding sites
binding sites are
sites are present
are present in
present in the
in the promoters
the promoters of
promoters of several
of several genes
several genes expressed
genes expressed during
expressed during myeloid
during myeloid differentiation
myeloid differentiation including
differentiation including the
including the CD34
the CD34 promoter
MZF-1 transcriptional regulation
transcriptional regulation of
regulation of this
of this physiologically
this physiologically relevant
physiologically relevant promoter
relevant promoter was
promoter was assessed
was assessed in
assessed in both
in both hematopoietic
both hematopoietic and
hematopoietic and nonhematopoietic
and nonhematopoietic cell
nonhematopoietic cell lines
Recombinant MZF-1 protein
MZF-1 protein specifically
protein specifically binds
specifically binds to
binds to the
to the consensus
the consensus binding
consensus binding sites
binding sites in
sites in the
in the CD34
the CD34 promoter
CD34 promoter in
promoter in mobility
in mobility shift
mobility shift assays
MZF-1 expression vectors
expression vectors were
vectors were cotransfected
were cotransfected with
cotransfected with the
with the luciferase
the luciferase reporter
luciferase reporter plasmids
reporter plasmids regulated
plasmids regulated by
regulated by the
by the CD34
the CD34 promoter
CD34 promoter into
promoter into both
into both nonhematopoietic
both nonhematopoietic and
nonhematopoietic and hematopoietic
and hematopoietic cell
hematopoietic cell lines
As with the
with the heterologous
the heterologous DNA
heterologous DNA binding
DNA binding domain
binding domain MZF-1
domain MZF-1 represses
MZF-1 represses reporter
represses reporter gene
reporter gene expression
gene expression in
expression in nonhematopoietic
in nonhematopoietic cell
nonhematopoietic cell lines
cell lines and
lines and activates
and activates expression
activates expression in
expression in hematopoietic
in hematopoietic cell
hematopoietic cell lines
Activation of CD34
of CD34 expression
CD34 expression in
expression in hematopoietic
in hematopoietic cell
hematopoietic cell lines
cell lines is
lines is dependent
is dependent on
dependent on the
on the presence
the presence of
presence of intact
of intact MZF-1
intact MZF-1 binding
MZF-1 binding sites
The cell type-specific
cell type-specific regulation
type-specific regulation of
regulation of the
of the CD34
the CD34 promoter
CD34 promoter by
promoter by MZF-1
by MZF-1 suggests
MZF-1 suggests the
suggests the presence
the presence of
presence of tissue-specific
of tissue-specific regulators/adapters
tissue-specific regulators/adapters or
regulators/adapters or differential
or differential MZF-1
differential MZF-1 modifications
MZF-1 modifications that
modifications that determine
that determine MZF-1
determine MZF-1 transcriptional
MZF-1 transcriptional regulatory
transcriptional regulatory function
The murine BCL6
murine BCL6 gene
BCL6 gene is
gene is induced
is induced in
induced in activated
in activated lymphocytes
activated lymphocytes as
lymphocytes as an
as an immediate
an immediate early
immediate early gene
The chromosomal translocation
chromosomal translocation involving
translocation involving 3q27
involving 3q27 is
3q27 is often
is often detected
often detected in
detected in human
in human B-cell
human B-cell lymphomas
B-cell lymphomas especially
lymphomas especially diffuse
especially diffuse lymphomas
diffuse lymphomas with
lymphomas with a
with a large-cell
a large-cell component
The BCL6 gene
BCL6 gene has
gene has been
has been isolated
been isolated from
isolated from the
from the chromosomal
the chromosomal breakpoint
chromosomal breakpoint in
breakpoint in these
in these lymphomas
Here we cloned
we cloned the
cloned the murine
the murine BCL6
murine BCL6 mBCL6
BCL6 mBCL6 cDNA
mBCL6 cDNA from
cDNA from the
from the muscle
the muscle cDNA
muscle cDNA library
cDNA library using
library using the
using the human
the human BCL6
human BCL6 hBCL6
BCL6 hBCL6 cDNA
hBCL6 cDNA as
cDNA as a
as a probe
The predicted amino
predicted amino acid
amino acid sequence
acid sequence was
sequence was 95%
was 95% identical
95% identical to
identical to that
to that of
that of hBCL6
It contains six
contains six repeats
six repeats of
repeats of the
of the Kruppel-like
the Kruppel-like zinc-finger
Kruppel-like zinc-finger motif
zinc-finger motif that
motif that are
that are completely
are completely identical
completely identical to
identical to those
to those of
those of hBCL6
of hBCL6 indicating
hBCL6 indicating that
indicating that the
that the BCL6
the BCL6 gene
BCL6 gene is
gene is well
is well conserved
well conserved between
conserved between humans
between humans and
humans and mice
Expression of the
of the mBCL6
the mBCL6 gene
mBCL6 gene was
gene was ubiquitously
was ubiquitously detected
ubiquitously detected in
detected in adult
in adult mouse
adult mouse tissues
mouse tissues including
tissues including lymphatic
including lymphatic organs
Furthermore it was
it was induced
was induced in
induced in lymphocytes
in lymphocytes activated
lymphocytes activated with
activated with phorbol
with phorbol ester
phorbol ester and
ester and Ca2+
and Ca2+ ionophore
Ca2+ ionophore within
ionophore within 30
within 30 min
30 min after
min after stimulation
This induction was
induction was not
was not inhibited
not inhibited by
inhibited by treatment
by treatment of
treatment of the
of the cells
the cells with
cells with a
with a protein
a protein synthesis
protein synthesis inhibitor
synthesis inhibitor cycloheximide
These results suggest
results suggest that
suggest that BCL6
that BCL6 plays
BCL6 plays a
plays a role
a role in
role in activated
in activated lymphocytes
activated lymphocytes as
lymphocytes as an
as an immediate
an immediate early
immediate early gene
The role of
role of BSAP
of BSAP Pax-5
BSAP Pax-5 in
Pax-5 in B-cell
in B-cell development
The hierarchy of
hierarchy of transcriptional
of transcriptional control
transcriptional control in
control in B-cell
in B-cell development
B-cell development has
development has recently
has recently been
recently been analyzed
been analyzed by
analyzed by targeted
by targeted gene
targeted gene inactivation
gene inactivation in
inactivation in the
in the mouse
In this manner
this manner the
manner the paired
the paired box
paired box containing
box containing gene
containing gene Pax-5
gene Pax-5 encoding
Pax-5 encoding the
encoding the B
the B cell
B cell specific
cell specific transcription
specific transcription factor
transcription factor BSAP
factor BSAP has
BSAP has been
has been shown
been shown to
shown to play
to play a
play a key
a key role
key role in
role in early
in early B
early B lymphopoiesis
Other experimental strategies
experimental strategies have
strategies have implicated
have implicated BSAP
implicated BSAP in
BSAP in the
in the control
the control of
control of cell
of cell proliferation
cell proliferation isotype
proliferation isotype switching
isotype switching and
switching and transcription
and transcription of
transcription of the
of the immunoglobulin
the immunoglobulin heavy-chain
immunoglobulin heavy-chain gene
heavy-chain gene at
gene at late
at late stages
late stages of
stages of B-cell
of B-cell differentiation
The DNA-binding properties
DNA-binding properties of
properties of two
of two heat
two heat shock
heat shock factors
shock factors HSF1
factors HSF1 and
HSF1 and HSF3
and HSF3 are
HSF3 are induced
are induced in
induced in the
in the avian
the avian erythroblast
avian erythroblast cell
erythroblast cell line
cell line HD6
Avian cells express
cells express three
express three heat
three heat shock
heat shock transcription
shock transcription factor
transcription factor HSF
factor HSF genes
HSF genes corresponding
genes corresponding to
corresponding to a
to a novel
a novel factor
novel factor HSF3
factor HSF3 and
HSF3 and homologs
and homologs of
homologs of mouse
of mouse and
mouse and human
and human HSF1
human HSF1 and
HSF1 and HSF2
Analysis of the
of the biochemical
the biochemical and
biochemical and cell
and cell biological
cell biological properties
biological properties of
properties of these
of these HSFs
these HSFs reveals
HSFs reveals that
reveals that HSF3
that HSF3 has
HSF3 has properties
has properties in
properties in common
in common with
common with both
with both HSF1
both HSF1 and
HSF1 and HSF2
and HSF2 and
HSF2 and yet
and yet has
yet has features
has features which
features which are
which are distinct
are distinct from
distinct from both
HSF3 is constitutively
is constitutively expressed
constitutively expressed in
expressed in the
in the erythroblast
the erythroblast cell
erythroblast cell line
cell line HD6
line HD6 the
HD6 the lymphoblast
the lymphoblast cell
lymphoblast cell line
cell line MSB
line MSB and
MSB and embryo
and embryo fibroblasts
embryo fibroblasts and
fibroblasts and yet
and yet its
yet its DNA-binding
its DNA-binding activity
DNA-binding activity is
activity is induced
is induced only
induced only upon
only upon exposure
upon exposure of
exposure of HD6
of HD6 cells
HD6 cells to
cells to heat
to heat shock
Acquisition of HSF3
of HSF3 DNA-binding
HSF3 DNA-binding activity
DNA-binding activity in
activity in HD6
in HD6 cells
HD6 cells is
cells is accompanied
is accompanied by
accompanied by oligomerization
by oligomerization from
oligomerization from a
from a non-DNA-binding
a non-DNA-binding dimer
non-DNA-binding dimer to
dimer to a
to a DNA-binding
a DNA-binding trimer
DNA-binding trimer whereas
trimer whereas the
whereas the effect
the effect of
effect of heat
of heat shock
heat shock on
shock on HSF1
on HSF1 is
HSF1 is oligomerization
is oligomerization of
oligomerization of an
of an inert
an inert monomer
inert monomer to
monomer to a
to a DNA-binding
a DNA-binding trimer
Induction of HSF3
of HSF3 DNA-binding
HSF3 DNA-binding activity
DNA-binding activity is
activity is delayed
is delayed compared
delayed compared with
compared with that
with that of
that of HSF1
As occurs for
occurs for HSF1
for HSF1 heat
HSF1 heat shock
heat shock leads
shock leads to
leads to the
to the translocation
the translocation of
translocation of HSF3
of HSF3 to
HSF3 to the
to the nucleus
HSF exhibits the
exhibits the properties
the properties of
properties of a
of a transcriptional
a transcriptional activator
transcriptional activator as
activator as judged
as judged from
judged from the
from the stimulatory
the stimulatory activity
stimulatory activity of
activity of transiently
of transiently overexpressed
transiently overexpressed HSF3
overexpressed HSF3 measured
HSF3 measured by
measured by using
by using a
using a heat
a heat shock
heat shock element-containing
shock element-containing reporter
element-containing reporter construct
reporter construct and
construct and as
and as independently
as independently assayed
independently assayed by
assayed by the
by the activity
the activity of
activity of a
of a chimeric
a chimeric GAL4-HSF3
chimeric GAL4-HSF3 protein
GAL4-HSF3 protein on
protein on a
on a GAL4
a GAL4 reporter
GAL4 reporter construct
These results reveal
results reveal that
reveal that HSF3
that HSF3 is
HSF3 is negatively
is negatively regulated
negatively regulated in
regulated in avian
in avian cells
avian cells and
cells and acquires
and acquires DNA-binding
acquires DNA-binding activity
DNA-binding activity in
activity in certain
in certain cells
certain cells upon
cells upon heat
upon heat shock
Direct demonstration of
demonstration of NFATp
of NFATp dephosphorylation
NFATp dephosphorylation and
dephosphorylation and nuclear
and nuclear localization
nuclear localization in
localization in activated
in activated HT-2
activated HT-2 cells
HT-2 cells using
cells using a
using a specific
a specific NFATp
specific NFATp polyclonal
NFATp polyclonal antibody
Nuclear factor of
factor of activated
of activated T
activated T cells
T cells NFAT
cells NFAT regulates
NFAT regulates transcription
regulates transcription of
transcription of a
of a number
a number of
number of cytokine
of cytokine genes
cytokine genes and
genes and NFAT
and NFAT DNA
NFAT DNA binding
DNA binding activity
binding activity is
activity is stimulated
is stimulated following
stimulated following T
following T cell
T cell activation
Several lines of
lines of evidence
of evidence have
evidence have suggested
have suggested that
suggested that NFAT
that NFAT is
NFAT is a
is a substrate
a substrate for
substrate for calcineurin
for calcineurin a
calcineurin a serine/threonine
a serine/threonine phosphatase
Using a polyclonal
a polyclonal antibody
polyclonal antibody to
antibody to murine
to murine NFATp
murine NFATp Western
NFATp Western blot
Western blot analysis
blot analysis of
analysis of various
of various mouse
various mouse tissues
mouse tissues demonstrated
tissues demonstrated that
demonstrated that the
that the 110-130-kDa
the 110-130-kDa NFATp
110-130-kDa NFATp protein
NFATp protein was
protein was highly
was highly expressed
highly expressed in
expressed in thymus
in thymus and
thymus and spleen
Treatment of immunoprecipitated
of immunoprecipitated NFATp
immunoprecipitated NFATp from
NFATp from untreated
from untreated HT-2
untreated HT-2 cells
HT-2 cells with
cells with calcineurin
with calcineurin resulted
calcineurin resulted in
resulted in the
in the dephosphorylation
the dephosphorylation of
dephosphorylation of NFATp
of NFATp demonstrating
NFATp demonstrating that
demonstrating that NFATp
that NFATp is
NFATp is an
is an in
an in vitro
in vitro substrate
vitro substrate for
substrate for calcineurin
NFATp immunoprecipitated from
immunoprecipitated from 32P-labeled
from 32P-labeled HT-2
32P-labeled HT-2 cells
HT-2 cells migrated
cells migrated as
migrated as an
as an approximately
an approximately 120-kDa
approximately 120-kDa protein
120-kDa protein that
protein that was
that was localized
was localized to
localized to the
to the cytosol
the cytosol of
cytosol of the
of the cells
Treatment of the
of the cells
the cells with
cells with ionomycin
with ionomycin resulted
ionomycin resulted in
resulted in a
in a decrease
a decrease in
decrease in the
in the molecular
the molecular weight
molecular weight of
weight of NFATp
of NFATp and
NFATp and a
and a loss
a loss of
loss of 32P
of 32P consistent
32P consistent with
consistent with NFATp
with NFATp dephosphorylation
The dephosphorylation of
dephosphorylation of NFATp
of NFATp was
NFATp was accompanied
was accompanied by
accompanied by localization
by localization of
localization of the
of the protein
the protein to
protein to the
to the nuclear
the nuclear fraction
Both of these
of these events
these events were
events were blocked
were blocked by
blocked by preincubation
by preincubation of
preincubation of the
of the cells
the cells with
cells with FK506
with FK506 a
FK506 a calcineurin
a calcineurin inhibitor
calcineurin inhibitor consistent
inhibitor consistent with
consistent with the
with the hypothesis
the hypothesis that
hypothesis that NFATp
that NFATp is
NFATp is a
is a calcineurin
a calcineurin substrate
calcineurin substrate in
substrate in cells
Activation and expression
and expression of
expression of the
of the nuclear
the nuclear factors
nuclear factors of
factors of activated
of activated T
activated T cells
T cells NFATp
cells NFATp and
NFATp and NFATc
and NFATc in
NFATc in human
in human natural
human natural killer
natural killer cells:
killer cells: regulation
cells: regulation upon
regulation upon CD16
upon CD16 ligand
CD16 ligand binding
The putative factors
putative factors that
factors that couple
that couple the
couple the signal
the signal transduction
signal transduction from
transduction from surface
from surface receptors
surface receptors to
receptors to the
to the activation
the activation of
activation of cytokine
of cytokine synthesis
cytokine synthesis in
synthesis in natural
in natural killer
natural killer NK
killer NK cells
NK cells have
cells have not
have not been
not been elucidated
We report here
report here that
here that the
that the nuclear
the nuclear factor
nuclear factor of
factor of activated
of activated T
activated T cells
T cells NFATp
cells NFATp a
NFATp a cyclosporin
a cyclosporin A
cyclosporin A CsA-sensitive
A CsA-sensitive factor
CsA-sensitive factor that
factor that regulates
that regulates the
regulates the transcription
the transcription of
transcription of several
of several cytokines
several cytokines mediates
cytokines mediates CD16-induced
mediates CD16-induced activation
CD16-induced activation of
activation of cytokine
of cytokine genes
cytokine genes in
genes in human
in human NK
human NK cells
CD16 Fc gamma
Fc gamma RIIIA-induced
gamma RIIIA-induced expression
RIIIA-induced expression of
expression of cytokine
of cytokine mRNA
cytokine mRNA in
mRNA in NK
in NK cells
NK cells occurs
cells occurs via
occurs via a
via a CsA-sensitive
a CsA-sensitive and
CsA-sensitive and Ca2+-dependent
and Ca2+-dependent mechanism
Stimulation of NK
of NK cells
NK cells with
cells with CD16
with CD16 ligands
CD16 ligands induces
ligands induces NFAT-like
induces NFAT-like DNA
NFAT-like DNA binding
DNA binding activity
binding activity in
activity in the
in the nuclear
the nuclear extracts
nuclear extracts from
extracts from these
from these cells
these cells as
cells as detected
as detected in
detected in electrophoretic
in electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
This occurs with
occurs with fast
with fast kinetics
fast kinetics after
kinetics after stimulation
after stimulation via
stimulation via a
via a CsA-sensitive
a CsA-sensitive and
CsA-sensitive and Ca2+-dependent
and Ca2+-dependent mechanism
Ca2+-dependent mechanism that
mechanism that does
that does not
does not require
not require de
require de novo
de novo protein
novo protein synthesis
NK cell NFAT
cell NFAT is
NFAT is present
is present in
present in the
in the cytosol
the cytosol of
cytosol of nonstimulated
of nonstimulated cells
nonstimulated cells migrates
cells migrates to
migrates to the
to the nucleus
the nucleus upon
nucleus upon stimulation
upon stimulation and
stimulation and can
and can associate
can associate with
associate with AP-1
Two distinct molecules
distinct molecules NFATp
molecules NFATp and
NFATp and NFATc
and NFATc have
NFATc have been
have been reported
been reported to
reported to mediate
to mediate NFAT
mediate NFAT activity
The results of
results of supershift
of supershift assays
supershift assays using
assays using NFATp-
using NFATp- and
NFATp- and NFATc-
and NFATc- specific
NFATc- specific antibodies
specific antibodies indicate
antibodies indicate that
indicate that NK
that NK cell
NK cell activation
cell activation early
activation early after
early after CD16
after CD16 ligand
CD16 ligand binding
ligand binding involves
binding involves primarily
involves primarily if
primarily if not
if not exclusively
not exclusively NFATp
exclusively NFATp and
NFATp and Western
and Western blot
Western blot analysis
blot analysis shows
analysis shows that
shows that this
that this has
this has the
has the same
the same electrophoretic
same electrophoretic mobility
electrophoretic mobility approximately
mobility approximately 120
approximately 120 kD
120 kD as
kD as that
as that of
that of T
of T lymphocytes
NK cells do
cells do not
do not express
not express NFATc
express NFATc constitutively
NFATc constitutively but
constitutively but NFATc
but NFATc mRNA
NFATc mRNA accumulation
mRNA accumulation is
accumulation is induced
is induced in
induced in these
in these cells
these cells within
cells within 2
within 2 h
2 h of
h of stimulation
of stimulation with
stimulation with CD16
with CD16 ligands
However supershift assays
supershift assays using
assays using the
using the available
the available mAb
available mAb recognizing
mAb recognizing the
recognizing the T
the T cell
T cell NFATc
cell NFATc revealed
NFATc revealed no
revealed no detectable
no detectable NFATc
detectable NFATc protein
NFATc protein in
protein in nuclear
in nuclear and
nuclear and cytoplasmic
and cytoplasmic extracts
cytoplasmic extracts from
extracts from CD16-
from CD16- or
CD16- or phorbol
or phorbol ester-stimulated
phorbol ester-stimulated cells
ester-stimulated cells at
cells at any
at any time
any time tested
time tested up
tested up to
up to 4
to 4 h
These results provide
results provide the
provide the first
the first direct
first direct evidence
direct evidence that
evidence that both
that both CsA-sensitive
both CsA-sensitive transcription
CsA-sensitive transcription factors
transcription factors NFATp
factors NFATp and
NFATp and NFATc
and NFATc are
NFATc are expressed
are expressed in
expressed in human
in human NK
human NK cells
NK cells and
cells and that
and that their
that their activation
their activation and/or
activation and/or expression
and/or expression can
expression can be
can be regulated
be regulated in
regulated in primary
in primary cells
primary cells by
cells by a
by a single
a single stimulus
single stimulus that
stimulus that in
that in the
in the case
the case of
case of CD16
of CD16 in
CD16 in NK
in NK cells
NK cells results
cells results in
results in early
in early activation
early activation of
activation of NFATp
of NFATp and
NFATp and subsequently
and subsequently induced
subsequently induced expression
induced expression of
expression of NFATc
of NFATc mRNA
Interleukin 2 signaling
2 signaling involves
signaling involves the
involves the phosphorylation
the phosphorylation of
phosphorylation of Stat
of Stat proteins
One of the
of the most
the most important
most important cytokines
important cytokines involved
cytokines involved in
involved in immune
in immune response
immune response regulation
response regulation is
regulation is interleukin
is interleukin 2
interleukin 2 IL-2
2 IL-2 a
IL-2 a potent
a potent activator
potent activator of
activator of the
of the proliferation
the proliferation and
proliferation and function
and function of
function of T
of T lymphocytes
T lymphocytes and
lymphocytes and natural
and natural killer
natural killer cells
The mechanisms by
mechanisms by which
by which the
which the effects
the effects of
effects of IL-2
of IL-2 are
IL-2 are propagated
are propagated within
propagated within cells
within cells are
cells are not
are not understood
While the binding
the binding of
binding of IL-2
of IL-2 to
IL-2 to its
to its receptor
its receptor was
receptor was recently
was recently shown
recently shown to
shown to lead
to lead to
lead to the
to the activation
the activation of
activation of two
of two kinases
two kinases Jak-1
kinases Jak-1 and
Jak-1 and Jak-3
and Jak-3 subsequent
Jak-3 subsequent steps
subsequent steps in
steps in the
in the signaling
the signaling pathway
signaling pathway to
pathway to the
to the nucleus
the nucleus that
nucleus that lead
that lead to
lead to the
to the activation
the activation of
activation of specific
of specific genes
specific genes had
genes had not
had not been
not been characterized
Since many cytokines
many cytokines that
cytokines that activate
that activate Jak
activate Jak kinases
Jak kinases also
kinases also lead
also lead to
lead to the
to the tyrosine
the tyrosine phosphorylation
tyrosine phosphorylation and
phosphorylation and activation
and activation of
activation of members
of members of
members of the
of the Stat
the Stat family
Stat family of
family of transcription
of transcription factors
transcription factors the
factors the ability
the ability of
ability of IL-2
of IL-2 to
IL-2 to trigger
to trigger Stat
trigger Stat phosphorylation
Stat phosphorylation was
phosphorylation was examined
Exposure of activated
of activated human
activated human T
human T lymphocytes
T lymphocytes or
lymphocytes or of
or of a
of a natural
a natural killer
natural killer cell
killer cell line
cell line NKL
line NKL to
NKL to IL-2
to IL-2 leads
IL-2 leads to
leads to the
to the phosphorylation
the phosphorylation of
phosphorylation of Stat1
of Stat1 alpha
Stat1 alpha Stat1
alpha Stat1 beta
Stat1 beta and
beta and Stat3
and Stat3 as
Stat3 as well
as well as
well as of
as of two
of two Stat-related
two Stat-related proteins
Stat-related proteins p94
proteins p94 and
p94 and p95
p94 and p95
and p95 share
p95 share homology
share homology with
homology with Stat1
with Stat1 at
Stat1 at the
at the phosphorylation
the phosphorylation site
phosphorylation site and
site and in
and in the
in the Src
the Src homology
Src homology 2
homology 2 SH2
2 SH2 domain
SH2 domain but
domain but otherwise
but otherwise are
otherwise are immunologically
are immunologically distinct
immunologically distinct from
distinct from Stat1
These Stat proteins
Stat proteins were
proteins were found
were found to
found to translocate
to translocate to
translocate to the
to the nucleus
the nucleus and
nucleus and to
and to bind
to bind to
bind to a
to a specific
a specific DNA
specific DNA sequence
These findings suggest
findings suggest a
suggest a mechanism
a mechanism by
mechanism by which
by which IL-2
which IL-2 binding
IL-2 binding to
binding to its
to its receptor
its receptor may
receptor may activate
may activate specific
activate specific genes
specific genes involved
genes involved in
involved in immune
in immune cell
immune cell function
Expression of c-fos
of c-fos correlates
c-fos correlates with
correlates with IFN-alpha
with IFN-alpha responsiveness
IFN-alpha responsiveness in
responsiveness in Philadelphia
in Philadelphia chromosome
Philadelphia chromosome positive
chromosome positive chronic
positive chronic myelogenous
chronic myelogenous leukemia
This study evaluates
study evaluates i
evaluates i constitutive
i constitutive levels
constitutive levels of
levels of oncogene
of oncogene and
oncogene and p53
and p53 transcripts
p53 transcripts in
transcripts in chronic
in chronic phase
chronic phase CML
phase CML patients
CML patients and
patients and ii
and ii their
ii their modulations
their modulations subsequent
modulations subsequent to
subsequent to in
to in vivo
in vivo therapy
vivo therapy with
therapy with rIFN-alpha
with rIFN-alpha 2c
Peripheral blood mononuclear
blood mononuclear cells
mononuclear cells pbmc
cells pbmc and
pbmc and bone
and bone marrow
bone marrow cells
marrow cells of
cells of 26
of 26 patients
26 patients were
patients were examined
were examined for
examined for c-fos
for c-fos c-myc
c-fos c-myc p53
c-myc p53 and
p53 and the
and the hybrid
the hybrid bcr/abl
hybrid bcr/abl mRNA
bcr/abl mRNA levels
Results indicated that
indicated that i
that i constitutive
i constitutive c-fos
constitutive c-fos transcript
c-fos transcript levels
transcript levels are
levels are significantly
are significantly higher
significantly higher in
higher in patients
in patients subsequently
patients subsequently responding
subsequently responding to
responding to IFN-alpha
to IFN-alpha therapy
IFN-alpha therapy p
therapy p <
p < 001
< 001 and
001 and positively
and positively correlated
positively correlated with
correlated with the
with the proportion
the proportion of
proportion of lymphocytes
of lymphocytes r
lymphocytes r =
r = 06895
= 06895 p
06895 p <
p < 001
< 001 and
001 and negatively
and negatively with
negatively with the
with the proportion
the proportion of
proportion of immature
of immature cells
immature cells r
cells r =
r = -0568
= -0568 p
-0568 p <
p < 001
< 001 contained
001 contained in
contained in the
in the pbmc
the pbmc preparations
pbmc preparations tested
preparations tested ii
tested ii constitutive
ii constitutive mRNA
constitutive mRNA levels
mRNA levels of
levels of the
of the hybrid
the hybrid bcr/abl
hybrid bcr/abl c-myc
bcr/abl c-myc and
c-myc and p53
and p53 are
p53 are positively
are positively correlated
positively correlated with
correlated with each
with each other
each other but
other but failed
but failed to
failed to relate
to relate to
relate to disease
to disease parameters
disease parameters and
parameters and iii
and iii acute
iii acute and
acute and chronic
and chronic in
chronic in vivo
in vivo exposure
vivo exposure to
exposure to IFN-alpha
to IFN-alpha is
IFN-alpha is accompanied
is accompanied by
accompanied by upregulation
by upregulation of
upregulation of c-fos
of c-fos and
c-fos and downregulation
and downregulation of
downregulation of c-myc
of c-myc mRNA
c-myc mRNA levels
mRNA levels in
levels in responder
in responder patients
Menopause is associated
is associated with
associated with a
with a significant
a significant increase
significant increase in
increase in blood
in blood monocyte
blood monocyte number
monocyte number and
number and a
and a relative
a relative decrease
relative decrease in
decrease in the
in the expression
the expression of
expression of estrogen
of estrogen receptors
estrogen receptors in
receptors in human
in human peripheral
human peripheral monocytes
PROBLEM: The clinical
The clinical significance
clinical significance of
significance of the
of the differential
the differential expression
differential expression of
expression of estrogen
of estrogen receptor
estrogen receptor ER
receptor ER in
ER in human
in human monocytes
human monocytes was
monocytes was evaluated
METHOD: Two color
Two color flow
color flow cytometry
flow cytometry analysis
cytometry analysis was
analysis was used
was used on
used on peripheral
on peripheral blood
peripheral blood samples
blood samples of
samples of young
of young and
young and postmenopausal
and postmenopausal females
postmenopausal females and
females and postmenopausal
and postmenopausal females
postmenopausal females treated
females treated with
treated with estrogen
with estrogen replacement
estrogen replacement therapy
In addition the
addition the monocyte
the monocyte and
monocyte and lymphocyte
and lymphocyte counts
lymphocyte counts and
counts and the
and the blood
the blood estrogen
blood estrogen levels
estrogen levels of
levels of each
of each patient
each patient were
patient were determine
RESULTS: During menopause
During menopause there
menopause there is
there is a
is a significant
a significant decrease
significant decrease in
decrease in the
in the percentage
the percentage of
percentage of ER
of ER positive
ER positive monocytes
positive monocytes and
monocytes and an
and an increase
an increase in
increase in blood
in blood monocyte
blood monocyte number
monocyte number which
number which declines
which declines following
declines following estrogen
following estrogen replacement
estrogen replacement therapy
replacement therapy to
therapy to values
to values of
values of the
of the young
CONCLUSIONS: These findings
These findings suggest
findings suggest that
suggest that estrogen
that estrogen modulates
estrogen modulates the
modulates the monocyte
the monocyte numbers
monocyte numbers and
numbers and its
and its effects
its effects may
effects may be
may be mediated
be mediated through
mediated through the
through the ER
the ER in
ER in the
in the monocytes
Staphylococcal enterotoxins modulate
enterotoxins modulate interleukin
modulate interleukin 2
interleukin 2 receptor
2 receptor expression
receptor expression and
expression and ligand-induced
and ligand-induced tyrosine
ligand-induced tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of the
of the Janus
the Janus protein-tyrosine
Janus protein-tyrosine kinase
protein-tyrosine kinase 3
kinase 3 Jak3
3 Jak3 and
Jak3 and signal
and signal transducers
signal transducers and
transducers and activators
and activators of
activators of transcription
of transcription Stat
transcription Stat proteins
Staphylococcal enterotoxins SE
enterotoxins SE stimulate
SE stimulate T
stimulate T cells
T cells expressing
cells expressing the
expressing the appropriate
the appropriate variable
appropriate variable region
variable region beta
region beta chain
beta chain of
chain of V
of V beta
V beta T-cell
beta T-cell receptors
T-cell receptors and
receptors and have
and have been
have been implicated
been implicated in
implicated in the
in the pathogenesis
the pathogenesis of
pathogenesis of several
of several autoimmune
several autoimmune diseases
Depending on costimulatory
on costimulatory signals
costimulatory signals SE
signals SE induce
SE induce either
induce either proliferation
either proliferation or
proliferation or anergy
or anergy in
anergy in T
in T cells
In addition SE
addition SE can
SE can induce
can induce an
induce an interleukin-2
an interleukin-2 IL-2
interleukin-2 IL-2 nonresponsive
IL-2 nonresponsive state
nonresponsive state and
state and apoptosis
Here we show
we show that
show that SE
that SE induce
SE induce dynamic
induce dynamic changes
dynamic changes in
changes in the
in the expression
the expression of
expression of and
of and signal
and signal transduction
signal transduction through
transduction through the
through the IL-2
the IL-2 receptor
IL-2 receptor IL-2R
receptor IL-2R beta
IL-2R beta and
beta and gamma
and gamma chains
gamma chains IL-2R
chains IL-2R beta
IL-2R beta and
beta and IL-2R
and IL-2R gamma
IL-2R gamma in
gamma in human
in human antigen-specific
human antigen-specific CD4+
antigen-specific CD4+ T-cell
CD4+ T-cell lines
Thus after 4
after 4 hr
4 hr of
hr of exposure
of exposure to
exposure to SEA
to SEA and
SEA and SEB
and SEB the
SEB the expression
the expression of
expression of IL-2R
of IL-2R beta
IL-2R beta was
beta was down-regulated
was down-regulated IL-2R
down-regulated IL-2R gamma
IL-2R gamma was
gamma was slightly
was slightly up-regulated
slightly up-regulated while
up-regulated while IL-2R
while IL-2R alpha
IL-2R alpha remained
alpha remained largely
remained largely unaffected
The changes in
changes in the
in the composition
the composition of
composition of IL-2Rs
of IL-2Rs were
IL-2Rs were accompanied
were accompanied by
accompanied by inhibition
by inhibition of
inhibition of IL-2-induced
of IL-2-induced tyrosine
IL-2-induced tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of the
of the Janus
the Janus protein-tyrosine
Janus protein-tyrosine kinase
protein-tyrosine kinase 3
kinase 3 Jak3
3 Jak3 and
Jak3 and signal
and signal transducers
signal transducers and
transducers and activators
and activators of
activators of transcription
of transcription called
transcription called Stat3
called Stat3 and
Stat3 and Stat5
In parallel experiments
parallel experiments IL-2-driven
experiments IL-2-driven proliferation
IL-2-driven proliferation was
proliferation was inhibited
was inhibited significantly
After 16 hr
16 hr of
hr of exposure
of exposure to
exposure to SE
to SE the
SE the expression
the expression of
expression of IL-2R
of IL-2R beta
IL-2R beta remained
beta remained low
remained low while
low while that
while that of
that of IL2R
of IL2R alpha
IL2R alpha and
alpha and IL2R
and IL2R gamma
IL2R gamma was
gamma was further
was further up-regulated
further up-regulated and
up-regulated and ligand-induced
and ligand-induced tyrosine
ligand-induced tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of Jak3
of Jak3 and
Jak3 and Stat
and Stat proteins
Stat proteins was
proteins was partly
was partly normalized
Yet IL-2-driven proliferation
IL-2-driven proliferation remained
proliferation remained profoundly
remained profoundly inhibited
profoundly inhibited suggesting
inhibited suggesting that
suggesting that signaling
that signaling events
signaling events other
events other than
other than Jak3/Stat
than Jak3/Stat activation
Jak3/Stat activation had
activation had also
had also been
also been changed
been changed following
changed following SE
following SE stimulation
In conclusion our
conclusion our data
our data suggest
data suggest that
suggest that SE
that SE can
SE can modulate
can modulate IL-2R
modulate IL-2R expression
IL-2R expression and
expression and signal
and signal transduction
signal transduction involving
transduction involving the
involving the Jak/Stat
the Jak/Stat pathway
Jak/Stat pathway in
pathway in CD4+
in CD4+ T-cell
CD4+ T-cell lines
Constitutive NF-kappa B
NF-kappa B activation
B activation enhanced
activation enhanced granulopoiesis
enhanced granulopoiesis and
granulopoiesis and neonatal
and neonatal lethality
neonatal lethality in
lethality in I
in I kappa
I kappa B
kappa B alpha-deficient
B alpha-deficient mice
Transcription factors belonging
factors belonging to
belonging to the
to the NF-kappa
the NF-kappa B
NF-kappa B family
B family are
family are controlled
are controlled by
controlled by inhibitory
by inhibitory I
inhibitory I kappa
I kappa B
kappa B proteins
B proteins mainly
proteins mainly I
mainly I kappa
I kappa B
kappa B alpha
B alpha and
alpha and I
and I kappa
I kappa B
kappa B beta
Apparently normal at
normal at birth
at birth I
birth I kappa
I kappa B
kappa B alpha-/-
B alpha-/- mice
alpha-/- mice exhibit
mice exhibit severe
exhibit severe runting
severe runting skin
runting skin defects
skin defects and
defects and extensive
and extensive granulopoiesis
extensive granulopoiesis postnatally
granulopoiesis postnatally typically
postnatally typically dying
typically dying by
dying by 8
by 8 days
Hematopoietic tissues from
tissues from these
from these mice
these mice display
mice display elevated
display elevated levels
elevated levels of
levels of both
of both nuclear
both nuclear NF-kappa
nuclear NF-kappa B
NF-kappa B and
B and mRNAs
and mRNAs of
mRNAs of some
of some but
some but not
but not all
not all genes
all genes thought
genes thought to
thought to be
to be regulated
be regulated by
regulated by NF-kappa
by NF-kappa B
NF-kappa B elevation
B elevation results
elevation results in
results in these
in these phenotypic
these phenotypic abnormalities
phenotypic abnormalities because
abnormalities because mice
because mice lacking
mice lacking both
lacking both I
both I kappa
I kappa B
kappa B alpha
B alpha and
alpha and the
and the p50
the p50 subunit
p50 subunit of
subunit of NF-kappa
of NF-kappa B
NF-kappa B show
B show a
show a dramatically
a dramatically delayed
dramatically delayed onset
delayed onset of
onset of abnormalities
In contrast to
contrast to hematopoietic
to hematopoietic cells
hematopoietic cells I
cells I kappa
I kappa B
kappa B alpha-/-
B alpha-/- embryonic
alpha-/- embryonic fibroblasts
embryonic fibroblasts show
fibroblasts show minimal
show minimal constitutive
minimal constitutive NF-kappa
constitutive NF-kappa B
NF-kappa B as
B as well
as well as
well as normal
as normal signal-dependent
normal signal-dependent NF-kappa
signal-dependent NF-kappa B
NF-kappa B activation
B activation that
activation that is
that is concomitant
is concomitant with
concomitant with I
with I kappa
I kappa B
kappa B beta
B beta degradation
Our results indicate
results indicate that
indicate that I
that I kappa
I kappa b
kappa b beta
b beta but
beta but not
but not I
not I kappa
I kappa B
kappa B alpha
B alpha is
alpha is required
is required for
required for the
for the signal-dependent
the signal-dependent activation
signal-dependent activation of
activation of NF-kappa
of NF-kappa B
NF-kappa B in
B in fibroblasts
However I kappa
I kappa B
kappa B alpha
B alpha is
alpha is required
is required for
required for the
for the postinduction
the postinduction repression
postinduction repression of
repression of NF-kappa
of NF-kappa B
NF-kappa B in
B in fibroblasts
These results define
results define distinct
define distinct roles
distinct roles for
roles for the
for the two
the two forms
two forms of
forms of I
of I kappa
I kappa B
kappa B and
B and demonstrate
and demonstrate the
demonstrate the necessity
the necessity for
necessity for stringent
for stringent control
stringent control of
control of NF-kappa
of NF-kappa B
Interleukin-7 can induce
can induce the
induce the activation
the activation of
activation of Jak
of Jak 1
Jak 1 Jak
1 Jak 3
Jak 3 and
3 and STAT
and STAT 5
STAT 5 proteins
5 proteins in
proteins in murine
in murine T
murine T cells
The activation of
activation of Janus
of Janus protein
Janus protein tyrosine
protein tyrosine kinases
tyrosine kinases Jak
kinases Jak and
Jak and STAT
and STAT signal
STAT signal transducer
signal transducer and
transducer and activator
and activator of
activator of transcription
of transcription proteins
transcription proteins has
proteins has recently
has recently been
recently been linked
been linked to
linked to the
to the signal
the signal transduction
signal transduction mechanism
transduction mechanism of
mechanism of several
of several cytokines
IL-7 was observed
was observed to
observed to induce
to induce a
induce a rapid
a rapid and
rapid and dose-dependent
and dose-dependent tyrosine
dose-dependent tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of Jak
of Jak 1
Jak 1 and
1 and Jak
and Jak 3
Jak 3 and
3 and concomitantly
and concomitantly the
concomitantly the tyrosine
the tyrosine phosphorylation
tyrosine phosphorylation and
phosphorylation and DNA
and DNA binding
DNA binding activity
binding activity of
activity of multiple
of multiple STAT
multiple STAT proteins
The STAT proteins
STAT proteins utilized
proteins utilized by
utilized by IL-7
by IL-7 were
IL-7 were identical
were identical to
identical to those
to those induced
those induced by
induced by IL-2
by IL-2 and
IL-2 and could
and could be
could be identified
be identified as
identified as various
as various STAT
various STAT 5
STAT 5 isoforms
Moreover the induction
the induction of
induction of both
of both Jak
both Jak 1
Jak 1 and
1 and 3
and 3 and
3 and STAT
and STAT 5
STAT 5 activity
5 activity strongly
activity strongly correlated
strongly correlated with
correlated with the
with the growth-promoting
the growth-promoting effects
growth-promoting effects of
effects of IL-7
of IL-7 suggesting
IL-7 suggesting that
suggesting that this
that this signal
this signal transduction
signal transduction mechanism
transduction mechanism may
mechanism may play
may play a
play a key
a key role
key role in
role in IL-7-induced
in IL-7-induced proliferation
Cytokine-modulating activity of
activity of tepoxalin
of tepoxalin a
tepoxalin a new
a new potential
new potential antirheumatic
Tepoxalin is a
is a new
a new dual
new dual cyclooxygenase/5-lipoxygenase
dual cyclooxygenase/5-lipoxygenase anti-inflammatory
cyclooxygenase/5-lipoxygenase anti-inflammatory compound
anti-inflammatory compound currently
compound currently under
currently under clinical
under clinical investigation
It has been
has been shown
been shown to
shown to possess
to possess anti-inflammatory
possess anti-inflammatory activity
anti-inflammatory activity in
activity in a
in a variety
a variety of
variety of animal
of animal models
animal models and
models and more
and more recently
more recently to
recently to inhibit
to inhibit IL-2
inhibit IL-2 induced
IL-2 induced signal
induced signal transduction
The current study
current study was
study was conducted
was conducted to
conducted to evaluate
to evaluate the
evaluate the cytokine
the cytokine modulating
cytokine modulating activity
modulating activity of
activity of tepoxalin
of tepoxalin and
tepoxalin and the
and the role
the role of
role of iron
of iron in
iron in these
in these effects
In human peripheral
human peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells PBMC
cells PBMC stimulated
PBMC stimulated with
stimulated with OKT3/PMA
with OKT3/PMA tepoxalin
OKT3/PMA tepoxalin inhibited
tepoxalin inhibited lymphocyte
inhibited lymphocyte proliferation
lymphocyte proliferation with
proliferation with an
with an IC50
an IC50 of
IC50 of 6
of 6 microM
Additionally it inhibited
it inhibited the
inhibited the production
the production of
production of LTB4
of LTB4 IC50
LTB4 IC50 =
IC50 = 05
= 05 microM
05 microM and
microM and the
and the cytokines
the cytokines IL-2
cytokines IL-2 IL-6
IL-2 IL-6 and
IL-6 and TNF
and TNF alpha
TNF alpha IC50
alpha IC50 =
IC50 = 10-12
= 10-12 microM
Cytotoxicity was not
was not demonstrated
not demonstrated at
demonstrated at these
at these concentrations
Add-back experiments with
experiments with either
with either cytokines
either cytokines IL-2
cytokines IL-2 or
IL-2 or IL-6
or IL-6 LTB4
IL-6 LTB4 or
LTB4 or conditioned
or conditioned media
conditioned media failed
media failed to
failed to restore
to restore the
restore the proliferative
the proliferative response
proliferative response in
response in the
in the presence
the presence of
presence of tepoxalin
However the concurrent
the concurrent addition
concurrent addition of
addition of iron
of iron in
iron in the
in the form
the form of
form of ferrous
of ferrous or
ferrous or ferric
or ferric chloride
ferric chloride and
chloride and other
and other iron
other iron salts
iron salts reversed
salts reversed the
reversed the inhibition
the inhibition of
inhibition of proliferation
of proliferation caused
proliferation caused by
caused by tepoxalin
Tepoxalin also inhibits
also inhibits the
inhibits the activation
the activation of
activation of NF
of NF kappa
NF kappa B
kappa B a
B a transcription
a transcription factor
transcription factor which
factor which acts
which acts on
acts on several
on several cytokine
several cytokine genes
Tepoxalin's effect on
effect on NF
on NF kappa
NF kappa B
kappa B is
B is also
is also reversed
also reversed by
reversed by the
by the addition
the addition of
addition of iron
of iron salts
These data suggest
data suggest that
suggest that the
that the action
the action of
action of tepoxalin
of tepoxalin to
tepoxalin to inhibit
to inhibit proliferation
inhibit proliferation in
proliferation in PBMC
in PBMC may
PBMC may be
may be at
be at least
at least in
least in part
in part due
part due to
due to its
to its ability
its ability to
ability to reduce
to reduce the
reduce the amount
the amount of
amount of available
of available iron
available iron resulting
iron resulting in
resulting in decreased
in decreased activation
decreased activation of
activation of NF
of NF kappa
NF kappa B
kappa B and
B and subsequent
and subsequent inhibition
subsequent inhibition of
inhibition of cytokine
of cytokine production
N- and C-terminal
and C-terminal sequences
C-terminal sequences control
sequences control degradation
control degradation of
degradation of MAD3/I
of MAD3/I kappa
MAD3/I kappa B
kappa B alpha
B alpha in
alpha in response
in response to
response to inducers
to inducers of
inducers of NF-kappa
of NF-kappa B
NF-kappa B activity
The proteolytic degradation
proteolytic degradation of
degradation of the
of the inhibitory
the inhibitory protein
inhibitory protein MAD3/I
protein MAD3/I kappa
MAD3/I kappa B
kappa B alpha
B alpha in
alpha in response
in response to
response to extracellular
to extracellular stimulation
extracellular stimulation is
stimulation is a
is a prerequisite
a prerequisite step
prerequisite step in
step in the
in the activation
the activation of
activation of the
of the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
Analysis of the
of the expression
the expression of
expression of human
of human I
human I kappa
I kappa B
kappa B alpha
B alpha protein
alpha protein in
protein in stable
in stable transfectants
stable transfectants of
transfectants of mouse
of mouse 70Z/3
mouse 70Z/3 cells
70Z/3 cells shows
cells shows that
shows that as
that as for
as for the
for the endogenous
the endogenous murine
endogenous murine protein
murine protein exogenous
protein exogenous I
exogenous I kappa
I kappa B
kappa B alpha
B alpha is
alpha is degraded
is degraded in
degraded in response
in response to
response to inducers
to inducers of
inducers of NF-kappa
of NF-kappa B
NF-kappa B activity
B activity such
activity such as
such as phorbol
as phorbol myristate
phorbol myristate acetate
myristate acetate or
acetate or lipopolysaccharide
In addition pretreatment
addition pretreatment of
pretreatment of the
of the cells
the cells with
cells with the
with the proteasome
the proteasome inhibitor
proteasome inhibitor N-Ac-Leu-Leu-norleucinal
inhibitor N-Ac-Leu-Leu-norleucinal inhibits
N-Ac-Leu-Leu-norleucinal inhibits this
inhibits this ligand-induced
this ligand-induced degradation
ligand-induced degradation and
degradation and in
and in agreement
in agreement with
agreement with previous
with previous studies
previous studies stabilizes
studies stabilizes a
stabilizes a hyperphosphorylated
a hyperphosphorylated form
hyperphosphorylated form of
form of the
of the human
the human I
human I kappa
I kappa B
kappa B alpha
B alpha protein
By expressing mutant
expressing mutant forms
mutant forms of
forms of the
of the human
the human protein
human protein in
protein in this
in this cell
this cell line
cell line we
line we have
we have been
have been able
been able to
able to delineate
to delineate the
delineate the sequences
the sequences responsible
sequences responsible for
responsible for both
for both the
both the ligand-induced
the ligand-induced phosphorylation
ligand-induced phosphorylation and
phosphorylation and the
and the degradation
the degradation of
degradation of I
of I kappa
I kappa B
kappa B alpha
Our results show
results show that
show that deletion
that deletion of
deletion of the
of the C
the C terminus
C terminus of
terminus of the
of the I
the I kappa
I kappa B
kappa B alpha
B alpha molecule
alpha molecule up
molecule up to
up to amino
to amino acid
amino acid 279
acid 279 abolishes
279 abolishes constitutive
abolishes constitutive but
constitutive but not
but not ligand-inducible
not ligand-inducible phosphorylation
ligand-inducible phosphorylation and
phosphorylation and inhibits
and inhibits ligand-inducible
inhibits ligand-inducible degradation
Further analysis reveals
analysis reveals that
reveals that the
that the inducible
the inducible phosphorylation
inducible phosphorylation of
phosphorylation of I
of I kappa
I kappa B
kappa B alpha
B alpha maps
alpha maps to
maps to two
to two serines
two serines in
serines in the
in the N
the N terminus
N terminus of
terminus of the
of the protein
the protein residues
protein residues 32
residues 32 and
32 and 36
and 36 and
36 and that
and that the
that the mutation
the mutation of
mutation of either
of either residue
either residue is
residue is sufficient
is sufficient to
sufficient to abolish
to abolish ligand-induced
abolish ligand-induced degradation
ligand-induced degradation whereas
degradation whereas both
whereas both residues
both residues must
residues must be
must be mutated
be mutated to
mutated to abolish
to abolish inducible
abolish inducible phosphorylation
inducible phosphorylation of
phosphorylation of the
of the protein
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Microtubules mediate cellular
mediate cellular 25-hydroxyvitamin
cellular 25-hydroxyvitamin D3
25-hydroxyvitamin D3 trafficking
D3 trafficking and
trafficking and the
and the genomic
the genomic response
genomic response to
response to 125-dihydroxyvitamin
to 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 in
D3 in normal
in normal human
normal human monocytes
The genomic actions
genomic actions of
actions of 125-dihydroxyvitamin
of 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 125OH2D3
D3 125OH2D3 are
125OH2D3 are mediated
are mediated by
mediated by the
by the intracellular
the intracellular vitamin
intracellular vitamin D
vitamin D receptor
D receptor VDR
Although immunocytochemistry has
immunocytochemistry has shown
has shown that
shown that disruption
that disruption of
disruption of microtubular
of microtubular assembly
microtubular assembly prevents
assembly prevents nuclear
prevents nuclear access
nuclear access of
access of the
of the sterol-VDR
the sterol-VDR complex
sterol-VDR complex the
complex the role
the role of
role of microtubules
of microtubules in
microtubules in the
in the response
the response to
response to 125OH2D3
to 125OH2D3 has
125OH2D3 has not
has not been
not been studied
been studied in
studied in viable
in viable cells
Our studies examined
studies examined this
examined this interaction
this interaction in
interaction in normal
in normal human
normal human monocytes
Monocytes convert 25OHD3
convert 25OHD3 to
25OHD3 to 125OH2D3
to 125OH2D3 and
125OH2D3 and to
and to 24-hydroxylated
to 24-hydroxylated metabolites
24-hydroxylated metabolites more
metabolites more polar
more polar than
polar than 125OH2D3
Microtubule disruption totally
disruption totally abolished
totally abolished the
abolished the ability
the ability of
ability of exogenous
of exogenous 125OH2D3
exogenous 125OH2D3 to
125OH2D3 to suppress
to suppress its
suppress its own
its own synthesis
own synthesis and
synthesis and to
and to induce
to induce 24-hydroxylase
induce 24-hydroxylase mRNA
24-hydroxylase mRNA and
mRNA and activity
and activity without
activity without affecting
without affecting either
affecting either total
either total 125OH2D3
total 125OH2D3 uptake
125OH2D3 uptake or
uptake or maximal
or maximal 125OH2D3-VDR
maximal 125OH2D3-VDR binding
Thus intact microtubules
intact microtubules are
microtubules are essential
are essential for
essential for 125OH2D3-dependent
for 125OH2D3-dependent modulation
125OH2D3-dependent modulation of
modulation of gene
of gene transcription
Interestingly microtubule disruption
microtubule disruption also
disruption also decreased
also decreased monocyte
decreased monocyte 125OH2D3
monocyte 125OH2D3 synthesis
125OH2D3 synthesis not
synthesis not by
not by decreasing
by decreasing the
decreasing the Vmax
the Vmax of
Vmax of monocyte
of monocyte mitochondrial
monocyte mitochondrial 1
mitochondrial 1 alpha-hydroxylase
1 alpha-hydroxylase but
alpha-hydroxylase but through
but through an
through an increase
an increase in
increase in the
in the Km
the Km for
Km for 25OH2D3
We examined 25OHD3
examined 25OHD3 transport
Microtubule disruption did
disruption did not
did not affect
not affect total
affect total cellular
total cellular 25OHD3
cellular 25OHD3 uptake
25OHD3 uptake but
uptake but reduced
but reduced its
reduced its intracellular
its intracellular trafficking
intracellular trafficking to
trafficking to the
to the mitochondria
Thus microtubules participate
microtubules participate in
participate in intracellular
in intracellular 25OHD3
intracellular 25OHD3 transport
25OHD3 transport and
transport and their
and their integrity
their integrity determines
integrity determines normal
determines normal 125OH2D3
normal 125OH2D3 synthesis
Relationship between Rap1
between Rap1 protein
Rap1 protein phosphorylation
protein phosphorylation and
phosphorylation and regulation
and regulation of
regulation of Ca2+
of Ca2+ transport
Ca2+ transport in
transport in platelets:
in platelets: a
platelets: a new
a new approach
Although the interrelationship
the interrelationship between
interrelationship between the
between the two
the two messengers
two messengers Ca2+
messengers Ca2+ and
Ca2+ and cyclic
and cyclic AMP
cyclic AMP in
AMP in platelet
in platelet function
platelet function is
function is well
is well documented
well documented its
documented its mechanism
its mechanism of
mechanism of action
of action still
action still remains
still remains to
remains to be
to be established
We investigated here
investigated here the
here the question
the question of
question of the
of the regulation
the regulation of
regulation of platelet
of platelet Ca2+-ATPases
platelet Ca2+-ATPases by
Ca2+-ATPases by cyclic
by cyclic AMP
cyclic AMP through
AMP through the
through the phosphorylation
the phosphorylation of
phosphorylation of the
of the Rap1
the Rap1 protein
Rap1 protein using
protein using a
using a pathological
a pathological model
We first found
first found experimental
found experimental conditions
experimental conditions where
conditions where Ca2+-transport
where Ca2+-transport by
Ca2+-transport by platelet
by platelet membrane
platelet membrane vesicles
membrane vesicles appeared
vesicles appeared to
appeared to be
to be dependent
be dependent on
dependent on the
on the phosphorylation
the phosphorylation of
phosphorylation of the
of the Rap1
the Rap1 protein
Then we studied
we studied platelets
studied platelets of
platelets of patients
of patients with
patients with congestive
with congestive heart
congestive heart failure
heart failure for
failure for their
for their expression
their expression of
expression of the
of the potential
the potential 97
potential 97 kDa
97 kDa Ca2+-ATPase
kDa Ca2+-ATPase target
Ca2+-ATPase target of
target of regulation
of regulation through
regulation through the
through the Rap1
the Rap1 protein
Rap1 protein as
protein as well
as well as
well as the
as the phosphorylation
the phosphorylation of
phosphorylation of the
of the Rap1
the Rap1 protein
Rap1 protein using
protein using the
using the catalytic
the catalytic subunit
catalytic subunit of
subunit of the
of the cyclic
the cyclic AMP-dependent
cyclic AMP-dependent protein
AMP-dependent protein kinase
protein kinase C
kinase C Sub
In the first
the first patients
first patients studied
patients studied we
studied we found
we found no
found no significant
no significant modification
significant modification in
modification in the
in the expression
the expression of
expression of the
of the 97
the 97 kDa
97 kDa Ca2+-ATPase
kDa Ca2+-ATPase by
Ca2+-ATPase by Western
by Western blotting
Western blotting using
blotting using the
using the PL/IM
the PL/IM 430
PL/IM 430 monoclonal
430 monoclonal antibody
monoclonal antibody which
antibody which specifically
which specifically recognized
specifically recognized this
recognized this isoform
In contrast the
contrast the Rap1
the Rap1 protein
Rap1 protein was
protein was differentially
was differentially phosphorylated
differentially phosphorylated when
phosphorylated when using
when using 15
using 15 micrograms/ml
15 micrograms/ml of
micrograms/ml of the
of the C
the C Sub
These results allowed
results allowed us
allowed us to
us to use
to use these
use these pathological
these pathological platelets
pathological platelets to
platelets to study
to study the
study the relationship
the relationship between
relationship between the
between the expression
the expression of
expression of Rap1
of Rap1 protein
Rap1 protein and
protein and the
and the regulation
the regulation of
regulation of Ca2+
of Ca2+ transport
Ca2+ transport by
transport by selecting
by selecting a
selecting a patient
a patient with
patient with severe
with severe heart
severe heart failure
We could show
could show a
show a decrease
a decrease in
decrease in the
in the expression
the expression as
expression as well
as well as
well as in
as in the
in the phosphorylation
the phosphorylation of
phosphorylation of Rap1
of Rap1 protein
Rap1 protein and
protein and demonstrate
and demonstrate a
demonstrate a lower
a lower effect
lower effect of
effect of C
of C Sub
C Sub on
Sub on Ca2+
on Ca2+ transport
Finally by studying
by studying a
studying a further
a further series
further series of
series of patients
of patients we
patients we could
we could confirm
could confirm that
confirm that the
that the decrease
the decrease in
decrease in Rap1
in Rap1 protein
Rap1 protein expression
protein expression in
expression in heart
in heart failure
heart failure whatever
failure whatever its
whatever its extent
its extent was
extent was variable
was variable and
variable and could
and could strictly
could strictly correlate
strictly correlate the
correlate the expression
the expression of
expression of Rap1
of Rap1 protein
Rap1 protein with
protein with the
with the stimulatory
the stimulatory effect
stimulatory effect of
effect of C
of C Sub
C Sub on
Sub on Ca2+
on Ca2+ transport
Besides the evidence
the evidence for
evidence for regulation
for regulation of
regulation of the
of the expression
the expression of
expression of the
of the Rap1
the Rap1 protein
Rap1 protein in
protein in platelets
in platelets from
platelets from patients
from patients with
patients with heart
with heart failure
heart failure these
failure these findings
these findings constitute
findings constitute a
constitute a new
a new approach
new approach in
approach in favour
in favour of
favour of the
of the regulation
the regulation of
regulation of platelet
of platelet Ca2+
platelet Ca2+ transport
Ca2+ transport through
transport through the
through the phosphorylation
the phosphorylation of
phosphorylation of the
of the Rap1
the Rap1 protein
An IRF-1-dependent pathway
IRF-1-dependent pathway of
pathway of DNA
of DNA damage-induced
DNA damage-induced apoptosis
damage-induced apoptosis in
apoptosis in mitogen-activated
in mitogen-activated T
mitogen-activated T lymphocytes
Lymphocytes are particularly
are particularly susceptible
particularly susceptible to
susceptible to DNA
to DNA damage-induced
DNA damage-induced apoptosis
damage-induced apoptosis a
apoptosis a response
a response which
response which may
which may serve
may serve as
serve as a
as a form
a form of
form of 'altruistic
of 'altruistic suicide'
'altruistic suicide' to
suicide' to counter
to counter their
counter their intrinsic
their intrinsic high
intrinsic high potential
high potential for
potential for mutation
for mutation and
mutation and clonal
and clonal expansion
The tumour suppressor
tumour suppressor p53
suppressor p53 has
p53 has been
has been shown
been shown to
shown to regulate
to regulate this
regulate this type
this type of
type of apoptosis
of apoptosis in
apoptosis in thymocytes
in thymocytes but
thymocytes but an
but an as
an as yet
as yet unknown
yet unknown p53-independent
unknown p53-independent pathways
p53-independent pathways appears
pathways appears to
appears to mediate
to mediate the
mediate the same
the same event
same event in
event in mitogen-activated
in mitogen-activated mature
mitogen-activated mature T
mature T lymphocytes
Here we show
we show DNA
show DNA damage-induced
DNA damage-induced apoptosis
damage-induced apoptosis in
apoptosis in these
in these T
these T lymphocytes
T lymphocytes is
lymphocytes is dependent
is dependent on
dependent on the
on the antioncogenic
the antioncogenic transcription
antioncogenic transcription factor
transcription factor interferon
factor interferon regulatory
interferon regulatory factor
regulatory factor IRF-1
Thus two different
two different anti-onco-genic
different anti-onco-genic transcription
anti-onco-genic transcription factors
transcription factors p53
factors p53 and
p53 and IRF-1
and IRF-1 are
IRF-1 are required
are required for
required for distinct
for distinct apoptotic
distinct apoptotic pathways
apoptotic pathways in
pathways in T
in T lymphocytes
We also show
also show that
show that mitogen
that mitogen induction
mitogen induction of
induction of the
of the interleukin-1
the interleukin-1 beta
interleukin-1 beta converting
beta converting enzyme
converting enzyme ICE
enzyme ICE gene
ICE gene a
gene a mammalian
a mammalian homologue
mammalian homologue of
homologue of the
of the Caenorhabditis
the Caenorhabditis elegans
Caenorhabditis elegans cell
elegans cell death
cell death gene
death gene ced-3
gene ced-3 is
ced-3 is IRF-1-dependent
Ectopic overexpression of
overexpression of IRF-1
of IRF-1 results
IRF-1 results in
results in the
in the activation
the activation of
activation of the
of the endogenous
the endogenous gene
endogenous gene for
gene for ICE
for ICE and
ICE and enhances
and enhances the
enhances the sensitivity
the sensitivity of
sensitivity of cells
of cells to
cells to radiation-induced
to radiation-induced apoptosis
Circadian rhythm of
rhythm of glucocorticoid
of glucocorticoid receptors
glucocorticoid receptors in
receptors in human
in human peripheral
human peripheral leukocytes
peripheral leukocytes and
leukocytes and their
and their reactivity
their reactivity to
reactivity to glucocorticoids
1 There exists
There exists a
exists a CR
a CR of
CR of GR
of GR in
GR in human
in human leukocytes
human leukocytes PMN
leukocytes PMN and
PMN and monocytes
and monocytes with
monocytes with the
with the peak
the peak values
peak values from
values from 0400
from 0400 to
0400 to 0800
to 0800 hr
0800 hr and
hr and the
and the trough
the trough values
trough values between
values between 2300
between 2300 and
2300 and 0000
and 0000 hr
The difference between
difference between them
between them was
them was significant
was significant statistically
2 The FI
The FI of
FI of the
of the chemotactic
the chemotactic migration
chemotactic migration rate
migration rate of
rate of PMN
of PMN by
PMN by cortisol
by cortisol also
cortisol also showed
also showed diurnal
showed diurnal changes
diurnal changes which
changes which were
which were synchronous
were synchronous with
synchronous with that
with that of
that of GR
This indicates that
indicates that the
that the CR
the CR of
CR of GR
of GR may
GR may be
may be of
be of functional
of functional significance
3 In Cushing's
In Cushing's syndrome
Cushing's syndrome the
syndrome the CR
the CR of
CR of GR
of GR was
GR was normal
was normal in
normal in spite
in spite of
spite of the
of the fact
the fact that
fact that the
that the CR
the CR of
CR of plasma
of plasma cortisol
plasma cortisol was
cortisol was disturbed
This indicates the
indicates the independency
the independency of
independency of the
of the CR
the CR of
CR of GR
of GR from
GR from that
from that of
that of cortisol
4 In apoplexy
In apoplexy caused
apoplexy caused by
caused by brain
by brain ischemia
brain ischemia the
ischemia the CR
the CR of
CR of GR
of GR was
GR was abolished
was abolished in
abolished in patients
in patients with
patients with basal
with basal lesions
basal lesions but
lesions but preserved
but preserved when
preserved when the
when the lesions
the lesions were
lesions were located
were located in
located in the
in the cerebral
the cerebral cortex
These results strongly
results strongly suggest
strongly suggest that
suggest that the
that the main
the main "circadian
main "circadian pacemaker"
"circadian pacemaker" of
pacemaker" of GR
of GR is
GR is located
is located in
located in the
in the basal
the basal brain
basal brain most
brain most probably
most probably in
probably in the
in the suprachiasmatic
the suprachiasmatic nuclei
suprachiasmatic nuclei as
nuclei as has
as has been
has been suggested
been suggested for
suggested for rodents
B-lymphoblastoid cell lines
cell lines from
lines from multiple
from multiple sclerosis
multiple sclerosis patients
sclerosis patients and
patients and a
and a healthy
a healthy control
healthy control producing
control producing a
producing a putative
a putative new
putative new human
new human retrovirus
human retrovirus and
retrovirus and Epstein-Barr
and Epstein-Barr virus
On several occasions
several occasions we
occasions we have
we have observed
have observed retrovirus-like
observed retrovirus-like particles
retrovirus-like particles RVLPs
particles RVLPs by
RVLPs by transmission
by transmission electron
transmission electron microscopy
electron microscopy EM
microscopy EM of
EM of cultured
of cultured T
cultured T cells
T cells from
cells from a
from a patient
a patient with
patient with MS
Later we established
we established spontaneously
established spontaneously formed
spontaneously formed B-lymphoblastoid
formed B-lymphoblastoid cell
B-lymphoblastoid cell lines
cell lines LCLs
lines LCLs from
LCLs from a
from a patient
a patient with
patient with an
with an MS-like
an MS-like disease
MS-like disease and
disease and from
and from another
from another patient
another patient with
patient with MS
with MS who
MS who had
who had a
had a reactivated
a reactivated Epstein-Barr
reactivated Epstein-Barr virus
Epstein-Barr virus EBV
virus EBV infection
Both LCLs were
LCLs were found
were found by
found by EM
by EM to
EM to produce
to produce RVLP
produce RVLP and
RVLP and EBV
and EBV particles
Reverse transcriptase RT
transcriptase RT assays
RT assays were
assays were positive
were positive in
positive in purified
in purified viral
purified viral material
viral material from
material from both
from both LCLs
To substantiate these
substantiate these findings
these findings we
findings we initiated
we initiated an
initiated an intensified
an intensified culturing
intensified culturing procedure
culturing procedure and
procedure and were
and were able
were able to
able to establish
to establish LCLs
establish LCLs from
LCLs from 5
from 5 out
5 out of
out of 21
of 21 consecutive
21 consecutive MS
consecutive MS patients
MS patients and
patients and 1
and 1 out
1 out of
out of 13
of 13 consecutive
13 consecutive healthy
consecutive healthy controls
All LCLs were
LCLs were found
were found to
found to produce
to produce both
produce both RVLP
both RVLP and
RVLP and EBV
and EBV particles
EBV particles by
particles by EM
Whether the putative
the putative new
putative new retroviruses
new retroviruses and
retroviruses and EBV
and EBV have
EBV have any
have any causal
any causal relationship
causal relationship to
relationship to MS
to MS is
MS is still
is still not
still not known
not known but
known but the
but the findings
the findings support
findings support this
support this possibility
Identification of an
of an ionomycin/cyclosporin
an ionomycin/cyclosporin A-responsive
ionomycin/cyclosporin A-responsive element
A-responsive element within
element within the
within the human
the human T
human T cell
T cell receptor
cell receptor gamma
receptor gamma enhancer
Activation through the
through the Ca2+/calcineurin
the Ca2+/calcineurin pathway
Ca2+/calcineurin pathway is
pathway is essential
is essential to
essential to the
to the transcription
the transcription of
transcription of many
of many cytokine
many cytokine genes
The conserved cis-acting
conserved cis-acting sequence
cis-acting sequence GGAAAA
sequence GGAAAA and
GGAAAA and transcription
and transcription factors
transcription factors binding
factors binding to
binding to this
to this sequence
this sequence are
sequence are involved
are involved in
involved in the
in the response
the response to
response to increased
to increased intracellular
increased intracellular Ca2+
intracellular Ca2+ concentrations
Here we report
we report the
report the identification
the identification and
identification and importance
and importance of
importance of the
of the same
the same sequence
same sequence in
sequence in a
in a non-cytokine
a non-cytokine gene
non-cytokine gene the
gene the human
the human T
human T cell
T cell receptor
cell receptor gamma
receptor gamma TCRG
gamma TCRG enhancer
Results from site-directed
from site-directed mutations
site-directed mutations and
mutations and electrophoretic
and electrophoretic mobility
electrophoretic mobility shift
mobility shift assays
shift assays strongly
assays strongly suggest
strongly suggest that
suggest that this
that this sequence
this sequence mediates
sequence mediates the
mediates the ionomycin-induced
the ionomycin-induced activation
ionomycin-induced activation of
activation of the
of the TCRG
the TCRG enhancer
Our studies provide
studies provide an
provide an explanation
an explanation for
explanation for a
for a previous
a previous observation
previous observation that
observation that TCRG
that TCRG mRNA
TCRG mRNA levels
mRNA levels but
levels but not
but not mRNA
not mRNA levels
mRNA levels for
levels for T
for T cell
T cell receptor
cell receptor alpha
receptor alpha and
alpha and -beta
and -beta are
-beta are increased
are increased by
increased by ionomycin
by ionomycin treatment
Coexpression of NF-kappa
of NF-kappa B/Rel
NF-kappa B/Rel and
B/Rel and Sp1
and Sp1 transcription
Sp1 transcription factors
transcription factors in
factors in human
in human immunodeficiency
human immunodeficiency virus
immunodeficiency virus 1-induced
virus 1-induced dendritic
1-induced dendritic cell-T-cell
dendritic cell-T-cell syncytia
Productive infection of
infection of T
of T cells
T cells with
cells with human
with human immunodeficiency
human immunodeficiency virus
immunodeficiency virus 1
virus 1 HIV-1
1 HIV-1 typically
HIV-1 typically requires
typically requires that
requires that the
that the T
the T cells
T cells be
cells be stimulated
be stimulated with
stimulated with antigens
with antigens or
antigens or mitogens
This requirement has
requirement has been
has been attributed
been attributed to
attributed to the
to the activation
the activation of
activation of the
of the transcription
the transcription factor
transcription factor NF-kappa
factor NF-kappa B
NF-kappa B which
B which synergizes
which synergizes with
synergizes with the
with the constitutive
the constitutive transcription
constitutive transcription factor
transcription factor Sp1
factor Sp1 to
Sp1 to drive
to drive the
drive the HIV-1
the HIV-1 promoter
Recently we have
we have found
have found that
found that vigorous
that vigorous replication
vigorous replication of
replication of HIV-1
of HIV-1 takes
HIV-1 takes place
takes place in
place in nonactivated
in nonactivated memory
nonactivated memory T
memory T cells
T cells after
cells after syncytium
after syncytium formation
syncytium formation with
formation with dendritic
with dendritic cells
dendritic cells DCs
These syncytia lack
syncytia lack activated
lack activated cells
activated cells as
cells as determined
as determined by
determined by an
by an absence
an absence of
absence of staining
of staining for
staining for Ki-67
for Ki-67 cell
Ki-67 cell cycle
cell cycle antigen
The expression and
expression and activity
and activity of
activity of NF-kappa
of NF-kappa B
NF-kappa B and
B and Sp1
and Sp1 were
Sp1 were therefore
were therefore analyzed
therefore analyzed in
analyzed in isolated
in isolated T
isolated T cells
T cells and
cells and DCs
and DCs from
DCs from humans
from humans and
humans and mice
We have used
have used immunolabeling
used immunolabeling Western
immunolabeling Western blot
Western blot analysis
blot analysis and
analysis and electrophoretic
and electrophoretic mobility
electrophoretic mobility shift
mobility shift and
shift and supershift
and supershift assays
T cells lack
cells lack active
lack active NF-kappa
active NF-kappa B
NF-kappa B but
B but express
but express Sp1
express Sp1 as
Sp1 as expected
DCs express high
express high levels
high levels of
levels of all
of all known
all known NF-kappa
known NF-kappa B
NF-kappa B and
B and Rel
and Rel proteins
Rel proteins with
proteins with activity
with activity residing
activity residing primarily
residing primarily within
primarily within RelB
within RelB p50
RelB p50 and
p50 and p65
However DCs lack
DCs lack Sp1
lack Sp1 which
Sp1 which may
which may explain
may explain the
explain the failure
the failure of
failure of HIV-1
of HIV-1 to
HIV-1 to replicate
to replicate in
replicate in purified
in purified DCs
Coexpression of NF-kappa
of NF-kappa B
NF-kappa B and
B and Sp1
and Sp1 occurs
Sp1 occurs in
occurs in the
in the heterologous
the heterologous DC-T-cell
heterologous DC-T-cell syncytia
DC-T-cell syncytia that
syncytia that are
that are induced
are induced by
induced by HIV-1
Therefore HIV-1-induced cell
HIV-1-induced cell fusion
cell fusion brings
fusion brings together
brings together factors
together factors that
factors that upregulate
that upregulate virus
upregulate virus transcription
Since DCs and
DCs and memory
and memory T
memory T cells
T cells frequently
cells frequently traffic
frequently traffic together
traffic together in
together in situ
in situ these
situ these unusual
these unusual heterologous
unusual heterologous syncytia
heterologous syncytia could
syncytia could develop
could develop in
develop in infected
in infected individuals
infected individuals and
individuals and lead
and lead to
lead to chronic
to chronic HIV-1
chronic HIV-1 replication
HIV-1 replication without
replication without ostensible
without ostensible immune
ostensible immune stimulation
Cupric ion blocks
ion blocks NF
blocks NF kappa
NF kappa B
kappa B activation
B activation through
activation through inhibiting
through inhibiting the
inhibiting the signal-induced
the signal-induced phosphorylation
signal-induced phosphorylation of
phosphorylation of I
of I kappa
I kappa B
kappa B alpha
A transcription factor
transcription factor NF
factor NF kappa
NF kappa B
kappa B which
B which regulates
which regulates expression
regulates expression of
expression of various
of various cellular
various cellular genes
cellular genes involved
genes involved in
involved in immune
in immune responses
immune responses and
responses and viral
and viral genes
viral genes including
genes including HIV
including HIV is
HIV is sequestered
is sequestered in
sequestered in the
in the cytoplasm
the cytoplasm as
cytoplasm as a
as a complex
a complex with
complex with an
with an inhibitory
an inhibitory protein
inhibitory protein I
protein I kappa
I kappa B
Various extracellular signals
extracellular signals induce
signals induce phosphorylation
induce phosphorylation and
phosphorylation and rapid
and rapid degradation
rapid degradation of
degradation of I
of I kappa
I kappa B
kappa B alpha
B alpha to
alpha to release
to release NF
release NF kappa
NF kappa B
Cu2+ was found
was found to
found to inhibit
to inhibit the
inhibit the activation
the activation of
activation of NF
of NF kappa
NF kappa B
kappa B induced
B induced by
induced by TNF-alpha
by TNF-alpha TPA
TNF-alpha TPA or
TPA or H2O2
Deoxycholate treatment of
treatment of the
of the cytoplasmic
the cytoplasmic extract
cytoplasmic extract prepared
extract prepared from
prepared from cells
from cells stimulated
cells stimulated by
stimulated by TNF-alpha
by TNF-alpha in
TNF-alpha in the
in the presence
the presence of
presence of Cu2+
of Cu2+ resulted
Cu2+ resulted in
resulted in the
in the release
the release of
release of NF
of NF kappa
NF kappa B
kappa B from
B from I
from I kappa
I kappa B
kappa B alpha
B alpha indicating
alpha indicating that
indicating that Cu2+
that Cu2+ interferes
Cu2+ interferes with
interferes with the
with the dissociation
the dissociation of
dissociation of the
of the NF
the NF kappa
NF kappa B-I
kappa B-I kappa
B-I kappa B
kappa B complex
Neither phosphorylation nor
phosphorylation nor degradation
nor degradation of
degradation of I
of I kappa
I kappa B
kappa B alpha
B alpha was
alpha was observed
was observed upon
observed upon TNF-alpha
upon TNF-alpha stimulation
TNF-alpha stimulation in
stimulation in the
in the presence
the presence of
presence of Cu2+
These results indicate
results indicate that
indicate that Cu2+
that Cu2+ inhibits
Cu2+ inhibits the
inhibits the release
the release of
release of NF
of NF kappa
NF kappa B
kappa B by
B by blockade
by blockade of
blockade of a
of a signal
a signal leading
signal leading to
leading to the
to the phosphorylation
the phosphorylation of
phosphorylation of I
of I kappa
I kappa B
kappa B alpha
Cloning a cDNA
a cDNA from
cDNA from human
from human NK/T
human NK/T cells
NK/T cells which
cells which codes
which codes for
codes for a
for a protein
a protein with
protein with high
with high proline
high proline content
A cDNA clone
cDNA clone B4-2
clone B4-2 was
B4-2 was isolated
was isolated from
isolated from a
from a natural
a natural killer
natural killer NK
killer NK minus
NK minus T
minus T cell
T cell subtractive
cell subtractive library
The B4-2 clone
B4-2 clone coded
clone coded for
coded for an
for an mRNA
an mRNA of
mRNA of 2061
of 2061 bp
2061 bp in
bp in length
It encodes a
encodes a deduced
a deduced 327
deduced 327 aa
327 aa protein
aa protein with
protein with a
with a calculated
a calculated molecular
calculated molecular mass
molecular mass of
mass of 352
of 352 kDa
Searching of B4-2
of B4-2 DNA
B4-2 DNA and
DNA and protein
and protein sequences
protein sequences against
sequences against various
against various databases
various databases revealed
databases revealed no
revealed no high
no high homology
high homology to
homology to other
to other sequences
However B4-2 has
B4-2 has an
has an unusually
an unusually high
unusually high proline
high proline content
proline content 13%
content 13% contains
13% contains a
contains a putative
a putative nuclear
putative nuclear targeting
nuclear targeting sequence
targeting sequence and
sequence and has
and has several
has several SPXX
several SPXX motifs
SPXX motifs which
motifs which are
which are frequently
are frequently found
frequently found in
found in gene
in gene regulatory
gene regulatory proteins
One of the
of the stretches
the stretches of
stretches of prolines
of prolines in
prolines in B4-2
in B4-2 closely
B4-2 closely resembles
closely resembles the
resembles the ligand
the ligand for
ligand for proteins
for proteins with
proteins with SH3
with SH3 domains
Northern hybridization data
hybridization data showed
data showed that
showed that B4-2
that B4-2 is
B4-2 is not
is not a
not a lymphoid
a lymphoid specific
lymphoid specific gene
specific gene and
gene and is
and is expressed
is expressed in
expressed in a
in a hepatoma
a hepatoma cell
hepatoma cell line
cell line and
line and also
and also weakly
also weakly transcribed
weakly transcribed or
transcribed or absent
or absent in
absent in a
in a variety
a variety of
variety of other
of other cells
A polyclonal antiserum
polyclonal antiserum raised
antiserum raised against
raised against recombinant
against recombinant B4-2
recombinant B4-2 recognizes
B4-2 recognizes a
recognizes a 32-34
a 32-34 kDa
32-34 kDa protein
kDa protein in
protein in lymphocytes
Activation of JAK3
of JAK3 but
JAK3 but not
but not JAK1
not JAK1 is
JAK1 is critical
is critical for
critical for IL-2-induced
for IL-2-induced proliferation
IL-2-induced proliferation and
proliferation and STAT5
and STAT5 recruitment
STAT5 recruitment by
recruitment by a
by a COOH-terminal
a COOH-terminal region
COOH-terminal region of
region of the
of the IL-2
the IL-2 receptor
IL-2 receptor beta-chain
A number of
number of cytokines
of cytokines and
cytokines and growth
and growth factors
growth factors use
factors use the
use the JAK-STAT
the JAK-STAT pathway
JAK-STAT pathway to
pathway to signal
to signal from
signal from the
from the cell
the cell membrane
cell membrane to
membrane to the
to the nucleus
While homodimerizing cytokine
homodimerizing cytokine receptors
cytokine receptors may
receptors may transmit
may transmit signal
transmit signal via
signal via a
via a single
a single form
single form of
form of JAK
of JAK ie
JAK ie growth
ie growth hormone
growth hormone receptors
hormone receptors several
receptors several multicomponent
several multicomponent cytokine
multicomponent cytokine receptors
cytokine receptors have
receptors have been
have been shown
been shown to
shown to require
to require simultaneous
require simultaneous activation
simultaneous activation of
activation of pairs
of pairs of
pairs of different
of different JAK
different JAK kinases
JAK kinases ie
kinases ie interferon
ie interferon receptors
Recent evidence for
evidence for a
for a preferential
a preferential coupling
preferential coupling of
coupling of JAK3
of JAK3 to
JAK3 to interleukin-2
to interleukin-2 receptor-gamma
interleukin-2 receptor-gamma IL-2R
receptor-gamma IL-2R gamma
IL-2R gamma and
gamma and JAK1
and JAK1 to
JAK1 to IL-2R
to IL-2R beta
IL-2R beta supports
beta supports the
supports the concept
the concept of
concept of heterotrans-activation
of heterotrans-activation of
heterotrans-activation of JAK1
of JAK1 and
JAK1 and JAK3
and JAK3 caused
JAK3 caused by
caused by IL-2-induced
by IL-2-induced heterodimerization
IL-2-induced heterodimerization of
heterodimerization of their
of their receptor
their receptor partners
The present study
present study verified
study verified the
verified the ability
the ability of
ability of IL-2
of IL-2 to
IL-2 to cause
to cause tyrosine
cause tyrosine phosphorylation
tyrosine phosphorylation and
phosphorylation and activation
and activation of
activation of JAK1
of JAK1 and
JAK1 and JAK3
and JAK3 but
JAK3 but demonstrated
but demonstrated that
demonstrated that IL-2
that IL-2 stimulated
IL-2 stimulated JAK3
stimulated JAK3 to
JAK3 to a
to a significantly
a significantly larger
significantly larger extent
larger extent than
extent than JAK1
than JAK1 in
JAK1 in human
in human T
human T lymphocytes
T lymphocytes and
lymphocytes and the
and the YT
the YT cell
YT cell line
This conclusion was
conclusion was based
was based upon
based upon several
upon several independent
several independent criteria
independent criteria including
criteria including more
including more vigorous
more vigorous tyrosine
vigorous tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of JAK3
of JAK3 more
JAK3 more marked
more marked enzymatic
marked enzymatic activation
enzymatic activation of
activation of JAK3
of JAK3 as
JAK3 as well
as well as
well as higher
as higher abundance
higher abundance of
abundance of JAK3
of JAK3 in
JAK3 in activated
in activated IL-2
activated IL-2 receptor
IL-2 receptor complexes
Furthermore when human
when human IL-2R
human IL-2R beta
IL-2R beta was
beta was stably
was stably expressed
stably expressed in
expressed in murine
in murine BA/F3
murine BA/F3 cells
BA/F3 cells robust
cells robust IL-2-induced
robust IL-2-induced proliferation
IL-2-induced proliferation and
proliferation and JAK3
and JAK3 activation
JAK3 activation occurred
activation occurred without
occurred without detectable
without detectable involvement
detectable involvement of
involvement of either
of either JAK1
either JAK1 JAK2
JAK1 JAK2 or
JAK2 or TYK2
We therefore propose
therefore propose that
propose that IL-2
that IL-2 receptor
IL-2 receptor signal
receptor signal transduction
signal transduction does
transduction does not
does not depend
not depend on
depend on equimolar
on equimolar heterodimerization
equimolar heterodimerization of
heterodimerization of JAK1
of JAK1 and
JAK1 and JAK3
and JAK3 following
JAK3 following IL-2-induced
following IL-2-induced heterodimerization
IL-2-induced heterodimerization of
heterodimerization of IL-2R
of IL-2R beta
IL-2R beta and
beta and IL-2R
and IL-2R gamma
Nonetheless a membrane-proximal
a membrane-proximal region
membrane-proximal region of
region of human
of human IL-2R
human IL-2R beta
IL-2R beta Asn240-Leu335
beta Asn240-Leu335 was
Asn240-Leu335 was critical
was critical for
critical for JAK3
for JAK3 activation
JAK3 activation and
activation and the
and the amount
the amount of
amount of JAK3
of JAK3 present
JAK3 present in
present in activated
in activated IL-2
activated IL-2 receptor
IL-2 receptor complexes
receptor complexes increased
complexes increased with
increased with time
with time suggesting
time suggesting that
suggesting that stabilization
that stabilization of
stabilization of JAK3
of JAK3 binding
JAK3 binding to
binding to the
to the receptor
the receptor complex
receptor complex relies
complex relies on
relies on both
on both IL-2R
both IL-2R beta
IL-2R beta and
beta and IL-2R
and IL-2R gamma
Moreover STAT5 was
STAT5 was found
was found to
found to be
to be the
be the predominant
the predominant STAT
predominant STAT transcription
STAT transcription factor
transcription factor used
factor used by
used by IL-2
by IL-2 in
IL-2 in human
in human T
human T cells
T cells and
cells and specifically
and specifically required
specifically required a
required a COOH-terminal
a COOH-terminal region
COOH-terminal region of
region of IL-2R
of IL-2R beta
IL-2R beta Ser386-Val525
beta Ser386-Val525 while
Ser386-Val525 while STAT5
while STAT5 recruitment
STAT5 recruitment was
recruitment was not
was not correlated
not correlated to
correlated to activation
to activation of
activation of IL-2R
of IL-2R gamma
IL-2R gamma or
gamma or JAK3
Up-regulation of high-affinity
of high-affinity dehydroepiandrosterone
high-affinity dehydroepiandrosterone binding
dehydroepiandrosterone binding activity
binding activity by
activity by dehydroepiandrosterone
by dehydroepiandrosterone in
dehydroepiandrosterone in activated
in activated human
activated human T
human T lymphocytes
Although evidence indicates
evidence indicates that
indicates that dehydroepiandrosterone
that dehydroepiandrosterone DHEA
dehydroepiandrosterone DHEA exerts
DHEA exerts direct
exerts direct physiological
direct physiological effects
physiological effects its
effects its mechanism
its mechanism of
mechanism of action
of action remains
action remains unknown
DHEA binding sites
binding sites were
sites were examined
were examined using
examined using a
using a whole-cell
a whole-cell binding
whole-cell binding assay
binding assay in
assay in a
in a human
a human T
human T lymphoid
T lymphoid cell
lymphoid cell line
cell line PEER
line PEER revealing
PEER revealing that
revealing that a
that a single
a single class
single class of
class of high-affinity
of high-affinity binding
high-affinity binding sites
binding sites for
sites for DHEA
for DHEA dissociation
DHEA dissociation constant
dissociation constant =
constant = 74
= 74 +/-
74 +/- 053
+/- 053 nmol/L
053 nmol/L mean
nmol/L mean +/-
mean +/- SE
+/- SE n
SE n =
n = 4
= 4 was
4 was greatly
was greatly increased
greatly increased when
increased when treated
when treated with
treated with DHEA
with DHEA phorbol-12-myristate-13-acetate
DHEA phorbol-12-myristate-13-acetate and
phorbol-12-myristate-13-acetate and the
and the Ca2+
the Ca2+ ionophore
Ca2+ ionophore A23187
Bound [3H]DHEA was
[3H]DHEA was displaced
was displaced sensitively
displaced sensitively by
sensitively by DHEA
by DHEA and
DHEA and secondarily
and secondarily by
secondarily by dihydrotestosterone
by dihydrotestosterone but
dihydrotestosterone but not
but not effectively
not effectively by
effectively by other
by other steroids
other steroids including
steroids including DHEA
including DHEA sulfate
These results not
results not only
not only indicate
only indicate the
indicate the existence
the existence of
existence of a
of a DHEA
a DHEA receptor
DHEA receptor but
receptor but also
but also suggest
also suggest that
suggest that T
that T cells
T cells become
cells become susceptible
become susceptible to
susceptible to regulation
to regulation by
regulation by DHEA
by DHEA during
DHEA during the
during the process
the process of
process of signal-induced
of signal-induced activation
Ubiquitin-mediated processing of
processing of NF-kappa
of NF-kappa B
NF-kappa B transcriptional
B transcriptional activator
transcriptional activator precursor
activator precursor p105
Reconstitution of a
of a cell-free
a cell-free system
cell-free system and
system and identification
and identification of
identification of the
of the ubiquitin-carrier
the ubiquitin-carrier protein
ubiquitin-carrier protein E2
protein E2 and
E2 and a
and a novel
a novel ubiquitin-protein
novel ubiquitin-protein ligase
ubiquitin-protein ligase E3
ligase E3 involved
E3 involved in
involved in conjugation
In most cases
most cases the
cases the transcriptional
the transcriptional factor
transcriptional factor NF-kappa
factor NF-kappa B
NF-kappa B is
B is a
is a heterodimer
a heterodimer consisting
heterodimer consisting of
consisting of two
of two subunits
two subunits p50
subunits p50 and
p50 and p65
and p65 which
p65 which are
which are encoded
are encoded by
encoded by two
by two distinct
two distinct genes
distinct genes of
genes of the
of the Rel
the Rel family
p50 is translated
is translated as
translated as a
as a precursor
a precursor of
precursor of 105
of 105 kDa
The C-terminal domain
C-terminal domain of
domain of the
of the precursor
the precursor is
precursor is rapidly
is rapidly degraded
rapidly degraded forming
degraded forming the
forming the mature
the mature p50
mature p50 subunit
p50 subunit consisted
subunit consisted of
consisted of the
of the N-terminal
the N-terminal region
N-terminal region of
region of the
of the molecule
The mechanism of
mechanism of generation
of generation of
generation of p50
of p50 is
p50 is not
is not known
It has been
has been suggested
been suggested that
suggested that the
that the ubiquitin-proteasome
the ubiquitin-proteasome system
ubiquitin-proteasome system is
system is involved
is involved in
involved in the
in the process;
the process; however
process; however the
however the specific
the specific enzymes
specific enzymes involved
enzymes involved and
involved and the
and the mechanism
the mechanism of
mechanism of limited
of limited proteolysis
limited proteolysis in
proteolysis in which
in which half
which half of
half of the
of the molecule
the molecule is
molecule is spared
is spared have
spared have been
have been obscure
Palombella and colleagues
and colleagues Palombella
colleagues Palombella VJ
Palombella VJ Rando
VJ Rando OJ
Rando OJ Goldberg
OJ Goldberg AL
Goldberg AL and
AL and Maniatis
and Maniatis T1994
Maniatis T1994 Cell
T1994 Cell 78
Cell 78 773-785
78 773-785 have
773-785 have shown
have shown that
shown that ubiquitin
that ubiquitin is
ubiquitin is required
is required for
required for the
for the processing
the processing in
processing in a
in a cell-free
a cell-free system
cell-free system of
system of a
of a truncated
a truncated artificially
truncated artificially constructed
artificially constructed 60-kDa
constructed 60-kDa precursor
They have also
have also shown
also shown that
shown that proteasome
that proteasome inhibitors
proteasome inhibitors block
inhibitors block the
block the processing
the processing both
processing both in
both in vitro
in vitro and
vitro and in
and in vivo
In this study
this study we
study we demonstrate
we demonstrate reconstitution
demonstrate reconstitution of
reconstitution of a
of a cell-free
a cell-free processing
cell-free processing system
processing system and
system and demonstrate
and demonstrate directly
demonstrate directly that:
directly that: a
that: a the
a the ubiquitin-proteasome
the ubiquitin-proteasome system
ubiquitin-proteasome system is
system is involved
is involved in
involved in processing
in processing of
processing of the
of the intact
the intact p105
intact p105 precursor
p105 precursor b
precursor b conjugation
b conjugation of
conjugation of ubiquitin
of ubiquitin to
ubiquitin to the
to the precursor
the precursor is
precursor is an
is an essential
an essential intermediate
essential intermediate step
intermediate step in
step in the
in the processing
the processing c
processing c the
c the recently
the recently discovered
recently discovered novel
discovered novel species
novel species of
species of the
of the ubiquitin-carrier
the ubiquitin-carrier protein
ubiquitin-carrier protein E2-F1
protein E2-F1 that
E2-F1 that is
that is involved
is involved in
involved in the
in the conjugation
the conjugation and
conjugation and degradation
and degradation of
degradation of p53
of p53 is
p53 is also
is also required
also required for
required for the
for the limited
the limited processing
limited processing of
processing of the
of the p105
the p105 precursor
p105 precursor and
precursor and d
and d a
d a novel
a novel approximately
novel approximately 320-kDa
approximately 320-kDa species
320-kDa species of
species of ubiquitin-protein
of ubiquitin-protein ligase
ubiquitin-protein ligase is
ligase is involved
is involved in
involved in the
in the process
This novel enzyme
novel enzyme is
enzyme is distinct
is distinct from
distinct from E6-AP
from E6-AP the
E6-AP the p53-conjugating
the p53-conjugating ligase
p53-conjugating ligase and
ligase and from
and from E3
from E3 alpha
E3 alpha the
alpha the "N-end
the "N-end rule"
"N-end rule" ligase
Flutamide in the
in the treatment
the treatment of
treatment of hirsutism:
of hirsutism: long-term
hirsutism: long-term clinical
long-term clinical effects
clinical effects endocrine
effects endocrine changes
endocrine changes and
changes and androgen
and androgen receptor
androgen receptor behavior
OBJECTIVE: To investigate
To investigate the
investigate the long-term
the long-term effects
long-term effects of
effects of treatment
of treatment with
treatment with low
with low doses
low doses of
doses of flutamide
of flutamide on
flutamide on clinical
on clinical and
clinical and hormonal
and hormonal parameters
hormonal parameters as
parameters as well
as well as
well as on
as on the
on the androgen
the androgen receptor
androgen receptor status
receptor status in
status in hirsute
in hirsute women
DESIGN: Eighteen hirsute
Eighteen hirsute patients
hirsute patients with
patients with regular
with regular menses
regular menses were
menses were studied
were studied basally
studied basally and
basally and during
and during treatment
during treatment with
treatment with 125
with 125 mg
125 mg flutamide
mg flutamide three
flutamide three times
three times per
times per day
per day for
day for 12
for 12 months
Barrier or intrauterine
or intrauterine contraception
intrauterine contraception was
contraception was used
was used during
used during the
during the study
the study in
study in sexually
in sexually active
sexually active women
Safety parameters were
parameters were assessed
were assessed throughout
assessed throughout the
throughout the study
Hirsutism graded by
graded by the
by the modified
the modified Ferriman-Gallwey
modified Ferriman-Gallwey score
Ferriman-Gallwey score and
score and hormonal
and hormonal parameters
hormonal parameters were
parameters were evaluated
were evaluated basally
evaluated basally and
basally and at
and at 4-month
at 4-month intervals
4-month intervals during
intervals during treatment
Gonadotropin-releasing hormone and
hormone and ACTH
and ACTH stimulation
ACTH stimulation tests
stimulation tests were
tests were performed
were performed before
performed before and
before and after
and after 3
after 3 to
3 to 4
to 4 months
4 months of
months of therapy
In addition the
addition the concentration
the concentration of
concentration of androgen
of androgen receptors
androgen receptors in
receptors in mononuclear
in mononuclear leukocytes
mononuclear leukocytes was
leukocytes was measured
was measured in
measured in both
in both the
both the follicular
the follicular and
follicular and luteal
and luteal phases
luteal phases of
phases of the
of the menstrual
the menstrual cycle
menstrual cycle basally
cycle basally and
basally and after
and after 4
after 4 months
4 months of
months of flutamide
of flutamide treatment
RESULTS: Flutamide was
Flutamide was well
was well tolerated
well tolerated in
tolerated in all
in all women
all women with
women with the
with the noticeable
the noticeable exception
noticeable exception of
exception of one
of one patient
one patient who
patient who presented
who presented increased
presented increased serum
increased serum transaminase
serum transaminase after
transaminase after 8
after 8 months
8 months of
months of therapy
Hirsutism markedly improved
markedly improved in
improved in all
in all women
all women during
women during the
during the treatment
the treatment Ferriman-Gallwey
treatment Ferriman-Gallwey score
Ferriman-Gallwey score after
score after 1
after 1 year:
1 year: 41
year: 41 +/-
41 +/- 05
+/- 05 versus
05 versus 141
versus 141 +/-
141 +/- 09
A reduction of
reduction of serum
of serum androgens
serum androgens was
androgens was found
was found whereas
found whereas no
whereas no change
no change was
change was observed
was observed in
observed in either
in either basal
either basal or
basal or GnRH-stimulated
or GnRH-stimulated gonadotropins
GnRH-stimulated gonadotropins or
gonadotropins or in
or in the
in the cortisol
the cortisol and
cortisol and 17
and 17 alpha-hydroxyprogesterone
17 alpha-hydroxyprogesterone response
alpha-hydroxyprogesterone response to
response to ACTH
Cycles remained ovulatory
Before treatment the
treatment the number
the number of
number of androgen
of androgen receptors
androgen receptors was
receptors was higher
was higher in
higher in the
in the luteal
the luteal than
luteal than in
than in the
in the follicular
the follicular phase
This rhythmic differentiation
rhythmic differentiation disappeared
differentiation disappeared after
disappeared after the
after the patients
the patients had
patients had been
had been given
been given the
given the antiandrogen
the antiandrogen drug
CONCLUSIONS: Flutamide is
Flutamide is effective
is effective in
effective in the
in the treatment
the treatment of
treatment of hirsutism
of hirsutism but
hirsutism but requires
but requires constant
requires constant surveillance
constant surveillance of
surveillance of liver
of liver function
Androgen receptor blockade
receptor blockade might
blockade might be
might be potentiated
be potentiated by
potentiated by a
by a reduction
a reduction of
reduction of serum
of serum androgens
Flutamide affects androgen
affects androgen receptor
androgen receptor behavior
receptor behavior during
behavior during the
during the menstrual
the menstrual cycle
The meaning of
meaning of this
of this finding
this finding remains
finding remains to
remains to be
to be elucidated
Constitutive expression of
expression of HIV-1
of HIV-1 tat
HIV-1 tat protein
tat protein in
protein in human
in human Jurkat
human Jurkat T
Jurkat T cells
T cells using
cells using a
using a BK
a BK virus
BK virus vector
The production and
production and characterization
and characterization of
characterization of Jurkat
of Jurkat cell
Jurkat cell lines
cell lines that
lines that constitutively
that constitutively express
constitutively express functional
express functional human
functional human immune
human immune deficiency
immune deficiency virus
deficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 tat
HIV-1 tat protein
tat protein using
protein using a
using a BK
a BK virus
BK virus plasmid
virus plasmid expression
plasmid expression vector
expression vector and
vector and HIV-1
and HIV-1 tat
HIV-1 tat cDNA
tat cDNA is
cDNA is described
An increased growth
increased growth rate
growth rate of
rate of these
of these Jurkat-tat
these Jurkat-tat cell
Jurkat-tat cell lines
cell lines as
lines as compared
as compared with
compared with control
with control cell
control cell lines
cell lines was
lines was observed
A PEBP2 alpha/AML-1-related
PEBP2 alpha/AML-1-related factor
alpha/AML-1-related factor increases
factor increases osteocalcin
increases osteocalcin promoter
osteocalcin promoter activity
promoter activity through
activity through its
through its binding
its binding to
binding to an
to an osteoblast-specific
an osteoblast-specific cis-acting
osteoblast-specific cis-acting element
To identify osteoblast-specific
identify osteoblast-specific cis-acting
osteoblast-specific cis-acting elements
cis-acting elements and
elements and trans-acting
and trans-acting factors
trans-acting factors we
factors we initiated
we initiated an
initiated an analysis
an analysis of
analysis of the
of the promoter
the promoter of
promoter of a
of a mouse
a mouse osteocalcin
mouse osteocalcin gene
osteocalcin gene an
gene an osteoblast-specific
an osteoblast-specific gene
In this promoter
this promoter we
promoter we identified
we identified two
identified two osteoblast-specific
two osteoblast-specific cis-acting
osteoblast-specific cis-acting elements
cis-acting elements Ducy
elements Ducy Pand
Ducy Pand Karsenty
Pand Karsenty G1995
Karsenty G1995 MolCellBiol15
G1995 MolCellBiol15 1858-1869
The sequence of
sequence of one
of one of
one of these
of these elements
these elements OSE2
elements OSE2 is
OSE2 is identical
is identical to
identical to the
to the DNA-binding
the DNA-binding site
DNA-binding site of
site of the
of the PEBP2
the PEBP2 alpha/AML-1
PEBP2 alpha/AML-1 transcription
alpha/AML-1 transcription factors
transcription factors the
factors the mammalian
the mammalian homologues
mammalian homologues of
homologues of the
of the Drosophila
the Drosophila Runt
Drosophila Runt protein
Here we show
we show using
show using nuclear
using nuclear extracts
nuclear extracts recombinant
extracts recombinant protein
recombinant protein and
protein and a
and a specific
a specific antiserum
specific antiserum against
antiserum against AML-1
against AML-1 proteins
AML-1 proteins in
proteins in DNA-binding
in DNA-binding assays
DNA-binding assays that
assays that one
that one member
one member of
member of this
of this family
this family AML-1B
family AML-1B binds
AML-1B binds specifically
binds specifically to
specifically to OSE2
to OSE2 and
OSE2 and is
and is immunologically
is immunologically related
immunologically related to
related to OSF2
to OSF2 the
OSF2 the factor
the factor present
factor present in
present in osteoblast
in osteoblast nuclear
osteoblast nuclear extracts
nuclear extracts that
extracts that binds
that binds to
binds to OSE2
By DNA cotransfection
DNA cotransfection experiments
cotransfection experiments we
experiments we also
we also demonstrate
also demonstrate that
demonstrate that AML-1B
that AML-1B can
AML-1B can increase
can increase the
increase the activity
the activity of
activity of a
of a short
a short osteocalcin
short osteocalcin promoter
osteocalcin promoter through
promoter through its
through its binding
its binding to
binding to OSE2
Lastly the different
the different mobilities
different mobilities of
mobilities of osteoblast
of osteoblast nuclear
osteoblast nuclear extract-DNA
nuclear extract-DNA complexes
extract-DNA complexes compared
complexes compared with
compared with T-cell
with T-cell nuclear
T-cell nuclear extract-DNA
nuclear extract-DNA complexes
extract-DNA complexes along
complexes along with
along with the
with the inability
the inability of
inability of OSF2
of OSF2 to
OSF2 to be
to be upregulated
be upregulated by
upregulated by retinoic
by retinoic acid
retinoic acid unlike
acid unlike the
unlike the other
the other PEBP2
other PEBP2 alpha
PEBP2 alpha factors
alpha factors suggest
factors suggest that
suggest that OSF2
that OSF2 is
OSF2 is a
is a new
a new member
new member of
member of this
of this family
this family of
family of transcription
of transcription factors
Thus this study
this study demonstrates
study demonstrates that
demonstrates that AML-1B
that AML-1B can
AML-1B can increase
can increase gene
increase gene expression
gene expression of
expression of an
of an osteoblast-specific
an osteoblast-specific gene
osteoblast-specific gene through
gene through its
through its binding
its binding to
binding to an
to an osteoblast-specific
an osteoblast-specific cis-acting
osteoblast-specific cis-acting element
cis-acting element and
element and presents
and presents evidence
presents evidence that
evidence that OSF2
that OSF2 is
OSF2 is a
is a member
a member of
member of the
of the PEBP2
the PEBP2 alpha/AML-1
PEBP2 alpha/AML-1 family
alpha/AML-1 family of
family of transcription
of transcription factors
Initiation binding repressor
binding repressor a
repressor a factor
a factor that
factor that binds
that binds to
binds to the
to the transcription
the transcription initiation
transcription initiation site
initiation site of
site of the
of the histone
the histone h5
histone h5 gene
h5 gene is
gene is a
is a glycosylated
a glycosylated member
glycosylated member of
member of a
of a family
a family of
family of cell
of cell growth
cell growth regulators
growth regulators [corrected]
regulators [corrected] [published
[corrected] [published erratum
[published erratum appears
erratum appears in
appears in Mol
in Mol Cell
Mol Cell Biol
Cell Biol 1996
Biol 1996 Feb;162:735]
Initiation binding repressor
binding repressor [corrected]
repressor [corrected] IBR
[corrected] IBR is
IBR is a
is a chicken
a chicken erythrocyte
chicken erythrocyte factor
erythrocyte factor apparent
factor apparent molecular
apparent molecular mass
molecular mass 70
mass 70 to
70 to 73
to 73 kDa
73 kDa that
kDa that binds
that binds to
binds to the
to the sequences
the sequences spanning
sequences spanning the
spanning the transcription
the transcription initiation
transcription initiation site
initiation site of
site of the
of the histone
the histone h5
histone h5 gene
h5 gene repressing
gene repressing its
repressing its transcription
A variety of
variety of other
of other cells
other cells including
cells including transformed
including transformed erythroid
transformed erythroid precursors
erythroid precursors do
precursors do not
do not have
not have IBR
have IBR but
IBR but a
but a factor
a factor referred
factor referred to
referred to as
to as IBF
as IBF 68
IBF 68 to
68 to 70
to 70 kDa
70 kDa that
kDa that recognizes
that recognizes the
recognizes the same
the same IBR
same IBR sites
We have cloned
have cloned the
cloned the IBR
the IBR cDNA
IBR cDNA and
cDNA and studied
and studied the
studied the relationship
the relationship of
relationship of IBR
of IBR and
IBR and IBF
IBR is a
is a 503-amino-acid-long
a 503-amino-acid-long acidic
503-amino-acid-long acidic protein
acidic protein which
protein which is
which is 990%
is 990% identical
990% identical to
identical to the
to the recently
the recently reported
recently reported human
reported human NRF-1/alpha-Pal
human NRF-1/alpha-Pal factor
NRF-1/alpha-Pal factor and
factor and highly
and highly related
highly related to
related to the
to the invertebrate
the invertebrate transcription
invertebrate transcription factors
transcription factors P3A2
factors P3A2 and
P3A2 and erected
and erected wing
erected wing gene
wing gene product
gene product EWG
We present evidence
present evidence that
evidence that IBR
that IBR and
IBR and IBF
and IBF are
IBF are most
are most likely
most likely identical
likely identical proteins
identical proteins differing
proteins differing in
differing in their
in their degree
their degree of
degree of glycosylation
We have analyzed
have analyzed several
analyzed several molecular
several molecular aspects
molecular aspects of
aspects of IBR/F
of IBR/F and
IBR/F and shown
and shown that
shown that the
that the factor
the factor associates
factor associates as
associates as stable
as stable homodimers
stable homodimers and
homodimers and that
and that the
that the dimer
the dimer is
dimer is the
is the relevant
the relevant DNA-binding
relevant DNA-binding species
The evolutionarily conserved
evolutionarily conserved N-terminal
conserved N-terminal half
N-terminal half of
half of IBR/F
of IBR/F harbors
IBR/F harbors the
harbors the DNA-binding/dimerization
the DNA-binding/dimerization domain
DNA-binding/dimerization domain outer
domain outer limits
outer limits 127
limits 127 to
127 to 283
to 283 one
283 one or
one or several
or several casein
several casein kinase
casein kinase II
kinase II sites
II sites 37
sites 37 to
37 to 67
to 67 and
67 and a
and a bipartite
a bipartite nuclear
bipartite nuclear localization
nuclear localization signal
localization signal 89
signal 89 to
89 to 106
to 106 which
106 which appears
which appears to
appears to be
to be necessary
be necessary for
necessary for nuclear
for nuclear targeting
Binding site selection
site selection revealed
selection revealed that
revealed that the
that the alternating
the alternating RCGCRYGCGY
alternating RCGCRYGCGY consensus
RCGCRYGCGY consensus constitutes
consensus constitutes high-affinity
constitutes high-affinity IBR/F
high-affinity IBR/F binding
IBR/F binding sites
binding sites and
sites and that
and that the
that the direct-repeat
the direct-repeat palindrome
direct-repeat palindrome TGCGCATGCGCA
palindrome TGCGCATGCGCA is
TGCGCATGCGCA is the
is the optimal
the optimal site
A survey of
survey of genes
of genes potentially
genes potentially regulated
potentially regulated by
regulated by this
by this family
this family of
family of factors
of factors primarily
factors primarily revealed
primarily revealed genes
revealed genes involved
genes involved in
involved in growth-related
in growth-related metabolism
Triggering of the
of the human
the human interleukin-6
human interleukin-6 gene
interleukin-6 gene by
gene by interferon-gamma
by interferon-gamma and
interferon-gamma and tumor
and tumor necrosis
tumor necrosis factor-alpha
necrosis factor-alpha in
factor-alpha in monocytic
in monocytic cells
monocytic cells involves
cells involves cooperation
involves cooperation between
cooperation between interferon
between interferon regulatory
interferon regulatory factor-1
regulatory factor-1 NF
factor-1 NF kappa
NF kappa B
kappa B and
B and Sp1
and Sp1 transcription
Sp1 transcription factors
We investigated the
investigated the molecular
the molecular basis
molecular basis of
basis of the
of the synergistic
the synergistic induction
synergistic induction by
induction by interferon-gamma
by interferon-gamma IFN-gamma/tumor
interferon-gamma IFN-gamma/tumor necrosis
IFN-gamma/tumor necrosis factor-alpha
necrosis factor-alpha TNF-alpha
factor-alpha TNF-alpha of
TNF-alpha of human
of human interleukin-6
human interleukin-6 IL-6
interleukin-6 IL-6 gene
IL-6 gene in
gene in THP-1
in THP-1 monocytic
THP-1 monocytic cells
monocytic cells and
cells and compared
and compared it
compared it with
it with the
with the basis
the basis of
basis of this
of this induction
this induction by
induction by lipopolysaccharide
by lipopolysaccharide LPS
Functional studies with
studies with IL-6
with IL-6 promoter
IL-6 promoter demonstrated
promoter demonstrated that
demonstrated that three
that three regions
three regions are
regions are the
are the targets
the targets of
targets of the
of the IFN-gamma
the IFN-gamma and/or
IFN-gamma and/or TNF-alpha
and/or TNF-alpha action
TNF-alpha action whereas
action whereas only
whereas only one
only one of
one of these
of these regions
these regions seemed
regions seemed to
seemed to be
to be implicated
be implicated in
implicated in LPS
in LPS activation
The three regions
three regions concerned
regions concerned are:
concerned are: 1
are: 1 a
1 a region
a region between
region between -73
between -73 and
-73 and -36
and -36 which
-36 which is
which is the
is the minimal
the minimal element
minimal element inducible
element inducible by
inducible by LPS
by LPS or
LPS or TNF-alpha;
or TNF-alpha; 2
TNF-alpha; 2 an
2 an element
an element located
element located between
located between -181
between -181 and
-181 and -73
and -73 which
-73 which appeared
which appeared to
appeared to regulate
to regulate the
regulate the response
the response to
response to IFN-gamma
to IFN-gamma and
IFN-gamma and TNF-alpha
and TNF-alpha negatively;
TNF-alpha negatively; and
negatively; and 3
and 3 a
3 a distal
a distal element
distal element upstream
element upstream of
upstream of -224
of -224 which
-224 which was
which was inducible
was inducible by
inducible by IFN-gamma
by IFN-gamma alone
LPS signaling was
signaling was found
was found to
found to involve
to involve NF
involve NF kappa
NF kappa B
kappa B activation
B activation by
activation by the
by the p50/p65
the p50/p65 heterodimers
Synergistic induction of
induction of the
of the IL-6
the IL-6 gene
IL-6 gene by
gene by IFN-gamma
by IFN-gamma and
IFN-gamma and TNF-alpha
and TNF-alpha in
TNF-alpha in monocytic
in monocytic cells
monocytic cells involved
cells involved cooperation
involved cooperation between
cooperation between the
between the IRF-1
the IRF-1 and
IRF-1 and NF
and NF kappa
NF kappa B
kappa B p65
B p65 homodimers
p65 homodimers with
homodimers with concomitant
with concomitant removal
concomitant removal of
removal of the
of the negative
the negative effect
negative effect of
effect of the
of the retinoblastoma
the retinoblastoma control
retinoblastoma control element
control element present
element present in
present in the
in the IL-6
the IL-6 promoter
This removal occurred
removal occurred by
occurred by activation
by activation of
activation of the
of the constitutive
the constitutive Sp1
constitutive Sp1 factor
Sp1 factor whose
factor whose increased
whose increased binding
increased binding activity
binding activity and
activity and phosphorylation
and phosphorylation were
phosphorylation were mediated
were mediated by
mediated by IFN-gamma
Mutation of Jak3
of Jak3 in
Jak3 in a
in a patient
a patient with
patient with SCID:
with SCID: essential
SCID: essential role
essential role of
role of Jak3
of Jak3 in
Jak3 in lymphoid
in lymphoid development
Males with X-linked
with X-linked severe
X-linked severe combined
severe combined immunodeficiency
combined immunodeficiency XSCID
immunodeficiency XSCID have
XSCID have defects
have defects in
defects in the
in the common
the common cytokine
common cytokine receptor
cytokine receptor gamma
receptor gamma chain
gamma chain gamma
chain gamma c
gamma c gene
c gene that
gene that encodes
that encodes a
encodes a shared
a shared essential
shared essential component
essential component of
component of the
of the receptors
the receptors of
receptors of interleukin-2
of interleukin-2 IL-2
interleukin-2 IL-2 IL-4
IL-2 IL-4 IL-7
IL-4 IL-7 IL-9
IL-7 IL-9 and
IL-9 and IL-15
The Janus family
Janus family tyrosine
family tyrosine kinase
tyrosine kinase Jak3
kinase Jak3 is
Jak3 is the
is the only
the only signaling
only signaling molecule
signaling molecule known
molecule known to
known to be
to be associated
be associated with
associated with gamma
with gamma c
gamma c so
c so it
so it was
it was hypothesized
was hypothesized that
hypothesized that defects
that defects in
defects in Jak3
in Jak3 might
Jak3 might cause
might cause an
cause an XSCID-like
an XSCID-like phenotype
A girl with
girl with immunological
with immunological features
immunological features indistinguishable
features indistinguishable from
indistinguishable from those
from those of
those of XSCID
of XSCID was
XSCID was therefore
was therefore selected
therefore selected for
selected for analysis
An Epstein-Barr virus
Epstein-Barr virus EBV-transformed
virus EBV-transformed cell
EBV-transformed cell line
cell line derived
line derived from
derived from her
from her lymphocytes
her lymphocytes had
lymphocytes had normal
had normal gamma
normal gamma c
gamma c expression
c expression but
expression but lacked
but lacked Jak3
lacked Jak3 protein
Jak3 protein and
protein and had
and had greatly
had greatly diminished
greatly diminished Jak3
diminished Jak3 messenger
Jak3 messenger RNA
Sequencing revealed a
revealed a different
a different mutation
different mutation on
mutation on each
on each allele:
each allele: a
allele: a single
a single nucleotide
single nucleotide insertion
nucleotide insertion resulting
insertion resulting in
resulting in a
in a frame
a frame shift
frame shift and
shift and premature
and premature termination
premature termination in
termination in the
in the Jak3
the Jak3 JH4
Jak3 JH4 domain
JH4 domain and
domain and a
and a nonsense
a nonsense mutation
nonsense mutation in
mutation in the
in the Jak3
the Jak3 JH2
Jak3 JH2 domain
The lack of
lack of Jak3
of Jak3 expression
Jak3 expression correlated
expression correlated with
correlated with impaired
with impaired B
impaired B cell
B cell signaling
cell signaling as
signaling as demonstrated
as demonstrated by
demonstrated by the
by the inability
the inability of
inability of IL-4
of IL-4 to
IL-4 to activate
to activate Stat6
activate Stat6 in
Stat6 in the
in the EBV-transformed
the EBV-transformed cell
EBV-transformed cell line
cell line from
line from the
from the patient
the patient These
patient These observations
These observations indicate
observations indicate that
indicate that the
that the functions
the functions of
functions of gamma
of gamma c
gamma c are
c are dependent
are dependent on
dependent on Jak3
on Jak3 and
Jak3 and that
and that Jak3
that Jak3 is
Jak3 is essential
is essential for
essential for lymphoid
for lymphoid development
lymphoid development and
development and signaling
Constitutive overexpression of
overexpression of the
of the L-selectin
the L-selectin gene
L-selectin gene in
gene in fresh
in fresh leukemic
fresh leukemic cells
leukemic cells of
cells of adult
of adult T-cell
adult T-cell leukemia
T-cell leukemia that
leukemia that can
that can be
can be transactivated
be transactivated by
transactivated by human
by human T-cell
human T-cell lymphotropic
T-cell lymphotropic virus
lymphotropic virus type
virus type 1
type 1 Tax
L-selectin is an
is an adhesion
an adhesion molecule
adhesion molecule of
molecule of the
of the selectin
the selectin family
selectin family that
family that mediates
that mediates the
mediates the initial
the initial step
initial step of
step of leukocyte
of leukocyte adhesion
leukocyte adhesion to
adhesion to vascular
to vascular endothelium
Upon cellular activation
cellular activation expression
activation expression of
expression of the
of the L-selectin
the L-selectin gene
L-selectin gene is
gene is downregulated
is downregulated at
downregulated at both
at both the
both the protein
the protein and
protein and mRNA
and mRNA levels
To understand the
understand the mechanism
the mechanism of
mechanism of leukemic
of leukemic cell
leukemic cell infiltration
cell infiltration into
infiltration into organs
into organs we
organs we studied
we studied the
studied the expression
the expression and
expression and regulation
and regulation of
regulation of L-selectin
of L-selectin mRNA
L-selectin mRNA in
mRNA in fresh
in fresh leukemic
fresh leukemic cells
leukemic cells of
cells of adult
of adult T-cell
adult T-cell leukemia
T-cell leukemia ATL
leukemia ATL patients
ATL patients and
patients and investigated
and investigated the
investigated the response
the response of
response of the
of the L-selectin
the L-selectin promoter
L-selectin promoter to
promoter to human
to human T-cell
human T-cell lymphotropic
T-cell lymphotropic virus
lymphotropic virus type
virus type 1
type 1 HTLV-1
1 HTLV-1 Tax
HTLV-1 Tax which
Tax which is
which is a
is a viral
a viral transcriptional
viral transcriptional transactivator
Flow cytometry showed
cytometry showed that
showed that L-selectin
that L-selectin was
L-selectin was expressed
was expressed on
expressed on fresh
on fresh ATL
fresh ATL cells
ATL cells along
cells along with
along with other
with other activation
other activation antigens
Northern blot analysis
blot analysis showed
analysis showed that
showed that ATL
that ATL cells
ATL cells overexpressed
cells overexpressed that
overexpressed that L-selectin
that L-selectin mRNA
L-selectin mRNA and
mRNA and that
and that the
that the level
the level was
level was aberrantly
was aberrantly upregulated
aberrantly upregulated after
upregulated after PMA
after PMA stimulation
Studies using in
using in situ
in situ hybridization
situ hybridization showed
hybridization showed expression
showed expression of
expression of the
of the L-selectin
the L-selectin mRNA
L-selectin mRNA in
mRNA in the
in the infiltrating
the infiltrating leukemic
infiltrating leukemic cells
leukemic cells in
cells in the
in the liver
the liver of
liver of two
of two ATL
two ATL patients
Intravenous injection of
injection of a
of a rat
a rat T-cell
rat T-cell line
T-cell line that
line that overexpresses
that overexpresses L-selectin
overexpresses L-selectin showed
L-selectin showed increased
showed increased organ
increased organ infiltration
The induction of
induction of Tax
of Tax expression
Tax expression in
expression in JPX9
in JPX9 cells
JPX9 cells resulted
cells resulted in
resulted in about
in about a
about a twofold
a twofold increase
twofold increase in
increase in the
in the mRNA
the mRNA expression
mRNA expression levels
expression levels compared
levels compared with
compared with the
with the basal
the basal level
Chloramphenicol acetyltransferase CAT
acetyltransferase CAT assay
CAT assay after
assay after transient
after transient cotransfection
transient cotransfection showed
cotransfection showed about
showed about a
about a fivefold
a fivefold transactivation
fivefold transactivation of
transactivation of the
of the L-selectin
the L-selectin promoter
L-selectin promoter by
promoter by Tax
The serum level
serum level of
level of the
of the shed
the shed form
shed form of
form of L-selectin
of L-selectin was
L-selectin was significantly
was significantly increased
significantly increased in
increased in ATL
in ATL patients
ATL patients mean
patients mean +/-
mean +/- SD
+/- SD 42154
SD 42154 +/-
42154 +/- 4111
+/- 4111 ng/mL
4111 ng/mL compared
ng/mL compared with
compared with those
with those of
those of asymptomatic
of asymptomatic carriers
asymptomatic carriers and
carriers and healthy
and healthy blood
healthy blood donors
blood donors mean
donors mean +/-
mean +/- SD
+/- SD 11480
SD 11480 +/-
11480 +/- 2690
+/- 2690 ng/mL
2690 ng/mL and
ng/mL and 9919
and 9919 +/-
9919 +/- 224
+/- 224 ng/mL
224 ng/mL respectively
These results indicated
results indicated that
indicated that ATL
that ATL cells
ATL cells constitutively
cells constitutively overexpress
constitutively overexpress the
overexpress the L-selectin
the L-selectin gene
L-selectin gene that
gene that can
that can be
can be transactivated
be transactivated by
transactivated by HTLV-1
by HTLV-1 Tax
The overexpression of
overexpression of L-selectin
of L-selectin as
L-selectin as well
as well as
well as of
as of inflammatory
of inflammatory cytokines
inflammatory cytokines by
cytokines by ATL
by ATL cells
ATL cells may
cells may provide
may provide a
provide a basis
a basis for
basis for ATL
for ATL cells
ATL cells to
cells to attach
to attach the
attach the vascular
the vascular endothelium
vascular endothelium leading
endothelium leading to
leading to transmigration
to transmigration and
transmigration and organ
and organ infitration
Human herpesvirus 6
herpesvirus 6 variant
6 variant A
variant A but
A but not
but not variant
not variant B
variant B infects
B infects EBV-positive
infects EBV-positive B
EBV-positive B lymphoid
B lymphoid cells
lymphoid cells activating
cells activating the
activating the latent
the latent EBV
latent EBV genome
EBV genome through
genome through a
through a BZLF-1-dependent
a BZLF-1-dependent mechanism
Human herpesvirus 6
herpesvirus 6 a
6 a predominantly
a predominantly T
predominantly T lymphotropic
T lymphotropic virus
lymphotropic virus has
virus has been
has been recently
been recently shown
recently shown to
shown to infect
to infect some
infect some EBV-positive
some EBV-positive B
EBV-positive B cell
B cell lines
cell lines and
lines and to
and to induce
to induce in
induce in them
in them the
them the activation
the activation of
activation of the
of the EBV
the EBV lytic
EBV lytic cycle
Here we have
we have confirmed
have confirmed and
confirmed and extended
and extended such
extended such observations
such observations showing
observations showing that
showing that 1
that 1 this
1 this phenomenon
this phenomenon is
phenomenon is restricted
is restricted to
restricted to the
to the variant
the variant A
variant A of
A of HHV-6:
of HHV-6: in
HHV-6: in fact
in fact two
fact two isolates
two isolates belonging
isolates belonging to
belonging to the
to the HHV-6
the HHV-6 variant
HHV-6 variant B
variant B BA92
B BA92 and
BA92 and Z29
and Z29 were
Z29 were neither
were neither able
neither able to
able to infect
to infect any
infect any B
any B cell
B cell line
cell line independently
line independently of
independently of the
of the EBV
the EBV status
EBV status nor
status nor to
nor to induce
to induce the
induce the EBV
the EBV genome
EBV genome expression
The only exception
only exception is
exception is represented
is represented by
represented by the
by the P3HR1
the P3HR1 cells
P3HR1 cells in
cells in which
in which however
which however the
however the infection
the infection by
infection by the
by the variant
the variant B
variant B does
B does not
does not determine
not determine induction
determine induction of
induction of EBV
of EBV antigens;
EBV antigens; 2
antigens; 2 the
2 the presence
the presence of
presence of the
of the EBV
the EBV genome
EBV genome contributes
genome contributes to
contributes to the
to the susceptibility
the susceptibility of
susceptibility of the
of the B
the B cell
B cell lines
cell lines to
lines to HHV-6
to HHV-6 infection
HHV-6 infection increasing
infection increasing the
increasing the binding
the binding sites
binding sites and
sites and the
and the percentage
the percentage of
percentage of infectable
of infectable cells
infectable cells as
cells as detected
as detected by
detected by immunoelectron
by immunoelectron microscopy;
immunoelectron microscopy; and
microscopy; and 3
and 3 HHV-6
3 HHV-6 infected
HHV-6 infected T
infected T cells
T cells transfected
cells transfected with
transfected with plasmids
with plasmids bearing
plasmids bearing the
bearing the promoter
the promoter regions
promoter regions of
regions of the
of the EBV
the EBV early
EBV early genes
early genes BZLF1
genes BZLF1 and
BZLF1 and BMRF1
and BMRF1 show
BMRF1 show a
show a strong
a strong transactivation
strong transactivation of
transactivation of these
of these promoters
Evidence for normal
for normal vitamin
normal vitamin D
vitamin D receptor
D receptor messenger
receptor messenger ribonucleic
messenger ribonucleic acid
ribonucleic acid and
acid and genotype
and genotype in
genotype in absorptive
in absorptive hypercalciuria
Absorptive hypercalciuria a
hypercalciuria a stone-forming
a stone-forming condition
stone-forming condition is
condition is characterized
is characterized by
characterized by gut
by gut hyperabsorption
gut hyperabsorption of
hyperabsorption of calcium
of calcium hypercalciuria
calcium hypercalciuria and
hypercalciuria and reduced
and reduced bone
reduced bone density
Inasmuch as these
as these features
these features implicate
features implicate enhanced
implicate enhanced calcitriol
enhanced calcitriol action
calcitriol action in
action in gut
in gut and
gut and bone
and bone we
bone we analyzed
we analyzed the
analyzed the vitamin
the vitamin D
vitamin D receptor
D receptor VDR
receptor VDR gene
VDR gene to
gene to ascertain
to ascertain whether
ascertain whether an
whether an abnormality
an abnormality of
abnormality of this
of this gene
this gene marks
gene marks patients
marks patients with
patients with intestinal
with intestinal hyperabsorption
intestinal hyperabsorption of
hyperabsorption of calcium
We have compared
have compared the
compared the frequency
the frequency of
frequency of a
of a restriction
a restriction fragment
restriction fragment length
fragment length polymorphism
length polymorphism Bsm
polymorphism Bsm I
Bsm I associated
I associated with
associated with different
with different alleles
different alleles of
alleles of the
of the VDR
the VDR gene
VDR gene in
gene in a
in a group
a group of
group of 33
of 33 well
33 well characterized
well characterized absorptive
characterized absorptive hypercalciuric
absorptive hypercalciuric patients
hypercalciuric patients and
patients and a
and a group
a group of
group of 36
of 36 normal
36 normal race-
normal race- and
race- and age-matched
and age-matched control
age-matched control subjects
There was no
was no difference
no difference between
difference between the
between the distribution
the distribution of
distribution of the
of the VDR
the VDR alleles
VDR alleles in
alleles in the
in the patient
the patient population
patient population when
population when compared
when compared with
compared with the
with the normal
the normal population
The coding region
coding region of
region of VDR
of VDR messenger
VDR messenger RNA
messenger RNA was
RNA was also
was also normal
also normal as
normal as determined
as determined by
determined by both
by both DNA
both DNA sequence
DNA sequence analysis
sequence analysis and
analysis and chemical
and chemical mismatch
chemical mismatch cleavage
mismatch cleavage analysis
cleavage analysis of
analysis of copy
of copy DNA
copy DNA from
DNA from 11
from 11 index
11 index absorptive
index absorptive hypercalciuric
absorptive hypercalciuric patients
On the basis
the basis of
basis of these
of these results
these results we
results we propose
we propose that
propose that the
that the enhanced
the enhanced intestinal
enhanced intestinal calcium
intestinal calcium absorption
calcium absorption invariably
absorption invariably seen
invariably seen in
seen in absorptive
in absorptive hypercalciuria
absorptive hypercalciuria and
hypercalciuria and attendant
and attendant symptoms
attendant symptoms of
symptoms of this
of this disorder
this disorder are
disorder are not
are not attributable
not attributable to
attributable to mutations
to mutations of
mutations of the
of the VDR
the VDR and
VDR and are
and are not
are not linked
not linked to
linked to a
to a common
a common VDR
common VDR genotype
Transcriptional regulation of
regulation of the
of the gene
the gene encoding
gene encoding the
encoding the human
the human C-type
human C-type lectin
C-type lectin leukocyte
lectin leukocyte receptor
leukocyte receptor AIM/CD69
receptor AIM/CD69 and
AIM/CD69 and functional
and functional characterization
functional characterization of
characterization of its
of its tumor
its tumor necrosis
tumor necrosis factor-alpha-responsive
necrosis factor-alpha-responsive elements
The human activation
human activation antigen
activation antigen CD69
antigen CD69 is
CD69 is a
is a member
a member of
member of the
of the C-type
the C-type animal
C-type animal lectin
animal lectin superfamily
lectin superfamily that
superfamily that functions
that functions as
functions as a
as a signal-transmitting
a signal-transmitting receptor
Although the expression
the expression of
expression of CD69
of CD69 can
CD69 can be
can be induced
be induced in
induced in vitro
in vitro on
vitro on cells
on cells of
cells of most
of most hematopoietic
most hematopoietic lineages
hematopoietic lineages with
lineages with a
with a wide
a wide variety
wide variety of
variety of stimuli
of stimuli in
stimuli in vivo
in vivo it
vivo it is
it is mainly
is mainly expressed
mainly expressed by
expressed by T-lymphocytes
by T-lymphocytes located
T-lymphocytes located in
located in the
in the inflammatory
the inflammatory infiltrates
inflammatory infiltrates of
infiltrates of several
of several human
several human diseases
To elucidate the
elucidate the mechanisms
the mechanisms that
mechanisms that regulate
that regulate the
regulate the constitutive
the constitutive and
constitutive and inducible
and inducible expression
inducible expression of
expression of CD69
of CD69 by
CD69 by leukocytes
by leukocytes we
leukocytes we isolated
we isolated the
isolated the promoter
the promoter region
promoter region of
region of the
of the CD69
the CD69 gene
CD69 gene and
gene and carried
and carried out
carried out its
out its functional
its functional characterization
Sequence analysis of
analysis of the
of the 5'-flanking
the 5'-flanking region
5'-flanking region of
region of the
of the CD69
the CD69 gene
CD69 gene revealed
gene revealed the
revealed the presence
the presence of
presence of a
of a potential
a potential TATA
potential TATA element
TATA element 30
element 30 base
30 base pairs
base pairs upstream
pairs upstream of
upstream of the
of the major
the major transcription
major transcription initiation
transcription initiation site
initiation site and
site and several
and several putative
several putative binding
putative binding sequences
binding sequences for
sequences for inducible
for inducible transcription
inducible transcription factors
transcription factors NF-kappa
factors NF-kappa B
NF-kappa B Egr-1
B Egr-1 AP-1
Egr-1 AP-1 which
AP-1 which might
which might mediate
might mediate the
mediate the inducible
the inducible expression
inducible expression of
expression of this
of this gene
Transient expression of
expression of CD69
of CD69 promoter-based
CD69 promoter-based reporter
promoter-based reporter gene
reporter gene constructs
gene constructs in
constructs in K562
in K562 cells
K562 cells indicated
cells indicated that
indicated that the
that the proximal
the proximal promoter
proximal promoter region
promoter region spanning
region spanning positions
spanning positions -78
positions -78 to
-78 to +16
to +16 contained
+16 contained the
contained the cis-acting
the cis-acting sequences
cis-acting sequences necessary
sequences necessary for
necessary for basal
for basal and
basal and phorbol
and phorbol 12-myristate
phorbol 12-myristate 13-acetate-inducible
12-myristate 13-acetate-inducible transcription
13-acetate-inducible transcription of
transcription of the
of the CD69
the CD69 gene
Removal of the
of the upstream
the upstream sequences
upstream sequences located
sequences located between
located between positions
between positions -78
positions -78 and
-78 and -38
and -38 resulted
-38 resulted in
resulted in decreased
in decreased promoter
decreased promoter strength
promoter strength and
strength and abolished
and abolished the
abolished the response
the response to
response to phorbol
to phorbol 12-myristate
phorbol 12-myristate 13-acetate
We also found
also found that
found that tumor
that tumor necrosis
tumor necrosis factor-alpha
necrosis factor-alpha TNF-alpha
factor-alpha TNF-alpha is
TNF-alpha is capable
is capable of
capable of inducing
of inducing the
inducing the surface
the surface expression
surface expression of
expression of the
of the CD69
the CD69 molecule
CD69 molecule as
molecule as well
as well as
well as the
as the promoter
the promoter activity
promoter activity of
activity of fusion
of fusion plasmids
fusion plasmids that
plasmids that contain
that contain 5'-flanking
contain 5'-flanking sequences
5'-flanking sequences of
sequences of the
of the CD69
the CD69 gene
CD69 gene suggesting
gene suggesting that
suggesting that this
that this cytokine
this cytokine may
cytokine may regulate
may regulate in
regulate in vivo
in vivo the
vivo the expression
the expression of
expression of CD69
ABSTRACT TRUNCATED AT
TRUNCATED AT 250
AT 250 WORDS
Characterization of 5'
of 5' end
5' end of
end of human
of human thromboxane
human thromboxane receptor
thromboxane receptor gene
Organizational analysis and
analysis and mapping
and mapping of
mapping of protein
of protein kinase
protein kinase C--responsive
kinase C--responsive elements
C--responsive elements regulating
elements regulating expression
regulating expression in
expression in platelets
Platelet thromboxane receptors
thromboxane receptors are
receptors are acutely
are acutely and
acutely and reversibly
and reversibly upregulated
reversibly upregulated after
upregulated after acute
after acute myocardial
acute myocardial infarction
To determine if
determine if platelet
if platelet thromboxane
platelet thromboxane receptors
thromboxane receptors are
receptors are under
are under transcriptional
under transcriptional control
transcriptional control we
control we isolated
we isolated and
isolated and characterized
and characterized human
characterized human genomic
human genomic DNA
genomic DNA clones
DNA clones containing
clones containing the
containing the 5'
the 5' flanking
5' flanking region
flanking region of
region of the
of the thromboxane
the thromboxane receptor
thromboxane receptor gene
The exon-intron structure
exon-intron structure of
structure of the
of the 5'
the 5' portion
5' portion of
portion of the
of the thromboxane
the thromboxane receptor
thromboxane receptor gene
receptor gene was
gene was determined
was determined initially
determined initially by
initially by comparing
by comparing the
comparing the nucleotide
the nucleotide sequence
nucleotide sequence of
sequence of the
of the 5'
the 5' flanking
5' flanking genomic
flanking genomic clone
genomic clone with
clone with that
with that of
that of a
of a novel
a novel human
novel human uterine
human uterine thromboxane
uterine thromboxane receptor
thromboxane receptor cDNA
receptor cDNA that
cDNA that extended
that extended the
extended the mRNA
the mRNA 141
mRNA 141 bp
141 bp further
bp further upstream
further upstream than
upstream than the
than the previously
the previously identified
previously identified human
identified human placental
human placental cDNA
A major transcription
major transcription initiation
transcription initiation site
initiation site was
site was located
was located in
located in three
in three human
three human tissues
human tissues approximately
tissues approximately 560
approximately 560 bp
560 bp upstream
bp upstream from
upstream from the
from the translation
the translation initiation
translation initiation codon
initiation codon and
codon and 380
and 380 bp
380 bp upstream
bp upstream from
upstream from any
from any previously
any previously identified
previously identified transcription
identified transcription initiation
transcription initiation site
The thromboxane receptor
thromboxane receptor gene
receptor gene has
gene has neither
has neither a
neither a TATA
a TATA nor
TATA nor a
nor a CAAT
a CAAT consensus
CAAT consensus site
Promoter function of
function of the
of the 5'
the 5' flanking
5' flanking region
flanking region of
region of the
of the thromboxane
the thromboxane receptor
thromboxane receptor gene
receptor gene was
gene was evaluated
was evaluated by
evaluated by transfection
by transfection of
transfection of thromboxane
of thromboxane receptor
thromboxane receptor gene
receptor gene promoter/chloramphenicol
gene promoter/chloramphenicol acetyltransferase
promoter/chloramphenicol acetyltransferase CAT
acetyltransferase CAT chimera
CAT chimera plasmids
chimera plasmids into
plasmids into platelet-like
into platelet-like K562
platelet-like K562 cells
Thromboxane receptor promoter
receptor promoter activity
promoter activity as
activity as assessed
as assessed by
assessed by CAT
by CAT expression
CAT expression was
expression was relatively
was relatively weak
relatively weak but
weak but was
but was significantly
was significantly enhanced
significantly enhanced by
enhanced by phorbol
by phorbol ester
phorbol ester treatment
Functional analysis of
analysis of 5'
of 5' deletion
5' deletion constructs
deletion constructs in
constructs in transfected
in transfected K562
transfected K562 cells
K562 cells and
cells and gel
and gel mobility
gel mobility shift
mobility shift localized
shift localized the
localized the major
the major phorbol
major phorbol ester-responsive
phorbol ester-responsive motifs
ester-responsive motifs in
motifs in the
in the thromboxane
the thromboxane receptor
thromboxane receptor gene
receptor gene promoter
gene promoter to
promoter to a
to a cluster
a cluster of
cluster of activator
of activator protein-2
activator protein-2 AP-2
protein-2 AP-2 binding
AP-2 binding consensus
binding consensus sites
consensus sites located
sites located approximately
located approximately 18
approximately 18 kb
18 kb 5'
kb 5' from
5' from the
from the transcription
the transcription initiation
transcription initiation site
These studies are
studies are the
are the first
the first to
first to determine
to determine the
determine the structure
the structure and
structure and organization
and organization of
organization of the
of the 5'
the 5' end
5' end of
end of the
of the thromboxane
the thromboxane receptor
thromboxane receptor gene
receptor gene and
gene and demonstrate
and demonstrate that
demonstrate that thromboxane
that thromboxane receptor
thromboxane receptor gene
receptor gene expression
gene expression can
expression can be
can be regulated
be regulated by
regulated by activation
by activation of
activation of protein
of protein kinase
protein kinase C
kinase C via
C via induction
via induction of
induction of an
of an AP-2-like
an AP-2-like nuclear
AP-2-like nuclear factor
nuclear factor binding
factor binding to
binding to upstream
to upstream promoter
upstream promoter elements
These findings strongly
findings strongly suggest
strongly suggest that
suggest that the
that the mechanism
the mechanism for
mechanism for previously
for previously described
previously described upregulation
described upregulation of
upregulation of platelet
of platelet thromboxane
platelet thromboxane receptors
thromboxane receptors after
receptors after acute
after acute myocardial
acute myocardial infarction
myocardial infarction is
infarction is increased
is increased thromboxane
increased thromboxane receptor
thromboxane receptor gene
receptor gene transcription
gene transcription in
transcription in platelet-progenitor
in platelet-progenitor cells
Estrogen receptor concentration
receptor concentration and
concentration and social
and social factors
social factors as
factors as predictors
as predictors of
predictors of natural
of natural killer
natural killer cell
killer cell activity
cell activity in
activity in early-stage
in early-stage breast
early-stage breast cancer
breast cancer patients
Confirmation of a
of a model
Previous work of
work of ours
of ours has
ours has demonstrated
has demonstrated that
demonstrated that a
that a significant
a significant amount
significant amount of
amount of natural
of natural killer
natural killer NK
killer NK activity
NK activity variance
activity variance after
variance after surgery
after surgery in
surgery in stage
in stage I
stage I and
I and II
and II breast
II breast cancer
breast cancer patients
cancer patients could
patients could be
could be accounted
be accounted for
accounted for by
for by both
by both the
both the estrogen
the estrogen receptor
estrogen receptor ER
receptor ER status
ER status of
status of the
of the tumor
the tumor and
tumor and by
and by social
by social factors
social factors namely
factors namely perceived
namely perceived social
perceived social support
social support and
support and seeking
and seeking social
seeking social support
social support as
support as a
as a general
a general coping
general coping strategy
As considerable evidence
considerable evidence has
evidence has accumulated
has accumulated that
accumulated that social
that social support
social support in
support in both
in both animal
both animal and
animal and human
and human populations
human populations may
populations may have
may have survival
have survival value
survival value we
value we sought
we sought to
sought to test
to test the
test the reliability
the reliability of
reliability of this
of this regression
this regression model
regression model using
model using coping
using coping and
coping and perceived
and perceived support
perceived support factor
support factor values
factor values obtained
values obtained at
obtained at 3
at 3 months
3 months after
months after surgery
after surgery to
surgery to account
to account for
account for concurrent
for concurrent follow-up
concurrent follow-up NK
follow-up NK activity
NK activity in
activity in this
in this serially
this serially assessed
serially assessed group
assessed group of
group of patients
It was found
was found that
found that the
that the most
the most significant
most significant variable
significant variable predicting
variable predicting NK
predicting NK activity
NK activity at
activity at follow-up
at follow-up was
follow-up was tumor
was tumor ER
tumor ER concentration
ER concentration with
concentration with higher
with higher NK
higher NK activity
NK activity associated
activity associated with
associated with ER
with ER -status
In addition seeking
addition seeking social
seeking social support
social support as
support as a
as a coping
a coping strategy
coping strategy as
strategy as well
as well as
well as the
as the perceived
the perceived quality
perceived quality of
quality of support
of support also
support also entered
also entered the
entered the model
the model to
model to account
to account for
account for a
for a significant
a significant amount
significant amount of
amount of NK
of NK activity
NK activity variance
activity variance multivariate
variance multivariate F
multivariate F =
F = 525
= 525 p
525 p less
p less than
less than 0001
If as the
as the literature
the literature suggests
literature suggests NK
suggests NK activity
NK activity is
activity is relevant
is relevant to
relevant to breast
to breast cancer
breast cancer control
cancer control and
control and since
and since ER
since ER -tumors
ER -tumors have
-tumors have a
have a worse
a worse prognosis
worse prognosis we
prognosis we suggest
we suggest here
suggest here that
here that perhaps
that perhaps such
perhaps such tumors
such tumors are
tumors are resistant
are resistant to
resistant to control
to control by
control by NK
by NK cells
NK cells because
cells because they
because they lack
they lack the
lack the ability
the ability to
ability to attract
to attract an
attract an accumulation
an accumulation of
accumulation of effector
of effector cells
effector cells to
cells to the
to the tumor
the tumor site
tumor site or
site or because
or because blocking
because blocking factors
blocking factors at
factors at the
at the site
the site of
site of the
of the tumor
the tumor prevent
tumor prevent local
prevent local tumor
local tumor control
tumor control at
control at the
at the site
the site of
site of action
The finding related
finding related to
related to social
to social support
social support also
support also replicates
also replicates results
replicates results from
results from an
from an independent
an independent sample
independent sample of
sample of breast
of breast cancer
breast cancer patients
This finding taken
finding taken together
taken together with
together with other
with other evidence
other evidence that
evidence that this
that this social
this social variable
social variable is
variable is associated
is associated with
associated with longer
with longer survival
longer survival in
survival in breast
in breast cancer
breast cancer populations
cancer populations underscores
populations underscores the
underscores the potential
the potential importance
potential importance of
importance of this
of this social
this social support
social support variable
Our findings also
findings also suggest
also suggest one
suggest one possible
one possible immunological
possible immunological variable
immunological variable involved
variable involved with
involved with potential
with potential clinical
potential clinical significance
clinical significance for
significance for this
for this patient
this patient population
Solution structure of
structure of the
of the sequence-specific
the sequence-specific HMG
sequence-specific HMG box
HMG box of
box of the
of the lymphocyte
the lymphocyte transcriptional
lymphocyte transcriptional activator
transcriptional activator Sox-4
Two groups of
groups of HMG
of HMG box
HMG box proteins
box proteins are
proteins are distinguished
Proteins in the
in the first
the first group
first group contain
group contain multiple
contain multiple HMG
multiple HMG boxes
HMG boxes are
boxes are non-sequence-specific
are non-sequence-specific and
non-sequence-specific and recognize
and recognize structural
recognize structural features
structural features as
features as found
as found in
found in cruciform
in cruciform DNA
cruciform DNA and
DNA and cross-over
and cross-over DNA
The abundant chromosomal
abundant chromosomal protein
chromosomal protein HMG-1
protein HMG-1 belongs
HMG-1 belongs to
belongs to this
to this subgroup
Proteins in the
in the second
the second group
second group carry
group carry a
carry a single
a single HMG
single HMG box
HMG box with
box with affinity
with affinity for
affinity for the
for the minor
the minor groove
minor groove of
groove of the
of the heptamer
the heptamer motif
heptamer motif AACAAAG
motif AACAAAG or
AACAAAG or variations
or variations thereof
A solution structure
solution structure for
structure for the
for the non-sequence-specific
the non-sequence-specific C-terminal
non-sequence-specific C-terminal HMG
C-terminal HMG box
HMG box of
box of HMG-1
of HMG-1 has
HMG-1 has recently
has recently been
recently been proposed
Now we report
we report the
report the solution
the solution structure
solution structure of
structure of the
of the sequence-specific
the sequence-specific HMG-box
sequence-specific HMG-box of
HMG-box of the
of the SRY-related
the SRY-related protein
SRY-related protein Sox-4
NMR analysis demonstrated
analysis demonstrated the
demonstrated the presence
the presence of
presence of three
of three alpha-helices
three alpha-helices Val10-Gln22
alpha-helices Val10-Gln22 Glu30-Leu41
Val10-Gln22 Glu30-Leu41 and
Glu30-Leu41 and Phe50-Tyr65
and Phe50-Tyr65 connected
Phe50-Tyr65 connected by
connected by loop
by loop regions
loop regions Ser23-Ala49
regions Ser23-Ala49 and
Ser23-Ala49 and Leu42-Pro49
Helices I and
I and II
and II are
II are positioned
are positioned in
positioned in an
in an antiparallel
an antiparallel mode
antiparallel mode and
mode and form
and form one
form one arm
one arm of
arm of the
of the HMG
the HMG box
Helix III is
III is less
is less rigid
less rigid makes
rigid makes an
makes an average
an average angle
average angle of
angle of about
of about 90
about 90 degrees
90 degrees with
degrees with helices
with helices I
helices I and
I and II
and II and
II and constitutes
and constitutes the
constitutes the other
the other arm
other arm of
arm of the
of the molecule
As in HMG1B
in HMG1B the
HMG1B the overall
the overall structure
overall structure of
structure of the
of the Sox-4
the Sox-4 HMG
Sox-4 HMG box
HMG box is
box is L-shaped
is L-shaped and
L-shaped and is
and is maintained
is maintained by
maintained by a
by a cluster
a cluster of
cluster of conserved
of conserved mainly
conserved mainly aromatic
mainly aromatic residues
Nuclear factor-IL6 activates
factor-IL6 activates the
activates the human
the human IL-4
human IL-4 promoter
IL-4 promoter in
promoter in T
in T cells
Positive regulatory element
regulatory element I
element I PRE-I
I PRE-I is
PRE-I is a
is a strong
a strong enhancer
strong enhancer element
enhancer element essential
element essential for
essential for expression
for expression of
expression of the
of the human
the human IL-4
human IL-4 gene
To identify transcription
identify transcription factors
transcription factors binding
factors binding to
binding to PRE-I
to PRE-I we
PRE-I we screened
we screened a
screened a cDNA
a cDNA expression
cDNA expression library
expression library from
library from Jurkat
from Jurkat T
Jurkat T cells
T cells and
cells and isolated
and isolated a
isolated a cDNA
a cDNA encoding
cDNA encoding nuclear
encoding nuclear factor
nuclear factor NF-IL6
factor NF-IL6 also
NF-IL6 also known
also known as
known as C/EBP
as C/EBP beta
NF-IL6 mRNA was
mRNA was found
was found in
found in human
in human Jurkat
human Jurkat T
Jurkat T cells
T cells and
cells and in
and in the
in the mouse
the mouse Th2
mouse Th2 clone
Th2 clone D10
clone D10 but
D10 but not
but not in
not in Th1
in Th1 clone
Th1 clone 29
rNF-IL6 expressed in
expressed in bacteria
in bacteria was
bacteria was shown
was shown to
shown to specifically
to specifically bind
specifically bind to
bind to PRE-I
PRE-I forms multiple
forms multiple DNA-protein
multiple DNA-protein complexes
DNA-protein complexes with
complexes with nuclear
with nuclear extracts
nuclear extracts from
extracts from Jurkat
from Jurkat cells
Some of these
of these complexes
these complexes were
complexes were demonstrated
were demonstrated to
demonstrated to contain
to contain NF-IL6
contain NF-IL6 by
NF-IL6 by using
by using anti-C/EBP
using anti-C/EBP beta
anti-C/EBP beta Abs
Overexpression of NF-IL6
of NF-IL6 enhanced
NF-IL6 enhanced expression
enhanced expression of
expression of the
of the chloramphenicol
the chloramphenicol acetyl
chloramphenicol acetyl transferase
acetyl transferase reporter
transferase reporter gene
reporter gene linked
gene linked to
linked to the
to the PRE-I-thymidine
the PRE-I-thymidine kinase
PRE-I-thymidine kinase or
kinase or the
or the human
the human IL-4
human IL-4 promoter
IL-4 promoter more
promoter more than
more than 10-fold
than 10-fold in
10-fold in Jurkat
in Jurkat cells
Promoter deletion studies
deletion studies revealed
studies revealed two
revealed two additional
two additional NF-IL6
additional NF-IL6 binding
NF-IL6 binding sites
binding sites located
sites located at
located at positions
at positions -44
positions -44 to
-44 to -36
to -36 C/EBP
-36 C/EBP proximal
C/EBP proximal and
proximal and -87
and -87 to
-87 to -79
to -79 C/EBP
-79 C/EBP medial
C/EBP medial respectively
Our results demonstrate
results demonstrate that
demonstrate that NF-IL6
that NF-IL6 is
NF-IL6 is involved
is involved in
involved in transcriptional
in transcriptional activation
transcriptional activation of
activation of the
of the human
the human IL-4
human IL-4 promoter
IL-4 promoter in
promoter in T
in T cells
Identification of an
of an I
an I kappa
I kappa B
kappa B alpha-associated
B alpha-associated protein
alpha-associated protein kinase
protein kinase in
kinase in a
in a human
a human monocytic
human monocytic cell
monocytic cell line
cell line and
line and determination
and determination of
determination of its
of its phosphorylation
its phosphorylation sites
phosphorylation sites on
sites on I
on I kappa
I kappa B
kappa B alpha
Nuclear factor kappa
factor kappa B
kappa B NF-kappa
B NF-kappa B
NF-kappa B is
B is stored
is stored in
stored in the
in the cytoplasm
the cytoplasm as
cytoplasm as an
as an inactive
an inactive form
inactive form through
form through interaction
through interaction with
interaction with I
with I kappa
I kappa B
Stimulation of cells
of cells leads
cells leads to
leads to a
to a rapid
a rapid phosphorylation
rapid phosphorylation of
phosphorylation of I
of I kappa
I kappa B
kappa B alpha
B alpha which
alpha which is
which is presumed
is presumed to
presumed to be
to be important
be important for
important for the
for the subsequent
the subsequent degradation
We have recently
have recently reported
recently reported the
reported the establishment
the establishment of
establishment of a
of a lipopolysaccharide
a lipopolysaccharide LPS-dependent
lipopolysaccharide LPS-dependent cell-free
LPS-dependent cell-free activation
cell-free activation system
activation system of
system of NF-kappa
of NF-kappa B
NF-kappa B in
B in association
in association with
association with the
with the induction
the induction of
induction of I
of I kappa
I kappa B
kappa B alpha
B alpha phosphorylation
In this study
this study we
study we have
we have identified
have identified a
identified a kinase
a kinase in
kinase in cell
in cell extracts
cell extracts from
extracts from the
from the LPS-stimulated
the LPS-stimulated human
LPS-stimulated human monocytic
human monocytic cell
monocytic cell line
cell line THP-1
line THP-1 that
THP-1 that specifically
that specifically binds
specifically binds and
binds and phosphorylates
and phosphorylates I
phosphorylates I kappa
I kappa B
kappa B alpha
LPS stimulation transiently
stimulation transiently enhanced
transiently enhanced the
enhanced the I
the I kappa
I kappa B
kappa B alpha-bound
B alpha-bound kinase
alpha-bound kinase activity
kinase activity in
activity in THP-1
in THP-1 cells
Mutational analyses of
analyses of I
of I kappa
I kappa B
kappa B alpha
B alpha and
alpha and competition
and competition experiments
competition experiments with
experiments with the
with the synthetic
the synthetic peptides
synthetic peptides identified
peptides identified major
identified major phosphorylation
major phosphorylation sites
phosphorylation sites by
sites by the
by the bound
the bound kinase
bound kinase as
kinase as Ser
as Ser and
Ser and Thr
and Thr residues
Thr residues in
residues in the
in the C-terminal
the C-terminal acidic
C-terminal acidic domain
acidic domain of
domain of I
of I kappa
I kappa B
kappa B alpha
Moreover we show
we show that
show that the
that the peptide
the peptide corresponding
peptide corresponding to
corresponding to the
to the C-terminal
the C-terminal acidic
C-terminal acidic domain
acidic domain of
domain of I
of I kappa
I kappa B
kappa B alpha
B alpha blocked
alpha blocked the
blocked the LPS-induced
the LPS-induced NF-kappa
LPS-induced NF-kappa B
NF-kappa B activation
B activation as
activation as well
as well as
well as inducible
as inducible phosphorylation
inducible phosphorylation of
phosphorylation of endogenous
of endogenous I
endogenous I kappa
I kappa B
kappa B alpha
B alpha in
alpha in a
in a cell-free
a cell-free system
cell-free system using
system using THP-1
using THP-1 cells
These results suggested
results suggested that
suggested that the
that the bound
the bound kinase
bound kinase is
kinase is involved
is involved in
involved in the
in the signaling
the signaling pathway
signaling pathway of
pathway of LPS
of LPS by
LPS by inducing
by inducing the
inducing the phosphorylation
the phosphorylation of
phosphorylation of the
of the C-terminal
the C-terminal region
C-terminal region of
region of I
of I kappa
I kappa B
kappa B alpha
B alpha and
alpha and subsequent
and subsequent dissociation
subsequent dissociation of
dissociation of the
of the NF-kappa
the NF-kappa BI
NF-kappa BI kappa
BI kappa B
kappa B alpha
B alpha complex
Bik a novel
a novel death-inducing
novel death-inducing protein
death-inducing protein shares
protein shares a
shares a distinct
a distinct sequence
distinct sequence motif
sequence motif with
motif with Bcl-2
with Bcl-2 family
Bcl-2 family proteins
family proteins and
proteins and interacts
and interacts with
interacts with viral
with viral and
viral and cellular
and cellular survival-promoting
cellular survival-promoting proteins
The survival-promoting activity
survival-promoting activity of
activity of the
of the Bcl-2
the Bcl-2 family
Bcl-2 family of
family of proteins
of proteins appears
proteins appears to
appears to be
to be modulated
be modulated by
modulated by interactions
by interactions between
interactions between various
between various cellular
various cellular proteins
We have identified
have identified a
identified a novel
a novel cellular
novel cellular protein
cellular protein Bik
protein Bik that
Bik that interacts
that interacts with
interacts with the
with the cellular
the cellular survival-promoting
cellular survival-promoting proteins
survival-promoting proteins Bcl-2
proteins Bcl-2 and
Bcl-2 and Bcl-xL
and Bcl-xL as
Bcl-xL as well
as well as
well as the
as the viral
the viral survival-promoting
viral survival-promoting proteins
survival-promoting proteins Epstein
proteins Epstein Barr
Epstein Barr virus-BHRF1
Barr virus-BHRF1 and
virus-BHRF1 and adenovirus
and adenovirus E1B-19
adenovirus E1B-19 kDa
In transient transfection
transient transfection assays
transfection assays Bik
assays Bik promotes
Bik promotes cell
promotes cell death
cell death in
death in a
in a manner
a manner similar
manner similar to
similar to the
to the death-promoting
the death-promoting members
death-promoting members of
members of the
of the Bcl-2
the Bcl-2 family
Bcl-2 family Bax
family Bax and
Bax and Bak
This death-promoting activity
death-promoting activity of
activity of Bik
of Bik can
Bik can be
can be suppressed
be suppressed by
suppressed by coexpression
by coexpression of
coexpression of Bcl-2
of Bcl-2 Bcl-XL
Bcl-2 Bcl-XL EBV-BHRF1
Bcl-XL EBV-BHRF1 and
EBV-BHRF1 and E1B-19
and E1B-19 kDa
E1B-19 kDa proteins
kDa proteins suggesting
proteins suggesting that
suggesting that Bik
that Bik may
Bik may be
may be a
be a common
a common target
common target for
target for both
for both cellular
both cellular and
cellular and viral
and viral anti-apoptotic
viral anti-apoptotic proteins
While Bik does
Bik does not
does not show
not show overt
show overt homology
overt homology to
homology to the
to the BH1
the BH1 and
BH1 and BH2
and BH2 conserved
BH2 conserved domains
conserved domains characteristic
domains characteristic of
characteristic of the
of the Bcl-2
the Bcl-2 family
Bcl-2 family it
family it does
it does share
does share a
share a 9
a 9 amino
9 amino acid
amino acid domain
acid domain BH3
domain BH3 with
BH3 with Bax
with Bax and
Bax and Bak
and Bak which
Bak which may
which may be
may be a
be a critical
a critical determinant
critical determinant for
determinant for the
for the death-promoting
the death-promoting activity
death-promoting activity of
activity of these
of these proteins
The human TCF-1
human TCF-1 gene
TCF-1 gene encodes
gene encodes a
encodes a nuclear
a nuclear DNA-binding
nuclear DNA-binding protein
DNA-binding protein uniquely
protein uniquely expressed
uniquely expressed in
expressed in normal
in normal and
normal and neoplastic
and neoplastic T-lineage
neoplastic T-lineage lymphocytes
The TCF-1 gene
TCF-1 gene encodes
gene encodes a
encodes a putative
a putative transcription
putative transcription factor
transcription factor with
factor with affinity
with affinity for
affinity for a
for a sequence
a sequence motif
sequence motif occurring
motif occurring in
occurring in a
in a number
a number of
number of T-cell
of T-cell enhancers
TCF-1 mRNA was
mRNA was originally
was originally found
originally found to
found to be
to be expressed
be expressed in
expressed in a
in a T
a T cell-specific
T cell-specific fashion
cell-specific fashion within
fashion within a
within a set
a set of
set of human
of human and
human and mouse
and mouse cell
mouse cell lines
In contrast expression
contrast expression reportedly
expression reportedly occurs
reportedly occurs in
occurs in multiple
in multiple nonlymphoid
multiple nonlymphoid tissues
nonlymphoid tissues during
tissues during murine
during murine embryogenesis
We have now
have now raised
now raised a
raised a monoclonal
a monoclonal antibody
monoclonal antibody to
antibody to document
to document expression
document expression and
expression and biochemistry
and biochemistry of
biochemistry of the
of the human
the human TCF-1
human TCF-1 protein
As expected the
expected the TCF-1
the TCF-1 protein
TCF-1 protein was
protein was detectable
was detectable only
detectable only in
only in cell
in cell lines
cell lines of
lines of T
of T lineage
Its expression was
expression was always
was always restricted
always restricted to
restricted to the
to the nucleus
Immunohistochemistry on a
on a panel
a panel of
panel of human
of human tissues
human tissues revealed
tissues revealed that
revealed that the
that the TCF-1
the TCF-1 protein
TCF-1 protein was
protein was found
was found exclusively
found exclusively in
exclusively in thymocytes
in thymocytes and
thymocytes and in
and in CD3+
in CD3+ T
CD3+ T cells
T cells in
cells in peripheral
in peripheral lymphoid
peripheral lymphoid tissues
Western blotting yielded
blotting yielded a
yielded a set
a set of
set of bands
of bands ranging
bands ranging from
ranging from 25
from 25 kD
25 kD to
kD to 55
to 55 kD
55 kD resulting
kD resulting from
resulting from extensive
from extensive alternative
extensive alternative splicing
The TCF-1 protein
TCF-1 protein was
protein was detectable
was detectable in
detectable in all
in all samples
all samples of
samples of a
of a set
a set of
set of 22
of 22 T-cell
22 T-cell malignancies
T-cell malignancies of
malignancies of various
of various stages
various stages of
stages of maturation
of maturation but
maturation but was
but was absent
was absent from
absent from a
from a large
a large number
large number of
number of other
of other hematologic
other hematologic neoplasms
These observations imply
observations imply a
imply a T
a T cell-specific
T cell-specific function
cell-specific function for
function for TCF-1
for TCF-1 a
TCF-1 a notion
a notion corroborated
notion corroborated by
corroborated by recent
by recent observations
recent observations on
observations on Tcf-1
on Tcf-1 knock-out
Tcf-1 knock-out mice
In addition these
addition these results
these results indicate
results indicate that
indicate that nuclear
that nuclear TCF-1
nuclear TCF-1 expression
TCF-1 expression can
expression can serve
can serve as
serve as a
as a pan-T-lineage
a pan-T-lineage marker
pan-T-lineage marker in
marker in the
in the diagnosis
the diagnosis of
diagnosis of lymphoid
of lymphoid malignancies
Cross-linking of Fc
of Fc gamma
Fc gamma receptors
gamma receptors activates
receptors activates HIV-1
activates HIV-1 long
HIV-1 long terminal
long terminal repeat-driven
terminal repeat-driven transcription
repeat-driven transcription in
transcription in human
in human monocytes
Elevation of the
of the levels
the levels of
levels of circulating
of circulating immune
circulating immune complexes
immune complexes frequently
complexes frequently accompanies
frequently accompanies HIV-1
accompanies HIV-1 infection
HIV-1 infection and
infection and is
and is a
is a prognostic
a prognostic indicator
prognostic indicator of
indicator of clinical
of clinical progression
clinical progression from
progression from asymptomatic
from asymptomatic infection
asymptomatic infection to
infection to AIDS
Here we report
we report that
report that cross-linking
that cross-linking of
cross-linking of Fc
of Fc gamma
Fc gamma RI
gamma RI or
RI or Fc
or Fc gamma
Fc gamma RII
gamma RII by
RII by adherent
by adherent human
adherent human IgG
human IgG or
IgG or by
or by specific
by specific anti-Fc
specific anti-Fc gamma
anti-Fc gamma R
gamma R mAb
R mAb activates
mAb activates HIV-1
activates HIV-1 gene
HIV-1 gene expression
gene expression in
expression in the
in the human
the human monocytic
human monocytic cell
monocytic cell line
cell line BF24
line BF24 and
BF24 and increased
and increased HIV
increased HIV RNA
HIV RNA expression
RNA expression in
expression in monocytes
in monocytes from
monocytes from HIV
from HIV infected
HIV infected patients
infected patients as
patients as assayed
as assayed by
assayed by reverse
by reverse transcription-PCR
In THP-1 cells
THP-1 cells Fc
cells Fc gamma
Fc gamma R
gamma R cross-linking
R cross-linking induced
cross-linking induced NF-kappa
induced NF-kappa B
NF-kappa B which
B which is
which is known
is known to
known to bind
to bind to
bind to the
to the regulatory
the regulatory region
regulatory region of
region of the
of the long
the long terminal
long terminal repeat
terminal repeat LTR
repeat LTR of
LTR of HIV-1
of HIV-1 and
HIV-1 and to
and to activate
to activate HIV-1
activate HIV-1 transcription
HIV-1 transcription Anti-TNF-alpha
transcription Anti-TNF-alpha antibody
Anti-TNF-alpha antibody but
antibody but not
but not anti-IL-1
not anti-IL-1 beta
anti-IL-1 beta antibody
beta antibody strongly
antibody strongly inhibited
strongly inhibited both
inhibited both the
both the induction
the induction of
induction of HIV-1-LTR-driven
of HIV-1-LTR-driven transcription
HIV-1-LTR-driven transcription and
transcription and the
and the induction
the induction of
induction of NF-kappa
of NF-kappa B
NF-kappa B by
B by Fc
by Fc gamma
Fc gamma R
gamma R cross-linking
These results indicate
results indicate that
indicate that Fc
that Fc gamma
Fc gamma R
gamma R can
R can mediate
can mediate a
mediate a TNF-alpha-dependent
a TNF-alpha-dependent induction
TNF-alpha-dependent induction of
induction of HIV-1
of HIV-1 gene
HIV-1 gene transcription
gene transcription and
transcription and suggest
and suggest that
suggest that immune
that immune complexes
immune complexes may
complexes may contribute
may contribute to
contribute to the
to the pathophysiology
the pathophysiology of
pathophysiology of HIV-1
of HIV-1 infection
HIV-1 infection by
infection by augmenting
by augmenting viral
augmenting viral replication
viral replication in
replication in monocytes
Signalling via CD28
via CD28 of
CD28 of human
of human naive
human naive neonatal
naive neonatal T
neonatal T lymphocytes
Accessory molecules play
molecules play a
play a crucial
a crucial role
crucial role in
role in the
in the development
the development of
development of the
of the T
the T cell
T cell response
cell response to
response to antigenic
to antigenic challenge
We have examined
have examined the
examined the role
the role of
role of CD28
of CD28 in
CD28 in modulating
in modulating the
modulating the 'naive'
the 'naive' neonatal
'naive' neonatal T
neonatal T cell
T cell response
cell response to
response to anti-CD2-mediated
to anti-CD2-mediated activation
To compare the
compare the role
the role of
role of CD28
of CD28 neonatal
CD28 neonatal and
neonatal and adult
and adult T
adult T cells
T cells were
cells were stimulated
were stimulated with
stimulated with a
with a pair
a pair of
pair of mitogenic
of mitogenic anti-CD2
mitogenic anti-CD2 antibodies
anti-CD2 antibodies in
antibodies in the
in the presence
the presence or
presence or absence
or absence of
absence of anti-CD28
of anti-CD28 MoAb
With anti-CD2 alone
anti-CD2 alone neonatal
alone neonatal T
neonatal T cells
T cells proliferated
cells proliferated slightly
proliferated slightly but
slightly but produced
but produced no
produced no detectable
no detectable IL-2
detectable IL-2 whereas
IL-2 whereas adult
whereas adult T
adult T cells
T cells proliferated
cells proliferated vigorously
proliferated vigorously with
vigorously with significant
with significant IL-2
significant IL-2 production
Costimulation with anti-CD28
with anti-CD28 MoAb
anti-CD28 MoAb greatly
MoAb greatly enhanced
greatly enhanced the
enhanced the proliferative
the proliferative response
proliferative response of
response of neonatal
of neonatal T
neonatal T cells
T cells to
cells to levels
to levels equivalent
levels equivalent to
equivalent to those
to those of
those of adult
of adult T
adult T cells
T cells whereas
cells whereas adult
whereas adult T
adult T cells
T cells showed
cells showed only
showed only slight
only slight increases
Although IL-2 secretion
IL-2 secretion was
secretion was increased
was increased in
increased in the
in the presence
the presence of
presence of anti-CD28
of anti-CD28 MoAb
anti-CD28 MoAb neonatal
MoAb neonatal T
neonatal T cell
T cell IL-2
cell IL-2 production
IL-2 production remained
production remained lower
remained lower than
lower than in
than in adults
In contrast enhancement
contrast enhancement of
enhancement of IL-2
of IL-2 mRNA
IL-2 mRNA expression
mRNA expression in
expression in neonates
in neonates was
neonates was similar
was similar to
similar to adult
to adult levels
Anti-CD28 MoAb costimulation
MoAb costimulation increased
costimulation increased NF
increased NF kappa
NF kappa B
kappa B levels
B levels in
levels in neonates
in neonates albeit
neonates albeit to
albeit to levels
to levels lower
levels lower than
lower than that
than that of
that of adults
The cellular mechanism
cellular mechanism governing
mechanism governing the
governing the diminished
the diminished proliferative
diminished proliferative response
proliferative response of
response of neonatal
of neonatal T
neonatal T lymphocytes
T lymphocytes to
lymphocytes to anti-CD2
to anti-CD2 may
anti-CD2 may therefore
may therefore be
therefore be due
be due to
due to decreased
to decreased NF
decreased NF kappa
NF kappa B
kappa B induction
B induction reduced
induction reduced IL-2
reduced IL-2 mRNA
IL-2 mRNA expression
mRNA expression and
expression and deficient
and deficient IL-2
deficient IL-2 production
Although anti-CD28 MoAb
anti-CD28 MoAb costimulation
MoAb costimulation enhances
costimulation enhances all
enhances all of
all of the
of the above
the above signals
above signals NF
signals NF kappa
NF kappa B
kappa B and
B and IL-2
and IL-2 levels
IL-2 levels remain
levels remain lower
remain lower than
lower than in
than in adults
in adults suggesting
adults suggesting the
suggesting the need
the need for
need for further
for further activation
further activation requirements
activation requirements in
requirements in the
in the neonate
TCL1 oncogene activation
oncogene activation in
activation in preleukemic
in preleukemic T
preleukemic T cells
T cells from
cells from a
from a case
a case of
case of ataxia-telangiectasia
The TCL1 oncogene
TCL1 oncogene on
oncogene on human
on human chromosome
human chromosome 14q321
chromosome 14q321 is
14q321 is involved
is involved in
involved in chromosome
in chromosome translocations
chromosome translocations [t14;14q11;q321
translocations [t14;14q11;q321 and
[t14;14q11;q321 and t7;14q35;q321]
and t7;14q35;q321] and
t7;14q35;q321] and inversions
and inversions [inv14q11;q321]
inversions [inv14q11;q321] with
[inv14q11;q321] with TCR
with TCR alpha/beta
TCR alpha/beta loci
alpha/beta loci in
loci in T-cell
in T-cell leukemias
T-cell leukemias such
leukemias such as
such as T-prolymphocytic
as T-prolymphocytic T-PLL
It is also
is also involved
also involved in
involved in T-
in T- acute
T- acute and-
acute and- chronic
and- chronic leukemias
chronic leukemias arising
leukemias arising in
arising in cases
in cases of
cases of ataxia-telangiectasia
of ataxia-telangiectasia AT
ataxia-telangiectasia AT an
AT an immunodeficiency
an immunodeficiency syndrome
Similar chromosomal rearrangements
chromosomal rearrangements occur
rearrangements occur also
occur also in
also in the
in the clonally
the clonally expanded
clonally expanded T
expanded T cells
T cells in
cells in AT
in AT patients
AT patients before
patients before the
before the appearance
the appearance of
appearance of the
of the overt
the overt leukemia
We have analyzed
have analyzed the
analyzed the expression
the expression of
expression of TCL1
of TCL1 mRNA
TCL1 mRNA and
mRNA and protein
and protein in
protein in peripheral
in peripheral blood
peripheral blood lymphocytes
blood lymphocytes PBLs
lymphocytes PBLs from
PBLs from four
from four AT
four AT cases
AT cases and
cases and from
and from healthy
from healthy controls
We found that
found that the
that the TCL1
the TCL1 gene
TCL1 gene was
gene was overexpressed
was overexpressed in
overexpressed in the
in the PBLs
the PBLs of
PBLs of an
of an AT
an AT patient
AT patient with
patient with a
with a large
a large clonal
large clonal T-cell
clonal T-cell population
T-cell population exhibiting
population exhibiting the
exhibiting the t14;14
the t14;14 translocation
t14;14 translocation but
translocation but not
but not in
not in the
in the lymphocytes
the lymphocytes of
lymphocytes of the
of the other
the other cases
Fluorescence in situ
in situ hybridization
situ hybridization of
hybridization of the
of the TCL1
the TCL1 genomic
TCL1 genomic locus
genomic locus to
locus to lymphocyte
to lymphocyte metaphases
lymphocyte metaphases from
metaphases from the
from the AT
the AT patient
AT patient with
patient with the
with the T-cell
the T-cell clonal
T-cell clonal expansion
clonal expansion showed
expansion showed that
showed that the
that the breakpoint
the breakpoint of
breakpoint of the
of the t14;14
the t14;14 translocation
t14;14 translocation lies
translocation lies within
lies within the
within the TCL1
the TCL1 locus
TCL1 locus and
locus and is
and is accompanied
is accompanied by
accompanied by an
by an inverted
an inverted duplication
inverted duplication of
duplication of the
of the distal
the distal part
distal part of
part of chromosome
of chromosome 14
These data indicate
data indicate that
indicate that TCL1
that TCL1 is
TCL1 is activated
is activated in
activated in preleukemic
in preleukemic clonal
preleukemic clonal cells
clonal cells as
cells as a
as a consequence
a consequence of
consequence of chromosome
of chromosome translocation
chromosome translocation involving
translocation involving sequences
involving sequences from
sequences from the
from the TCR
the TCR locus
TCR locus at
locus at 14q11
Deregulation of TCL1
of TCL1 is
TCL1 is the
is the first
the first event
first event in
event in the
in the initiation
the initiation of
initiation of malignancy
of malignancy in
malignancy in these
in these types
these types of
types of leukemias
of leukemias and
leukemias and represents
and represents a
represents a potential
a potential tool
potential tool for
tool for clinical
for clinical evaluation
C/EBP proteins activate
proteins activate transcription
activate transcription from
transcription from the
from the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 long
1 long terminal
long terminal repeat
terminal repeat in
repeat in macrophages/monocytes
Three binding sites
binding sites for
sites for C/EBP
for C/EBP proteins
C/EBP proteins are
proteins are found
are found in
found in the
in the human
the human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 long
HIV-1 long terminal
long terminal repeat
terminal repeat LTR
repeat LTR VM
LTR VM Tesmer
VM Tesmer ARajadhyaksha
Tesmer ARajadhyaksha JBabin
ARajadhyaksha JBabin and
JBabin and MBina
and MBina ProcNatlAcadSci
MBina ProcNatlAcadSci USA
ProcNatlAcadSci USA 90:7298-7302
USA 90:7298-7302 1993
We have determined
have determined the
determined the functional
the functional role
functional role of
role of C/EBP
of C/EBP proteins
C/EBP proteins and
proteins and C/EBP
and C/EBP sites
C/EBP sites in
sites in regulating
in regulating transcription
regulating transcription from
transcription from the
from the HIV-
the HIV- 1
HIV- 1 LTR
1 LTR in
LTR in monocytes/macrophages
Inhibition of endogenous
of endogenous C/EBP
endogenous C/EBP proteins
C/EBP proteins using
proteins using either
using either an
either an excess
an excess of
excess of C/EBP
of C/EBP binding
C/EBP binding sites
binding sites or
sites or a
or a trans-
a trans- dominant
trans- dominant negative
dominant negative inhibitor
negative inhibitor demonstrated
inhibitor demonstrated that
demonstrated that C/EBP
that C/EBP proteins
C/EBP proteins are
proteins are required
are required for
required for basal
for basal and
basal and activated
and activated levels
activated levels of
levels of HIV-1
of HIV-1 LTR
HIV-1 LTR transcription
LTR transcription in
transcription in the
in the promonocytic
the promonocytic cell
promonocytic cell line
cell line U937
Northern RNA blots
RNA blots and
blots and binding
and binding assays
binding assays showed
assays showed that
showed that NF-IL6
that NF-IL6 is
NF-IL6 is the
is the only
the only known
only known C/EBP
known C/EBP family
C/EBP family member
family member which
member which is
which is increased
is increased when
increased when U937
when U937 cells
U937 cells are
cells are activated
Mutational analyses of
analyses of the
of the HIV-1
the HIV-1 LTR
HIV-1 LTR showed
LTR showed that
showed that one
that one C/EBP
one C/EBP site
C/EBP site is
site is required
is required for
required for normal
for normal LTR
normal LTR transcription
LTR transcription both
transcription both before
both before and
before and after
and after cellular
after cellular activation
cellular activation and
activation and that
and that the
that the two
the two 3'
two 3' C/EBP
3' C/EBP sites
C/EBP sites are
sites are functionally
are functionally equivalent
However transcription from
transcription from crippled
from crippled HIV-1
crippled HIV-1 LTRs
HIV-1 LTRs lacking
LTRs lacking C/EBP
lacking C/EBP sites
C/EBP sites can
sites can still
can still be
still be induced
be induced following
induced following activation
following activation of
activation of U937
of U937 cells
Several models are
models are suggested
are suggested for
suggested for how
for how elevated
how elevated NF-IL6
elevated NF-IL6 may
NF-IL6 may participate
may participate in
participate in an
in an autostimulatory
an autostimulatory loop
autostimulatory loop involving
loop involving HIV
involving HIV infection
HIV infection macrophage
infection macrophage activation
macrophage activation cytokine
activation cytokine expression
cytokine expression and
expression and HIV
and HIV replication
Human immunodeficiency virus
immunodeficiency virus type-2
virus type-2 gene
type-2 gene expression:
gene expression: two
expression: two enhancers
two enhancers and
enhancers and their
and their activation
their activation by
activation by T-cell
by T-cell activators
The human immunodeficiency
human immunodeficiency viruses
immunodeficiency viruses HIVs
viruses HIVs may
HIVs may include
may include a
include a spectrum
a spectrum of
spectrum of retroviruses
of retroviruses with
retroviruses with varying
with varying potential
varying potential to
potential to infect
to infect their
infect their host
their host undergo
host undergo long
undergo long periods
long periods of
periods of latent
of latent infection
latent infection and
infection and induce
and induce pathology
Since expression of
expression of the
of the viruses
the viruses is
viruses is in
is in large
in large part
large part regulated
part regulated by
regulated by the
by the sequence
the sequence elements
sequence elements in
elements in their
in their long
their long terminal
long terminal repeats
terminal repeats LTRs
repeats LTRs this
LTRs this study
this study was
study was directed
was directed to
directed to an
to an analysis
an analysis of
analysis of the
of the regulatory
the regulatory elements
regulatory elements in
elements in the
in the HIV-2
the HIV-2 LTR
The HIV-2 LTR
HIV-2 LTR was
LTR was found
was found to
found to contain
to contain two
contain two enhancers
One of these
of these enhancers
these enhancers is
enhancers is in
is in part
in part identical
part identical to
identical to the
to the HIV-1
the HIV-1 enhancer
This enhancer in
enhancer in HIV-1
in HIV-1 is
HIV-1 is the
is the T-cell
the T-cell activation
T-cell activation response
activation response element;
response element; in
element; in HIV-2
in HIV-2 however
HIV-2 however it
however it is
it is the
is the second
the second enhancer
second enhancer that
enhancer that is
that is mainly
is mainly responsible
mainly responsible for
responsible for activation
for activation in
activation in response
in response to
response to T-cell
to T-cell activators
The second enhancer
second enhancer interacts
enhancer interacts with
interacts with two
with two nuclear
two nuclear binding
nuclear binding proteins
binding proteins 85
proteins 85 kD
85 kD and
kD and 27
and 27 kD
27 kD mobility
kD mobility that
mobility that appear
that appear to
appear to be
to be required
be required for
required for optimal
for optimal enhancer
optimal enhancer function
enhancer function and
function and activation
Observations such as
such as these
as these encourage
these encourage the
encourage the speculation
the speculation that
speculation that there
that there may
there may be
may be subtle
be subtle differences
subtle differences in
differences in the
in the regulation
the regulation of
regulation of HIV-1
of HIV-1 and
HIV-1 and HIV-2
and HIV-2 expression
HIV-2 expression that
expression that may
that may be
may be relevant
be relevant to
relevant to the
to the possible
the possible longer
possible longer latency
longer latency and
latency and reduced
and reduced pathogenicity
reduced pathogenicity of
pathogenicity of HIV-2
NF-M chicken C/EBP
chicken C/EBP beta
C/EBP beta induces
beta induces eosinophilic
induces eosinophilic differentiation
eosinophilic differentiation and
differentiation and apoptosis
and apoptosis in
apoptosis in a
in a hematopoietic
a hematopoietic progenitor
hematopoietic progenitor cell
progenitor cell line
CAAT/enhancer binding proteins
binding proteins C/EBPs
proteins C/EBPs are
C/EBPs are transcriptional
are transcriptional activators
transcriptional activators implicated
activators implicated in
implicated in the
in the differentiation
the differentiation processes
differentiation processes of
processes of various
of various cell
various cell lineages
We have shown
have shown earlier
shown earlier that
earlier that NF-M
that NF-M the
NF-M the chicken
the chicken homolog
chicken homolog of
homolog of C/EBP
of C/EBP beta
C/EBP beta is
beta is specifically
is specifically expressed
specifically expressed in
expressed in myelomonocytic
in myelomonocytic and
myelomonocytic and eosinophilic
and eosinophilic cells
eosinophilic cells of
cells of the
of the hematopoietic
the hematopoietic system
To investigate the
investigate the role
the role of
role of NF-M
of NF-M in
NF-M in hematopoietic
in hematopoietic cell
hematopoietic cell lineage
cell lineage commitment
lineage commitment we
commitment we constructed
we constructed a
constructed a conditional
a conditional form
conditional form of
form of the
of the protein
the protein by
protein by fusing
by fusing it
fusing it to
it to the
to the hormone
the hormone binding
hormone binding domain
binding domain of
domain of the
of the human
the human estrogen
human estrogen receptor
This construct was
construct was stably
was stably expressed
stably expressed in
expressed in a
in a multipotent
a multipotent progenitor
multipotent progenitor cell
progenitor cell line
cell line transformed
line transformed by
transformed by the
by the Myb-Ets
the Myb-Ets oncoprotein
We report here
report here that
here that both
that both NF-M-dependent
both NF-M-dependent promoter
NF-M-dependent promoter constructs
promoter constructs and
constructs and resident
and resident genes
resident genes could
genes could be
could be activated
be activated by
activated by addition
by addition of
addition of beta-estradiol
of beta-estradiol to
beta-estradiol to the
to the NF-M-estrogen
the NF-M-estrogen receptor
NF-M-estrogen receptor expressing
receptor expressing progenitors
At the same
the same time
same time we
time we observed
we observed a
observed a down-regulation
a down-regulation of
down-regulation of progenitor-specific
of progenitor-specific surface
progenitor-specific surface markers
surface markers and
markers and the
and the up-regulation
the up-regulation of
up-regulation of differentiation
of differentiation markers
differentiation markers restricted
markers restricted to
restricted to the
to the eosinophil
the eosinophil and
eosinophil and myeloid
and myeloid lineages
In addition to
addition to the
to the onset
the onset of
onset of differentiation
of differentiation cell
differentiation cell death
cell death was
death was induced
was induced with
induced with typical
with typical apoptotic
typical apoptotic features
Our results suggest
results suggest that
suggest that NF-M
that NF-M plays
NF-M plays an
plays an important
an important role
important role in
role in commitment
in commitment along
commitment along the
along the eosinophil
the eosinophil lineage
eosinophil lineage and
lineage and in
and in the
in the induction
the induction of
induction of apoptosis
Prolactin and interleukin-2
and interleukin-2 receptors
interleukin-2 receptors in
receptors in T
in T lymphocytes
T lymphocytes signal
lymphocytes signal through
signal through a
through a MGF-STAT5-like
a MGF-STAT5-like transcription
MGF-STAT5-like transcription factor
The cell surface
cell surface receptors
surface receptors for
receptors for PRL
for PRL and
PRL and interleukin-2
and interleukin-2 IL-2
interleukin-2 IL-2 are
IL-2 are structurally
are structurally distinct
structurally distinct but
distinct but share
but share regulatory
share regulatory tasks
regulatory tasks in
tasks in T
in T lymphocytes
They can stimulate
can stimulate proliferation
stimulate proliferation and
proliferation and activate
and activate transcription
activate transcription of
transcription of over-lapping
of over-lapping sets
over-lapping sets of
sets of genes
of genes of
genes of T
of T cells
PRL and IL-2
and IL-2 receptor
IL-2 receptor activation
receptor activation are
activation are both
are both linked
both linked to
linked to the
to the Jak/Stat
the Jak/Stat signal
Jak/Stat signal transducer
signal transducer and
transducer and activator
and activator of
activator of transcription
of transcription pathway
We investigated the
investigated the ability
the ability of
ability of PRL
of PRL and
PRL and IL-2
and IL-2 to
IL-2 to activate
to activate Stat
activate Stat proteins
Stat proteins in
proteins in different
in different T
different T cell
T cell lines
The DNA binding
DNA binding specificities
binding specificities the
specificities the reactivities
the reactivities toward
reactivities toward Stat-specific
toward Stat-specific antisera
Stat-specific antisera and
antisera and the
and the mol
the mol wt
mol wt of
wt of IL-2
of IL-2 -and
IL-2 -and PRL-induced
-and PRL-induced DNA-binding
PRL-induced DNA-binding proteins
DNA-binding proteins in
proteins in Nb2
in Nb2 and
Nb2 and C196
and C196 T
C196 T cell
T cell lines
cell lines were
lines were investigated
A comparison with
comparison with the
with the Stat
the Stat proteins
Stat proteins induced
proteins induced by
induced by interferon-gamma
by interferon-gamma PRL
interferon-gamma PRL and
PRL and IL-6
and IL-6 in
IL-6 in T47D
in T47D mammary
T47D mammary tumor
mammary tumor cells
tumor cells was
cells was made
We found that
found that these
that these parameters
these parameters were
parameters were indistinguishable
were indistinguishable for
indistinguishable for one
for one of
one of the
of the PRL-
the PRL- and
PRL- and IL-2-induced
and IL-2-induced factors
A transcription factor
transcription factor closely
factor closely related
closely related to
related to mammary
to mammary gland
mammary gland factor-Stat5
gland factor-Stat5 is
factor-Stat5 is rapidly
is rapidly activated
rapidly activated upon
activated upon interaction
upon interaction of
interaction of IL-2
of IL-2 and
IL-2 and PRL
and PRL with
PRL with their
with their respective
their respective receptors
Activation of a
of a second
a second protein
second protein related
protein related to
related to Stat1
to Stat1 was
Stat1 was also
was also observed
Our results emphasize
results emphasize the
emphasize the role
the role of
role of PRL
of PRL as
PRL as a
as a regulator
a regulator of
regulator of the
of the immune
the immune response
immune response and
response and indicate
and indicate that
indicate that the
that the Stat
the Stat factors
Stat factors mammary
factors mammary gland
mammary gland factor-Stat5
gland factor-Stat5 and
factor-Stat5 and Stat1
and Stat1 play
Stat1 play a
play a role
a role in
role in the
in the regulation
the regulation of
regulation of gene
of gene expression
gene expression during
expression during T
during T cell
T cell development
ETS1 transactivates the
transactivates the human
the human GM-CSF
human GM-CSF promoter
GM-CSF promoter in
promoter in Jurkat
in Jurkat T
Jurkat T cells
T cells stimulated
cells stimulated with
stimulated with PMA
with PMA and
PMA and ionomycin
Activation of T
of T helper
T helper cells
helper cells results
cells results in
results in coordinate
in coordinate expression
coordinate expression of
expression of a
of a number
a number of
number of cytokines
of cytokines involved
cytokines involved in
involved in differentiation
in differentiation proliferation
differentiation proliferation and
proliferation and activation
and activation of
activation of the
of the haematopoietic
the haematopoietic system
Granulocyte-macrophage colony-stimulating factor
colony-stimulating factor GM-CSF
factor GM-CSF is
GM-CSF is one
is one such
one such cytokine
such cytokine whose
cytokine whose increased
whose increased expression
increased expression results
expression results partly
results partly from
partly from increases
from increases in
increases in transcription
Cis-acting elements with
elements with NF
with NF kappa
NF kappa B
kappa B AP-1
B AP-1 and
AP-1 and ETS-like
and ETS-like motifs
ETS-like motifs have
motifs have been
have been identified
been identified in
identified in the
in the promoter
the promoter region
promoter region of
region of the
of the GM-CSF
the GM-CSF gene
GM-CSF gene which
gene which are
which are important
are important for
important for transcriptional
for transcriptional activity
transcriptional activity following
activity following PMA
following PMA and
PMA and ionomycin
and ionomycin stimulation
A number of
number of the
of the ETS
the ETS family
ETS family of
family of transcription
of transcription factors
transcription factors are
factors are expressed
are expressed in
expressed in T
in T cells
T cells including
cells including ETS1
including ETS1 and
ETS1 and ELF1
Here we describe
we describe the
describe the ability
the ability of
ability of these
of these factors
these factors to
factors to interact
to interact with
interact with a
with a site
a site GM5
site GM5 located
GM5 located within
located within the
within the CLE0
the CLE0 element
CLE0 element -47
element -47 to
-47 to -40
to -40 upstream
-40 upstream of
upstream of the
of the GM-CSF
the GM-CSF transcription
GM-CSF transcription initiation
transcription initiation site
Exogenous ETS1 but
ETS1 but not
but not ELF1
not ELF1 can
ELF1 can transactivate
can transactivate GM-CSF
transactivate GM-CSF through
GM-CSF through the
through the GM5
the GM5 site
GM5 site in
site in a
in a PMA/ionomycin
a PMA/ionomycin dependent
PMA/ionomycin dependent manner
Other unidentified ETS-like
unidentified ETS-like factors
ETS-like factors present
factors present in
present in Jurkat
in Jurkat cells
Jurkat cells are
cells are also
are also capable
also capable of
capable of binding
of binding GM5
Mutation of the
of the core
the core ETS
core ETS binding
ETS binding site
binding site from
site from -GGAA-
from -GGAA- to
-GGAA- to -GGAT-
to -GGAT- prevents
-GGAT- prevents the
prevents the binding
the binding of
binding of ETS-like
of ETS-like factors
ETS-like factors with
factors with the
with the exception
the exception of
exception of ETS1
The GM-CSF promoter
GM-CSF promoter modified
promoter modified in
modified in this
in this way
this way to
way to be
to be ETS1
be ETS1 specific
ETS1 specific is
specific is fully
is fully responsive
fully responsive to
responsive to PMA/ionomycin
to PMA/ionomycin induction
PMA/ionomycin induction in
induction in addition
in addition to
addition to ETS1
to ETS1 transactivation
ETS1 transactivation in
transactivation in the
in the presence
the presence of
presence of PMA
of PMA and
PMA and ionomycin
Together these data
these data suggest
data suggest that
suggest that ETS1
that ETS1 may
ETS1 may be
may be involved
be involved in
involved in mediating
in mediating the
mediating the increased
the increased GM-CSF
increased GM-CSF production
GM-CSF production associated
production associated with
associated with T
with T cell
T cell activation
Quantitation of beta
of beta 1
beta 1 triiodothyronine
1 triiodothyronine receptor
triiodothyronine receptor mRNA
receptor mRNA in
mRNA in human
in human tissues
human tissues by
tissues by competitive
by competitive reverse
competitive reverse transcription
reverse transcription polymerase
transcription polymerase chain
polymerase chain reaction
Thyroid hormones act
hormones act by
act by binding
by binding to
binding to nuclear
to nuclear receptor
nuclear receptor proteins
receptor proteins the
proteins the thyroid
the thyroid hormone
thyroid hormone receptors
hormone receptors TR
receptors TR alpha
TR alpha and
alpha and beta
Data from cell
from cell culture
cell culture and
culture and animal
and animal studies
animal studies indicate
studies indicate that
indicate that TR
that TR expression
TR expression may
expression may be
may be regulated
be regulated to
regulated to modulate
to modulate target
modulate target organ
target organ responsiveness
organ responsiveness to
responsiveness to thyroid
to thyroid hormone
To investigate whether
investigate whether such
whether such adaptive
such adaptive changes
adaptive changes in
changes in TR
in TR expression
TR expression occur
expression occur in
occur in humans
in humans we
humans we determined
we determined the
determined the mRNA
the mRNA levels
mRNA levels of
levels of the
of the hTR
the hTR beta
hTR beta 1
beta 1 in
1 in various
in various thyroid
various thyroid states
Patients with overt
with overt hypo
overt hypo -or
hypo -or hyperthyroidism
-or hyperthyroidism were
hyperthyroidism were enrolled
were enrolled in
enrolled in the
in the study
Total RNA was
RNA was isolated
was isolated from
isolated from peripheral
from peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells and
cells and hTR
and hTR beta
hTR beta 1
beta 1 mRNA
1 mRNA levels
mRNA levels determined
levels determined by
determined by quantitative
by quantitative competitive
quantitative competitive reverse
competitive reverse transcription
reverse transcription PCR
For comparison hTR
comparison hTR beta
hTR beta 1
beta 1 mRNA
1 mRNA levels
mRNA levels were
levels were determined
were determined in
determined in lymphocytes
in lymphocytes and
lymphocytes and normal
and normal thyroid
normal thyroid tissue
thyroid tissue of
tissue of euthyroid
of euthyroid patients
Human TR beta
TR beta 1
beta 1 mRNA
1 mRNA levels
mRNA levels in
levels in lymphocytes
in lymphocytes were
lymphocytes were 18
were 18 +/-
18 +/- 04
+/- 04 19
04 19 +/-
19 +/- 05
+/- 05 11
05 11 +/-
11 +/- 04
+/- 04 10-18
04 10-18 mol/microgram
10-18 mol/microgram RNA
mol/microgram RNA in
RNA in hypo-
in hypo- eu
hypo- eu -and
eu -and hyperthyroid
-and hyperthyroid patients
hyperthyroid patients respectively
patients respectively corresponding
respectively corresponding to
corresponding to an
to an estimated
an estimated 05
estimated 05 -2
05 -2 molecules
-2 molecules per
molecules per cell
Although the mean
the mean hTR
mean hTR beta
hTR beta 1
beta 1 mRNA
1 mRNA levels
mRNA levels were
levels were 40%
were 40% lower
40% lower in
lower in hyperthyroid
in hyperthyroid than
hyperthyroid than in
than in euthyroid
in euthyroid subjects
euthyroid subjects this
subjects this difference
this difference did
difference did not
did not reach
not reach statistical
reach statistical significance
Similar levels of
levels of hTR
of hTR beta
hTR beta 1
beta 1 mRNA
1 mRNA levels
mRNA levels were
levels were detected
were detected in
detected in thyroid
in thyroid gland
thyroid gland from
gland from euthyroid
from euthyroid patients
In summary we
summary we developed
we developed an
developed an assay
an assay for
assay for the
for the quantitative
the quantitative determination
quantitative determination of
determination of hTR
of hTR beta
hTR beta 1
beta 1 mRNA
1 mRNA levels
mRNA levels in
levels in small
in small human
small human tissue
human tissue samples
tissue samples containing
samples containing as
containing as little
as little as
little as 50
as 50 ng
50 ng of
ng of total
of total RNA
Absolute hTR beta
hTR beta 1
beta 1 mRNA
1 mRNA levels
mRNA levels are
levels are very
are very low
very low with
low with an
with an estimated
an estimated one
estimated one molecule
one molecule of
molecule of mRNA
of mRNA being
mRNA being present
being present in
present in a
in a mononuclear
a mononuclear blood
mononuclear blood cell
blood cell or
cell or thyrocyte
No up-regulation of
up-regulation of hTR
of hTR beta
hTR beta 1
beta 1 was
1 was seen
was seen in
seen in hypothyroid
in hypothyroid relative
hypothyroid relative to
relative to euthyroid
to euthyroid patients
However there is
there is a
is a non-significant
a non-significant trend
non-significant trend towards
trend towards a
towards a down-regulation
a down-regulation of
down-regulation of hTR
of hTR beta
hTR beta 1
beta 1 mRNA
1 mRNA levels
mRNA levels in
levels in hyperthyroid
in hyperthyroid patients
Multiple proteins interact
proteins interact with
interact with the
with the nuclear
the nuclear inhibitory
nuclear inhibitory protein
inhibitory protein repressor
protein repressor element
repressor element in
element in the
in the human
the human interleukin-3
human interleukin-3 promoter
T cell expression
cell expression of
expression of interleukin
of interleukin 3
interleukin 3 IL-3
3 IL-3 is
IL-3 is directed
is directed by
directed by positive
by positive and
positive and negative
and negative cis-acting
negative cis-acting DNA
cis-acting DNA elements
DNA elements clustered
elements clustered within
clustered within 300
within 300 base
300 base pairs
base pairs of
pairs of the
of the transcriptional
the transcriptional start
transcriptional start site
A strong repressor
strong repressor element
repressor element termed
element termed nuclear
termed nuclear inhibitory
nuclear inhibitory protein
inhibitory protein NIP
protein NIP was
NIP was previously
was previously mapped
previously mapped to
mapped to a
to a segment
a segment of
segment of the
of the IL-3
the IL-3 promoter
IL-3 promoter between
promoter between nucleotides
between nucleotides -271
nucleotides -271 and
-271 and -250
Functional characterization of
characterization of this
of this element
this element demonstrates
element demonstrates that
demonstrates that it
that it can
it can mediate
can mediate repression
mediate repression when
repression when linked
when linked in
linked in cis
in cis to
cis to a
to a heterologous
a heterologous promoter
DNA binding experiments
binding experiments were
experiments were carried
were carried out
carried out to
out to characterize
to characterize the
characterize the repressor
the repressor activity
Using varying conditions
varying conditions three
conditions three distinct
three distinct complexes
distinct complexes were
complexes were shown
were shown to
shown to interact
to interact specifically
interact specifically with
specifically with the
with the NIP
the NIP region
NIP region although
region although only
although only one
only one correlates
one correlates with
correlates with repressor
with repressor activity
Complex 1 results
1 results from
results from binding
from binding of
binding of a
of a ubiquitous
a ubiquitous polypeptide
ubiquitous polypeptide that
polypeptide that recognizes
that recognizes the
recognizes the 3'
the 3' portion
3' portion of
portion of this
of this sequence
this sequence and
sequence and is
and is not
is not required
not required for
required for repression
Complex 2 corresponds
2 corresponds to
corresponds to binding
to binding of
binding of transcription
of transcription factor
transcription factor upstream
factor upstream stimulatory
upstream stimulatory factor
stimulatory factor to
factor to an
to an E-box
an E-box motif
E-box motif in
motif in the
in the 5'
the 5' portion
5' portion of
portion of the
of the NIP
the NIP region
DNA binding specificity
binding specificity of
specificity of complex
of complex 3
complex 3 overlaps
3 overlaps with
overlaps with that
with that of
that of upstream
of upstream stimulatory
upstream stimulatory factor
stimulatory factor but
factor but is
but is clearly
is clearly distinct
To determine which
determine which of
which of the
of the latter
the latter two
latter two complexes
two complexes represents
complexes represents NIP
represents NIP activity
NIP activity we
activity we incorporated
we incorporated small
incorporated small alterations
small alterations into
alterations into the
into the NIP
the NIP site
NIP site of
site of an
of an IL-3
an IL-3 promoter-linked
IL-3 promoter-linked reporter
promoter-linked reporter construct
reporter construct and
construct and examined
and examined their
examined their effects
their effects on
effects on NIP-mediated
on NIP-mediated repression
Functional specificity for
specificity for repression
for repression matches
repression matches the
matches the DNA
the DNA binding
DNA binding specificity
binding specificity of
specificity of complex
of complex 3;
complex 3; both
3; both repressor
both repressor activity
repressor activity and
activity and complex
and complex 3
complex 3 binding
3 binding require
binding require the
require the consensus
the consensus sequence
consensus sequence CTCACNTNC
The hematopoietic transcription
hematopoietic transcription factor
transcription factor PU1
factor PU1 is
PU1 is downregulated
is downregulated in
downregulated in human
in human multiple
human multiple myeloma
multiple myeloma cell
myeloma cell lines
PU1 is a
is a hematopoietic
a hematopoietic transcription
hematopoietic transcription factor
transcription factor belonging
factor belonging to
belonging to the
to the Ets-family
It is identical
is identical to
identical to the
to the Spi-1
the Spi-1 oncogene
Spi-1 oncogene which
oncogene which is
which is implicated
is implicated in
implicated in spleen
in spleen focus-forming
spleen focus-forming virus-induced
focus-forming virus-induced murine
virus-induced murine erythroleukemias
PU1 seems to
seems to be
to be required
be required for
required for early
for early development
early development of
development of multiple
of multiple hematopoietic
multiple hematopoietic lineages
hematopoietic lineages but
lineages but its
but its expression
its expression in
expression in mature
in mature cells
mature cells is
cells is preferentially
is preferentially observed
preferentially observed in
observed in cells
in cells of
cells of the
of the B-cell-and
the B-cell-and monocyte/macrophage-differentiation
B-cell-and monocyte/macrophage-differentiation lineage
It binds the
binds the so-called
the so-called Pu
so-called Pu box
Pu box an
box an important
an important tissue-specific
important tissue-specific regulatory
tissue-specific regulatory DNA
regulatory DNA element
DNA element present
element present in
present in a
in a number
a number of
number of genes
of genes expressed
genes expressed in
expressed in these
in these cell
these cell lineages
We have analyzed
have analyzed the
analyzed the expression
the expression and
expression and activity
and activity of
activity of PU1
of PU1 during
PU1 during human
during human B-cell
human B-cell development
B-cell development using
development using a
using a panel
a panel of
panel of B-cell
of B-cell lines
B-cell lines representing
lines representing different
representing different stages
different stages of
stages of maturation
of maturation from
maturation from early
from early precursors
early precursors to
precursors to differentiated
to differentiated plasma
differentiated plasma cells
PU1 mRNA expression
mRNA expression and
expression and PU1
and PU1 DNA
PU1 DNA binding
DNA binding activity
binding activity as
activity as measured
as measured by
measured by Northern
by Northern blot
Northern blot analysis
blot analysis and
analysis and electrophoretic
and electrophoretic mobility
electrophoretic mobility shift
mobility shift assay
shift assay respectively
assay respectively were
respectively were evident
were evident in
evident in cell
in cell lines
cell lines representing
lines representing pro-B
representing pro-B pre-B
pro-B pre-B and
pre-B and mature
and mature B
mature B cells
We could also
could also show
also show Pu
show Pu box-dependent
Pu box-dependent transactivation
box-dependent transactivation of
transactivation of a
of a reporter
a reporter gene
reporter gene in
gene in transient
in transient transfections
transient transfections in
transfections in these
in these cell
these cell lines
In contrast in
contrast in a
in a number
a number of
number of multiple
of multiple myeloma
multiple myeloma cell
myeloma cell lines
cell lines representing
lines representing differentiated
representing differentiated plasma
differentiated plasma cell-like
plasma cell-like B
cell-like B cells
B cells PU1
cells PU1 DNA
PU1 DNA binding
DNA binding activity
binding activity mRNA
activity mRNA expression
mRNA expression and
expression and Pu
and Pu box-dependent
Pu box-dependent transactivation
box-dependent transactivation were
transactivation were absent
were absent or
absent or detectable
or detectable at
detectable at a
at a very
a very low
very low level
In lymphoblastoid cell
lymphoblastoid cell lines
cell lines which
lines which exemplify
which exemplify an
exemplify an intermediate
an intermediate stage
intermediate stage of
stage of B-cell
of B-cell differentiation
B-cell differentiation a
differentiation a reduced
a reduced expression
reduced expression and
expression and activity
and activity were
activity were observed
The findings in
findings in the
in the human
the human multiple
human multiple myeloma
multiple myeloma cell
myeloma cell lines
cell lines represent
lines represent the
represent the first
the first examples
first examples of
examples of B
of B cells
B cells with
cells with downregulated
with downregulated PU1
downregulated PU1 expression
PU1 expression and
expression and apparently
and apparently contradict
apparently contradict observations
contradict observations in
observations in the
in the murine
the murine system
murine system in
system in which
in which PU1
which PU1 is
PU1 is expressed
is expressed and
expressed and active
and active in
active in plasmacytoma
in plasmacytoma cell
plasmacytoma cell lines
At present it
present it is
it is unclear
is unclear whether
unclear whether the
whether the lack
the lack of
lack of PU1
of PU1 expression
PU1 expression and
expression and activity
and activity in
activity in human
in human multiple
human multiple myeloma
multiple myeloma cell
myeloma cell lines
cell lines represents
lines represents a
represents a malignancy-associated
a malignancy-associated defect
malignancy-associated defect in
defect in these
in these cells
these cells or
cells or exemplifies
or exemplifies a
exemplifies a normal
a normal developmental
normal developmental regulation
developmental regulation in
regulation in terminally
in terminally differentiated
terminally differentiated B
differentiated B cells
Regulation of granulocyte-macrophage
of granulocyte-macrophage colony-stimulating
granulocyte-macrophage colony-stimulating factor
colony-stimulating factor and
factor and E-selectin
and E-selectin expression
E-selectin expression in
expression in endothelial
in endothelial cells
endothelial cells by
cells by cyclosporin
by cyclosporin A
cyclosporin A and
A and the
and the T-cell
the T-cell transcription
T-cell transcription factor
transcription factor NFAT
Nuclear factor of
factor of activated
of activated T
activated T cells
T cells NFAT
cells NFAT was
NFAT was originally
was originally described
originally described as
described as a
as a T-cell-specific
a T-cell-specific transcription
T-cell-specific transcription factor
transcription factor athat
factor athat supported
athat supported the
supported the activation
the activation of
activation of cytokine
of cytokine gene
cytokine gene expression
gene expression and
expression and mediated
and mediated the
mediated the immunoregulatory
the immunoregulatory effects
immunoregulatory effects of
effects of cyclosporin
of cyclosporin A
cyclosporin A CsA
As we observed
we observed that
observed that activated
that activated endothelial
activated endothelial cells
endothelial cells also
cells also expressed
also expressed NFAT
expressed NFAT we
NFAT we tested
we tested the
tested the antiinflammatory
the antiinflammatory properties
antiinflammatory properties of
properties of CsA
of CsA in
CsA in endothelial
in endothelial cells
Significantly CsA completely
CsA completely suppressed
completely suppressed the
suppressed the induction
the induction of
induction of NFAT
of NFAT in
NFAT in endothelial
in endothelial cells
endothelial cells and
cells and inhibited
and inhibited the
inhibited the activity
the activity of
activity of granulocyte-macrophage
of granulocyte-macrophage colony-stimulating
granulocyte-macrophage colony-stimulating factor
colony-stimulating factor GM-CSF
factor GM-CSF gene
GM-CSF gene regulatory
gene regulatory elements
regulatory elements that
elements that use
that use NFAT
use NFAT by
NFAT by 60%
CsA similarly mediated
similarly mediated a
mediated a reduction
a reduction of
reduction of up
of up to
up to 65%
to 65% in
65% in GM-CSF
in GM-CSF mRNA
GM-CSF mRNA and
mRNA and protein
and protein expression
protein expression in
expression in activated
in activated endothelial
activated endothelial cells
CsA also suppressed
also suppressed E-selectin
suppressed E-selectin but
E-selectin but not
but not vascular
not vascular cell
vascular cell adhesion
cell adhesion molecule-1
adhesion molecule-1 VCAM-1
molecule-1 VCAM-1 expression
VCAM-1 expression in
expression in endothelial
in endothelial cells
endothelial cells even
cells even though
even though the
though the E-selectin
the E-selectin promoter
E-selectin promoter is
promoter is activated
is activated by
activated by NF-kappa
by NF-kappa B
NF-kappa B rather
B rather than
rather than NFAT
Hence induction of
induction of cell
of cell surface
cell surface expression
surface expression of
expression of this
of this leukocyte
this leukocyte adhesion
leukocyte adhesion molecule
adhesion molecule by
molecule by tumor
by tumor necrosis
tumor necrosis factor
necrosis factor TNF-alpha
factor TNF-alpha was
TNF-alpha was reduced
was reduced by
reduced by 40%
by 40% in
40% in the
in the presence
the presence of
presence of CsA
of CsA and
CsA and this
and this was
this was reflected
was reflected by
reflected by a
by a 29%
a 29% decrease
29% decrease in
decrease in neutrophil
in neutrophil adhesion
The effects of
effects of CsA
of CsA on
CsA on endothelial
on endothelial cells
endothelial cells were
cells were also
were also detected
also detected at
detected at the
at the chromatin
the chromatin structure
chromatin structure level
structure level as
level as DNasel
as DNasel hypersensitive
DNasel hypersensitive sites
hypersensitive sites within
sites within both
within both the
both the GM-CSF
the GM-CSF enhancer
GM-CSF enhancer and
enhancer and the
and the E-selectin
the E-selectin promoter
E-selectin promoter were
promoter were suppressed
were suppressed by
suppressed by CsA
This represents the
represents the first
the first report
first report of
report of NFAT
of NFAT in
NFAT in endothelial
in endothelial cells
endothelial cells and
cells and suggests
and suggests mechanisms
suggests mechanisms by
mechanisms by which
by which CsA
which CsA could
CsA could function
could function as
function as an
as an antiinflammatory
an antiinflammatory agent
Costimulation requirement for
requirement for AP-1
for AP-1 and
AP-1 and NF-kappa
and NF-kappa B
NF-kappa B transcription
B transcription factor
transcription factor activation
factor activation in
activation in T
in T cells
The transcriptional activity
transcriptional activity of
activity of the
of the IL-2
the IL-2 promoter
IL-2 promoter requires
promoter requires T-cell
requires T-cell costimulation
T-cell costimulation delivered
costimulation delivered by
delivered by the
by the TCR
the TCR and
TCR and the
and the auxiliary
the auxiliary receptor
auxiliary receptor CD28
Several transcription factors
transcription factors participate
factors participate in
participate in IL-2
in IL-2 promoter
IL-2 promoter activation
promoter activation among
activation among which
among which are
which are AP-1-like
are AP-1-like factors
AP-1-like factors and
factors and NF-kappa
and NF-kappa B
Protein phosphorylation has
phosphorylation has an
has an important
an important role
important role in
role in the
in the regulation
the regulation of
regulation of these
of these two
these two factors:
two factors: 1
factors: 1 it
1 it induces
it induces the
induces the transactivating
the transactivating capacity
transactivating capacity of
capacity of the
of the AP-1
the AP-1 protein
AP-1 protein c-Jun;
protein c-Jun; and
c-Jun; and 2
and 2 it
2 it is
it is involved
is involved in
involved in the
in the release
the release of
release of the
of the cytoplasmic
the cytoplasmic inhibitor
cytoplasmic inhibitor I
inhibitor I kappa
I kappa B
kappa B from
B from NF-kappa
from NF-kappa B
NF-kappa B allowing
B allowing translocation
allowing translocation of
translocation of the
of the latter
the latter into
latter into the
into the nucleus
We have recently
have recently shown
recently shown that
shown that both
that both phosphorylation
both phosphorylation processes
phosphorylation processes require
processes require T-cell
require T-cell costimulation
Furthermore in activated
in activated T
activated T cells
T cells the
cells the kinetics
the kinetics of
kinetics of the
of the two
the two phosphorylation
two phosphorylation events
phosphorylation events are
events are essentially
are essentially similar
According to our
to our results
our results however
results however the
however the kinases
the kinases responsible
kinases responsible for
responsible for the
for the two
the two processes
two processes are
processes are distinct
are distinct entities
Whereas TPCK inhibits
TPCK inhibits phosphorylation
inhibits phosphorylation of
phosphorylation of I
of I kappa
I kappa B
kappa B and
B and consequently
and consequently activation
consequently activation of
activation of NF-kappa
of NF-kappa B
NF-kappa B it
B it markedly
it markedly enhances
markedly enhances the
enhances the activity
the activity of
activity of JNK
of JNK the
JNK the MAP
the MAP kinase-related
MAP kinase-related kinase
kinase-related kinase that
kinase that phosphorylates
that phosphorylates the
phosphorylates the transactivation
the transactivation domain
transactivation domain of
domain of c-Jun
We therefore propose
therefore propose the
propose the activation
the activation scheme
activation scheme presented
scheme presented in
presented in FIGURE
in FIGURE 3
FIGURE 3 for
3 for T-cell
for T-cell costimulation
Costimulation results in
results in the
in the activation
the activation of
activation of a
of a signaling
a signaling pathway
signaling pathway that
pathway that leads
that leads to
leads to the
to the simultaneous
the simultaneous induction
simultaneous induction of
induction of the
of the two
the two transcription
two transcription factors
transcription factors AP-1
factors AP-1 and
AP-1 and NF-kappa
and NF-kappa B
Integration of the
of the signals
the signals generated
signals generated by
generated by TCR
by TCR and
TCR and CD28
and CD28 engagement
CD28 engagement occurs
engagement occurs along
occurs along this
along this pathway
this pathway which
pathway which then
which then bifurcates
then bifurcates to
bifurcates to induce
to induce I
induce I kappa
I kappa B
kappa B phosphorylation
B phosphorylation and
phosphorylation and NF-kappa
and NF-kappa B
NF-kappa B activation
B activation on
activation on the
on the one
the one hand
one hand and
hand and JNK
and JNK activation
JNK activation and
activation and c-Jun
and c-Jun phosphorylation
c-Jun phosphorylation on
phosphorylation on the
on the other
We are currently
are currently engaged
currently engaged in
engaged in defining
in defining where
defining where the
where the two
the two signals
two signals integrate
signals integrate along
integrate along the
along the AP-1/NF-kappa
the AP-1/NF-kappa B
AP-1/NF-kappa B pathway
Regulation of human
of human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 and
1 and cytokine
and cytokine gene
cytokine gene expression
gene expression in
expression in myeloid
in myeloid cells
myeloid cells by
cells by NF-kappa
by NF-kappa B/Rel
NF-kappa B/Rel transcription
B/Rel transcription factors
CD4+ macrophages in
macrophages in tissues
in tissues such
tissues such as
such as lung
as lung skin
lung skin and
skin and lymph
and lymph nodes
lymph nodes promyelocytic
nodes promyelocytic cells
promyelocytic cells in
cells in bone
in bone marrow
bone marrow and
marrow and peripheral
and peripheral blood
peripheral blood monocytes
blood monocytes serve
monocytes serve as
serve as important
as important targets
important targets and
targets and reservoirs
and reservoirs for
reservoirs for human
for human immunodeficiency
human immunodeficiency virus
immunodeficiency virus type
virus type 1
type 1 HIV-1
1 HIV-1 replication
HIV-1-infected myeloid cells
myeloid cells are
cells are often
are often diminished
often diminished in
diminished in their
in their ability
their ability to
ability to participate
to participate in
participate in chemotaxis
in chemotaxis phagocytosis
chemotaxis phagocytosis and
phagocytosis and intracellular
and intracellular killing
HIV-1 infection of
infection of myeloid
of myeloid cells
myeloid cells can
cells can lead
can lead to
lead to the
to the expression
the expression of
expression of surface
of surface receptors
surface receptors associated
receptors associated with
associated with cellular
with cellular activation
cellular activation and/or
activation and/or differentiation
and/or differentiation that
differentiation that increase
that increase the
increase the responsiveness
the responsiveness of
responsiveness of these
of these cells
these cells to
cells to cytokines
to cytokines secreted
cytokines secreted by
secreted by neighboring
by neighboring cells
neighboring cells as
cells as well
as well as
well as to
as to bacteria
to bacteria or
bacteria or other
or other pathogens
Enhancement of HIV-1
of HIV-1 replication
HIV-1 replication is
replication is related
is related in
related in part
in part to
part to increased
to increased DNA-binding
increased DNA-binding activity
DNA-binding activity of
activity of cellular
of cellular transcription
cellular transcription factors
transcription factors such
factors such as
such as NF-kappa
as NF-kappa B
NF-kappa B binds
B binds to
binds to the
to the HIV-1
the HIV-1 enhancer
HIV-1 enhancer region
enhancer region of
region of the
of the long
the long terminal
long terminal repeat
terminal repeat and
repeat and contributes
and contributes to
contributes to the
to the inducibility
the inducibility of
inducibility of HIV-1
of HIV-1 gene
HIV-1 gene expression
gene expression in
expression in response
in response to
response to multiple
to multiple activating
multiple activating agents
Phosphorylation and degradation
and degradation of
degradation of the
of the cytoplasmic
the cytoplasmic inhibitor
cytoplasmic inhibitor I
inhibitor I kappa
I kappa B
kappa B alpha
B alpha are
alpha are crucial
are crucial regulatory
crucial regulatory events
regulatory events in
events in the
in the activation
the activation of
activation of NF-kappa
of NF-kappa B
NF-kappa B DNA-binding
B DNA-binding activity
Both N- and
N- and C-terminal
and C-terminal residues
C-terminal residues of
residues of I
of I kappa
I kappa B
kappa B alpha
B alpha are
alpha are required
are required for
required for inducer-mediated
for inducer-mediated degradation
Chronic HIV-1 infection
HIV-1 infection of
infection of myeloid
of myeloid cells
myeloid cells leads
cells leads to
leads to constitutive
to constitutive NF-kappa
constitutive NF-kappa B
NF-kappa B DNA-binding
B DNA-binding activity
DNA-binding activity and
activity and provides
and provides an
provides an intranuclear
an intranuclear environment
intranuclear environment capable
environment capable of
capable of perpetuating
of perpetuating HIV-1
perpetuating HIV-1 replication
Increased intracellular stores
intracellular stores of
stores of latent
of latent NF-kappa
latent NF-kappa B
NF-kappa B may
B may also
may also result
also result in
result in rapid
in rapid inducibility
rapid inducibility of
inducibility of NF-kappa
of NF-kappa B-dependent
NF-kappa B-dependent cytokine
B-dependent cytokine gene
cytokine gene expression
In response to
response to secondary
to secondary pathogenic
secondary pathogenic infections
pathogenic infections or
infections or antigenic
or antigenic challenge
antigenic challenge cytokine
challenge cytokine gene
cytokine gene expression
gene expression is
expression is rapidly
is rapidly induced
rapidly induced enhanced
induced enhanced and
enhanced and sustained
and sustained over
sustained over prolonged
over prolonged periods
prolonged periods in
periods in HIV-1-infected
in HIV-1-infected myeloid
HIV-1-infected myeloid cells
myeloid cells compared
cells compared with
compared with uninfected
with uninfected cells
Elevated levels of
levels of several
of several inflammatory
several inflammatory cytokines
inflammatory cytokines have
cytokines have been
have been detected
been detected in
detected in the
in the sera
the sera of
sera of HIV-1-infected
of HIV-1-infected individuals
Secretion of myeloid
of myeloid cell-derived
myeloid cell-derived cytokines
cell-derived cytokines may
cytokines may both
may both increase
both increase virus
increase virus production
virus production and
production and contribute
and contribute to
contribute to AIDS-associated
to AIDS-associated disorders
Steroid mediated lysis
mediated lysis of
lysis of lymphoblasts
of lymphoblasts requires
lymphoblasts requires the
requires the DNA
the DNA binding
DNA binding region
binding region of
region of the
of the steroid
the steroid hormone
steroid hormone receptor
Glucocorticoids kill certain
kill certain types
certain types of
types of lymphoblasts
of lymphoblasts but
lymphoblasts but the
but the mechanisms
the mechanisms are
mechanisms are unknown
It is clear
is clear that
clear that sufficient
that sufficient numbers
sufficient numbers of
numbers of functional
of functional glucocorticoid
functional glucocorticoid receptors
glucocorticoid receptors are
receptors are required
are required to
required to mediate
to mediate lysis
mediate lysis but
lysis but whether
but whether they
whether they do
they do so
do so through
so through the
through the classical
the classical model
classical model of
model of steroid
of steroid hormone
steroid hormone activation
hormone activation and
activation and modulation
and modulation of
modulation of gene
of gene expression
gene expression has
expression has not
has not been
not been established
In this report
this report we
report we have
we have asked
have asked which
asked which regions
which regions of
regions of the
of the steroid
the steroid receptor
steroid receptor are
receptor are important
are important for
important for mediating
for mediating lysis
mediating lysis in
lysis in leukemic
in leukemic T
leukemic T lymphoblasts
CEM-ICR 27 leukemic
27 leukemic lymphoblasts
leukemic lymphoblasts a
lymphoblasts a clone
a clone of
clone of CEM
of CEM cells
CEM cells which
cells which lack
which lack functional
lack functional glucocorticoid
functional glucocorticoid receptors
glucocorticoid receptors and
receptors and therefore
and therefore are
therefore are neither
are neither lysed
neither lysed by
lysed by dexamethasone
by dexamethasone nor
dexamethasone nor capable
nor capable of
capable of showing
of showing glutamine
showing glutamine synthetase
glutamine synthetase induction
synthetase induction were
induction were provided
were provided with
provided with steroid
with steroid receptors
steroid receptors by
receptors by DNA
by DNA transfections
DNA transfections of
transfections of various
of various receptor
various receptor gene
receptor gene constructs
We measured steroid
measured steroid mediated
steroid mediated lysis
mediated lysis receptor
lysis receptor number
receptor number and
number and induction
and induction of
induction of glutamine
of glutamine synthetase
glutamine synthetase in
synthetase in the
in the transfected
the transfected cells
Our results provide
results provide evidence
provide evidence that
evidence that the
that the lysis
the lysis mechanism
lysis mechanism in
mechanism in the
in the ICR27
the ICR27 lymphoblasts
ICR27 lymphoblasts is
lymphoblasts is restored
is restored when
restored when functional
when functional receptor
functional receptor number
receptor number is
number is restored
The DNA binding
DNA binding region
binding region specifying
region specifying high
specifying high affinity
high affinity for
affinity for GRE
for GRE sites
GRE sites is
sites is required
Lysis is mediated
is mediated by
mediated by any
by any steroid
any steroid that
steroid that allows
that allows for
allows for activation
for activation of
activation of the
of the receptor
the receptor containing
receptor containing such
containing such a
such a region
Our data support
data support the
support the view
the view that
view that steroid-mediated
that steroid-mediated cell
steroid-mediated cell death
cell death occurs
death occurs by
occurs by a
by a process
a process requiring
process requiring direct
requiring direct interaction
direct interaction of
interaction of steroid-receptor
of steroid-receptor complexes
steroid-receptor complexes with
complexes with the
with the genome
Functional characterization of
characterization of the
of the murine
the murine homolog
murine homolog of
homolog of the
of the B
the B cell-specific
B cell-specific coactivator
cell-specific coactivator BOB1/OBF1
B cell-specific transcriptional
cell-specific transcriptional promoter
transcriptional promoter activity
promoter activity mediated
activity mediated by
mediated by the
by the octamer
the octamer motif
octamer motif requires
motif requires the
requires the Oct1
the Oct1 or
Oct1 or Oct2
or Oct2 protein
Oct2 protein and
protein and additional
and additional B
additional B cell-restricted
B cell-restricted cofactors
One such cofactor
such cofactor BOB1/OBF1
cofactor BOB1/OBF1 was
BOB1/OBF1 was recently
was recently isolated
recently isolated from
isolated from human
from human B
human B cells
Here we describe
we describe the
describe the isolation
the isolation and
isolation and detailed
and detailed characterization
detailed characterization of
characterization of the
of the murine
the murine homolog
Full-length cDNAs and
cDNAs and genomic
and genomic clones
genomic clones were
clones were isolated
were isolated and
isolated and the
and the gene
the gene structure
gene structure was
structure was determined
was determined Comparison
determined Comparison of
Comparison of the
of the deduced
the deduced amino
deduced amino acids
amino acids shows
acids shows 88%
shows 88% sequence
88% sequence identity
sequence identity between
identity between mouse
between mouse and
mouse and human
and human BOB1/OBF1
The NH2-terminal 126
NH2-terminal 126 amino
126 amino acids
amino acids of
acids of BOB1/OBF1
of BOB1/OBF1 are
BOB1/OBF1 are both
are both essential
both essential and
essential and sufficient
and sufficient for
sufficient for interaction
for interaction with
interaction with the
with the POU
the POU domains
POU domains of
domains of either
of either Oct1
either Oct1 or
Oct1 or Oct2
This protein-protein interaction
protein-protein interaction does
interaction does not
does not require
not require the
require the simultaneous
the simultaneous binding
simultaneous binding of
binding of Oct
of Oct proteins
Oct proteins to
proteins to DNA
to DNA and
DNA and high
and high resolution
high resolution footprinting
resolution footprinting of
footprinting of the
of the Oct-DNA
the Oct-DNA interaction
Oct-DNA interaction reveals
interaction reveals that
reveals that binding
that binding of
binding of BOB1/OBF1
of BOB1/OBF1 to
BOB1/OBF1 to Oct1
to Oct1 or
Oct1 or Oct2
or Oct2 does
Oct2 does not
does not alter
not alter the
alter the interaction
the interaction with
interaction with DNA
BOB1/OBF1 can efficiently
can efficiently activate
efficiently activate octamer-dependent
activate octamer-dependent promoters
octamer-dependent promoters in
promoters in fibroblasts;
in fibroblasts; however
fibroblasts; however it
however it fails
it fails to
fails to stimulate
to stimulate octamer-dependent
stimulate octamer-dependent enhancer
octamer-dependent enhancer activity
Fusion of subdomains
of subdomains of
subdomains of BOB1/OBF1
of BOB1/OBF1 with
BOB1/OBF1 with the
with the GAL4
the GAL4 DNA
GAL4 DNA binding
DNA binding domain
binding domain reveals
domain reveals that
reveals that both
that both NH2-
both NH2- and
NH2- and COOH-terminal
and COOH-terminal domains
COOH-terminal domains of
domains of BOB1/OBF1
of BOB1/OBF1 contribute
BOB1/OBF1 contribute to
contribute to full
to full transactivation
full transactivation function
transactivation function the
function the COOH-terminal
the COOH-terminal domain
COOH-terminal domain is
domain is more
is more efficient
more efficient in
efficient in this
in this transactivation
this transactivation assay
Consistent with the
with the failure
the failure of
failure of full-length
of full-length BOB1/OBF1
full-length BOB1/OBF1 to
BOB1/OBF1 to stimulate
to stimulate octamer-dependent
stimulate octamer-dependent enhancer
octamer-dependent enhancer elements
enhancer elements in
elements in non
in non B
non B cells
B cells the
cells the GAL4
the GAL4 fusions
GAL4 fusions likewise
fusions likewise only
likewise only stimulate
only stimulate from
stimulate from a
from a promoter-proximal
a promoter-proximal position
Anti-immunoglobulin M activates
M activates nuclear
activates nuclear calcium/calmodulin-dependent
nuclear calcium/calmodulin-dependent protein
calcium/calmodulin-dependent protein kinase
protein kinase II
kinase II in
II in human
in human B
human B lymphocytes
We and others
and others have
others have previously
have previously shown
previously shown that
shown that the
that the nuclear
the nuclear protein
nuclear protein Ets-1
protein Ets-1 is
Ets-1 is phosphorylated
is phosphorylated in
phosphorylated in a
in a calcium-dependent
a calcium-dependent manner
calcium-dependent manner after
manner after ligation
after ligation of
ligation of immunoglobulin
of immunoglobulin Ig
immunoglobulin Ig M
Ig M on
M on B
on B lymphocytes
As this phosphorylation
this phosphorylation was
phosphorylation was independent
was independent of
independent of protein
of protein kinase
protein kinase C
kinase C activity
C activity we
activity we tested
we tested whether
tested whether a
whether a calcium/calmodulin-dependent
a calcium/calmodulin-dependent protein
calcium/calmodulin-dependent protein kinase
protein kinase CaM
kinase CaM kinase
CaM kinase might
kinase might phosphorylate
might phosphorylate the
phosphorylate the Ets-1
the Ets-1 protein
Ets-1 protein after
protein after elevation
after elevation of
elevation of intracellular
of intracellular free
intracellular free calcium
free calcium concentrations
The dephosphorylated form
dephosphorylated form of
form of Ets-1
of Ets-1 has
Ets-1 has been
has been shown
been shown to
shown to bind
to bind to
bind to chromatin
to chromatin suggesting
chromatin suggesting that
suggesting that the
that the operative
the operative kinase
operative kinase should
kinase should be
should be detectable
be detectable in
detectable in the
in the nucleus
We prepared nuclear
prepared nuclear extracts
nuclear extracts from
extracts from two
from two human
two human B
human B cell
B cell lines
cell lines in
lines in which
in which increased
which increased intracellular
increased intracellular free
intracellular free calcium
free calcium levels
calcium levels correlated
levels correlated with
correlated with increased
with increased phosphorylation
increased phosphorylation of
phosphorylation of the
of the Ets-1
the Ets-1 protein
Activity of the
of the CaM
the CaM kinases
CaM kinases was
kinases was determined
was determined using
determined using a
using a synthetic
a synthetic peptide
synthetic peptide substrate
peptide substrate both
substrate both in
both in the
in the absence
the absence and
absence and presence
and presence of
presence of an
of an inhibitor
an inhibitor specific
inhibitor specific for
specific for the
for the CaM
the CaM kinase
CaM kinase family
kinase family KN-62
Stimulation of cells
of cells with
cells with anti-IgM
with anti-IgM led
anti-IgM led to
led to increased
to increased activity
increased activity of
activity of a
of a nuclear
a nuclear kinase
nuclear kinase that
kinase that could
that could phosphorylate
could phosphorylate the
phosphorylate the peptide
the peptide and
peptide and this
and this activity
this activity was
activity was reduced
was reduced by
reduced by 10
by 10 microM
10 microM KN-62
Kinase activity was
activity was reduced
was reduced in
reduced in lysates
in lysates preadsorbed
lysates preadsorbed using
preadsorbed using an
using an antibody
an antibody specific
antibody specific for
specific for CaM
for CaM kinase
CaM kinase II
Two-dimensional phosphopeptide maps
phosphopeptide maps of
maps of the
of the Ets-1
the Ets-1 protein
Ets-1 protein from
protein from cells
from cells incubated
cells incubated with
incubated with ionomycin
with ionomycin or
ionomycin or anti-IgM
or anti-IgM contained
anti-IgM contained two
contained two unique
two unique phosphopeptides
unique phosphopeptides that
phosphopeptides that were
that were absent
were absent in
absent in untreated
in untreated cells
Incubation of isolated
of isolated Ets-1
isolated Ets-1 protein
Ets-1 protein with
protein with purified
with purified CaM
purified CaM kinase
CaM kinase II
kinase II produced
II produced phosphorylation
produced phosphorylation of
phosphorylation of peptides
of peptides that
peptides that migrated
that migrated identically
migrated identically to
identically to those
to those found
those found in
found in cells
in cells incubated
cells incubated with
incubated with either
with either anti-IgM
either anti-IgM or
anti-IgM or ionomycin
These data suggest
data suggest a
suggest a model
a model of
model of signal
of signal transduction
signal transduction by
transduction by the
by the antigen
the antigen receptor
antigen receptor on
receptor on B
on B lymphocytes
B lymphocytes in
lymphocytes in which
in which increased
which increased intracellular
increased intracellular free
intracellular free calcium
free calcium can
calcium can rapidly
can rapidly activate
rapidly activate nuclear
activate nuclear CaM
nuclear CaM kinase
CaM kinase II
kinase II potentially
II potentially resulting
potentially resulting in
resulting in phosphorylation
in phosphorylation and
phosphorylation and regulation
and regulation of
regulation of DNA-binding
of DNA-binding proteins
Transcriptional activation and
activation and repression
and repression two
repression two properties
two properties of
properties of the
of the lymphoid-specific
the lymphoid-specific transcription
lymphoid-specific transcription factor
transcription factor Oct-2a
The lymphoid-specific transcription
lymphoid-specific transcription factor
transcription factor Oct-2a
factor Oct-2a contains
Oct-2a contains two
contains two transcriptional
two transcriptional activation
transcriptional activation domains
activation domains which
domains which are
which are located
are located within
located within the
within the N-terminal
the N-terminal and
N-terminal and C-terminal
and C-terminal regions
To study their
study their differential
their differential activation
differential activation properties
activation properties we
properties we linked
we linked the
linked the isolated
the isolated effector
isolated effector domains
effector domains to
domains to the
to the GAL4
the GAL4 DNA-binding
GAL4 DNA-binding domain
We have shown
have shown that
shown that both
that both activating
both activating regions
activating regions of
regions of Oct-2a
of Oct-2a isolated
Oct-2a isolated from
isolated from their
from their natural
their natural context
natural context can
context can activate
can activate transcription
activate transcription as
transcription as promoter
as promoter factors
In contrast to
contrast to the
to the C-terminus
the C-terminus activation
C-terminus activation by
activation by the
by the N-terminal
the N-terminal domain
N-terminal domain is
domain is dependent
is dependent on
dependent on a
on a yet
a yet unidentified
yet unidentified factors
unidentified factors binding
factors binding to
binding to the
to the simian
the simian virus
simian virus 40
virus 40 enhancer
The results obtained
results obtained by
obtained by duplication
by duplication of
duplication of activation
of activation domains
activation domains or
domains or their
or their mixed
their mixed combination
mixed combination suggest
combination suggest that
suggest that the
that the domains
the domains are
domains are functionally
are functionally independent
However activation from
activation from a
from a remote
a remote position
remote position could
position could only
could only be
only be achieved
be achieved with
achieved with the
with the C-terminus
the C-terminus of
C-terminus of Oct-2a
of Oct-2a in
Oct-2a in B
in B cells
In lymphoid cells
lymphoid cells higher
cells higher activation
higher activation levels
activation levels were
levels were observed
were observed suggesting
observed suggesting that
suggesting that distinct
that distinct B-cell-specific
distinct B-cell-specific cofactors
B-cell-specific cofactors in
cofactors in concert
in concert with
concert with the
with the effector
the effector domains
effector domains of
domains of Oct-2a
of Oct-2a might
Oct-2a might be
might be involved
be involved in
involved in mediating
in mediating transcription
mediating transcription from
transcription from proximal
from proximal and
proximal and remote
and remote positions
Furthermore we identified
we identified a
identified a repression
a repression domain
repression domain at
domain at the
at the N-terminus
the N-terminus of
N-terminus of Oct-2a
When transferred to
transferred to a
to a potent
a potent activator
potent activator transcriptional
activator transcriptional stimulation
transcriptional stimulation was
stimulation was inhibited
was inhibited efficiently
These results underscore
results underscore the
underscore the modular
the modular structure
modular structure of
structure of Oct-2a
of Oct-2a with
Oct-2a with separable
with separable domains
separable domains for
domains for activation
for activation and
activation and repression
and repression and
repression and suggest
and suggest that
suggest that Oct-2a
that Oct-2a might
Oct-2a might have
might have complex
have complex regulatory
complex regulatory functions
regulatory functions in
functions in vivo
Nonopsonic phagocytosis of
phagocytosis of Pseudomonas
of Pseudomonas aeruginosa
Pseudomonas aeruginosa by
aeruginosa by macrophages
by macrophages and
macrophages and polymorphonuclear
and polymorphonuclear leukocytes
polymorphonuclear leukocytes requires
leukocytes requires the
requires the presence
the presence of
presence of the
of the bacterial
the bacterial flagellum
Whereas the mechanism
the mechanism of
mechanism of nonopsonic
of nonopsonic phagocytosis
nonopsonic phagocytosis of
phagocytosis of Pseudomonas
of Pseudomonas aeruginosa
Pseudomonas aeruginosa has
aeruginosa has been
has been described
been described the
described the bacterial
the bacterial ligands
bacterial ligands required
ligands required are
required are poorly
are poorly understood
To identify the
identify the requisite
the requisite bacterial
requisite bacterial ligands
bacterial ligands studies
ligands studies with
studies with isogenic
with isogenic mutants
isogenic mutants of
mutants of P
of P aeruginosa
P aeruginosa PAK
aeruginosa PAK lacking
PAK lacking pili
lacking pili flagella
pili flagella and
flagella and the
and the RpoN
the RpoN sigma
RpoN sigma factor
sigma factor were
factor were undertaken
The RpoN mutant
RpoN mutant lacking
mutant lacking pili
lacking pili flagella
pili flagella and
flagella and nonpilus
and nonpilus adhesins
nonpilus adhesins bound
adhesins bound poorly
bound poorly and
poorly and was
and was resistant
was resistant to
resistant to ingestion
to ingestion by
ingestion by both
by both macrophages
both macrophages and
macrophages and neutrophils
Pili were not
were not absolutely
not absolutely required
absolutely required for
required for binding
for binding or
binding or phagocytosis
or phagocytosis of
phagocytosis of P
of P aeruginosa
The presence of
presence of a
of a flagellum
a flagellum was
flagellum was not
was not required
not required for
required for binding
for binding of
binding of P
of P aeruginosa
P aeruginosa to
aeruginosa to macrophages
to macrophages but
macrophages but was
but was critical
was critical for
critical for the
for the subsequent
the subsequent internalization
subsequent internalization of
internalization of the
of the bacterium
the bacterium suggesting
bacterium suggesting that
suggesting that this
that this factor
this factor or
factor or a
or a surface
a surface ligand
surface ligand associated
ligand associated with
associated with its
with its assembly
its assembly was
assembly was responsible
was responsible for
responsible for stimulation
for stimulation of
stimulation of nonopsonic
of nonopsonic phagocytosis
Identification of essential
of essential GATA
essential GATA and
GATA and Ets
and Ets binding
Ets binding motifs
binding motifs within
motifs within the
within the promoter
the promoter of
promoter of the
of the platelet
the platelet glycoprotein
platelet glycoprotein Ib
glycoprotein Ib alpha
Ib alpha gene
Platelet glycoprotein GP
glycoprotein GP Ib-IX-V
GP Ib-IX-V is
Ib-IX-V is a
is a multisubunit
a multisubunit adhesion
multisubunit adhesion receptor
adhesion receptor that
receptor that supports
that supports platelet
supports platelet attachment
platelet attachment to
attachment to thrombogenic
to thrombogenic surfaces
thrombogenic surfaces at
surfaces at sites
at sites of
sites of vascular
of vascular injury
The congenital absence
congenital absence of
absence of the
of the receptor
the receptor results
receptor results in
results in a
in a bleeding
a bleeding disorder
bleeding disorder associated
disorder associated with
associated with "giant"
with "giant" platelets
"giant" platelets a
platelets a condition
a condition linking
condition linking the
linking the expression
the expression of
expression of the
of the complex
the complex to
complex to platelet
to platelet morphogenesis
To understand better
understand better the
better the expression
the expression of
expression of the
of the GP
the GP Ib-IX-V
GP Ib-IX-V complex
Ib-IX-V complex studies
complex studies were
studies were undertaken
were undertaken to
undertaken to define
to define the
define the essential
the essential genetic
essential genetic elements
genetic elements supporting
elements supporting the
supporting the expression
the expression of
expression of the
of the alpha-subunit
the alpha-subunit of
alpha-subunit of the
of the complex
the complex GP
complex GP Ib
GP Ib alpha
GP Ib alpha
Ib alpha promoter
alpha promoter activity
promoter activity was
activity was evaluated
was evaluated by
evaluated by transfection
by transfection of
transfection of human
of human erythroleukemia
human erythroleukemia cells
erythroleukemia cells with
cells with reporter
with reporter plasmids
reporter plasmids coding
plasmids coding for
coding for the
for the enzyme
the enzyme luciferase
Studies were initiated
were initiated with
initiated with a
with a fragment
a fragment extending
fragment extending 2738
extending 2738 nucleotides
2738 nucleotides 5'
nucleotides 5' to
5' to the
to the transcription
the transcription start
transcription start site
start site and
site and lead
and lead to
lead to the
to the identification
the identification of
identification of 253
of 253 nucleotides
253 nucleotides retaining
nucleotides retaining full
retaining full promoter
full promoter activity
promoter activity in
activity in human
in human erythroleukemia
human erythroleukemia cells
In cells of
cells of nonhematopoietic
of nonhematopoietic lineage
nonhematopoietic lineage human
lineage human endothelial
human endothelial and
endothelial and HeLa
and HeLa cells
HeLa cells the
cells the GP
the GP Ib
GP Ib alpha
Ib alpha promoter
alpha promoter activity
promoter activity was
activity was no
was no greater
no greater than
greater than background
than background levels
background levels obtained
levels obtained with
obtained with promoterless
with promoterless constructs
Gel shift assays
shift assays and
assays and site-directed
and site-directed mutagenesis
site-directed mutagenesis studies
mutagenesis studies defined
studies defined essential
defined essential GATA
essential GATA and
GATA and Ets
and Ets binding
Ets binding motifs
binding motifs 93
motifs 93 and
93 and 150
and 150 nucleotides
150 nucleotides upstream
nucleotides upstream of
upstream of the
of the transcription
the transcription start
transcription start site
start site a
site a finding
a finding which
finding which further
which further substantiates
further substantiates these
substantiates these elements
these elements as
elements as important
as important determinants
important determinants of
determinants of megakaryocytic
of megakaryocytic gene
megakaryocytic gene expression
The results define
results define essential
define essential cis-acting
essential cis-acting elements
cis-acting elements responsible
elements responsible for
responsible for the
for the expression
the expression of
expression of GP
of GP Ib
GP Ib alpha
Ib alpha and
alpha and provide
and provide insights
provide insights into
insights into molecular
into molecular events
molecular events coinciding
events coinciding with
coinciding with the
with the release
the release of
release of normal
of normal platelets
normal platelets into
platelets into the
into the bloodstream
CD30 ligation induces
ligation induces nuclear
induces nuclear factor-kappa
nuclear factor-kappa B
factor-kappa B activation
B activation in
activation in human
in human T
human T cell
T cell lines
CD30 is a
is a recently
a recently described
recently described member
described member of
member of the
of the tumor
the tumor necrosis
tumor necrosis factor/nerve
necrosis factor/nerve growth
factor/nerve growth factor
growth factor receptor
factor receptor superfamily
In this report
this report we
report we show
we show that
show that following
that following incubation
following incubation of
incubation of L540
of L540 cells
L540 cells Hodgkin's
cells Hodgkin's disease-derived
Hodgkin's disease-derived T
disease-derived T cell-like
T cell-like CD30+
cell-like CD30+ cells
CD30+ cells with
cells with the
with the agonistic
the agonistic anti-CD30
agonistic anti-CD30 monoclonal
anti-CD30 monoclonal antibodies
monoclonal antibodies mAb
antibodies mAb M44
mAb M44 and
M44 and M67
and M67 two
M67 two nuclear
two nuclear factor
nuclear factor NF-kappa
factor NF-kappa B
NF-kappa B DNA
B DNA binding
DNA binding activities
binding activities were
activities were induced
were induced in
induced in nuclear
in nuclear extracts
nuclear extracts as
extracts as determined
as determined in
determined in gel
in gel retardation
gel retardation assays
The effect of
effect of the
of the mAb
the mAb towards
mAb towards NF-kappa
towards NF-kappa B
NF-kappa B activation
B activation was
activation was rapid
was rapid as
rapid as it
as it occurred
it occurred within
occurred within 20
within 20 min
20 min and
min and was
and was sustained
was sustained for
sustained for up
for up to
up to 6
to 6 h
By comparison an
comparison an isotype-matched
an isotype-matched antibody
isotype-matched antibody had
antibody had no
had no effect
no effect on
effect on NF-kappa
on NF-kappa B
NF-kappa B activation
Moreover in human
in human T
human T helper
T helper Th
helper Th clones
Th clones functionally
clones functionally characterized
functionally characterized as
characterized as being
as being of
being of the
of the type
the type 0
type 0 type
0 type 1
type 1 and
1 and type
and type 2
type 2 28%
2 28% <
28% < 1%
< 1% und
1% und 93%
und 93% CD30+
93% CD30+ respectively
CD30+ respectively the
respectively the extent
the extent of
extent of CD30-mediated
of CD30-mediated NF-kappa
CD30-mediated NF-kappa B
NF-kappa B activation
B activation correlated
activation correlated with
correlated with the
with the proportion
the proportion of
proportion of CD30+
of CD30+ cells
In all cell
all cell lines
cell lines investigated
lines investigated the
investigated the NF-kappa
the NF-kappa B
NF-kappa B complexes
B complexes induced
complexes induced following
induced following CD30
following CD30 engagement
CD30 engagement were
engagement were shown
were shown to
shown to contain
to contain p50
contain p50 NF-kappa
p50 NF-kappa B1
NF-kappa B1 p65
B1 p65 RelA
p65 RelA and
RelA and possibly
and possibly other
possibly other transcription
other transcription factors
Collectively our results
our results demonstrate
results demonstrate that
demonstrate that nuclear
that nuclear translocation
nuclear translocation and
translocation and activation
and activation of
activation of NF-kappa
of NF-kappa B
NF-kappa B rank
B rank among
rank among the
among the short-term
the short-term cellular
short-term cellular responses
cellular responses elicited
responses elicited following
elicited following CD30
following CD30 ligation
Pathogenesis of atherosclerosis
The earliest lesion
earliest lesion in
lesion in the
in the development
the development of
development of an
of an atherosclerotic
an atherosclerotic plaque
atherosclerotic plaque is
plaque is the
is the fatty
the fatty streak
This chronic inflammatory
chronic inflammatory reaction
inflammatory reaction results
reaction results from
results from a
from a sequence
a sequence of
sequence of events
of events that
events that begins
that begins with
begins with the
with the trapping
the trapping of
trapping of low
of low density
low density lipoprotein
density lipoprotein LDL
lipoprotein LDL in
LDL in the
in the subendothelial
the subendothelial space
subendothelial space of
space of the
of the artery
the artery wall
The trapped LDL
trapped LDL is
LDL is seeded
is seeded with
seeded with oxidative
with oxidative species
oxidative species released
species released by
released by the
by the overlying
the overlying endothelium
overlying endothelium and
endothelium and lipid
and lipid oxidation
lipid oxidation is
oxidation is initiated
is initiated within
initiated within the
within the LDL
the LDL particle
LDL particle Some
particle Some of
Some of the
of the lipids
the lipids that
lipids that result
that result lead
result lead to
lead to the
to the activation
the activation of
activation of NFkB-like
of NFkB-like transcription
NFkB-like transcription factors
transcription factors that
factors that cause
that cause the
cause the expression
the expression of
expression of genes
of genes whose
genes whose protein
whose protein products
protein products mediate
products mediate monocyte
mediate monocyte binding
monocyte binding monocyte
binding monocyte chemotaxis
monocyte chemotaxis into
chemotaxis into the
into the subendothelial
the subendothelial space
subendothelial space and
space and conversion
and conversion into
conversion into macrophages
At least 1
least 1 major
1 major gene
major gene modulates
gene modulates the
modulates the oxidation
the oxidation of
oxidation of LDL
of LDL lipids
LDL lipids and/or
lipids and/or the
and/or the biologic
the biologic response
biologic response to
response to these
to these lipids
The inverse relation
inverse relation between
relation between high
between high density
high density lipoprotein
density lipoprotein HDL
lipoprotein HDL and
HDL and atherosclerotic
and atherosclerotic events
atherosclerotic events may
events may in
may in part
in part be
part be due
be due to
due to enzymes
to enzymes associated
enzymes associated with
associated with HDL
with HDL that
HDL that destroy
that destroy the
destroy the biologically
the biologically active
biologically active lipids
active lipids generated
lipids generated in
generated in LDL
Estrogen and progesterone
and progesterone receptors
progesterone receptors in
receptors in vernal
in vernal keratoconjunctivitis
PURPOSE: Sex-related influences
Sex-related influences have
influences have been
have been implicated
been implicated in
implicated in the
in the pathogenesis
the pathogenesis of
pathogenesis of vernal
of vernal keratoconjunctivitis
vernal keratoconjunctivitis VKC
keratoconjunctivitis VKC an
VKC an allergic
an allergic eosinophilic
allergic eosinophilic disease
METHODS: The authors
The authors evaluated
authors evaluated tarsal
evaluated tarsal and
tarsal and bulbar
and bulbar conjunctival
bulbar conjunctival biopsies
conjunctival biopsies from
biopsies from seven
from seven patients
seven patients with
patients with severe
with severe and
severe and symptomatic
and symptomatic VKC
symptomatic VKC for
VKC for the
for the presence
the presence of
presence of estrogen
of estrogen and
estrogen and progesterone
and progesterone receptors
progesterone receptors by
receptors by using
by using monoclonal
using monoclonal antibodies
monoclonal antibodies with
antibodies with a
with a peroxidase-antiperoxidase
a peroxidase-antiperoxidase technique
RESULTS: Both the
Both the epithelium
the epithelium and
epithelium and subepithelium
and subepithelium of
subepithelium of the
of the tarsal
the tarsal and
tarsal and bulbar
and bulbar conjunctiva
bulbar conjunctiva of
conjunctiva of patients
of patients with
patients with VKC
with VKC but
VKC but not
but not those
not those of
those of four
of four nonatopic
four nonatopic control
nonatopic control subjects
control subjects showed
subjects showed intense
showed intense positive
intense positive staining
positive staining for
staining for estrogen
for estrogen and
estrogen and progesterone
and progesterone receptors
Immunofluorescence colocalization of
colocalization of both
of both estrogen
both estrogen and
estrogen and progesterone
and progesterone receptors
progesterone receptors with
receptors with eosinophil
with eosinophil cationic
eosinophil cationic protein
cationic protein showed
protein showed that
showed that approximately
that approximately 70%
approximately 70% of
70% of positive
of positive cells
positive cells were
cells were eosinophils
CONCLUSIONS: Sexual hormones
Sexual hormones through
hormones through their
through their receptors
their receptors may
receptors may influence
may influence the
influence the activity
the activity of
activity of eosinophils
of eosinophils in
eosinophils in patients
in patients with
patients with VKC
CIITA activates the
activates the expression
the expression of
expression of MHC
of MHC class
MHC class II
class II genes
II genes in
genes in mouse
in mouse T
mouse T cells
It has long
has long been
long been a
been a puzzle
a puzzle that
puzzle that MHC
that MHC class
MHC class II
class II molecules
II molecules are
molecules are expressed
are expressed in
expressed in human
in human T
human T cells
T cells after
cells after activation
after activation but
activation but not
but not in
not in mouse
in mouse T
mouse T cells;
T cells; this
cells; this expression
this expression is
expression is believed
is believed to
believed to play
to play a
play a role
a role in
role in the
in the cell
the cell mediated
cell mediated immune
mediated immune response
Recently the MHC
the MHC class
MHC class II
class II transactivator
II transactivator CIITA
transactivator CIITA has
CIITA has been
has been reported
been reported to
reported to be
to be a
be a major
a major regulatory
major regulatory factor
regulatory factor for
factor for both
for both the
both the constitutive
the constitutive and
constitutive and IFN
and IFN inducible
IFN inducible expression
inducible expression of
expression of MHC
of MHC class
MHC class II
class II genes
Here we show
we show that
show that human
that human T
human T cells
T cells expressing
cells expressing MHC
expressing MHC class
MHC class II
class II have
II have CIITA
have CIITA transcripts
CIITA transcripts while
transcripts while MHC
while MHC class
MHC class II-negative
class II-negative human
II-negative human T
human T cells
T cells and
cells and mouse
and mouse T
mouse T cells
T cells do
cells do not
The expression of
expression of MHC
of MHC class
MHC class II
class II genes
II genes in
genes in mouse
in mouse T
mouse T cells
T cells can
cells can be
can be reconstituted
be reconstituted upon
reconstituted upon transfection
upon transfection with
transfection with the
with the human
the human CIITA
human CIITA cDNA
These data indicate
data indicate that
indicate that the
that the expression
the expression of
expression of CIITA
of CIITA explains
CIITA explains the
explains the expression
the expression or
expression or lack
or lack of
lack of expression
of expression of
expression of MHC
of MHC class
MHC class II
class II in
II in human
in human and
human and mouse
and mouse T
mouse T cells
T cells respectively
Anti-RoSSA autoantibodies are
autoantibodies are associated
are associated with
associated with T
with T cell
T cell receptor
cell receptor beta
receptor beta genes
beta genes in
genes in systemic
in systemic lupus
systemic lupus erythematosus
lupus erythematosus patients
Several of the
of the heterogeneous
the heterogeneous clinical
heterogeneous clinical manifestations
clinical manifestations of
manifestations of systemic
of systemic lupus
systemic lupus erythematosus
lupus erythematosus have
erythematosus have been
have been associated
been associated with
associated with specific
with specific autoantibodies
Associations between HLA
between HLA class
HLA class II
class II antigens
II antigens and
antigens and autoantibodies
and autoantibodies to
autoantibodies to the
to the ribonucleoproteins
the ribonucleoproteins RoSSA
ribonucleoproteins RoSSA and
RoSSA and LaSSB
and LaSSB have
LaSSB have been
have been reported
been reported in
reported in these
in these patients
Because HLA class
HLA class II
class II molecules
II molecules present
molecules present antigen
present antigen to
antigen to T
to T cell
T cell receptors
cell receptors TCRs
receptors TCRs we
TCRs we have
we have searched
have searched for
searched for a
for a TCR
a TCR gene
TCR gene associated
gene associated with
associated with the
with the production
the production of
production of anti-RoSSA
of anti-RoSSA antibodies
A pair of
pair of restriction
of restriction fragment
restriction fragment length
fragment length polymorphisms
length polymorphisms RFLPs
polymorphisms RFLPs one
RFLPs one of
one of which
of which hybridizes
which hybridizes to
hybridizes to the
to the TCR
the TCR constant
TCR constant region
constant region C
region C beta
C beta 1
beta 1 and
1 and the
and the other
the other to
other to the
to the C
the C beta
C beta 2
beta 2 gene
2 gene has
gene has been
has been identified
been identified suggesting
identified suggesting these
suggesting these may
these may be
may be genotypic
be genotypic markers
genotypic markers for
markers for an
for an extended
an extended region
extended region of
region of the
of the TCR
the TCR beta
TCR beta locus
This RFLP pair
RFLP pair occurs
pair occurs in
occurs in 76%
in 76% of
76% of patients
of patients with
patients with RoSSA
with RoSSA precipitins
RoSSA precipitins 84%
precipitins 84% of
84% of anti-RoSSA-positive
of anti-RoSSA-positive patients
anti-RoSSA-positive patients lacking
patients lacking LaSSB
lacking LaSSB precipitins
LaSSB precipitins but
precipitins but only
but only 41%
only 41% of
41% of the
of the patients
the patients lacking
patients lacking both
lacking both precipitins
both precipitins P
precipitins P =
P = 00004
This disproportionate occurrence
disproportionate occurrence in
occurrence in a
in a subset
a subset of
subset of lupus
of lupus patients
lupus patients indicates
patients indicates that
indicates that these
that these RFLPs
these RFLPs are
RFLPs are not
are not disease
not disease susceptibility
disease susceptibility markers
susceptibility markers but
markers but rather
but rather are
rather are important
are important markers
important markers for
markers for TCR
for TCR genes
TCR genes whose
genes whose products
whose products are
products are involved
are involved in
involved in the
in the production
the production of
production of anti-RoSSA
of anti-RoSSA antibodies
The majority of
majority of patients
of patients who
patients who have
who have these
have these RFLPs
these RFLPs and
RFLPs and HLA
and HLA class
HLA class II
class II antigens
II antigens previously
antigens previously associated
previously associated with
associated with the
with the anti-RoSSA
the anti-RoSSA response
anti-RoSSA response make
response make this
make this antibody
this antibody suggesting
antibody suggesting that
suggesting that interactions
that interactions between
interactions between products
between products of
products of these
of these loci
these loci occur
loci occur in
occur in response
in response to
response to RoSSA
Inhibition of NF-AT-dependent
of NF-AT-dependent transcription
NF-AT-dependent transcription by
transcription by NF-kappa
by NF-kappa B:
NF-kappa B: implications
B: implications for
implications for differential
for differential gene
differential gene expression
gene expression in
expression in T
in T helper
T helper cell
helper cell subsets
Activation of individual
of individual CD4+
individual CD4+ T
CD4+ T cells
T cells results
cells results in
results in differential
in differential lymphokine
differential lymphokine expression:
lymphokine expression: interleukin
expression: interleukin 2
interleukin 2 IL-2
2 IL-2 is
IL-2 is preferentially
is preferentially produced
preferentially produced by
produced by T
by T helper
T helper type
helper type 1
type 1 TH1
1 TH1 cells
TH1 cells which
cells which are
which are involved
are involved in
involved in cell-mediated
in cell-mediated immune
cell-mediated immune responses
immune responses whereas
responses whereas IL-4
whereas IL-4 is
IL-4 is synthesized
is synthesized by
synthesized by TH2
by TH2 cells
TH2 cells which
cells which are
which are essential
are essential for
essential for humoral
for humoral immunity
The Ca2+-dependent factor
Ca2+-dependent factor NF-ATp
factor NF-ATp plays
NF-ATp plays a
plays a key
a key role
key role in
role in the
in the inducible
the inducible transcription
inducible transcription of
transcription of both
of both these
both these lymphokine
these lymphokine genes
However while IL2
while IL2 expression
IL2 expression requires
expression requires the
requires the contribution
the contribution of
contribution of Ca2+-
of Ca2+- and
Ca2+- and protein
and protein kinase
protein kinase C-dependent
kinase C-dependent signals
C-dependent signals we
signals we report
we report that
report that activation
that activation of
activation of human
of human IL4
human IL4 transcription
IL4 transcription through
transcription through the
through the Ca2+-dependent
the Ca2+-dependent pathway
Ca2+-dependent pathway is
pathway is diminished
is diminished by
diminished by protein
by protein kinase
protein kinase C
kinase C stimulation
C stimulation in
stimulation in Jurkat
in Jurkat T
Jurkat T cells
This phenomenon is
phenomenon is due
is due to
due to mutually
to mutually exclusive
mutually exclusive binding
exclusive binding of
binding of NF-ATp
of NF-ATp and
NF-ATp and NF-kappa
and NF-kappa B
NF-kappa B to
B to the
to the P
the P sequence
P sequence an
sequence an element
an element located
element located 69
located 69 bp
69 bp upstream
bp upstream of
upstream of the
of the IL4
the IL4 transcription
IL4 transcription initiation
transcription initiation site
Human IL4 promoter-mediated
IL4 promoter-mediated transcription
promoter-mediated transcription is
transcription is downregulated
is downregulated in
downregulated in Jurkat
in Jurkat cells
Jurkat cells stimulated
cells stimulated with
stimulated with the
with the NF-kappa
the NF-kappa B-activating
NF-kappa B-activating cytokine
B-activating cytokine tumor
cytokine tumor necrosis
tumor necrosis factor
necrosis factor alpha
factor alpha and
alpha and suppressed
and suppressed in
suppressed in RelA-overexpressing
in RelA-overexpressing cells
In contrast protein
contrast protein kinase
protein kinase C
kinase C stimulation
C stimulation or
stimulation or RelA
or RelA overexpression
RelA overexpression does
overexpression does not
does not affect
not affect the
affect the activity
the activity of
activity of a
of a human
a human IL4
human IL4 promoter
IL4 promoter containing
promoter containing a
containing a mouse
a mouse P
mouse P sequence
P sequence which
sequence which is
which is a
is a higher-affinity
a higher-affinity site
higher-affinity site for
site for NF-ATp
for NF-ATp and
NF-ATp and a
and a lower-affinity
a lower-affinity site
lower-affinity site for
site for RelA
Thus competition between
competition between two
between two general
two general transcriptional
general transcriptional activators
transcriptional activators RelA
activators RelA and
RelA and NF-ATp
and NF-ATp mediates
NF-ATp mediates the
mediates the inhibitory
the inhibitory effect
inhibitory effect of
effect of protein
of protein kinase
protein kinase C
kinase C stimulation
C stimulation on
stimulation on IL4
on IL4 expression
IL4 expression and
expression and may
and may contribute
may contribute to
contribute to differential
to differential gene
differential gene expression
gene expression in
expression in TH
in TH cells
Regulation of the
of the balance
the balance of
balance of cytokine
of cytokine production
cytokine production and
production and the
and the signal
the signal transducer
signal transducer and
transducer and activator
and activator of
activator of transcription
of transcription STAT
transcription STAT transcription
STAT transcription factor
transcription factor activity
factor activity by
activity by cytokines
by cytokines and
cytokines and inflammatory
and inflammatory synovial
inflammatory synovial fluids
The balance between
balance between type
between type 1
type 1 and
1 and 2
and 2 T
2 T helper
T helper cell
helper cell cytokine
cell cytokine production
cytokine production plays
production plays an
plays an important
an important role
important role in
role in several
in several animal
several animal models
animal models of
models of autoimmunity
of autoimmunity and
autoimmunity and skewed
and skewed patterns
skewed patterns of
patterns of cytokine
of cytokine expression
cytokine expression have
expression have been
have been described
been described in
described in human
in human inflammatory
human inflammatory diseases
Many cytokines activate
cytokines activate signal
activate signal transducer
signal transducer and
transducer and activation
and activation of
activation of transcription
of transcription STAT
transcription STAT transcription
STAT transcription factors
transcription factors which
factors which in
which in turn
in turn activate
turn activate transcription
activate transcription of
transcription of inflammatory
of inflammatory effector
inflammatory effector genes
We used mononuclear
used mononuclear cell
mononuclear cell priming
cell priming cultures
priming cultures and
cultures and inflammatory
and inflammatory synovial
inflammatory synovial fluids
synovial fluids SFs
fluids SFs derived
SFs derived from
derived from arthritis
from arthritis patients
arthritis patients to
patients to examine
to examine the
examine the regulation
the regulation of
regulation of cytokine
of cytokine production
cytokine production and
production and STAT
and STAT activity
STAT activity by
activity by an
by an inflammatory
an inflammatory synovial
inflammatory synovial microenvironment
Exposure to SFs
to SFs during
SFs during priming
during priming resulted
priming resulted in
resulted in an
in an 81%
an 81% inhibition
81% inhibition of
inhibition of interferon
of interferon IFN-gamma
interferon IFN-gamma but
IFN-gamma but not
but not interleukin
not interleukin IL
interleukin IL 4
IL 4 production
4 production by
production by effector
by effector cells
effector cells generated
cells generated in
generated in priming
in priming cultures
SF suppression was
suppression was mediated
was mediated by
mediated by IL-4
by IL-4 and
IL-4 and IL-10
and IL-10 and
IL-10 and inhibition
and inhibition of
inhibition of IL-12
of IL-12 expression
IL-12 expression and
expression and it
and it was
it was reversed
was reversed in
reversed in a
in a dominant
a dominant fashion
dominant fashion by
fashion by exogenous
by exogenous IL-12
SFs blocked the
blocked the sustained
the sustained activity
sustained activity of
activity of transcription
of transcription factor
transcription factor Stat1
factor Stat1 but
Stat1 but not
but not Stat3
not Stat3 during
Stat3 during the
during the priming
the priming period
priming period and
period and Stat1
and Stat1 activity
Stat1 activity was
activity was differentially
was differentially regulated
differentially regulated by
regulated by cytokines
by cytokines in
cytokines in parallel
in parallel with
parallel with their
with their positive
their positive or
positive or negative
or negative regulation
negative regulation of
regulation of IFN-gamma
of IFN-gamma production
Active Stat3 but
Stat3 but not
but not Stat1
not Stat1 was
Stat1 was detected
was detected in
detected in cells
in cells from
cells from inflamed
from inflamed joints
These results suggest
results suggest a
suggest a role
a role for
role for altered
for altered balance
altered balance of
balance of Stat1
of Stat1 and
Stat1 and Stat3
and Stat3 transcriptional
Stat3 transcriptional activity
transcriptional activity in
activity in the
in the regulation
the regulation of
regulation of T
of T cell
T cell differentiation
cell differentiation and
differentiation and in
and in the
in the pathogenesis
the pathogenesis of
pathogenesis of inflammatory
of inflammatory synovitis
Triggering of complement
of complement receptors
complement receptors CR1
receptors CR1 CD35
CR1 CD35 and
CD35 and CR3
and CR3 CD11b/CD18
CR3 CD11b/CD18 induces
CD11b/CD18 induces nuclear
induces nuclear translocation
nuclear translocation of
translocation of NF-kappa
of NF-kappa B
NF-kappa B p50/p65
B p50/p65 in
p50/p65 in human
in human monocytes
human monocytes and
monocytes and enhances
and enhances viral
enhances viral replication
viral replication in
replication in HIV-infected
in HIV-infected monocytic
HIV-infected monocytic cells
Monocyte/macrophages may harbor
may harbor HIV
harbor HIV in
HIV in a
in a nonproductive
a nonproductive fashion
nonproductive fashion for
fashion for prolonged
for prolonged periods
prolonged periods of
periods of time
Viral gene expression
gene expression may
expression may be
may be reactivated
be reactivated by
reactivated by stimulation
by stimulation of
stimulation of the
of the cells
the cells with
cells with LPS
with LPS or
LPS or cytokines
or cytokines such
cytokines such as
such as TNF-alpha
as TNF-alpha in
TNF-alpha in vitro
The effect of
effect of LPS
of LPS and
LPS and TNF-alpha
and TNF-alpha is
TNF-alpha is mediated
is mediated by
mediated by their
by their ability
their ability to
ability to induce
to induce nuclear
induce nuclear translocation
nuclear translocation of
translocation of the
of the DNA-binding
the DNA-binding heterodimer
DNA-binding heterodimer NF-kappa
heterodimer NF-kappa B
NF-kappa B p50/p65
B p50/p65 which
p50/p65 which binds
which binds to
binds to a
to a specific
a specific sequence
specific sequence in
sequence in the
in the HIV-long
the HIV-long terminal
HIV-long terminal repeat
The present study
present study demonstrates
study demonstrates that
demonstrates that triggering
that triggering of
triggering of complement
of complement receptors
complement receptors CR1
receptors CR1 CD35
CR1 CD35 and
CD35 and CR3
and CR3 CD11b/CD18
CR3 CD11b/CD18 enhances
CD11b/CD18 enhances viral
enhances viral replication
viral replication in
replication in HIV-infected
in HIV-infected human
HIV-infected human monocytic
human monocytic cells
Monocytic cell lines
cell lines and
lines and normal
and normal peripheral
normal peripheral blood
peripheral blood monocytes
blood monocytes were
monocytes were infected
were infected with
infected with HIV-1
with HIV-1 in
HIV-1 in vitro
in vitro and
vitro and cultured
and cultured in
cultured in the
in the presence
the presence or
presence or absence
or absence of
absence of Fab'2
of Fab'2 fragments
Fab'2 fragments of
fragments of monoclonal
of monoclonal anti-CR1
monoclonal anti-CR1 or
anti-CR1 or anti-CR3
or anti-CR3 Abs
anti-CR3 Abs or
Abs or with
or with C3
with C3 fragments
Stimulation of CR1
of CR1 or
CR1 or CR3
or CR3 induces
CR3 induces a
induces a two-
a two- to
two- to fourfold
to fourfold increase
fourfold increase in
increase in the
in the amount
the amount of
amount of cell-associated
of cell-associated and
cell-associated and released
and released p24
released p24 Ag
p24 Ag in
Ag in cell
in cell cultures
cell cultures that
cultures that was
that was equivalent
was equivalent to
equivalent to that
to that observed
that observed in
observed in control
in control cultures
control cultures triggered
cultures triggered with
triggered with LPS
We further observed
further observed that
observed that stimulation
that stimulation of
stimulation of CR1
of CR1 or
CR1 or CR3
or CR3 induces
CR3 induces the
induces the nuclear
the nuclear translocation
nuclear translocation of
translocation of NF-kappa
of NF-kappa B
NF-kappa B p50/p65
B p50/p65 in
p50/p65 in infected
in infected cells
Translocation of NF-kappa
of NF-kappa B
NF-kappa B p50/p65
B p50/p65 was
p50/p65 was also
was also observed
also observed following
observed following stimulation
following stimulation of
stimulation of CR1
of CR1 or
CR1 or CR3
or CR3 of
CR3 of uninfected
of uninfected peripheral
uninfected peripheral blood
peripheral blood monocytes
blood monocytes from
monocytes from HIV-seronegative
from HIV-seronegative donors
The amount of
amount of protein
of protein translocated
protein translocated was
translocated was similar
was similar to
similar to that
to that observed
that observed when
observed when cells
when cells were
cells were stimulated
were stimulated with
stimulated with rhTNF-alpha
TNF-alpha did not
did not mediate
not mediate the
mediate the translocation
the translocation of
translocation of NF-kappa
of NF-kappa B
NF-kappa B p50/p65
B p50/p65 induced
p50/p65 induced by
induced by triggering
by triggering of
triggering of complement
of complement receptors
Taken together these
together these observations
these observations suggest
observations suggest that
suggest that HIV
that HIV gene
HIV gene expression
gene expression may
expression may be
may be activated
be activated in
activated in infected
in infected monocytes
infected monocytes through
monocytes through interaction
through interaction of
interaction of the
of the cells
the cells with
cells with complement-opsonized
with complement-opsonized particles
complement-opsonized particles and
particles and that
and that enhanced
that enhanced viral
enhanced viral replication
viral replication is
replication is associated
is associated with
associated with C3
with C3 receptor-mediated
C3 receptor-mediated nuclear
receptor-mediated nuclear translocation
nuclear translocation of
translocation of the
of the NF-kappa
the NF-kappa B
NF-kappa B complex
Attenuation of gamma
of gamma interferon-induced
gamma interferon-induced tyrosine
interferon-induced tyrosine phosphorylation
tyrosine phosphorylation in
phosphorylation in mononuclear
in mononuclear phagocytes
mononuclear phagocytes infected
phagocytes infected with
infected with Leishmania
with Leishmania donovani:
Leishmania donovani: selective
donovani: selective inhibition
selective inhibition of
inhibition of signaling
of signaling through
signaling through Janus
through Janus kinases
Janus kinases and
kinases and Stat1
The induction of
induction of gene
of gene transcription
gene transcription in
transcription in response
in response to
response to gamma
to gamma interferon
gamma interferon is
interferon is impaired
is impaired in
impaired in mononuclear
in mononuclear phagocytes
mononuclear phagocytes infected
phagocytes infected with
infected with Leishmania
with Leishmania donovani
Leishmania donovani and
donovani and the
and the mechanisms
the mechanisms involved
mechanisms involved are
involved are not
are not fully
not fully understood
The changes in
changes in gene
in gene expression
gene expression brought
expression brought about
brought about by
about by gamma
by gamma interferon
gamma interferon are
interferon are thought
are thought to
thought to involve
to involve transient
involve transient increases
transient increases in
increases in the
in the activities
the activities of
activities of cellular
of cellular protein
cellular protein tyrosine
protein tyrosine kinases
tyrosine kinases including
kinases including the
including the Janus
the Janus kinases
Janus kinases Jak1
kinases Jak1 and
Jak1 and Jak2
and Jak2 leading
Jak2 leading to
leading to tyrosine
to tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of the
of the transcription
the transcription factor
transcription factor Stat1
To investigate the
investigate the mechanisms
the mechanisms accounting
mechanisms accounting for
accounting for the
for the impaired
the impaired responses
impaired responses to
responses to gamma
to gamma interferon
gamma interferon a
interferon a model
a model system
model system for
system for examining
for examining overall
examining overall changes
overall changes in
changes in protein
in protein tyrosine
protein tyrosine phosphorylation
tyrosine phosphorylation activation
phosphorylation activation of
activation of Jak1
of Jak1 and
Jak1 and Jak2
and Jak2 and
Jak2 and phosphorylation
and phosphorylation of
phosphorylation of Stat1
of Stat1 was
Stat1 was developed
was developed in
developed in phorbol
in phorbol 12-myristate
phorbol 12-myristate 13-acetate-differentiated
12-myristate 13-acetate-differentiated U-937
13-acetate-differentiated U-937 cells
Analysis of whole-cell
of whole-cell lysates
whole-cell lysates by
lysates by antiphosphotyrosine
by antiphosphotyrosine immunoblotting
antiphosphotyrosine immunoblotting showed
immunoblotting showed that
showed that incubation
that incubation with
incubation with gamma
with gamma interferon
gamma interferon brought
interferon brought about
brought about specific
about specific increases
specific increases in
increases in phosphotyrosine
in phosphotyrosine labeling
phosphotyrosine labeling of
labeling of several
of several proteins
Increased labeling of
labeling of these
of these proteins
these proteins occurred
proteins occurred to
occurred to similar
to similar extents
similar extents in
extents in control
in control cells
control cells and
cells and in
and in cells
in cells that
cells that had
that had been
had been infected
been infected with
infected with L
with L donovani
L donovani for
donovani for 16
for 16 h
Jak1 Jak2 and
Jak2 and Stat1
and Stat1 were
Stat1 were immunoprecipitated
were immunoprecipitated from
immunoprecipitated from control
from control and
control and interferon-treated
and interferon-treated cells
interferon-treated cells and
cells and tyrosine
and tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of these
of these proteins
these proteins detected
proteins detected by
detected by antiphosphotyrosine
by antiphosphotyrosine immunoblotting
antiphosphotyrosine immunoblotting was
immunoblotting was used
was used to
used to measured
to measured their
measured their activation
Tyrosine phosphorylation of
phosphorylation of Jak1
of Jak1 Jak2
Jak1 Jak2 and
Jak2 and Stat1
and Stat1 increased
Stat1 increased markedly
increased markedly in
markedly in a
in a dose-dependent
a dose-dependent manner
dose-dependent manner in
manner in U-937
in U-937 cells
U-937 cells incubated
cells incubated with
incubated with gamma
with gamma interferon
In contrast in
contrast in cells
in cells infected
cells infected with
infected with L
with L donovani
L donovani tyrosine
donovani tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of Jak1
of Jak1 Jak2
Jak1 Jak2 and
Jak2 and Stat1
and Stat1 was
Stat1 was markedly
was markedly impaired
This effect was
effect was dependent
was dependent upon
dependent upon the
upon the duration
the duration of
duration of exposure
of exposure to
exposure to L
to L donovani
L donovani and
donovani and was
and was maximal
was maximal and
maximal and complete
and complete at
complete at 16
at 16 h
Results similar to
similar to those
to those observed
those observed with
observed with U-937
with U-937 cells
U-937 cells were
cells were also
were also obtained
also obtained with
obtained with human
with human peripheral
human peripheral blood
peripheral blood monocytes
These findings indicate
findings indicate that
indicate that infection
that infection of
infection of human
of human mononuclear
human mononuclear phagocytes
mononuclear phagocytes with
phagocytes with L
with L donovani
L donovani leads
donovani leads to
leads to impaired
to impaired gamma
impaired gamma interferon-mediated
gamma interferon-mediated tyrosine
interferon-mediated tyrosine phosphorylation
tyrosine phosphorylation and
phosphorylation and selective
and selective effects
selective effects on
effects on the
on the Jak-Stat1
the Jak-Stat1 pathway
Unresponsiveness to gamma
to gamma interferon
gamma interferon for
interferon for activation
for activation of
activation of this
of this pathway
this pathway may
pathway may explain
may explain impaired
explain impaired transcriptional
impaired transcriptional responses
transcriptional responses in
responses in leishmania-infected
in leishmania-infected cells
Mutually exclusive interaction
exclusive interaction of
interaction of a
of a novel
a novel matrix
novel matrix attachment
matrix attachment region
attachment region binding
region binding protein
binding protein and
protein and the
and the NF-muNR
the NF-muNR enhancer
NF-muNR enhancer repressor
Implications for regulation
for regulation of
regulation of immunoglobulin
of immunoglobulin heavy
immunoglobulin heavy chain
heavy chain expression
The immunoglobulin heavy
immunoglobulin heavy chain
heavy chain IgH
chain IgH intronic
IgH intronic enhancer
intronic enhancer stimulates
enhancer stimulates transcription
stimulates transcription from
transcription from functional
from functional promoters
functional promoters in
promoters in B
in B lymphocytes
B lymphocytes but
lymphocytes but not
but not other
not other cell
other cell types
The observation that
observation that binding
that binding sites
binding sites for
sites for the
for the nuclear
the nuclear factor-mu
nuclear factor-mu negative
factor-mu negative regulator
negative regulator NF-muNR
regulator NF-muNR enhancer
NF-muNR enhancer repressor
enhancer repressor overlap
repressor overlap nuclear
overlap nuclear matrix
nuclear matrix attachment
matrix attachment regions
attachment regions MARs
regions MARs in
MARs in this
in this enhancer
this enhancer has
enhancer has lead
has lead to
lead to the
to the hypothesis
the hypothesis that
hypothesis that the
that the cell
the cell type
cell type specificity
type specificity of
specificity of the
of the enhancer
the enhancer might
enhancer might be
might be controlled
be controlled by
controlled by regulating
by regulating nuclear
regulating nuclear matrix
nuclear matrix attachment
matrix attachment Scheuermann
attachment Scheuermann R
Scheuermann R H
R H and
H and Chen
and Chen U
Chen U 1989
U 1989 Genes
1989 Genes &
Genes & Dev
& Dev 3
Dev 3 1255-1266
To understand the
understand the role
the role of
role of MARs
of MARs in
MARs in IgH
in IgH enhancer
IgH enhancer regulation
enhancer regulation we
regulation we have
we have identified
have identified a
identified a novel
a novel MAR-binding
novel MAR-binding protein
MAR-binding protein MAR-BP1
protein MAR-BP1 from
MAR-BP1 from soluble
from soluble nuclear
soluble nuclear matrix
nuclear matrix preparations
matrix preparations based
preparations based on
based on its
on its ability
its ability to
ability to bind
to bind to
bind to the
to the MARs
the MARs associated
MARs associated with
associated with the
with the IgH
the IgH enhancer
Purified MAR-BP1 migrates
MAR-BP1 migrates as
migrates as a
as a 33-kDa
a 33-kDa protein
33-kDa protein and
protein and it
and it can
it can be
can be found
be found in
found in nuclear
in nuclear matrix
nuclear matrix preparations
matrix preparations from
preparations from a
from a number
a number of
number of different
of different types
different types of
types of lymphoid
of lymphoid cell
lymphoid cell lines
Although specific binding
specific binding sites
binding sites have
sites have been
have been difficult
been difficult to
difficult to localize
to localize by
localize by chemical
by chemical or
chemical or enzymatic
or enzymatic footprinting
enzymatic footprinting procedures
footprinting procedures NF-muNR
procedures NF-muNR binding
NF-muNR binding sites
binding sites are
sites are critical
are critical for
critical for efficient
for efficient MAR-BP1
efficient MAR-BP1 binding
Indeed binding of
binding of the
of the IgH
the IgH enhancer
IgH enhancer to
enhancer to either
to either intact
either intact nuclear
intact nuclear matrix
nuclear matrix preparations
matrix preparations or
preparations or to
or to MAR-BP1
to MAR-BP1 is
MAR-BP1 is mutually
is mutually exclusive
mutually exclusive to
exclusive to NF-muNR
to NF-muNR binding
These results are
results are consistent
are consistent with
consistent with a
with a model
a model for
model for cell-type
for cell-type specific
cell-type specific regulation
specific regulation in
regulation in which
in which binding
which binding of
binding of the
of the NF-muNR
the NF-muNR repressor
NF-muNR repressor to
repressor to the
to the IgH
the IgH enhancer
IgH enhancer prevents
enhancer prevents nuclear
prevents nuclear matrix
nuclear matrix attachment
matrix attachment in
attachment in inappropriate
in inappropriate cells
inappropriate cells by
cells by interfering
by interfering with
interfering with MAR-BP1/enhancer
with MAR-BP1/enhancer interaction
PU1 Spi-1 and
Spi-1 and C/EBP
and C/EBP alpha
C/EBP alpha regulate
alpha regulate expression
regulate expression of
expression of the
of the granulocyte-macrophage
the granulocyte-macrophage colony-stimulating
granulocyte-macrophage colony-stimulating factor
colony-stimulating factor receptor
factor receptor alpha
receptor alpha gene
Growth factor receptors
factor receptors play
receptors play an
play an important
an important role
important role in
role in hematopoiesis
In order to
order to further
to further understand
further understand the
understand the mechanisms
the mechanisms directing
mechanisms directing the
directing the expression
the expression of
expression of these
of these key
these key regulators
key regulators of
regulators of hematopoiesis
of hematopoiesis we
hematopoiesis we initiated
we initiated a
initiated a study
a study investigating
study investigating the
investigating the transcription
the transcription factors
transcription factors activating
factors activating the
activating the expression
the expression of
expression of the
of the granulocyte-macrophage
the granulocyte-macrophage colony-stimulating
granulocyte-macrophage colony-stimulating factor
colony-stimulating factor GM-CSF
factor GM-CSF receptor
GM-CSF receptor alpha
receptor alpha gene
Here we demonstrate
we demonstrate that
demonstrate that the
that the human
the human GM-CSF
human GM-CSF receptor
GM-CSF receptor alpha
receptor alpha promoter
alpha promoter directs
promoter directs reporter
directs reporter gene
reporter gene activity
gene activity in
activity in a
in a tissue-specific
a tissue-specific fashion
tissue-specific fashion in
fashion in myelomonocytic
in myelomonocytic cells
myelomonocytic cells which
cells which correlates
which correlates with
correlates with its
with its expression
its expression pattern
expression pattern as
pattern as analyzed
as analyzed by
analyzed by reverse
by reverse transcription
reverse transcription PCR
The GM-CSF receptor
GM-CSF receptor alpha
receptor alpha promoter
alpha promoter contains
promoter contains an
contains an important
an important functional
important functional site
functional site between
site between positions
between positions -53
positions -53 and
-53 and -41
and -41 as
-41 as identified
as identified by
identified by deletion
by deletion analysis
deletion analysis of
analysis of reporter
of reporter constructs
We show that
show that the
that the myeloid
the myeloid and
myeloid and B
and B cell
B cell transcription
cell transcription factor
transcription factor PU1
factor PU1 binds
PU1 binds specifically
binds specifically to
specifically to this
to this site
Furthermore we demonstrate
we demonstrate that
demonstrate that a
that a CCAAT
a CCAAT site
CCAAT site located
site located upstream
located upstream of
upstream of the
of the PU1
the PU1 site
PU1 site between
site between positions
between positions -70
positions -70 and
-70 and -54
and -54 is
-54 is involved
is involved in
involved in positive-negative
in positive-negative regulation
positive-negative regulation of
regulation of the
of the GM-CSF
the GM-CSF receptor
GM-CSF receptor alpha
receptor alpha promoter
alpha promoter activity
C/EBP alpha is
alpha is the
is the major
the major CCAAT/enhancer-binding
major CCAAT/enhancer-binding protein
CCAAT/enhancer-binding protein C/EBP
protein C/EBP form
C/EBP form binding
form binding to
binding to this
to this site
this site in
site in nuclear
in nuclear extracts
nuclear extracts of
extracts of U937
of U937 cells
Point mutations of
mutations of either
of either the
either the PU1
the PU1 site
PU1 site or
site or the
or the C/EBP
the C/EBP site
C/EBP site that
site that abolish
that abolish the
abolish the binding
the binding of
binding of the
of the respective
the respective factors
respective factors result
factors result in
result in a
in a significant
a significant decrease
significant decrease of
decrease of GM-CSF
of GM-CSF receptor
GM-CSF receptor alpha
receptor alpha promoter
alpha promoter activity
promoter activity in
activity in myelomonocytic
in myelomonocytic cells
myelomonocytic cells only
Furthermore we demonstrate
we demonstrate that
demonstrate that in
that in myeloid
in myeloid and
myeloid and B
and B cell
B cell extracts
cell extracts PU1
extracts PU1 forms
PU1 forms a
forms a novel
a novel specific
novel specific more
specific more slowly
more slowly migrating
slowly migrating complex
migrating complex PU-SF
complex PU-SF when
PU-SF when binding
when binding the
binding the GM-CSF
the GM-CSF receptor
GM-CSF receptor alpha
receptor alpha promoter
alpha promoter PU1
promoter PU1 site
This is the
is the first
the first demonstration
first demonstration of
demonstration of a
of a specific
a specific interaction
specific interaction with
interaction with PU1
with PU1 on
PU1 on a
on a myeloid
a myeloid PU1
myeloid PU1 binding
PU1 binding site
The novel complex
novel complex is
complex is distinct
is distinct from
distinct from that
from that described
that described previously
described previously as
previously as binding
as binding to
binding to B
to B cell
B cell enhancer
cell enhancer sites
enhancer sites and
sites and can
and can be
can be formed
be formed by
formed by addition
by addition of
addition of PU1
of PU1 to
PU1 to extracts
to extracts from
extracts from certain
from certain nonmyeloid
certain nonmyeloid cell
nonmyeloid cell types
cell types which
types which do
which do not
do not express
not express PU1
express PU1 including
PU1 including T
including T cells
T cells and
cells and epithelial
and epithelial cells
epithelial cells but
cells but not
but not from
not from erythroid
from erythroid cells
Furthermore we demonstrate
we demonstrate that
demonstrate that the
that the PU-SF
the PU-SF complex
PU-SF complex binds
complex binds to
binds to PU1
to PU1 sites
PU1 sites found
sites found on
found on a
on a number
a number of
number of myeloid
of myeloid promoters
myeloid promoters and
promoters and its
and its formation
its formation requires
formation requires an
requires an intact
an intact PU1
intact PU1 site
PU1 site adjacent
site adjacent to
adjacent to a
to a single-stranded
a single-stranded region
Expression of PU1
of PU1 in
PU1 in nonmyeloid
in nonmyeloid cells
nonmyeloid cells can
cells can activate
can activate the
activate the GM-CSF
the GM-CSF receptor
GM-CSF receptor alpha
receptor alpha promoter
Deletion of the
of the amino-terminal
the amino-terminal region
amino-terminal region of
region of PU1
of PU1 results
PU1 results in
results in a
in a failure
a failure to
failure to form
to form the
form the PU-SF
the PU-SF complex
PU-SF complex and
complex and in
and in a
in a concomitant
a concomitant loss
concomitant loss of
loss of transactivation
of transactivation suggesting
transactivation suggesting that
suggesting that formation
that formation of
formation of the
of the PU-SF
the PU-SF complex
PU-SF complex is
complex is of
is of functional
of functional importance
functional importance for
importance for the
for the activity
the activity of
activity of the
of the GM-CSF
the GM-CSF receptor
GM-CSF receptor alpha
receptor alpha promoter
Finally we demonstrate
we demonstrate that
demonstrate that C/EBP
that C/EBP alpha
C/EBP alpha can
alpha can also
can also active
also active the
active the GM-CSF
the GM-CSF receptor
GM-CSF receptor alpha
receptor alpha promoter
alpha promoter in
promoter in nonmyeloid
in nonmyeloid cells
ABSTRACT TRUNCATED AT
TRUNCATED AT 400
AT 400 WORDS
HMG-I binds to
binds to GATA
to GATA motifs:
GATA motifs: implications
motifs: implications for
implications for an
for an HPFH
an HPFH syndrome
We have examined
have examined binding
examined binding of
binding of the
of the nuclear
the nuclear protein
nuclear protein HMG-I
protein HMG-I to
HMG-I to the
to the human
the human gamma-globin
human gamma-globin promoter
We find that
find that HMG-I
that HMG-I binds
HMG-I binds preferentially
binds preferentially to
preferentially to the
to the more
the more 3'
more 3' of
3' of a
of a pair
a pair of
pair of GATA
of GATA motifs
GATA motifs in
motifs in the
in the gamma-globin
the gamma-globin promoter;
gamma-globin promoter; this
promoter; this paired
this paired motif
paired motif is
motif is bound
is bound by
bound by the
by the erythroid
the erythroid factor
erythroid factor GATA-1
A naturally occurring
naturally occurring mutation
occurring mutation -175
mutation -175 T-C
-175 T-C in
T-C in the
in the area
the area bound
area bound by
bound by HMG-I
by HMG-I results
HMG-I results in
results in overexpression
in overexpression of
overexpression of gamma-globin
of gamma-globin in
gamma-globin in adult
in adult red
adult red blood
red blood cells
blood cells HPFH
cells HPFH and
HPFH and up-regulation
and up-regulation of
up-regulation of the
of the gamma-globin
the gamma-globin promoter
gamma-globin promoter in
promoter in in
in in vitro
in vitro expression
vitro expression assays;
expression assays; HMG-I
assays; HMG-I does
HMG-I does not
does not bind
not bind to
bind to this
to this mutant
this mutant sequence
A survey of
survey of GATA
of GATA motifs
GATA motifs from
motifs from other
from other globin
other globin cis-elements
globin cis-elements demonstrates
cis-elements demonstrates HMG-I
demonstrates HMG-I binding
HMG-I binding to
binding to most
to most of
most of them
These findings implicate
findings implicate HMG-I
implicate HMG-I in
HMG-I in the
in the HPFH
the HPFH phenotype;
HPFH phenotype; we
phenotype; we speculate
we speculate that
speculate that it
that it may
it may participate
may participate in
participate in the
in the formation
the formation of
formation of multiprotein
of multiprotein complexes
multiprotein complexes that
complexes that regulate
that regulate globin
regulate globin gene
globin gene expression
Constitutive activation of
activation of different
of different Jak
different Jak tyrosine
Jak tyrosine kinases
tyrosine kinases in
kinases in human
in human T
human T cell
T cell leukemia
cell leukemia virus
leukemia virus type
virus type 1
type 1 HTLV-1
1 HTLV-1 tax
HTLV-1 tax protein
tax protein or
protein or virus-transformed
or virus-transformed cells
HTLV-1 infection causes
infection causes an
causes an adult
an adult T
adult T cell
T cell leukemia
cell leukemia in
leukemia in humans
The viral encoded
viral encoded protein
encoded protein tax
protein tax is
tax is thought
is thought to
thought to play
to play an
play an important
an important role
important role in
role in oncogenesis
Our previous data
previous data obtained
data obtained from
obtained from a
from a tax
a tax transgenic
tax transgenic mouse
transgenic mouse model
mouse model revealed
model revealed that
revealed that tax
that tax transforms
tax transforms mouse
transforms mouse fibroblasts
mouse fibroblasts but
fibroblasts but not
but not thymocytes
not thymocytes despite
thymocytes despite comparable
despite comparable levels
comparable levels of
levels of tax
of tax expression
tax expression in
expression in both
in both tissues
Constitutive tyrosine phosphorylation
tyrosine phosphorylation of
phosphorylation of a
of a 130-kD
a 130-kD proteins
130-kD proteins was
proteins was observed
was observed in
observed in the
in the tax
the tax transformed
tax transformed fibroblast
transformed fibroblast B
fibroblast B line
B line and
line and in
and in HTLV-1
in HTLV-1 transformed
HTLV-1 transformed human
transformed human lymphoid
human lymphoid lines
lymphoid lines but
lines but not
but not in
not in thymocytes
in thymocytes from
thymocytes from Thy-tax
from Thy-tax transgenic
Thy-tax transgenic mice
Phosphotyrosine immunoprecipitation followed
immunoprecipitation followed by
followed by Western
by Western blot
Western blot analysis
blot analysis with
analysis with a
with a set
a set of
set of Jak
of Jak kinase
Jak kinase specific
kinase specific antibodies
specific antibodies identified
antibodies identified p130
identified p130 as
p130 as Jak2
as Jak2 in
Jak2 in the
in the tax
the tax transformed
tax transformed mouse
transformed mouse fibroblastic
mouse fibroblastic cell
fibroblastic cell line
cell line and
line and Jak3
and Jak3 in
Jak3 in HTLV-1
in HTLV-1 transformed
HTLV-1 transformed human
transformed human T
human T cell
T cell lines
Phosphorylation of Jak2
of Jak2 in
Jak2 in tax
in tax transformed
tax transformed cells
transformed cells resulted
cells resulted from
resulted from high
from high expression
high expression of
expression of IL-6
Tyrosine phosphorylation of
phosphorylation of this
of this protein
this protein could
protein could also
could also be
also be induced
be induced in
induced in Balb/c3T3
in Balb/c3T3 cells
Balb/c3T3 cells using
cells using a
using a supernatant
a supernatant from
supernatant from the
from the B
the B line
B line which
line which was
which was associated
was associated with
associated with induction
with induction of
induction of cell
of cell proliferation
Both phosphorylation and
phosphorylation and proliferation
and proliferation were
proliferation were inhibited
were inhibited by
inhibited by IL-6
by IL-6 neutralizing
IL-6 neutralizing antibodies
Constitutive phosphorylation of
phosphorylation of Jak
of Jak kinases
Jak kinases may
kinases may facilitate
may facilitate tumor
facilitate tumor growth
tumor growth in
growth in both
in both HTLV-1
both HTLV-1 infected
HTLV-1 infected human
infected human T
human T cells
T cells and
cells and the
and the transgenic
the transgenic mouse
transgenic mouse model
Regulation of c-jun
of c-jun mRNA
c-jun mRNA expression
mRNA expression by
expression by hydroxyurea
by hydroxyurea in
hydroxyurea in human
in human K562
human K562 cells
K562 cells during
cells during erythroid
during erythroid differentiation
erythroid differentiation [published
differentiation [published erratum
[published erratum appears
erratum appears in
appears in Biochim
in Biochim Biophys
Biochim Biophys Acta
Biophys Acta 1995
Acta 1995 Dec
1995 Dec 27;12643:409]
Hydroxyurea HU is
HU is an
is an antitumor
an antitumor agent
antitumor agent which
agent which also
which also induces
also induces hemoglobinization
induces hemoglobinization during
hemoglobinization during erythroid
during erythroid differentiation
In addition HU
addition HU stimulates
HU stimulates the
stimulates the synthesis
the synthesis of
synthesis of fetal
of fetal hemoglobin
fetal hemoglobin in
hemoglobin in sickle
in sickle cell
sickle cell anemia
cell anemia patients
To further understand
further understand its
understand its mechanism
its mechanism of
mechanism of action
of action we
action we investigated
we investigated the
investigated the effects
the effects of
effects of HU
of HU on
HU on regulation
on regulation of
regulation of c-jun
of c-jun expression
c-jun expression prior
expression prior to
prior to the
to the onset
the onset of
onset of erythroid
of erythroid differentiation
erythroid differentiation of
differentiation of K562
of K562 cells
HU induced a
induced a dose-dependent
a dose-dependent stimulation
dose-dependent stimulation of
stimulation of c-jun
of c-jun synthesis
The levels of
levels of c-jun
of c-jun mRNA
c-jun mRNA was
mRNA was elevated
was elevated 4
elevated 4 to
4 to 75-fold
to 75-fold by
75-fold by HU
by HU within
HU within 2
within 2 h
This was followed
was followed by
followed by a
by a gradual
a gradual decline
gradual decline to
decline to the
to the basal
the basal level
basal level by
level by 24
by 24 h
Both nuclear run-on
nuclear run-on and
run-on and actinomycin
and actinomycin D
actinomycin D pulse
D pulse experiments
pulse experiments strongly
experiments strongly indicate
strongly indicate that
indicate that HU
that HU regulates
HU regulates c-jun
regulates c-jun mRNA
c-jun mRNA expression
mRNA expression by
expression by increasing
by increasing the
increasing the rate
the rate of
rate of synthesis
of synthesis as
synthesis as well
as well as
well as stabilizing
as stabilizing the
stabilizing the c-jun
the c-jun mRNA
In addition the
addition the level
the level of
level of jun
of jun protein
jun protein was
protein was elevated
was elevated by
elevated by 2
by 2 to
2 to 5-fold
to 5-fold within
5-fold within 4
within 4 h
4 h in
h in HU
in HU treated
HU treated cells
Furthermore concentrations of
concentrations of HU
of HU below
HU below 250
below 250 microM
250 microM slightly
microM slightly increased
slightly increased the
increased the 5X
the 5X AP-1/CAT
5X AP-1/CAT activity
These results strongly
results strongly suggest
strongly suggest that
suggest that HU
that HU induces
HU induces both
induces both transcriptional
both transcriptional and
transcriptional and post-transcription
and post-transcription regulation
post-transcription regulation of
regulation of c-jun
of c-jun during
c-jun during erythroid
during erythroid differentiation
In vivo and
vivo and in
and in vitro
in vitro effects
vitro effects of
effects of glucocorticoids
of glucocorticoids on
glucocorticoids on lymphocyte
on lymphocyte proliferation
lymphocyte proliferation in
proliferation in man:
in man: relationship
man: relationship to
relationship to glucocorticoid
to glucocorticoid receptors
Interrelations between the
between the hypothalamic-pituitary-adrenal
the hypothalamic-pituitary-adrenal system
hypothalamic-pituitary-adrenal system HPA
system HPA and
HPA and the
and the immune
the immune system
immune system represent
system represent a
represent a well-documented
a well-documented biological
well-documented biological phenomenon
While in vitro
in vitro administration
vitro administration of
administration of glucocorticoids
of glucocorticoids may
glucocorticoids may inhibit
may inhibit concanavalin
inhibit concanavalin A
concanavalin A Con
A Con A-
Con A- and
A- and phytohemagglutinin
and phytohemagglutinin PHA-induced
phytohemagglutinin PHA-induced T-cell
PHA-induced T-cell proliferation
T-cell proliferation pokeweed
proliferation pokeweed mitogen
pokeweed mitogen PWM-driven
mitogen PWM-driven B-cell
PWM-driven B-cell mitogenesis
B-cell mitogenesis is
mitogenesis is relatively
is relatively resistant
relatively resistant to
resistant to glucocorticoids
To further explore
further explore the
explore the link
the link between
link between the
between the HPA
the HPA and
HPA and the
and the immune
the immune system
immune system in
system in relation
in relation to
relation to glucocorticoid
to glucocorticoid receptor
glucocorticoid receptor function
receptor function dose-response
function dose-response curves
dose-response curves were
curves were obtained
were obtained for
obtained for Con
for Con A
Con A -and
A -and PHA-induced
-and PHA-induced T-cell
PHA-induced T-cell mitogenesis
T-cell mitogenesis PWM-generated
mitogenesis PWM-generated B-cell
PWM-generated B-cell mitogenesis
B-cell mitogenesis and
mitogenesis and spontaneous
and spontaneous lymphocyte
spontaneous lymphocyte proliferation
lymphocyte proliferation in
proliferation in 13
in 13 healthy
13 healthy controls
Glucocorticoid effects were
effects were assessed
were assessed in
assessed in vivo
in vivo by
vivo by depletion
by depletion of
depletion of endogenous
of endogenous glucocorticoids
endogenous glucocorticoids after
glucocorticoids after oral
after oral administration
oral administration of
administration of 15
of 15 g
15 g metyrapone
g metyrapone MET
metyrapone MET and
MET and subsequent
and subsequent glucocorticoid
subsequent glucocorticoid replacement
glucocorticoid replacement and
replacement and in
and in vitro
in vitro by
vitro by incubation
by incubation of
incubation of the
of the cells
the cells with
cells with different
with different doses
different doses of
doses of dexamethasone
of dexamethasone DEX
There was a
was a significant
a significant decrease
significant decrease in
decrease in PWM-induced
in PWM-induced B-cell
PWM-induced B-cell mitogenesis
B-cell mitogenesis and
mitogenesis and a
and a more
a more pronounced
more pronounced effect
pronounced effect of
effect of DEX
of DEX administered
DEX administered in
administered in vitro
in vitro on
vitro on spontaneous
on spontaneous lymphocyte
spontaneous lymphocyte proliferation
lymphocyte proliferation after
proliferation after MET
after MET treatment
MET treatment when
treatment when compared
when compared with
compared with the
with the DEX
the DEX plus
DEX plus MET
plus MET pretreated
MET pretreated condition
pretreated condition in
condition in vivo
These data suggest
data suggest that
suggest that the
that the inhibition
the inhibition of
inhibition of spontaneous
of spontaneous lymphocyte
spontaneous lymphocyte proliferation
lymphocyte proliferation by
proliferation by glucocorticoids
by glucocorticoids in
glucocorticoids in vitro
in vitro is
vitro is related
is related to
related to glucocorticoid
to glucocorticoid receptor
glucocorticoid receptor function
The decrease in
decrease in PWM-generated
in PWM-generated B-cell
PWM-generated B-cell proliferation
B-cell proliferation following
proliferation following cortisol
following cortisol depletion
cortisol depletion by
depletion by MET
by MET may
MET may be
may be seen
be seen in
seen in connection
in connection with
connection with impaired
with impaired glucocorticoid-mediated
impaired glucocorticoid-mediated induction
glucocorticoid-mediated induction of
induction of interleukin-1
of interleukin-1 receptor
interleukin-1 receptor synthesis
Transcription specific differences
specific differences visualized
differences visualized by
visualized by fluorescence
by fluorescence in
fluorescence in situ
in situ hybridization
situ hybridization pattern
hybridization pattern on
pattern on interphase
on interphase nuclei
interphase nuclei of
nuclei of different
of different cell
different cell types
Application of a
of a "formamide
a "formamide free"
"formamide free" and
free" and thus
and thus "material
thus "material preserving"
"material preserving" in
preserving" in situ
in situ hybridization
situ hybridization technique
hybridization technique using
technique using the
using the cDNA
the cDNA of
cDNA of the
of the myf3
the myf3 gene
myf3 gene revealed
gene revealed the
revealed the following
the following results:
following results: Human
results: Human rhabdomyosarcoma
Human rhabdomyosarcoma cells
rhabdomyosarcoma cells characterized
cells characterized by
characterized by a
by a high
a high expression
high expression of
expression of myf3
of myf3 show
myf3 show intensive
show intensive hybridization
intensive hybridization signals
hybridization signals in
signals in their
in their interphase
RNase treatment prior
treatment prior to
prior to hybridization
to hybridization considerably
hybridization considerably reduces
considerably reduces the
reduces the size
the size of
size of this
of this signals
In comparison isolated
comparison isolated nuclei
isolated nuclei of
nuclei of human
of human lymphocytes
human lymphocytes in
lymphocytes in which
in which no
which no need
no need for
need for the
for the expression
the expression of
expression of this
of this gene
this gene exists
gene exists show
exists show barely
show barely hybridization
barely hybridization signals
Correspondingly RNase treatment
RNase treatment had
treatment had no
had no effect
no effect on
effect on hybridization
on hybridization pattern
hybridization pattern at
pattern at all
In conclusion an
conclusion an increased
an increased transcription
increased transcription efficiency
transcription efficiency of
efficiency of a
of a cell
a cell type
cell type specific
type specific gene
specific gene is
gene is accompanied
is accompanied by
accompanied by a
by a higher
a higher hybridization
higher hybridization accessibility
hybridization accessibility in
accessibility in the
in the corresponding
the corresponding cell
corresponding cell nuclei
Oncogenicity of human
of human papillomavirus-
human papillomavirus- or
papillomavirus- or adenovirus-transformed
or adenovirus-transformed cells
adenovirus-transformed cells correlates
cells correlates with
correlates with resistance
with resistance to
resistance to lysis
to lysis by
lysis by natural
by natural killer
natural killer cells
The reasons for
reasons for the
for the dissimilar
the dissimilar oncogenicities
dissimilar oncogenicities of
oncogenicities of human
of human adenoviruses
human adenoviruses and
adenoviruses and human
and human papillomaviruses
human papillomaviruses HPV
papillomaviruses HPV in
HPV in humans
in humans are
humans are unknown
are unknown but
unknown but may
but may relate
may relate to
relate to differences
to differences in
differences in the
in the capacities
the capacities of
capacities of the
of the E1A
the E1A and
E1A and E7
and E7 proteins
E7 proteins to
proteins to target
to target cells
target cells for
cells for rejection
for rejection by
rejection by the
by the host
the host natural
host natural killer
natural killer NK
killer NK cell
NK cell response
As one test
one test of
test of this
of this hypothesis
this hypothesis we
hypothesis we compared
we compared the
compared the abilities
the abilities of
abilities of E1A
of E1A -and
E1A -and E7-expressing
-and E7-expressing human
E7-expressing human fibroblastic
human fibroblastic or
fibroblastic or keratinocyte-derived
or keratinocyte-derived human
keratinocyte-derived human cells
human cells to
cells to be
to be selectively
be selectively killed
selectively killed by
killed by either
by either unstimulated
either unstimulated or
unstimulated or interferon
or interferon IFN-activated
interferon IFN-activated NK
IFN-activated NK cells
Cells expressing the
expressing the E1A
the E1A oncoprotein
E1A oncoprotein were
oncoprotein were selectively
were selectively killed
selectively killed by
killed by unstimulated
by unstimulated NK
unstimulated NK cells
NK cells while
cells while the
while the same
the same parental
same parental cells
parental cells but
cells but expressing
but expressing the
expressing the HPV
the HPV type
HPV type 16
type 16 HPV-16
16 HPV-16 or
HPV-16 or HPV-18
or HPV-18 E7
HPV-18 E7 oncoprotein
E7 oncoprotein were
oncoprotein were resistant
were resistant to
resistant to NK
to NK cell
NK cell lysis
The ability of
ability of IFN-activated
of IFN-activated NK
IFN-activated NK cells
NK cells to
cells to selectively
to selectively kill
selectively kill virally
kill virally transformed
virally transformed cells
transformed cells depends
cells depends on
depends on IFN's
on IFN's ability
IFN's ability to
ability to induce
to induce resistance
induce resistance to
resistance to NK
to NK cell
NK cell lysis
cell lysis in
lysis in normal
in normal ie
normal ie non-viral
ie non-viral oncogene-expressing
non-viral oncogene-expressing but
oncogene-expressing but not
but not virally
not virally transformed
virally transformed cells
E1A blocked IFN's
blocked IFN's induction
IFN's induction of
induction of cytolytic
of cytolytic resistance
cytolytic resistance resulting
resistance resulting in
resulting in the
in the selective
the selective lysis
selective lysis of
lysis of adenovirus-transformed
of adenovirus-transformed cells
adenovirus-transformed cells by
cells by IFN-activated
by IFN-activated NK
IFN-activated NK cells
The extent of
extent of IFN-induced
of IFN-induced NK
IFN-induced NK cell
NK cell killing
cell killing of
killing of E1A-expressing
of E1A-expressing cells
E1A-expressing cells was
cells was proportional
was proportional to
proportional to the
to the level
the level of
level of E1A
of E1A expression
E1A expression and
expression and correlated
and correlated with
correlated with the
with the ability
the ability of
ability of E1A
of E1A to
E1A to block
to block IFN-stimulated
block IFN-stimulated gene
IFN-stimulated gene expression
gene expression in
expression in target
in target cells
In contrast E7
contrast E7 blocked
E7 blocked neither
blocked neither IFN-stimulated
neither IFN-stimulated gene
IFN-stimulated gene expression
gene expression nor
expression nor IFN's
nor IFN's induction
IFN's induction of
induction of cytolytic
of cytolytic resistance
cytolytic resistance thereby
resistance thereby precluding
thereby precluding the
precluding the selective
the selective lysis
selective lysis of
lysis of HPV-transformed
of HPV-transformed cells
HPV-transformed cells by
cells by IFN-activated
by IFN-activated NK
IFN-activated NK cells
In conclusion E1A
conclusion E1A expression
E1A expression marks
expression marks cells
marks cells for
cells for destruction
for destruction by
destruction by the
by the host
the host NK
host NK cell
NK cell response
cell response whereas
response whereas the
whereas the E7
the E7 oncoprotein
E7 oncoprotein lacks
oncoprotein lacks this
lacks this activity
Regulation of IkB
of IkB alpha
IkB alpha phosphorylation
alpha phosphorylation by
phosphorylation by PKC-
by PKC- and
PKC- and Ca2+-dependent
and Ca2+-dependent signal
Ca2+-dependent signal transduction
signal transduction pathways
The Ca2+-dependent phosphatase
Ca2+-dependent phosphatase calcineurin
phosphatase calcineurin a
calcineurin a target
a target of
target of FK506
of FK506 and
FK506 and CsA
and CsA synergizes
CsA synergizes with
synergizes with PKC-induced
with PKC-induced activation
PKC-induced activation of
activation of nuclear
of nuclear factor
nuclear factor NF-kappa
factor NF-kappa B
NF-kappa B in
B in T
in T cell
T cell lines
We have investigated
have investigated whether
investigated whether this
whether this synergy
this synergy is
synergy is present
is present in
present in other
in other cell
other cell types
cell types and
types and the
and the mechanisms
the mechanisms by
mechanisms by which
by which these
which these two
these two pathways
two pathways lead
pathways lead to
lead to NF-kappa
to NF-kappa B
NF-kappa B activation
While this synergy
this synergy is
synergy is present
is present in
present in other
in other cell
other cell types
cell types in
types in the
in the monocytic
the monocytic cell
monocytic cell line
cell line U937
line U937 calcineurin
U937 calcineurin is
calcineurin is also
is also sufficient
also sufficient to
sufficient to activate
to activate NF-kappa
activate NF-kappa B
Having previously shown
previously shown that
shown that Ca2+-
that Ca2+- and
Ca2+- and PKC-dependent
and PKC-dependent pathways
PKC-dependent pathways synergize
pathways synergize by
synergize by accelerating
by accelerating the
accelerating the degradation
the degradation of
degradation of IkB
of IkB alpha
IkB alpha we
alpha we focused
we focused on
focused on the
on the regulation
the regulation of
regulation of IkB
of IkB alpha
IkB alpha phosphorylation
While PKC-dependent pathways
PKC-dependent pathways sequentially
pathways sequentially result
sequentially result in
result in the
in the phosphorylation
the phosphorylation and
phosphorylation and in
and in an
in an incomplete
an incomplete degradation
incomplete degradation of
degradation of IkB
of IkB alpha
IkB alpha in
alpha in T
in T cell
T cell lines
cell lines co-activation
lines co-activation of
co-activation of Ca2+-dependent
of Ca2+-dependent pathways
Ca2+-dependent pathways accelerates
pathways accelerates the
accelerates the rate
the rate of
rate of IkB
of IkB alpha
IkB alpha phosphorylation
alpha phosphorylation and
phosphorylation and results
and results in
results in its
in its complete
its complete degradation
Activation of Ca2+-dependent
of Ca2+-dependent pathways
Ca2+-dependent pathways alone
pathways alone do
alone do not
do not result
not result in
result in the
in the phosphorylation
the phosphorylation and/or
phosphorylation and/or degradation
and/or degradation of
degradation of IkB
of IkB alpha
IkB alpha in
alpha in Jurkat
in Jurkat T
Jurkat T or
T or in
or in U937
in U937 cells
Treatment of T
of T cells
T cells with
cells with the
with the selective
the selective PKC
selective PKC inhibitor
PKC inhibitor GF109203X
inhibitor GF109203X abrogates
GF109203X abrogates the
abrogates the PMA-induced
the PMA-induced IkB
PMA-induced IkB alpha
IkB alpha phosphorylation/degradation
alpha phosphorylation/degradation irrespective
phosphorylation/degradation irrespective of
irrespective of activation
of activation of
activation of Ca2+-dependent
of Ca2+-dependent pathways
Ca2+-dependent pathways but
pathways but not
but not the
not the phosphorylation
the phosphorylation and
phosphorylation and degradation
and degradation of
degradation of IkB
of IkB alpha
IkB alpha induced
alpha induced by
induced by TNF-alpha
by TNF-alpha a
TNF-alpha a PKC-independent
a PKC-independent stimulus
Contrary to the
to the interaction
the interaction with
interaction with PKC
with PKC Ca2+-dependent
PKC Ca2+-dependent pathways
Ca2+-dependent pathways synergize
pathways synergize with
synergize with TNF-alpha
with TNF-alpha not
TNF-alpha not at
not at the
at the level
the level of
level of IkB
of IkB alpha
IkB alpha phosphorylation
alpha phosphorylation but
phosphorylation but at
but at the
at the level
the level of
level of its
of its degradation
These results indicate
results indicate that
indicate that Ca2+-dependent
that Ca2+-dependent pathways
Ca2+-dependent pathways including
pathways including the
including the phosphatase
the phosphatase calcineurin
phosphatase calcineurin participate
calcineurin participate in
participate in the
in the regulation
the regulation of
regulation of NF-kappa
of NF-kappa B
NF-kappa B in
B in a
in a cell
a cell specific
cell specific fashion
specific fashion and
fashion and synergize
and synergize with
synergize with PKC-dependent
with PKC-dependent and
PKC-dependent and -independent
and -independent pathways
-independent pathways at
pathways at the
at the level
the level of
level of IkB
of IkB alpha
IkB alpha phosphorylation
alpha phosphorylation and
phosphorylation and degradation
Vitamin E therapy
E therapy of
therapy of acute
of acute CCl4-induced
acute CCl4-induced hepatic
CCl4-induced hepatic injury
hepatic injury in
injury in mice
in mice is
mice is associated
is associated with
associated with inhibition
with inhibition of
inhibition of nuclear
of nuclear factor
nuclear factor kappa
factor kappa B
kappa B binding
Oxidative stress with
stress with reactive
with reactive oxygen
reactive oxygen intermediate
oxygen intermediate formation
intermediate formation may
formation may represent
may represent a
represent a common
a common mechanism
common mechanism by
mechanism by which
by which liver
which liver injury
liver injury is
injury is induced
is induced by
induced by diverse
by diverse etiologies
Oxidative stress enhances
stress enhances nuclear
enhances nuclear factor
nuclear factor kappa
factor kappa B
kappa B NF-kappa
B NF-kappa B
NF-kappa B activity
B activity and
activity and NF-kappa
and NF-kappa B
NF-kappa B activity
B activity has
activity has been
has been shown
been shown to
shown to enhance
to enhance the
enhance the expression
the expression of
expression of cytotoxic
of cytotoxic cytokines
Acute hepatic injury
hepatic injury caused
injury caused by
caused by reactive
by reactive oxygen
reactive oxygen intermediate
oxygen intermediate production
intermediate production was
production was induced
was induced by
induced by an
by an intraperitoneal
an intraperitoneal injection
intraperitoneal injection of
injection of CCl4
of CCl4 in
CCl4 in mice
This injury was
injury was significantly
was significantly inhibited
significantly inhibited by
inhibited by intravenous
by intravenous pretreatment
intravenous pretreatment of
pretreatment of the
of the mice
the mice with
mice with a
with a water-soluble
a water-soluble emulsion
water-soluble emulsion of
emulsion of alpha-tocopherol
Alpha-tocopherol treatment of
treatment of the
of the mice
the mice given
mice given the
given the CCl4
the CCl4 also
CCl4 also reduced
also reduced the
reduced the NF-kappa
the NF-kappa B
NF-kappa B binding
B binding to
binding to levels
to levels approaching
levels approaching those
approaching those found
those found in
found in normal
in normal mice
In vitro treatment
vitro treatment of
treatment of a
of a monocyte/macrophage
a monocyte/macrophage cell
monocyte/macrophage cell line
cell line with
line with CCl4
with CCl4 led
CCl4 led to
led to enhanced
to enhanced NF-kappa
enhanced NF-kappa B
NF-kappa B binding
B binding and
binding and an
and an increase
an increase in
increase in tumor
in tumor necrosis
tumor necrosis factor-alpha
necrosis factor-alpha TNF-alpha
factor-alpha TNF-alpha messenger
TNF-alpha messenger RNA
messenger RNA levels
Liver specimens taken
specimens taken from
taken from patients
from patients with
patients with acute
with acute fulminant
acute fulminant hepatitis
fulminant hepatitis had
hepatitis had markedly
had markedly increased
markedly increased NF-kappa
increased NF-kappa B
NF-kappa B binding
B binding activity
binding activity in
activity in comparison
in comparison with
comparison with the
with the binding
the binding of
binding of normal
of normal livers
These data demonstrate
data demonstrate that
demonstrate that abolishing
that abolishing acute
abolishing acute hepatic
acute hepatic injury
hepatic injury with
injury with alpha-tocopherol
with alpha-tocopherol a
alpha-tocopherol a free
a free radical
free radical scavenger
radical scavenger also
scavenger also eliminated
also eliminated increased
eliminated increased NF-kappa
increased NF-kappa B
NF-kappa B binding
It is tempting
is tempting to
tempting to speculate
to speculate that
speculate that enhanced
that enhanced NF-kappa
enhanced NF-kappa B
NF-kappa B expression
B expression caused
expression caused by
caused by free
by free radical
free radical production/oxidative
radical production/oxidative stress
production/oxidative stress may
stress may modulate
may modulate liver
modulate liver injury
liver injury perhaps
injury perhaps through
perhaps through an
through an effect
an effect on
effect on cytotoxic
on cytotoxic cytokine
cytotoxic cytokine synthesis
Immunosuppression by glucocorticoids:
by glucocorticoids: inhibition
glucocorticoids: inhibition of
inhibition of NF-kappa
of NF-kappa B
NF-kappa B activity
B activity through
activity through induction
through induction of
induction of I
of I kappa
I kappa B
kappa B synthesis
B synthesis [see
synthesis [see comments]
Glucocorticoids are among
are among the
among the most
the most potent
most potent anti-inflammatory
potent anti-inflammatory and
anti-inflammatory and immunosuppressive
and immunosuppressive agents
They inhibit synthesis
inhibit synthesis of
synthesis of almost
of almost all
almost all known
all known cytokines
known cytokines and
cytokines and of
and of several
of several cell
several cell surface
cell surface molecules
surface molecules required
molecules required for
required for immune
for immune function
immune function but
function but the
but the mechanism
the mechanism underlying
mechanism underlying this
underlying this activity
this activity has
activity has been
has been unclear
been unclear Here
unclear Here it
Here it is
it is shown
is shown that
shown that glucocorticoids
that glucocorticoids are
glucocorticoids are potent
are potent inhibitors
potent inhibitors of
inhibitors of nuclear
of nuclear factor
nuclear factor kappa
factor kappa B
kappa B NF-kappa
B NF-kappa B
NF-kappa B activation
B activation in
activation in mice
in mice and
mice and cultured
and cultured cells
This inhibition is
inhibition is mediated
is mediated by
mediated by induction
by induction of
induction of the
of the I
the I kappa
I kappa B
kappa B alpha
B alpha inhibitory
alpha inhibitory protein
inhibitory protein which
protein which traps
which traps activated
traps activated NF-kappa
activated NF-kappa B
NF-kappa B in
B in inactive
in inactive cytoplasmic
inactive cytoplasmic complexes
Because NF-kappa B
NF-kappa B activates
B activates many
activates many immunoregulatory
many immunoregulatory genes
immunoregulatory genes in
genes in response
in response to
response to pro-inflammatory
to pro-inflammatory stimuli
pro-inflammatory stimuli the
stimuli the inhibition
the inhibition of
inhibition of its
of its activity
its activity can
activity can be
can be a
be a major
a major component
major component of
component of the
of the anti-inflammatory
the anti-inflammatory activity
anti-inflammatory activity of
activity of glucocorticoids
Transcriptional repression of
repression of the
of the interleukin-2
the interleukin-2 gene
interleukin-2 gene by
gene by vitamin
by vitamin D3:
vitamin D3: direct
D3: direct inhibition
direct inhibition of
inhibition of NFATp/AP-1
of NFATp/AP-1 complex
NFATp/AP-1 complex formation
complex formation by
formation by a
by a nuclear
a nuclear hormone
nuclear hormone receptor
T-lymphocyte proliferation is
proliferation is suppressed
is suppressed by
suppressed by 125-dihydroxyvitamin
by 125-dihydroxyvitamin D3
125-dihydroxyvitamin D3 [125OH2D3]
D3 [125OH2D3] the
[125OH2D3] the active
the active metabolite
active metabolite of
metabolite of vitamin
of vitamin D3
vitamin D3 and
D3 and is
and is associated
is associated with
associated with a
with a decrease
a decrease in
decrease in interleukin
in interleukin 2
interleukin 2 IL-2
2 IL-2 gamma
IL-2 gamma interferon
gamma interferon and
interferon and granulocyte-macrophage
and granulocyte-macrophage colony-stimulating
granulocyte-macrophage colony-stimulating factor
colony-stimulating factor mRNA
factor mRNA levels
We report here
report here that
here that 125OH2D3-mediated
that 125OH2D3-mediated repression
125OH2D3-mediated repression in
repression in Jurkat
in Jurkat cells
Jurkat cells is
cells is cycloheximide
is cycloheximide resistant
cycloheximide resistant suggesting
resistant suggesting that
suggesting that it
that it is
it is a
is a direct
a direct transcriptional
direct transcriptional repressive
transcriptional repressive effect
repressive effect on
effect on IL-2
on IL-2 expression
IL-2 expression by
expression by the
by the vitamin
the vitamin D3
vitamin D3 receptor
D3 receptor VDR
We therefore examined
therefore examined vitamin
examined vitamin D3-mediated
vitamin D3-mediated repression
D3-mediated repression of
repression of activated
of activated IL-2
activated IL-2 expression
IL-2 expression by
expression by cotransfecting
by cotransfecting Jurkat
cotransfecting Jurkat cells
Jurkat cells with
cells with IL-2
with IL-2 promoter/reporter
IL-2 promoter/reporter constructs
promoter/reporter constructs and
constructs and a
and a VDR
a VDR overexpression
VDR overexpression vector
overexpression vector and
vector and by
and by DNA
by DNA binding
We delineated an
delineated an element
an element conferring
element conferring both
conferring both DNA
both DNA binding
DNA binding by
binding by the
by the receptor
the receptor in
receptor in vitro
in vitro and
vitro and 125OH2D3-mediated
and 125OH2D3-mediated repression
125OH2D3-mediated repression in
repression in vivo
in vivo to
vivo to a
to a short
a short 40-bp
short 40-bp region
40-bp region encompassing
region encompassing an
encompassing an important
an important positive
important positive regulatory
positive regulatory element
regulatory element NF-AT-1
element NF-AT-1 which
NF-AT-1 which is
which is bound
is bound by
bound by a
by a T-cell-specific
a T-cell-specific transcription
T-cell-specific transcription factor
transcription factor NFATp
factor NFATp as
NFATp as well
as well as
well as by
as by AP-1
VDR DNA-binding mutants
DNA-binding mutants were
mutants were unable
were unable to
unable to either
to either bind
either bind to
bind to this
to this element
this element in
element in vitro
in vitro or
vitro or repress
or repress in
repress in vivo;
in vivo; the
vivo; the VDR
the VDR DNA-binding
VDR DNA-binding domain
DNA-binding domain alone
domain alone however
alone however bound
however bound the
bound the element
the element but
element but also
but also could
also could not
could not repress
not repress IL-2
repress IL-2 expression
These results indicate
results indicate that
indicate that DNA
that DNA binding
DNA binding by
binding by VDR
by VDR is
VDR is necessary
is necessary but
necessary but not
but not sufficient
not sufficient to
sufficient to mediate
to mediate IL-2
mediate IL-2 repression
By combining partially
combining partially purified
partially purified proteins
purified proteins in
proteins in vitro
in vitro we
vitro we observed
we observed the
observed the loss
the loss of
loss of the
of the bound
the bound NFATp/AP-1-DNA
bound NFATp/AP-1-DNA complex
NFATp/AP-1-DNA complex upon
complex upon inclusion
upon inclusion of
inclusion of VDR
of VDR or
VDR or VDR-retinoid
or VDR-retinoid X
VDR-retinoid X receptor
Order of addition
of addition and
addition and off-rate
and off-rate experiments
off-rate experiments indicate
experiments indicate that
indicate that the
that the VDR-retinoid
the VDR-retinoid X
VDR-retinoid X receptor
X receptor heterodimer
receptor heterodimer blocks
heterodimer blocks NFATp/AP-1
blocks NFATp/AP-1 complex
NFATp/AP-1 complex formation
complex formation and
formation and then
and then stably
then stably associates
stably associates with
associates with the
with the NF-AT-1
the NF-AT-1 element
This direct inhibition
direct inhibition by
inhibition by a
by a nuclear
a nuclear hormone
nuclear hormone receptor
hormone receptor of
receptor of transcriptional
of transcriptional activators
transcriptional activators of
activators of the
of the IL-2
the IL-2 gene
IL-2 gene may
gene may provide
may provide a
provide a mechanistic
a mechanistic explanation
mechanistic explanation of
explanation of how
of how vitamin
how vitamin derivatives
vitamin derivatives can
derivatives can act
can act as
act as potent
as potent immunosuppressive
potent immunosuppressive agents
Tissue-specific regulation of
regulation of the
of the rabbit
the rabbit 15-lipoxygenase
rabbit 15-lipoxygenase gene
15-lipoxygenase gene in
gene in erythroid
in erythroid cells
erythroid cells by
cells by a
by a transcriptional
a transcriptional silencer
The 15-lipoxygenase lox
15-lipoxygenase lox gene
lox gene is
gene is expressed
is expressed in
expressed in a
in a tissue-specific
a tissue-specific manner
tissue-specific manner predominantly
manner predominantly in
predominantly in erythroid
in erythroid cells
erythroid cells but
cells but also
but also in
also in airway
in airway epithelial
airway epithelial cells
epithelial cells and
cells and eosinophils
We demonstrate in
demonstrate in this
in this report
this report that
report that the
that the 5'
the 5' flanking
5' flanking DNA
flanking DNA of
DNA of the
of the 15-lox
the 15-lox gene
15-lox gene contains
gene contains sequences
contains sequences which
sequences which down-regulate
which down-regulate its
down-regulate its activity
its activity in
activity in a
in a variety
a variety of
variety of non-erythroid
of non-erythroid cell
non-erythroid cell lines
cell lines but
lines but not
but not in
not in two
in two erythroid
two erythroid cell
erythroid cell lines
The element has
element has characteristics
has characteristics of
characteristics of a
of a transcriptional
a transcriptional 'silencer'
transcriptional 'silencer' since
'silencer' since it
since it functions
it functions in
functions in both
in both orientations
The main activity
main activity of
activity of the
of the silencer
the silencer has
silencer has been
has been mapped
been mapped to
mapped to the
to the first
the first 900
first 900 bp
900 bp of
bp of 5'
of 5' flanking
5' flanking DNA
flanking DNA which
DNA which contains
which contains nine
contains nine binding
nine binding sites
binding sites for
sites for a
for a nuclear
a nuclear factor
nuclear factor present
factor present in
present in non-erythroid
in non-erythroid cells
non-erythroid cells but
cells but not
but not in
not in erythroid
in erythroid cells
These binding sites
binding sites have
sites have similar
have similar sequences
similar sequences and
sequences and multiple
and multiple copies
multiple copies of
copies of the
of the binding
the binding sites
binding sites confer
sites confer tissue-specific
confer tissue-specific down-regulation
tissue-specific down-regulation when
down-regulation when attached
when attached to
attached to a
to a minimal
a minimal lox
minimal lox promoter
lox promoter fragment
The 5' flanking
5' flanking DNA
flanking DNA also
DNA also contains
also contains a
contains a cluster
a cluster of
cluster of three
of three binding
three binding sites
binding sites for
sites for the
for the GATA
the GATA family
GATA family of
family of transcription
of transcription factors
Phosphorylation of the
of the transcription
the transcription factor
transcription factor NFATp
factor NFATp inhibits
NFATp inhibits its
inhibits its DNA
its DNA binding
DNA binding activity
binding activity in
activity in cyclosporin
in cyclosporin A-treated
cyclosporin A-treated human
A-treated human B
human B and
B and T
and T cells
Cyclosporin A CsA
A CsA exerts
CsA exerts its
exerts its immunosuppressive
its immunosuppressive effect
immunosuppressive effect by
effect by inhibiting
by inhibiting the
inhibiting the activity
the activity of
activity of nuclear
of nuclear factor
nuclear factor of
factor of activated
of activated T
activated T cells
T cells NFAT
cells NFAT thus
NFAT thus preventing
thus preventing transcriptional
preventing transcriptional induction
transcriptional induction of
induction of several
of several cytokine
several cytokine genes
This effect is
effect is thought
is thought to
thought to be
to be largely
be largely mediated
largely mediated through
mediated through inactivation
through inactivation of
inactivation of the
of the phosphatase
the phosphatase calcineurin
phosphatase calcineurin which
calcineurin which in
which in turn
in turn inhibits
turn inhibits translocation
inhibits translocation of
translocation of an
of an NFAT
an NFAT component
NFAT component to
component to the
to the nucleus
Here we report
we report that
report that CsA
that CsA treatment
CsA treatment of
treatment of Raji
of Raji B
Raji B and
B and Jurkat
and Jurkat T
Jurkat T cell
T cell lines
cell lines yields
lines yields a
yields a phosphorylated
a phosphorylated form
phosphorylated form of
form of NFATp
of NFATp that
NFATp that is
that is inhibited
is inhibited in
inhibited in DNA-binding
in DNA-binding and
DNA-binding and in
and in its
in its ability
its ability to
ability to form
to form an
form an NFAT
an NFAT complex
NFAT complex with
complex with Fos
with Fos and
Fos and Jun
Immunoblot analyses and
analyses and metabolic
and metabolic labeling
metabolic labeling with
labeling with [32P]orthophosphate
with [32P]orthophosphate show
[32P]orthophosphate show that
show that CsA
that CsA alters
CsA alters NFATp
alters NFATp migration
NFATp migration on
migration on SDS-polyacrylamide
on SDS-polyacrylamide gel
SDS-polyacrylamide gel electrophoresis
gel electrophoresis by
electrophoresis by increasing
by increasing its
increasing its phosphorylation
its phosphorylation level
phosphorylation level without
level without affecting
without affecting subcellular
affecting subcellular distribution
Dephosphorylation by in
by in vitro
in vitro treatment
vitro treatment with
treatment with calcineurin
with calcineurin or
calcineurin or alkaline
or alkaline phosphatase
alkaline phosphatase restores
phosphatase restores NFATp
restores NFATp DNA
NFATp DNA binding
DNA binding activity
binding activity and
activity and its
and its ability
its ability to
ability to reconstitute
to reconstitute an
reconstitute an NFAT
an NFAT complex
NFAT complex with
complex with Fos
with Fos and
Fos and Jun
and Jun proteins
These data point
data point to
point to a
to a new
a new mechanism
new mechanism for
mechanism for CsA-sensitive
for CsA-sensitive regulation
CsA-sensitive regulation of
regulation of NFATp
of NFATp in
NFATp in which
in which dephosphorylation
which dephosphorylation is
dephosphorylation is critical
is critical for
critical for DNA
for DNA binding
Transcription factors as
factors as targets
as targets for
targets for oxidative
for oxidative signalling
oxidative signalling during
signalling during lymphocyte
during lymphocyte activation
We previously have
previously have demonstrated
have demonstrated a
demonstrated a requirement
a requirement for
requirement for oxidative
for oxidative events
oxidative events during
events during cell
during cell cycle
cell cycle entry
cycle entry in
entry in T
in T lymphocytes
T lymphocytes and
lymphocytes and have
and have hypothesised
have hypothesised that
hypothesised that reactive
that reactive oxygen
reactive oxygen species
oxygen species may
species may act
may act as
act as intracellular
as intracellular signalling
intracellular signalling agents
signalling agents during
agents during lymphocyte
during lymphocyte activation
In the current
the current study
current study cysteamine
study cysteamine an
cysteamine an aminothiol
an aminothiol compound
aminothiol compound with
compound with antioxidant
with antioxidant activity
antioxidant activity has
activity has been
has been used
been used to
used to further
to further investigate
further investigate the
investigate the role
the role of
role of oxidative
of oxidative signalling
oxidative signalling during
signalling during lymphocyte
during lymphocyte activation
Treatment of normal
of normal human
normal human peripheral
human peripheral blood
peripheral blood lymphocytes
blood lymphocytes with
lymphocytes with cysteamine
with cysteamine in
cysteamine in vitro
in vitro was
vitro was found
was found to
found to inhibit
to inhibit proliferation
inhibit proliferation in
proliferation in a
in a dose-dependent
a dose-dependent manner
dose-dependent manner with
manner with essentially
with essentially complete
essentially complete inhibition
complete inhibition occurring
inhibition occurring at
occurring at a
at a dose
a dose of
dose of 400
of 400 microM
This inhibitory effect
inhibitory effect was
effect was limited
was limited to
limited to the
to the first
the first 2
first 2 h
2 h after
h after mitogenic
after mitogenic activation
mitogenic activation localizing
activation localizing the
localizing the time-frame
the time-frame of
time-frame of action
of action of
action of cysteamine
of cysteamine to
cysteamine to within
to within the
within the commitment
the commitment period
It therefore was
therefore was of
was of interest
of interest to
interest to establish
to establish which
establish which if
which if any
if any commitment
any commitment events
commitment events were
events were affected
were affected by
affected by oxidative
by oxidative signalling
oxidative signalling during
signalling during cell
during cell cycle
cell cycle entry
Taking the IL-2
the IL-2 gene
IL-2 gene as
gene as a
as a candidate
a candidate we
candidate we examined
we examined the
examined the effect
the effect of
effect of cysteamine
of cysteamine treatment
cysteamine treatment on
treatment on early
on early gene
early gene expression
gene expression during
expression during lymphocyte
during lymphocyte activation
lymphocyte activation and
activation and on
and on the
on the activity
the activity of
activity of transcription
of transcription factors
transcription factors AP-1
factors AP-1 NF-kappa
AP-1 NF-kappa B
NF-kappa B NF-AT
B NF-AT and
NF-AT and Oct1
and Oct1 whose
Oct1 whose functions
whose functions are
functions are required
are required for
required for expression
for expression of
expression of the
of the IL-2
the IL-2 mRNA
Cysteamine treatment inhibited
treatment inhibited both
inhibited both expression
both expression of
expression of the
of the IL-2
the IL-2 mRNA
IL-2 mRNA and
mRNA and secretion
and secretion of
secretion of IL-2
of IL-2 into
IL-2 into the
into the culture
the culture medium
The inhibitory effect
inhibitory effect of
effect of cysteamine
of cysteamine may
cysteamine may be
may be mediated
be mediated at
mediated at least
at least in
least in part
in part by
part by an
by an effect
an effect on
effect on transcription
on transcription factor
transcription factor function
factor function as
function as the
as the DNA
the DNA binding
DNA binding activities
binding activities of
activities of AP-1
of AP-1 and
AP-1 and NF-kappa
and NF-kappa B
NF-kappa B extracted
B extracted from
extracted from mitogen-stimulated
from mitogen-stimulated cells
mitogen-stimulated cells were
cells were significantly
were significantly inhibited
significantly inhibited by
inhibited by cysteamine
by cysteamine treatment
Interestingly Oct1 and
Oct1 and NF-AT
and NF-AT DNA
NF-AT DNA binding
DNA binding activity
binding activity were
activity were not
were not affected
not affected by
affected by cysteamine
by cysteamine treatment
cysteamine treatment suggesting
treatment suggesting that
suggesting that oxidative
that oxidative signalling
oxidative signalling processes
signalling processes operate
processes operate in
operate in a
in a selective
a selective manner
The identification of
identification of regulatory
of regulatory proteins
regulatory proteins such
proteins such as
such as transcription
as transcription factors
transcription factors as
factors as molecular
as molecular targets
molecular targets for
targets for oxidative
for oxidative signalling
oxidative signalling provides
signalling provides further
provides further evidence
further evidence to
evidence to implicate
to implicate oxidative
implicate oxidative signalling
oxidative signalling as
signalling as being
as being intimately
being intimately involved
intimately involved in
involved in the
in the G0
the G0 to
G0 to G1
to G1 phase
G1 phase transition
phase transition in
transition in T
in T lymphocytes
Sex and age
and age distribution
age distribution of
distribution of 125OH2D3
of 125OH2D3 receptors
125OH2D3 receptors in
receptors in peripheral
in peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells from
cells from normal
from normal human
normal human subjects
Specific receptors for
receptors for 125
for 125 Dihydroxyvitamin
125 Dihydroxyvitamin D3
Dihydroxyvitamin D3 have
D3 have been
have been described
been described in
described in human
in human peripheral
human peripheral blood
peripheral blood mononuclear
blood mononuclear cells
mononuclear cells PBMC
We have tried
have tried to
tried to find
to find out
find out whether
out whether these
whether these receptors
these receptors could
receptors could show
could show any
show any difference
any difference in
difference in sex
in sex or
sex or age
or age distribution
Twenty two healthy
two healthy men
healthy men aged
men aged 21-66
aged 21-66 yr
21-66 yr mean
yr mean +/-
mean +/- SD
+/- SD 410
SD 410 +/-
410 +/- 136
+/- 136 and
136 and nineteen
and nineteen healthy
nineteen healthy women
healthy women aged
women aged 22-60
aged 22-60 yr
22-60 yr 389
yr 389 +/-
389 +/- 139
+/- 139 have
139 have been
have been studied
The mean dissociation
mean dissociation constant
dissociation constant Kd
constant Kd was
Kd was similar
was similar in
similar in both
in both sexes
both sexes 135
sexes 135 +/-
135 +/- 070
+/- 070 x
070 x 10-10
x 10-10 M
10-10 M in
M in males
in males 113
males 113 +/-
113 +/- 066
+/- 066 x
066 x 10-10
x 10-10 M
10-10 M in
M in females
in females but
females but the
but the concentration
the concentration of
concentration of binding
of binding sites
binding sites Nmax
sites Nmax was
Nmax was significantly
was significantly lower
significantly lower in
lower in females
in females 232
females 232 +/-
232 +/- 092
+/- 092 fmol/107
092 fmol/107 PBMC
fmol/107 PBMC vs
PBMC vs 443
vs 443 +/-
443 +/- 138
+/- 138 fmol/107
138 fmol/107 PBMC
fmol/107 PBMC in
PBMC in males;
in males; p
males; p =
p = 00001
Neither Kd nor
Kd nor Nmax
nor Nmax were
Nmax were significantly
were significantly correlated
significantly correlated with
correlated with age
No difference was
difference was found
was found between
found between pre
between pre and
pre and postmenopausal
and postmenopausal women
Further studies are
studies are needed
are needed to
needed to elucidate
to elucidate if
elucidate if this
if this sex
this sex difference
sex difference in
difference in PBMC
in PBMC receptors
PBMC receptors for
receptors for 125
for 125 Dihydroxyvitamin
125 Dihydroxyvitamin D3
Dihydroxyvitamin D3 is
D3 is of
is of any
of any pathophysiological
any pathophysiological relevance
Expression of Id2
of Id2 and
Id2 and Id3
and Id3 mRNA
Id3 mRNA in
mRNA in human
in human lymphocytes
Helix-loop-helix HLH transcription
HLH transcription factors
transcription factors are
factors are involved
are involved in
involved in cellular
in cellular growth
cellular growth and
growth and differentiation
The Id inhibitor
Id inhibitor of
inhibitor of DNA
of DNA binding
DNA binding and
binding and differentiation
and differentiation HLH
differentiation HLH proteins
HLH proteins in
proteins in a
in a dominantly
a dominantly negative
dominantly negative fashion
negative fashion regulate
fashion regulate transcriptional
regulate transcriptional activities
transcriptional activities of
activities of basic
of basic HLH
basic HLH proteins
We examined by
examined by northern
by northern hybridization
northern hybridization the
hybridization the expression
the expression of
expression of Id2
of Id2 and
Id2 and Id3
and Id3 mRNA
Id3 mRNA in
mRNA in human
in human leukemia/lymphoma
human leukemia/lymphoma lines
leukemia/lymphoma lines and
lines and patient
and patient samples
patient samples as
samples as well
as well as
well as resting
as resting and
resting and activated
and activated normal
activated normal human
normal human lymphocytes
human lymphocytes from
lymphocytes from peripheral
from peripheral blood
peripheral blood PBL
The Id2 mRNA
Id2 mRNA was
mRNA was abundantly
was abundantly expressed
abundantly expressed in
expressed in 5/12
in 5/12 T-cell
5/12 T-cell and
T-cell and 3/4
and 3/4 B-cell
3/4 B-cell lines
B-cell lines and
lines and Id3
and Id3 mRNA
Id3 mRNA was
mRNA was detected
was detected in
detected in 4/12
in 4/12 T-cell
4/12 T-cell and
T-cell and 3/4
and 3/4 B-cell
3/4 B-cell lines
Interestingly Id2 but
Id2 but not
but not Id3
not Id3 mRNA
Id3 mRNA was
mRNA was strongly
was strongly expressed
strongly expressed in
expressed in 4/5
in 4/5 T-cell
4/5 T-cell lines
T-cell lines infected
lines infected with
infected with human
with human T-cell
human T-cell leukemia
T-cell leukemia virus
leukemia virus type
virus type I
type I HTLV-I
I HTLV-I ATL-1k
HTLV-I ATL-1k MT-2
ATL-1k MT-2 S-LB1
MT-2 S-LB1 and
S-LB1 and type
and type II
type II Mo
Another unexpected finding
unexpected finding was
finding was that
was that T-cell
that T-cell leukemias
T-cell leukemias and
leukemias and T-cell
and T-cell lines
T-cell lines often
lines often expressed
often expressed either
expressed either Id2
either Id2 or
Id2 or Id3
or Id3 mRNA
In addition resting
addition resting PBL
resting PBL constitutively
PBL constitutively expressed
constitutively expressed prominent
expressed prominent levels
prominent levels of
levels of Id2
of Id2 mRNA
Id2 mRNA but
mRNA but not
but not Id3
not Id3 mRNA
Upon PHA-stimulation Id2
PHA-stimulation Id2 expression
Id2 expression decreased
expression decreased and
decreased and Id3
and Id3 levels
Id3 levels increased
levels increased with
increased with biphasic
with biphasic kinetics
Taken together our
together our studies
our studies revealed
studies revealed three
revealed three unexpected
three unexpected findings
unexpected findings which
findings which require
which require further
require further analysis:
further analysis: 1
analysis: 1 expression
1 expression of
expression of Id2
of Id2 mRNA
Id2 mRNA is
mRNA is often
is often associated
often associated with
associated with lymphocytic
with lymphocytic transformation
lymphocytic transformation by
transformation by HTLV-I
by HTLV-I or
HTLV-I or -II;
or -II; 2
-II; 2 T-cells
2 T-cells usually
T-cells usually express
usually express either
express either Id2
either Id2 or
Id2 or Id3
or Id3 mRNA
Id3 mRNA but
mRNA but B-cells
but B-cells often
B-cells often express
often express both
express both simultaneously;
both simultaneously; 3
simultaneously; 3 non-dividing
3 non-dividing normal
non-dividing normal PBL
normal PBL express
PBL express high
express high levels
high levels of
levels of Id2
of Id2 and
Id2 and no
and no Id3
no Id3 mRNA;
Id3 mRNA; and
mRNA; and with
and with the
with the onset
the onset of
onset of cellular
of cellular proliferation
cellular proliferation levels
proliferation levels of
levels of Id2
of Id2 mRNA
Id2 mRNA decrease
mRNA decrease while
decrease while levels
while levels of
levels of Id3
of Id3 mRNA
Id3 mRNA increase
mRNA increase suggesting
increase suggesting that
suggesting that regulation
that regulation of
regulation of expression
of expression of
expression of these
of these closely
these closely related
closely related genes
related genes is
genes is disparate
Salicylates inhibit lipopolysaccharide-induced
inhibit lipopolysaccharide-induced transcriptional
lipopolysaccharide-induced transcriptional activation
transcriptional activation of
activation of the
of the tissue
the tissue factor
tissue factor gene
factor gene in
gene in human
in human monocytic
human monocytic cells
Binding of plasma
of plasma Factor
plasma Factor VII/VIIa
Factor VII/VIIa to
VII/VIIa to the
to the tissue
the tissue factor
tissue factor TF
factor TF receptor
TF receptor initiates
receptor initiates the
initiates the coagulation
the coagulation protease
coagulation protease cascades
TF expression by
expression by circulating
by circulating monocytes
circulating monocytes is
monocytes is associated
is associated with
associated with thrombotic
with thrombotic and
thrombotic and inflammatory
and inflammatory complications
inflammatory complications in
complications in a
in a variety
a variety of
variety of diseases
Transcriptional activation of
activation of the
of the human
the human TF
human TF gene
TF gene in
gene in monocytic
in monocytic cells
monocytic cells exposed
cells exposed to
exposed to bacterial
to bacterial lipopolysaccharide
bacterial lipopolysaccharide LPS
lipopolysaccharide LPS is
LPS is mediated
is mediated by
mediated by binding
by binding of
binding of c-Rel/p65
of c-Rel/p65 heterodimers
c-Rel/p65 heterodimers to
heterodimers to a
to a kappa
a kappa B
kappa B site
B site in
site in the
in the TF
the TF promoter
Here we report
we report that
report that a
that a family
a family of
family of anti-inflammatory
of anti-inflammatory agents
anti-inflammatory agents known
agents known as
known as the
as the salicylates
the salicylates inhibited
salicylates inhibited LPS
inhibited LPS induction
LPS induction of
induction of TF
of TF activity
TF activity and
activity and TF
and TF gene
TF gene transcription
gene transcription in
transcription in human
in human monocytes
human monocytes and
monocytes and monocytic
and monocytic THP-1
monocytic THP-1 cells
THP-1 cells at
cells at clinically
at clinically relevant
clinically relevant doses
Furthermore sodium salicylate
sodium salicylate blocked
salicylate blocked the
blocked the LPS-induced
the LPS-induced proteolytic
LPS-induced proteolytic degradation
proteolytic degradation of
degradation of I
of I kappa
I kappa B
kappa B alpha
B alpha which
alpha which prevented
which prevented the
prevented the nuclear
the nuclear translocation
nuclear translocation of
translocation of c-Rel/p65
of c-Rel/p65 heterodimers
In contrast two
contrast two other
two other nonsteroidal
other nonsteroidal anti-inflammatory
nonsteroidal anti-inflammatory drugs
anti-inflammatory drugs ibuprofen
drugs ibuprofen and
ibuprofen and indomethacin
and indomethacin did
indomethacin did not
did not inhibit
not inhibit LPS
inhibit LPS induction
LPS induction of
induction of the
of the TF
the TF gene
These results indicated
results indicated that
indicated that salicylates
that salicylates inhibited
salicylates inhibited LPS
inhibited LPS induction
LPS induction of
induction of TF
of TF gene
TF gene transcription
gene transcription in
transcription in monocytic
in monocytic cells
monocytic cells by
cells by preventing
by preventing nuclear
preventing nuclear translocation
nuclear translocation of
translocation of c-Rel/p65
of c-Rel/p65 heterodimers
The clinical benefits
clinical benefits of
benefits of salicylates
of salicylates in
salicylates in the
in the treatment
the treatment of
treatment of several
of several diseases
several diseases including
diseases including atherosclerosis
including atherosclerosis and
atherosclerosis and rheumatoid
and rheumatoid arthritis
rheumatoid arthritis may
arthritis may be
may be related
be related to
related to their
to their ability
their ability to
ability to reduce
to reduce monocyte
reduce monocyte gene
monocyte gene expression
Activation of the
of the signal
the signal transducer
signal transducer and
transducer and transcription
and transcription STAT
transcription STAT signaling
STAT signaling pathway
signaling pathway in
pathway in a
in a primary
a primary T
primary T cell
T cell response
Critical role for
role for IL-6
The T cell
T cell activation
cell activation is
activation is initiated
is initiated by
initiated by interaction
by interaction of
interaction of specific
of specific Ags
specific Ags with
Ags with TCR
with TCR followed
TCR followed by
followed by activation
by activation of
activation of intracellular
of intracellular biochemical
intracellular biochemical events
biochemical events leading
events leading to
leading to activation
to activation of
activation of several
of several genes
The activation of
activation of signal
of signal transducer
signal transducer and
transducer and activator
and activator of
activator of transcription
of transcription STAT
transcription STAT proteins
STAT proteins in
proteins in a
in a primary
a primary TCR-mediated
primary TCR-mediated activation
TCR-mediated activation of
activation of T
of T cells
T cells have
cells have been
have been explored
In purified human
purified human peripheral
human peripheral blood
peripheral blood T
blood T cells
T cells nuclear
cells nuclear STAT
nuclear STAT proteins
STAT proteins were
proteins were activated
were activated approximately
activated approximately 3
approximately 3 h
3 h after
h after activation
after activation by
activation by cross-linked
by cross-linked anti-CD3
cross-linked anti-CD3 Abs
These STAT proteins
STAT proteins were
proteins were detected
were detected by
detected by using
by using the
using the IFN-gamma-activated
the IFN-gamma-activated sequence
IFN-gamma-activated sequence GAS
sequence GAS and
GAS and related
and related oligonucleotides
related oligonucleotides as
oligonucleotides as probes
as probes in
probes in electrophoretic
in electrophoretic mobility
electrophoretic mobility shift
mobility shift assay
Analysis of the
of the nuclear
the nuclear extracts
nuclear extracts with
extracts with anti-STAT
with anti-STAT Abs
anti-STAT Abs indicated
Abs indicated that
indicated that they
that they contained
they contained STAT-3
contained STAT-3 and
STAT-3 and additional
and additional proteins
additional proteins crossreactive
proteins crossreactive with
crossreactive with the
with the STAT
the STAT family
The induction of
induction of STAT
of STAT activity
STAT activity was
activity was inhibited
was inhibited completely
inhibited completely by
completely by pretreatment
by pretreatment with
pretreatment with either
with either cycloheximide
either cycloheximide or
cycloheximide or cyclosporin
or cyclosporin A
cyclosporin A thus
A thus indicating
thus indicating that
indicating that the
that the induction
the induction was
induction was due
was due to
due to a
to a secondary
a secondary factor
secondary factor produced
factor produced by
produced by the
by the activated
the activated T
activated T cells
As neutralizing anti-IL-6
neutralizing anti-IL-6 Abs
anti-IL-6 Abs effectively
Abs effectively down-regulated
effectively down-regulated the
down-regulated the early
the early induction
early induction of
induction of STAT
of STAT proteins
STAT proteins and
proteins and as
and as exogenously
as exogenously added
exogenously added IL-6
added IL-6 rapidly
IL-6 rapidly activated
rapidly activated DNA
activated DNA binding
DNA binding similar
binding similar to
similar to TCR-mediated
to TCR-mediated bindings
TCR-mediated bindings it
bindings it can
it can be
can be concluded
be concluded that
concluded that IL-6
that IL-6 is
IL-6 is the
is the factor
the factor responsible
factor responsible for
responsible for the
for the activation
the activation of
activation of STAT
of STAT proteins
STAT proteins in
proteins in a
in a primary
a primary T
primary T cell
T cell response
The normal cell
normal cell cycle
cell cycle activation
cycle activation program
activation program is
program is exploited
is exploited during
exploited during the
during the infection
the infection of
infection of quiescent
of quiescent B
quiescent B lymphocytes
B lymphocytes by
lymphocytes by Epstein-Barr
by Epstein-Barr virus
B lymphocytes in
lymphocytes in the
in the peripheral
the peripheral circulation
peripheral circulation are
circulation are maintained
are maintained in
maintained in a
in a non-proliferative
a non-proliferative state
Antigen recognition stimulates
recognition stimulates limited
stimulates limited proliferation
limited proliferation whereas
proliferation whereas infection
whereas infection with
infection with Epstein-Barr
with Epstein-Barr virus
Epstein-Barr virus EBV
virus EBV results
EBV results in
results in continual
in continual proliferation
continual proliferation and
proliferation and the
and the outgrowth
the outgrowth of
outgrowth of immortal
of immortal cell
immortal cell lines
Because it is
it is not
is not clear
not clear at
clear at which
at which point
which point in
point in cell
in cell cycle
cell cycle the
cycle the peripheral
the peripheral B
peripheral B lymphocytes
B lymphocytes are
lymphocytes are arrested
are arrested we
arrested we characterized
we characterized the
characterized the expression
the expression of
expression of several
of several cell
several cell cycle-associated
cell cycle-associated genes
cycle-associated genes in
genes in quiescent
in quiescent and
quiescent and stimulated
and stimulated cells
We show that
show that the
that the expression
the expression of
expression of four
of four cell
four cell genes
cell genes cdc-2
genes cdc-2 cyclin
cdc-2 cyclin E
cyclin E CD23
E CD23 and
CD23 and cyclin
and cyclin D2
cyclin D2 are
D2 are up-regulated
are up-regulated approximately
up-regulated approximately 100-fold
approximately 100-fold as
100-fold as a
as a result
a result of
result of EBV-mediated
of EBV-mediated immortalization
Because these genes
these genes play
genes play a
play a positive
a positive role
positive role in
role in cell
in cell proliferation
cell proliferation we
proliferation we suggest
we suggest that
suggest that this
that this regulatory
this regulatory switch
regulatory switch contributes
switch contributes to
contributes to controlling
to controlling entry
controlling entry into
entry into the
into the cell
the cell cycle
Transient stimulation of
stimulation of quiescent
of quiescent B
quiescent B lymphocytes
B lymphocytes with
lymphocytes with either
with either a
either a cocktail
a cocktail of
cocktail of anti-CD40
of anti-CD40 anti-IgM
anti-CD40 anti-IgM and
anti-IgM and IL4
and IL4 or
IL4 or EBV
or EBV results
EBV results in
results in the
in the rapid
the rapid expression
rapid expression of
expression of the
of the same
the same four
same four genes
four genes suggesting
genes suggesting that
suggesting that after
that after infection
after infection EBV
infection EBV exploits
EBV exploits the
exploits the normal
the normal program
normal program of
program of B-lymphocyte
of B-lymphocyte cell
B-lymphocyte cell cycle
cell cycle activation
Expression of the
of the chemokine
the chemokine receptor
chemokine receptor BLR2/EBI1
receptor BLR2/EBI1 is
BLR2/EBI1 is specifically
is specifically transactivated
specifically transactivated by
transactivated by Epstein-Barr
by Epstein-Barr virus
Epstein-Barr virus nuclear
virus nuclear antigen
nuclear antigen 2
In our attempt
our attempt to
attempt to identify
to identify chemokine
identify chemokine receptors
chemokine receptors that
receptors that are
that are related
are related to
related to Burkitt's
to Burkitt's lymphoma
Burkitt's lymphoma receptor
lymphoma receptor 1
receptor 1 BLR1
1 BLR1 and
BLR1 and are
and are expressed
are expressed in
expressed in activated
in activated lymphocytes
activated lymphocytes we
lymphocytes we used
we used RT-PCR
used RT-PCR resulting
RT-PCR resulting in
resulting in the
in the isolation
the isolation of
isolation of a
of a cDNA
a cDNA encoding
cDNA encoding a
encoding a seven
a seven transmembrane
seven transmembrane receptor
transmembrane receptor termed
receptor termed BLR2
The protein shows
protein shows significant
shows significant sequence
significant sequence similarities
sequence similarities to
similarities to the
to the family
the family of
family of G-protein
of G-protein coupled
G-protein coupled chemokine
coupled chemokine receptors
chemokine receptors and
receptors and turned
and turned out
turned out to
out to be
to be identical
be identical to
identical to the
to the recently
the recently described
recently described receptor
described receptor EBI1
Northern blot analysis
blot analysis revealed
analysis revealed that
revealed that BLR2
that BLR2 mRNA
BLR2 mRNA could
mRNA could be
could be highly
be highly stimulated
highly stimulated in
stimulated in mitogen-
in mitogen- and
mitogen- and anti-CD3-treated
and anti-CD3-treated peripheral
anti-CD3-treated peripheral blood
peripheral blood lymphocytes
BLR2-specific mRNA could
mRNA could be
could be detected
be detected in
detected in all
in all Epstein-Barr
all Epstein-Barr virus
Epstein-Barr virus positive
virus positive B
positive B cell
B cell lines
We show that
show that transcription
that transcription of
transcription of the
of the BLR2
the BLR2 gene
BLR2 gene could
gene could be
could be specifically
be specifically induced
specifically induced in
induced in Epstein-Barr
in Epstein-Barr virus
Epstein-Barr virus negative
virus negative BL
negative BL 41
BL 41 cells
41 cells via
cells via estrogen-mediated
via estrogen-mediated activation
estrogen-mediated activation of
activation of Epstein-Barr
of Epstein-Barr virus
Epstein-Barr virus nuclear
virus nuclear antigen
nuclear antigen 2
antigen 2 a
2 a key
a key regulator
key regulator of
regulator of viral
of viral and
viral and cellular
and cellular genes
cellular genes in
genes in immortalized
in immortalized B
immortalized B cells
Our data suggest
data suggest an
suggest an involvement
an involvement of
involvement of BLR2
of BLR2 in
BLR2 in the
in the regulation
the regulation of
regulation of migration
of migration in
migration in activated
in activated lymphocytes
activated lymphocytes and
lymphocytes and in
and in viral
in viral pathogenesis
A central role
central role for
role for a
for a single
a single c-Myb
single c-Myb binding
c-Myb binding site
binding site in
site in a
in a thymic
a thymic locus
thymic locus control
locus control region
Locus control regions
control regions LCRs
regions LCRs are
LCRs are powerful
are powerful assemblies
powerful assemblies of
assemblies of cis
of cis elements
cis elements that
elements that organize
that organize the
organize the actions
the actions of
actions of cell-type-specific
of cell-type-specific trans-acting
cell-type-specific trans-acting factors
A 23-kb LCR
23-kb LCR in
LCR in the
in the human
the human adenosine
human adenosine deaminase
adenosine deaminase ADA
deaminase ADA gene
ADA gene first
gene first intron
first intron which
intron which controls
which controls expression
controls expression in
expression in thymocytes
in thymocytes is
thymocytes is composed
is composed of
composed of a
of a 200-bp
a 200-bp enhancer
200-bp enhancer domain
enhancer domain and
domain and extended
and extended flanking
extended flanking sequences
flanking sequences that
sequences that facilitate
that facilitate activation
facilitate activation from
activation from within
from within chromatin
Prior analyses have
analyses have demonstrated
have demonstrated that
demonstrated that the
that the enhancer
the enhancer contains
enhancer contains a
contains a 28-bp
a 28-bp core
28-bp core region
core region and
region and local
and local adjacent
local adjacent augmentative
adjacent augmentative cis
augmentative cis elements
We now show
now show that
show that the
that the core
the core contains
core contains a
contains a single
a single critical
single critical c-Myb
critical c-Myb binding
c-Myb binding site
In both transiently
both transiently cotransfected
transiently cotransfected human
cotransfected human cells
human cells and
cells and stable
and stable chromatin-integrated
stable chromatin-integrated yeast
chromatin-integrated yeast cells
yeast cells c-Myb
cells c-Myb strongly
c-Myb strongly transactivated
strongly transactivated reporter
transactivated reporter constructs
reporter constructs that
constructs that contained
that contained polymerized
contained polymerized core
polymerized core sequences
c-Myb protein was
protein was strongly
was strongly evident
strongly evident in
evident in T
in T lymphoblasts
T lymphoblasts in
lymphoblasts in which
in which the
which the enhancer
the enhancer was
enhancer was active
was active and
active and was
and was localized
was localized within
localized within discrete
within discrete nuclear
discrete nuclear structures
Fetal murine thymus
murine thymus exhibited
thymus exhibited a
exhibited a striking
a striking concordance
striking concordance of
concordance of endogenous
of endogenous c-myb
endogenous c-myb expression
c-myb expression with
expression with that
with that of
that of mouse
of mouse ADA
mouse ADA and
ADA and human
and human ADA
human ADA LCR-directed
ADA LCR-directed transgene
LCR-directed transgene expression
Point mutation of
mutation of the
of the c-Myb
the c-Myb site
c-Myb site within
site within the
within the intact
the intact 23-kb
intact 23-kb LCR
23-kb LCR severely
LCR severely attenuated
severely attenuated enhancer
attenuated enhancer activity
enhancer activity in
activity in transfections
in transfections and
transfections and LCR
and LCR activity
LCR activity in
activity in transgenic
in transgenic thymocytes
Within the context
the context of
context of a
of a complex
a complex enhancer
complex enhancer and
enhancer and LCR
and LCR c-Myb
LCR c-Myb can
c-Myb can act
can act as
act as an
as an organizer
an organizer of
organizer of thymocyte-specific
of thymocyte-specific gene
thymocyte-specific gene expression
gene expression via
expression via a
via a single
a single binding
single binding site
A regulatory element
regulatory element in
element in the
in the human
the human interleukin
human interleukin 2
interleukin 2 gene
2 gene promoter
gene promoter is
promoter is a
is a binding
a binding site
binding site for
site for the
for the zinc
the zinc finger
zinc finger proteins
finger proteins Sp1
proteins Sp1 and
Sp1 and EGR-1
Activation of the
of the interleukin
the interleukin 2
interleukin 2 IL-2
2 IL-2 gene
IL-2 gene after
gene after antigen
after antigen recognition
antigen recognition is
recognition is a
is a critical
a critical event
critical event for
event for T
for T cell
T cell proliferation
cell proliferation and
proliferation and effector
and effector function
Prior studies have
studies have identified
have identified several
identified several transcription
several transcription factors
transcription factors that
factors that contribute
that contribute to
contribute to the
to the activity
the activity of
activity of the
of the IL-2
the IL-2 promoter
IL-2 promoter in
promoter in stimulated
in stimulated T
stimulated T lymphocytes
Here we describe
we describe a
describe a novel
a novel regulatory
novel regulatory element
regulatory element within
element within the
within the IL-2
the IL-2 promoter
IL-2 promoter located
promoter located immediately
located immediately upstream
immediately upstream of
upstream of the
of the nuclear
the nuclear factor
nuclear factor of
factor of activated
of activated T
activated T cell
T cell NFAT
cell NFAT domain
This region termed
region termed the
termed the zinc
the zinc finger
zinc finger protein
finger protein binding
protein binding region
binding region ZIP
region ZIP serves
ZIP serves as
serves as binding
as binding site
binding site for
site for two
for two differently
two differently regulated
differently regulated zinc
regulated zinc finger
zinc finger proteins:
finger proteins: the
proteins: the constitutively
the constitutively expressed
constitutively expressed transcription
expressed transcription factor
transcription factor Sp1
factor Sp1 and
Sp1 and the
and the inducible
the inducible early
inducible early growth
early growth response
growth response protein
response protein EGR-1
In unstimulated cells
unstimulated cells which
cells which do
which do not
do not secrete
not secrete IL-2
secrete IL-2 only
IL-2 only Sp1
only Sp1 binds
Sp1 binds to
binds to this
to this region
this region while
region while in
while in stimulated
in stimulated IL-2
stimulated IL-2 secreting
IL-2 secreting cells
secreting cells the
cells the inducible
the inducible EGR-1
inducible EGR-1 protein
EGR-1 protein recognizes
protein recognizes this
recognizes this element
In Jurkat T
Jurkat T cells
T cells the
cells the ZIP
the ZIP site
ZIP site serves
site serves as
serves as an
as an activator
an activator for
activator for IL-2
for IL-2 gene
IL-2 gene expression
gene expression and
expression and a
and a combination
a combination of
combination of ZIP
of ZIP and
ZIP and NFAT
and NFAT binding
NFAT binding sites
binding sites is
sites is required
is required for
required for maximal
for maximal IL-2
maximal IL-2 promoter
IL-2 promoter activity
These results suggest
results suggest a
suggest a critical
a critical role
critical role of
role of the
of the ZIP
the ZIP site
ZIP site for
site for IL-2
for IL-2 promoter
IL-2 promoter activity
Activation of the
of the HIV-1
the HIV-1 enhancer
HIV-1 enhancer by
enhancer by the
by the LEF-1
the LEF-1 HMG
LEF-1 HMG protein
HMG protein on
protein on nucleosome-assembled
on nucleosome-assembled DNA
nucleosome-assembled DNA in
DNA in vitro
Lymphoid enhancer-binding factor
enhancer-binding factor 1
factor 1 LEF-1
1 LEF-1 is
LEF-1 is a
is a regulatory
a regulatory high
regulatory high mobility
high mobility group
mobility group HMG
group HMG protein
HMG protein that
protein that activates
that activates the
activates the T
the T cell
T cell receptor
cell receptor alpha
receptor alpha TCR
alpha TCR alpha
TCR alpha enhancer
alpha enhancer in
enhancer in a
in a context-restricted
a context-restricted manner
context-restricted manner in
manner in T
in T cells
In this paper
this paper we
paper we demonstrate
we demonstrate that
demonstrate that the
that the distal
the distal region
distal region of
region of the
of the human
the human immunodeficiency
human immunodeficiency virus-1
immunodeficiency virus-1 HIV-1
virus-1 HIV-1 enhancer
HIV-1 enhancer which
enhancer which contains
which contains DNA-binding
contains DNA-binding sites
DNA-binding sites for
sites for LEF-1
for LEF-1 and
LEF-1 and Ets-1
and Ets-1 also
Ets-1 also provides
also provides a
provides a functional
a functional context
functional context for
context for activation
for activation by
activation by LEF-1
First we show
we show that
show that mutations
that mutations in
mutations in the
in the LEF-1-binding
the LEF-1-binding site
LEF-1-binding site inhibit
site inhibit the
inhibit the activity
the activity of
activity of multimerized
of multimerized copies
multimerized copies of
copies of the
of the HIV-1
the HIV-1 enhancer
HIV-1 enhancer in
enhancer in Jurkat
in Jurkat T
Jurkat T cells
T cells and
cells and that
and that LEF-1/GAL4
that LEF-1/GAL4 can
LEF-1/GAL4 can activate
can activate a
activate a GAL4-substituted
a GAL4-substituted HIV-1
GAL4-substituted HIV-1 enhancer
HIV-1 enhancer 80-
enhancer 80- to
80- to 100-fold
to 100-fold in
100-fold in vivo
Second recombinant LEF-1
recombinant LEF-1 is
LEF-1 is shown
is shown to
shown to activate
to activate HIV-1
activate HIV-1 transcription
HIV-1 transcription on
transcription on chromatin-assembled
on chromatin-assembled DNA
chromatin-assembled DNA in
DNA in vitro
By using a
using a nucleosome-assembly
a nucleosome-assembly system
nucleosome-assembly system derived
system derived from
derived from Drosophila
from Drosophila embryos
Drosophila embryos we
embryos we find
we find that
find that the
that the packaging
the packaging of
packaging of DNA
of DNA into
DNA into chromatin
into chromatin in
chromatin in vitro
in vitro strongly
vitro strongly represses
strongly represses HIV-1
represses HIV-1 transcription
HIV-1 transcription and
transcription and that
and that repression
that repression can
repression can be
can be counteracted
be counteracted efficiently
counteracted efficiently by
efficiently by preincubation
by preincubation of
preincubation of the
of the DNA
the DNA with
DNA with LEF-1
with LEF-1 or
LEF-1 or LEF-1
or LEF-1 and
LEF-1 and Ets-1
and Ets-1 supplemented
Ets-1 supplemented with
supplemented with fractions
with fractions containing
fractions containing the
containing the promoter-binding
the promoter-binding protein
promoter-binding protein Sp1
Addition of TFE-3
of TFE-3 which
TFE-3 which binds
which binds to
binds to an
to an E-box
an E-box motif
E-box motif upstream
motif upstream of
upstream of the
of the LEF-1
the LEF-1 and
LEF-1 and Ets-1
and Ets-1 sites
Ets-1 sites further
sites further augments
further augments transcription
augments transcription in
transcription in this
in this system
Individually or collectively
or collectively none
collectively none of
none of the
of the three
the three enhancer-binding
three enhancer-binding proteins
enhancer-binding proteins LEF-1
proteins LEF-1 Ets-1
LEF-1 Ets-1 and
Ets-1 and TFE-3
and TFE-3 could
TFE-3 could activate
could activate transcription
activate transcription in
transcription in the
in the absence
the absence of
absence of Sp1
A truncation mutant
truncation mutant of
mutant of LEF-1
of LEF-1 HMG-88
LEF-1 HMG-88 which
HMG-88 which contains
which contains the
contains the HMG
the HMG box
HMG box but
box but lacks
but lacks the
lacks the trans-activation
the trans-activation domain
trans-activation domain did
domain did not
did not activate
not activate transcription
activate transcription from
transcription from nucleosomal
from nucleosomal DNA
nucleosomal DNA indicating
DNA indicating that
indicating that bending
that bending of
bending of DNA
of DNA by
DNA by the
by the HMG
the HMG domain
HMG domain is
domain is not
is not sufficient
not sufficient to
sufficient to activate
to activate transcription
activate transcription in
transcription in vitro
We conclude that
conclude that transcription
that transcription activation
transcription activation by
activation by LEF-1
by LEF-1 in
LEF-1 in vitro
in vitro is
vitro is a
is a chromatin-dependent
a chromatin-dependent process
chromatin-dependent process that
process that requires
that requires a
requires a functional
a functional trans-activation
functional trans-activation domain
trans-activation domain in
domain in addition
in addition to
addition to the
to the HMG
the HMG domain
HIV-1 envelope glycoproteins
envelope glycoproteins induce
glycoproteins induce activation
induce activation of
activation of activated
of activated protein-1
activated protein-1 in
protein-1 in CD4+
in CD4+ T
CD4+ T cells
T cells [published
cells [published erratum
[published erratum appears
erratum appears in
appears in J
in J Biol
J Biol Chem
Biol Chem 1995
Chem 1995 Dec
1995 Dec 1;27048:29038]
Activation of CD4
of CD4 positive
CD4 positive T
positive T cells
T cells is
cells is a
is a primary
a primary requirement
primary requirement for
requirement for human
for human immunodeficiency
human immunodeficiency virus
immunodeficiency virus HIV
virus HIV entry
HIV entry efficient
entry efficient HIV
efficient HIV replication
HIV replication and
replication and progression
and progression to
progression to AIDS
to AIDS Utilizing
AIDS Utilizing CD4
Utilizing CD4 positive
CD4 positive T
positive T cell
T cell lines
cell lines and
lines and purified
and purified T
purified T cells
T cells from
cells from normal
from normal individuals
normal individuals we
individuals we have
we have demonstrated
have demonstrated that
demonstrated that native
that native envelope
native envelope glycoproteins
envelope glycoproteins of
glycoproteins of HIV
of HIV gp
HIV gp 160
gp 160 can
160 can induce
can induce activation
induce activation of
activation of transcription
of transcription factor
transcription factor activated
factor activated protein-1
activated protein-1 AP-1
The stimulatory effects
stimulatory effects of
effects of gp160
of gp160 are
gp160 are mediated
are mediated through
mediated through the
through the CD4
the CD4 molecule
CD4 molecule since
molecule since treatment
since treatment of
treatment of gp160
of gp160 with
gp160 with soluble
with soluble CD4-IgG
soluble CD4-IgG abrogates
CD4-IgG abrogates its
abrogates its activity
its activity and
activity and CD4
and CD4 negative
CD4 negative T
negative T cell
T cell lines
cell lines fail
lines fail to
fail to be
to be stimulated
be stimulated with
stimulated with gp160
Immunoprecipitation of the
of the gp
the gp 160-induced
gp 160-induced nuclear
160-induced nuclear extracts
nuclear extracts with
extracts with polyclonal
with polyclonal antibodies
polyclonal antibodies to
antibodies to Fos
to Fos and
Fos and Jun
and Jun proteins
Jun proteins indicates
proteins indicates that
indicates that AP-1
that AP-1 complex
AP-1 complex is
complex is comprised
is comprised of
comprised of members
of members of
members of these
of these family
these family of
family of proteins
The gp160-induced AP-1
gp160-induced AP-1 complex
AP-1 complex is
complex is dependent
is dependent upon
dependent upon protein
upon protein tyrosine
protein tyrosine phosphorylation
tyrosine phosphorylation and
phosphorylation and is
and is protein
is protein synthesis-independent
This stimulation can
stimulation can also
can also be
also be abolished
be abolished by
abolished by inhibitors
by inhibitors of
inhibitors of protein
of protein kinase
protein kinase C
kinase C but
C but it
but it is
it is unaffected
is unaffected by
unaffected by calcium
by calcium channel
calcium channel blocker
channel blocker or
blocker or cyclosporine
or cyclosporine A
This gp160 treatment
gp160 treatment adversely
treatment adversely affects
adversely affects the
affects the functional
the functional capabilities
functional capabilities of
capabilities of T
of T cells:
T cells: pre-treatment
cells: pre-treatment of
pre-treatment of CD4+
of CD4+ T
CD4+ T cells
T cells with
cells with gp160
with gp160 for
gp160 for 4
for 4 h
4 h at
h at 37
at 37 degrees
37 degrees C
degrees C inhibited
C inhibited anti-CD3-induced
inhibited anti-CD3-induced interleukin-2
anti-CD3-induced interleukin-2 secretion
Effects similar to
similar to gp160
to gp160 were
gp160 were seen
were seen with
seen with anti-CD4
with anti-CD4 mAb
The aberrant activation
aberrant activation of
activation of AP-1
of AP-1 by
AP-1 by gp160
by gp160 in
gp160 in CD4
in CD4 positive
CD4 positive T
positive T cells
T cells could
cells could result
could result in
result in up-regulation
in up-regulation of
up-regulation of cytokines
of cytokines containing
cytokines containing AP-1
containing AP-1 sites
AP-1 sites eg
sites eg interleukin-3
eg interleukin-3 and
interleukin-3 and granulocyte
and granulocyte macrophage
granulocyte macrophage colony-stimulating
macrophage colony-stimulating factor
colony-stimulating factor and
factor and concurrently
and concurrently lead
concurrently lead to
lead to T
to T cell
T cell unresponsiveness
cell unresponsiveness by
unresponsiveness by inhibiting
by inhibiting interleukin-2
inhibiting interleukin-2 secretion
